{"data": [{"Element": "<div class=\"WordSection1\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:green'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image001.gif\" width=\"20\"/></span><span lang=\"EN-GB\">This medicinal product is subject\nto additional monitoring. This will allow quick identification of new safety\ninformation. Healthcare professionals are asked to report any suspected adverse\nreactions. See section\u00a04.8 for how to report adverse reactions.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah 1.2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells dispersion for infusion</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND\nQUANTITATIVE COMPOSITION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.1\u00a0\u00a0\u00a0\u00a0 General description</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is an\nimmunocellular therapy containing tisagenlecleucel, autologous T cells\ngenetically modified <i>ex vivo</i> using a lentiviral vector encoding an anti\u2011CD19\nchimeric antigen receptor (CAR).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.2\u00a0\u00a0\u00a0\u00a0 Qualitative and\nquantitative composition</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each </span><span lang=\"EN-GB\">ethylene vinyl acetate (EVA) infusion bag of Kymriah </span><span lang=\"EN-GB\">contains tisagenlecleucel cell dispersion at a batch\u2011dependent\nconcentration of </span><span lang=\"EN-GB\">autologous T cells genetically\nmodified to express an </span><span lang=\"EN-GB\">anti\u2011CD19 chimeric antigen\nreceptor</span><span lang=\"EN-GB\"> (CAR\u2011positive viable T cells) (see section\u00a04.2)</span><span lang=\"EN-GB\" style=\"color:black\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">The concentration of CAR\u2011positive viable T cells is dependent\non indication and patient body weight (for B\u2011cell acute lymphoblastic\nleukaemia [ALL]). The cellular composition</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\" style=\"color:black\">and the final cell number varies between\nindividual patient batches. In addition to T cells, NK cells may be present. The\nquantitative information regarding CAR\u2011positive viable T cells/mL and\ntotal cells in the product is presented in the batch\u2011specific documentation\naccompanying Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 or more infusion\nbags containing a total of 1.2\u00a0x\u00a010<sup>6</sup> to 6\u00a0x\u00a010<sup>8</sup>\nCAR\u2011positive viable T cells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><u><span lang=\"EN-GB\">Excipient with\nknown effect</span></u></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">This medicinal product contains 2.43\u00a0mg sodium per mL\nand 24.3 to 121.5\u00a0mg sodium per dose.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full\nlist of excipients, see section\u00a06.1.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>FORM</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Dispersion for infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A colourless to\nslightly yellow dispersion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">CLINICAL</span></b><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>\nPARTICULARS</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Kymriah is indicated for the treatment of:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Paediatric and young adult patients up to and\nincluding 25\u00a0years of age with B\u2011cell acute lymphoblastic leukaemia\n(ALL) that is refractory, in relapse post\u2011transplant or in second or\nlater relapse</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">Adult patients with relapsed\n</span><span lang=\"EN-GB\">or refractory diffuse large B\u2011cell lymphoma\n(DLBCL) after two or more lines of systemic therapy.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method\nof administration</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah must be\nadministered in a qualified treatment centre. Therapy should be initiated under\nthe direction of and supervised by a healthcare professional experienced in the\ntreatment of haematological malignancies and trained for administration and\nmanagement of patients treated with Kymriah. Tocilizumab for use in the event\nof cytokine release syndrome and emergency equipment must be available per\npatient prior to infusion. The treatment centre must have access to additional\ndoses of tocilizumab within 8\u00a0hours.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is\nintended for autologous use only (see section\u00a04.4). Manufacture and\nrelease of Kymriah usually takes about 3\u20114\u00a0weeks.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Dosage in paediatric and young adult B\u2011cell ALL patients</span></u></i></p>\n<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">For patients 50\u00a0kg\nand below: 0.2 to 5\u00a0x\u00a010<sup>6</sup> CAR\u2011positive viable T\ncells/kg body weight.</span></p>\n<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">For patients above\n50\u00a0kg: 0.1 to 2.5\u00a0x\u00a010<sup>8</sup> CAR\u2011positive viable T\ncells (non\u2011weight based).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Dosage in adult DLBCL patients</span></u></i></p>\n<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">0.6 to 6\u00a0x\u00a010<sup>8</sup>\nCAR\u2011positive viable T cells (non\u2011weight based).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pre\u2011treatment conditioning (lymphodepleting chemotherapy)</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lymphodepleting\nchemotherapy is recommended to be administered before Kymriah infusion unless\nthe white blood cell (WBC) count within one week prior to infusion is\n\u22641,000\u00a0cells/\u03bcL.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is\nrecommended to be infused 2 to 14\u00a0days after completion of the\nlymphodepleting chemotherapy. The availability of Kymriah must be confirmed\nprior to starting the lymphodepleting regimen. If there is a delay of more than\n4\u00a0weeks between completing lymphodepleting chemotherapy and the infusion\nand the WBC count is &gt;1,000\u00a0cells/\u03bcL, then the patient should be\nre\u2011treated with lymphodepleting chemotherapy prior to receiving Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span></u></i></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The recommended\nlymphodepleting chemotherapy regimen is:</span></p>\n<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Fludarabine (30\u00a0mg/m<sup>2</sup>\nintravenous daily for 4\u00a0days) and cyclophosphamide (500\u00a0mg/m<sup>2</sup>\nintravenous daily for 2\u00a0days starting with the first dose of fludarabine).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If the patient experienced a previous Grade\u00a04 haemorrhagic\ncystitis with cyclophosphamide, or demonstrated a chemorefractory state to a\ncyclophosphamide\u2011containing regimen administered shortly before\nlymphodepleting chemotherapy, then the following should be used:</span></p>\n<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Cytarabine (500\u00a0mg/m<sup>2</sup>\nintravenous daily for 2\u00a0days) and etoposide (150\u00a0mg/m<sup>2</sup> intravenous\ndaily for 3\u00a0days starting with the first dose of cytarabine).</span></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></u></i></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The recommended\nlymphodepleting chemotherapy regimen is:</span></p>\n<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Fludarabine (25\u00a0mg/m<sup>2</sup>\nintravenous daily for 3\u00a0days) and cyclophosphamide (250\u00a0mg/m<sup>2</sup>\nintravenous daily for 3\u00a0days starting with the first dose of fludarabine).</span></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If the patient experienced a previous Grade\u00a04 haemorrhagic\ncystitis with cyclophosphamide, or demonstrated a chemorefractory state to a\ncyclophosphamide\u2011containing regimen administered shortly before\nlymphodepleting chemotherapy, then the following should be used:</span></p>\n<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Bendamustine\n(90\u00a0mg/m<sup>2</sup> intravenous daily for 2\u00a0days).</span></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Lymphodepleting chemotherapy may be omitted\nif a patient\u2019s white blood cell (WBC) count is \u22641,000\u00a0cells/\u00b5L\nwithin 1\u00a0week prior to Kymriah infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Pre\u2011medication</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To minimise\npotential acute infusion reactions, it is recommended that patients be pre\u2011medicated\nwith paracetamol and diphenhydramine or another H1 antihistamine within\napproximately 30 to 60\u00a0minutes prior to Kymriah infusion. Corticosteroids\nshould not be used at any time except in the case of a life\u2011threatening\nemergency (see section\u00a04.4).</span></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"Nottoc-headings\" style=\"margin:0in\"><u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal'>Clinical\nassessment prior to infusion</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah\ntreatment should be delayed in some patient groups at risk (see section\u00a04.4).</span></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Monitoring after infusion</span></u></i></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Patients should be monitored daily for the first\n10\u00a0days following infusion for signs and symptoms of potential cytokine\nrelease syndrome, neurological events and other toxicities. Physicians should\nconsider hospitalisation for the first 10\u00a0days post infusion</span><span lang=\"EN-GB\"> or at the first signs/symptoms of </span><span lang=\"EN-GB\">cytokine\nrelease syndrome</span><span lang=\"EN-GB\"> and/or neurological events</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">After the first 10\u00a0days following the\ninfusion, the patient should be monitored at the physician\u2019s discretion.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Patients should be instructed to remain within\nproximity (within 2\u00a0hours of travel) of a qualified clinical facility for\nat least 4\u00a0weeks following infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric population</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">B-cell ALL</span></i><span lang=\"EN-GB\">: No formal studies have been\nperformed in paediatric patients below 3\u00a0years of age.</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">: The safety and efficacy of Kymriah in children and\nadolescents below 18\u00a0years of age have not yet been established. No data\nare available.</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Elderly</span></u></i></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span></i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">: The safety and efficacy of Kymriah in\nthis population have not been established.</span></p>\n<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">: No dose adjustment is required in patients over 65\u00a0years\nof age.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Patients seropositive for hepatitis B virus (HBV), hepatitis C virus\n(HCV), or human immunodeficiency virus (HIV)</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no\nexperience with manufacturing Kymriah for patients with a positive test for HIV,\nactive HBV, or active HCV infection. Leukapheresis material from these patients\nwill not be accepted for Kymriah manufacturing. </span><span lang=\"EN-GB\">Screening\nfor HBV, HCV, and HIV must be performed in accordance with clinical guidelines\nbefore collection of cells for manufacturing.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is for\nintravenous use only.</span></p>\n<p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoCommentText\" style=\"page-break-after:avoid\"><i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Precautions to be taken before handling or\nadministering the medicinal product</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct contains genetically modified human blood cells. Healthcare\nprofessionals handling Kymriah should take appropriate precautions (wearing\ngloves and glasses) to avoid potential transmission of infectious diseases as\nfor any human-derived material.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Preparation for infusion</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Prior to Kymriah\ninfusion, it must be confirmed that the patient\u2019s identity matches the\nessential unique patient information on the infusion bag(s).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The timing of\nthaw of Kymriah and infusion should be coordinated. </span><span lang=\"EN-GB\">Please\nrefer to section\u00a06.6 for details on inspection and thawing of the infusion\nbag. </span><span lang=\"EN-GB\">The infusion start time should be confirmed in\nadvance and adjusted for thaw so that Kymriah is available for infusion when\nthe recipient is ready. Once Kymriah has been thawed and is at room temperature\n</span><span lang=\"EN-GB\">(20\u00b0C \u201125\u00b0C)</span><span lang=\"EN-GB\">, it should\nbe infused within 30\u00a0minutes to maintain maximum product viability,</span><span lang=\"EN-GB\"> including any interruption during the infusion</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Administration</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah should\nbe administered as an intravenous infusion through latex\u2011free intravenous\ntubing without a leukocyte depleting filter, at approximately 10 to 20\u00a0mL\nper minute by gravity flow. All contents of the infusion bag(s) should be\ninfused. Sodium chloride 9\u00a0mg/mL (0.9%) solution for injection should be\nused to prime the tubing prior to infusion and to rinse it after infusion. When\nthe full volume of Kymriah has been infused, the infusion bag should be rinsed\nwith 10 to 30\u00a0mL sodium chloride 9\u00a0mg/mL (0.9%) solution for\ninjection by back priming to ensure as many cells as possible are infused into\nthe patient.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If the volume of\nKymriah to be administered is \u226420\u00a0mL, intravenous push may be used\nas an alternative method of administration.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For special\nprecautions for disposal see section\u00a06.6.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity\nto the active substance or to any of the excipients listed in section\u00a06.1.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Contraindications\nof the lymphodepleting chemotherapy must be considered.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">To ensure traceability the name\nof the product, the batch number and the name of the treated patient should be\nkept for a period of 30\u00a0years.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reasons to delay treatment</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Due to the risks associated with Kymriah treatment, infusion should\nbe delayed if a patient has any of the following conditions:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Unresolved serious adverse reactions\n(especially pulmonary reactions, cardiac reactions or hypotension) from\npreceding chemotherapies.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active uncontrolled infection.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active graft\u2011versus\u2011host disease\n(GVHD).</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Significant clinical worsening of leukaemia\nburden or rapid progression of lymphoma following lymphodepleting chemotherapy.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Blood, organ, tissue and\ncell donation</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">Patients treated with Kymriah should not donate blood,\norgans, tissues or cells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Active central nervous system (CNS) leukaemia or\nlymphoma</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is limited\nexperience of use of Kymriah in patients with active CNS leukaemia </span><span lang=\"EN-GB\" style='font-family:\"TimesNewRomanPSMT,Times New Rom\",serif'>and\nactive CNS lymphoma.</span><span lang=\"EN-GB\"> Therefore, the risk/benefit of\nKymriah has not been established in these populations.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cytokine release syndrome</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytokine release\nsyndrome, including fatal or life\u2011threatening events, has been frequently\nobserved after Kymriah infusion (see section\u00a04.8). In almost all cases,\ndevelopment of cytokine release syndrome occurred between 1 to 10\u00a0days (median\nonset 3\u00a0days) after Kymriah infusion</span><span lang=\"EN-GB\">. The median\ntime to resolution of </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> was 8\u00a0days</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Symptoms of cytokine\nrelease syndrome may include high fever, rigors, myalgia, arthralgia, nausea,\nvomiting, diarrhoea, diaphoresis, rash, anorexia, fatigue, headache,\nhypotension, dyspnoea, tachypnoea, and hypoxia. Organ dysfunction, including\ncardiac insufficiency and arrhythmia, renal insufficiency and liver injury with\naccompanying elevated aspartate aminotransferase (AST), elevated alanine\naminotransferase (ALT) or elevated total bilirubin may also be observed. In\nsome cases, disseminated intravascular coagulation (DIC) with low fibrinogen\nlevels, capillary leak syndrome (CLS), macrophage activation syndrome (MAS) and\nhaemophagocytic lymphohistiocytosis(HLH) may occur in the setting of cytokine\nrelease syndrome. Patients should be closely monitored for signs or symptoms of\nthese events, including fever.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Risk factors for\nsevere cytokine release syndrome in paediatric and young adult B\u2011cell ALL\npatients are: high pre\u2011infusion tumour burden, uncontrolled or\naccelerating tumour burden following lymphodepleting chemotherapy, active\ninfection and early onset of fever or cytokine release syndrome following\nKymriah infusion. High tumour burden prior to Kymriah infusion was identified\nas a risk factor for developing severe cytokine release syndrome in adult DLBCL\npatients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In all\nindications, appropriate prophylactic and therapeutic treatment for infections\nshould be provided, and complete resolution of any existing infections should\nbe ensured. Infections may also occur during cytokine release syndrome and may\nincrease the risk of a fatal event.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Management of cytokine release syndrome associated with Kymriah</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytokine release\nsyndrome should be managed solely based on the patient\u2019s clinical presentation\nand according to the cytokine release syndrome management algorithm provided in\nTable\u00a01. Anti\u2011IL\u20116 based therapy such as tocilizumab has been\nadministered for moderate or severe cytokine release syndrome associated with\nKymriah. One dose of tocilizumab per patient must be on site and available for\nadministration prior to Kymriah infusion. The treatment centre should have\naccess to additional doses of tocilizumab within 8\u00a0hours. Corticosteroids\nmay be administered in cases of life\u2011threatening emergencies.\nTisagenlecleucel continues to expand and persist following administration of\ntocilizumab and corticosteroids.</span><span lang=\"EN-GB\"> Patients with\nmedically significant cardiac dysfunction should be managed by standards of\ncritical care and measures such as echocardiography should be considered. </span><span lang=\"EN-GB\">Tumour necrosis factor (TNF) antagonists are not recommended for\nmanagement of Kymriah\u2011associated cytokine release syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cytokine\nrelease syndrome management algorithm</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.38%;border-collapse:collapse;border:none\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Cytokine release syndrome severity</span></b></p>\n</td>\n<td style=\"width:57.78%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Management</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Prodromal syndrome</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Low\u2011grade fever, fatigue, anorexia</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Observe in person; exclude infection; administer antibiotics per\n  local guidelines if neutropenic; provide symptomatic support.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">High fever</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Hypoxia</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Mild hypotension</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Administer antipyretics, oxygen, intravenous fluids and/or low\u2011dose\n  vasopressors as needed.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Haemodynamic instability despite intravenous\n  fluids and vasopressor support</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Worsening respiratory distress, including\n  pulmonary infiltrates, increasing oxygen requirement including high\u2011flow\n  oxygen and/or need for mechanical ventilation</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Rapid clinical deterioration</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer high\u2011dose or multiple\n  vasopressors, oxygen, mechanical ventilation and/or other supportive care as\n  needed.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer tocilizumab.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight less than 30\u00a0kg:\n  12\u00a0mg/kg intravenously over 1\u00a0hour</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight \u226530\u00a0kg: 8\u00a0mg/kg\n  intravenously over 1\u00a0hour (maximum dose 800\u00a0mg)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Repeat tocilizumab as needed at a minimum interval of 8\u00a0hours\n  if there is no clinical improvement.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If no response to second dose of tocilizumab, consider a third\n  dose of tocilizumab or pursue alternative measures for treatment of cytokine\n  release syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Limit to a maximum total of 4\u00a0tocilizumab doses.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">If no clinical improvement within 12 to\n  18\u00a0hours of the first tocilizumab dose, or worsening at any time,\n  administer methylprednisolone 2\u00a0mg/kg as an initial dose, then\n  2\u00a0mg/kg per day until vasopressors and high\u2011flow oxygen are no\n  longer needed, then taper.</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Neurological adverse reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Neurological events,\nin particular encephalopathy, confusional state or delirium, occur frequently\nwith Kymriah and can be severe or life\u2011threatening (see section\u00a04.8).\nOther manifestations included</span><span lang=\"EN-GB\"> </span>depressed level of\nconsciousness, seizures, aphasia and speech disorder<span lang=\"EN-GB\">. The\nmajority of neurological events occurred within 8\u00a0weeks following Kymriah\ninfusion and were transient. The median time to onset of the first neurological\nevents was 8\u00a0days in B\u2011cell ALL and 6\u00a0days in DLBCL. The median\ntime to resolution was 7\u00a0days for B\u2011cell ALL and 13\u00a0days for\nDLBCL. Neurological events can be concurrent with cytokine release syndrome,\nfollowing resolution of cytokine release syndrome or in the absence of cytokine\nrelease syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients should\nbe monitored for neurological events. In case of neurological events, patients\nshould be diagnostically worked up and managed depending on the underlying\npathophysiology and in accordance with local standard of care.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infections and febrile neutropenia</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients with\nactive, uncontrolled infection should not start Kymriah treatment until the\ninfection is resolved. Prior to Kymriah infusion, infection prophylaxis should\nfollow standard guidelines based on the degree of preceding immunosuppression.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Serious\ninfections, including life\u2011threatening or fatal infections, occurred\nfrequently in patients after Kymriah infusion (see section\u00a04.8). Patients\nshould be monitored for signs and symptoms of infection and treated\nappropriately. As appropriate, prophylactic antibiotics should be administered\nand surveillance testing should be employed prior to and during treatment with\nKymriah. Infections are known to complicate the course and management of\nconcurrent </span><span lang=\"EN-GB\">cytokine release syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Febrile\nneutropenia was frequently observed in patients after Kymriah infusion (see\nsection\u00a04.8) and may be concurrent with </span><span lang=\"EN-GB\">cytokine\nrelease syndrome. In the event of febrile neutropenia, infection should be\nevaluated and managed appropriately with broad\u2011spectrum antibiotics,\nfluids and other supportive care, as medically indicated.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In patients\nachieving complete remission following Kymriah, resulting low immunoglobulin\nlevels can increase the risk for infections. Attention to signs and symptoms of\ninfection should be implemented according to age and standard specific guidelines.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Prolonged cytopenias</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients may\ncontinue to exhibit cytopenias for several weeks following lymphodepleting\nchemotherapy and Kymriah infusion and should be managed according to standard guidelines.\nThe majority of patients who had cytopenias at day\u00a028 following Kymriah\ntreatment resolved to Grade\u00a02 or below within three months after treatment.\nProlonged neutropenia has been associated with increased risk of infection.\nMyeloid growth factors, particularly granulocyte macrophage\u2011colony\nstimulating factor (GM\u2011CSF), have the potential to worsen </span><span lang=\"EN-GB\">cytokine release syndrome symptoms and are not recommended during\nthe first 3\u00a0weeks after Kymriah infusion or until cytokine release\nsyndrome has resolved.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Secondary malignancies</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients treated\nwith Kymriah may develop secondary malignancies or recurrence of their cancer. They\nshould be monitored life\u2011long for secondary malignancies. In the event\nthat a secondary malignancy occurs, the company should be contacted to obtain\ninstructions on patient samples to collect for testing.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Hypogammaglobulinaemia</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypogammaglobulinaemia\nand agammaglobulinaemia can occur in patients after Kymriah infusion. </span><span lang=\"EN-GB\">I</span><span lang=\"EN-GB\">mmunoglobulin levels should be monitored\nafter treatment with Kymriah. In patients with low immunoglobulin levels pre\u2011emptive\nmeasures such as infection precautions, antibiotic prophylaxis and\nimmunoglobulin replacement should be taken according to age and standard guidelines.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Tumour lysis syndrome (TLS)</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">TLS, which may\nbe severe, has occasionally been observed. To minimise risk of TLS, patients\nwith elevated uric acid or high tumour burden should receive allopurinol, or an\nalternative prophylaxis, prior to Kymriah infusion. Signs and symptoms of TLS\nshould be monitored and events managed according to standard guidelines.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Concomitant disease</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients with a\nhistory of active CNS disorder or inadequate renal, hepatic, pulmonary or\ncardiac function were excluded from the studies. These patient are likely to be\nmore vulnerable to the consequences of the adverse reactions described below\nand require special attention.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Prior stem cell transplantation</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is not\nrecommended that patients receive Kymriah within 4\u00a0months of undergoing an\nallogeneic stem cell transplant (SCT) because of the potential risk of Kymriah\nworsening GVHD. Leukapheresis for Kymriah manufacturing should be performed at\nleast 12\u00a0weeks after allogeneic SCT.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Serological testing</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is\ncurrently no experience with manufacturing Kymriah for patients testing\npositive for HBV, HCV and HIV.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Screening for\nHBV, HCV and HIV must be performed in accordance with clinical guidelines\nbefore collection of cells for manufacturing.</span><span lang=\"EN-GB\"> Hepatitis\nB virus (HBV) reactivation, can occur in patients treated with medicinal\nproducts directed against B cells and could result in fulminant hepatitis,\nhepatic failure and death.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Prior treatment with anti\u2011CD19\ntherapy</span></u></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">There is limited experience with Kymriah in\npatients exposed to prior CD19\u2011directed therapy. Kymriah is not\nrecommended if the patient has relapsed with CD19\u2011negative leukaemia\nafter prior anti\u2011CD19 therapy.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Interference with serological testing</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Due to limited\nand short spans of identical genetic information between the lentiviral vector\nused to create Kymriah and HIV, some commercial HIV nucleic acid tests (NAT)\nmay give a false positive result.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><u><span style=\"font-size:11.0pt\">Sodium\nand potassium content</span></u></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span style=\"font-size:11.0pt\">\u00a0</span></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">This medicinal product contains 24.3 to 121.5\u00a0mg sodium\nper dose, equivalent to 1 to 6% of the WHO recommended maximum daily intake of\n2\u00a0g sodium for an adult.</p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">\u00a0</p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">This medicinal product contains potassium, less than\n1\u00a0mmol (39\u00a0mg) per dose, i.e. essentially \u201cpotassium\u2011free\u201d.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><u><span lang=\"EN-GB\">Content of\ndextran 40 and dimethyl sulfoxide (DMSO)</span></u></p>\n<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct contains 11\u00a0mg dextran 40 and 82.5\u00a0mg dimethyl sulfoxide\n(DMSO) per mL. Each of these excipients are known to possibly cause\nanaphylactic reaction following parenteral administration. Patients not\npreviously exposed to dextran and DMSO should be observed closely during the\nfirst minutes of the infusion period.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with\nother medicinal products and other forms of interaction</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:white\">No pharmacokinetic or pharmacodynamic drug\ninteraction studies with tisagenlecleucel have been performed</span><span lang=\"EN-GB\">. </span>The co\u2011administration of agents known to inhibit T\u2011cell\nfunction has not been formally studied. Administration of low\u2011dose\nsteroids as per the cytokine release syndrome treatment algorithm does not\nimpact the expansion and persistence of CAR\u2011T cells. The co\u2011administration\nof agents known to stimulate T\u2011cell function has not been investigated\nand the effects are unknown.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Live vaccines</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety of\nimmunisation with live vaccines during or following Kymriah treatment has not\nbeen studied. Vaccination with live vaccines is not recommended for at least\n6\u00a0weeks prior to the start of lymphodepleting chemotherapy, during Kymriah\ntreatment, and until immune recovery following treatment with Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pregnancy status\nfor females of child\u2011bearing age should be verified prior to starting\ntreatment with Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">See the\nprescribing information for lymphodepleting chemotherapy for information on the\nneed for effective contraception in patients who receive the lymphodepleting\nchemotherapy.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are insufficient\nexposure data to provide a recommendation concerning duration of contraception\nfollowing treatment with Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no\ndata from the use of Kymriah in pregnant women. No animal studies have been\nconducted with Kymriah to assess whether it can cause foetal harm when\nadministered to a pregnant woman (see section\u00a05.3). It is not known\nwhether Kymriah has the potential to be transferred to the foetus via the\nplacenta and could cause foetal toxicity, including B\u2011cell\nlymphocytopenia. Kymriah is not recommended during pregnancy and in women of\nchildbearing potential not using contraception.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pregnant women\nshould be advised on the potential risks to the foetus. Pregnancy after Kymriah\ntherapy should be discussed with the treating physician. Pregnant women who\nhave received Kymriah may have hypogammaglobulinaemia. Assessment of\nimmunoglobulin levels is indicated in newborns of mothers treated with Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast\u2011feeding</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown\nwhether Kymriah cells are excreted in human milk. A risk to the breast\u2011fed\ninfant cannot be excluded. Women who are breast\u2011feeding should be advised\nof the potential risk to the breast\u2011fed infant.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following administration\nof Kymriah, breast\u2011feeding should be discussed with the treating\nphysician.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no\ndata on the effect of Kymriah on fertility. Effects of Kymriah on male and\nfemale fertility have not been evaluated in animal studies.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability\nto drive and use machines</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah has major\ninfluence on the ability to drive and use machines.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Due to the\npotential for neurological events, including altered mental status or seizures,\npatients receiving Kymriah are at risk for altered or decreased consciousness\nor coordination in the 8\u00a0weeks following infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Safety\nassessment was based on a total of 194\u00a0patients (with paediatric and young\nadult B-cell ALL and DLBCL) who received Kymriah in two multi-centre pivotal\nclinical studies.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">B\u2011cell ALL</span></u></i></p>\n<p class=\"Text\" style=\"margin-top:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The\nadverse reactions described in this section were characterised in 79\u00a0patients\ninfused with Kymriah in the multi-centre, pivotal clinical study CCTL019B2202.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common non\u2011haematological adverse reactions were\ncytokine release syndrome (77%), infections (73%), hypogammaglobulinaemia (53%),\npyrexia (42%) and decreased appetite (38%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common haematological adverse reactions were decreased\nwhite blood cells (100%), decreased haemoglobin (100%), decreased neutrophils\n(100%), decreased lymphocytes (100%) and decreased platelets (97%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were reported in 89% of\npatients. The most common Grade\u00a03 and 4 non\u2011haematological adverse\nreaction was </span><span lang=\"EN-GB\">cytokine release syndrome (48%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common Grade\u00a03 and 4 haematological laboratory\nabnormalities were white blood cells decreased (97%), lymphocytes decreased\n(96%), neutrophils decreased (95%), platelets decreased (77%) and haemoglobin\ndecreased (48%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were more often observed within\nthe initial 8\u00a0weeks post\u2011infusion (82% of patients) compared to\nafter 8\u00a0weeks post\u2011infusion (51% of patients).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">DLBCL</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The adverse reactions described in this section were characterised in\n115\u00a0patients </span><span lang=\"EN-GB\">infused </span><span lang=\"EN-GB\">with\nKymriah in one global multicentre international study, i.e. the ongoing pivotal\nclinical study CCTL019C2201.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common non\u2011haematological adverse reactions were </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> (57%), infections\n(58%), pyrexia (35%), diarrhoea (31%), nausea (29%), fatigue (27%) and hypotension\n(25%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">The most\ncommon haematological adverse reactions were decreased lymphocytes (100%),\ndecreased white blood cells (99%), decreased haemoglobin (99%), decreased\nneutrophils (97%), and decreased platelets (95%).</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were reported in 88% of\npatients. The most common Grade\u00a03 and 4 non\u2011haematological adverse\nreactions were infections (34%) and </span><span lang=\"EN-GB\">cytokine release\nsyndrome</span><span lang=\"EN-GB\"> (23%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common (&gt;25%) Grade\u00a03 and 4 haematological\nlaboratory abnormalities were </span><span lang=\"EN-GB\">lymphocyte count</span><span lang=\"EN-GB\"> decreased (95%), </span><span lang=\"EN-GB\">neutrophil count decreased</span><span lang=\"EN-GB\"> (82%), </span><span lang=\"EN-GB\">white blood cell count decreased</span><span lang=\"EN-GB\"> (78%), </span><span lang=\"EN-GB\">haemoglobin decreased</span><span lang=\"EN-GB\"> (59%) and </span><span lang=\"EN-GB\">platelet count decreased</span><span lang=\"EN-GB\"> (56%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were more often observed within\nthe initial 8\u00a0weeks post\u2011infusion (82%) compared to after\n8\u00a0weeks post\u2011infusion (48%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Tabulated list of adverse drug reactions</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The adverse reactions described in this section were identified in 79\nand 115\u00a0patients in the ongoing multicentre pivotal clinical studies (CCTL019B2202\nand CCTL019C2201). Adverse drug reactions from these clinical studies (Table\u00a02)\nare listed by MedDRA system organ class. Within each system organ class, the\nadverse drug reactions are ranked by frequency, with the most frequent\nreactions first,</span> using the following convention: very common\n(\u22651/10); common (\u22651/100 to &lt;1/10); uncommon (\u22651/1,000 to\n&lt;1/100); rare (\u22651/10,000 to &lt;1/1,000); very rare (&lt;1/10,000);\nnot known (cannot be estimated from the available data)<span lang=\"EN-GB\">.\nWithin each frequency grouping, adverse drug reactions are presented in order\nof decreasing seriousness.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Table\u00a02\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adverse\ndrug reactions observed in clinical studies</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse;border:none\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"2\" style=\"width:17.86%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adverse drug reaction (MedDRA\n  system organ class)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:82.14%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"82%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>Studies\n  B2202 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>N=</span></b><b><span lang=\"DE-CH\" style='font-family:\n  \"Times New Roman\",serif'>79) + C2201 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>N</span></b><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>=115)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:29.74%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"29%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very\n  common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/10)</span></b></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"28%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/100\n  to &lt;1/10)</span></b></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"24%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/1000\n  to &lt;1/100)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Infections\n  and infestations<sup>1)</sup></span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infections \u2011 pathogen unspecified</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Viral infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Bacterial infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fungal infections</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood\n  and lymphatic system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemorrhage<sup>2)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Febrile neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombocytopenia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemophagocytic lymphohistiocytosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Leukopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pancytopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Coagulopathy</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphopenia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>B-cell aplasia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune\n  system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cytokine release syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypogammaglobulinaemia<sup>3)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infusion\u2011related reaction</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Graft\u2011versus\u2011host disease</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism\n  and nutrition disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Decreased appetite</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypokalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypophosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypomagnesaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypocalcaemia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoalbuminaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperglycaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyponatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperuricaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fluid overload</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypercalcaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tumour lysis syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperkalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperphosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypernatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypermagnesaemia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anxiety</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Delirium<sup>4)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Sleep disorder<sup>5)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous\n  system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Headache<sup>6)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Encephalopathy<sup>7)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dizziness<sup>8)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Peripheral neuropathy<sup>9)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tremor<sup>10)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Motor dysfunction<sup>11)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Seizure<sup>12)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Speech disorders<sup>13)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neuralgia<sup>14)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ataxia<sup>15)</sup></span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Ischaemic cerebral infarction</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Visual impairment<sup>16)</sup></span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arrhythmia<sup>17)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac failure<sup>18)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac arrest</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypotension<sup>19)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypertension</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombosis<sup>20)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Capillary leak syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Flushing</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory,\n  thoracic and mediastinal disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cough<sup>21)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dyspnoea<sup>22)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoxia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oropharyngeal pain<sup>23)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pulmonary oedema<sup>24)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nasal congestion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pleural effusion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tachypnoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute respiratory distress syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lung infiltration</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Diarrhoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nausea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Vomiting</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Constipation</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal pain<sup>25)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Stomatitis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal distension</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dry mouth</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ascites</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif'>Hepatobiliary\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperbilirubinaemia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin\n  and subcutaneous tissue disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Rash<sup>26)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pruritus</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Erythema</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperhidrosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Night sweats</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal\n  and connective tissue disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arthralgia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Back pain</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Myalgia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Musculoskeletal pain</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal\n  and urinary disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute kidney injury<sup>27)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General\n  disorders and administration site conditions</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pyrexia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fatigue<sup>28)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oedema<sup>29)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pain<sup>30)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Chills</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Influenza\u2011like illness</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Asthenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Multiple organ dysfunction syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphocyte count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>White blood cell count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemoglobin decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutrophil count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Platelet count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Aspartate aminotransferase increased</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Alanine aminotransferase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood bilirubin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Weight decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Serum ferritin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood fibrinogen decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>International normalised ratio increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fibrin D dimer increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Activated partial thromboplastin time prolonged</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood alkaline phosphatase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Prothrombin time prolonged</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"height:16.55pt\">\n<td colspan=\"4\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.55pt\" valign=\"top\" width=\"100%\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and\n  infestations presented reflect high\u2011level group terms.</span></p>\n<p class=\"Legend\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Haemorrhage\n  includes anal haemorrhage, blood urine present, catheter site haemorrhage,\n  cerebral haemorrhage, conjunctival haemorrhage, contusion, cystitis\n  haemorrhagic, duodenal ulcer haemorrhage, disseminated intravascular\n  coagulation, epistaxis, eye contusion, gastrointestinal haemorrhage, gingival\n  bleeding, haematochezia, haemarthrosis, haematemesis, haematuria,\n  haemoptysis, large intestinal haemorrhage, melaena, menorrhagia, mouth\n  haemorrhage, peritoneal haematoma, petechiae, pharyngeal haemorrhage, post\u2011procedural\n  haemorrhage, pulmonary haemorrhage, purpura, retinal haemorrhage, traumatic\n  haematoma, tumour haemorrhage, upper gastrointestinal haemorrhage and vaginal\n  haemorrhage.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypogammaglobulinaemia\n  includes immunoglobulins decreased, blood immunoglobulin A decreased, blood\n  immunoglobulin G decreased, blood immunoglobulin M decreased,\n  immunodeficiency, immunodeficiency common variable and\n  hypogammaglobulinaemia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Delirium includes\n  agitation, delirium, hallucination, hallucination visual, irritability and\n  restlessness.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sleep disorder includes\n  sleep disorder, insomnia and nightmare.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Headache includes\n  headache and migraine.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Encephalopathy includes\n  depressed level of consciousness, mental status changes, automatism,\n  cognitive disorder, confusional state, disturbance in attention,\n  encephalopathy, somnolence, lethargy, memory impairment, metabolic\n  encephalopathy and thinking abnormal.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dizziness includes\n  dizziness, presyncope and syncope.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Peripheral neuropathy\n  includes paraesthesia, peripheral sensory neuropathy, neuropathy peripheral,\n  hyperaesthesia and hypoaesthesia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tremor includes\n  dyskinesia and tremor.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Motor dysfunction\n  includes muscle spasms, muscle twitching, myoclonus and myopathy.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Seizure includes seizure,\n  generalised tonic\u2011clonic seizures and status epilepticus.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Speech disorders includes\n  speech disorders, dysarthria and aphasia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neuralgia includes\n  neuralgia and sciatica.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ataxia includes ataxia\n  and dysmetria.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Visual impairment\n  includes vision blurred and visual impairment.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;color:black'>Arrhythmia\n  includes atrial fibrillation, supraventricular tachycardia, </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tachycardia and\n  ventricular extrasystoles.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac failure includes\n  cardiac failure, left ventricular dysfunction, cardiac failure congestive and\n  right ventricular dysfunction.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>19)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypotension includes\n  hypotension and orthostatic hypotension.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>20)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombosis includes deep\n  vein thrombosis, embolism, pulmonary embolism, thrombosis, vena cava\n  thrombosis and venous thrombosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cough includes cough,\n  productive cough and upper\u2011airway cough syndrome.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Dyspnoea\n  includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory\n  failure.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>23)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oropharyngeal pain\n  includes oral pain and oropharyngeal pain.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>24)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pulmonary oedema includes\n  acute pulmonary oedema and pulmonary oedema</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>25)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Abdominal pain includes\n  abdominal pain, abdominal pain upper and abdominal discomfort.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>26)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Rash includes dermatitis,\n  dermatitis acneiform, dermatitis contact,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash maculo\u2011papular,\n  rash papular and rash pruritic.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>27)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute kidney injury\n  includes acute kidney injury, anuria, azotaemia, blood creatinine abnormal,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood creatinine\n  increased, renal failure, renal tubular dysfunction and renal tubular\n  necrosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>28)</span></sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fatigue includes fatigue\n  and malaise.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>29)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Oedema\n  includes oedema peripheral, generalised oedema, localised oedema, face oedema\n  and peripheral swelling.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>30)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pain includes pain and\n  pain in extremity.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\">*\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style='font-family:\n  \"Times New Roman\",serif'>Frequency is based on laboratory values. Patients\n  are counted only for the worst grade observed post baseline.</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Description of selected adverse drug reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Cytokine release syndrome</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the ongoing clinical study in paediatric and young adult B\u2011cell\nALL (N=79), </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> was reported in 77% of patients (48% with Grade\u00a03 or 4). Two\ndeaths occurred within 30\u00a0days of tisagenlecleucel infusion, including one\npatient, who died from progressive leukaemia in the setting of possible cytokine\nrelease syndrome and one patient who experienced fatal intracranial haemorrhage\nthat developed during the course of resolved </span><span lang=\"EN-GB\">cytokine\nrelease syndrome,</span><span lang=\"EN-GB\"> abdominal compartment syndrome,\ncoagulopathy and renal failure.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the ongoing clinical study in DLBCL (N=115), </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> was reported in 57%\nof patients (23% with Grade\u00a03 or 4).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Cytokine release syndrome</span><span lang=\"EN-GB\"> was graded with\nthe Penn scale as follows: Grade\u00a01:\u00a0mild reactions, reactions\nrequiring supportive care; Grade\u00a02:\u00a0moderate reactions, reactions\nrequiring intravenous therapies; Grade\u00a03:\u00a0severe reactions, reactions\nrequiring low\u2011dose vasopressors or supplemental oxygen;\nGrade\u00a04:\u00a0life\u2011threatening reactions, those requiring high\u2011dose\nvasopressors or intubation; Grade\u00a05:\u00a0death.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">For clinical management of </span><span lang=\"EN-GB\">cytokine release\nsyndrome</span><span lang=\"EN-GB\">, see section\u00a04.4 and Table\u00a01.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Infections and febrile neutropenia</span></u></i></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In B\u2011cell ALL\npatients severe infections (Grade\u00a03 and higher), which can be life\u2011threatening\nor fatal, occurred in 48% of patients after Kymriah infusion. The overall\nincidence (all grades) was 73% (unspecified 57%, viral 38%, bacterial 27% and\nfungal 15%) (see section\u00a04.4). 43% of the patients experienced an\ninfection of any type within 8\u00a0weeks after Kymriah infusion.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">In DLBCL patients </span><span lang=\"EN-GB\" style=\"color:black\">severe </span><span lang=\"EN-GB\">infections (Grade\u00a03 and\nhigher), which can be life\u2011threatening or fatal, occurred in 34% of\npatients. The overall incidence (all grades) was 58% (unspecified 48%, bacterial\n15%, fungal 11% and viral 11%) (see section\u00a04.4). 37% of the patients\nexperienced an infection of any type within 8\u00a0weeks.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Severe febrile neutropenia (Grade\u00a03 or 4) was observed in 34%\nof paediatric and young adult B\u2011cell ALL patients and 17% of DLBCL\npatients. See section\u00a04.4 for the management of febrile neutropenia before\nand after Kymriah infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Prolonged cytopenias</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Cytopenias are very common based on prior chemotherapies and Kymriah\ntherapy.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">All paediatric and young adult B\u2011cell ALL patients had a Grade\u00a03\nor 4 cytopenia at </span><span class=\"MsoCommentReference\"><span lang=\"EN-GB\">some</span></span><span lang=\"EN-GB\"> time after Kymriah infusion. Grade\u00a03 and 4 cytopenias not\nresolved by day\u00a028 after Kymriah infusion based on laboratory findings\nincluded decreased count of white blood cells (57%), neutrophils (54%), lymphocytes\n(44%), and thrombocytes (42%) and decreased haemoglobin (13%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">All adult DLBCL patients had Grade\u00a03 and 4 cytopenias at some time\nafter Kymriah infusion. Grade\u00a03 and 4 cytopenias not resolved by day\u00a028\nbased on laboratory findings included decreased count of thrombocytes (39%),\nlymphocytes (29%), neutrophils (25%), and white blood cells (21%) and decreased\nhaemoglobin (14%).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Neurological adverse reactions</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The majority of neurotoxic events occurred within 8\u00a0weeks\nfollowing infusion and were transient.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In paediatric and young adult B\u2011cell ALL patients, manifestations\nof encephalopathy and/or delirium occurred in 39% of patients (10% were Grade\u00a03\nor 4) within 8\u00a0weeks after Kymriah infusion. In DLBCL patients, manifestations\nof encephalopathy and/or delirium occurred in 20% of patients (11% were Grade\u00a03\nor 4) within 8\u00a0weeks after Kymriah infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Hypogammaglobulinaemia</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Hypogammaglobulinaemia was reported in 53% of patients treated with\nKymriah for r/r ALL and 17% of patients with r/r DLBCL.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Pregnant women who have received Kymriah may have\nhypogammaglobulinaemia. Immunoglobulin levels should be assessed in newborns of\nmothers treated with Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Immunogenicity</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">In clinical studies, humoral immunogenicity of tisagenlecleucel was\nmeasured by determination of anti\u2011murine CAR19 antibodies (anti\u2011mCAR19)\nin serum pre\u2011 and post\u2011administration. The majority of patients\ntested positive for pre\u2011dose anti\u2011mCAR19 antibodies in paediatric\nand young adult ALL (B2202, 91.1%) and adult DLBCL (C2201, 93.9%) patients.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Treatment\u2011induced anti\u2011mCAR19 antibodies were found in 40.5%\nof paediatric and young adult ALL and 8.7% of adult DLBCL patients. Pre\u2011existing\nand treatment\u2011induced antibodies were not associated with an impact on\nclinical response nor did they have an impact on the expansion and persistence\nof tisagenlecleucel. There is no evidence that the presence of pre\u2011existing\nand treatment\u2011induced anti\u2011mCAR19 antibodies impacts the safety or\neffectiveness of Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">T\u2011cell immunogenicity responses were not observed in paediatric\nand young adult B\u2011cell ALL and adult r/r DLBCL patients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\nmedicinal product is important. It allows continued monitoring of the\nbenefit/risk balance of the medicinal product. Healthcare professionals are\nasked to report any suspected adverse reactions via <span style=\"color:black;\nbackground:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not applicable.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: </span><span lang=\"EN-GB\">other\nantineoplastic agents, ATC code: L01XX71<span style=\"color:black;background:\n#D9D9D9\">.</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:#262626\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:#262626\">Tisagenlecleucel</span><span lang=\"EN-GB\"> is an\nautologous, immunocellular cancer therapy which involves reprogramming a\npatient\u2019s own T cells with a transgene encoding a chimeric antigen receptor\n(CAR) to identify and eliminate CD19 expressing cells. The CAR is comprised of\na murine single chain antibody fragment which recognises CD19 and is fused to\nintracellular signalling domains from 4\u20111BB (CD137) and CD3 zeta. The CD3\nzeta component is critical for initiating T\u2011cell activation and anti-tumour\nactivity, while 4\u20111BB enhances the expansion and persistence of tisagenlecleucel.\nUpon binding to CD19\u2011expressing cells, the CAR transmits a signal promoting\nT\u2011cell expansion and persistence of tisagenlecleucel.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Acute lymphoblastic leukaemia (ALL)</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of Kymriah treatment in paediatric and young\nadult patients up to and including 25\u00a0years of age, with relapsed or\nrefractory (r/r) B-cell ALL were evaluated in a total of 203\u00a0patients in\none pivotal (B2202, N=79) and two supportive (B2205J, N=64, and B2101J, N=60) open\u2011label,\nsingle\u2011arm phase I/II studies. All patients had leukapheresis products\ncollected and cryopreserved prior to or during study entry.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The pivotal study B2202 (ELIANA) is a multicentre, single\u2011arm\nphase II study in paediatric and young adult patients with r/r B-cell ALL. Of 97\u00a0patients\nenrolled, 79 received infusion with Kymriah; for 8\u00a0patients (8%) Kymriah\ncould not be manufactured; reasons for discontinuation prior to Kymriah\ninfusion included death (n=7; 7%) or adverse events (n=3; 3%) while awaiting\nKymriah manufacturing in the clinical study. The median duration of study\nfollow-up defined as the time from Kymriah infusion to the date of completion\nor discontinuation from follow-up prior to the data cut-off date was 16.0\u00a0months\n(range: 0.4-34.4). The median time from Kymriah infusion to the data cut-off\ndate was 24.2\u00a0months (range: 4.5-35.1). The study is still ongoing.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Key baseline information for enrolled and infused patients is\npresented in Table\u00a03. </span><span lang=\"EN-GB\">The majority of patients </span><span lang=\"EN-GB\">(69/79, 87%) </span><span lang=\"EN-GB\">received bridging therapy while\nwaiting for Kymriah. </span><span lang=\"EN-GB\">A total of 76 out of 79\u00a0patients\n(96%) who received Kymriah infusion also received lymphodepleting chemotherapy\nafter enrolment and prior to infusion of a single dose of Kymriah (see section\u00a04.2\nfor condition of lymphodepleting chemotherapy).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a03\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Baseline information across the enrolled and the infused patient\npopulation</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse;border:none\" width=\"100%\">\n<thead>\n<tr style=\"height:29.4pt\">\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:25.72%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=97</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:25.74%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=79</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>\n</thead>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>\n<td style=\"width:25.72%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.48)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.38)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  27)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  24)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;10\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">32\n  (40.5)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226510\u00a0years\n  and &lt;18\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">33\n  (41.8)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226518\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">17 (17.5)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">14\n  (17.7)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (55.7)\n  </p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">45\n  (57.0)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">43 (44.3)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">34 (43)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary refractory<sup>1</sup></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">8 (8.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapsed disease<sup>2</sup></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">89 (91.8)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">73 (92.4)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Prior\n  stem-cell transplantation - n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">39 (40.2)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">31\n  (39.2)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">50 (51.5)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">42\n  (53.2)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">8 (8.2)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>\n</tr>\n<tr style=\"height:18.25pt\">\n<td colspan=\"3\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:18.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><sup>1</sup>Primary\n  refractory: Never had a morphologic complete remission (CR) prior to the\n  study;</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><sup>2</sup>Relapsed disease:\n  Had at least one relapse prior to the study</p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Efficacy was established through the primary endpoint of overall\nremission rate (ORR), which includes best overall response as complete\nremission (CR) or complete remission with incomplete blood count recovery (CRi)\nwithin 3\u00a0months post infusion, as determined by Independent Review\nCommittee (IRC) assessment, as well as secondary endpoints including duration\nof remission (DOR) and the proportion of patients who achieved CR or CRi with\nminimal residual disease (MRD) &lt;0.01% by flow cytometry (MRD\u2011negative).</span><span lang=\"EN-GB\"> See Table\u00a04 for efficacy results from this study. ORR was\nconsistent across all subgroups. Eight </span><span lang=\"EN-GB\">patients (10.1%)\nwho achieved CR/CRi after Kymriah infusion went to haematopoietic stem cell transplant\nwhile in remission of which 6 of the patients (7.6%) proceeded to transplant\nwithin the first 6\u00a0months post\u2011infusion while in remission</span><span lang=\"EN-GB\">. Kymriah was administered in a qualified Kymriah treatment centre\nin an inpatient and outpatient setting.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Table\u00a04\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Efficacy results in paediatric and young adult patients with\nrelapsed/refractory B\u2011cell acute lymphoblastic leukaemia (ALL)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr style=\"page-break-inside:avoid;height:12.9pt\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border:solid windowtext 1.0pt;border-left:\n  none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  remission rate (ORR)<sup>1,2</sup>, n (%)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>95% CI</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65 (67.0)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(56.7,\n  76.2)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65\n  (82.3)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(72.1,\n  90.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CR<sup>3</sup>,\n  n (%)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49 (50.5)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49\n  (62.0)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CRi<sup>4</sup>,\n  n (%)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (16.5)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (20.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Key secondary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>CR\n  or CRi with MRD negative bone marrow<sup>5,6</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">95% CI</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64 (66.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(55.7,\n  75.3)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">p&lt;0.0001</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64\n  (81.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(70.6,\n  89.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Duration of\n  remission (DOR)</span></b><sup><span style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>7</span></sup></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 18\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Median\n  (months) (95% CI)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE<sup>9</sup>)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  survival (OS)<sup>8</sup></span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 %\n  survival probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>69.8</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>76.4</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:14.2pt;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:\n  11.0pt;font-family:\"Times New Roman\",serif;color:black'>% survival probability\n  at 24\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>56.9</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 Median\n  (months) (95% CI)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (19.4, NE)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (28.2, NE)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>1</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requires remission\n  status to be maintained for at least 28\u00a0days without clinical evidence\n  of relapse.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: ORR \u226420% vs. Ha: ORR &gt;20%</span></p>\n<p class=\"MsoCommentText\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  page-break-after:avoid\"><sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">3</span></sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CR (complete remission) was defined as &lt;5% of blasts\n  in the bone marrow, circulating blasts in blood should be &lt;1%, no evidence\n  of extramedullary disease, and full recovery of peripheral blood counts\n  (platelets &gt;100,000/\u03bcL and absolute neutrophil counts [ANC]\n  &gt;1,000/\u03bcL) without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>4</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CRi (complete\n  remission with incomplete blood count recovery) was defined as &lt;5% of\n  blasts in the bone marrow, circulating blasts in blood should be &lt;1%, no\n  evidence of extramedullary disease, and without full recovery of peripheral\n  blood counts with or without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>5</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MRD (minimal\n  residual disease) negative was defined as MRD by flow cytometry &lt;0.01%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>6</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: Rate of MRD negative remission \u226415%\n  vs. Ha:\u00a0&gt;15%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>7</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOR was defined as\n  time since onset of CR or CRi to relapse or death due to underlying\n  indication, whichever is earlier (N=65).</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>8</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause for\n  infused patients and from time of date of enrolment to the date of death due\n  to any cause for enrolled patients.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  estimable</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Health\u2011related quality of life (HRQoL) was evaluated by PedsQL\nand EQ\u20115D questionnaires completed by patients aged 8\u00a0years and\nabove (n=61). Among patients responding (n=51), the mean</span><u><span lang=\"EN-GB\"> </span></u><span lang=\"EN-GB\">(SD) change from baseline in the PedsQL\ntotal score was 13.1 (13.45) at month\u00a03, 15.4 (16.81) at month\u00a06 and\n25.0 (19.09) at month\u00a012, and the mean (SD) change from baseline in the EQ\u20115D\nVAS score was 16.0 (16.45) at month\u00a03, 15.3 (18.33) at month\u00a06 and </span><span lang=\"EN-GB\" style=\"color:black\">21.7 (17.14) at month\u00a012</span><span lang=\"EN-GB\">, indicating overall clinically meaningful improvement in HRQoL </span><span lang=\"EN-GB\">following Kymriah infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The supportive study B2205J (ENSIGN) was a multicentre single-arm phase\u00a0II\nstudy in paediatric and young adult patients with r/r B\u2011cell ALL. The\nstudy had similar study design and enrolled comparable patient populations as\nthe pivotal study B2202. The main difference between the two studies was the\ndefinition of the primary efficacy endpoint ORR, which was measured within 6\u00a0months\nafter Kymriah infusion in study B2205J compared to 3\u00a0months in the pivotal\nstudy. Of 75\u00a0patients enrolled, 64 received infusion of Kymriah; for 5\u00a0patients\n(6.7%), Kymriah could not be manufactured and 6\u00a0patients (8.0%) died while\nawaiting Kymriah manufacturing in the clinical study. The median duration of\nstudy follow-up defined as the time from Kymriah infusion to the date of completion\nor discontinuation from follow-up prior to the data cut-off date in the final\nanalyses was 12.2\u00a0months (range: 0.4-49.3). The median time from Kymriah\ninfusion to the data cut-off date was 31.7\u00a0months (range: 17.6-56.0).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Among the patients infused, the median age was 12.5\u00a0years\n(range: 3 to 25), 34 (53.1%) were female and 30 (46.9%) were male, 10.9% had\nprimary refractory disease, 89.1% had relapsed disease, and 43.8% of patients\nhad at least one prior haematopoietic stem cell <span style=\"color:black\">transplant.\n</span></span><span lang=\"EN-GB\" style=\"color:black\">Baseline disease\ncharacteristics were similar in the enrolled patients with regard to age\n(median age 13.0\u00a0years, range: 3 to 25), gender (46.7% female and 53.3%\nmale), primary refractoriness (10.7%), and prior transplant history (42.7%).</span><span lang=\"EN-GB\" style=\"color:black\"> The </span><span lang=\"EN-GB\">majority of infused\npatients (57/64, 89.1%) received bridging chemotherapy while waiting for\nKymriah. A total of 60 out of 64\u00a0patients (93.8%) who received Kymriah\ninfusion also received lymphodepleting chemotherapy after enrolment and prior\nto infusion of a single dose of Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Efficacy was established through the primary endpoint of ORR, which\nincluded best overall response as CR or CRi that were maintained for at least\n28\u00a0days within 6\u00a0months post\u2011infusion, as determined by IRC\nassessment, as well as secondary endpoints including DOR, proportion of\npatients who achieved CR or CRi with MRD\u2011negative disease status, and OS.\nAmong the patients infused, ORR was demonstrated in 45\u00a0patients (70.3%; 59.4%\nCR and 10.9% CRi). CR/CRi with MRD\u2011negative bone marrow was reported in 43\u00a0patients\n(67.2%). The median DOR was not reached and the event\u2011free probability at\n12\u00a0months was 70.5%. The survival probability at 24\u00a0months was 54.7%,\nand the median OS was estimated as 29.9\u00a0months (95% CI: 15.1, 42.4)<span style=\"color:black\">. The OS results were confirmed in an updated OS analyses\n(i.e. median OS 29.9\u00a0months [95% CI: 15.2, NE] with 57.6% survival\nprobability at 24\u00a0months; with a median follow\u2011up for OS of 25.9\u00a0months),\nwhich included patients transitioned to a separate long\u2011term follow\u2011up\nstudy. </span>Seven patients (10.9%) who achieved CR/CRi after Kymriah infusion\nproceeded to haematopoietic stem cell transplant while in remission during the\nstudy, of which 5 of the patients (7.8%) proceeded to transplant within the\nfirst 6\u00a0months post\u2011infusion.</span><span lang=\"EN-GB\" style=\"color:black\"> Efficacy results reported for the enrolled patients (n=75)\ndemonstrate an ORR of 60.0% (50.7% CR and 9.3% CRi; 57.3% with MRD\u2011negative\nbone marrow). The reported overall survival in the enrolled population is in accordance\nwith the infused population.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><span lang=\"EN-GB\">Special populations</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">No differences in efficacy or safety were observed between different\nage subgroups.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Patients with active CNS leukaemia</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Of four patients with active CNS leukaemia (i.e. CNS\u20113)\nincluded in study B2101J, three experienced cytokine release syndrome\n(Grade\u00a02\u20114) and transient neurological abnormalities (Grade\u00a01\u20113)\nthat resolved within 1\u20113\u00a0months of infusion. One patient died due to\ndisease progression and the remaining three patients achieved a CR or CRi and\nremain alive 1.5\u20112\u00a0years after infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Diffuse large B\u2011cell lymphoma (DLBCL)</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of Kymriah treatment in adult patients with\nrelapsed or refractory (r/r) diffuse large B\u2011cell lymphoma (DLBCL) who\nreceived \u22652\u00a0lines of chemotherapy, including rituximab and\nanthracycline, or relapsed following autologous haematopoietic stem cell\ntransplantation (HSCT), was evaluated in an open\u2011label, pivotal, single\u2011arm\nstudy. Patients with T\u2011cell rich/histiocyte\u2011rich large B\u2011cell\nlymphoma (THRBCL), primary cutaneous large B\u2011cell lymphoma, primary\nmediastinal B\u2011cell lymphoma (PMBCL), EBV\u2011positive DLBCL of the\nelderly, Richter\u2019s transformation, and Burkitt lymphoma were not enrolled in\nstudy C2201.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The pivotal study C2201 (JULIET) is a multicentre,\nsingle\u2011arm phase II study in adult patients with relapsed or refractory\nDLBCL. Of 167\u00a0patients enrolled, 115\u00a0patients received infusion with\nKymriah. Approximately 31% of patients discontinued the study prior to Kymriah infusion.\nFor 13\u00a0patients (8%) Kymriah could not be manufactured. Other reasons for\ndiscontinuation prior to Kymriah infusion included death (n=16; 10%), physician\ndecision/primary disease progression (n=16; 10%), patient decision (n=2; 1%),\nprotocol deviation (n=1; 1%) or adverse events (n=4; 2%) while awaiting Kymriah\nmanufacturing in the clinical study. </span><span style=\"font-size:11.0pt\">The\nmedian duration of study follow-up defined as the time from Kymriah infusion to\ndate of completion or discontinuation from follow-up prior to the data cut-off\ndate was 7.7\u00a0months (range: 0.4-35.6). The median time from Kymriah\ninfusion to the data cut-off date was 26.0\u00a0months (range: 9.7-38.2). The\nstudy is still ongoing.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Key baseline information for enrolled and\ninfused patients is presented in Table\u00a05. All patients had leukapheresis\nstarting material collected and cryopreserved prior to or during study entry.\nThe majority of patients (103/115, 90%) received bridging therapy for disease\nstabilisation. The type and duration of bridging therapy was left to the\ndiscretion of the physician. 107/115\u00a0patients (93%) received\nlymphodepleting chemotherapy prior to Kymriah infusion. Kymriah was given as a\nsingle\u2011dose (0.6\u20116.0\u00a0x\u00a010<sup>8</sup> CAR\u2011positive\nviable T cells) intravenous infusion in a qualified Kymriah treatment centre in\nan inpatient and outpatient setting.</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a05\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nC2201: Baseline information across the enrolled and the infused patient\npopulations</span></b></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"606\">\n<thead>\n<tr style=\"height:41.05pt\">\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=167</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=115</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>\n</thead>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>\n<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56\n  (12.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (13.1)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">58 (22 -\n  76)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56 (22 -\n  76)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;65\u00a0years</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">120\n  (71.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">89\n  (77.4)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226565\u00a0years</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">47 (28.1)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">26\n  (22.6)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">105\n  (62.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">71\n  (61.7)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">62 (37.1)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">44\n  (38.3)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Prior haematopoietic stem cell transplant (SCT) - n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">93 (55.7)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">59 (51.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">74 (44.3)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">56 (48.7)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Stage III/IV disease at study entry - n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">36 (21.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">27 (23.5)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">131 (78.4)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">88 (76.5)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Number of prior\n  lines of antineoplastic therapy \u2013 n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>6 (3.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5 (4.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>73 (43.7)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>51 (44.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>52 (31.1)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (31.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u22654</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (21.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>23 (20.0)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refractory to last line\n  of therapy</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">98 (58.7)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">63 (54.8)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapse to last line of therapy</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">69 (41.3)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">52 (45.2)</p>\n</td>\n</tr>\n</table>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The efficacy\nof Kymriah was evaluated through the primary endpoint of best overall response\nrate (ORR), which includes complete response (CR) and partial response (PR) as\ndetermined by Independent Review Committee (IRC) assessment as well as\nsecondary endpoints including duration of response (Table\u00a06).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><a name=\"_hd6_Table_4_2_Best_overall27158\"></a><a name=\"_hd7_Figure_4_1_Kaplan_Meie31722\"></a><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><a name=\"_Toc488242409\"><b><span lang=\"EN-GB\">Table\u00a06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b></a><b><span lang=\"EN-GB\">Study C2201:\nEfficacy results in adult patients with relapsed or refractory diffuse large B\u2011cell\nlymphoma (DLBCL) after two or more lines of systemic therapy</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:487.35pt;border-collapse:collapse;border:none\" width=\"650\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>\n<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint<sup>1</sup></span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=147</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=99</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Overall response\n  rate</span></b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\n<b>(ORR)</b> (CR+PR)<sup>2</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">95% CI</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (36.1)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(28.3, 44.4)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (53.5)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(43.2, 63.6)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">CR, n (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40 (27.2)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40(40.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">PR, n (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (8.8)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (13.1)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">Response a</span><span lang=\"EN-GB\">t\n  month\u00a03</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (26.5)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (39.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Response at month\u00a06</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (21.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (31.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Duration of response (DOR)<sup>3</sup></span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 18\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoints</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Overall survival (OS)<sup>4</sup></span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">40.9</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">47.9</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 24\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">32.5</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39.1</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">8.2 (5.8, 11.7)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">10.3 <span style=\"color:black\">(6.6, 21.1)</span></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:487.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"650\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\n  primary endpoint was analysed on all patients whose Kymriah was manufactured\n  at the Novartis US facility.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ORR\n  is the proportion of patients with best overall response (BOR) of CR or PR\n  based on the Lugano response criteria (Cheson 2014); non\u2011infused\n  patients were assigned BOR=Unknown (i.e. non\u2011responders).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>DOR\n  was defined as time from achievement of CR or PR to relapse or death due to\n  DLBCL, whichever occurs first.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal;page-break-after:avoid;text-autospace:none\"><sup><span lang=\"EN-GB\">4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\">OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause (N=115)\n  and time from date of enrolment to the date of death due to any cause for\n  enrolled patients (N=167).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5</span></sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not estimable.</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><a name=\"_Toc485048491\"></a><a name=\"_Toc488242412\"><span lang=\"EN-GB\">\u00a0</span></a></p>\n<p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Among the 40\u00a0patients\nwho achieved CR, 15\u00a0patients initially had an overall disease response of\nPR which improved to CR over time; most patients (13/15) achieved PR to CR\nconversion within 6\u00a0months post-tisagenlecleucel infusion. ORR was consistent\nacross subgroups.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are not\nenough data to determine whether there are any differences in efficacy or\nsafety between different age subgroups, although the clinical benefit and\nsafety experience in elderly patients with DLBCL above the age of 65\u00a0years\n(23% of the study population) were comparable to the overall population.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European\nMedicines Agency has deferred the obligation to submit the results of studies\nwith Kymriah</span><span lang=\"EN-GB\" style=\"color:#00B050\"> </span><span lang=\"EN-GB\">in one or more subsets of the paediatric population in the following\nconditions: a)\u00a0treatment of B\u2011cell lymphoblastic lymphoma, and b)\u00a0treatment\nof mature B\u2011cell neoplasms (see section\u00a04.2 for information on\npaediatric use).</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Following infusion of Kymriah into paediatric and young adult r/r B\u2011cell\nALL and r/r DLBCL patients, tisagenlecleucel typically exhibited an initial\nrapid expansion followed by a slower bi\u2011exponential decline.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cellular kinetics in paediatric and young adult B\u2011cell ALL\npatients</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">A summary of cellular kinetic parameters of tisagenlecleucel in\npaediatric and young adult B\u2011cell ALL patients is provided in Table\u00a07\nbelow. The maximal expansion (C<sub>max</sub>) was approximately 1.6\u2011fold\nhigher in CR/CRi patients (n=103) compared with non\u2011responding (NR)\npatients (n=10) as measured by qPCR. Delayed and lower expansion was observed\nin NR patients compared to CR/CRi patients.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<h6 style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:56.7pt;\ntext-indent:-56.7pt\"><a name=\"_Toc491696953\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a07\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of\ntisagenlecleucel in paediatric and young adult r/r B\u2011cell ALL</span></a><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> (Studies B2202 and\nB2205J)</span></h6>\n<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>\n<td style=\"width:112.3pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>\n<td style=\"width:115.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients (CR/CRi)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=105</span></p>\n</td>\n<td style=\"width:116.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients (NR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:black\">N</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">=12</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">35,300 (154.0), 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">21,900 (80.7), 10</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub><sup>\u2021</sup> (day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.83 [5.70; 27.8], 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">20.1 [12.6; 62.7], 10</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">309,000 (178.1), 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">232,000 (104.5), 8</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">25.2 (307.8), 71</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">3.80 (182.4), 4</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">166 [20.9; 916], 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">28.8 [26.7; 742], 9</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cellular kinetics in adult DLBCL patients</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A summary of\ncellular kinetic parameters of tisagenlecleucel in DLBCL patients is provided\nin Table\u00a08 below.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<h6 style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:56.7pt;\ntext-indent:-56.7pt\"><a name=\"_Toc491696954\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a08\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of tisagenlecleucel\nin r/r DLBCL patients</span></a></h6>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>\n<td style=\"width:110.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>\n<td style=\"width:113.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(CR and PR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=43</span></p>\n</td>\n<td style=\"width:122.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(SD/PD/Unknown)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=72</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,840 (254.3), 43</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,460 (326.89), 65</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub> (day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.00 [5.78; 19.8], 35</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">8.84 [3.04; 27.7], 65</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61,200 (177.7), 40</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">67,000 (275.2), 56</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">129 (199.2), 33</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">14.7 (147.1), 44</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">551 [17.1; 1030], 43</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61.4 [19.8; 685], 56</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u>Dis<span lang=\"EN-GB\">tribution</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">In paediatric and young adult B\u2011cell ALL patients, tisagenlecleucel\nhas been shown to be present in the blood and bone marrow beyond 2\u00a0years. The\nblood to bone marrow partitioning of tisagenlecleucel in bone marrow was 47.2% of\nthat present in blood at day\u00a028 while at months\u00a03 and 6 it distributes\nat 68.3% and 69%, respectively (</span><span lang=\"EN-GB\">Studies\u00a0B2202 and\nB2205J)</span><span lang=\"EN-GB\">. </span><span lang=\"EN-GB\">T</span><span lang=\"EN-GB\">isagenlecleucel also traffics and persists in cerebrospinal fluid in\npaediatric and young adult B\u2011cell ALL patients (Study B2101J) for up to\n1\u00a0year.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">In adult DLBCL patients (Study C2201), tisagenlecleucel has been\ndetected for up to 3\u00a0years in peripheral blood and up to month\u00a09 in\nbone marrow for complete responder patients. The blood to bone marrow\npartitioning in bone marrow was nearly 70% of that present in blood at day\u00a028\nand 50% at month\u00a03 in both responder and non\u2011responder patients.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The elimination profile of Kymriah includes a bi\u2011exponential\ndecline in peripheral blood and bone marrow.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><u><span lang=\"EN-GB\">Linearity/non\u2011linearity</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">There is no apparent relationship between dose and AUC<sub>0\u201128d</sub>\nor C<sub>max</sub>.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Special populations</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Elderly</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The scatter\nplots of cellular kinetic parameters versus age (22\u201176\u00a0years)\nrevealed no relevant relationship between cellular kinetic parameters (AUC<sub>0\u201128d</sub>\nand C<sub>max</sub>) with age.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Gender</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gender is not a significant characteristic influencing tisagenlecleucel\nexpansion in B\u2011cell ALL and DLBCL patients. In Study B2202, there were 43%\nfemale and 57% male patients and in Study C2201 38% female and 62% male\npatients who received Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Race/ethnicity</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is limited\nevidence that race/ethnicity impact the expansion of Kymriah in paediatric and\nyoung adult ALL and DLBCL patients. In Study B2202 there were 73.4% Caucasian, 12.7%\nAsian and 13.9% other ethnic patients. In Study C2201 there were 85% Caucasian,\n9% Asian, 4% Black or African American patients, and 3\u00a0patients (3%) of\nunknown race.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Body weight</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In ALL and DLBCL patients, across the weight ranges (ALL; 14.4 to\n137\u00a0kg; DLBCL: 38.4 to 186.7\u00a0kg), the scatter plots of qPCR cellular\nkinetic parameters versus weight revealed no apparent relationship between\ncellular kinetic parameters with weight.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Prior transplantation</span></u></i></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Prior transplantation did not impact the expansion/persistence of Kymriah\nin paediatric and young adult B\u2011Cell ALL patients or DLBCL patients.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety\ndata</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Non\u2011clinical\nsafety assessment of Kymriah addressed the safety concerns of potential\nuncontrolled cell growth of transduced T cells <i>in vitro</i> and <i>in vivo</i>\nas well as dose\u2011related toxicity, biodistribution and persistence. No\nsuch risks were identified based on these studies.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Carcinogenicity and mutagenicity</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Genotoxicity\nassays and carcinogenicity studies in rodents are not appropriate to assess the\nrisk of insertional mutagenesis for genetically\u2011modified cell therapy\nproducts. No alternative adequate animal models are available.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In vitro</span></i><span lang=\"EN-GB\"> expansion studies with CAR\u2011positive T cells (Kymriah) from\nhealthy donors and patients showed no evidence for transformation and/or\nimmortalisation of T cells. <i>In vivo</i> studies in immunocompromised mice\ndid not show signs of abnormal cell growth or signs of clonal cell expansion\nfor up to 7\u00a0months, which represents the longest meaningful observation\nperiod for immunocompromised mouse models. A genomic insertion site analysis of\nthe lentiviral vector was performed on Kymriah products from 14\u00a0individual\ndonors (12\u00a0patients and 2\u00a0healthy volunteers). There was no evidence\nfor preferential </span><span lang=\"EN-GB\">integration near genes of concern or\npreferential outgrowth of cells harbouring integration sites of concern</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reproductive toxicity</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No non\u2011clinical\nreproductive safety studies were conducted as no adequate animal model is\navailable.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Juvenile animal studies</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Juvenile\ntoxicity studies were not conducted.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Glucose</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium chloride</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Human albumin\nsolution</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dextran 40 for\ninjection</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dimethylsulfoxide</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium gluconate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium acetate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Potassium\nchloride</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Magnesium\nchloride</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium\u2011N\u2011acetyltryptophanate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium caprylate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Aluminium</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for\ninjections</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the absence\nof compatibility studies, this medicinal product must not be mixed with other\nmedicinal products.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">9\u00a0months.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The product\nshould be administered immediately after thawing. After thawing, the product\nshould be kept at room temperature (20\u00b0C\u201125\u00b0C) and infused within 30\u00a0minutes\nto maintain maximum product viability, including any interruption during the infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span></b></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store and\ntransport below \u2011120\u00b0C, e.g. in a container for cryogenic storage (Dewar)\nin the vapour phase of liquid nitrogen.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in the\noriginal protective envelope (Tyvek) containing the cassette protecting the infusion\nbag.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage\nconditions after thawing of the medicinal product, see section\u00a06.3.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents\nof container and special equipment for use, administration or implantation</span></b></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ethylene vinyl\nacetate (EVA) infusion bag with polyvinyl chloride (PVC) tubing and a luer\nspike interconnector closed by a luer\u2011lock cap containing either\n10\u201330\u00a0mL (50\u00a0mL bags) or 30\u201350\u00a0mL (250\u00a0mL bags) cell\ndispersion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Each infusion bag is placed into\nan aluminum cassette, then put in a plastic overwrap bag with absorbent sheets\nand sealed in a protective envelope (Tyvek).</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">One individual treatment dose comprises\n1 or more infusion bags.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b></a></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Inspection and thawing of the infusion bag(s)</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not thaw the\nproduct until it is ready to be used.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The infusion bag\nshould be placed inside a second sterile bag during thawing to protect ports\nfrom contamination and avoid spills in the unlikely event of the bag leaking. </span><span lang=\"EN-GB\">Kymriah should be thawed at 37\u00b0C using either a water bath or dry\nthaw method until there is no visible ice in the infusion bag. The bag should\nbe removed immediately from the thawing device and kept at room temperature (20\u00b0C\u201125\u00b0C)\nuntil infusion. If more than one infusion bag has been received for the\ntreatment dose, the next bag should only be thawed after the contents of the preceding\nbag have been infused.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah should <u>not</u>\nbe manipulated. For example, Kymriah should not be washed (spun down and\nresuspended in new media) prior to infusion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The infusion bag(s)\nshould be examined for any breaks or cracks prior to thawing. If the infusion bag\nappears to have been damaged or to be leaking, it should not be infused and\nshould be disposed of according to local procedures on handling of biological\nwaste (see section\u00a04.2.).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoHeader\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Precautions\nto be taken for transport and disposal of the medicinal product</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah should\nbe transported within the facility in closed, break\u2011proof, leak\u2011proof\ncontainers.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah contains\ngenetically\u2011modified human blood cells. Local guidelines on handling of\nbiological waste should be followed for unused medicinal product or waste\nmaterial. All material that has been in contact with Kymriah (solid and liquid\nwaste) should be handled and disposed in accordance with local guidelines on\nhandling of biological waste.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Novartis Europharm Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black\">Vista Building</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black\">Elm Park, Merrion Road</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black\">Dublin 4</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/18/1297/001</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">23 August 2018</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency <a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"margin-right:-.1pt;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE\nAND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY\nAND USE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions\nor restrictions with regard to the safe and effective use of the medicinal\nproduct</span></span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE\nSUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Name and\naddress of the manufacturers of the biological active substance</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Fraunhofer\nInstitut f\u00fcr Zelltherapie und Immunologie</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Perlickstrasse 1</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Hauptgeb\u00e4ude und\nErweiterungsbau 1</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">D-04103 Leipzig</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Germany</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\nPharmaceutical Corporation</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">220 East Hanover\nAvenue</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Morris Plains</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">New Jersey</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NJ07950</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">United States</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis Pharma\nStein AG</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis Technical\nOperations Schweiz</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Stein Cell and\nGene Therapy,</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Schaffhauserstrasse</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">4332 Stein</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Switzerland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">CELLFORCURE</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">ZA de Courtab\u0153uf</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">11 avenue des\nTropiques</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">91940 Les Ulis</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">France</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis Pharma\nGmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Roonstrasse 25</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">D-90429\nNuremberg</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Germany</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">CELLFORCURE</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">ZA de Courtab\u0153uf</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">11 avenue des\nTropiques</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">91940 Les Ulis</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">France</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The printed\npackage leaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\">B.</span></b></a><b><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex I: Summary of\nProduct Characteristics, section\u00a04.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The requirements for submission of </span><span lang=\"EN-GB\">PSURs</span><span lang=\"EN-GB\"> for this medicinal product are set out in the list of Union\nreference dates (EURD list) </span><span lang=\"EN-GB\">provided for under Article\n107c(7) of Directive 2001/83</span><span lang=\"EN-GB\">/EC</span><span lang=\"EN-GB\">\nand </span><span lang=\"EN-GB\">any subsequent updates published on the European\nmedicines web-portal.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\nauthorisation holder (MAH) shall submit the first PSUR for this product within\n6\u00a0months following authorisation.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The marketing authorisation holder (MAH) shall perform the required\npharmacovigilance activities and interventions detailed in the agreed RMP\npresented in Module 1.8.2 of the marketing authorisation and any agreed\nsubsequent updates of the RMP.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An updated RMP should be submitted:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Additional risk minimisation measures</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Key elements:</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Availability of tocilizumab and site qualification</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">To minimise the risks associated with KYMRIAH treatment, the MAH\nmust ensure that hospitals and their associated centres that dispense KYMRIAH\nare specially qualified in accordance with the agreed control distribution\nprogramme.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">The MAH must ensure on\u2011site, immediate access to tocilizumab\nfor each patient as CRS management medication prior to treating patients. </span><span lang=\"EN-GB\">Hospitals should have access to additional doses of tocilizumab\nwithin 8\u00a0hours.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">KYMRIAH will only be supplied to hospitals and associated centres that\nare qualified and only if the healthcare professionals involved in the\ntreatment of a patient have completed the educational programme.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Educational programme</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">Prior to the launch of KYMRIAH in each Member State, the MAH must\nagree about the content and format of the educational materials with the\nNational Competent Authority.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">HCP educational programme</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The MAH shall ensure that in each Member State where KYMRIAH is\nmarketed, all HCPs who are expected to prescribe, dispense annd administer\nKYMRIAH shall be provided with a guidance document to:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">facilitate identification of CRS and serious\nneurological adverse reactions</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">facilitate management of the CRS and serious\nneurological adverse reactions</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">ensure adequate monitoring of CRS and serious\nneurological adverse reactions</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">facilitate provision of all relevant information\nto patients</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">ensure that adverse reactions are adequately and\nappropriately reported</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">ensure that detailed instructions about the\nthawing procedure are provided</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">before treating a patient, ensure that\ntocilizumab for each patient are available on site</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient educational programme</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">To inform and explain to patients:</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the risks of CRS and serious neurological\nadverse reactions associated with KYMRIAH</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the need to report the symptoms to their\ntreating doctor immediately</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the need to remain in the proximity of the\nlocation where KYMRIAH was received for at least 4\u00a0weeks following KYMRIAH\ninfusion</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the need to carry the patient alert card at all\ntimes</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe,\nthe below measures:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse;border:none\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:30.4%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Non\u2011interventional post\u2011authorisation\n  safety study (PASS): In order to further characterise the safety \u2013 including\n  long\u2011term safety \u2013 of Kymriah, the applicant should conduct and submit\n  a study based on data from a disease registry in ALL and DLBCL patients.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Annual safety reports and 5\u2011yearly interim\n  reports</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report of study results:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">December 2038</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In\n  order to further evaluate the efficacy and safety of Kymriah in ALL patients\n  below the age of 3\u00a0years, the applicant should conduct and submit a\n  study based on data from a disease registry in ALL patients.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Included as part of the annual reports of the non\u2011interventional\n  PASS</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report: December 2023</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further evaluate the efficacy of Kymriah in patients with relapsed/refractory\n  DLBCL, the applicant should conduct and submit a prospective, observational\n  study in patients with r/r DLBCL based on data from registry with efficacy\n  outcome measures in line with study C2201, including details of the\n  manufacturing turnaround time (i.e. time from last relapse or confirmed\n  refractory status, time from decision to treat, and time from leukapheresis\n  to infusion).</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the 24\u00a0months\n  follow\u2011up of all infused patients from study C2201. In addition the\n  applicant should submit the final CSR including 5\u00a0years of follow\u2011up.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Updated report:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">November 2020</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Final CSR: August 2023</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the results of study\n  CCTL019H2301 \u2013 open\u2011label, Phase III study of Kymriah versus standard\n  of care in adult patients with relapsed or refractory aggressive B\u2011cell\n  non\u2011Hodgkin lymphoma.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">A. LABELLING</span></b></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">INFUSION BAG LABEL</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE\nMEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Kymriah 1.</span><span lang=\"FR-CH\">2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells</span><span lang=\"FR-CH\"> dispersion for infusion</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">tisagenlecleucel\n(CAR+ viable T cells)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF\nACTIVE SUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Autologous human\nT cells genetically modified <i>ex vivo</i> using a lentiviral vector encoding\nan anti\u2011CD19 chimeric antigen receptor (CAR).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Contains 1.2\u00a0x\u00a010<sup>6</sup>\nto 6\u00a0x\u00a010<sup>8</sup> CAR+ viable T cells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Also contains:\nglucose, sodium chloride, human albumin solution, dextran 40 for injection,\ndimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride,\nmagnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate,\naluminium, water for injections. <span style=\"color:black;background:#D9D9D9\">See\nleaflet for further information.</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Dispersion for infusion</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10\u00a0mL\u00a0\u2011\u00a050\u00a0mL\nper bag.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND\nROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Intravenous use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use\nleukocyte depleting filter.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING\nTHAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Keep out of the sight and reach of\nchildren.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL\nWARNING(S), IF NECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For autologous\nuse only.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Store and transport below \u2011120\u00b0C; do not thaw the product\nuntil use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS\nFOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Contains genetically\u2011modified\ncells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dispose of as\nper local guideline on handling of biological waste.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Novartis Europharm Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">Vista Building</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">Elm Park, Merrion Road</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">Dublin 4</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black;\nbackground:#D9D9D9\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse\">\n<tr>\n<td style=\"width:232.15pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/18/1297/001</span></p>\n</td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">10 \u2013 50\u00a0ml</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER,\nDONATION AND PRODUCT CODES</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Name:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of birth: <span style=\"color:black;background:#D9D9D9\">{DD MMM YYYY}</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Aph ID/DIN:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Batch:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Bag <span style=\"color:black;background:#D9D9D9\">x</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN\nBRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Justification for not including Braille\naccepted.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Not applicable</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2011 HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Not applicable</span><span lang=\"EN-GB\"><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></b></p>\n<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the patient or carer</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"FR-CH\">Kymriah 1.</span></b><b><span lang=\"FR-CH\">2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells</span></b><b><span lang=\"FR-CH\"> dispersion for infusion</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"FR-CH\">tisagenlecleucel (CAR+ viable T cells)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Picture 1\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image002.gif\" width=\"21\"/></span><span lang=\"EN-GB\">This medicine is subject to\nadditional monitoring. This will allow quick identification of new safety\ninformation. You can help by reporting any side effects you may get. See the\nend of section\u00a04 for how to report side effects.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you (or your child) are given this medicine\nbecause it contains important information.</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you get any side effects, talk to your\ndoctor.</span><span lang=\"EN-GB\" style=\"color:red\"> </span><span lang=\"EN-GB\">This\nincludes any possible side effects not listed in this leaflet. See section\u00a04.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will give you a Patient Alert Card.\nRead it carefully and follow the instructions on it.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Always show the Patient Alert Card to the doctor\nor nurse when you see them or if you go to hospital.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The information in this leaflet is for you or\nyour child \u2013 but in the leaflet it will just say \u201cyou\u201d.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and what it is used for</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you are given Kymriah</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is given</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Kymriah</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and\nwhat it is used for</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What </span></b><b><span lang=\"EN-GB\">Kymriah is</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah, also\nknown as tisagenlecleucel, is made from some of your own white blood</span><span lang=\"EN-GB\"> cells</span> called T cells. T cells <span lang=\"EN-GB\">are important\nfor your immune system (the body\u2019s defences) to work properly.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How does Kymriah work?</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The T cells are\ntaken</span><span lang=\"EN-GB\"> from your blood and a new gene is put into the T\ncells so that they can target the cancer cells in your body. When Kymriah is\ninfused into your blood, the modified T cells will find and kill the cancer cells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Kymriah is used for</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Kymriah is used to treat:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">B\u2011cell acute lymphoblastic leukaemia (B\u2011cell\nALL)</span></b><span lang=\"EN-GB\"> \u2011 a form of cancer that affects some other\ntypes of white blood cells. The medicine can be used in children and young\nadults up to and including 25\u00a0years of age with this cancer.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Diffuse</span></b><b><span lang=\"EN-GB\"> large\nB\u2011cell lymphoma (DLBCL)</span></b><span lang=\"EN-GB\"> \u2011</span><span lang=\"EN-GB\"> another form of cancer that affects some types of white blood\ncells, mostly in the lymph nodes. The medicine can be used in adults\n(18\u00a0years of age or older) with this cancer.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any\nquestions about how Kymriah works or why this medicine has been prescribed for\nyou, ask your doctor.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to\nknow before you are given Kymriah</span></b></p>\n<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">You should not be given Kymriah:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you are allergic to any of the ingredients of\nthis medicine (listed in section\u00a06).</span><span lang=\"EN-GB\"> If you think\nyou may be allergic, ask your doctor for advice.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is made\nfrom your own white blood cells and should only be given to you.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Before you are given Kymriah you should tell your doctor if:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have had a stem cell transplant in the last 4\u00a0months.\nYour doctor will check if you have signs or symptoms of graft\u2011versus\u2011host\ndisease. This happens when transplanted cells attack your body, causing\nsymptoms such as rash, nausea, vomiting, diarrhoea and bloody stools.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have any lung, heart or blood pressure (low\nor raised) problems.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You notice the symptoms of your cancer are\ngetting worse. If you have leukaemia this might include fever, feeling weak,\nbleeding gums, bruising. If you have lymphoma, this might include unexplained\nfever, feeling weak, night sweats, sudden weight loss.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have an infection. The infection will be\ntreated before the Kymriah infusion.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have had hepatitis B, hepatitis C or human\nimmunodeficiency virus (HIV) infection.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You are pregnant, think you may be pregnant, or\nplan to become pregnant (see sections \u201cPregnancy and breast\u2011feeding\u201d and \u201cContraception\nfor women and men\u201d below).</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You had a vaccination in the previous\n6\u00a0weeks or are planning to have one in the next few months.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If any of the\nabove apply to you (or you are not sure), talk to your doctor before being\ngiven Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Test and checks</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Before you are given Kymriah</span></b><span lang=\"EN-GB\"> <b>your\ndoctor will:</b></span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Check your lungs, heart and blood pressure.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Look for signs of infection; any infection will\nbe treated before you are given Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Check if your lymphoma or leukaemia is getting\nworse.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Look for signs of graft\u2011versus\u2011host disease\nthat can happen after a transplant.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><s><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></s><span lang=\"EN-GB\">Check your blood for uric acid and for how\nmany cancer cells there are in your blood. This will show if you are likely to\ndevelop a condition called tumour lysis syndrome. You may be given medicines to\nhelp prevent the condition.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Check for hepatitis B, hepatitis C or HIV infection.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">After you have been given Kymriah</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor or nurse immediately if you have any of the\nfollowing:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Fever, which may be a symptom of an infection.\nYour doctor will regularly check your blood counts as the number of blood cells\nand other blood components may decrease.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Take your temperature twice a day for 3\u20114\u00a0weeks\nafter treatment with Kymriah. If your temperature is high, see your doctor\nimmediately.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Extreme tiredness, weakness and shortness of\nbreath, which may be symptoms of a lack of red blood cells.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Bleeding or bruising more easily, which may be\nsymptoms of low levels of cells in the blood known as platelets.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There may be an\neffect on the results of some types of HIV test \u2013 ask your doctor about this.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor will\nregularly monitor your blood counts after you receive Kymriah as you may\nexperience a reduction in the number of blood cells and other blood components.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not donate\nblood, organs, tissues or cells.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">No formal studies have been performed in paediatric\npatients below 3\u00a0years of age in B\u2011cell ALL.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Kymriah should not be used in children and adolescents\nbelow 18\u00a0years of age to treat DLBCL</span><span lang=\"EN-GB\">. This is\nbecause Kymriah has</span><span lang=\"EN-GB\"> not been studied in this age group.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other medicines and Kymriah</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Tell your doctor if you are taking, have recently taken or might\ntake any other medicines, including medicines obtained without a prescription.\nThis is because other medicines can affect the way Kymriah works.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">In particular, you must not be given certain vaccines called live\nvaccines:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">in the 6\u00a0weeks before you are given the\nshort course of chemotherapy (called lymphodepleting chemotherapy) to prepare\nyour body for the Kymriah cells.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">during Kymriah treatment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">after treatment while the immune system is\nrecovering.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Talk to your\ndoctor if you need to have any vaccinations.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:1.4pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:1.4pt;line-height:normal\"><span lang=\"EN-GB\">Before<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>ou<span style=\"letter-spacing:-.3pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>given<span style=\"letter-spacing:-.25pt\"> </span>Kymriah<span style=\"letter-spacing:-.3pt\"> </span>tell<span style=\"letter-spacing:-.2pt\"> </span>your<span style=\"letter-spacing:-.25pt\"> </span>doctor<span style=\"letter-spacing:-.25pt\">\n</span>or<span style=\"letter-spacing:-.3pt\"> </span>nurse<span style=\"letter-spacing:-.3pt\"> </span>if<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>ou<span style=\"letter-spacing:-.25pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>taking<span style=\"letter-spacing:-.25pt\">\n</span>any<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:\n-.1pt\">m</span>edicines<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:.05pt\">t</span>hat we<span style=\"letter-spacing:-.05pt\">a</span>ken<span style=\"letter-spacing:-.35pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>our\n<span style=\"letter-spacing:.05pt\">i</span>m<span style=\"letter-spacing:-.15pt\">m</span>une<span style=\"letter-spacing:-.35pt\"> </span>s<span style=\"letter-spacing:.05pt\">y</span>stem<span style=\"letter-spacing:-.35pt\"> </span>such<span style=\"letter-spacing:-.3pt\"> </span>as<span style=\"letter-spacing:-.35pt\"> </span>co<span style=\"letter-spacing:.05pt\">r</span>ticosteroids,<span style=\"letter-spacing:-.35pt\"> </span>since<span style=\"letter-spacing:-.35pt\">\n</span>these<span style=\"letter-spacing:-.3pt\"> </span>medicines<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:-.1pt\">m</span>ay<span style=\"letter-spacing:-.3pt\"> </span>interfere<span style=\"letter-spacing:-.35pt\">\n</span>with<span style=\"letter-spacing:-.3pt\"> </span>the effe<span style=\"letter-spacing:-.05pt\">c</span>t<span style=\"letter-spacing:-.55pt\"> </span>of<span style=\"letter-spacing:-.5pt\"> </span>Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If you are pregnant or breast\u2011feeding, think you may be\npregnant or are planning to have a baby, ask your doctor for advice before being\ngiven this medicine. This is because the effects of Kymriah in pregnant or\nbreast\u2011feeding women are not known, and it may harm your unborn baby or\nyour newborn/infant.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If</span><span lang=\"EN-GB\"> you become pregnant\nor think you may be pregnant after treatment with Kymriah, talk your doctor\nimmediately.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You will be given a pregnancy test before\ntreatment starts. Kymriah should only be given if the result shows you are not\npregnant.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Contraception for women and men</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discuss\npregnancy with your doctor if you have received Kymriah.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not drive, use machines, or take part in activities that need you\nto be alert for. Kymriah can cause problems such as altered or decreased\nconsciousness, confusion and seizures (fits) in the 8\u00a0weeks following\ninfusion.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Kymriah contains sodium, dimethylsulfoxide (DMSO) and dextran 40.</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">This medicine contains 24.3 to 121.5\u00a0mg sodium per dose. This\nis equivalent to 1 to 6% of the recommended maximum daily dietary intake of 2\u00a0g\nsodium for an adult. If you have not been previously exposed to dextran or DMSO\nyou should be observed closely during the first minutes of the infusion period.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is\ngiven</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">Kymriah will always be given to you by a doctor in a\nqualified treatment centre.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah contains\nhuman blood cells. Your doctor handling Kymriah will therefore take appropriate\nprecautions (wearing gloves and glasses) to avoid potential transmission of\ninfectious diseases.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><b><span lang=\"EN-GB\">Giving blood to make Kymriah</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Kymriah is made from your own white blood cells.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will take some of your blood using a\ncatheter placed in your vein (a procedure called leukapheresis). Some of your\nwhite blood cells are separated from your blood and the rest of your blood is\nreturned to your vein. This can take 3 to 6\u00a0hours and may need to be\nrepeated.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your white blood cells are frozen and sent away\nto make Kymriah. It usually takes about 3 to 4\u00a0weeks to make Kymriah but\nthe time may vary.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Kymriah is a treatment that is manufactured\nspecifically for you. There are situations where Kymriah cannot be successfully\nmanufactured and be given to you. In some cases, a second manufacturing of\nKymriah may be attempted.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Before you are\ngiven Kymriah, your doctor may give you a type of treatment called\nlymphodepleting chemotherapy for a few days to prepare your body.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><b><span style=\"font-size:11.0pt\">Cancer treatment while Kymriah is\nbeing made</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">During the period while Kymriah is being made, your </span><span lang=\"EN-GB\">lymphoma or leukaemia may get worse and your doctor may decide to\nuse an additional treatment (a type of chemotherapy known as \u201cbridging\ntherapy\u201d) to stabilise your cancer </span><span lang=\"EN-GB\">by stopping new\ncancer cells from developing</span><span lang=\"EN-GB\">. This t</span><span lang=\"EN-GB\">reatment </span><span lang=\"EN-GB\">may lead to side effects and these\nmay be severe or life-threatening. Your doctor will inform you of the potential\nside effects of this treatment.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Medicines given immediately before Kymriah treatment</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">During the 30 to 60\u00a0minutes before you are given Kymriah you\nmay be given other medicines. This is to help prevent infusion reactions and\nfever. These other medicines may include:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Paracetamol</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">An antihistamine such as diphenhydramine.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How you are given Kymriah</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will check that the individual\npatient identifiers on the Kymriah infusion bag match up to you.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will give you Kymriah by infusion,\nwhich means it will be given as a drip through a tube in your vein. This\nusually takes less than 1\u00a0hour.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Kymriah is a one\u2011time treatment.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">After you are given Kymriah</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Plan to stay within 2\u00a0hours\u2019 travel from\nthe hospital where you were treated for at least 4\u00a0weeks after you have\nbeen given Kymriah. Your doctor will recommend that you return to the hospital daily\nfor at least 10\u00a0days and will consider whether you need to stay at the hospital\nas an in\u2011patient for the first 10\u00a0days after infusion. This is so\nyour doctor can check if your treatment is working and help you if you have any\nside effects.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">If you miss an appointment, call your doctor or the hospital as soon\nas possible to reschedule.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">Like all medicines, this medicine can cause side\neffects, although not everybody gets them.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor immediately</span></b><span lang=\"EN-GB\"> if you get\nany of the following side effects after the Kymriah infusion. They usually\nhappen in the first 8\u00a0weeks after the infusion, but can also develop later:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Very common: may affect more than 1 in 10\u00a0people</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">high fever and chills. These may be symptoms of\na serious condition called cytokine release syndrome which </span><span lang=\"EN-GB\">may be life-threatening or fatal</span><span lang=\"EN-GB\">. Other\nsymptoms of cytokine release syndrome are difficulty breathing, nausea,\nvomiting, diarrhoea, loss of appetite, fatigue, muscle pain, joint pain, swelling,\nlow blood pressure, headache, heart, lung and kidney failure and liver injury.\nThese symptoms almost always occur </span><span lang=\"EN-GB\">within the first\n10\u00a0days after infusion.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">problems such as altered thinking or decreased\nconsciousness, loss of contact with reality, confusion, agitation, seizures,\ndifficulty speaking and understanding speech, difficulty walking.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">feeling warm, fever, chills or shivering, sore\nthroat or mouth ulcers may be signs of an infection. </span><span lang=\"EN-GB\">Some\ninfections may be life-threatening or fatal.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Common: may affect up to 1 in 10\u00a0people</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Rapid breakdown of tumour cells causing release\nof their contents into the bloodstream. This can interfere with the workings of\nvarious body organs, especially the kidneys, heart and nervous system</span><span lang=\"EN-GB\"> </span>(tumour lysis syndrome).</p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.4pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><b><span lang=\"EN-GB\">Other possible side effects</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">Other side effects are listed below. If these side\neffects become severe or serious, tell your doctor immediately.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Very common:</span></b><span lang=\"EN-GB\"> <i>may affect more than 1\nin 10\u00a0people</i></span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Pale skin, weakness, breathlessness due to low\nnumber of red blood cells or low haemoglobin</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Excessive or prolonged bleeding or bruising due\nto l</span><span lang=\"EN-GB\" style=\"color:black;background:white\">ow number of\nplatelets</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black;background:white\">Fever with dangerously\nlow white blood cell count</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black;background:white\">Increased\nrisk of infection due to abnormally low number of white blood cells</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"letter-spacing:-.05pt\">Frequent</span><span lang=\"EN-GB\" style=\"letter-spacing:.3pt\"> </span><span lang=\"EN-GB\">and<span style=\"letter-spacing:1.35pt\"> </span><span style=\"letter-spacing:-.05pt\">persistent\ninfections due to decreased</span><span style=\"letter-spacing:.3pt\"> </span>antibodies\nin<span style=\"letter-spacing:.45pt\"> </span><span style=\"letter-spacing:-.1pt\">your</span><span style=\"letter-spacing:.4pt\"> </span>blood</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Weakness, abnormal heart rhythms, muscle\nspasms/cramping due to abnormal low level of blood salts including </span><span lang=\"EN-GB\">phosphorus</span><span lang=\"EN-GB\">, calcium, potassium, magnesium</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">High levels of liver enzymes or creatinine in\nthe blood that show that your liver or kidneys are not working normally</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Anxiety, irritability</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Fast or irregular heart beat</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Raised blood pressure</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Shortness of breath, laboured breathing, rapid\nbreathing, fluid in the lungs</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Cough</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Abdominal pain, constipation</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Skin rash</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Difficulty sleeping</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swollen ankles, limbs and face</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Common:</span></b><span lang=\"EN-GB\"> <i>may affect up to 1 in 10\u00a0people</i></span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">F</span><span lang=\"EN-GB\">ever, malaise, enlarged\nliver, yellow colour of your skin and eyes, low blood cell counts due to severe\nimmune activation</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Dizziness or fainting, flushing, rash, itching,\nfever, shortness of breath or vomiting, abdominal pain, diarrhoea due to\ninfusion related reaction</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Rash, nausea, vomiting, diarrhoea including\nbloody stools (possible symptoms of graft-versus-host disease which is when\ntransplanted cells attack your cells)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black;background:white\">Pain in the\njoints</span><span lang=\"EN-GB\"> due to high level of uric acid</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Abnormal blood test results (high level of:\nphosphorus, potassium, calcium, magnesium and sodium, an enzyme called alkaline\nphosphatase to help detect liver disease, fibrin d-dimer, serum ferritin; low\nlevel of: blood protein called albumin, sodium)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Convulsion, fits (seizures)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Involuntary or uncontrollable movements</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Tingling or numbness, </span><span lang=\"EN-GB\">difficulty\nmoving because of nerve damage</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Decreased vision</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Thirst</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">W</span><span lang=\"EN-GB\">eight loss</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Nerve pain</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Breathlessness, difficulty breathing when lying\ndown, swelling of the feet or legs (possible symptoms of h</span><span lang=\"EN-GB\">eart failure), stopped heart beat</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swelling and pain due to blood clots</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swelling due to fluids leaking from blood\nvessels into the surrounding tissue</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Bloating and discomfort (abdominal distension),due\nto an accumulation of fluid in the abdomen</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Dry mouth, sore mouth, bleeding in the mouth,\ninflammation in the gums</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Yellow skin and eyes due to abnormally high\nlevels of bilirubin in the blood</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Itching</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Excessive sweating, n</span><span lang=\"EN-GB\">ight\nsweats</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Bone and back pain</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Flu\u2011like illness</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Failure of multiple organs</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Uncommon: </span></b><i><span lang=\"EN-GB\">may affect up to 1 in\n100\u00a0people</span></i></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Weakness or paralysis of limbs or face,\ndifficulty speaking (possible symptoms of stroke as a result of reduced blood\nsupply)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Warm or rapidly reddening skin</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Cough that produces phlegm or sometimes blood,\nfever, shortness of breath or difficulty breathing</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you get any\nside effects, talk to your doctor.</span><span lang=\"EN-GB\" style=\"color:red\"> </span><span lang=\"EN-GB\">This includes any possible side effects not listed in this leaflet.</span><span lang=\"EN-GB\" style='font-family:\"Verdana\",sans-serif'> </span><span lang=\"EN-GB\">You\ncan also report side effects directly via <span style=\"color:black;background:\n#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span><span lang=\"EN-GB\"> By reporting side effects, you can help provide more information on\nthe safety of this medicine.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nKymriah</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">The following information is intended for doctors only.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not use this medicine after the expiry date which is stated on\nthe infusion bag label after EXP. The expiry date refers to the last day of\nthat month.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Store and transport below \u2011120\u00b0C. Do not thaw the product\nuntil it is ready to be used.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine if the infusion bag is damaged or leaking.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine\ncontains genetically\u2011modified blood cells. Local guidelines on handling\nof biological waste should be followed for unused medicine or waste material.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the\npack and other information</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Kymriah contains</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The active substance of Kymriah is called tisagenlecleucel.\nEach infusion bag of Kmyriah contains </span><span lang=\"EN-GB\">tisagenlecleucel cell\ndispersion at a batch\u2011dependent concentration of </span><span lang=\"EN-GB\">autologous\nT cells genetically modified to express an </span><span lang=\"EN-GB\">anti\u2011CD19\nchimeric antigen receptor</span><span lang=\"EN-GB\"> (CAR\u2011positive viable T\ncells). 1 or more bags contain a total of </span>1.2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8\n</sup>CAR+ viable T cells.</p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">other ingredients are\nglucose, sodium chloride, human albumin solution, dextran 40 for injection,\ndimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride,\nmagnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate,\naluminium, and water for injections. See section\u00a02, \u201cKymriah contains\nsodium, dimethylsulfoxide (DMSO) and dextran 40\u201d.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Kymriah looks like and contents of the pack</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is a cell\ndispersion for infusion. It is supplied as an infusion bag containing a cloudy\nto clear, colourless to slightly yellow dispersion of cells. Each bag contains\n10\u00a0mL to 50\u00a0mL of dispersion.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Novartis Europharm Limited</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:4.8pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:4.8pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:4.8pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:black\">Novartis Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:black\">Roonstrasse 25</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:black\">90429 Nuremberg</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Germany</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">CELLFORCURE</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"FR-CH\" style=\"color:black;background:#D9D9D9\">ZA de Courtab\u0153uf</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"FR-CH\" style=\"color:black;background:#D9D9D9\">11 avenue des Tropiques</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">91940 Les Ulis</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">France</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">For any information about this medicine, please contact\nthe local representative of the Marketing Authorisation Holder:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"624\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">SIA Novartis\n  Baltics Lietuvos filialas</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Tel: +370 5 269\n  16 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Bulgaria\n  EOOD</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b</span><span lang=\"ES\">: +359 2 489 98 28</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +420 225\n  775 111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Hung\u00e1ria Kft.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel.: +36 1\n  457 65 00</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Healthcare A/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: +45 39 16\n  84 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +356 2122\n  2872</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +49 911\n  273 0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +31 </span><span lang=\"DE-CH\" style=\"color:black\">88 04 52 </span><span lang=\"DE-CH\">555</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +372 66\n  30 810</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Novartis\n  Norge AS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Tlf: +47 23\n  05 20 00</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis (Hellas)\n  A.E.B.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 281 17 12</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +43 1 86\n  6570</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis\n  Farmac\u00e9utica, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +34 93\n  306 42 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Tel.: +48 22 375\n  4888</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">T\u00e9l: +33 1 55\n  47 66 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma \u2011\n  Produtos Farmac\u00eauticos, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +351 21\n  000 8600</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel. +385 1\n  6274 220</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Romania SRL</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21 31299\n  01</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Ireland Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +353 1\n  260 12 55</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +386 1\n  300 75 50</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +354 535\n  7000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Novartis Slovakia\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 2\n  5542 5439</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma\n  S.p.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 02 96\n  54 1</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Finland Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Puh/Tel: +358\n  (0)10 6133 200</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +357 22 690 690</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Sverige AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +46 8 732\n  32 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Tel: +371 67 887\n  070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Pharmaceuticals UK Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 1276\n  698370</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">This leaflet was last revised in</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other sources of information</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicine is available on the European\nMedicines Agency web site: </span><span lang=\"EN-GB\"><span class=\"MsoHyperlink\">http://www.ema.europa.eu</span></span></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.4pt;margin-bottom:\n0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">The following information is intended for\nhealthcare professionals only:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.4pt;margin-bottom:\n0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparation of the infusion bag</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The timing of thaw of Kymriah and of infusion should be coordinated.\nConfirm the infusion time in advance and adjust the start time for thaw so that\nKymriah is available for infusion when the recipient is ready. Once Kymriah has\nbeen thawed and is at room temperature (20\u00b0C\u201125\u00b0C), it should be infused\nwithin 30\u00a0minutes to maintain maximum product viability, including any\ninterruption during the infusion.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The infusion bag should be placed inside a second, sterile bag\nduring thawing to protect ports from contamination and avoid spills in the\nunlikely event of the bag leaking. Kymriah should be thawed at 37\u00b0C using\neither a water bath or dry thaw method until there is no visible ice in the\ninfusion bag. The bag should be removed immediately from the thawing device and\nkept at room temperature (20\u00b0C\u201125\u00b0C) until infusion. If more than one infusion\nbag has been received for the treatment dose (refer to the batch certificate\nfor number of bags constituting one dose), the next bag should only be thawed\nafter the contents of the preceding bag have been infused.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah should not be manipulated. For example, Kymriah should not\nbe washed (spun down and resuspended in new media) prior to infusion.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The infusion bag(s) should be examined for any breaks or cracks\nprior to thawing. If the infusion bag appears to have been damaged or to be\nleaking, it should not be infused and should be disposed of according to local guidelines\non handling of biological waste.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah intravenous infusion should be administered by a healthcare\nprofessional experienced with immunosuppressed patients and prepared to manage\nanaphylaxis. </span><span lang=\"EN-GB\">Ensure that one dose of tocilizumab per\npatient and emergency equipment are available prior to infusion and during the\nrecovery period. </span><span lang=\"EN-GB\">Hospitals should have access to\nadditional doses of tocilizumab </span><span lang=\"EN-GB\">within 8\u00a0hours</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The patient\u2019s identity should be matched with the patient\nidentifiers on the infusion bag. </span><span lang=\"EN-GB\">Kymriah is for\nautologous use only. Kymriah should be administered as an intravenous infusion\nusing latex\u2011free intravenous tubing without a leukocyte depleting filter,\nat approximately 10 to 20\u00a0mL per minute by gravity flow. All contents of\nthe infusion bags should be infused. Sterile sodium chloride 9\u00a0mg/mL\n(0.9%) solution for injection should be used to prime the tubing prior to\ninfusion as well as rinse it afterwards. When the full volume of Kymriah has\nbeen infused, the infusion bag should be rinsed with 10 to 30\u00a0mL sodium\nchloride 9\u00a0mg/mL (0.9%) solution for injection by back priming to ensure\nas many cells as possible are infused into the patient.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Precautions to be taken before handling or administering Kymriah</span></u></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah contains genetically\u2011modified human blood cells. Local\nguidelines on handling of biological waste should be followed for disposal.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">All material that has been in contact with Kymriah (solid and liquid\nwaste) should be handled and disposed of as potentially infectious waste in\naccordance with local guidelines on handling of biological waste.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah should be transported within the facility in closed, break\u2011proof,\nleak\u2011proof containers.</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah is prepared from autologous blood of the patient collected\nby leukapheresis. Patient leukapheresis material and Kymriah may carry a risk\nof transmitting infectious viruses to healthcare professionals handling the\nproduct. Accordingly, healthcare professionals should employ appropriate\nprecautions (wearing gloves and glasses) when handling leukapheresis material\nor Kymriah to avoid potential transmission of infectious diseases.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</div>", "ID": "fa248be5-e55e-4243-9779-a5e681e0dcb3", "Styles": "None", "Classes": "['WordSection1']", "Text": "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ", "ParentId": "0102270e-7ca8-4df6-a9f1-c1ab7064c2cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "16318f84-42cc-4d91-a80f-7e3f2e84f0b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "47f7c66a-2899-4145-b3c7-7697caa17070", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "16318f84-42cc-4d91-a80f-7e3f2e84f0b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "113c6417-016a-420f-9531-1c5d5ecaf6c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aab5a334-3bc4-40bf-a601-cab5f7fcef5a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "113c6417-016a-420f-9531-1c5d5ecaf6c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6370260d-c29b-42e7-b72f-c916c5fdd300", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac074bf2-a86b-4097-92dc-c65c76f84d2b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6370260d-c29b-42e7-b72f-c916c5fdd300"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8ecd7859-a392-4bf6-af23-3e40c79f4c8c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "576027ce-1a39-481c-9c8f-dfab3861b7e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8ecd7859-a392-4bf6-af23-3e40c79f4c8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1aeb4fb-c52a-4bb5-9826-e9cd8a629072", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8c7957fa-aa44-4a66-a637-43e96c1f8472", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1aeb4fb-c52a-4bb5-9826-e9cd8a629072"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "49c37034-5fb8-4bdc-9154-0e115cfe39d8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a3291251-dc9b-4111-a6db-0c629b09ad01", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "49c37034-5fb8-4bdc-9154-0e115cfe39d8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ef79f171-f5d9-4902-be44-fa69e429a6d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "629155c1-a3b7-4215-8368-766a8903eb97", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ef79f171-f5d9-4902-be44-fa69e429a6d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dac71fda-e5fe-4da9-b030-a4d8ee950588", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "801bea11-cfe3-428e-87a1-b26ed4812982", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dac71fda-e5fe-4da9-b030-a4d8ee950588"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "85a4825a-ce86-458c-8125-c22c193b97a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5132d4ca-4b9f-40b1-b487-c1a75eeb8f2f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "85a4825a-ce86-458c-8125-c22c193b97a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f249944-0f06-4497-bbb8-5cd39ba29886", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a3eeaeca-90e2-406c-946a-17eb2d2d092a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f249944-0f06-4497-bbb8-5cd39ba29886"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44feebd5-4d6c-400c-a0e0-5a282ee5655c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bd97c14b-9be3-4556-a06d-d75fca323df6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44feebd5-4d6c-400c-a0e0-5a282ee5655c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b48f3c65-6bf8-4a54-bad6-25e3eae541e1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "17e91aa3-f541-4e2c-b0e6-db06922bd7c0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b48f3c65-6bf8-4a54-bad6-25e3eae541e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1237252a-3813-4e59-99ab-a9d35dfcb63f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8034a955-e935-4637-bc2e-3554667209ad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1237252a-3813-4e59-99ab-a9d35dfcb63f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e84aca40-39ea-4b8f-bae8-f420b0947540", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a57d8947-1703-4edb-a9c1-aa683218cb94", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e84aca40-39ea-4b8f-bae8-f420b0947540"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "603c522f-2b2c-4aa8-a907-9b554d5c97e6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "660ffcf0-79b3-4d90-9517-067224b25ca9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "603c522f-2b2c-4aa8-a907-9b554d5c97e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cf210e7f-b8e8-4558-bbd1-1543203e3819", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dc1eb537-b66d-4b09-b1bd-9f644eef7f4f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cf210e7f-b8e8-4558-bbd1-1543203e3819"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2dcf5059-0673-47f0-a8bd-cd02daf3e05b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e38cc679-5045-40ab-aa84-570032f56bc1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2dcf5059-0673-47f0-a8bd-cd02daf3e05b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e930a94-55a0-449a-81e2-43d4ff961ef6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3c458e71-73d5-4999-8811-290bc3b1e023", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e930a94-55a0-449a-81e2-43d4ff961ef6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e2d3e886-a7b9-42fe-8081-141eb18a2e6f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4f7f650e-8774-499e-b5f7-338d3e47719b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e2d3e886-a7b9-42fe-8081-141eb18a2e6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3179cc79-b8c4-4bab-a3ef-1e3346c36b6f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7227dbab-bebc-4a45-a432-2d53f8c1b101", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3179cc79-b8c4-4bab-a3ef-1e3346c36b6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6449f117-59b1-46ab-be24-25499ecc3f8f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d82b1ec-10d3-45f5-998b-cd022a2b34c4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6449f117-59b1-46ab-be24-25499ecc3f8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b602060-bf31-42db-bb96-1f15ff972bd8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eb5d152b-e3ed-4e99-8bde-fee06ae89a2f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b602060-bf31-42db-bb96-1f15ff972bd8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>", "ID": "59101126-247c-4e07-b00e-a1e6c0b02e1a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX I</span></b>", "ID": "4076a1f7-ec74-4ea5-82fa-1b963b8014bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "59101126-247c-4e07-b00e-a1e6c0b02e1a"}, {"Element": "<span lang=\"EN-GB\">ANNEX I</span>", "ID": "179b2acb-3f7b-4e9a-8abc-31f63340df97", "Styles": "None", "Classes": "None", "Text": "ANNEX I", "ParentId": "4076a1f7-ec74-4ea5-82fa-1b963b8014bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c16357f-9bdb-4b0a-a43f-2ca69ea037f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aacb8c6f-b9d4-4916-aef3-640673fba554", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c16357f-9bdb-4b0a-a43f-2ca69ea037f4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p>", "ID": "af6fb063-7a3f-425d-be99-dac0fc53484d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b>", "ID": "48a2da80-18ff-49f9-a72d-c8fbe86293ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af6fb063-7a3f-425d-be99-dac0fc53484d"}, {"Element": "<span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span>", "ID": "9ab91e78-c822-44dc-8614-61352c706b2a", "Styles": "None", "Classes": "None", "Text": "SUMMARY OF PRODUCT CHARACTERISTICS", "ParentId": "48a2da80-18ff-49f9-a72d-c8fbe86293ed"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:green'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "f51cbcfa-c265-459a-ae00-b53d1f518eee", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:green", "Classes": "None", "Text": " ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "c646e8c1-b5d2-4b11-bc99-a73fbf5aa84c", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "f51cbcfa-c265-459a-ae00-b53d1f518eee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image001.gif\" width=\"20\"/></span><span lang=\"EN-GB\">This medicinal product is subject\nto additional monitoring. This will allow quick identification of new safety\ninformation. Healthcare professionals are asked to report any suspected adverse\nreactions. See section\u00a04.8 for how to report adverse reactions.</span></p>", "ID": "8d470366-d6a7-4ab3-ae1c-2d54afb13a36", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image001.gif\" width=\"20\"/></span>", "ID": "1c770754-dc8c-443b-81a5-f512e6f96cad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d470366-d6a7-4ab3-ae1c-2d54afb13a36"}, {"Element": "<img alt=\"BT_1000x858px\" height=\"18\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image001.gif\" width=\"20\"/>", "ID": "2f3ec56e-bf66-4275-9c09-6f33ef50504f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1c770754-dc8c-443b-81a5-f512e6f96cad"}, {"Element": "<span lang=\"EN-GB\">This medicinal product is subject\nto additional monitoring. This will allow quick identification of new safety\ninformation. Healthcare professionals are asked to report any suspected adverse\nreactions. See section\u00a04.8 for how to report adverse reactions.</span>", "ID": "4550bbbe-5a3f-4920-a67e-b868d8e96071", "Styles": "None", "Classes": "None", "Text": "This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section\u00a04.8 for how to report adverse reactions.", "ParentId": "8d470366-d6a7-4ab3-ae1c-2d54afb13a36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fb02ddcd-2521-4469-882d-9a81b6a3e206", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f4b4955f-8340-4eb7-b9bd-1ca444f738e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fb02ddcd-2521-4469-882d-9a81b6a3e206"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "446557ba-f544-48cc-a8f8-e7f9329538a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9aa4d5c1-8630-4b92-bfa9-265e2f84fc5a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "446557ba-f544-48cc-a8f8-e7f9329538a8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p>", "ID": "6b98c085-42ab-44d3-9d66-34a081377ed2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF </span></b>", "ID": "8b15ee1a-f1f7-4968-9e81-cf10c07610fa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b98c085-42ab-44d3-9d66-34a081377ed2"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF </span>", "ID": "1e2bd1a9-20f8-4864-81a2-beb99c36a65c", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF ", "ParentId": "8b15ee1a-f1f7-4968-9e81-cf10c07610fa"}, {"Element": "<b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b>", "ID": "b8738ef7-3ad6-410d-a02f-a8e50e8a6783", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b98c085-42ab-44d3-9d66-34a081377ed2"}, {"Element": "<span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span>", "ID": "00105415-dc8e-4ac0-8ae1-230a0fd4f9d3", "Styles": "None", "Classes": "None", "Text": "THE MEDICINAL PRODUCT", "ParentId": "b8738ef7-3ad6-410d-a02f-a8e50e8a6783"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fe388d1d-0781-40a8-adda-4a6e049998f5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5820232b-180f-46fa-a119-af72a8d3c032", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fe388d1d-0781-40a8-adda-4a6e049998f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah 1.2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells dispersion for infusion</span></p>", "ID": "25f819ec-498f-4040-b994-7b53a3daf033", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah 1.2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells dispersion for infusion</span>", "ID": "7781e77f-6494-42cd-ba25-f1864a22db4d", "Styles": "None", "Classes": "None", "Text": "Kymriah 1.2\u00a0x\u00a010\u00a0\u2013\u00a06\u00a0x\u00a010 cells dispersion for infusion", "ParentId": "25f819ec-498f-4040-b994-7b53a3daf033"}, {"Element": "<sup>6</sup>", "ID": "46152ac2-4667-4874-9eef-b37e27c20386", "Styles": "None", "Classes": "None", "Text": "6", "ParentId": "7781e77f-6494-42cd-ba25-f1864a22db4d"}, {"Element": "<sup>8</sup>", "ID": "4d552dab-3073-4791-921d-cb3e51643760", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "7781e77f-6494-42cd-ba25-f1864a22db4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ddf7ab6-0b11-4a77-8de5-57dfb1e8f65a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45856cf3-d9a9-45db-a692-a630c129d520", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ddf7ab6-0b11-4a77-8de5-57dfb1e8f65a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "64132145-f94c-4bcc-9f66-05582c069629", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "52a2c6eb-540f-4ae7-aad1-0843ddfebc73", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "64132145-f94c-4bcc-9f66-05582c069629"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND\nQUANTITATIVE COMPOSITION</span></b></p>", "ID": "a24adec4-c9b6-4c23-baf0-e8a1a06d018d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND\nQUANTITATIVE COMPOSITION</span></b>", "ID": "fff84e1b-2c66-45b9-bc55-295d999d0b7c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a24adec4-c9b6-4c23-baf0-e8a1a06d018d"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND\nQUANTITATIVE COMPOSITION</span>", "ID": "5483791b-af21-4201-9960-d9c93c353c51", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE COMPOSITION", "ParentId": "fff84e1b-2c66-45b9-bc55-295d999d0b7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3b5efed6-57b9-486c-bcd4-95eb7e39c1cd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce0c6887-eaad-49b7-a46f-9f146ec7f5c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3b5efed6-57b9-486c-bcd4-95eb7e39c1cd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.1\u00a0\u00a0\u00a0\u00a0 General description</span></b></p>", "ID": "0af84490-5c03-460a-8280-fde758580f8f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">2.1\u00a0\u00a0\u00a0\u00a0 General description</span></b>", "ID": "b3ee3a7e-b3d0-4474-84fa-1ac481ec7b98", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0af84490-5c03-460a-8280-fde758580f8f"}, {"Element": "<span lang=\"EN-GB\">2.1\u00a0\u00a0\u00a0\u00a0 General description</span>", "ID": "0fd9684e-35fb-4102-85bd-cd8bfc0a6c4f", "Styles": "None", "Classes": "None", "Text": "2.1\u00a0\u00a0\u00a0\u00a0 General description", "ParentId": "b3ee3a7e-b3d0-4474-84fa-1ac481ec7b98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5abab458-3042-4698-bd95-3662b24be51e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dd03f845-f72a-4db0-b896-387ed6544044", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5abab458-3042-4698-bd95-3662b24be51e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is an\nimmunocellular therapy containing tisagenlecleucel, autologous T cells\ngenetically modified <i>ex vivo</i> using a lentiviral vector encoding an anti\u2011CD19\nchimeric antigen receptor (CAR).</span></p>", "ID": "8213e7d1-6b14-472d-9f8c-8c59419e9332", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is an\nimmunocellular therapy containing tisagenlecleucel, autologous T cells\ngenetically modified <i>ex vivo</i> using a lentiviral vector encoding an anti\u2011CD19\nchimeric antigen receptor (CAR).</span>", "ID": "e96d5e05-505b-4e91-a9e6-60abccc1d2d4", "Styles": "None", "Classes": "None", "Text": "Kymriah is an immunocellular therapy containing tisagenlecleucel, autologous T cells genetically modified  using a lentiviral vector encoding an anti\u2011CD19 chimeric antigen receptor (CAR).", "ParentId": "8213e7d1-6b14-472d-9f8c-8c59419e9332"}, {"Element": "<i>ex vivo</i>", "ID": "18d443fc-e488-4253-9d6f-329b0b1d8444", "Styles": "None", "Classes": "None", "Text": "ex vivo", "ParentId": "e96d5e05-505b-4e91-a9e6-60abccc1d2d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1f2f6993-c136-4309-8a4a-fd607d136e9f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9fa080e-472a-4ce3-8d88-8b37bce130a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1f2f6993-c136-4309-8a4a-fd607d136e9f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.2\u00a0\u00a0\u00a0\u00a0 Qualitative and\nquantitative composition</span></b></p>", "ID": "28d253bf-6752-419c-ab62-1fbc450cf82a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">2.2\u00a0\u00a0\u00a0\u00a0 Qualitative and\nquantitative composition</span></b>", "ID": "d35ca8f9-a4e4-4ad2-855c-6d33c7dc2e20", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "28d253bf-6752-419c-ab62-1fbc450cf82a"}, {"Element": "<span lang=\"EN-GB\">2.2\u00a0\u00a0\u00a0\u00a0 Qualitative and\nquantitative composition</span>", "ID": "22ace1ba-1efc-4cac-beca-1f7dbf0a86c0", "Styles": "None", "Classes": "None", "Text": "2.2\u00a0\u00a0\u00a0\u00a0 Qualitative and quantitative composition", "ParentId": "d35ca8f9-a4e4-4ad2-855c-6d33c7dc2e20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "499632fd-0ab0-48cd-ac0a-3588977ed40f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4ee4371-77e6-4528-83e1-30953e19f53b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "499632fd-0ab0-48cd-ac0a-3588977ed40f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each </span><span lang=\"EN-GB\">ethylene vinyl acetate (EVA) infusion bag of Kymriah </span><span lang=\"EN-GB\">contains tisagenlecleucel cell dispersion at a batch\u2011dependent\nconcentration of </span><span lang=\"EN-GB\">autologous T cells genetically\nmodified to express an </span><span lang=\"EN-GB\">anti\u2011CD19 chimeric antigen\nreceptor</span><span lang=\"EN-GB\"> (CAR\u2011positive viable T cells) (see section\u00a04.2)</span><span lang=\"EN-GB\" style=\"color:black\">.</span></p>", "ID": "d597ff31-d439-4b83-b89d-bcdf4406836f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Each </span>", "ID": "f2eb4633-f038-4e14-b551-1c35fa3ed109", "Styles": "None", "Classes": "None", "Text": "Each ", "ParentId": "d597ff31-d439-4b83-b89d-bcdf4406836f"}, {"Element": "<span lang=\"EN-GB\">ethylene vinyl acetate (EVA) infusion bag of Kymriah </span>", "ID": "51b390ec-7c3c-4aa0-bb65-65160c3ecfe5", "Styles": "None", "Classes": "None", "Text": "ethylene vinyl acetate (EVA) infusion bag of Kymriah ", "ParentId": "d597ff31-d439-4b83-b89d-bcdf4406836f"}, {"Element": "<span lang=\"EN-GB\">contains tisagenlecleucel cell dispersion at a batch\u2011dependent\nconcentration of </span>", "ID": "7d2e5e92-c560-497a-b0b1-2af9ca46942e", "Styles": "None", "Classes": "None", "Text": "contains tisagenlecleucel cell dispersion at a batch\u2011dependent concentration of ", "ParentId": "d597ff31-d439-4b83-b89d-bcdf4406836f"}, {"Element": "<span lang=\"EN-GB\">autologous T cells genetically\nmodified to express an </span>", "ID": "6563fe00-6831-4c5b-8dcd-521fd7c1afd1", "Styles": "None", "Classes": "None", "Text": "autologous T cells genetically modified to express an ", "ParentId": "d597ff31-d439-4b83-b89d-bcdf4406836f"}, {"Element": "<span lang=\"EN-GB\">anti\u2011CD19 chimeric antigen\nreceptor</span>", "ID": "a1856284-d062-4c86-ae95-3247139bccc8", "Styles": "None", "Classes": "None", "Text": "anti\u2011CD19 chimeric antigen receptor", "ParentId": "d597ff31-d439-4b83-b89d-bcdf4406836f"}, {"Element": "<span lang=\"EN-GB\"> (CAR\u2011positive viable T cells) (see section\u00a04.2)</span>", "ID": "84247b20-edf0-4b8c-abf2-b9289744973c", "Styles": "None", "Classes": "None", "Text": " (CAR\u2011positive viable T cells) (see section\u00a04.2)", "ParentId": "d597ff31-d439-4b83-b89d-bcdf4406836f"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">.</span>", "ID": "1e02aa2b-60d0-45bb-ae76-3066cd91372e", "Styles": "color:black", "Classes": "None", "Text": ".", "ParentId": "d597ff31-d439-4b83-b89d-bcdf4406836f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42381aa4-8ac4-48ba-ba4b-fed46e113752", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ea78e943-622c-4953-9f05-ad85ae7dff87", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42381aa4-8ac4-48ba-ba4b-fed46e113752"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">The concentration of CAR\u2011positive viable T cells is dependent\non indication and patient body weight (for B\u2011cell acute lymphoblastic\nleukaemia [ALL]). The cellular composition</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\" style=\"color:black\">and the final cell number varies between\nindividual patient batches. In addition to T cells, NK cells may be present. The\nquantitative information regarding CAR\u2011positive viable T cells/mL and\ntotal cells in the product is presented in the batch\u2011specific documentation\naccompanying Kymriah.</span></p>", "ID": "bf873183-d7bf-4c95-a24a-05e2e94efdf9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">The concentration of CAR\u2011positive viable T cells is dependent\non indication and patient body weight (for B\u2011cell acute lymphoblastic\nleukaemia [ALL]). The cellular composition</span>", "ID": "d3cf66df-f14a-45c9-9822-4820edcd60fc", "Styles": "color:black", "Classes": "None", "Text": "The concentration of CAR\u2011positive viable T cells is dependent on indication and patient body weight (for B\u2011cell acute lymphoblastic leukaemia [ALL]). The cellular composition", "ParentId": "bf873183-d7bf-4c95-a24a-05e2e94efdf9"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "bc1fcfd8-0987-4bc4-a557-c40ec3c3db21", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "bf873183-d7bf-4c95-a24a-05e2e94efdf9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">and the final cell number varies between\nindividual patient batches. In addition to T cells, NK cells may be present. The\nquantitative information regarding CAR\u2011positive viable T cells/mL and\ntotal cells in the product is presented in the batch\u2011specific documentation\naccompanying Kymriah.</span>", "ID": "1fda7e6f-ddd4-4b0d-8fa4-1ce87edb442d", "Styles": "color:black", "Classes": "None", "Text": "and the final cell number varies between individual patient batches. In addition to T cells, NK cells may be present. The quantitative information regarding CAR\u2011positive viable T cells/mL and total cells in the product is presented in the batch\u2011specific documentation accompanying Kymriah.", "ParentId": "bf873183-d7bf-4c95-a24a-05e2e94efdf9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "accd2776-5164-4420-b6c0-9b2ab40a7592", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "03e63287-7015-4abe-a18b-6d1d2ce9bcc6", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "accd2776-5164-4420-b6c0-9b2ab40a7592"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 or more infusion\nbags containing a total of 1.2\u00a0x\u00a010<sup>6</sup> to 6\u00a0x\u00a010<sup>8</sup>\nCAR\u2011positive viable T cells.</span></p>", "ID": "e7a615ee-4b9e-4a27-b6ac-76e3fbc728cc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">1 or more infusion\nbags containing a total of 1.2\u00a0x\u00a010<sup>6</sup> to 6\u00a0x\u00a010<sup>8</sup>\nCAR\u2011positive viable T cells.</span>", "ID": "3e622b52-93d9-4cc3-b632-f1ff8ff80fc7", "Styles": "None", "Classes": "None", "Text": "1 or more infusion bags containing a total of 1.2\u00a0x\u00a010 to 6\u00a0x\u00a010 CAR\u2011positive viable T cells.", "ParentId": "e7a615ee-4b9e-4a27-b6ac-76e3fbc728cc"}, {"Element": "<sup>6</sup>", "ID": "cdc126f3-b164-41e1-972e-4e2dff4b90f5", "Styles": "None", "Classes": "None", "Text": "6", "ParentId": "3e622b52-93d9-4cc3-b632-f1ff8ff80fc7"}, {"Element": "<sup>8</sup>", "ID": "20cd0e9b-0c42-481d-860f-ffeec51cc347", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "3e622b52-93d9-4cc3-b632-f1ff8ff80fc7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cee75ef9-19c7-42fe-8726-c857e83ba80a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dee6984c-e240-4dfc-ae56-51fec7986c53", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cee75ef9-19c7-42fe-8726-c857e83ba80a"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><u><span lang=\"EN-GB\">Excipient with\nknown effect</span></u></p>", "ID": "1f9b8286-d3ba-4314-8188-4ef3221aec14", "Styles": "margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Excipient with\nknown effect</span></u>", "ID": "ca6ec979-cf47-4944-a400-766cf3d2cbd0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1f9b8286-d3ba-4314-8188-4ef3221aec14"}, {"Element": "<span lang=\"EN-GB\">Excipient with\nknown effect</span>", "ID": "c0da67a2-85cc-49e5-901f-fcc0b012eaec", "Styles": "None", "Classes": "None", "Text": "Excipient with known effect", "ParentId": "ca6ec979-cf47-4944-a400-766cf3d2cbd0"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5d6acb32-f99c-4208-a9ff-3c3e9c163ad6", "Styles": "margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ba2d980-3c43-46bb-b237-8835f92b9d54", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5d6acb32-f99c-4208-a9ff-3c3e9c163ad6"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">This medicinal product contains 2.43\u00a0mg sodium per mL\nand 24.3 to 121.5\u00a0mg sodium per dose.</p>", "ID": "8d0fb1fe-73ca-4706-8aa9-fda3066ed644", "Styles": "margin:0in;text-align:left;\ntext-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "This medicinal product contains 2.43\u00a0mg sodium per mL and 24.3 to 121.5\u00a0mg sodium per dose.", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e37da3d8-4a76-43d2-b1c0-0265105a62a5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6725676b-e58e-41ee-b4e8-1b5f4c2c6a6d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e37da3d8-4a76-43d2-b1c0-0265105a62a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full\nlist of excipients, see section\u00a06.1.</span></p>", "ID": "34c182a7-3dc3-4d6e-bc8e-611181e5b94d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">For the full\nlist of excipients, see section\u00a06.1.</span>", "ID": "479181e6-d5d6-4611-b846-a69de4c00b95", "Styles": "None", "Classes": "None", "Text": "For the full list of excipients, see section\u00a06.1.", "ParentId": "34c182a7-3dc3-4d6e-bc8e-611181e5b94d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5480709a-51a7-4257-b9da-eb466963439f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b5d38dcf-6e18-4975-810c-9529d5ed4fe0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5480709a-51a7-4257-b9da-eb466963439f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b3a7a558-c4d7-4011-a891-86230ffbca26", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6614e39-0aa4-4f87-99fc-c46e7d05a4df", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b3a7a558-c4d7-4011-a891-86230ffbca26"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>FORM</span></b></p>", "ID": "eefaefa5-24e1-4718-bf6e-8453369b7213", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL </span></b>", "ID": "77c4eb75-d4ef-4129-8ebf-38640efbeaec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eefaefa5-24e1-4718-bf6e-8453369b7213"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL </span>", "ID": "b1d77a10-5d09-4ec3-898d-f638513d7769", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL ", "ParentId": "77c4eb75-d4ef-4129-8ebf-38640efbeaec"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>FORM</span></b>", "ID": "c36d5fe8-a004-4182-928b-1b502e32ec8e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eefaefa5-24e1-4718-bf6e-8453369b7213"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>FORM</span>", "ID": "b7c1b9d8-9ea9-4f32-b78e-0a49a796351d", "Styles": "font-family:\"Times New Roman Bold\",serif", "Classes": "None", "Text": "FORM", "ParentId": "c36d5fe8-a004-4182-928b-1b502e32ec8e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cc1ab210-d2ae-4b93-9472-723a51d08486", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4103620-75c9-4b3f-9dba-430ddcfe08d2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc1ab210-d2ae-4b93-9472-723a51d08486"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Dispersion for infusion.</span></p>", "ID": "1c5fe7e6-da41-4dd7-8a85-35e8d7861831", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Dispersion for infusion.</span>", "ID": "3a62c896-51e8-4071-a53f-7f6827d5add2", "Styles": "None", "Classes": "None", "Text": "Dispersion for infusion.", "ParentId": "1c5fe7e6-da41-4dd7-8a85-35e8d7861831"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6a42d232-8b18-4795-a375-d2c1ca0b758b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c05a639c-cc5b-463f-ade3-68abb6e23c09", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6a42d232-8b18-4795-a375-d2c1ca0b758b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A colourless to\nslightly yellow dispersion.</span></p>", "ID": "9d182a17-58e1-49ae-84af-99ec1000094b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">A colourless to\nslightly yellow dispersion.</span>", "ID": "dfe53a06-d41d-492c-9a02-4b716ad6ee13", "Styles": "None", "Classes": "None", "Text": "A colourless to slightly yellow dispersion.", "ParentId": "9d182a17-58e1-49ae-84af-99ec1000094b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0e811769-9b3f-4b59-acda-dd27afbcf817", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c1c4fd05-1b26-458a-b744-33afa8d18fa9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0e811769-9b3f-4b59-acda-dd27afbcf817"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "242d4fda-dcb7-4af7-b993-26f4a109da5a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c392a6d-3b57-434c-aa36-bf31c5550ee7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "242d4fda-dcb7-4af7-b993-26f4a109da5a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">CLINICAL</span></b><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>\nPARTICULARS</span></b></p>", "ID": "cb198f73-c574-43b3-b22d-9d453ef9879c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b>", "ID": "3f72fcdf-5bea-4755-a8a4-9c2849817282", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb198f73-c574-43b3-b22d-9d453ef9879c"}, {"Element": "<span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "757479a2-8a22-42a4-b046-4db0e8ea017a", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3f72fcdf-5bea-4755-a8a4-9c2849817282"}, {"Element": "<b><span lang=\"EN-GB\">CLINICAL</span></b>", "ID": "ca40f943-42b7-4ad8-95e0-fe7bb74424b0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb198f73-c574-43b3-b22d-9d453ef9879c"}, {"Element": "<span lang=\"EN-GB\">CLINICAL</span>", "ID": "d1598f4d-3169-4788-8b71-662aecf2aa54", "Styles": "None", "Classes": "None", "Text": "CLINICAL", "ParentId": "ca40f943-42b7-4ad8-95e0-fe7bb74424b0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>\nPARTICULARS</span></b>", "ID": "135ae2c5-9063-4c28-b75b-1e743b58437a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cb198f73-c574-43b3-b22d-9d453ef9879c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman Bold\",serif'>\nPARTICULARS</span>", "ID": "3fc809ea-2526-406b-ab96-fdb17e5ad02a", "Styles": "font-family:\"Times New Roman Bold\",serif", "Classes": "None", "Text": " PARTICULARS", "ParentId": "135ae2c5-9063-4c28-b75b-1e743b58437a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5dffd949-940b-44b2-8520-178900ec90aa", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "07f9494a-2929-46f2-a10d-70f6feaeabf8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5dffd949-940b-44b2-8520-178900ec90aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span></b></p>", "ID": "31af4c0a-d6a4-41d3-987a-61f920277d18", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span></b>", "ID": "ab28e0a1-59fc-41cf-9cd4-622adb60c25f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "31af4c0a-d6a4-41d3-987a-61f920277d18"}, {"Element": "<span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic\nindications</span>", "ID": "428ab3d9-2943-47db-a625-ef3d90d218e9", "Styles": "None", "Classes": "None", "Text": "4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications", "ParentId": "ab28e0a1-59fc-41cf-9cd4-622adb60c25f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "52378ecd-94cc-485d-8c47-fcf25550bd2d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0a3686ad-ff83-4e77-9eaa-39423e03bc19", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "52378ecd-94cc-485d-8c47-fcf25550bd2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Kymriah is indicated for the treatment of:</span></p>", "ID": "ca05f09c-02b3-46c3-865d-c10aebb4bb22", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is indicated for the treatment of:</span>", "ID": "27423282-f985-4e47-b562-d29ff8b0a786", "Styles": "None", "Classes": "None", "Text": "Kymriah is indicated for the treatment of:", "ParentId": "ca05f09c-02b3-46c3-865d-c10aebb4bb22"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Paediatric and young adult patients up to and\nincluding 25\u00a0years of age with B\u2011cell acute lymphoblastic leukaemia\n(ALL) that is refractory, in relapse post\u2011transplant or in second or\nlater relapse</span><span lang=\"EN-GB\">.</span></p>", "ID": "baa9ace7-3085-4219-aae5-59293cc514dc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "be4797d9-821c-44d8-b83e-fd19666532cf", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "baa9ace7-3085-4219-aae5-59293cc514dc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "89e72816-a9b8-4f0a-8fc5-3efa83cdd6b6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "be4797d9-821c-44d8-b83e-fd19666532cf"}, {"Element": "<span lang=\"EN-GB\">Paediatric and young adult patients up to and\nincluding 25\u00a0years of age with B\u2011cell acute lymphoblastic leukaemia\n(ALL) that is refractory, in relapse post\u2011transplant or in second or\nlater relapse</span>", "ID": "223ec22e-6ae8-46ac-930b-fa84f03ceca3", "Styles": "None", "Classes": "None", "Text": "Paediatric and young adult patients up to and including 25\u00a0years of age with B\u2011cell acute lymphoblastic leukaemia (ALL) that is refractory, in relapse post\u2011transplant or in second or later relapse", "ParentId": "baa9ace7-3085-4219-aae5-59293cc514dc"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "2c2fcaee-bac5-4d78-9b43-e260580589ea", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "baa9ace7-3085-4219-aae5-59293cc514dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black\">Adult patients with relapsed\n</span><span lang=\"EN-GB\">or refractory diffuse large B\u2011cell lymphoma\n(DLBCL) after two or more lines of systemic therapy.</span></p>", "ID": "80898628-7c21-4412-97e4-c59b58eabd05", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol;color:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "904ab45b-ab47-4ba6-9d40-f3f742603674", "Styles": "font-family:Symbol;color:black", "Classes": "None", "Text": "\u00b7", "ParentId": "80898628-7c21-4412-97e4-c59b58eabd05"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4938de29-cec1-4114-a985-5406102fd7d7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "904ab45b-ab47-4ba6-9d40-f3f742603674"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Adult patients with relapsed\n</span>", "ID": "699de1e0-145e-446b-b4b5-dde38e240190", "Styles": "color:black", "Classes": "None", "Text": "Adult patients with relapsed ", "ParentId": "80898628-7c21-4412-97e4-c59b58eabd05"}, {"Element": "<span lang=\"EN-GB\">or refractory diffuse large B\u2011cell lymphoma\n(DLBCL) after two or more lines of systemic therapy.</span>", "ID": "46e7f08e-fd05-4dc5-a050-1766452dfa8a", "Styles": "None", "Classes": "None", "Text": "or refractory diffuse large B\u2011cell lymphoma (DLBCL) after two or more lines of systemic therapy.", "ParentId": "80898628-7c21-4412-97e4-c59b58eabd05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2be48eef-b3a0-4087-9feb-6dbce3a87cf1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4ae400a1-be06-4c40-9a1f-f1cc02c45fef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2be48eef-b3a0-4087-9feb-6dbce3a87cf1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method\nof administration</span></b></p>", "ID": "d21468bb-8f01-4e75-ad5d-5a669ed2485b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method\nof administration</span></b>", "ID": "8b95e4e5-77c0-498a-831b-29996e8d9d9c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d21468bb-8f01-4e75-ad5d-5a669ed2485b"}, {"Element": "<span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method\nof administration</span>", "ID": "4ca37a77-4f75-440c-8b7e-de2dee8b7ee0", "Styles": "None", "Classes": "None", "Text": "4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration", "ParentId": "8b95e4e5-77c0-498a-831b-29996e8d9d9c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1f24bec7-4b60-403d-a13d-65c9a71bf5cd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4a1e1b81-8790-470d-be04-d383f9342282", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1f24bec7-4b60-403d-a13d-65c9a71bf5cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah must be\nadministered in a qualified treatment centre. Therapy should be initiated under\nthe direction of and supervised by a healthcare professional experienced in the\ntreatment of haematological malignancies and trained for administration and\nmanagement of patients treated with Kymriah. Tocilizumab for use in the event\nof cytokine release syndrome and emergency equipment must be available per\npatient prior to infusion. The treatment centre must have access to additional\ndoses of tocilizumab within 8\u00a0hours.</span></p>", "ID": "e32c7a9b-e4ef-4349-b6c5-8abf55ed6f2c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah must be\nadministered in a qualified treatment centre. Therapy should be initiated under\nthe direction of and supervised by a healthcare professional experienced in the\ntreatment of haematological malignancies and trained for administration and\nmanagement of patients treated with Kymriah. Tocilizumab for use in the event\nof cytokine release syndrome and emergency equipment must be available per\npatient prior to infusion. The treatment centre must have access to additional\ndoses of tocilizumab within 8\u00a0hours.</span>", "ID": "c6050266-37b7-43be-8398-beccf21daf52", "Styles": "None", "Classes": "None", "Text": "Kymriah must be administered in a qualified treatment centre. Therapy should be initiated under the direction of and supervised by a healthcare professional experienced in the treatment of haematological malignancies and trained for administration and management of patients treated with Kymriah. Tocilizumab for use in the event of cytokine release syndrome and emergency equipment must be available per patient prior to infusion. The treatment centre must have access to additional doses of tocilizumab within 8\u00a0hours.", "ParentId": "e32c7a9b-e4ef-4349-b6c5-8abf55ed6f2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "69a9a7b0-785f-4f49-b10c-6b0815103c33", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7afabc44-c593-4c43-8e78-82d335e526f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "69a9a7b0-785f-4f49-b10c-6b0815103c33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is\nintended for autologous use only (see section\u00a04.4). Manufacture and\nrelease of Kymriah usually takes about 3\u20114\u00a0weeks.</span></p>", "ID": "80e6827b-886d-4960-ac5a-bc686da952e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is\nintended for autologous use only (see section\u00a04.4). Manufacture and\nrelease of Kymriah usually takes about 3\u20114\u00a0weeks.</span>", "ID": "6ecc42fb-6e54-40ea-87d0-f9011c1153d5", "Styles": "None", "Classes": "None", "Text": "Kymriah is intended for autologous use only (see section\u00a04.4). Manufacture and release of Kymriah usually takes about 3\u20114\u00a0weeks.", "ParentId": "80e6827b-886d-4960-ac5a-bc686da952e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fe79de8a-66d0-4558-9bfb-0c8b3edf472f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "659007c2-49bc-426e-a5cd-a004195bd0d6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fe79de8a-66d0-4558-9bfb-0c8b3edf472f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u></p>", "ID": "d36a8d3f-efd8-4076-85c6-651b7416f9fa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Posology</span></u>", "ID": "effc9ac6-3aa9-4472-9a8e-cc610848d7cc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d36a8d3f-efd8-4076-85c6-651b7416f9fa"}, {"Element": "<span lang=\"EN-GB\">Posology</span>", "ID": "11d00710-487b-426b-854d-d6bc9f83f5bb", "Styles": "None", "Classes": "None", "Text": "Posology", "ParentId": "effc9ac6-3aa9-4472-9a8e-cc610848d7cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ca90a88c-8df2-4c00-afd0-4530a77f7a86", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0eb8a5c3-20b9-4866-a6ac-d22c69ff5ce3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ca90a88c-8df2-4c00-afd0-4530a77f7a86"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Dosage in paediatric and young adult B\u2011cell ALL patients</span></u></i></p>", "ID": "a93d627b-5301-4217-bdb7-843d4485de06", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Dosage in paediatric and young adult B\u2011cell ALL patients</span></u></i>", "ID": "9279cb1d-4d8d-4abc-a0ee-d2c8b011ef3a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a93d627b-5301-4217-bdb7-843d4485de06"}, {"Element": "<u><span lang=\"EN-GB\">Dosage in paediatric and young adult B\u2011cell ALL patients</span></u>", "ID": "e8bb7b34-4b8b-43ce-922e-a1272e4ea056", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9279cb1d-4d8d-4abc-a0ee-d2c8b011ef3a"}, {"Element": "<span lang=\"EN-GB\">Dosage in paediatric and young adult B\u2011cell ALL patients</span>", "ID": "9bcab5d2-73e1-4530-8900-708402659b65", "Styles": "None", "Classes": "None", "Text": "Dosage in paediatric and young adult B\u2011cell ALL patients", "ParentId": "e8bb7b34-4b8b-43ce-922e-a1272e4ea056"}, {"Element": "<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">For patients 50\u00a0kg\nand below: 0.2 to 5\u00a0x\u00a010<sup>6</sup> CAR\u2011positive viable T\ncells/kg body weight.</span></p>", "ID": "cca6010b-4cdc-4a98-aa67-f913fc366286", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e24a12a1-4790-4ca6-bb99-38d9f3ff914c", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "cca6010b-4cdc-4a98-aa67-f913fc366286"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "780ef424-82d0-4917-9550-c812133596a6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e24a12a1-4790-4ca6-bb99-38d9f3ff914c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">For patients 50\u00a0kg\nand below: 0.2 to 5\u00a0x\u00a010<sup>6</sup> CAR\u2011positive viable T\ncells/kg body weight.</span>", "ID": "ed320569-3612-4b6f-b0d3-b7baae0e239f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "For patients 50\u00a0kg and below: 0.2 to 5\u00a0x\u00a010 CAR\u2011positive viable T cells/kg body weight.", "ParentId": "cca6010b-4cdc-4a98-aa67-f913fc366286"}, {"Element": "<sup>6</sup>", "ID": "fb92170f-e2cc-4923-a6f7-7df0a6b9f89b", "Styles": "None", "Classes": "None", "Text": "6", "ParentId": "ed320569-3612-4b6f-b0d3-b7baae0e239f"}, {"Element": "<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">For patients above\n50\u00a0kg: 0.1 to 2.5\u00a0x\u00a010<sup>8</sup> CAR\u2011positive viable T\ncells (non\u2011weight based).</span></p>", "ID": "4da39d57-0868-47ba-aa7d-9aa04c25a6b7", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "eec855f8-e8af-4f34-90e7-836d6d59cc78", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "4da39d57-0868-47ba-aa7d-9aa04c25a6b7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8240c2eb-b904-4176-a29f-06a46620c97a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "eec855f8-e8af-4f34-90e7-836d6d59cc78"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">For patients above\n50\u00a0kg: 0.1 to 2.5\u00a0x\u00a010<sup>8</sup> CAR\u2011positive viable T\ncells (non\u2011weight based).</span>", "ID": "1f73f7d2-b405-41ed-9568-d32f0bc358e8", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "For patients above 50\u00a0kg: 0.1 to 2.5\u00a0x\u00a010 CAR\u2011positive viable T cells (non\u2011weight based).", "ParentId": "4da39d57-0868-47ba-aa7d-9aa04c25a6b7"}, {"Element": "<sup>8</sup>", "ID": "d0f10900-2836-47dc-862d-5766cc105683", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "1f73f7d2-b405-41ed-9568-d32f0bc358e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8be7b780-ba38-49a8-a456-6803e88db843", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "49c570e7-f31c-430f-a108-44ae00d74b2d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8be7b780-ba38-49a8-a456-6803e88db843"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Dosage in adult DLBCL patients</span></u></i></p>", "ID": "be980ed5-96d1-402d-bfb4-e294cf9a62ea", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Dosage in adult DLBCL patients</span></u></i>", "ID": "47a2ebb6-f0a1-4243-9757-09881b6487df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be980ed5-96d1-402d-bfb4-e294cf9a62ea"}, {"Element": "<u><span lang=\"EN-GB\">Dosage in adult DLBCL patients</span></u>", "ID": "a054657f-9d5f-49d9-8141-a1840e43ee0d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "47a2ebb6-f0a1-4243-9757-09881b6487df"}, {"Element": "<span lang=\"EN-GB\">Dosage in adult DLBCL patients</span>", "ID": "8aec3a7f-7b01-4c16-a9d5-31c654737ade", "Styles": "None", "Classes": "None", "Text": "Dosage in adult DLBCL patients", "ParentId": "a054657f-9d5f-49d9-8141-a1840e43ee0d"}, {"Element": "<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">0.6 to 6\u00a0x\u00a010<sup>8</sup>\nCAR\u2011positive viable T cells (non\u2011weight based).</span></p>", "ID": "af7d29ac-17c5-41f0-90a4-5582d2a966e6", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "03332ecc-3705-4f89-9d80-2b2162218e03", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "af7d29ac-17c5-41f0-90a4-5582d2a966e6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fa94cfa9-4bcb-4499-af2c-79fdfd6539b1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "03332ecc-3705-4f89-9d80-2b2162218e03"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">0.6 to 6\u00a0x\u00a010<sup>8</sup>\nCAR\u2011positive viable T cells (non\u2011weight based).</span>", "ID": "f412e70b-2838-4f66-8142-73d2fbb0a4bb", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "0.6 to 6\u00a0x\u00a010 CAR\u2011positive viable T cells (non\u2011weight based).", "ParentId": "af7d29ac-17c5-41f0-90a4-5582d2a966e6"}, {"Element": "<sup>8</sup>", "ID": "3063f0f7-9eec-4865-8561-66a004e4f314", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "f412e70b-2838-4f66-8142-73d2fbb0a4bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8091a064-8df6-4995-bf2e-a3db070272f8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c6757698-82d8-4498-ba98-57946259c301", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8091a064-8df6-4995-bf2e-a3db070272f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pre\u2011treatment conditioning (lymphodepleting chemotherapy)</span></u></p>", "ID": "eb1d4897-0ce7-4376-a816-1ef5d162f2ef", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Pre\u2011treatment conditioning (lymphodepleting chemotherapy)</span></u>", "ID": "cc763055-8fe1-451f-b4cb-a24e8346051c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb1d4897-0ce7-4376-a816-1ef5d162f2ef"}, {"Element": "<span lang=\"EN-GB\">Pre\u2011treatment conditioning (lymphodepleting chemotherapy)</span>", "ID": "7580e20c-9bdd-4d92-ab50-3cd26e742f49", "Styles": "None", "Classes": "None", "Text": "Pre\u2011treatment conditioning (lymphodepleting chemotherapy)", "ParentId": "cc763055-8fe1-451f-b4cb-a24e8346051c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9cb3dfd9-ab96-4d90-a044-6a4023407d29", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92ec108a-b812-4557-81b4-72f3c04fc67d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9cb3dfd9-ab96-4d90-a044-6a4023407d29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lymphodepleting\nchemotherapy is recommended to be administered before Kymriah infusion unless\nthe white blood cell (WBC) count within one week prior to infusion is\n\u22641,000\u00a0cells/\u03bcL.</span></p>", "ID": "2cf33de8-b9b0-4245-ae2b-4f632960b87a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Lymphodepleting\nchemotherapy is recommended to be administered before Kymriah infusion unless\nthe white blood cell (WBC) count within one week prior to infusion is\n\u22641,000\u00a0cells/\u03bcL.</span>", "ID": "4390def3-5d0a-4637-ab7b-f95a155e4141", "Styles": "None", "Classes": "None", "Text": "Lymphodepleting chemotherapy is recommended to be administered before Kymriah infusion unless the white blood cell (WBC) count within one week prior to infusion is \u22641,000\u00a0cells/\u03bcL.", "ParentId": "2cf33de8-b9b0-4245-ae2b-4f632960b87a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "741ae60c-1207-4b05-9c32-ce734f333b2c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8ed8909f-523f-4532-b164-9845eb0bd640", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "741ae60c-1207-4b05-9c32-ce734f333b2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is\nrecommended to be infused 2 to 14\u00a0days after completion of the\nlymphodepleting chemotherapy. The availability of Kymriah must be confirmed\nprior to starting the lymphodepleting regimen. If there is a delay of more than\n4\u00a0weeks between completing lymphodepleting chemotherapy and the infusion\nand the WBC count is &gt;1,000\u00a0cells/\u03bcL, then the patient should be\nre\u2011treated with lymphodepleting chemotherapy prior to receiving Kymriah.</span></p>", "ID": "5382e47d-3725-4a4d-98ab-df6dc2f5ed59", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is\nrecommended to be infused 2 to 14\u00a0days after completion of the\nlymphodepleting chemotherapy. The availability of Kymriah must be confirmed\nprior to starting the lymphodepleting regimen. If there is a delay of more than\n4\u00a0weeks between completing lymphodepleting chemotherapy and the infusion\nand the WBC count is &gt;1,000\u00a0cells/\u03bcL, then the patient should be\nre\u2011treated with lymphodepleting chemotherapy prior to receiving Kymriah.</span>", "ID": "6581bcb4-bbb2-4bf3-9367-753ee856e79f", "Styles": "None", "Classes": "None", "Text": "Kymriah is recommended to be infused 2 to 14\u00a0days after completion of the lymphodepleting chemotherapy. The availability of Kymriah must be confirmed prior to starting the lymphodepleting regimen. If there is a delay of more than 4\u00a0weeks between completing lymphodepleting chemotherapy and the infusion and the WBC count is >1,000\u00a0cells/\u03bcL, then the patient should be re\u2011treated with lymphodepleting chemotherapy prior to receiving Kymriah.", "ParentId": "5382e47d-3725-4a4d-98ab-df6dc2f5ed59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "46197422-7814-4f0c-9a61-c9dd9dba20a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "49cd3350-528a-4cee-abb5-7f67bc448d52", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "46197422-7814-4f0c-9a61-c9dd9dba20a4"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span></u></i></p>", "ID": "3bf00119-46f1-4093-a453-a3561ca53c66", "Styles": "margin-top:0in;text-align:left;page-break-after:\navoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span></u></i>", "ID": "e2fb0bd3-184c-40ff-b1a5-26f17bd36f21", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3bf00119-46f1-4093-a453-a3561ca53c66"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span></u>", "ID": "e250288e-67eb-4c49-ac61-f3734e2c01cb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e2fb0bd3-184c-40ff-b1a5-26f17bd36f21"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span>", "ID": "1a9f90dc-d889-4d36-829a-8c45e1540de6", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "B\u2011cell ALL", "ParentId": "e250288e-67eb-4c49-ac61-f3734e2c01cb"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The recommended\nlymphodepleting chemotherapy regimen is:</span></p>", "ID": "c11441d1-7803-4d4c-9873-f4e7e9e5a8cd", "Styles": "margin-top:0in;text-align:left;page-break-after:\navoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The recommended\nlymphodepleting chemotherapy regimen is:</span>", "ID": "609a9aae-873b-43b7-a062-bdd40f6170e5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The recommended lymphodepleting chemotherapy regimen is:", "ParentId": "c11441d1-7803-4d4c-9873-f4e7e9e5a8cd"}, {"Element": "<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Fludarabine (30\u00a0mg/m<sup>2</sup>\nintravenous daily for 4\u00a0days) and cyclophosphamide (500\u00a0mg/m<sup>2</sup>\nintravenous daily for 2\u00a0days starting with the first dose of fludarabine).</span></p>", "ID": "6bb6c846-2c58-4e33-bea5-c04b6756a477", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "9f32ff45-d544-4b28-bbbd-bb80b09cb697", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "6bb6c846-2c58-4e33-bea5-c04b6756a477"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4419020e-8671-48db-aef8-313c50c4a526", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "9f32ff45-d544-4b28-bbbd-bb80b09cb697"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Fludarabine (30\u00a0mg/m<sup>2</sup>\nintravenous daily for 4\u00a0days) and cyclophosphamide (500\u00a0mg/m<sup>2</sup>\nintravenous daily for 2\u00a0days starting with the first dose of fludarabine).</span>", "ID": "61612c0c-1c09-4118-9ce3-c4624c07b435", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Fludarabine (30\u00a0mg/m intravenous daily for 4\u00a0days) and cyclophosphamide (500\u00a0mg/m intravenous daily for 2\u00a0days starting with the first dose of fludarabine).", "ParentId": "6bb6c846-2c58-4e33-bea5-c04b6756a477"}, {"Element": "<sup>2</sup>", "ID": "549a8450-b64a-4cfa-a198-427ee12ca5da", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "61612c0c-1c09-4118-9ce3-c4624c07b435"}, {"Element": "<sup>2</sup>", "ID": "671529be-64e7-4364-b5dc-4b94ca929845", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "61612c0c-1c09-4118-9ce3-c4624c07b435"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "91825608-e78a-499b-86a6-a45c30b62bb5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "46733b30-b6e8-409f-977c-e40b1a986b56", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "91825608-e78a-499b-86a6-a45c30b62bb5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If the patient experienced a previous Grade\u00a04 haemorrhagic\ncystitis with cyclophosphamide, or demonstrated a chemorefractory state to a\ncyclophosphamide\u2011containing regimen administered shortly before\nlymphodepleting chemotherapy, then the following should be used:</span></p>", "ID": "828820ca-7109-44c9-a456-8da3cc33f3b7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If the patient experienced a previous Grade\u00a04 haemorrhagic\ncystitis with cyclophosphamide, or demonstrated a chemorefractory state to a\ncyclophosphamide\u2011containing regimen administered shortly before\nlymphodepleting chemotherapy, then the following should be used:</span>", "ID": "91eeb7f3-5ab6-426c-86c6-d2a3ad1779b3", "Styles": "None", "Classes": "None", "Text": "If the patient experienced a previous Grade\u00a04 haemorrhagic cystitis with cyclophosphamide, or demonstrated a chemorefractory state to a cyclophosphamide\u2011containing regimen administered shortly before lymphodepleting chemotherapy, then the following should be used:", "ParentId": "828820ca-7109-44c9-a456-8da3cc33f3b7"}, {"Element": "<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Cytarabine (500\u00a0mg/m<sup>2</sup>\nintravenous daily for 2\u00a0days) and etoposide (150\u00a0mg/m<sup>2</sup> intravenous\ndaily for 3\u00a0days starting with the first dose of cytarabine).</span></p>", "ID": "168207f8-ea6a-4b6a-9e64-c2ffb1051607", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ca7c7e8b-6c20-456f-a18a-5c498e2503cc", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "168207f8-ea6a-4b6a-9e64-c2ffb1051607"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4abccc71-3aef-481f-af62-4e135f3ec40d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ca7c7e8b-6c20-456f-a18a-5c498e2503cc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Cytarabine (500\u00a0mg/m<sup>2</sup>\nintravenous daily for 2\u00a0days) and etoposide (150\u00a0mg/m<sup>2</sup> intravenous\ndaily for 3\u00a0days starting with the first dose of cytarabine).</span>", "ID": "8ecc85ac-6cbf-4a88-adca-2ccb4199a297", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Cytarabine (500\u00a0mg/m intravenous daily for 2\u00a0days) and etoposide (150\u00a0mg/m intravenous daily for 3\u00a0days starting with the first dose of cytarabine).", "ParentId": "168207f8-ea6a-4b6a-9e64-c2ffb1051607"}, {"Element": "<sup>2</sup>", "ID": "b2569124-eff9-423c-a5a4-04dd7279bde5", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "8ecc85ac-6cbf-4a88-adca-2ccb4199a297"}, {"Element": "<sup>2</sup>", "ID": "6eecb718-367f-4f59-9b37-e576978066d7", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "8ecc85ac-6cbf-4a88-adca-2ccb4199a297"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "f28cf79e-00f9-44fe-8b4e-e8bbf2e1f50a", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "44dd7948-ab2d-4ce9-8d02-9378308a0cb7", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "f28cf79e-00f9-44fe-8b4e-e8bbf2e1f50a"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></u></i></p>", "ID": "5d3aacb0-9e6a-4fd1-93be-516356d6fd73", "Styles": "margin-top:0in;text-align:left;page-break-after:\navoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></u></i>", "ID": "677b4411-90f0-480b-a093-40cf995f8657", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d3aacb0-9e6a-4fd1-93be-516356d6fd73"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></u>", "ID": "0545b4c6-66b5-45ce-b988-6701ab83a134", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "677b4411-90f0-480b-a093-40cf995f8657"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span>", "ID": "70d1868d-7361-4269-bf4b-937fe796c548", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "DLBCL", "ParentId": "0545b4c6-66b5-45ce-b988-6701ab83a134"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The recommended\nlymphodepleting chemotherapy regimen is:</span></p>", "ID": "def2a4c1-670f-491f-bbe4-03dc4657b8d9", "Styles": "margin-top:0in;text-align:left;page-break-after:\navoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The recommended\nlymphodepleting chemotherapy regimen is:</span>", "ID": "e1c90480-5a40-4cc2-9b37-64a4cb0060e1", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The recommended lymphodepleting chemotherapy regimen is:", "ParentId": "def2a4c1-670f-491f-bbe4-03dc4657b8d9"}, {"Element": "<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Fludarabine (25\u00a0mg/m<sup>2</sup>\nintravenous daily for 3\u00a0days) and cyclophosphamide (250\u00a0mg/m<sup>2</sup>\nintravenous daily for 3\u00a0days starting with the first dose of fludarabine).</span></p>", "ID": "ad64d2a4-4145-423f-a7dc-eddfb1cd53ac", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6edba09d-67c6-4d20-89d8-134f7a6d905e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "ad64d2a4-4145-423f-a7dc-eddfb1cd53ac"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6e64b859-6194-4368-b67a-a6700bd4ea93", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6edba09d-67c6-4d20-89d8-134f7a6d905e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Fludarabine (25\u00a0mg/m<sup>2</sup>\nintravenous daily for 3\u00a0days) and cyclophosphamide (250\u00a0mg/m<sup>2</sup>\nintravenous daily for 3\u00a0days starting with the first dose of fludarabine).</span>", "ID": "4ef3e57f-b431-4b92-9e29-5b2b51870dc6", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Fludarabine (25\u00a0mg/m intravenous daily for 3\u00a0days) and cyclophosphamide (250\u00a0mg/m intravenous daily for 3\u00a0days starting with the first dose of fludarabine).", "ParentId": "ad64d2a4-4145-423f-a7dc-eddfb1cd53ac"}, {"Element": "<sup>2</sup>", "ID": "5e36655d-d728-49ef-a0fc-572ef7ddd67c", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "4ef3e57f-b431-4b92-9e29-5b2b51870dc6"}, {"Element": "<sup>2</sup>", "ID": "93a5410e-ee74-41b3-b0ed-d94ee6c21367", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "4ef3e57f-b431-4b92-9e29-5b2b51870dc6"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "f810be7a-4aad-4671-b3bf-95c2d0a5b4b0", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "6e3ae240-3789-41c2-b63e-b748eb9139d7", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "f810be7a-4aad-4671-b3bf-95c2d0a5b4b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If the patient experienced a previous Grade\u00a04 haemorrhagic\ncystitis with cyclophosphamide, or demonstrated a chemorefractory state to a\ncyclophosphamide\u2011containing regimen administered shortly before\nlymphodepleting chemotherapy, then the following should be used:</span></p>", "ID": "937a2416-32f8-4090-a9d7-380afd109a14", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If the patient experienced a previous Grade\u00a04 haemorrhagic\ncystitis with cyclophosphamide, or demonstrated a chemorefractory state to a\ncyclophosphamide\u2011containing regimen administered shortly before\nlymphodepleting chemotherapy, then the following should be used:</span>", "ID": "7d4ab3e4-b236-4e52-a69f-57ea0df3c449", "Styles": "None", "Classes": "None", "Text": "If the patient experienced a previous Grade\u00a04 haemorrhagic cystitis with cyclophosphamide, or demonstrated a chemorefractory state to a cyclophosphamide\u2011containing regimen administered shortly before lymphodepleting chemotherapy, then the following should be used:", "ParentId": "937a2416-32f8-4090-a9d7-380afd109a14"}, {"Element": "<p class=\"Listlevel2\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Bendamustine\n(90\u00a0mg/m<sup>2</sup> intravenous daily for 2\u00a0days).</span></p>", "ID": "7c1fdb38-3114-4400-b78b-b4656f5e089d", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "95301f59-6c95-4006-9f5a-750540b8baa1", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "7c1fdb38-3114-4400-b78b-b4656f5e089d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8ee8b510-13a2-41df-98fa-1782dcec3b79", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "95301f59-6c95-4006-9f5a-750540b8baa1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Bendamustine\n(90\u00a0mg/m<sup>2</sup> intravenous daily for 2\u00a0days).</span>", "ID": "3a158f05-8342-4227-a660-a39efaa10961", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Bendamustine (90\u00a0mg/m intravenous daily for 2\u00a0days).", "ParentId": "7c1fdb38-3114-4400-b78b-b4656f5e089d"}, {"Element": "<sup>2</sup>", "ID": "791acd64-7bb6-4028-a0ae-dfa7f1a1554c", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "3a158f05-8342-4227-a660-a39efaa10961"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "554d0723-8a39-45e6-8acd-b2b51346c536", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "cf38b3e4-e6a5-4074-ac3f-c03ce13ba63e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "554d0723-8a39-45e6-8acd-b2b51346c536"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Lymphodepleting chemotherapy may be omitted\nif a patient\u2019s white blood cell (WBC) count is \u22641,000\u00a0cells/\u00b5L\nwithin 1\u00a0week prior to Kymriah infusion.</span></p>", "ID": "2522b5c7-cace-4fe0-b778-e0a6ac923218", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Lymphodepleting chemotherapy may be omitted\nif a patient\u2019s white blood cell (WBC) count is \u22641,000\u00a0cells/\u00b5L\nwithin 1\u00a0week prior to Kymriah infusion.</span>", "ID": "f2b08a05-fd5e-40ac-9476-7567ba6ed08e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Lymphodepleting chemotherapy may be omitted if a patient\u2019s white blood cell (WBC) count is \u22641,000\u00a0cells/\u00b5L within 1\u00a0week prior to Kymriah infusion.", "ParentId": "2522b5c7-cace-4fe0-b778-e0a6ac923218"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9b7ada88-7aa8-438b-892a-6c07951a8445", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "851bd216-e15c-42c0-b925-47a11d0110bb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9b7ada88-7aa8-438b-892a-6c07951a8445"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Pre\u2011medication</span></u></i></p>", "ID": "0f350656-8851-44d8-a615-c2d807438234", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Pre\u2011medication</span></u></i>", "ID": "bfb303c3-5ad4-4880-8e67-f5438872b3ee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f350656-8851-44d8-a615-c2d807438234"}, {"Element": "<u><span lang=\"EN-GB\">Pre\u2011medication</span></u>", "ID": "6432fb93-e94b-446b-b6cb-f553138ec4cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bfb303c3-5ad4-4880-8e67-f5438872b3ee"}, {"Element": "<span lang=\"EN-GB\">Pre\u2011medication</span>", "ID": "941f53c3-4231-4938-8e1f-9c06142040b9", "Styles": "None", "Classes": "None", "Text": "Pre\u2011medication", "ParentId": "6432fb93-e94b-446b-b6cb-f553138ec4cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To minimise\npotential acute infusion reactions, it is recommended that patients be pre\u2011medicated\nwith paracetamol and diphenhydramine or another H1 antihistamine within\napproximately 30 to 60\u00a0minutes prior to Kymriah infusion. Corticosteroids\nshould not be used at any time except in the case of a life\u2011threatening\nemergency (see section\u00a04.4).</span></p>", "ID": "179da2fc-b0c8-40a7-90c0-989763d69b2f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">To minimise\npotential acute infusion reactions, it is recommended that patients be pre\u2011medicated\nwith paracetamol and diphenhydramine or another H1 antihistamine within\napproximately 30 to 60\u00a0minutes prior to Kymriah infusion. Corticosteroids\nshould not be used at any time except in the case of a life\u2011threatening\nemergency (see section\u00a04.4).</span>", "ID": "d43ca443-9981-44a0-adb0-e86fe90660e7", "Styles": "None", "Classes": "None", "Text": "To minimise potential acute infusion reactions, it is recommended that patients be pre\u2011medicated with paracetamol and diphenhydramine or another H1 antihistamine within approximately 30 to 60\u00a0minutes prior to Kymriah infusion. Corticosteroids should not be used at any time except in the case of a life\u2011threatening emergency (see section\u00a04.4).", "ParentId": "179da2fc-b0c8-40a7-90c0-989763d69b2f"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "a051459a-f673-431f-a366-589f17a51609", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "62b9cf94-07a9-4a3d-aed6-100ab9ca6cfd", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "a051459a-f673-431f-a366-589f17a51609"}, {"Element": "<p class=\"Nottoc-headings\" style=\"margin:0in\"><u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal'>Clinical\nassessment prior to infusion</span></u></p>", "ID": "1f43660b-ca58-4488-8dfc-a4cc7385e9eb", "Styles": "margin:0in", "Classes": "['Nottoc-headings']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal'>Clinical\nassessment prior to infusion</span></u>", "ID": "00386763-b561-4a83-8f38-da09a59094eb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1f43660b-ca58-4488-8dfc-a4cc7385e9eb"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal'>Clinical\nassessment prior to infusion</span>", "ID": "57961c42-4145-4fb5-b566-6ad8e5b11260", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal", "Classes": "None", "Text": "Clinical assessment prior to infusion", "ParentId": "00386763-b561-4a83-8f38-da09a59094eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "22ca5e1f-bf74-4be3-9332-a22a61cd46d5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9d227a8c-bdb4-43de-8918-127966cde631", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "22ca5e1f-bf74-4be3-9332-a22a61cd46d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah\ntreatment should be delayed in some patient groups at risk (see section\u00a04.4).</span></p>", "ID": "2ede3021-575f-4ef2-8ae4-5249dc9c2ee4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah\ntreatment should be delayed in some patient groups at risk (see section\u00a04.4).</span>", "ID": "d8acee4f-d085-4d5d-91dd-5128e6bb7c68", "Styles": "None", "Classes": "None", "Text": "Kymriah treatment should be delayed in some patient groups at risk (see section\u00a04.4).", "ParentId": "2ede3021-575f-4ef2-8ae4-5249dc9c2ee4"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "a5715481-658a-44e1-b83f-333d9d426bfd", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "e89b588e-df98-4f52-ba45-41588e55b21e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "a5715481-658a-44e1-b83f-333d9d426bfd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Monitoring after infusion</span></u></i></p>", "ID": "ce8bf62f-66ab-4618-843c-51507f45ae66", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Monitoring after infusion</span></u></i>", "ID": "03a47cc9-61bc-490c-bad8-d9f95039c313", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce8bf62f-66ab-4618-843c-51507f45ae66"}, {"Element": "<u><span lang=\"EN-GB\">Monitoring after infusion</span></u>", "ID": "3c154b71-e7c6-4180-84cc-0f3e6d2b2c1f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "03a47cc9-61bc-490c-bad8-d9f95039c313"}, {"Element": "<span lang=\"EN-GB\">Monitoring after infusion</span>", "ID": "c54464ad-5519-4ca1-8e3e-900b811e022d", "Styles": "None", "Classes": "None", "Text": "Monitoring after infusion", "ParentId": "3c154b71-e7c6-4180-84cc-0f3e6d2b2c1f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Patients should be monitored daily for the first\n10\u00a0days following infusion for signs and symptoms of potential cytokine\nrelease syndrome, neurological events and other toxicities. Physicians should\nconsider hospitalisation for the first 10\u00a0days post infusion</span><span lang=\"EN-GB\"> or at the first signs/symptoms of </span><span lang=\"EN-GB\">cytokine\nrelease syndrome</span><span lang=\"EN-GB\"> and/or neurological events</span><span lang=\"EN-GB\">.</span></p>", "ID": "22baf06d-0f48-4f31-adab-161f48f8eb77", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "aeb26901-1e8a-48c8-afb2-5a9f5544740f", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "22baf06d-0f48-4f31-adab-161f48f8eb77"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6de6b89c-31fc-41f1-ac03-50c2b01d8ab2", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "aeb26901-1e8a-48c8-afb2-5a9f5544740f"}, {"Element": "<span lang=\"EN-GB\">Patients should be monitored daily for the first\n10\u00a0days following infusion for signs and symptoms of potential cytokine\nrelease syndrome, neurological events and other toxicities. Physicians should\nconsider hospitalisation for the first 10\u00a0days post infusion</span>", "ID": "5f93bc80-fba7-4149-a60b-42a5716692d5", "Styles": "None", "Classes": "None", "Text": "Patients should be monitored daily for the first 10\u00a0days following infusion for signs and symptoms of potential cytokine release syndrome, neurological events and other toxicities. Physicians should consider hospitalisation for the first 10\u00a0days post infusion", "ParentId": "22baf06d-0f48-4f31-adab-161f48f8eb77"}, {"Element": "<span lang=\"EN-GB\"> or at the first signs/symptoms of </span>", "ID": "f65bf1ea-678a-4645-ac0d-e878b469c3dd", "Styles": "None", "Classes": "None", "Text": " or at the first signs/symptoms of ", "ParentId": "22baf06d-0f48-4f31-adab-161f48f8eb77"}, {"Element": "<span lang=\"EN-GB\">cytokine\nrelease syndrome</span>", "ID": "e5c4015e-8a2e-407c-be34-be3302297e97", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome", "ParentId": "22baf06d-0f48-4f31-adab-161f48f8eb77"}, {"Element": "<span lang=\"EN-GB\"> and/or neurological events</span>", "ID": "ec5005e0-3bcb-4b3f-bd83-f7f486be7dc0", "Styles": "None", "Classes": "None", "Text": " and/or neurological events", "ParentId": "22baf06d-0f48-4f31-adab-161f48f8eb77"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "ef207b71-c02b-4515-96cb-abec1b26aeec", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "22baf06d-0f48-4f31-adab-161f48f8eb77"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">After the first 10\u00a0days following the\ninfusion, the patient should be monitored at the physician\u2019s discretion.</span></p>", "ID": "c6e04be5-0764-4e07-adde-b38e6387bc27", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "389177bc-30af-4c8a-a943-dcf858325a2c", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "c6e04be5-0764-4e07-adde-b38e6387bc27"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "276d67fa-ebf1-4b00-904b-61fc80280839", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "389177bc-30af-4c8a-a943-dcf858325a2c"}, {"Element": "<span lang=\"EN-GB\">After the first 10\u00a0days following the\ninfusion, the patient should be monitored at the physician\u2019s discretion.</span>", "ID": "ef0f3465-df46-408c-a7f6-51b40d81324b", "Styles": "None", "Classes": "None", "Text": "After the first 10\u00a0days following the infusion, the patient should be monitored at the physician\u2019s discretion.", "ParentId": "c6e04be5-0764-4e07-adde-b38e6387bc27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Patients should be instructed to remain within\nproximity (within 2\u00a0hours of travel) of a qualified clinical facility for\nat least 4\u00a0weeks following infusion.</span></p>", "ID": "fa51fde7-077a-49e6-82e5-0f7e8a4bcb1a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e96156ba-7e2f-4ed6-9bcc-74fd60643281", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "fa51fde7-077a-49e6-82e5-0f7e8a4bcb1a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "74b5ec26-9266-4f85-9e75-e27847496306", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e96156ba-7e2f-4ed6-9bcc-74fd60643281"}, {"Element": "<span lang=\"EN-GB\">Patients should be instructed to remain within\nproximity (within 2\u00a0hours of travel) of a qualified clinical facility for\nat least 4\u00a0weeks following infusion.</span>", "ID": "6972a0be-abba-4123-a4ea-65a520c5eb17", "Styles": "None", "Classes": "None", "Text": "Patients should be instructed to remain within proximity (within 2\u00a0hours of travel) of a qualified clinical facility for at least 4\u00a0weeks following infusion.", "ParentId": "fa51fde7-077a-49e6-82e5-0f7e8a4bcb1a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2f410cf1-9c78-47bb-882a-b0fe04493810", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "acab0a33-3b98-44de-aea1-6b78afd3774f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2f410cf1-9c78-47bb-882a-b0fe04493810"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>", "ID": "8cdc90e3-9e60-483e-8069-7fc401206dec", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Special populations</span></u>", "ID": "28191f36-2b36-4bf9-a2b6-06c52e994d0b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8cdc90e3-9e60-483e-8069-7fc401206dec"}, {"Element": "<span lang=\"EN-GB\">Special populations</span>", "ID": "81a0c4a6-539b-43e0-a622-9ed073a3c2ce", "Styles": "None", "Classes": "None", "Text": "Special populations", "ParentId": "28191f36-2b36-4bf9-a2b6-06c52e994d0b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a7be8d49-9ac7-43e6-9553-8473561b03c0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d8845176-5820-4d81-b368-68ecc30e111a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a7be8d49-9ac7-43e6-9553-8473561b03c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric population</span></u></i></p>", "ID": "bc075c76-86ce-4871-b6f6-5610e463cdd9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Paediatric population</span></u></i>", "ID": "98d595ac-ad54-4c1c-8fdd-7c6c1022820e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc075c76-86ce-4871-b6f6-5610e463cdd9"}, {"Element": "<u><span lang=\"EN-GB\">Paediatric population</span></u>", "ID": "49c70aad-3711-4e17-97ac-e37f3549bb26", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "98d595ac-ad54-4c1c-8fdd-7c6c1022820e"}, {"Element": "<span lang=\"EN-GB\">Paediatric population</span>", "ID": "8167e9db-603b-4b5e-a272-b1a7de2f2497", "Styles": "None", "Classes": "None", "Text": "Paediatric population", "ParentId": "49c70aad-3711-4e17-97ac-e37f3549bb26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">B-cell ALL</span></i><span lang=\"EN-GB\">: No formal studies have been\nperformed in paediatric patients below 3\u00a0years of age.</span></p>", "ID": "9828a793-36f9-4ab1-a28d-56f674eff384", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\">B-cell ALL</span></i>", "ID": "24a9efe4-776b-4685-a6c6-43a449615152", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9828a793-36f9-4ab1-a28d-56f674eff384"}, {"Element": "<span lang=\"EN-GB\">B-cell ALL</span>", "ID": "3ead9563-b59b-48f2-9c59-8ebd1bef25af", "Styles": "None", "Classes": "None", "Text": "B-cell ALL", "ParentId": "24a9efe4-776b-4685-a6c6-43a449615152"}, {"Element": "<span lang=\"EN-GB\">: No formal studies have been\nperformed in paediatric patients below 3\u00a0years of age.</span>", "ID": "8e02c841-ceec-4e57-80eb-abff659533a2", "Styles": "None", "Classes": "None", "Text": ": No formal studies have been performed in paediatric patients below 3\u00a0years of age.", "ParentId": "9828a793-36f9-4ab1-a28d-56f674eff384"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">: The safety and efficacy of Kymriah in children and\nadolescents below 18\u00a0years of age have not yet been established. No data\nare available.</span></p>", "ID": "26246b29-3298-422b-a394-086c1caab866", "Styles": "margin-top:0in;text-align:left", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></i>", "ID": "3c732acb-6eec-40f8-b90d-92e72b168b6c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26246b29-3298-422b-a394-086c1caab866"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span>", "ID": "e3c4216f-ab48-4ce6-9b6d-33a2e5b5de9b", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "DLBCL", "ParentId": "3c732acb-6eec-40f8-b90d-92e72b168b6c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">: The safety and efficacy of Kymriah in children and\nadolescents below 18\u00a0years of age have not yet been established. No data\nare available.</span>", "ID": "b4802bbd-13aa-4d0b-ac3f-12a8e94e561e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": ": The safety and efficacy of Kymriah in children and adolescents below 18\u00a0years of age have not yet been established. No data are available.", "ParentId": "26246b29-3298-422b-a394-086c1caab866"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "f1513d8f-198d-4303-bb01-8a98ac608590", "Styles": "margin-top:0in;text-align:left", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"font-size:11.0pt\">\u00a0</span>", "ID": "bb0541e8-ee65-4bd4-94a5-d11e5fb6b1c5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "f1513d8f-198d-4303-bb01-8a98ac608590"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Elderly</span></u></i></p>", "ID": "e1ac6bff-3b59-48a5-aa29-c450a6eff8ac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Elderly</span></u></i>", "ID": "7c20f3bf-23aa-4d40-a7b8-81d3d6c901f4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e1ac6bff-3b59-48a5-aa29-c450a6eff8ac"}, {"Element": "<u><span lang=\"EN-GB\">Elderly</span></u>", "ID": "922a8f4e-8531-4a5b-9cec-6e620d63a5c9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c20f3bf-23aa-4d40-a7b8-81d3d6c901f4"}, {"Element": "<span lang=\"EN-GB\">Elderly</span>", "ID": "2e13e36e-b443-450b-8b6d-918e17939a39", "Styles": "None", "Classes": "None", "Text": "Elderly", "ParentId": "922a8f4e-8531-4a5b-9cec-6e620d63a5c9"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span></i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">: The safety and efficacy of Kymriah in\nthis population have not been established.</span></p>", "ID": "6e024fe0-b32b-4e22-b2a1-d09cfbe8be50", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span></i>", "ID": "a3bb1a27-78e4-4e60-8822-6c8c99fb74ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6e024fe0-b32b-4e22-b2a1-d09cfbe8be50"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">B\u2011cell ALL</span>", "ID": "af6373e7-bb0f-4ab5-a667-51e41ac15ae5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "B\u2011cell ALL", "ParentId": "a3bb1a27-78e4-4e60-8822-6c8c99fb74ac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">: The safety and efficacy of Kymriah in\nthis population have not been established.</span>", "ID": "a170ba35-76d9-4194-97d8-96f67a2b6910", "Styles": "font-size:11.0pt", "Classes": "None", "Text": ": The safety and efficacy of Kymriah in this population have not been established.", "ParentId": "6e024fe0-b32b-4e22-b2a1-d09cfbe8be50"}, {"Element": "<p class=\"Listlevel2\" style=\"margin:0in;margin-bottom:.0001pt;text-indent:0in\"><i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">: No dose adjustment is required in patients over 65\u00a0years\nof age.</span></p>", "ID": "46331165-707d-4c9c-af7b-df0d60312fbe", "Styles": "margin:0in;margin-bottom:.0001pt;text-indent:0in", "Classes": "['Listlevel2']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span></i>", "ID": "fad85042-277b-4b5d-a44b-448989083bc9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46331165-707d-4c9c-af7b-df0d60312fbe"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">DLBCL</span>", "ID": "61286b95-0b46-4d62-b6a0-6ce8f7c0f951", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "DLBCL", "ParentId": "fad85042-277b-4b5d-a44b-448989083bc9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">: No dose adjustment is required in patients over 65\u00a0years\nof age.</span>", "ID": "192c0d85-421f-4089-8344-48baf6b9de79", "Styles": "font-size:11.0pt", "Classes": "None", "Text": ": No dose adjustment is required in patients over 65\u00a0years of age.", "ParentId": "46331165-707d-4c9c-af7b-df0d60312fbe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8914fae3-1ed3-4e59-a42b-051c83ad2ddf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b9a7972a-100f-4aed-9e3e-9653f7a25249", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8914fae3-1ed3-4e59-a42b-051c83ad2ddf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Patients seropositive for hepatitis B virus (HBV), hepatitis C virus\n(HCV), or human immunodeficiency virus (HIV)</span></u></i></p>", "ID": "43373641-c209-4e02-b946-a737f6837684", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Patients seropositive for hepatitis B virus (HBV), hepatitis C virus\n(HCV), or human immunodeficiency virus (HIV)</span></u></i>", "ID": "9acbfd67-d45a-4387-afd7-de7ff185aed6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "43373641-c209-4e02-b946-a737f6837684"}, {"Element": "<u><span lang=\"EN-GB\">Patients seropositive for hepatitis B virus (HBV), hepatitis C virus\n(HCV), or human immunodeficiency virus (HIV)</span></u>", "ID": "3cbdbd36-201a-4031-a7f2-8bb2735767dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9acbfd67-d45a-4387-afd7-de7ff185aed6"}, {"Element": "<span lang=\"EN-GB\">Patients seropositive for hepatitis B virus (HBV), hepatitis C virus\n(HCV), or human immunodeficiency virus (HIV)</span>", "ID": "d2fd93be-d6cf-430b-8a40-62e418f36ce0", "Styles": "None", "Classes": "None", "Text": "Patients seropositive for hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV)", "ParentId": "3cbdbd36-201a-4031-a7f2-8bb2735767dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no\nexperience with manufacturing Kymriah for patients with a positive test for HIV,\nactive HBV, or active HCV infection. Leukapheresis material from these patients\nwill not be accepted for Kymriah manufacturing. </span><span lang=\"EN-GB\">Screening\nfor HBV, HCV, and HIV must be performed in accordance with clinical guidelines\nbefore collection of cells for manufacturing.</span></p>", "ID": "59dd6e86-e222-4c0b-b2b2-92758537c490", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There is no\nexperience with manufacturing Kymriah for patients with a positive test for HIV,\nactive HBV, or active HCV infection. Leukapheresis material from these patients\nwill not be accepted for Kymriah manufacturing. </span>", "ID": "afc8189f-30f2-4ac6-82b4-035f4bebc0c0", "Styles": "None", "Classes": "None", "Text": "There is no experience with manufacturing Kymriah for patients with a positive test for HIV, active HBV, or active HCV infection. Leukapheresis material from these patients will not be accepted for Kymriah manufacturing. ", "ParentId": "59dd6e86-e222-4c0b-b2b2-92758537c490"}, {"Element": "<span lang=\"EN-GB\">Screening\nfor HBV, HCV, and HIV must be performed in accordance with clinical guidelines\nbefore collection of cells for manufacturing.</span>", "ID": "ff367157-214e-434e-8af0-67e40d2318c4", "Styles": "None", "Classes": "None", "Text": "Screening for HBV, HCV, and HIV must be performed in accordance with clinical guidelines before collection of cells for manufacturing.", "ParentId": "59dd6e86-e222-4c0b-b2b2-92758537c490"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c39aa7c3-cb56-427d-899d-69be0cc963ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "00a5416e-4a44-44eb-b86b-1a230abfeb93", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c39aa7c3-cb56-427d-899d-69be0cc963ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>", "ID": "ec4f01e4-4b0d-4a4a-9313-2d7c9571e6ac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Method of administration</span></u>", "ID": "4c5aba7f-273c-47be-bc0b-e7aa5c96f3ca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec4f01e4-4b0d-4a4a-9313-2d7c9571e6ac"}, {"Element": "<span lang=\"EN-GB\">Method of administration</span>", "ID": "31db4fe2-f3b1-4d2f-943c-528c5a20afab", "Styles": "None", "Classes": "None", "Text": "Method of administration", "ParentId": "4c5aba7f-273c-47be-bc0b-e7aa5c96f3ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "b5dc20e9-0033-474e-806c-a87d08a314d9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "ecf981f9-3d19-4727-9253-2eec87c9d431", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5dc20e9-0033-474e-806c-a87d08a314d9"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "a3521bb4-2765-4abc-bb7d-80c919f78b8a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ecf981f9-3d19-4727-9253-2eec87c9d431"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "84cf5307-ccc2-455e-ba00-1c30abb5a12d", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "a3521bb4-2765-4abc-bb7d-80c919f78b8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is for\nintravenous use only.</span></p>", "ID": "67e5d741-220d-4b79-bbcc-f470ce412207", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is for\nintravenous use only.</span>", "ID": "809e17ec-e89d-4a9e-8f24-0be50f0f640f", "Styles": "None", "Classes": "None", "Text": "Kymriah is for intravenous use only.", "ParentId": "67e5d741-220d-4b79-bbcc-f470ce412207"}, {"Element": "<p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "dab22f52-7ef1-46b2-93d1-205413b9be2a", "Styles": "None", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "fbed4bf3-e6f1-4ec4-8b2d-a56486179e7e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "dab22f52-7ef1-46b2-93d1-205413b9be2a"}, {"Element": "<p class=\"MsoCommentText\" style=\"page-break-after:avoid\"><i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Precautions to be taken before handling or\nadministering the medicinal product</span></u></i></p>", "ID": "449dc991-98a4-4c4d-9e62-a28b6ee4ba06", "Styles": "page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Precautions to be taken before handling or\nadministering the medicinal product</span></u></i>", "ID": "a1a99672-da59-4883-8722-96a69ff531e0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "449dc991-98a4-4c4d-9e62-a28b6ee4ba06"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Precautions to be taken before handling or\nadministering the medicinal product</span></u>", "ID": "6a816b91-377a-420a-84e8-2020bc87eb47", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a1a99672-da59-4883-8722-96a69ff531e0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Precautions to be taken before handling or\nadministering the medicinal product</span>", "ID": "391dc322-1cbf-4676-862f-cec8c050cb49", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Precautions to be taken before handling or administering the medicinal product", "ParentId": "6a816b91-377a-420a-84e8-2020bc87eb47"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct contains genetically modified human blood cells. Healthcare\nprofessionals handling Kymriah should take appropriate precautions (wearing\ngloves and glasses) to avoid potential transmission of infectious diseases as\nfor any human-derived material.</span></p>", "ID": "6d2e27b6-b605-40b6-a670-4c89288a8097", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">This medicinal\nproduct contains genetically modified human blood cells. Healthcare\nprofessionals handling Kymriah should take appropriate precautions (wearing\ngloves and glasses) to avoid potential transmission of infectious diseases as\nfor any human-derived material.</span>", "ID": "94b4dcf7-faba-4e58-8909-116764935d13", "Styles": "None", "Classes": "None", "Text": "This medicinal product contains genetically modified human blood cells. Healthcare professionals handling Kymriah should take appropriate precautions (wearing gloves and glasses) to avoid potential transmission of infectious diseases as for any human-derived material.", "ParentId": "6d2e27b6-b605-40b6-a670-4c89288a8097"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b7e80593-9406-46fd-bf33-424e3d472a7c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a5f25327-70b8-47c1-bf86-8f7d6f9518ef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b7e80593-9406-46fd-bf33-424e3d472a7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Preparation for infusion</span></u></i></p>", "ID": "f79f33e5-a2e0-4c9d-bc42-6ac1e509b47b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Preparation for infusion</span></u></i>", "ID": "33d450f0-045f-4444-a10a-055506630707", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f79f33e5-a2e0-4c9d-bc42-6ac1e509b47b"}, {"Element": "<u><span lang=\"EN-GB\">Preparation for infusion</span></u>", "ID": "1ab8025e-7b02-4e8d-9d6a-35d38bbbe2b9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33d450f0-045f-4444-a10a-055506630707"}, {"Element": "<span lang=\"EN-GB\">Preparation for infusion</span>", "ID": "f87f9653-abb3-4480-96fe-9f5658bdfe51", "Styles": "None", "Classes": "None", "Text": "Preparation for infusion", "ParentId": "1ab8025e-7b02-4e8d-9d6a-35d38bbbe2b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Prior to Kymriah\ninfusion, it must be confirmed that the patient\u2019s identity matches the\nessential unique patient information on the infusion bag(s).</span></p>", "ID": "eb56f883-0b82-40ca-907e-200790a1d12f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Prior to Kymriah\ninfusion, it must be confirmed that the patient\u2019s identity matches the\nessential unique patient information on the infusion bag(s).</span>", "ID": "30fa6af0-a763-48ab-808c-0e51c43c33cb", "Styles": "None", "Classes": "None", "Text": "Prior to Kymriah infusion, it must be confirmed that the patient\u2019s identity matches the essential unique patient information on the infusion bag(s).", "ParentId": "eb56f883-0b82-40ca-907e-200790a1d12f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c0fccf5-537c-4622-a44d-41c8f94fce40", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45d6163e-6cc1-468f-885a-8e4781ac7a33", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c0fccf5-537c-4622-a44d-41c8f94fce40"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The timing of\nthaw of Kymriah and infusion should be coordinated. </span><span lang=\"EN-GB\">Please\nrefer to section\u00a06.6 for details on inspection and thawing of the infusion\nbag. </span><span lang=\"EN-GB\">The infusion start time should be confirmed in\nadvance and adjusted for thaw so that Kymriah is available for infusion when\nthe recipient is ready. Once Kymriah has been thawed and is at room temperature\n</span><span lang=\"EN-GB\">(20\u00b0C \u201125\u00b0C)</span><span lang=\"EN-GB\">, it should\nbe infused within 30\u00a0minutes to maintain maximum product viability,</span><span lang=\"EN-GB\"> including any interruption during the infusion</span><span lang=\"EN-GB\">.</span></p>", "ID": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The timing of\nthaw of Kymriah and infusion should be coordinated. </span>", "ID": "80bd0c69-0214-418f-bf96-52a3d7fb684b", "Styles": "None", "Classes": "None", "Text": "The timing of thaw of Kymriah and infusion should be coordinated. ", "ParentId": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270"}, {"Element": "<span lang=\"EN-GB\">Please\nrefer to section\u00a06.6 for details on inspection and thawing of the infusion\nbag. </span>", "ID": "c2408434-bcdd-44b2-b708-d7ee8a267e9d", "Styles": "None", "Classes": "None", "Text": "Please refer to section\u00a06.6 for details on inspection and thawing of the infusion bag. ", "ParentId": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270"}, {"Element": "<span lang=\"EN-GB\">The infusion start time should be confirmed in\nadvance and adjusted for thaw so that Kymriah is available for infusion when\nthe recipient is ready. Once Kymriah has been thawed and is at room temperature\n</span>", "ID": "dfa980d0-c457-4318-822e-599fed3bd922", "Styles": "None", "Classes": "None", "Text": "The infusion start time should be confirmed in advance and adjusted for thaw so that Kymriah is available for infusion when the recipient is ready. Once Kymriah has been thawed and is at room temperature ", "ParentId": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270"}, {"Element": "<span lang=\"EN-GB\">(20\u00b0C \u201125\u00b0C)</span>", "ID": "4d013b31-921a-4fc2-8ad2-5bda42336f22", "Styles": "None", "Classes": "None", "Text": "(20\u00b0C \u201125\u00b0C)", "ParentId": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270"}, {"Element": "<span lang=\"EN-GB\">, it should\nbe infused within 30\u00a0minutes to maintain maximum product viability,</span>", "ID": "abdbcef1-7b57-4e04-9a2c-1ceb69251440", "Styles": "None", "Classes": "None", "Text": ", it should be infused within 30\u00a0minutes to maintain maximum product viability,", "ParentId": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270"}, {"Element": "<span lang=\"EN-GB\"> including any interruption during the infusion</span>", "ID": "6a08bfcf-a86c-47d1-8617-17f832fe0c14", "Styles": "None", "Classes": "None", "Text": " including any interruption during the infusion", "ParentId": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "155e7340-98c2-4aa6-87e8-2774bb656305", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "c2b2105c-d1f6-40cb-a0c4-59ddaba2a270"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "349c47be-922d-47ee-b60d-15a657374507", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "167c0fa2-0129-420e-bdf1-dab8a7cea008", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "349c47be-922d-47ee-b60d-15a657374507"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Administration</span></u></i></p>", "ID": "efefb35d-1e1a-4dd0-bd20-d2b94d7b75b8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Administration</span></u></i>", "ID": "46396410-833d-4309-854f-1673d5ebd8ae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "efefb35d-1e1a-4dd0-bd20-d2b94d7b75b8"}, {"Element": "<u><span lang=\"EN-GB\">Administration</span></u>", "ID": "d08d9c41-9ba4-4354-9c94-a3007b4f597d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46396410-833d-4309-854f-1673d5ebd8ae"}, {"Element": "<span lang=\"EN-GB\">Administration</span>", "ID": "07dbb659-968b-4291-bee3-4f08f512793c", "Styles": "None", "Classes": "None", "Text": "Administration", "ParentId": "d08d9c41-9ba4-4354-9c94-a3007b4f597d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah should\nbe administered as an intravenous infusion through latex\u2011free intravenous\ntubing without a leukocyte depleting filter, at approximately 10 to 20\u00a0mL\nper minute by gravity flow. All contents of the infusion bag(s) should be\ninfused. Sodium chloride 9\u00a0mg/mL (0.9%) solution for injection should be\nused to prime the tubing prior to infusion and to rinse it after infusion. When\nthe full volume of Kymriah has been infused, the infusion bag should be rinsed\nwith 10 to 30\u00a0mL sodium chloride 9\u00a0mg/mL (0.9%) solution for\ninjection by back priming to ensure as many cells as possible are infused into\nthe patient.</span></p>", "ID": "85fc1600-5c0c-42c2-9500-e6a2d1eaff71", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah should\nbe administered as an intravenous infusion through latex\u2011free intravenous\ntubing without a leukocyte depleting filter, at approximately 10 to 20\u00a0mL\nper minute by gravity flow. All contents of the infusion bag(s) should be\ninfused. Sodium chloride 9\u00a0mg/mL (0.9%) solution for injection should be\nused to prime the tubing prior to infusion and to rinse it after infusion. When\nthe full volume of Kymriah has been infused, the infusion bag should be rinsed\nwith 10 to 30\u00a0mL sodium chloride 9\u00a0mg/mL (0.9%) solution for\ninjection by back priming to ensure as many cells as possible are infused into\nthe patient.</span>", "ID": "e440caf7-2ca6-4662-ae6b-ab0070e0b332", "Styles": "None", "Classes": "None", "Text": "Kymriah should be administered as an intravenous infusion through latex\u2011free intravenous tubing without a leukocyte depleting filter, at approximately 10 to 20\u00a0mL per minute by gravity flow. All contents of the infusion bag(s) should be infused. Sodium chloride 9\u00a0mg/mL (0.9%) solution for injection should be used to prime the tubing prior to infusion and to rinse it after infusion. When the full volume of Kymriah has been infused, the infusion bag should be rinsed with 10 to 30\u00a0mL sodium chloride 9\u00a0mg/mL (0.9%) solution for injection by back priming to ensure as many cells as possible are infused into the patient.", "ParentId": "85fc1600-5c0c-42c2-9500-e6a2d1eaff71"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cfc2b396-5fc8-49e9-a1e7-39e72f0933e6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5cda2347-3d62-4d0b-847f-e144e0b6aff7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cfc2b396-5fc8-49e9-a1e7-39e72f0933e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If the volume of\nKymriah to be administered is \u226420\u00a0mL, intravenous push may be used\nas an alternative method of administration.</span></p>", "ID": "ec79b161-c10e-49f0-9ef3-d6b45ef4084d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If the volume of\nKymriah to be administered is \u226420\u00a0mL, intravenous push may be used\nas an alternative method of administration.</span>", "ID": "d73d58d6-37aa-437b-83ec-bbf63ba40934", "Styles": "None", "Classes": "None", "Text": "If the volume of Kymriah to be administered is \u226420\u00a0mL, intravenous push may be used as an alternative method of administration.", "ParentId": "ec79b161-c10e-49f0-9ef3-d6b45ef4084d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "94831bdd-045e-4635-a3cf-f044dead89df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4f348ee5-16e7-408a-8a1b-0e0f72a98228", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "94831bdd-045e-4635-a3cf-f044dead89df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For special\nprecautions for disposal see section\u00a06.6.</span></p>", "ID": "cab5b03f-906d-4e67-b3cc-0ea6972d806b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">For special\nprecautions for disposal see section\u00a06.6.</span>", "ID": "4873000f-5f7f-427e-948c-3f59df215d82", "Styles": "None", "Classes": "None", "Text": "For special precautions for disposal see section\u00a06.6.", "ParentId": "cab5b03f-906d-4e67-b3cc-0ea6972d806b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b7317dda-012f-43ef-a429-dc763126d570", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7932ae85-537c-4123-9607-d2807b0dd967", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b7317dda-012f-43ef-a429-dc763126d570"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b></p>", "ID": "911d91a6-3f25-431f-8d82-98bce3bcb4b0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b>", "ID": "d7b091c8-9e85-484a-a5d8-1f59185efaac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "911d91a6-3f25-431f-8d82-98bce3bcb4b0"}, {"Element": "<span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span>", "ID": "27882286-0222-4dc2-b4cc-33783fbd3402", "Styles": "None", "Classes": "None", "Text": "4.3\u00a0\u00a0\u00a0\u00a0 Contraindications", "ParentId": "d7b091c8-9e85-484a-a5d8-1f59185efaac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "16d1b913-5427-4f86-abee-3867896fad48", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f80adec9-faad-49cb-a069-2d0acd03a150", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "16d1b913-5427-4f86-abee-3867896fad48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity\nto the active substance or to any of the excipients listed in section\u00a06.1.</span></p>", "ID": "155e1aec-47a5-4d81-9bf5-909994dfdd6b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Hypersensitivity\nto the active substance or to any of the excipients listed in section\u00a06.1.</span>", "ID": "3ccc58cd-d616-4ab1-8a92-3cef20903765", "Styles": "None", "Classes": "None", "Text": "Hypersensitivity to the active substance or to any of the excipients listed in section\u00a06.1.", "ParentId": "155e1aec-47a5-4d81-9bf5-909994dfdd6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26ceb8fc-6cf6-4374-a6c3-65f435a87283", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b154802-a428-4728-b96b-b000f44b6913", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26ceb8fc-6cf6-4374-a6c3-65f435a87283"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Contraindications\nof the lymphodepleting chemotherapy must be considered.</span></p>", "ID": "911264f5-d252-4532-bbb8-22629620354a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Contraindications\nof the lymphodepleting chemotherapy must be considered.</span>", "ID": "f04da507-b34f-414e-8ce3-b8f345a4c938", "Styles": "None", "Classes": "None", "Text": "Contraindications of the lymphodepleting chemotherapy must be considered.", "ParentId": "911264f5-d252-4532-bbb8-22629620354a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d82c5011-2eb6-4ec8-a3dd-08e3426c6a92", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d101a693-208b-4974-ab01-80bdcf9e83b7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d82c5011-2eb6-4ec8-a3dd-08e3426c6a92"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></b></p>", "ID": "6b792f25-924a-4ead-ac1e-2a08494f7124", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span></b>", "ID": "129d2102-d378-454b-8d5e-5ea7d71c6d92", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b792f25-924a-4ead-ac1e-2a08494f7124"}, {"Element": "<span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and\nprecautions for use</span>", "ID": "a0294951-548c-4acc-8353-e0195a667dfe", "Styles": "None", "Classes": "None", "Text": "4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use", "ParentId": "129d2102-d378-454b-8d5e-5ea7d71c6d92"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8a21ac8c-4240-49fa-871e-43402fc089d2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "728bb8c2-c826-4d9d-a2eb-c97dfcfe6c19", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8a21ac8c-4240-49fa-871e-43402fc089d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p>", "ID": "f31be484-c1f1-44bd-a8df-39eb440f7830", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Traceability</span></u>", "ID": "7b86487c-4f4e-4f85-93bd-cbbd72564801", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f31be484-c1f1-44bd-a8df-39eb440f7830"}, {"Element": "<span lang=\"EN-GB\">Traceability</span>", "ID": "51b1a3dd-5fbf-431a-aa76-2956ea91b34d", "Styles": "None", "Classes": "None", "Text": "Traceability", "ParentId": "7b86487c-4f4e-4f85-93bd-cbbd72564801"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6c9fdaec-2e99-4994-9391-335d1a7f18a0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0b1a6349-9207-4858-ba03-4cb5a483ab66", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6c9fdaec-2e99-4994-9391-335d1a7f18a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">To ensure traceability the name\nof the product, the batch number and the name of the treated patient should be\nkept for a period of 30\u00a0years.</p>", "ID": "e0c1af45-b88f-4468-be12-62e4e2e0f365", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "To ensure traceability the name of the product, the batch number and the name of the treated patient should be kept for a period of 30\u00a0years.", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "a5f49639-4b39-4440-ace1-573daa0906c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "f847a7f8-b53a-43d4-b0af-595f67d7563e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a5f49639-4b39-4440-ace1-573daa0906c0"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "842d9617-d0a6-4e6d-9e71-d8925ba0f1f0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f847a7f8-b53a-43d4-b0af-595f67d7563e"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "c0cf0aa0-31ca-4bb7-98bd-706aa770d2eb", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "842d9617-d0a6-4e6d-9e71-d8925ba0f1f0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reasons to delay treatment</span></u></p>", "ID": "e17e8171-0ce0-47b7-9209-23ed4664a6c9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Reasons to delay treatment</span></u>", "ID": "01a9b742-a4ae-4eb4-baad-0f406102051f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e17e8171-0ce0-47b7-9209-23ed4664a6c9"}, {"Element": "<span lang=\"EN-GB\">Reasons to delay treatment</span>", "ID": "8dfcd975-4d5d-49ff-9d25-5558f22ca786", "Styles": "None", "Classes": "None", "Text": "Reasons to delay treatment", "ParentId": "01a9b742-a4ae-4eb4-baad-0f406102051f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "04c63805-8590-4bdc-b26b-ec42d8aa9165", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fd849530-477f-4c5d-b8dc-105a70db625d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "04c63805-8590-4bdc-b26b-ec42d8aa9165"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Due to the risks associated with Kymriah treatment, infusion should\nbe delayed if a patient has any of the following conditions:</span></p>", "ID": "6c64a8fc-5c88-4153-b36c-d62cf05af0cb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Due to the risks associated with Kymriah treatment, infusion should\nbe delayed if a patient has any of the following conditions:</span>", "ID": "ee5186cf-015f-452c-94fa-1b1371753179", "Styles": "None", "Classes": "None", "Text": "Due to the risks associated with Kymriah treatment, infusion should be delayed if a patient has any of the following conditions:", "ParentId": "6c64a8fc-5c88-4153-b36c-d62cf05af0cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Unresolved serious adverse reactions\n(especially pulmonary reactions, cardiac reactions or hypotension) from\npreceding chemotherapies.</span></p>", "ID": "fdb434bb-a470-4549-965c-cfeb5f9e9e2e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Unresolved serious adverse reactions\n(especially pulmonary reactions, cardiac reactions or hypotension) from\npreceding chemotherapies.</span>", "ID": "a48f3d6a-765a-43ce-b904-745712e0a3a3", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Unresolved serious adverse reactions (especially pulmonary reactions, cardiac reactions or hypotension) from preceding chemotherapies.", "ParentId": "fdb434bb-a470-4549-965c-cfeb5f9e9e2e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active uncontrolled infection.</span></p>", "ID": "1d417055-7c21-40ab-a891-3ca47409857c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active uncontrolled infection.</span>", "ID": "f0869979-1591-4f02-831c-f4b7a1d34204", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active uncontrolled infection.", "ParentId": "1d417055-7c21-40ab-a891-3ca47409857c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active graft\u2011versus\u2011host disease\n(GVHD).</span></p>", "ID": "e9f8c22c-8d22-4084-b141-ddca80deb18d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active graft\u2011versus\u2011host disease\n(GVHD).</span>", "ID": "47f19b1d-9b7a-4dac-9353-1fcd5c05450b", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Active graft\u2011versus\u2011host disease (GVHD).", "ParentId": "e9f8c22c-8d22-4084-b141-ddca80deb18d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Significant clinical worsening of leukaemia\nburden or rapid progression of lymphoma following lymphodepleting chemotherapy.</span></p>", "ID": "23e9b13b-1c5e-44f3-a571-1613ca3ce49c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Significant clinical worsening of leukaemia\nburden or rapid progression of lymphoma following lymphodepleting chemotherapy.</span>", "ID": "a71f08d4-4318-4d65-bca8-f4af02fdfd93", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Significant clinical worsening of leukaemia burden or rapid progression of lymphoma following lymphodepleting chemotherapy.", "ParentId": "23e9b13b-1c5e-44f3-a571-1613ca3ce49c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "124a3366-69cb-4690-a43b-d1773b4c2928", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b460bb18-f3a8-4a82-974f-fb8a04eff5a3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "124a3366-69cb-4690-a43b-d1773b4c2928"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Blood, organ, tissue and\ncell donation</span></u></p>", "ID": "9cc6c575-33ec-4fc8-aaff-144a2d6728b2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Blood, organ, tissue and\ncell donation</span></u>", "ID": "0d305e6c-47f3-448c-b724-b970b81ff2b8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9cc6c575-33ec-4fc8-aaff-144a2d6728b2"}, {"Element": "<span lang=\"EN-GB\">Blood, organ, tissue and\ncell donation</span>", "ID": "b605b377-5220-49d7-8fef-2973adfc7496", "Styles": "None", "Classes": "None", "Text": "Blood, organ, tissue and cell donation", "ParentId": "0d305e6c-47f3-448c-b724-b970b81ff2b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dd133af1-a60a-491a-ae24-a2a17dccd24e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "29542dda-527f-4c7d-9707-02edb9bec5c4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dd133af1-a60a-491a-ae24-a2a17dccd24e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">Patients treated with Kymriah should not donate blood,\norgans, tissues or cells.</span></p>", "ID": "5aa0e73b-73f4-46a7-b96e-c5e532bbffa5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Patients treated with Kymriah should not donate blood,\norgans, tissues or cells.</span>", "ID": "58d712ce-677f-4e10-889e-1b7542e383df", "Styles": "None", "Classes": "None", "Text": "Patients treated with Kymriah should not donate blood, organs, tissues or cells.", "ParentId": "5aa0e73b-73f4-46a7-b96e-c5e532bbffa5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "87d6045b-4e0c-4aff-993f-962d3d0a5b3c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "81cd4b79-249e-417e-956d-608d61444826", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "87d6045b-4e0c-4aff-993f-962d3d0a5b3c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Active central nervous system (CNS) leukaemia or\nlymphoma</span></u></p>", "ID": "7bff0491-7596-46ad-a342-74437e66373d", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Active central nervous system (CNS) leukaemia or\nlymphoma</span></u>", "ID": "e0270bd4-2445-444d-9c14-5b1a5076a0ec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7bff0491-7596-46ad-a342-74437e66373d"}, {"Element": "<span lang=\"EN-GB\">Active central nervous system (CNS) leukaemia or\nlymphoma</span>", "ID": "5d6c3e46-4a07-423f-8a9c-35f5df8c2b0b", "Styles": "None", "Classes": "None", "Text": "Active central nervous system (CNS) leukaemia or lymphoma", "ParentId": "e0270bd4-2445-444d-9c14-5b1a5076a0ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7c397e5a-a089-4aa4-828e-ff097a584b8a", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2cb0b337-4fb1-4f27-bc75-250bbe5f5c6f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7c397e5a-a089-4aa4-828e-ff097a584b8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is limited\nexperience of use of Kymriah in patients with active CNS leukaemia </span><span lang=\"EN-GB\" style='font-family:\"TimesNewRomanPSMT,Times New Rom\",serif'>and\nactive CNS lymphoma.</span><span lang=\"EN-GB\"> Therefore, the risk/benefit of\nKymriah has not been established in these populations.</span></p>", "ID": "4bdb385c-36da-4151-85e7-d92af65ca8e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There is limited\nexperience of use of Kymriah in patients with active CNS leukaemia </span>", "ID": "ccb3a86b-fb00-4c32-815b-587f74a6b0f6", "Styles": "None", "Classes": "None", "Text": "There is limited experience of use of Kymriah in patients with active CNS leukaemia ", "ParentId": "4bdb385c-36da-4151-85e7-d92af65ca8e5"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"TimesNewRomanPSMT,Times New Rom\",serif'>and\nactive CNS lymphoma.</span>", "ID": "b18e5e88-361e-47d8-b57a-419acd713f67", "Styles": "font-family:\"TimesNewRomanPSMT,Times New Rom\",serif", "Classes": "None", "Text": "and active CNS lymphoma.", "ParentId": "4bdb385c-36da-4151-85e7-d92af65ca8e5"}, {"Element": "<span lang=\"EN-GB\"> Therefore, the risk/benefit of\nKymriah has not been established in these populations.</span>", "ID": "b9c35bb0-6b3e-4a5d-a02f-625e7ed3c496", "Styles": "None", "Classes": "None", "Text": " Therefore, the risk/benefit of Kymriah has not been established in these populations.", "ParentId": "4bdb385c-36da-4151-85e7-d92af65ca8e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba34e49d-633f-4121-bc23-6d3b3fdc8226", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5ee28c14-1559-452c-9da7-defcb3840716", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba34e49d-633f-4121-bc23-6d3b3fdc8226"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cytokine release syndrome</span></u></p>", "ID": "07458b8b-e778-410b-a045-f77937ec0977", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Cytokine release syndrome</span></u>", "ID": "1e60e840-1c77-4786-b4f8-7a7846484ea1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07458b8b-e778-410b-a045-f77937ec0977"}, {"Element": "<span lang=\"EN-GB\">Cytokine release syndrome</span>", "ID": "b3c60e71-f4d1-4fba-8370-6651894a7d89", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome", "ParentId": "1e60e840-1c77-4786-b4f8-7a7846484ea1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cec7cffc-f994-4b41-b55f-8be827644bc6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "96d75cf7-bbee-418b-a760-ac55dd95c9e6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cec7cffc-f994-4b41-b55f-8be827644bc6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytokine release\nsyndrome, including fatal or life\u2011threatening events, has been frequently\nobserved after Kymriah infusion (see section\u00a04.8). In almost all cases,\ndevelopment of cytokine release syndrome occurred between 1 to 10\u00a0days (median\nonset 3\u00a0days) after Kymriah infusion</span><span lang=\"EN-GB\">. The median\ntime to resolution of </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> was 8\u00a0days</span><span lang=\"EN-GB\">.</span></p>", "ID": "1fa0db17-b639-4745-b181-db67ead9dbe9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Cytokine release\nsyndrome, including fatal or life\u2011threatening events, has been frequently\nobserved after Kymriah infusion (see section\u00a04.8). In almost all cases,\ndevelopment of cytokine release syndrome occurred between 1 to 10\u00a0days (median\nonset 3\u00a0days) after Kymriah infusion</span>", "ID": "b6d4f3a6-2888-4902-8a68-0357c809a83f", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome, including fatal or life\u2011threatening events, has been frequently observed after Kymriah infusion (see section\u00a04.8). In almost all cases, development of cytokine release syndrome occurred between 1 to 10\u00a0days (median onset 3\u00a0days) after Kymriah infusion", "ParentId": "1fa0db17-b639-4745-b181-db67ead9dbe9"}, {"Element": "<span lang=\"EN-GB\">. The median\ntime to resolution of </span>", "ID": "4d11c245-217a-4c87-aff0-c4da3b4dce83", "Styles": "None", "Classes": "None", "Text": ". The median time to resolution of ", "ParentId": "1fa0db17-b639-4745-b181-db67ead9dbe9"}, {"Element": "<span lang=\"EN-GB\">cytokine release syndrome</span>", "ID": "4aad5195-ef54-46c4-a482-4b60977eef85", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome", "ParentId": "1fa0db17-b639-4745-b181-db67ead9dbe9"}, {"Element": "<span lang=\"EN-GB\"> was 8\u00a0days</span>", "ID": "ff210669-2109-4018-9a0e-09049cff6338", "Styles": "None", "Classes": "None", "Text": " was 8\u00a0days", "ParentId": "1fa0db17-b639-4745-b181-db67ead9dbe9"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "cd36a09c-117f-4076-8bbf-e46ee148f37d", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "1fa0db17-b639-4745-b181-db67ead9dbe9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2aaa80aa-4d29-4c12-ae56-9b6d0a83ec1a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "23338b26-3bd0-4ab6-b044-4304e45cedde", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2aaa80aa-4d29-4c12-ae56-9b6d0a83ec1a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Symptoms of cytokine\nrelease syndrome may include high fever, rigors, myalgia, arthralgia, nausea,\nvomiting, diarrhoea, diaphoresis, rash, anorexia, fatigue, headache,\nhypotension, dyspnoea, tachypnoea, and hypoxia. Organ dysfunction, including\ncardiac insufficiency and arrhythmia, renal insufficiency and liver injury with\naccompanying elevated aspartate aminotransferase (AST), elevated alanine\naminotransferase (ALT) or elevated total bilirubin may also be observed. In\nsome cases, disseminated intravascular coagulation (DIC) with low fibrinogen\nlevels, capillary leak syndrome (CLS), macrophage activation syndrome (MAS) and\nhaemophagocytic lymphohistiocytosis(HLH) may occur in the setting of cytokine\nrelease syndrome. Patients should be closely monitored for signs or symptoms of\nthese events, including fever.</span></p>", "ID": "9a90cea2-6fda-4382-a681-511918398b76", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Symptoms of cytokine\nrelease syndrome may include high fever, rigors, myalgia, arthralgia, nausea,\nvomiting, diarrhoea, diaphoresis, rash, anorexia, fatigue, headache,\nhypotension, dyspnoea, tachypnoea, and hypoxia. Organ dysfunction, including\ncardiac insufficiency and arrhythmia, renal insufficiency and liver injury with\naccompanying elevated aspartate aminotransferase (AST), elevated alanine\naminotransferase (ALT) or elevated total bilirubin may also be observed. In\nsome cases, disseminated intravascular coagulation (DIC) with low fibrinogen\nlevels, capillary leak syndrome (CLS), macrophage activation syndrome (MAS) and\nhaemophagocytic lymphohistiocytosis(HLH) may occur in the setting of cytokine\nrelease syndrome. Patients should be closely monitored for signs or symptoms of\nthese events, including fever.</span>", "ID": "2821587f-8192-4d4b-abef-14c0549f32a2", "Styles": "None", "Classes": "None", "Text": "Symptoms of cytokine release syndrome may include high fever, rigors, myalgia, arthralgia, nausea, vomiting, diarrhoea, diaphoresis, rash, anorexia, fatigue, headache, hypotension, dyspnoea, tachypnoea, and hypoxia. Organ dysfunction, including cardiac insufficiency and arrhythmia, renal insufficiency and liver injury with accompanying elevated aspartate aminotransferase (AST), elevated alanine aminotransferase (ALT) or elevated total bilirubin may also be observed. In some cases, disseminated intravascular coagulation (DIC) with low fibrinogen levels, capillary leak syndrome (CLS), macrophage activation syndrome (MAS) and haemophagocytic lymphohistiocytosis(HLH) may occur in the setting of cytokine release syndrome. Patients should be closely monitored for signs or symptoms of these events, including fever.", "ParentId": "9a90cea2-6fda-4382-a681-511918398b76"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a28044a7-af71-4e35-9bef-fbe6193e9de3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a53c8025-bd15-44c4-9db9-678a1b180f9d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a28044a7-af71-4e35-9bef-fbe6193e9de3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Risk factors for\nsevere cytokine release syndrome in paediatric and young adult B\u2011cell ALL\npatients are: high pre\u2011infusion tumour burden, uncontrolled or\naccelerating tumour burden following lymphodepleting chemotherapy, active\ninfection and early onset of fever or cytokine release syndrome following\nKymriah infusion. High tumour burden prior to Kymriah infusion was identified\nas a risk factor for developing severe cytokine release syndrome in adult DLBCL\npatients.</span></p>", "ID": "640c9b56-44ec-4313-87ca-1dcd787c1a77", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Risk factors for\nsevere cytokine release syndrome in paediatric and young adult B\u2011cell ALL\npatients are: high pre\u2011infusion tumour burden, uncontrolled or\naccelerating tumour burden following lymphodepleting chemotherapy, active\ninfection and early onset of fever or cytokine release syndrome following\nKymriah infusion. High tumour burden prior to Kymriah infusion was identified\nas a risk factor for developing severe cytokine release syndrome in adult DLBCL\npatients.</span>", "ID": "a81c3928-6100-4506-b143-f59148629e01", "Styles": "None", "Classes": "None", "Text": "Risk factors for severe cytokine release syndrome in paediatric and young adult B\u2011cell ALL patients are: high pre\u2011infusion tumour burden, uncontrolled or accelerating tumour burden following lymphodepleting chemotherapy, active infection and early onset of fever or cytokine release syndrome following Kymriah infusion. High tumour burden prior to Kymriah infusion was identified as a risk factor for developing severe cytokine release syndrome in adult DLBCL patients.", "ParentId": "640c9b56-44ec-4313-87ca-1dcd787c1a77"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2f0fb16-8f84-4458-aa4d-79d4ce331201", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2bfa447b-9b71-495d-94e4-cfd3d13370b9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2f0fb16-8f84-4458-aa4d-79d4ce331201"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In all\nindications, appropriate prophylactic and therapeutic treatment for infections\nshould be provided, and complete resolution of any existing infections should\nbe ensured. Infections may also occur during cytokine release syndrome and may\nincrease the risk of a fatal event.</span></p>", "ID": "9d199765-4121-4236-89f3-340655547291", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In all\nindications, appropriate prophylactic and therapeutic treatment for infections\nshould be provided, and complete resolution of any existing infections should\nbe ensured. Infections may also occur during cytokine release syndrome and may\nincrease the risk of a fatal event.</span>", "ID": "14768f44-3075-49f1-a2c0-0f15b1e4ed5c", "Styles": "None", "Classes": "None", "Text": "In all indications, appropriate prophylactic and therapeutic treatment for infections should be provided, and complete resolution of any existing infections should be ensured. Infections may also occur during cytokine release syndrome and may increase the risk of a fatal event.", "ParentId": "9d199765-4121-4236-89f3-340655547291"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6661492c-b1df-4ad1-8a21-119b6c4f4ce3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c2c29828-fe59-430d-8af7-aabdd4628641", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6661492c-b1df-4ad1-8a21-119b6c4f4ce3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Management of cytokine release syndrome associated with Kymriah</span></u></i></p>", "ID": "ad8bdf0e-d5e0-4481-9ad6-1f6786ae4489", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Management of cytokine release syndrome associated with Kymriah</span></u></i>", "ID": "18721a12-ec3f-4f94-9bcc-0ec55ffc3931", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad8bdf0e-d5e0-4481-9ad6-1f6786ae4489"}, {"Element": "<u><span lang=\"EN-GB\">Management of cytokine release syndrome associated with Kymriah</span></u>", "ID": "5356d4bf-0469-44f6-b8e9-753691086fcd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18721a12-ec3f-4f94-9bcc-0ec55ffc3931"}, {"Element": "<span lang=\"EN-GB\">Management of cytokine release syndrome associated with Kymriah</span>", "ID": "d3ae6748-2d72-42fa-a086-21f3af92ec49", "Styles": "None", "Classes": "None", "Text": "Management of cytokine release syndrome associated with Kymriah", "ParentId": "5356d4bf-0469-44f6-b8e9-753691086fcd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytokine release\nsyndrome should be managed solely based on the patient\u2019s clinical presentation\nand according to the cytokine release syndrome management algorithm provided in\nTable\u00a01. Anti\u2011IL\u20116 based therapy such as tocilizumab has been\nadministered for moderate or severe cytokine release syndrome associated with\nKymriah. One dose of tocilizumab per patient must be on site and available for\nadministration prior to Kymriah infusion. The treatment centre should have\naccess to additional doses of tocilizumab within 8\u00a0hours. Corticosteroids\nmay be administered in cases of life\u2011threatening emergencies.\nTisagenlecleucel continues to expand and persist following administration of\ntocilizumab and corticosteroids.</span><span lang=\"EN-GB\"> Patients with\nmedically significant cardiac dysfunction should be managed by standards of\ncritical care and measures such as echocardiography should be considered. </span><span lang=\"EN-GB\">Tumour necrosis factor (TNF) antagonists are not recommended for\nmanagement of Kymriah\u2011associated cytokine release syndrome.</span></p>", "ID": "59cf462f-eb80-42f2-bd40-68defbe97914", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Cytokine release\nsyndrome should be managed solely based on the patient\u2019s clinical presentation\nand according to the cytokine release syndrome management algorithm provided in\nTable\u00a01. Anti\u2011IL\u20116 based therapy such as tocilizumab has been\nadministered for moderate or severe cytokine release syndrome associated with\nKymriah. One dose of tocilizumab per patient must be on site and available for\nadministration prior to Kymriah infusion. The treatment centre should have\naccess to additional doses of tocilizumab within 8\u00a0hours. Corticosteroids\nmay be administered in cases of life\u2011threatening emergencies.\nTisagenlecleucel continues to expand and persist following administration of\ntocilizumab and corticosteroids.</span>", "ID": "aafd59a0-4922-4348-b765-7c21b8ac7d7b", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome should be managed solely based on the patient\u2019s clinical presentation and according to the cytokine release syndrome management algorithm provided in Table\u00a01. Anti\u2011IL\u20116 based therapy such as tocilizumab has been administered for moderate or severe cytokine release syndrome associated with Kymriah. One dose of tocilizumab per patient must be on site and available for administration prior to Kymriah infusion. The treatment centre should have access to additional doses of tocilizumab within 8\u00a0hours. Corticosteroids may be administered in cases of life\u2011threatening emergencies. Tisagenlecleucel continues to expand and persist following administration of tocilizumab and corticosteroids.", "ParentId": "59cf462f-eb80-42f2-bd40-68defbe97914"}, {"Element": "<span lang=\"EN-GB\"> Patients with\nmedically significant cardiac dysfunction should be managed by standards of\ncritical care and measures such as echocardiography should be considered. </span>", "ID": "449d1060-f3fc-4dbb-9326-1ed4fc5bb652", "Styles": "None", "Classes": "None", "Text": " Patients with medically significant cardiac dysfunction should be managed by standards of critical care and measures such as echocardiography should be considered. ", "ParentId": "59cf462f-eb80-42f2-bd40-68defbe97914"}, {"Element": "<span lang=\"EN-GB\">Tumour necrosis factor (TNF) antagonists are not recommended for\nmanagement of Kymriah\u2011associated cytokine release syndrome.</span>", "ID": "d01eb3eb-e81e-4f65-bad2-1bc21346aa44", "Styles": "None", "Classes": "None", "Text": "Tumour necrosis factor (TNF) antagonists are not recommended for management of Kymriah\u2011associated cytokine release syndrome.", "ParentId": "59cf462f-eb80-42f2-bd40-68defbe97914"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9618a3cb-4ce2-4ec4-afa7-0057ae2636fa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fcfb7289-682a-400d-9257-743de4e5d13a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9618a3cb-4ce2-4ec4-afa7-0057ae2636fa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table\u00a01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cytokine\nrelease syndrome management algorithm</span></b></p>", "ID": "1500b50d-822d-4467-995c-9b37ffc59241", "Styles": "margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cytokine\nrelease syndrome management algorithm</span></b>", "ID": "772eee02-fe0f-403e-a784-2c4bcda5332b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1500b50d-822d-4467-995c-9b37ffc59241"}, {"Element": "<span lang=\"EN-GB\">Table\u00a01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cytokine\nrelease syndrome management algorithm</span>", "ID": "6217da8f-d038-4a7e-bc48-66e8b73b3a3e", "Styles": "None", "Classes": "None", "Text": "Table\u00a01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cytokine release syndrome management algorithm", "ParentId": "772eee02-fe0f-403e-a784-2c4bcda5332b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e64620f-497e-4c89-963d-68b2df9e2dde", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0a90e269-3674-4b28-8ff0-3182c5b1ca6c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e64620f-497e-4c89-963d-68b2df9e2dde"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.38%;border-collapse:collapse;border:none\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Cytokine release syndrome severity</span></b></p>\n</td>\n<td style=\"width:57.78%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Management</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Prodromal syndrome</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Low\u2011grade fever, fatigue, anorexia</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Observe in person; exclude infection; administer antibiotics per\n  local guidelines if neutropenic; provide symptomatic support.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">High fever</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Hypoxia</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Mild hypotension</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Administer antipyretics, oxygen, intravenous fluids and/or low\u2011dose\n  vasopressors as needed.</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Haemodynamic instability despite intravenous\n  fluids and vasopressor support</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Worsening respiratory distress, including\n  pulmonary infiltrates, increasing oxygen requirement including high\u2011flow\n  oxygen and/or need for mechanical ventilation</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Rapid clinical deterioration</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer high\u2011dose or multiple\n  vasopressors, oxygen, mechanical ventilation and/or other supportive care as\n  needed.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer tocilizumab.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight less than 30\u00a0kg:\n  12\u00a0mg/kg intravenously over 1\u00a0hour</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight \u226530\u00a0kg: 8\u00a0mg/kg\n  intravenously over 1\u00a0hour (maximum dose 800\u00a0mg)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Repeat tocilizumab as needed at a minimum interval of 8\u00a0hours\n  if there is no clinical improvement.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If no response to second dose of tocilizumab, consider a third\n  dose of tocilizumab or pursue alternative measures for treatment of cytokine\n  release syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Limit to a maximum total of 4\u00a0tocilizumab doses.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">If no clinical improvement within 12 to\n  18\u00a0hours of the first tocilizumab dose, or worsening at any time,\n  administer methylprednisolone 2\u00a0mg/kg as an initial dose, then\n  2\u00a0mg/kg per day until vasopressors and high\u2011flow oxygen are no\n  longer needed, then taper.</span></p>\n</td>\n</tr>\n</table>", "ID": "eeabedb4-d3be-4d81-8f86-d3edc85f8813", "Styles": "width:100.38%;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "     ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Cytokine release syndrome severity</span></b></p>\n</td>\n<td style=\"width:57.78%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Management</span></b></p>\n</td>\n</tr>", "ID": "7b44b76f-37e6-4563-8d51-67d8fb9ad3ea", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "eeabedb4-d3be-4d81-8f86-d3edc85f8813"}, {"Element": "<td style=\"width:42.22%;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Cytokine release syndrome severity</span></b></p>\n</td>", "ID": "9cf4a4b1-9074-4e38-b25a-a4c25edf8d65", "Styles": "width:42.22%;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7b44b76f-37e6-4563-8d51-67d8fb9ad3ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Cytokine release syndrome severity</span></b></p>", "ID": "427deb36-1e56-4bbe-9b5e-af1fa4501136", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9cf4a4b1-9074-4e38-b25a-a4c25edf8d65"}, {"Element": "<b><span lang=\"EN-GB\">Cytokine release syndrome severity</span></b>", "ID": "b04a954e-da47-47e7-a6cb-b86b0efcd83d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "427deb36-1e56-4bbe-9b5e-af1fa4501136"}, {"Element": "<span lang=\"EN-GB\">Cytokine release syndrome severity</span>", "ID": "42eecb16-5aa8-41f5-910c-04b26ddfd07d", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome severity", "ParentId": "b04a954e-da47-47e7-a6cb-b86b0efcd83d"}, {"Element": "<td style=\"width:57.78%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Management</span></b></p>\n</td>", "ID": "216b1f67-3ebe-4432-8db6-b988e23332d8", "Styles": "width:57.78%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7b44b76f-37e6-4563-8d51-67d8fb9ad3ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Management</span></b></p>", "ID": "a446c000-ae95-4076-8f61-00e15ed3c6b1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "216b1f67-3ebe-4432-8db6-b988e23332d8"}, {"Element": "<b><span lang=\"EN-GB\">Management</span></b>", "ID": "e1ccd8a5-d2e7-48d4-b832-9cf57205526a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a446c000-ae95-4076-8f61-00e15ed3c6b1"}, {"Element": "<span lang=\"EN-GB\">Management</span>", "ID": "2f12eb16-15bf-4306-9e89-fda1f63c2f2c", "Styles": "None", "Classes": "None", "Text": "Management", "ParentId": "e1ccd8a5-d2e7-48d4-b832-9cf57205526a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Prodromal syndrome</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Low\u2011grade fever, fatigue, anorexia</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Observe in person; exclude infection; administer antibiotics per\n  local guidelines if neutropenic; provide symptomatic support.</span></p>\n</td>\n</tr>", "ID": "3b97ded1-7413-43f1-809e-74afd550e814", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "eeabedb4-d3be-4d81-8f86-d3edc85f8813"}, {"Element": "<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Prodromal syndrome</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Low\u2011grade fever, fatigue, anorexia</span></p>\n</td>", "ID": "d1a40a9a-e315-48a5-ad0d-f02537a41dde", "Styles": "width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "3b97ded1-7413-43f1-809e-74afd550e814"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Prodromal syndrome</span></i></b><span lang=\"EN-GB\">:</span></p>", "ID": "9ee582cf-41f5-48c7-bd5a-2e32109fb71a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d1a40a9a-e315-48a5-ad0d-f02537a41dde"}, {"Element": "<b><i><span lang=\"EN-GB\">Prodromal syndrome</span></i></b>", "ID": "da229bb1-07e0-45cb-91df-98f7a2a2bd65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9ee582cf-41f5-48c7-bd5a-2e32109fb71a"}, {"Element": "<i><span lang=\"EN-GB\">Prodromal syndrome</span></i>", "ID": "2d52b1ea-5939-4893-83ab-975f23a19007", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "da229bb1-07e0-45cb-91df-98f7a2a2bd65"}, {"Element": "<span lang=\"EN-GB\">Prodromal syndrome</span>", "ID": "e1850832-1448-42b6-9d20-059ef2dc6e5f", "Styles": "None", "Classes": "None", "Text": "Prodromal syndrome", "ParentId": "2d52b1ea-5939-4893-83ab-975f23a19007"}, {"Element": "<span lang=\"EN-GB\">:</span>", "ID": "3ce62ab1-ef96-4b0c-8a6c-36b0112885a2", "Styles": "None", "Classes": "None", "Text": ":", "ParentId": "9ee582cf-41f5-48c7-bd5a-2e32109fb71a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Low\u2011grade fever, fatigue, anorexia</span></p>", "ID": "f44fd018-625d-40ad-8421-1b025fe659ba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d1a40a9a-e315-48a5-ad0d-f02537a41dde"}, {"Element": "<span lang=\"EN-GB\">Low\u2011grade fever, fatigue, anorexia</span>", "ID": "5781220a-3819-43ea-8983-984ecf8ce56e", "Styles": "None", "Classes": "None", "Text": "Low\u2011grade fever, fatigue, anorexia", "ParentId": "f44fd018-625d-40ad-8421-1b025fe659ba"}, {"Element": "<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Observe in person; exclude infection; administer antibiotics per\n  local guidelines if neutropenic; provide symptomatic support.</span></p>\n</td>", "ID": "4469b6ce-77aa-4d78-9591-de3053f95f5a", "Styles": "width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3b97ded1-7413-43f1-809e-74afd550e814"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Observe in person; exclude infection; administer antibiotics per\n  local guidelines if neutropenic; provide symptomatic support.</span></p>", "ID": "19b4bb94-c2cb-4d55-ab83-cb93ca854be2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4469b6ce-77aa-4d78-9591-de3053f95f5a"}, {"Element": "<span lang=\"EN-GB\">Observe in person; exclude infection; administer antibiotics per\n  local guidelines if neutropenic; provide symptomatic support.</span>", "ID": "fcf9b9af-e1c4-485d-8ba0-26223d457399", "Styles": "None", "Classes": "None", "Text": "Observe in person; exclude infection; administer antibiotics per   local guidelines if neutropenic; provide symptomatic support.", "ParentId": "19b4bb94-c2cb-4d55-ab83-cb93ca854be2"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">High fever</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Hypoxia</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Mild hypotension</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Administer antipyretics, oxygen, intravenous fluids and/or low\u2011dose\n  vasopressors as needed.</span></p>\n</td>\n</tr>", "ID": "92b8b607-490c-4da5-af5e-30034a43951d", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "eeabedb4-d3be-4d81-8f86-d3edc85f8813"}, {"Element": "<td style=\"width:42.22%;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">High fever</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Hypoxia</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Mild hypotension</span></p>\n</td>", "ID": "fc46e5a2-557a-4b14-baab-ee83fc589d3d", "Styles": "width:42.22%;border:solid windowtext 1.0pt;border-top:\n  none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "92b8b607-490c-4da5-af5e-30034a43951d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>", "ID": "ad4a1731-9078-4470-996b-ce8188391f8e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc46e5a2-557a-4b14-baab-ee83fc589d3d"}, {"Element": "<b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span></i></b>", "ID": "fbfd6ec8-f219-42a2-9e68-eb37fc8b1130", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad4a1731-9078-4470-996b-ce8188391f8e"}, {"Element": "<i><span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span></i>", "ID": "3cab6a8b-2ed1-4162-b339-6e50e407ce45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbfd6ec8-f219-42a2-9e68-eb37fc8b1130"}, {"Element": "<span lang=\"EN-GB\">Cytokine release syndrome requiring mild intervention \u2011 one\n  or more of the following</span>", "ID": "c0a0bbf2-27a2-4160-8f64-7404d08d5e14", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome requiring mild intervention \u2011 one   or more of the following", "ParentId": "3cab6a8b-2ed1-4162-b339-6e50e407ce45"}, {"Element": "<span lang=\"EN-GB\">:</span>", "ID": "b1a1d5bf-542b-4883-9126-afc7717a5a73", "Styles": "None", "Classes": "None", "Text": ":", "ParentId": "ad4a1731-9078-4470-996b-ce8188391f8e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">High fever</span></p>", "ID": "7664e1cf-b5f4-4aa6-91d4-70deb7956c3a", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc46e5a2-557a-4b14-baab-ee83fc589d3d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "b6686d78-3190-4155-8726-4f1015d401d7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "-", "ParentId": "7664e1cf-b5f4-4aa6-91d4-70deb7956c3a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "34cfe30f-d2bc-41ee-afeb-c1ce39d425a1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "b6686d78-3190-4155-8726-4f1015d401d7"}, {"Element": "<span lang=\"EN-GB\">High fever</span>", "ID": "72916f42-1701-4019-aab8-11b6538503ed", "Styles": "None", "Classes": "None", "Text": "High fever", "ParentId": "7664e1cf-b5f4-4aa6-91d4-70deb7956c3a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Hypoxia</span></p>", "ID": "a6eedf41-e4a1-4b33-8690-9497ef580e82", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc46e5a2-557a-4b14-baab-ee83fc589d3d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "781ca177-154d-480d-9fcf-b189287102cc", "Styles": "font-family:Symbol", "Classes": "None", "Text": "-", "ParentId": "a6eedf41-e4a1-4b33-8690-9497ef580e82"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "09fcdc5f-fd30-4ad7-876d-619feef6c43c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "781ca177-154d-480d-9fcf-b189287102cc"}, {"Element": "<span lang=\"EN-GB\">Hypoxia</span>", "ID": "f110ad40-8a8a-4588-b8be-2eb76ac898bd", "Styles": "None", "Classes": "None", "Text": "Hypoxia", "ParentId": "a6eedf41-e4a1-4b33-8690-9497ef580e82"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Mild hypotension</span></p>", "ID": "ffd2e187-62ed-4e1e-9c40-9266165b482d", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc46e5a2-557a-4b14-baab-ee83fc589d3d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "07aeeb83-5e25-4cda-9601-1b793bde61a0", "Styles": "font-family:Symbol", "Classes": "None", "Text": "-", "ParentId": "ffd2e187-62ed-4e1e-9c40-9266165b482d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "8e75f596-b657-4f9c-9c66-63fde99988be", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "07aeeb83-5e25-4cda-9601-1b793bde61a0"}, {"Element": "<span lang=\"EN-GB\">Mild hypotension</span>", "ID": "68557c69-ea8c-4f1d-a9cb-69407a201f71", "Styles": "None", "Classes": "None", "Text": "Mild hypotension", "ParentId": "ffd2e187-62ed-4e1e-9c40-9266165b482d"}, {"Element": "<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Administer antipyretics, oxygen, intravenous fluids and/or low\u2011dose\n  vasopressors as needed.</span></p>\n</td>", "ID": "ebb1e670-4013-41e2-8f1d-cc36b536e636", "Styles": "width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "92b8b607-490c-4da5-af5e-30034a43951d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Administer antipyretics, oxygen, intravenous fluids and/or low\u2011dose\n  vasopressors as needed.</span></p>", "ID": "172685ce-461b-4f49-98ad-292301f99a8a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebb1e670-4013-41e2-8f1d-cc36b536e636"}, {"Element": "<span lang=\"EN-GB\">Administer antipyretics, oxygen, intravenous fluids and/or low\u2011dose\n  vasopressors as needed.</span>", "ID": "c65d1dfb-c7d8-48e0-b1ba-adc87881d01f", "Styles": "None", "Classes": "None", "Text": "Administer antipyretics, oxygen, intravenous fluids and/or low\u2011dose   vasopressors as needed.", "ParentId": "172685ce-461b-4f49-98ad-292301f99a8a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Haemodynamic instability despite intravenous\n  fluids and vasopressor support</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Worsening respiratory distress, including\n  pulmonary infiltrates, increasing oxygen requirement including high\u2011flow\n  oxygen and/or need for mechanical ventilation</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Rapid clinical deterioration</span></p>\n</td>\n<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer high\u2011dose or multiple\n  vasopressors, oxygen, mechanical ventilation and/or other supportive care as\n  needed.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer tocilizumab.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight less than 30\u00a0kg:\n  12\u00a0mg/kg intravenously over 1\u00a0hour</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight \u226530\u00a0kg: 8\u00a0mg/kg\n  intravenously over 1\u00a0hour (maximum dose 800\u00a0mg)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Repeat tocilizumab as needed at a minimum interval of 8\u00a0hours\n  if there is no clinical improvement.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If no response to second dose of tocilizumab, consider a third\n  dose of tocilizumab or pursue alternative measures for treatment of cytokine\n  release syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Limit to a maximum total of 4\u00a0tocilizumab doses.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">If no clinical improvement within 12 to\n  18\u00a0hours of the first tocilizumab dose, or worsening at any time,\n  administer methylprednisolone 2\u00a0mg/kg as an initial dose, then\n  2\u00a0mg/kg per day until vasopressors and high\u2011flow oxygen are no\n  longer needed, then taper.</span></p>\n</td>\n</tr>", "ID": "c7209646-e85e-4579-9af8-d9ec11e5c1ac", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "eeabedb4-d3be-4d81-8f86-d3edc85f8813"}, {"Element": "<td style=\"width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"42%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Haemodynamic instability despite intravenous\n  fluids and vasopressor support</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Worsening respiratory distress, including\n  pulmonary infiltrates, increasing oxygen requirement including high\u2011flow\n  oxygen and/or need for mechanical ventilation</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Rapid clinical deterioration</span></p>\n</td>", "ID": "8d4c52da-01b1-404c-b367-5994140cfc1c", "Styles": "width:42.22%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c7209646-e85e-4579-9af8-d9ec11e5c1ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span></i></b><span lang=\"EN-GB\">:</span></p>", "ID": "b3ff35d5-0311-4264-99b4-9ac9fd81b103", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d4c52da-01b1-404c-b367-5994140cfc1c"}, {"Element": "<b><i><span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span></i></b>", "ID": "d74b5d37-5e5a-4eb2-a139-7f312c0dc042", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b3ff35d5-0311-4264-99b4-9ac9fd81b103"}, {"Element": "<i><span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span></i>", "ID": "615fc718-41f8-43ae-af07-383fec5ce3be", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d74b5d37-5e5a-4eb2-a139-7f312c0dc042"}, {"Element": "<span lang=\"EN-GB\">Cytokine release syndrome requiring moderate to aggressive\n  intervention \u2011 one or more of the following</span>", "ID": "8707f59f-bac9-4163-9280-09c3e638d224", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome requiring moderate to aggressive   intervention \u2011 one or more of the following", "ParentId": "615fc718-41f8-43ae-af07-383fec5ce3be"}, {"Element": "<span lang=\"EN-GB\">:</span>", "ID": "35416816-9bb7-4b96-a33c-13aa47017e9d", "Styles": "None", "Classes": "None", "Text": ":", "ParentId": "b3ff35d5-0311-4264-99b4-9ac9fd81b103"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Haemodynamic instability despite intravenous\n  fluids and vasopressor support</span></p>", "ID": "ab131187-91a9-4a6c-84fa-0a8ed1e70b01", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d4c52da-01b1-404c-b367-5994140cfc1c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "137755ca-3430-4a06-98b9-32fea7c6bb04", "Styles": "font-family:Symbol", "Classes": "None", "Text": "-", "ParentId": "ab131187-91a9-4a6c-84fa-0a8ed1e70b01"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "3b59f507-0421-40ab-8fe4-ebaf1c0befef", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "137755ca-3430-4a06-98b9-32fea7c6bb04"}, {"Element": "<span lang=\"EN-GB\">Haemodynamic instability despite intravenous\n  fluids and vasopressor support</span>", "ID": "1598aeeb-6969-4771-9659-87da6c2bcf79", "Styles": "None", "Classes": "None", "Text": "Haemodynamic instability despite intravenous   fluids and vasopressor support", "ParentId": "ab131187-91a9-4a6c-84fa-0a8ed1e70b01"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Worsening respiratory distress, including\n  pulmonary infiltrates, increasing oxygen requirement including high\u2011flow\n  oxygen and/or need for mechanical ventilation</span></p>", "ID": "f56eb2f3-6cfd-4fc7-b852-6f1fd51d6d7d", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d4c52da-01b1-404c-b367-5994140cfc1c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "be126ee6-c4af-4c80-ab7f-454fdd9bc770", "Styles": "font-family:Symbol", "Classes": "None", "Text": "-", "ParentId": "f56eb2f3-6cfd-4fc7-b852-6f1fd51d6d7d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "f4524e4d-052c-4e01-99f7-8354a5e0aace", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "be126ee6-c4af-4c80-ab7f-454fdd9bc770"}, {"Element": "<span lang=\"EN-GB\">Worsening respiratory distress, including\n  pulmonary infiltrates, increasing oxygen requirement including high\u2011flow\n  oxygen and/or need for mechanical ventilation</span>", "ID": "d430b4f4-b107-4384-991c-e76ca71206d0", "Styles": "None", "Classes": "None", "Text": "Worsening respiratory distress, including   pulmonary infiltrates, increasing oxygen requirement including high\u2011flow   oxygen and/or need for mechanical ventilation", "ParentId": "f56eb2f3-6cfd-4fc7-b852-6f1fd51d6d7d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Rapid clinical deterioration</span></p>", "ID": "d95fe856-849d-4e36-b198-29a9b285f000", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d4c52da-01b1-404c-b367-5994140cfc1c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "2f445056-021c-44cb-b2ae-5ad4bfed3f67", "Styles": "font-family:Symbol", "Classes": "None", "Text": "-", "ParentId": "d95fe856-849d-4e36-b198-29a9b285f000"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "0d45b036-f83f-48cc-99d9-9a581e6e265f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "2f445056-021c-44cb-b2ae-5ad4bfed3f67"}, {"Element": "<span lang=\"EN-GB\">Rapid clinical deterioration</span>", "ID": "012a9c4b-f1d8-4f51-a5a6-b149dd21e95d", "Styles": "None", "Classes": "None", "Text": "Rapid clinical deterioration", "ParentId": "d95fe856-849d-4e36-b198-29a9b285f000"}, {"Element": "<td style=\"width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"57%\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer high\u2011dose or multiple\n  vasopressors, oxygen, mechanical ventilation and/or other supportive care as\n  needed.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer tocilizumab.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight less than 30\u00a0kg:\n  12\u00a0mg/kg intravenously over 1\u00a0hour</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight \u226530\u00a0kg: 8\u00a0mg/kg\n  intravenously over 1\u00a0hour (maximum dose 800\u00a0mg)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Repeat tocilizumab as needed at a minimum interval of 8\u00a0hours\n  if there is no clinical improvement.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If no response to second dose of tocilizumab, consider a third\n  dose of tocilizumab or pursue alternative measures for treatment of cytokine\n  release syndrome.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Limit to a maximum total of 4\u00a0tocilizumab doses.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">If no clinical improvement within 12 to\n  18\u00a0hours of the first tocilizumab dose, or worsening at any time,\n  administer methylprednisolone 2\u00a0mg/kg as an initial dose, then\n  2\u00a0mg/kg per day until vasopressors and high\u2011flow oxygen are no\n  longer needed, then taper.</span></p>\n</td>", "ID": "ab3530b2-61f9-477a-a144-ba6a52093088", "Styles": "width:57.78%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "              ", "ParentId": "c7209646-e85e-4579-9af8-d9ec11e5c1ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer high\u2011dose or multiple\n  vasopressors, oxygen, mechanical ventilation and/or other supportive care as\n  needed.</span></p>", "ID": "d95030d4-bd1f-42cd-8e56-6feea02fcd48", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "d8edc93b-f0f9-4c6f-bb01-63b347115304", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d95030d4-bd1f-42cd-8e56-6feea02fcd48"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "ab635557-ef6b-4f1b-82e0-c8e959e157a5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "d8edc93b-f0f9-4c6f-bb01-63b347115304"}, {"Element": "<span lang=\"EN-GB\">Administer high\u2011dose or multiple\n  vasopressors, oxygen, mechanical ventilation and/or other supportive care as\n  needed.</span>", "ID": "2bfb69be-5295-411c-abbc-13449f2b2c02", "Styles": "None", "Classes": "None", "Text": "Administer high\u2011dose or multiple   vasopressors, oxygen, mechanical ventilation and/or other supportive care as   needed.", "ParentId": "d95030d4-bd1f-42cd-8e56-6feea02fcd48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ad058505-be9f-4c72-ba30-6669fd2e8f99", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64d29346-76e6-4fd5-8692-9ad83be3be66", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ad058505-be9f-4c72-ba30-6669fd2e8f99"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Administer tocilizumab.</span></p>", "ID": "f7f9799f-9cdd-4579-a273-35de53860070", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "db122ee0-cad9-4cd3-a867-3f893dfcc9ff", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f7f9799f-9cdd-4579-a273-35de53860070"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "41971413-f4be-4a13-b7a6-2e76c21bf45f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "db122ee0-cad9-4cd3-a867-3f893dfcc9ff"}, {"Element": "<span lang=\"EN-GB\">Administer tocilizumab.</span>", "ID": "e37db7f1-d3f6-417e-96cc-a343ecac0371", "Styles": "None", "Classes": "None", "Text": "Administer tocilizumab.", "ParentId": "f7f9799f-9cdd-4579-a273-35de53860070"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight less than 30\u00a0kg:\n  12\u00a0mg/kg intravenously over 1\u00a0hour</span></p>", "ID": "21f91b60-a431-40ed-87c9-ed0a9557abfd", "Styles": "margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "51670b58-7bf3-4da1-8367-041721bb9df3", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "21f91b60-a431-40ed-87c9-ed0a9557abfd"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "3db204ab-07aa-4379-ac9a-58e620adec5a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "51670b58-7bf3-4da1-8367-041721bb9df3"}, {"Element": "<span lang=\"EN-GB\">Patient weight less than 30\u00a0kg:\n  12\u00a0mg/kg intravenously over 1\u00a0hour</span>", "ID": "1ea673d3-74f9-49e5-9ceb-2b41dac147eb", "Styles": "None", "Classes": "None", "Text": "Patient weight less than 30\u00a0kg:   12\u00a0mg/kg intravenously over 1\u00a0hour", "ParentId": "21f91b60-a431-40ed-87c9-ed0a9557abfd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">Patient weight \u226530\u00a0kg: 8\u00a0mg/kg\n  intravenously over 1\u00a0hour (maximum dose 800\u00a0mg)</span></p>", "ID": "9a115e37-0c41-41d6-996a-0de17ca3fc89", "Styles": "margin-left:29.3pt;text-indent:-14.35pt;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "1a434922-c9fc-4c26-91c5-fddb4cf29ea7", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "9a115e37-0c41-41d6-996a-0de17ca3fc89"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "eb686e4b-8c29-4f89-a0c7-a0a8e1e30089", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "1a434922-c9fc-4c26-91c5-fddb4cf29ea7"}, {"Element": "<span lang=\"EN-GB\">Patient weight \u226530\u00a0kg: 8\u00a0mg/kg\n  intravenously over 1\u00a0hour (maximum dose 800\u00a0mg)</span>", "ID": "67a66b9a-28e2-475f-8270-9937b231a075", "Styles": "None", "Classes": "None", "Text": "Patient weight \u226530\u00a0kg: 8\u00a0mg/kg   intravenously over 1\u00a0hour (maximum dose 800\u00a0mg)", "ParentId": "9a115e37-0c41-41d6-996a-0de17ca3fc89"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1326b8eb-60f4-41fc-84ba-15efbda6ebc4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cabf3359-6116-4b11-af87-9058cf58e32f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1326b8eb-60f4-41fc-84ba-15efbda6ebc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Repeat tocilizumab as needed at a minimum interval of 8\u00a0hours\n  if there is no clinical improvement.</span></p>", "ID": "296e5c0d-ec5a-41a1-b1a8-fe182c24493a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">Repeat tocilizumab as needed at a minimum interval of 8\u00a0hours\n  if there is no clinical improvement.</span>", "ID": "5344f60d-4cc9-4e25-8d4c-a72551fa2403", "Styles": "None", "Classes": "None", "Text": "Repeat tocilizumab as needed at a minimum interval of 8\u00a0hours   if there is no clinical improvement.", "ParentId": "296e5c0d-ec5a-41a1-b1a8-fe182c24493a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "76cccb37-0437-45fe-9708-bf6af2e4d5fe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "851925ca-acbe-4f25-8744-443f9581383d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "76cccb37-0437-45fe-9708-bf6af2e4d5fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If no response to second dose of tocilizumab, consider a third\n  dose of tocilizumab or pursue alternative measures for treatment of cytokine\n  release syndrome.</span></p>", "ID": "0206462b-8176-4433-a461-bc3129f661a3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">If no response to second dose of tocilizumab, consider a third\n  dose of tocilizumab or pursue alternative measures for treatment of cytokine\n  release syndrome.</span>", "ID": "279b009c-4bca-4493-9d5b-b98858ae5df4", "Styles": "None", "Classes": "None", "Text": "If no response to second dose of tocilizumab, consider a third   dose of tocilizumab or pursue alternative measures for treatment of cytokine   release syndrome.", "ParentId": "0206462b-8176-4433-a461-bc3129f661a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f7b4f5f1-780e-4a20-8c49-646e4c32e1c4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9c40ffd7-7cef-4234-892b-055770e36d70", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f7b4f5f1-780e-4a20-8c49-646e4c32e1c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Limit to a maximum total of 4\u00a0tocilizumab doses.</span></p>", "ID": "b08e2c44-a0c1-4c06-a730-36860dcd7d73", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">Limit to a maximum total of 4\u00a0tocilizumab doses.</span>", "ID": "ea29423b-24cf-42c3-a589-4c762aecbf48", "Styles": "None", "Classes": "None", "Text": "Limit to a maximum total of 4\u00a0tocilizumab doses.", "ParentId": "b08e2c44-a0c1-4c06-a730-36860dcd7d73"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bd45d5ca-797a-402c-a8c5-391e52e88fa6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f72d56d-6966-480e-b13f-8f262cb6826d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd45d5ca-797a-402c-a8c5-391e52e88fa6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\">If no clinical improvement within 12 to\n  18\u00a0hours of the first tocilizumab dose, or worsening at any time,\n  administer methylprednisolone 2\u00a0mg/kg as an initial dose, then\n  2\u00a0mg/kg per day until vasopressors and high\u2011flow oxygen are no\n  longer needed, then taper.</span></p>", "ID": "111dcca4-aaf2-4641-a5e0-8a1b85a68037", "Styles": "margin-left:.25in;text-indent:-.25in;line-height:\n  normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab3530b2-61f9-477a-a144-ba6a52093088"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "4111abe2-48c0-494e-bf4c-45fa434f5e88", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "111dcca4-aaf2-4641-a5e0-8a1b85a68037"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "ec32784e-9b3b-48b1-90fb-7d765ade70bb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "4111abe2-48c0-494e-bf4c-45fa434f5e88"}, {"Element": "<span lang=\"EN-GB\">If no clinical improvement within 12 to\n  18\u00a0hours of the first tocilizumab dose, or worsening at any time,\n  administer methylprednisolone 2\u00a0mg/kg as an initial dose, then\n  2\u00a0mg/kg per day until vasopressors and high\u2011flow oxygen are no\n  longer needed, then taper.</span>", "ID": "09cf26d9-9691-4e75-95a9-2ac74fc8d28e", "Styles": "None", "Classes": "None", "Text": "If no clinical improvement within 12 to   18\u00a0hours of the first tocilizumab dose, or worsening at any time,   administer methylprednisolone 2\u00a0mg/kg as an initial dose, then   2\u00a0mg/kg per day until vasopressors and high\u2011flow oxygen are no   longer needed, then taper.", "ParentId": "111dcca4-aaf2-4641-a5e0-8a1b85a68037"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "b04518c8-e6a3-4c34-aaf8-f60ea4e27871", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Neurological adverse reactions</span></u></p>", "ID": "0bf8ea0a-feff-4e66-ab5d-04233fc3c722", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Neurological adverse reactions</span></u>", "ID": "24630adf-aaf0-4c87-910b-d2ea9f4d5b0e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0bf8ea0a-feff-4e66-ab5d-04233fc3c722"}, {"Element": "<span lang=\"EN-GB\">Neurological adverse reactions</span>", "ID": "322c1191-f011-4b29-9eeb-1729e9cbb020", "Styles": "None", "Classes": "None", "Text": "Neurological adverse reactions", "ParentId": "24630adf-aaf0-4c87-910b-d2ea9f4d5b0e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4f8d581c-d9d3-4736-881b-05107cf1b291", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3a1d1cf0-a15b-4230-a9bb-ce006c24894b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f8d581c-d9d3-4736-881b-05107cf1b291"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Neurological events,\nin particular encephalopathy, confusional state or delirium, occur frequently\nwith Kymriah and can be severe or life\u2011threatening (see section\u00a04.8).\nOther manifestations included</span><span lang=\"EN-GB\"> </span>depressed level of\nconsciousness, seizures, aphasia and speech disorder<span lang=\"EN-GB\">. The\nmajority of neurological events occurred within 8\u00a0weeks following Kymriah\ninfusion and were transient. The median time to onset of the first neurological\nevents was 8\u00a0days in B\u2011cell ALL and 6\u00a0days in DLBCL. The median\ntime to resolution was 7\u00a0days for B\u2011cell ALL and 13\u00a0days for\nDLBCL. Neurological events can be concurrent with cytokine release syndrome,\nfollowing resolution of cytokine release syndrome or in the absence of cytokine\nrelease syndrome.</span></p>", "ID": "6bb88ac9-fe5a-4392-9560-ec96f921c1c9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "depressed level of consciousness, seizures, aphasia and speech disorder", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Neurological events,\nin particular encephalopathy, confusional state or delirium, occur frequently\nwith Kymriah and can be severe or life\u2011threatening (see section\u00a04.8).\nOther manifestations included</span>", "ID": "d3d21d5e-cc3c-43c1-aa46-5f901b1f4dba", "Styles": "None", "Classes": "None", "Text": "Neurological events, in particular encephalopathy, confusional state or delirium, occur frequently with Kymriah and can be severe or life\u2011threatening (see section\u00a04.8). Other manifestations included", "ParentId": "6bb88ac9-fe5a-4392-9560-ec96f921c1c9"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "8deab79c-c5be-4c87-8208-84253282f4f6", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "6bb88ac9-fe5a-4392-9560-ec96f921c1c9"}, {"Element": "<span lang=\"EN-GB\">. The\nmajority of neurological events occurred within 8\u00a0weeks following Kymriah\ninfusion and were transient. The median time to onset of the first neurological\nevents was 8\u00a0days in B\u2011cell ALL and 6\u00a0days in DLBCL. The median\ntime to resolution was 7\u00a0days for B\u2011cell ALL and 13\u00a0days for\nDLBCL. Neurological events can be concurrent with cytokine release syndrome,\nfollowing resolution of cytokine release syndrome or in the absence of cytokine\nrelease syndrome.</span>", "ID": "484c24f2-8f14-4524-ab18-d06be1cc7c4d", "Styles": "None", "Classes": "None", "Text": ". The majority of neurological events occurred within 8\u00a0weeks following Kymriah infusion and were transient. The median time to onset of the first neurological events was 8\u00a0days in B\u2011cell ALL and 6\u00a0days in DLBCL. The median time to resolution was 7\u00a0days for B\u2011cell ALL and 13\u00a0days for DLBCL. Neurological events can be concurrent with cytokine release syndrome, following resolution of cytokine release syndrome or in the absence of cytokine release syndrome.", "ParentId": "6bb88ac9-fe5a-4392-9560-ec96f921c1c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0d4fde17-ff3f-48c7-963d-fd6be0e58636", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a2ae522d-59f5-40f5-bb92-f6e8f95e6942", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d4fde17-ff3f-48c7-963d-fd6be0e58636"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients should\nbe monitored for neurological events. In case of neurological events, patients\nshould be diagnostically worked up and managed depending on the underlying\npathophysiology and in accordance with local standard of care.</span></p>", "ID": "75f02b8d-fbd4-4d8e-98a9-5642f9f4e5f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Patients should\nbe monitored for neurological events. In case of neurological events, patients\nshould be diagnostically worked up and managed depending on the underlying\npathophysiology and in accordance with local standard of care.</span>", "ID": "9a2ae6d7-4e95-4c7d-bbf2-a4aa338cc825", "Styles": "None", "Classes": "None", "Text": "Patients should be monitored for neurological events. In case of neurological events, patients should be diagnostically worked up and managed depending on the underlying pathophysiology and in accordance with local standard of care.", "ParentId": "75f02b8d-fbd4-4d8e-98a9-5642f9f4e5f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bbc71292-e86b-49b8-89f9-665670dc3cb8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4ad0f8c-c989-4b5e-b83e-740d37233b12", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bbc71292-e86b-49b8-89f9-665670dc3cb8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infections and febrile neutropenia</span></u></p>", "ID": "ab656a47-1231-4bd2-a2f1-4cb26f43f7c0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Infections and febrile neutropenia</span></u>", "ID": "5f1c8165-ba1a-482a-a5f8-0953b59f18cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab656a47-1231-4bd2-a2f1-4cb26f43f7c0"}, {"Element": "<span lang=\"EN-GB\">Infections and febrile neutropenia</span>", "ID": "6afb2fdd-5c31-4147-ab0d-8336b75f2a93", "Styles": "None", "Classes": "None", "Text": "Infections and febrile neutropenia", "ParentId": "5f1c8165-ba1a-482a-a5f8-0953b59f18cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2ffa3ff6-c439-40cd-a20a-3784248a2fca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c9b46af8-0aed-4b3c-9ca9-8e0b8cf9e2c4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2ffa3ff6-c439-40cd-a20a-3784248a2fca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients with\nactive, uncontrolled infection should not start Kymriah treatment until the\ninfection is resolved. Prior to Kymriah infusion, infection prophylaxis should\nfollow standard guidelines based on the degree of preceding immunosuppression.</span></p>", "ID": "e1f7007c-fc4f-4ecb-8059-6d838033e13f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Patients with\nactive, uncontrolled infection should not start Kymriah treatment until the\ninfection is resolved. Prior to Kymriah infusion, infection prophylaxis should\nfollow standard guidelines based on the degree of preceding immunosuppression.</span>", "ID": "fd33d748-2355-4ccf-9519-22ecfdc63593", "Styles": "None", "Classes": "None", "Text": "Patients with active, uncontrolled infection should not start Kymriah treatment until the infection is resolved. Prior to Kymriah infusion, infection prophylaxis should follow standard guidelines based on the degree of preceding immunosuppression.", "ParentId": "e1f7007c-fc4f-4ecb-8059-6d838033e13f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ef26cee0-cdd7-4841-871c-b4d40c82870b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "81d6a235-e37b-437e-8014-cd56415825fc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ef26cee0-cdd7-4841-871c-b4d40c82870b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Serious\ninfections, including life\u2011threatening or fatal infections, occurred\nfrequently in patients after Kymriah infusion (see section\u00a04.8). Patients\nshould be monitored for signs and symptoms of infection and treated\nappropriately. As appropriate, prophylactic antibiotics should be administered\nand surveillance testing should be employed prior to and during treatment with\nKymriah. Infections are known to complicate the course and management of\nconcurrent </span><span lang=\"EN-GB\">cytokine release syndrome.</span></p>", "ID": "7c59e861-c6fd-45b8-b5e3-b61917013150", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Serious\ninfections, including life\u2011threatening or fatal infections, occurred\nfrequently in patients after Kymriah infusion (see section\u00a04.8). Patients\nshould be monitored for signs and symptoms of infection and treated\nappropriately. As appropriate, prophylactic antibiotics should be administered\nand surveillance testing should be employed prior to and during treatment with\nKymriah. Infections are known to complicate the course and management of\nconcurrent </span>", "ID": "24268373-751d-4313-a168-699efbdeef48", "Styles": "None", "Classes": "None", "Text": "Serious infections, including life\u2011threatening or fatal infections, occurred frequently in patients after Kymriah infusion (see section\u00a04.8). Patients should be monitored for signs and symptoms of infection and treated appropriately. As appropriate, prophylactic antibiotics should be administered and surveillance testing should be employed prior to and during treatment with Kymriah. Infections are known to complicate the course and management of concurrent ", "ParentId": "7c59e861-c6fd-45b8-b5e3-b61917013150"}, {"Element": "<span lang=\"EN-GB\">cytokine release syndrome.</span>", "ID": "24e19156-dc86-4b0c-be72-b05cb6764214", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome.", "ParentId": "7c59e861-c6fd-45b8-b5e3-b61917013150"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "882ecf9e-167f-4252-b930-e082bdabac25", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05ed8efd-ff7d-4628-83c3-15df35595297", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "882ecf9e-167f-4252-b930-e082bdabac25"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Febrile\nneutropenia was frequently observed in patients after Kymriah infusion (see\nsection\u00a04.8) and may be concurrent with </span><span lang=\"EN-GB\">cytokine\nrelease syndrome. In the event of febrile neutropenia, infection should be\nevaluated and managed appropriately with broad\u2011spectrum antibiotics,\nfluids and other supportive care, as medically indicated.</span></p>", "ID": "14991e4e-bf01-41f7-b6c2-ed8319ed4769", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Febrile\nneutropenia was frequently observed in patients after Kymriah infusion (see\nsection\u00a04.8) and may be concurrent with </span>", "ID": "d4cd2705-0e18-4050-8cf9-c49eab7137ce", "Styles": "None", "Classes": "None", "Text": "Febrile neutropenia was frequently observed in patients after Kymriah infusion (see section\u00a04.8) and may be concurrent with ", "ParentId": "14991e4e-bf01-41f7-b6c2-ed8319ed4769"}, {"Element": "<span lang=\"EN-GB\">cytokine\nrelease syndrome. In the event of febrile neutropenia, infection should be\nevaluated and managed appropriately with broad\u2011spectrum antibiotics,\nfluids and other supportive care, as medically indicated.</span>", "ID": "508960a3-ab37-4966-ad7e-ac4c1ad92fe8", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome. In the event of febrile neutropenia, infection should be evaluated and managed appropriately with broad\u2011spectrum antibiotics, fluids and other supportive care, as medically indicated.", "ParentId": "14991e4e-bf01-41f7-b6c2-ed8319ed4769"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e089d8db-ffab-4bb5-809c-59687b035145", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0a3109c7-f971-4ab9-9843-e241ae2531f9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e089d8db-ffab-4bb5-809c-59687b035145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In patients\nachieving complete remission following Kymriah, resulting low immunoglobulin\nlevels can increase the risk for infections. Attention to signs and symptoms of\ninfection should be implemented according to age and standard specific guidelines.</span></p>", "ID": "87bddb5b-43af-4fa7-9d7b-e3faae783ae6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In patients\nachieving complete remission following Kymriah, resulting low immunoglobulin\nlevels can increase the risk for infections. Attention to signs and symptoms of\ninfection should be implemented according to age and standard specific guidelines.</span>", "ID": "f94ca3ef-374a-46c3-a9cf-1caefe0aeffb", "Styles": "None", "Classes": "None", "Text": "In patients achieving complete remission following Kymriah, resulting low immunoglobulin levels can increase the risk for infections. Attention to signs and symptoms of infection should be implemented according to age and standard specific guidelines.", "ParentId": "87bddb5b-43af-4fa7-9d7b-e3faae783ae6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8612129a-54e6-4954-8623-b3e4a8136795", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d294b49-8d15-4e82-bf3c-6f95793e2b2b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8612129a-54e6-4954-8623-b3e4a8136795"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Prolonged cytopenias</span></u></p>", "ID": "fc99bb3c-be01-4c9a-bbc0-82472dd20b38", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Prolonged cytopenias</span></u>", "ID": "17c249f5-98fa-4bad-943d-8f8d7654ff26", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fc99bb3c-be01-4c9a-bbc0-82472dd20b38"}, {"Element": "<span lang=\"EN-GB\">Prolonged cytopenias</span>", "ID": "20099f41-df7c-46d6-9b39-8a3ce2b5a55b", "Styles": "None", "Classes": "None", "Text": "Prolonged cytopenias", "ParentId": "17c249f5-98fa-4bad-943d-8f8d7654ff26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "959db86d-13d6-49cc-8cd3-6617e32257ab", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "33e2fb1b-fb25-43db-b079-e9158da64578", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "959db86d-13d6-49cc-8cd3-6617e32257ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients may\ncontinue to exhibit cytopenias for several weeks following lymphodepleting\nchemotherapy and Kymriah infusion and should be managed according to standard guidelines.\nThe majority of patients who had cytopenias at day\u00a028 following Kymriah\ntreatment resolved to Grade\u00a02 or below within three months after treatment.\nProlonged neutropenia has been associated with increased risk of infection.\nMyeloid growth factors, particularly granulocyte macrophage\u2011colony\nstimulating factor (GM\u2011CSF), have the potential to worsen </span><span lang=\"EN-GB\">cytokine release syndrome symptoms and are not recommended during\nthe first 3\u00a0weeks after Kymriah infusion or until cytokine release\nsyndrome has resolved.</span></p>", "ID": "340e7a45-6590-40be-bdd8-ad44b088d044", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Patients may\ncontinue to exhibit cytopenias for several weeks following lymphodepleting\nchemotherapy and Kymriah infusion and should be managed according to standard guidelines.\nThe majority of patients who had cytopenias at day\u00a028 following Kymriah\ntreatment resolved to Grade\u00a02 or below within three months after treatment.\nProlonged neutropenia has been associated with increased risk of infection.\nMyeloid growth factors, particularly granulocyte macrophage\u2011colony\nstimulating factor (GM\u2011CSF), have the potential to worsen </span>", "ID": "df9ec497-fdbe-4c38-a234-3825549a5f93", "Styles": "None", "Classes": "None", "Text": "Patients may continue to exhibit cytopenias for several weeks following lymphodepleting chemotherapy and Kymriah infusion and should be managed according to standard guidelines. The majority of patients who had cytopenias at day\u00a028 following Kymriah treatment resolved to Grade\u00a02 or below within three months after treatment. Prolonged neutropenia has been associated with increased risk of infection. Myeloid growth factors, particularly granulocyte macrophage\u2011colony stimulating factor (GM\u2011CSF), have the potential to worsen ", "ParentId": "340e7a45-6590-40be-bdd8-ad44b088d044"}, {"Element": "<span lang=\"EN-GB\">cytokine release syndrome symptoms and are not recommended during\nthe first 3\u00a0weeks after Kymriah infusion or until cytokine release\nsyndrome has resolved.</span>", "ID": "45f2a6fd-f1c5-4a49-8548-138b6e58ec37", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome symptoms and are not recommended during the first 3\u00a0weeks after Kymriah infusion or until cytokine release syndrome has resolved.", "ParentId": "340e7a45-6590-40be-bdd8-ad44b088d044"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b4242a13-f5aa-475b-9e72-9d5ce62901e0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e2bc7911-903e-4a99-b446-2182bbf090e0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b4242a13-f5aa-475b-9e72-9d5ce62901e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Secondary malignancies</span></u></p>", "ID": "328b1011-a606-4611-bd81-be37141f85c7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Secondary malignancies</span></u>", "ID": "a5ffb963-9f84-452a-84a8-d26c2d0e8698", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "328b1011-a606-4611-bd81-be37141f85c7"}, {"Element": "<span lang=\"EN-GB\">Secondary malignancies</span>", "ID": "a5038fc0-7211-4759-95f9-a5624db932a3", "Styles": "None", "Classes": "None", "Text": "Secondary malignancies", "ParentId": "a5ffb963-9f84-452a-84a8-d26c2d0e8698"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "02531b67-557b-4275-acd7-c01b3928f34d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5f7815b9-7656-4a6e-886a-e66f8b6cf285", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "02531b67-557b-4275-acd7-c01b3928f34d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients treated\nwith Kymriah may develop secondary malignancies or recurrence of their cancer. They\nshould be monitored life\u2011long for secondary malignancies. In the event\nthat a secondary malignancy occurs, the company should be contacted to obtain\ninstructions on patient samples to collect for testing.</span></p>", "ID": "e0a40bee-85fc-4b69-949c-10f59b6c6f74", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Patients treated\nwith Kymriah may develop secondary malignancies or recurrence of their cancer. They\nshould be monitored life\u2011long for secondary malignancies. In the event\nthat a secondary malignancy occurs, the company should be contacted to obtain\ninstructions on patient samples to collect for testing.</span>", "ID": "42714267-59f0-4314-bce8-1960aee11bbe", "Styles": "None", "Classes": "None", "Text": "Patients treated with Kymriah may develop secondary malignancies or recurrence of their cancer. They should be monitored life\u2011long for secondary malignancies. In the event that a secondary malignancy occurs, the company should be contacted to obtain instructions on patient samples to collect for testing.", "ParentId": "e0a40bee-85fc-4b69-949c-10f59b6c6f74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "64a73e01-b76e-4581-bc5c-df424c0ea4b1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d2c8a1ee-965c-49d0-a786-bad85c039109", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "64a73e01-b76e-4581-bc5c-df424c0ea4b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Hypogammaglobulinaemia</span></u></p>", "ID": "7ce669ac-1313-4e11-ba16-5497761ee654", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Hypogammaglobulinaemia</span></u>", "ID": "e3d51978-6e07-4801-8b0b-1469da9995b0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7ce669ac-1313-4e11-ba16-5497761ee654"}, {"Element": "<span lang=\"EN-GB\">Hypogammaglobulinaemia</span>", "ID": "c4bbb190-2e76-4014-a2ee-f9b7b7ad0f69", "Styles": "None", "Classes": "None", "Text": "Hypogammaglobulinaemia", "ParentId": "e3d51978-6e07-4801-8b0b-1469da9995b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b7f459fd-b8e8-4474-a2d0-79370001d2f1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9cdd79e5-17ed-49b4-8c2a-7981dc787b75", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b7f459fd-b8e8-4474-a2d0-79370001d2f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypogammaglobulinaemia\nand agammaglobulinaemia can occur in patients after Kymriah infusion. </span><span lang=\"EN-GB\">I</span><span lang=\"EN-GB\">mmunoglobulin levels should be monitored\nafter treatment with Kymriah. In patients with low immunoglobulin levels pre\u2011emptive\nmeasures such as infection precautions, antibiotic prophylaxis and\nimmunoglobulin replacement should be taken according to age and standard guidelines.</span></p>", "ID": "1dbddf6d-4081-4145-9b45-47b00ca03a02", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Hypogammaglobulinaemia\nand agammaglobulinaemia can occur in patients after Kymriah infusion. </span>", "ID": "05629384-0816-41e6-b55c-8fcc53ce0a11", "Styles": "None", "Classes": "None", "Text": "Hypogammaglobulinaemia and agammaglobulinaemia can occur in patients after Kymriah infusion. ", "ParentId": "1dbddf6d-4081-4145-9b45-47b00ca03a02"}, {"Element": "<span lang=\"EN-GB\">I</span>", "ID": "23bf9432-8f3d-47ca-acb5-8162560cb114", "Styles": "None", "Classes": "None", "Text": "I", "ParentId": "1dbddf6d-4081-4145-9b45-47b00ca03a02"}, {"Element": "<span lang=\"EN-GB\">mmunoglobulin levels should be monitored\nafter treatment with Kymriah. In patients with low immunoglobulin levels pre\u2011emptive\nmeasures such as infection precautions, antibiotic prophylaxis and\nimmunoglobulin replacement should be taken according to age and standard guidelines.</span>", "ID": "bb97c032-7a92-426f-b8e1-dd15638b3007", "Styles": "None", "Classes": "None", "Text": "mmunoglobulin levels should be monitored after treatment with Kymriah. In patients with low immunoglobulin levels pre\u2011emptive measures such as infection precautions, antibiotic prophylaxis and immunoglobulin replacement should be taken according to age and standard guidelines.", "ParentId": "1dbddf6d-4081-4145-9b45-47b00ca03a02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cfb545f7-c203-444c-8555-6cce60adb99d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "756ad776-4fa3-44ff-82c9-f0327688f5d0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cfb545f7-c203-444c-8555-6cce60adb99d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Tumour lysis syndrome (TLS)</span></u></p>", "ID": "1c5fe96b-2a5b-48f0-a36b-e4805942d83b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Tumour lysis syndrome (TLS)</span></u>", "ID": "d288ef8d-7551-446a-addb-5996eea1d581", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1c5fe96b-2a5b-48f0-a36b-e4805942d83b"}, {"Element": "<span lang=\"EN-GB\">Tumour lysis syndrome (TLS)</span>", "ID": "98d87d96-5991-421b-b95e-a212fef9f8d1", "Styles": "None", "Classes": "None", "Text": "Tumour lysis syndrome (TLS)", "ParentId": "d288ef8d-7551-446a-addb-5996eea1d581"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ad642bd8-8daa-4573-9603-fd4fe6abdeb8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "421a1b76-c1d0-4716-9bf5-912e3e1b6523", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ad642bd8-8daa-4573-9603-fd4fe6abdeb8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">TLS, which may\nbe severe, has occasionally been observed. To minimise risk of TLS, patients\nwith elevated uric acid or high tumour burden should receive allopurinol, or an\nalternative prophylaxis, prior to Kymriah infusion. Signs and symptoms of TLS\nshould be monitored and events managed according to standard guidelines.</span></p>", "ID": "9d72db09-f415-44ba-b865-f2d39446eff0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">TLS, which may\nbe severe, has occasionally been observed. To minimise risk of TLS, patients\nwith elevated uric acid or high tumour burden should receive allopurinol, or an\nalternative prophylaxis, prior to Kymriah infusion. Signs and symptoms of TLS\nshould be monitored and events managed according to standard guidelines.</span>", "ID": "f7c85dca-139a-4760-99d4-f2273936725d", "Styles": "None", "Classes": "None", "Text": "TLS, which may be severe, has occasionally been observed. To minimise risk of TLS, patients with elevated uric acid or high tumour burden should receive allopurinol, or an alternative prophylaxis, prior to Kymriah infusion. Signs and symptoms of TLS should be monitored and events managed according to standard guidelines.", "ParentId": "9d72db09-f415-44ba-b865-f2d39446eff0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e6bf9b4e-c49f-4993-8a6c-5d8bd9d9af3b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "24775631-b623-474e-a39d-bebc769cfbc7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e6bf9b4e-c49f-4993-8a6c-5d8bd9d9af3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Concomitant disease</span></u></p>", "ID": "cfb7593e-d942-4564-aeb5-d902de963e89", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Concomitant disease</span></u>", "ID": "9564bea8-809a-4454-b8be-bd86628c31d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cfb7593e-d942-4564-aeb5-d902de963e89"}, {"Element": "<span lang=\"EN-GB\">Concomitant disease</span>", "ID": "53f4b6ac-ef17-4c36-8bfc-f6fcd2102f07", "Styles": "None", "Classes": "None", "Text": "Concomitant disease", "ParentId": "9564bea8-809a-4454-b8be-bd86628c31d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "914edfce-c963-4148-b78e-7e9830c304bf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e33b8193-bddc-46e6-a9a1-1815a369e8a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "914edfce-c963-4148-b78e-7e9830c304bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Patients with a\nhistory of active CNS disorder or inadequate renal, hepatic, pulmonary or\ncardiac function were excluded from the studies. These patient are likely to be\nmore vulnerable to the consequences of the adverse reactions described below\nand require special attention.</span></p>", "ID": "dc98a849-e7a6-49aa-ad6f-57149891787c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Patients with a\nhistory of active CNS disorder or inadequate renal, hepatic, pulmonary or\ncardiac function were excluded from the studies. These patient are likely to be\nmore vulnerable to the consequences of the adverse reactions described below\nand require special attention.</span>", "ID": "21bcb068-e0e9-4972-9399-bd0b851063d7", "Styles": "None", "Classes": "None", "Text": "Patients with a history of active CNS disorder or inadequate renal, hepatic, pulmonary or cardiac function were excluded from the studies. These patient are likely to be more vulnerable to the consequences of the adverse reactions described below and require special attention.", "ParentId": "dc98a849-e7a6-49aa-ad6f-57149891787c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "54ae812d-b12e-4c42-aad8-331f03be9d3a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d182b1c8-8d4b-49b7-b654-0d658d4eecb6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "54ae812d-b12e-4c42-aad8-331f03be9d3a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Prior stem cell transplantation</span></u></p>", "ID": "3f4f4b11-8494-45d3-b97c-0f9f4669e9b4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Prior stem cell transplantation</span></u>", "ID": "6dafb3e3-b082-41a6-9576-162091723ff9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3f4f4b11-8494-45d3-b97c-0f9f4669e9b4"}, {"Element": "<span lang=\"EN-GB\">Prior stem cell transplantation</span>", "ID": "5ba3e3eb-4c01-4715-95e0-9a00205169ef", "Styles": "None", "Classes": "None", "Text": "Prior stem cell transplantation", "ParentId": "6dafb3e3-b082-41a6-9576-162091723ff9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d4b4ee6-4093-410a-8b9a-f22b601b32fb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b95893c0-78a1-461f-9dd8-2196d53e046d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d4b4ee6-4093-410a-8b9a-f22b601b32fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is not\nrecommended that patients receive Kymriah within 4\u00a0months of undergoing an\nallogeneic stem cell transplant (SCT) because of the potential risk of Kymriah\nworsening GVHD. Leukapheresis for Kymriah manufacturing should be performed at\nleast 12\u00a0weeks after allogeneic SCT.</span></p>", "ID": "d29e0be3-c130-424d-bb54-8021e719f1fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">It is not\nrecommended that patients receive Kymriah within 4\u00a0months of undergoing an\nallogeneic stem cell transplant (SCT) because of the potential risk of Kymriah\nworsening GVHD. Leukapheresis for Kymriah manufacturing should be performed at\nleast 12\u00a0weeks after allogeneic SCT.</span>", "ID": "cef9f698-8c06-4ed7-a422-bd3391234a54", "Styles": "None", "Classes": "None", "Text": "It is not recommended that patients receive Kymriah within 4\u00a0months of undergoing an allogeneic stem cell transplant (SCT) because of the potential risk of Kymriah worsening GVHD. Leukapheresis for Kymriah manufacturing should be performed at least 12\u00a0weeks after allogeneic SCT.", "ParentId": "d29e0be3-c130-424d-bb54-8021e719f1fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "025b581f-17e9-4662-bff1-b6fb53e10ae4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "aea92aef-94d5-4906-bfe4-94e1f5f1e19b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "025b581f-17e9-4662-bff1-b6fb53e10ae4"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "00afe5ab-448e-480c-91b6-569d81c12ba6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aea92aef-94d5-4906-bfe4-94e1f5f1e19b"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "4465bc7f-afbd-487b-8f64-19b34448199b", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "00afe5ab-448e-480c-91b6-569d81c12ba6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Serological testing</span></u></p>", "ID": "48ca2460-d6cf-43cc-9cd9-1d62e8897f20", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Serological testing</span></u>", "ID": "d985bef7-2b08-47c6-9529-11834e79ff57", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "48ca2460-d6cf-43cc-9cd9-1d62e8897f20"}, {"Element": "<span lang=\"EN-GB\">Serological testing</span>", "ID": "fea79564-0c40-47db-99ef-31c8ab0a5055", "Styles": "None", "Classes": "None", "Text": "Serological testing", "ParentId": "d985bef7-2b08-47c6-9529-11834e79ff57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3136a0c2-830f-46a9-9e31-fc536c2e1174", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "107c9dcc-4b6c-4677-b7f3-d00a90b2e260", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3136a0c2-830f-46a9-9e31-fc536c2e1174"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is\ncurrently no experience with manufacturing Kymriah for patients testing\npositive for HBV, HCV and HIV.</span></p>", "ID": "ba7e1693-6606-4fa6-9529-49932cb61a0e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There is\ncurrently no experience with manufacturing Kymriah for patients testing\npositive for HBV, HCV and HIV.</span>", "ID": "03f90717-0e07-4686-904e-b5df47b06820", "Styles": "None", "Classes": "None", "Text": "There is currently no experience with manufacturing Kymriah for patients testing positive for HBV, HCV and HIV.", "ParentId": "ba7e1693-6606-4fa6-9529-49932cb61a0e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3921633-b9b1-4f0f-9997-4802268343fa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c91966df-e2a0-4a5c-9814-7e849051d9f9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3921633-b9b1-4f0f-9997-4802268343fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Screening for\nHBV, HCV and HIV must be performed in accordance with clinical guidelines\nbefore collection of cells for manufacturing.</span><span lang=\"EN-GB\"> Hepatitis\nB virus (HBV) reactivation, can occur in patients treated with medicinal\nproducts directed against B cells and could result in fulminant hepatitis,\nhepatic failure and death.</span></p>", "ID": "feabd3db-786c-4d58-8340-ac6c06cc23a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Screening for\nHBV, HCV and HIV must be performed in accordance with clinical guidelines\nbefore collection of cells for manufacturing.</span>", "ID": "b5328c90-e4ca-437b-aac4-742125a8b5a0", "Styles": "None", "Classes": "None", "Text": "Screening for HBV, HCV and HIV must be performed in accordance with clinical guidelines before collection of cells for manufacturing.", "ParentId": "feabd3db-786c-4d58-8340-ac6c06cc23a4"}, {"Element": "<span lang=\"EN-GB\"> Hepatitis\nB virus (HBV) reactivation, can occur in patients treated with medicinal\nproducts directed against B cells and could result in fulminant hepatitis,\nhepatic failure and death.</span>", "ID": "ce1cddda-73be-4644-b6fb-0e0ddce02160", "Styles": "None", "Classes": "None", "Text": " Hepatitis B virus (HBV) reactivation, can occur in patients treated with medicinal products directed against B cells and could result in fulminant hepatitis, hepatic failure and death.", "ParentId": "feabd3db-786c-4d58-8340-ac6c06cc23a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3aefb88-9060-44de-b0f4-c2769f9608f9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2961f94b-b9af-469f-98a2-5d1a57047867", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3aefb88-9060-44de-b0f4-c2769f9608f9"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Prior treatment with anti\u2011CD19\ntherapy</span></u></p>", "ID": "bad92415-74c5-4da2-98b5-65b8faeb0f87", "Styles": "margin-top:0in;text-align:left;page-break-after:\navoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Prior treatment with anti\u2011CD19\ntherapy</span></u>", "ID": "b67e6e7e-2cef-4e6f-b067-54e4753f76a2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bad92415-74c5-4da2-98b5-65b8faeb0f87"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Prior treatment with anti\u2011CD19\ntherapy</span>", "ID": "186d710e-5985-4d3f-990c-0df009050486", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Prior treatment with anti\u2011CD19 therapy", "ParentId": "b67e6e7e-2cef-4e6f-b067-54e4753f76a2"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "8ca3ecae-790e-4e70-9d76-340ec9eaac32", "Styles": "margin-top:0in;text-align:left;page-break-after:\navoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "580f18d3-20bf-41a1-8dd8-b94a954fef3e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "8ca3ecae-790e-4e70-9d76-340ec9eaac32"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">There is limited experience with Kymriah in\npatients exposed to prior CD19\u2011directed therapy. Kymriah is not\nrecommended if the patient has relapsed with CD19\u2011negative leukaemia\nafter prior anti\u2011CD19 therapy.</span></p>", "ID": "6f80355c-23b6-4816-b872-ed84bec136ee", "Styles": "margin-top:0in;text-align:left", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">There is limited experience with Kymriah in\npatients exposed to prior CD19\u2011directed therapy. Kymriah is not\nrecommended if the patient has relapsed with CD19\u2011negative leukaemia\nafter prior anti\u2011CD19 therapy.</span>", "ID": "132a9a97-83ac-4348-ba9c-b57c936a25a0", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "There is limited experience with Kymriah in patients exposed to prior CD19\u2011directed therapy. Kymriah is not recommended if the patient has relapsed with CD19\u2011negative leukaemia after prior anti\u2011CD19 therapy.", "ParentId": "6f80355c-23b6-4816-b872-ed84bec136ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "528c0cf3-7e2f-4cab-aed0-12271c583585", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "481e3d35-feca-4119-b285-26e57c93a3f7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "528c0cf3-7e2f-4cab-aed0-12271c583585"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Interference with serological testing</span></u></p>", "ID": "04d1467f-45e2-4801-9ada-ee00ad025438", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Interference with serological testing</span></u>", "ID": "9a11bb64-c619-4436-80e0-11cd5de4f03c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "04d1467f-45e2-4801-9ada-ee00ad025438"}, {"Element": "<span lang=\"EN-GB\">Interference with serological testing</span>", "ID": "68795a58-be26-4f04-af7c-2d7ebcec3e65", "Styles": "None", "Classes": "None", "Text": "Interference with serological testing", "ParentId": "9a11bb64-c619-4436-80e0-11cd5de4f03c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e24b28c-0727-4f9c-9b56-cc6ee7b6a1d9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "80b697c0-c282-4df6-83b0-26c51764dbed", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e24b28c-0727-4f9c-9b56-cc6ee7b6a1d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Due to limited\nand short spans of identical genetic information between the lentiviral vector\nused to create Kymriah and HIV, some commercial HIV nucleic acid tests (NAT)\nmay give a false positive result.</span></p>", "ID": "72e3ed07-7b51-48f4-a588-d980bd09d000", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Due to limited\nand short spans of identical genetic information between the lentiviral vector\nused to create Kymriah and HIV, some commercial HIV nucleic acid tests (NAT)\nmay give a false positive result.</span>", "ID": "3be94dfd-09b3-4037-a034-6e37090a8568", "Styles": "None", "Classes": "None", "Text": "Due to limited and short spans of identical genetic information between the lentiviral vector used to create Kymriah and HIV, some commercial HIV nucleic acid tests (NAT) may give a false positive result.", "ParentId": "72e3ed07-7b51-48f4-a588-d980bd09d000"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fac1adc8-128f-4e3e-a6bf-4322311ee9b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fed60479-9b19-4290-a344-9702af1343f0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fac1adc8-128f-4e3e-a6bf-4322311ee9b5"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><u><span style=\"font-size:11.0pt\">Sodium\nand potassium content</span></u></p>", "ID": "22560f35-eafe-4bd8-9b3d-cc6136d63dfd", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span style=\"font-size:11.0pt\">Sodium\nand potassium content</span></u>", "ID": "51e847ef-e8b1-4f1b-a3ef-30de0d2521f3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "22560f35-eafe-4bd8-9b3d-cc6136d63dfd"}, {"Element": "<span style=\"font-size:11.0pt\">Sodium\nand potassium content</span>", "ID": "17b81803-1fec-484b-b5b5-fe46a1c0262c", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Sodium and potassium content", "ParentId": "51e847ef-e8b1-4f1b-a3ef-30de0d2521f3"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "d3699e5b-8366-4577-9e96-2b333922a591", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"font-size:11.0pt\">\u00a0</span>", "ID": "8eacb3d2-a34b-4c51-94a5-0b2ef335e208", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "d3699e5b-8366-4577-9e96-2b333922a591"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">This medicinal product contains 24.3 to 121.5\u00a0mg sodium\nper dose, equivalent to 1 to 6% of the WHO recommended maximum daily intake of\n2\u00a0g sodium for an adult.</p>", "ID": "ef1f8240-8fc8-4a18-bd12-e9ea877d91a1", "Styles": "margin:0in;text-align:left;\ntext-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "This medicinal product contains 24.3 to 121.5\u00a0mg sodium per dose, equivalent to 1 to 6% of the WHO recommended maximum daily intake of 2\u00a0g sodium for an adult.", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">\u00a0</p>", "ID": "3734b88f-6118-4043-9b07-44f941679bbb", "Styles": "margin:0in;text-align:left;\ntext-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "\u00a0", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\ntext-autospace:none\">This medicinal product contains potassium, less than\n1\u00a0mmol (39\u00a0mg) per dose, i.e. essentially \u201cpotassium\u2011free\u201d.</p>", "ID": "f58234ec-9b33-437f-9e94-b99f3a22156f", "Styles": "margin:0in;text-align:left;\ntext-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "This medicinal product contains potassium, less than 1\u00a0mmol (39\u00a0mg) per dose, i.e. essentially \u201cpotassium\u2011free\u201d.", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44bea265-f6fa-4489-acb9-a4a5e1c32349", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "57d362b3-5fbf-4a08-99b2-e6872501bbff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44bea265-f6fa-4489-acb9-a4a5e1c32349"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><u><span lang=\"EN-GB\">Content of\ndextran 40 and dimethyl sulfoxide (DMSO)</span></u></p>", "ID": "43171c0c-5053-42cf-9533-e37eac630221", "Styles": "margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Content of\ndextran 40 and dimethyl sulfoxide (DMSO)</span></u>", "ID": "82927524-89d3-4570-a8ca-25fb6f613da5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "43171c0c-5053-42cf-9533-e37eac630221"}, {"Element": "<span lang=\"EN-GB\">Content of\ndextran 40 and dimethyl sulfoxide (DMSO)</span>", "ID": "2c341705-479e-4938-9382-a7190e8985ed", "Styles": "None", "Classes": "None", "Text": "Content of dextran 40 and dimethyl sulfoxide (DMSO)", "ParentId": "82927524-89d3-4570-a8ca-25fb6f613da5"}, {"Element": "<p align=\"left\" class=\"EMEAEnBodyText\" style=\"margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "65c562c1-c053-4c7d-b6a1-611e4e459fc9", "Styles": "margin:0in;text-align:left;\npage-break-after:avoid;text-autospace:none", "Classes": "['EMEAEnBodyText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c30e2c5-c822-48ac-a6b3-b4e4eae7d04a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65c562c1-c053-4c7d-b6a1-611e4e459fc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal\nproduct contains 11\u00a0mg dextran 40 and 82.5\u00a0mg dimethyl sulfoxide\n(DMSO) per mL. Each of these excipients are known to possibly cause\nanaphylactic reaction following parenteral administration. Patients not\npreviously exposed to dextran and DMSO should be observed closely during the\nfirst minutes of the infusion period.</span></p>", "ID": "45d01a29-f743-44f0-a455-e66be1b22054", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">This medicinal\nproduct contains 11\u00a0mg dextran 40 and 82.5\u00a0mg dimethyl sulfoxide\n(DMSO) per mL. Each of these excipients are known to possibly cause\nanaphylactic reaction following parenteral administration. Patients not\npreviously exposed to dextran and DMSO should be observed closely during the\nfirst minutes of the infusion period.</span>", "ID": "c50efbc7-c2e3-4303-a854-aef8ac61356b", "Styles": "None", "Classes": "None", "Text": "This medicinal product contains 11\u00a0mg dextran 40 and 82.5\u00a0mg dimethyl sulfoxide (DMSO) per mL. Each of these excipients are known to possibly cause anaphylactic reaction following parenteral administration. Patients not previously exposed to dextran and DMSO should be observed closely during the first minutes of the infusion period.", "ParentId": "45d01a29-f743-44f0-a455-e66be1b22054"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9cecbbc4-2dd3-4544-b5e8-626c645e5998", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a8f68718-e9a9-4abb-a129-9a0c6a1f2372", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9cecbbc4-2dd3-4544-b5e8-626c645e5998"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with\nother medicinal products and other forms of interaction</span></b></p>", "ID": "42b37274-773e-4239-941b-4c439ff4674d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with\nother medicinal products and other forms of interaction</span></b>", "ID": "4df52a0e-ffc4-489f-8482-cf7553cc840c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "42b37274-773e-4239-941b-4c439ff4674d"}, {"Element": "<span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with\nother medicinal products and other forms of interaction</span>", "ID": "311b7965-1d91-4bca-a2ee-b9386f3d3a64", "Styles": "None", "Classes": "None", "Text": "4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal products and other forms of interaction", "ParentId": "4df52a0e-ffc4-489f-8482-cf7553cc840c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e35779f9-901a-4bbe-a4a4-e4afa7362c4a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ff90c4b-d9a8-4f19-aeae-e72dce590786", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e35779f9-901a-4bbe-a4a4-e4afa7362c4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:white\">No pharmacokinetic or pharmacodynamic drug\ninteraction studies with tisagenlecleucel have been performed</span><span lang=\"EN-GB\">. </span>The co\u2011administration of agents known to inhibit T\u2011cell\nfunction has not been formally studied. Administration of low\u2011dose\nsteroids as per the cytokine release syndrome treatment algorithm does not\nimpact the expansion and persistence of CAR\u2011T cells. The co\u2011administration\nof agents known to stimulate T\u2011cell function has not been investigated\nand the effects are unknown.</p>", "ID": "a0782d40-0c64-49e9-b3d3-0d5fc1eebbe3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "The co\u2011administration of agents known to inhibit T\u2011cell function has not been formally studied. Administration of low\u2011dose steroids as per the cytokine release syndrome treatment algorithm does not impact the expansion and persistence of CAR\u2011T cells. The co\u2011administration of agents known to stimulate T\u2011cell function has not been investigated and the effects are unknown.", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:white\">No pharmacokinetic or pharmacodynamic drug\ninteraction studies with tisagenlecleucel have been performed</span>", "ID": "fc16f44a-d97f-4ebc-978d-f2127e727d7a", "Styles": "color:black;background:white", "Classes": "None", "Text": "No pharmacokinetic or pharmacodynamic drug interaction studies with tisagenlecleucel have been performed", "ParentId": "a0782d40-0c64-49e9-b3d3-0d5fc1eebbe3"}, {"Element": "<span lang=\"EN-GB\">. </span>", "ID": "ede64381-1819-4987-8686-d9650a9d02a2", "Styles": "None", "Classes": "None", "Text": ". ", "ParentId": "a0782d40-0c64-49e9-b3d3-0d5fc1eebbe3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f36bf50-b925-4ba5-8989-4c4b53f5bd23", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "920d9724-44a0-45c5-a787-1fd9fabf91fb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f36bf50-b925-4ba5-8989-4c4b53f5bd23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Live vaccines</span></u></p>", "ID": "b20b030f-810e-46d7-bc92-a32265af3e6c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Live vaccines</span></u>", "ID": "847af072-650e-403c-a24d-d63ea53281f1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b20b030f-810e-46d7-bc92-a32265af3e6c"}, {"Element": "<span lang=\"EN-GB\">Live vaccines</span>", "ID": "ddb4690e-fff1-46fe-be92-a15bcc227454", "Styles": "None", "Classes": "None", "Text": "Live vaccines", "ParentId": "847af072-650e-403c-a24d-d63ea53281f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4b92333-6c86-4ddd-a807-95ca0fa47991", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6de3e91a-b4aa-4be4-81ec-a8b2566a0609", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4b92333-6c86-4ddd-a807-95ca0fa47991"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety of\nimmunisation with live vaccines during or following Kymriah treatment has not\nbeen studied. Vaccination with live vaccines is not recommended for at least\n6\u00a0weeks prior to the start of lymphodepleting chemotherapy, during Kymriah\ntreatment, and until immune recovery following treatment with Kymriah.</span></p>", "ID": "beb55c34-e17d-4760-bee4-8f5c96aecc96", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The safety of\nimmunisation with live vaccines during or following Kymriah treatment has not\nbeen studied. Vaccination with live vaccines is not recommended for at least\n6\u00a0weeks prior to the start of lymphodepleting chemotherapy, during Kymriah\ntreatment, and until immune recovery following treatment with Kymriah.</span>", "ID": "8afd89a3-5d77-48c0-8cd9-5d86a731d079", "Styles": "None", "Classes": "None", "Text": "The safety of immunisation with live vaccines during or following Kymriah treatment has not been studied. Vaccination with live vaccines is not recommended for at least 6\u00a0weeks prior to the start of lymphodepleting chemotherapy, during Kymriah treatment, and until immune recovery following treatment with Kymriah.", "ParentId": "beb55c34-e17d-4760-bee4-8f5c96aecc96"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e49089f-a2c9-425a-8566-5bef82e92c02", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "59f6e947-f686-40b6-9611-902cba9b1280", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e49089f-a2c9-425a-8566-5bef82e92c02"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p>", "ID": "efa6b568-58c4-4542-8e3f-dadc2052c9ef", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span></b>", "ID": "646b0752-e3d5-466e-b7cd-9300f18c03e4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "efa6b568-58c4-4542-8e3f-dadc2052c9ef"}, {"Element": "<span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "833268fa-aae2-4039-ad8a-02ce08ef2630", "Styles": "None", "Classes": "None", "Text": "4.6\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "646b0752-e3d5-466e-b7cd-9300f18c03e4"}, {"Element": "<b><span lang=\"EN-GB\">Fertility, p</span></b>", "ID": "8f39c9e9-b8d7-4580-bc4f-13e638d5b60b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "efa6b568-58c4-4542-8e3f-dadc2052c9ef"}, {"Element": "<span lang=\"EN-GB\">Fertility, p</span>", "ID": "275cb920-6521-4641-a039-7e831d3b2026", "Styles": "None", "Classes": "None", "Text": "Fertility, p", "ParentId": "8f39c9e9-b8d7-4580-bc4f-13e638d5b60b"}, {"Element": "<b><span lang=\"EN-GB\">regnancy and lactation</span></b>", "ID": "ca4bb2f1-4a69-40de-8fa7-2350c21004df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "efa6b568-58c4-4542-8e3f-dadc2052c9ef"}, {"Element": "<span lang=\"EN-GB\">regnancy and lactation</span>", "ID": "2ef939ec-50a7-4905-ae91-f2c95aba5140", "Styles": "None", "Classes": "None", "Text": "regnancy and lactation", "ParentId": "ca4bb2f1-4a69-40de-8fa7-2350c21004df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ceed4714-e0b5-488b-aee4-c811d2a8dc48", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "22f1c60d-50af-4e1e-ade4-f1fe66e35e74", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ceed4714-e0b5-488b-aee4-c811d2a8dc48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span></u></p>", "ID": "51e1f255-05c5-4ba5-98b0-6dcbb0b4ade7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span></u>", "ID": "10914fd9-781f-4c27-83b1-303553742375", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "51e1f255-05c5-4ba5-98b0-6dcbb0b4ade7"}, {"Element": "<span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span>", "ID": "fcaee279-4f8d-4e5f-8b0d-e22eb6e3a8cd", "Styles": "None", "Classes": "None", "Text": "Women of childbearing potential/Contraception in males and females", "ParentId": "10914fd9-781f-4c27-83b1-303553742375"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0cda701b-21c4-40b3-a7ad-40b9042900ca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac1dc04d-8905-4958-9999-010b148b0039", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0cda701b-21c4-40b3-a7ad-40b9042900ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pregnancy status\nfor females of child\u2011bearing age should be verified prior to starting\ntreatment with Kymriah.</span></p>", "ID": "06700971-b98e-4e9a-a245-f0190504d1d1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Pregnancy status\nfor females of child\u2011bearing age should be verified prior to starting\ntreatment with Kymriah.</span>", "ID": "2f0532d8-d16f-47b6-9ee0-b8900d4817b7", "Styles": "None", "Classes": "None", "Text": "Pregnancy status for females of child\u2011bearing age should be verified prior to starting treatment with Kymriah.", "ParentId": "06700971-b98e-4e9a-a245-f0190504d1d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b7f6c361-8a4f-4488-bd89-5b1a720fa4f1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6e8b1624-1ae1-48d1-bbb8-934b5e5b294d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b7f6c361-8a4f-4488-bd89-5b1a720fa4f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">See the\nprescribing information for lymphodepleting chemotherapy for information on the\nneed for effective contraception in patients who receive the lymphodepleting\nchemotherapy.</span></p>", "ID": "d84f423b-f00c-4dd5-88de-bdfacbf6e26d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">See the\nprescribing information for lymphodepleting chemotherapy for information on the\nneed for effective contraception in patients who receive the lymphodepleting\nchemotherapy.</span>", "ID": "5385609f-390b-4dfe-b07e-6fc62f81ff2a", "Styles": "None", "Classes": "None", "Text": "See the prescribing information for lymphodepleting chemotherapy for information on the need for effective contraception in patients who receive the lymphodepleting chemotherapy.", "ParentId": "d84f423b-f00c-4dd5-88de-bdfacbf6e26d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "760753c3-5d38-4192-afd8-6de153359705", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1da1d04a-2963-4d3c-b1f2-76cde56bbefe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "760753c3-5d38-4192-afd8-6de153359705"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are insufficient\nexposure data to provide a recommendation concerning duration of contraception\nfollowing treatment with Kymriah.</span></p>", "ID": "39d36380-49cd-4037-ad5b-74ae3d845bef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There are insufficient\nexposure data to provide a recommendation concerning duration of contraception\nfollowing treatment with Kymriah.</span>", "ID": "eb48c20f-de5d-4e8c-ad1a-84de14d97ae9", "Styles": "None", "Classes": "None", "Text": "There are insufficient exposure data to provide a recommendation concerning duration of contraception following treatment with Kymriah.", "ParentId": "39d36380-49cd-4037-ad5b-74ae3d845bef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b41f0f20-7b60-47dc-a162-b74b6a1caed8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b63f7849-0669-463c-8cf3-c87228ec5558", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b41f0f20-7b60-47dc-a162-b74b6a1caed8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>", "ID": "2e168ef7-7c42-4e92-8016-ee7816a928f0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Pregnancy</span></u>", "ID": "44ec9dc9-525b-46e8-8b6c-5b4e6a89e917", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2e168ef7-7c42-4e92-8016-ee7816a928f0"}, {"Element": "<span lang=\"EN-GB\">Pregnancy</span>", "ID": "70e94d0b-8dcc-42df-a40e-18b7e8bea029", "Styles": "None", "Classes": "None", "Text": "Pregnancy", "ParentId": "44ec9dc9-525b-46e8-8b6c-5b4e6a89e917"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cea8e3a4-1369-4f21-96a5-cb8d86ae6705", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2d09ef6c-8d13-440b-ba6c-296a4758c783", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cea8e3a4-1369-4f21-96a5-cb8d86ae6705"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no\ndata from the use of Kymriah in pregnant women. No animal studies have been\nconducted with Kymriah to assess whether it can cause foetal harm when\nadministered to a pregnant woman (see section\u00a05.3). It is not known\nwhether Kymriah has the potential to be transferred to the foetus via the\nplacenta and could cause foetal toxicity, including B\u2011cell\nlymphocytopenia. Kymriah is not recommended during pregnancy and in women of\nchildbearing potential not using contraception.</span></p>", "ID": "cfa8e53b-cf38-4ed6-9a46-73fd21c3e6d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There are no\ndata from the use of Kymriah in pregnant women. No animal studies have been\nconducted with Kymriah to assess whether it can cause foetal harm when\nadministered to a pregnant woman (see section\u00a05.3). It is not known\nwhether Kymriah has the potential to be transferred to the foetus via the\nplacenta and could cause foetal toxicity, including B\u2011cell\nlymphocytopenia. Kymriah is not recommended during pregnancy and in women of\nchildbearing potential not using contraception.</span>", "ID": "6f06557c-868b-4661-be30-7d090aaa932d", "Styles": "None", "Classes": "None", "Text": "There are no data from the use of Kymriah in pregnant women. No animal studies have been conducted with Kymriah to assess whether it can cause foetal harm when administered to a pregnant woman (see section\u00a05.3). It is not known whether Kymriah has the potential to be transferred to the foetus via the placenta and could cause foetal toxicity, including B\u2011cell lymphocytopenia. Kymriah is not recommended during pregnancy and in women of childbearing potential not using contraception.", "ParentId": "cfa8e53b-cf38-4ed6-9a46-73fd21c3e6d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3f384925-f783-4058-a9a4-a9f2b47c8268", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d8a3ef1e-1f67-427f-ac83-5acdfe2e1f3c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3f384925-f783-4058-a9a4-a9f2b47c8268"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pregnant women\nshould be advised on the potential risks to the foetus. Pregnancy after Kymriah\ntherapy should be discussed with the treating physician. Pregnant women who\nhave received Kymriah may have hypogammaglobulinaemia. Assessment of\nimmunoglobulin levels is indicated in newborns of mothers treated with Kymriah.</span></p>", "ID": "28dffa9e-bcbd-41f3-9a8b-92e83f0e1db5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Pregnant women\nshould be advised on the potential risks to the foetus. Pregnancy after Kymriah\ntherapy should be discussed with the treating physician. Pregnant women who\nhave received Kymriah may have hypogammaglobulinaemia. Assessment of\nimmunoglobulin levels is indicated in newborns of mothers treated with Kymriah.</span>", "ID": "5a88cede-07d9-4cad-b33f-057d3a5dca7b", "Styles": "None", "Classes": "None", "Text": "Pregnant women should be advised on the potential risks to the foetus. Pregnancy after Kymriah therapy should be discussed with the treating physician. Pregnant women who have received Kymriah may have hypogammaglobulinaemia. Assessment of immunoglobulin levels is indicated in newborns of mothers treated with Kymriah.", "ParentId": "28dffa9e-bcbd-41f3-9a8b-92e83f0e1db5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1771ff2a-3269-47ac-96b4-acac217be7b0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b2e324a-a7a5-4cde-9e49-9d94e02c5e57", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1771ff2a-3269-47ac-96b4-acac217be7b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast\u2011feeding</span></u></p>", "ID": "08010a8a-bef7-48c3-9d0e-d0bb84269ee4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Breast\u2011feeding</span></u>", "ID": "f0d0d03a-4ae8-48ec-9732-4d64067b1996", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "08010a8a-bef7-48c3-9d0e-d0bb84269ee4"}, {"Element": "<span lang=\"EN-GB\">Breast\u2011feeding</span>", "ID": "4cd47dd4-496a-4226-bb12-d24ef785ead6", "Styles": "None", "Classes": "None", "Text": "Breast\u2011feeding", "ParentId": "f0d0d03a-4ae8-48ec-9732-4d64067b1996"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3d40f85e-be0f-4499-82dd-217a391f7f42", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d02d654-b418-4409-8f06-5d44d672d765", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3d40f85e-be0f-4499-82dd-217a391f7f42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown\nwhether Kymriah cells are excreted in human milk. A risk to the breast\u2011fed\ninfant cannot be excluded. Women who are breast\u2011feeding should be advised\nof the potential risk to the breast\u2011fed infant.</span></p>", "ID": "d6a56b62-a1e2-4694-ba3a-8b0456718320", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">It is unknown\nwhether Kymriah cells are excreted in human milk. A risk to the breast\u2011fed\ninfant cannot be excluded. Women who are breast\u2011feeding should be advised\nof the potential risk to the breast\u2011fed infant.</span>", "ID": "1c430ac0-bdee-41e3-b1c1-e3b9582097e5", "Styles": "None", "Classes": "None", "Text": "It is unknown whether Kymriah cells are excreted in human milk. A risk to the breast\u2011fed infant cannot be excluded. Women who are breast\u2011feeding should be advised of the potential risk to the breast\u2011fed infant.", "ParentId": "d6a56b62-a1e2-4694-ba3a-8b0456718320"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "78938181-8e33-4a1c-a236-4bdc1fb90454", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4484d5f9-795c-4316-ae99-dcd19603f6b7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "78938181-8e33-4a1c-a236-4bdc1fb90454"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following administration\nof Kymriah, breast\u2011feeding should be discussed with the treating\nphysician.</span></p>", "ID": "a78bb6b3-7947-451e-a1d4-ccc2ec8f9d29", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Following administration\nof Kymriah, breast\u2011feeding should be discussed with the treating\nphysician.</span>", "ID": "fec2d3af-3bcf-4aae-bd09-20db1ef24871", "Styles": "None", "Classes": "None", "Text": "Following administration of Kymriah, breast\u2011feeding should be discussed with the treating physician.", "ParentId": "a78bb6b3-7947-451e-a1d4-ccc2ec8f9d29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3638240e-e686-4f94-afae-7ad2eba17a09", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6e3e8df6-eb17-4559-95a4-05f5e7685761", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3638240e-e686-4f94-afae-7ad2eba17a09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>", "ID": "1644a2d2-9085-4283-b0af-51b7da0eb76b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Fertility</span></u>", "ID": "43329dfe-a093-40a8-bb5f-c7ff6241e2d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1644a2d2-9085-4283-b0af-51b7da0eb76b"}, {"Element": "<span lang=\"EN-GB\">Fertility</span>", "ID": "4521bf85-995b-48dc-aa8e-db84034b5d0e", "Styles": "None", "Classes": "None", "Text": "Fertility", "ParentId": "43329dfe-a093-40a8-bb5f-c7ff6241e2d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a7bc9656-4e95-4ae0-8dab-af4587b59c8c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "185c82f6-c789-41e7-ad3c-65914af0637a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a7bc9656-4e95-4ae0-8dab-af4587b59c8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no\ndata on the effect of Kymriah on fertility. Effects of Kymriah on male and\nfemale fertility have not been evaluated in animal studies.</span></p>", "ID": "944f6e2e-9a46-401a-bbe7-444e4e032b0f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There are no\ndata on the effect of Kymriah on fertility. Effects of Kymriah on male and\nfemale fertility have not been evaluated in animal studies.</span>", "ID": "a7f06d33-b850-43a4-933b-765d248e4c7b", "Styles": "None", "Classes": "None", "Text": "There are no data on the effect of Kymriah on fertility. Effects of Kymriah on male and female fertility have not been evaluated in animal studies.", "ParentId": "944f6e2e-9a46-401a-bbe7-444e4e032b0f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "63f7078d-e31d-4fc8-9a3b-b886c8c18b5e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a5f272f9-aa7d-4bbb-9402-49738cba75bc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "63f7078d-e31d-4fc8-9a3b-b886c8c18b5e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability\nto drive and use machines</span></b></p>", "ID": "4b28b5d7-f98b-4ac8-90c4-7920332ed397", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability\nto drive and use machines</span></b>", "ID": "9fe09000-8fa6-4f54-90b0-8e66825ca274", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4b28b5d7-f98b-4ac8-90c4-7920332ed397"}, {"Element": "<span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability\nto drive and use machines</span>", "ID": "008785d3-bd8e-40c9-972b-d7e8ef8f6a1c", "Styles": "None", "Classes": "None", "Text": "4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use machines", "ParentId": "9fe09000-8fa6-4f54-90b0-8e66825ca274"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "77dbcfe2-cccd-4aee-95ca-e43971a3247b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "29fb8971-d94e-4412-bacb-cf61fc1a2f47", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "77dbcfe2-cccd-4aee-95ca-e43971a3247b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah has major\ninfluence on the ability to drive and use machines.</span></p>", "ID": "91a1679c-ccd4-4d14-a2b0-6e3cf0585603", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah has major\ninfluence on the ability to drive and use machines.</span>", "ID": "f989d5f0-0dde-4710-ad30-843b6c6fa9f4", "Styles": "None", "Classes": "None", "Text": "Kymriah has major influence on the ability to drive and use machines.", "ParentId": "91a1679c-ccd4-4d14-a2b0-6e3cf0585603"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aa057a97-70ba-4738-98d0-b850b8689c19", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "60b2423e-1fa7-48c9-a51a-7c68773742f9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa057a97-70ba-4738-98d0-b850b8689c19"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Due to the\npotential for neurological events, including altered mental status or seizures,\npatients receiving Kymriah are at risk for altered or decreased consciousness\nor coordination in the 8\u00a0weeks following infusion.</span></p>", "ID": "53781e23-bc4b-4609-97d5-b219f52276b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Due to the\npotential for neurological events, including altered mental status or seizures,\npatients receiving Kymriah are at risk for altered or decreased consciousness\nor coordination in the 8\u00a0weeks following infusion.</span>", "ID": "51f7da8d-4eff-4bff-9592-6c859d7231e2", "Styles": "None", "Classes": "None", "Text": "Due to the potential for neurological events, including altered mental status or seizures, patients receiving Kymriah are at risk for altered or decreased consciousness or coordination in the 8\u00a0weeks following infusion.", "ParentId": "53781e23-bc4b-4609-97d5-b219f52276b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f9494da7-c714-496b-9f05-692cea760d70", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d73c051a-894c-4ac5-90e1-ab347c2f5a98", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f9494da7-c714-496b-9f05-692cea760d70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></b></p>", "ID": "7b4acea7-2a7e-41a7-b3f5-3cef3a25c442", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></b>", "ID": "1edbbe65-3509-4497-8d9a-6a0316fe4d2d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7b4acea7-2a7e-41a7-b3f5-3cef3a25c442"}, {"Element": "<span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span>", "ID": "b307aa75-3428-4a7d-9182-fbf829c8113b", "Styles": "None", "Classes": "None", "Text": "4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects", "ParentId": "1edbbe65-3509-4497-8d9a-6a0316fe4d2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4df62928-bad5-4e60-87e8-512bbd5a825f", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45bee7f7-958f-44ba-9cc4-e3f411f980aa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4df62928-bad5-4e60-87e8-512bbd5a825f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u></p>", "ID": "1fb3809b-dced-4639-b764-43a628c21b5b", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Summary of the safety profile</span></u>", "ID": "ba1abf20-fe3b-4090-bb80-b4dda60b3f2b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1fb3809b-dced-4639-b764-43a628c21b5b"}, {"Element": "<span lang=\"EN-GB\">Summary of the safety profile</span>", "ID": "c4c9a688-dd6d-41cf-902f-cca6d632c51f", "Styles": "None", "Classes": "None", "Text": "Summary of the safety profile", "ParentId": "ba1abf20-fe3b-4090-bb80-b4dda60b3f2b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e795ba84-b6d1-4b1d-ae32-540dbd32da13", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "61e9c0c2-9aff-4805-b094-c2b0e0d409be", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e795ba84-b6d1-4b1d-ae32-540dbd32da13"}, {"Element": "<p class=\"MsoNormal\" style=\"text-autospace:none\"><span lang=\"EN-GB\">Safety\nassessment was based on a total of 194\u00a0patients (with paediatric and young\nadult B-cell ALL and DLBCL) who received Kymriah in two multi-centre pivotal\nclinical studies.</span></p>", "ID": "548f8d25-44b7-4ff7-ab40-adbc46711927", "Styles": "text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Safety\nassessment was based on a total of 194\u00a0patients (with paediatric and young\nadult B-cell ALL and DLBCL) who received Kymriah in two multi-centre pivotal\nclinical studies.</span>", "ID": "55aebea4-c361-4466-8c3d-f5a50cf6b946", "Styles": "None", "Classes": "None", "Text": "Safety assessment was based on a total of 194\u00a0patients (with paediatric and young adult B-cell ALL and DLBCL) who received Kymriah in two multi-centre pivotal clinical studies.", "ParentId": "548f8d25-44b7-4ff7-ab40-adbc46711927"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>", "ID": "6ac61810-c773-4ee2-81ed-f399500fe08f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "4db7190b-818d-485f-8d37-d3b4f3e657a7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ac61810-c773-4ee2-81ed-f399500fe08f"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "a151fb8b-2f01-4ad7-9e32-b30b98f05af5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4db7190b-818d-485f-8d37-d3b4f3e657a7"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "f8c47511-6c9d-4db1-8a27-5abf17aaea4c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a151fb8b-2f01-4ad7-9e32-b30b98f05af5"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "56420989-ea4e-4369-b960-e4e0727ea24d", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "f8c47511-6c9d-4db1-8a27-5abf17aaea4c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">B\u2011cell ALL</span></u></i></p>", "ID": "b1282aa9-7f39-43cc-81a0-26289d872c17", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">B\u2011cell ALL</span></u></i>", "ID": "227e8a2d-04af-49b2-a4b4-7d30fcade615", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b1282aa9-7f39-43cc-81a0-26289d872c17"}, {"Element": "<u><span lang=\"EN-GB\">B\u2011cell ALL</span></u>", "ID": "d8559e6c-c83d-4f36-8685-30f218cd6b0e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "227e8a2d-04af-49b2-a4b4-7d30fcade615"}, {"Element": "<span lang=\"EN-GB\">B\u2011cell ALL</span>", "ID": "e15006ca-610e-46b9-8673-2410a5c08650", "Styles": "None", "Classes": "None", "Text": "B\u2011cell ALL", "ParentId": "d8559e6c-c83d-4f36-8685-30f218cd6b0e"}, {"Element": "<p class=\"Text\" style=\"margin-top:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The\nadverse reactions described in this section were characterised in 79\u00a0patients\ninfused with Kymriah in the multi-centre, pivotal clinical study CCTL019B2202.</span></p>", "ID": "b4ed4dd1-bae0-4242-9116-08a228153f2f", "Styles": "margin-top:0in", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The\nadverse reactions described in this section were characterised in 79\u00a0patients\ninfused with Kymriah in the multi-centre, pivotal clinical study CCTL019B2202.</span>", "ID": "b69c0e16-8824-41bf-8c42-2aa894875880", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The adverse reactions described in this section were characterised in 79\u00a0patients infused with Kymriah in the multi-centre, pivotal clinical study CCTL019B2202.", "ParentId": "b4ed4dd1-bae0-4242-9116-08a228153f2f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "76cbecc9-4038-4876-b6a0-165547fc3461", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0377350a-c766-48cb-bb9a-766d9e7266de", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "76cbecc9-4038-4876-b6a0-165547fc3461"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common non\u2011haematological adverse reactions were\ncytokine release syndrome (77%), infections (73%), hypogammaglobulinaemia (53%),\npyrexia (42%) and decreased appetite (38%).</span></p>", "ID": "25737c12-d757-40a4-9f33-9c8dd02146a2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The most common non\u2011haematological adverse reactions were\ncytokine release syndrome (77%), infections (73%), hypogammaglobulinaemia (53%),\npyrexia (42%) and decreased appetite (38%).</span>", "ID": "abd8efe6-d3fa-4dc7-8234-05e4ef2fd2f0", "Styles": "None", "Classes": "None", "Text": "The most common non\u2011haematological adverse reactions were cytokine release syndrome (77%), infections (73%), hypogammaglobulinaemia (53%), pyrexia (42%) and decreased appetite (38%).", "ParentId": "25737c12-d757-40a4-9f33-9c8dd02146a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f4fbf433-fa2b-411e-8b07-f125de7fbe46", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "81f15133-cd0c-45cf-b3cf-233ef1d12718", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f4fbf433-fa2b-411e-8b07-f125de7fbe46"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common haematological adverse reactions were decreased\nwhite blood cells (100%), decreased haemoglobin (100%), decreased neutrophils\n(100%), decreased lymphocytes (100%) and decreased platelets (97%).</span></p>", "ID": "0755f7dc-f037-4b95-9a95-8ab195d4114f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The most common haematological adverse reactions were decreased\nwhite blood cells (100%), decreased haemoglobin (100%), decreased neutrophils\n(100%), decreased lymphocytes (100%) and decreased platelets (97%).</span>", "ID": "3bf856ac-4d6a-4afb-bf0a-033a1d6ed042", "Styles": "None", "Classes": "None", "Text": "The most common haematological adverse reactions were decreased white blood cells (100%), decreased haemoglobin (100%), decreased neutrophils (100%), decreased lymphocytes (100%) and decreased platelets (97%).", "ParentId": "0755f7dc-f037-4b95-9a95-8ab195d4114f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec597f0a-8db2-499f-9f0d-1f7d8a7ff6bc", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "70c24892-e366-4ad6-8b56-54aa6cecbb53", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec597f0a-8db2-499f-9f0d-1f7d8a7ff6bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were reported in 89% of\npatients. The most common Grade\u00a03 and 4 non\u2011haematological adverse\nreaction was </span><span lang=\"EN-GB\">cytokine release syndrome (48%).</span></p>", "ID": "d0fcdf15-fa98-40e9-a180-09461848b313", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were reported in 89% of\npatients. The most common Grade\u00a03 and 4 non\u2011haematological adverse\nreaction was </span>", "ID": "95ba933f-a7fb-42b6-aa21-eba77e51741d", "Styles": "None", "Classes": "None", "Text": "Grade\u00a03 and 4 adverse reactions were reported in 89% of patients. The most common Grade\u00a03 and 4 non\u2011haematological adverse reaction was ", "ParentId": "d0fcdf15-fa98-40e9-a180-09461848b313"}, {"Element": "<span lang=\"EN-GB\">cytokine release syndrome (48%).</span>", "ID": "d11881be-a118-432c-aa30-f337aeabb1ca", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome (48%).", "ParentId": "d0fcdf15-fa98-40e9-a180-09461848b313"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5d500f6b-31e1-4eda-b7ad-5e7c7ecdefbb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5777b1b2-d400-462c-8d98-64c2f3ffa4d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5d500f6b-31e1-4eda-b7ad-5e7c7ecdefbb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common Grade\u00a03 and 4 haematological laboratory\nabnormalities were white blood cells decreased (97%), lymphocytes decreased\n(96%), neutrophils decreased (95%), platelets decreased (77%) and haemoglobin\ndecreased (48%).</span></p>", "ID": "fe401e0f-b1fb-46e6-bc85-44febeaf3bd6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The most common Grade\u00a03 and 4 haematological laboratory\nabnormalities were white blood cells decreased (97%), lymphocytes decreased\n(96%), neutrophils decreased (95%), platelets decreased (77%) and haemoglobin\ndecreased (48%).</span>", "ID": "088e9230-3e05-4fe8-a2e7-cd3a3004c10e", "Styles": "None", "Classes": "None", "Text": "The most common Grade\u00a03 and 4 haematological laboratory abnormalities were white blood cells decreased (97%), lymphocytes decreased (96%), neutrophils decreased (95%), platelets decreased (77%) and haemoglobin decreased (48%).", "ParentId": "fe401e0f-b1fb-46e6-bc85-44febeaf3bd6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "207c2ea3-485c-4994-bc3c-39d98d661299", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "254c537b-c117-4c51-91dd-ec447999e47f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "207c2ea3-485c-4994-bc3c-39d98d661299"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were more often observed within\nthe initial 8\u00a0weeks post\u2011infusion (82% of patients) compared to\nafter 8\u00a0weeks post\u2011infusion (51% of patients).</span></p>", "ID": "7b35fe44-55d9-4f89-a6a4-17dc948ac93b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were more often observed within\nthe initial 8\u00a0weeks post\u2011infusion (82% of patients) compared to\nafter 8\u00a0weeks post\u2011infusion (51% of patients).</span>", "ID": "09d26dd8-255a-4b89-a059-553b79339a40", "Styles": "None", "Classes": "None", "Text": "Grade\u00a03 and 4 adverse reactions were more often observed within the initial 8\u00a0weeks post\u2011infusion (82% of patients) compared to after 8\u00a0weeks post\u2011infusion (51% of patients).", "ParentId": "7b35fe44-55d9-4f89-a6a4-17dc948ac93b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>", "ID": "32e19931-bf9c-4bff-bb08-a8e39055ad08", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "4317a62c-cf71-446e-ad54-0c28de7bef39", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "32e19931-bf9c-4bff-bb08-a8e39055ad08"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "fe5633df-693d-4033-8183-74377a26144d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4317a62c-cf71-446e-ad54-0c28de7bef39"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "58acb1f4-aa75-4c28-b4ae-88d212e69fd1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe5633df-693d-4033-8183-74377a26144d"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "b3cf9b3a-bf58-4579-9b9d-de7dddcb4769", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "58acb1f4-aa75-4c28-b4ae-88d212e69fd1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">DLBCL</span></u></i></p>", "ID": "af9ce2f1-4fa3-43be-b976-fc2387193af1", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">DLBCL</span></u></i>", "ID": "29a4015d-f3c3-430b-8136-d4ba1c427a21", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af9ce2f1-4fa3-43be-b976-fc2387193af1"}, {"Element": "<u><span lang=\"EN-GB\">DLBCL</span></u>", "ID": "a6a22ecf-6d4e-4139-8133-8dfa55da5297", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "29a4015d-f3c3-430b-8136-d4ba1c427a21"}, {"Element": "<span lang=\"EN-GB\">DLBCL</span>", "ID": "8570bb34-085a-4549-b642-f3ba60234f59", "Styles": "None", "Classes": "None", "Text": "DLBCL", "ParentId": "a6a22ecf-6d4e-4139-8133-8dfa55da5297"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The adverse reactions described in this section were characterised in\n115\u00a0patients </span><span lang=\"EN-GB\">infused </span><span lang=\"EN-GB\">with\nKymriah in one global multicentre international study, i.e. the ongoing pivotal\nclinical study CCTL019C2201.</span></p>", "ID": "4650ca5c-7a1b-48fa-af0f-9b4cc1f771d5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The adverse reactions described in this section were characterised in\n115\u00a0patients </span>", "ID": "cafeb820-6d27-4d34-9feb-c38577810692", "Styles": "None", "Classes": "None", "Text": "The adverse reactions described in this section were characterised in 115\u00a0patients ", "ParentId": "4650ca5c-7a1b-48fa-af0f-9b4cc1f771d5"}, {"Element": "<span lang=\"EN-GB\">infused </span>", "ID": "6c13d4d6-70b4-4f4f-8272-2f66a89c93e1", "Styles": "None", "Classes": "None", "Text": "infused ", "ParentId": "4650ca5c-7a1b-48fa-af0f-9b4cc1f771d5"}, {"Element": "<span lang=\"EN-GB\">with\nKymriah in one global multicentre international study, i.e. the ongoing pivotal\nclinical study CCTL019C2201.</span>", "ID": "471385f6-bf20-4eb5-a195-38f01ea6fce9", "Styles": "None", "Classes": "None", "Text": "with Kymriah in one global multicentre international study, i.e. the ongoing pivotal clinical study CCTL019C2201.", "ParentId": "4650ca5c-7a1b-48fa-af0f-9b4cc1f771d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "985d658a-9bad-438f-ac9b-725c3f24f9dd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "774969a9-d75d-4eed-b678-16690fa614bf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "985d658a-9bad-438f-ac9b-725c3f24f9dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common non\u2011haematological adverse reactions were </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> (57%), infections\n(58%), pyrexia (35%), diarrhoea (31%), nausea (29%), fatigue (27%) and hypotension\n(25%).</span></p>", "ID": "f7f3c976-4acc-4fb3-ad6b-de89b6c90247", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The most common non\u2011haematological adverse reactions were </span>", "ID": "9b18a519-a59c-4924-969a-cad861b6e107", "Styles": "None", "Classes": "None", "Text": "The most common non\u2011haematological adverse reactions were ", "ParentId": "f7f3c976-4acc-4fb3-ad6b-de89b6c90247"}, {"Element": "<span lang=\"EN-GB\">cytokine release syndrome</span>", "ID": "31b63293-f880-4cb5-8df6-f3289ffb1dcc", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome", "ParentId": "f7f3c976-4acc-4fb3-ad6b-de89b6c90247"}, {"Element": "<span lang=\"EN-GB\"> (57%), infections\n(58%), pyrexia (35%), diarrhoea (31%), nausea (29%), fatigue (27%) and hypotension\n(25%).</span>", "ID": "9cd7e215-a6e2-4d63-8d61-c4f53e1ce105", "Styles": "None", "Classes": "None", "Text": " (57%), infections (58%), pyrexia (35%), diarrhoea (31%), nausea (29%), fatigue (27%) and hypotension (25%).", "ParentId": "f7f3c976-4acc-4fb3-ad6b-de89b6c90247"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e455e3e-f101-4a94-a331-25bf1a0264f6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9bb2c4cb-6282-4705-98d9-1cd1d4a02294", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e455e3e-f101-4a94-a331-25bf1a0264f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">The most\ncommon haematological adverse reactions were decreased lymphocytes (100%),\ndecreased white blood cells (99%), decreased haemoglobin (99%), decreased\nneutrophils (97%), and decreased platelets (95%).</p>", "ID": "55926ea8-16f6-4b23-8b90-f7443c214185", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "The most common haematological adverse reactions were decreased lymphocytes (100%), decreased white blood cells (99%), decreased haemoglobin (99%), decreased neutrophils (97%), and decreased platelets (95%).", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "29942581-639c-418c-b86e-685f9e0399a6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "112989bd-9ab6-4291-84d5-c6b3e50569ee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "29942581-639c-418c-b86e-685f9e0399a6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were reported in 88% of\npatients. The most common Grade\u00a03 and 4 non\u2011haematological adverse\nreactions were infections (34%) and </span><span lang=\"EN-GB\">cytokine release\nsyndrome</span><span lang=\"EN-GB\"> (23%).</span></p>", "ID": "9ba35f40-eedc-49b9-8d03-b2b6b6775de9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were reported in 88% of\npatients. The most common Grade\u00a03 and 4 non\u2011haematological adverse\nreactions were infections (34%) and </span>", "ID": "39e54a19-02cf-40a1-9371-ee65ce633d21", "Styles": "None", "Classes": "None", "Text": "Grade\u00a03 and 4 adverse reactions were reported in 88% of patients. The most common Grade\u00a03 and 4 non\u2011haematological adverse reactions were infections (34%) and ", "ParentId": "9ba35f40-eedc-49b9-8d03-b2b6b6775de9"}, {"Element": "<span lang=\"EN-GB\">cytokine release\nsyndrome</span>", "ID": "59473f52-8e44-4533-874a-5e7717887ee8", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome", "ParentId": "9ba35f40-eedc-49b9-8d03-b2b6b6775de9"}, {"Element": "<span lang=\"EN-GB\"> (23%).</span>", "ID": "7df87110-8fe1-4443-aa60-7999e270465d", "Styles": "None", "Classes": "None", "Text": " (23%).", "ParentId": "9ba35f40-eedc-49b9-8d03-b2b6b6775de9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec7b0d1a-d729-40f1-8fda-801d15aa6f91", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e454a10d-2a06-4934-a1e0-c54aaa83b9a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec7b0d1a-d729-40f1-8fda-801d15aa6f91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most common (&gt;25%) Grade\u00a03 and 4 haematological\nlaboratory abnormalities were </span><span lang=\"EN-GB\">lymphocyte count</span><span lang=\"EN-GB\"> decreased (95%), </span><span lang=\"EN-GB\">neutrophil count decreased</span><span lang=\"EN-GB\"> (82%), </span><span lang=\"EN-GB\">white blood cell count decreased</span><span lang=\"EN-GB\"> (78%), </span><span lang=\"EN-GB\">haemoglobin decreased</span><span lang=\"EN-GB\"> (59%) and </span><span lang=\"EN-GB\">platelet count decreased</span><span lang=\"EN-GB\"> (56%).</span></p>", "ID": "df595f24-23b5-4c2d-983b-a0db087e116d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The most common (&gt;25%) Grade\u00a03 and 4 haematological\nlaboratory abnormalities were </span>", "ID": "d738501b-db94-4fe6-8bca-0098670aa6ce", "Styles": "None", "Classes": "None", "Text": "The most common (>25%) Grade\u00a03 and 4 haematological laboratory abnormalities were ", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\">lymphocyte count</span>", "ID": "10e67579-03d6-49f8-99e7-27b0ed3ca666", "Styles": "None", "Classes": "None", "Text": "lymphocyte count", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\"> decreased (95%), </span>", "ID": "1f1df255-9fa4-4495-a972-f2f59319f1b6", "Styles": "None", "Classes": "None", "Text": " decreased (95%), ", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\">neutrophil count decreased</span>", "ID": "40b1016f-8d53-4de1-8939-841ca2767acd", "Styles": "None", "Classes": "None", "Text": "neutrophil count decreased", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\"> (82%), </span>", "ID": "ebc919c8-2166-450a-aa2b-e938793990eb", "Styles": "None", "Classes": "None", "Text": " (82%), ", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\">white blood cell count decreased</span>", "ID": "faba30ed-48a6-4006-9669-d49c5a05e416", "Styles": "None", "Classes": "None", "Text": "white blood cell count decreased", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\"> (78%), </span>", "ID": "883eb850-24b2-4c6c-a083-839856e69844", "Styles": "None", "Classes": "None", "Text": " (78%), ", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\">haemoglobin decreased</span>", "ID": "86749fb9-18b5-4cb3-85f9-cdb9dac295a9", "Styles": "None", "Classes": "None", "Text": "haemoglobin decreased", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\"> (59%) and </span>", "ID": "36056388-81b7-4ed5-a2ac-4e560e9321ea", "Styles": "None", "Classes": "None", "Text": " (59%) and ", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\">platelet count decreased</span>", "ID": "a9ec3e59-956e-48fb-a5d3-da50d0fcb29a", "Styles": "None", "Classes": "None", "Text": "platelet count decreased", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<span lang=\"EN-GB\"> (56%).</span>", "ID": "4e10066e-8794-4dcf-8686-fe3cdef7d6e2", "Styles": "None", "Classes": "None", "Text": " (56%).", "ParentId": "df595f24-23b5-4c2d-983b-a0db087e116d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42c3cdf5-5ef7-429f-9d0a-99cfc13fd740", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dbce1202-78db-4696-838d-a378e8a0c72a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42c3cdf5-5ef7-429f-9d0a-99cfc13fd740"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were more often observed within\nthe initial 8\u00a0weeks post\u2011infusion (82%) compared to after\n8\u00a0weeks post\u2011infusion (48%).</span></p>", "ID": "6aa53e1d-e3c0-45ba-8c5b-1c453748ae38", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Grade\u00a03 and 4 adverse reactions were more often observed within\nthe initial 8\u00a0weeks post\u2011infusion (82%) compared to after\n8\u00a0weeks post\u2011infusion (48%).</span>", "ID": "fff6d8af-bd26-4c14-9ee5-11230d1597b5", "Styles": "None", "Classes": "None", "Text": "Grade\u00a03 and 4 adverse reactions were more often observed within the initial 8\u00a0weeks post\u2011infusion (82%) compared to after 8\u00a0weeks post\u2011infusion (48%).", "ParentId": "6aa53e1d-e3c0-45ba-8c5b-1c453748ae38"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0b2c56b3-48f3-4f1d-982a-1a61a42362a3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b01656b-df40-41e7-91a3-09dd39177f4b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0b2c56b3-48f3-4f1d-982a-1a61a42362a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Tabulated list of adverse drug reactions</span></u></i></p>", "ID": "7dc462dc-8ab5-4844-8ac1-25a797396930", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Tabulated list of adverse drug reactions</span></u></i>", "ID": "4700620a-e38f-4a9c-bce9-4723e940436a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7dc462dc-8ab5-4844-8ac1-25a797396930"}, {"Element": "<u><span lang=\"EN-GB\">Tabulated list of adverse drug reactions</span></u>", "ID": "de2b8de2-a752-487a-89fb-f3480eea5e75", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4700620a-e38f-4a9c-bce9-4723e940436a"}, {"Element": "<span lang=\"EN-GB\">Tabulated list of adverse drug reactions</span>", "ID": "be28f62d-39ed-473d-b6a5-f3b0625b8acf", "Styles": "None", "Classes": "None", "Text": "Tabulated list of adverse drug reactions", "ParentId": "de2b8de2-a752-487a-89fb-f3480eea5e75"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The adverse reactions described in this section were identified in 79\nand 115\u00a0patients in the ongoing multicentre pivotal clinical studies (CCTL019B2202\nand CCTL019C2201). Adverse drug reactions from these clinical studies (Table\u00a02)\nare listed by MedDRA system organ class. Within each system organ class, the\nadverse drug reactions are ranked by frequency, with the most frequent\nreactions first,</span> using the following convention: very common\n(\u22651/10); common (\u22651/100 to &lt;1/10); uncommon (\u22651/1,000 to\n&lt;1/100); rare (\u22651/10,000 to &lt;1/1,000); very rare (&lt;1/10,000);\nnot known (cannot be estimated from the available data)<span lang=\"EN-GB\">.\nWithin each frequency grouping, adverse drug reactions are presented in order\nof decreasing seriousness.</span></p>", "ID": "cb86c65c-1df2-4215-ae7a-7b6cf9a8870a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": " using the following convention: very common (\u22651/10); common (\u22651/100 to <1/10); uncommon (\u22651/1,000 to <1/100); rare (\u22651/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data)", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The adverse reactions described in this section were identified in 79\nand 115\u00a0patients in the ongoing multicentre pivotal clinical studies (CCTL019B2202\nand CCTL019C2201). Adverse drug reactions from these clinical studies (Table\u00a02)\nare listed by MedDRA system organ class. Within each system organ class, the\nadverse drug reactions are ranked by frequency, with the most frequent\nreactions first,</span>", "ID": "bb68376c-45f9-4a2a-bb3f-04e8c8f859db", "Styles": "None", "Classes": "None", "Text": "The adverse reactions described in this section were identified in 79 and 115\u00a0patients in the ongoing multicentre pivotal clinical studies (CCTL019B2202 and CCTL019C2201). Adverse drug reactions from these clinical studies (Table\u00a02) are listed by MedDRA system organ class. Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first,", "ParentId": "cb86c65c-1df2-4215-ae7a-7b6cf9a8870a"}, {"Element": "<span lang=\"EN-GB\">.\nWithin each frequency grouping, adverse drug reactions are presented in order\nof decreasing seriousness.</span>", "ID": "73cfbb9a-c575-4bc3-8647-24f36e056b1f", "Styles": "None", "Classes": "None", "Text": ". Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness.", "ParentId": "cb86c65c-1df2-4215-ae7a-7b6cf9a8870a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ded65147-a42e-4202-9554-e783aef0bfd6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "69554028-ac6c-4191-986b-9aab69609c4d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ded65147-a42e-4202-9554-e783aef0bfd6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Table\u00a02\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adverse\ndrug reactions observed in clinical studies</span></b></p>", "ID": "dd6d75e6-3316-4b33-a40c-d57573dbbc24", "Styles": "margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a02\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adverse\ndrug reactions observed in clinical studies</span></b>", "ID": "e3df6bb3-e7e5-4f2c-8f8c-5bef465abbbc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd6d75e6-3316-4b33-a40c-d57573dbbc24"}, {"Element": "<span lang=\"EN-GB\">Table\u00a02\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adverse\ndrug reactions observed in clinical studies</span>", "ID": "9a268984-febe-4f28-a26c-7a4b9b107b6b", "Styles": "None", "Classes": "None", "Text": "Table\u00a02\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Adverse drug reactions observed in clinical studies", "ParentId": "e3df6bb3-e7e5-4f2c-8f8c-5bef465abbbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "134d47d8-6ab6-464c-b564-547837bdafe2", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a1701278-db9e-4e6b-8b73-91476d80b49a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "134d47d8-6ab6-464c-b564-547837bdafe2"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse;border:none\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"2\" style=\"width:17.86%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adverse drug reaction (MedDRA\n  system organ class)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:82.14%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"82%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>Studies\n  B2202 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>N=</span></b><b><span lang=\"DE-CH\" style='font-family:\n  \"Times New Roman\",serif'>79) + C2201 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>N</span></b><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>=115)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:29.74%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"29%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very\n  common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/10)</span></b></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"28%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/100\n  to &lt;1/10)</span></b></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"24%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/1000\n  to &lt;1/100)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Infections\n  and infestations<sup>1)</sup></span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infections \u2011 pathogen unspecified</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Viral infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Bacterial infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fungal infections</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood\n  and lymphatic system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemorrhage<sup>2)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Febrile neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombocytopenia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemophagocytic lymphohistiocytosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Leukopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pancytopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Coagulopathy</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphopenia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>B-cell aplasia</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune\n  system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cytokine release syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypogammaglobulinaemia<sup>3)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infusion\u2011related reaction</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Graft\u2011versus\u2011host disease</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism\n  and nutrition disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Decreased appetite</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypokalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypophosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypomagnesaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypocalcaemia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoalbuminaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperglycaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyponatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperuricaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fluid overload</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypercalcaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tumour lysis syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperkalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperphosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypernatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypermagnesaemia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anxiety</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Delirium<sup>4)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Sleep disorder<sup>5)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous\n  system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Headache<sup>6)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Encephalopathy<sup>7)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dizziness<sup>8)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Peripheral neuropathy<sup>9)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tremor<sup>10)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Motor dysfunction<sup>11)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Seizure<sup>12)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Speech disorders<sup>13)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neuralgia<sup>14)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ataxia<sup>15)</sup></span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Ischaemic cerebral infarction</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Visual impairment<sup>16)</sup></span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arrhythmia<sup>17)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac failure<sup>18)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac arrest</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypotension<sup>19)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypertension</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombosis<sup>20)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Capillary leak syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Flushing</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory,\n  thoracic and mediastinal disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cough<sup>21)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dyspnoea<sup>22)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoxia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oropharyngeal pain<sup>23)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pulmonary oedema<sup>24)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nasal congestion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pleural effusion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tachypnoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute respiratory distress syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lung infiltration</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Diarrhoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nausea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Vomiting</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Constipation</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal pain<sup>25)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Stomatitis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal distension</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dry mouth</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ascites</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif'>Hepatobiliary\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperbilirubinaemia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin\n  and subcutaneous tissue disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Rash<sup>26)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pruritus</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Erythema</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperhidrosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Night sweats</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal\n  and connective tissue disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arthralgia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Back pain</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Myalgia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Musculoskeletal pain</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal\n  and urinary disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute kidney injury<sup>27)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General\n  disorders and administration site conditions</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pyrexia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fatigue<sup>28)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oedema<sup>29)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pain<sup>30)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Chills</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Influenza\u2011like illness</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Asthenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Multiple organ dysfunction syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphocyte count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>White blood cell count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemoglobin decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutrophil count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Platelet count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Aspartate aminotransferase increased</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Alanine aminotransferase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood bilirubin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Weight decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Serum ferritin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood fibrinogen decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>International normalised ratio increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fibrin D dimer increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Activated partial thromboplastin time prolonged</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood alkaline phosphatase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Prothrombin time prolonged</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"height:16.55pt\">\n<td colspan=\"4\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.55pt\" valign=\"top\" width=\"100%\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and\n  infestations presented reflect high\u2011level group terms.</span></p>\n<p class=\"Legend\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Haemorrhage\n  includes anal haemorrhage, blood urine present, catheter site haemorrhage,\n  cerebral haemorrhage, conjunctival haemorrhage, contusion, cystitis\n  haemorrhagic, duodenal ulcer haemorrhage, disseminated intravascular\n  coagulation, epistaxis, eye contusion, gastrointestinal haemorrhage, gingival\n  bleeding, haematochezia, haemarthrosis, haematemesis, haematuria,\n  haemoptysis, large intestinal haemorrhage, melaena, menorrhagia, mouth\n  haemorrhage, peritoneal haematoma, petechiae, pharyngeal haemorrhage, post\u2011procedural\n  haemorrhage, pulmonary haemorrhage, purpura, retinal haemorrhage, traumatic\n  haematoma, tumour haemorrhage, upper gastrointestinal haemorrhage and vaginal\n  haemorrhage.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypogammaglobulinaemia\n  includes immunoglobulins decreased, blood immunoglobulin A decreased, blood\n  immunoglobulin G decreased, blood immunoglobulin M decreased,\n  immunodeficiency, immunodeficiency common variable and\n  hypogammaglobulinaemia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Delirium includes\n  agitation, delirium, hallucination, hallucination visual, irritability and\n  restlessness.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sleep disorder includes\n  sleep disorder, insomnia and nightmare.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Headache includes\n  headache and migraine.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Encephalopathy includes\n  depressed level of consciousness, mental status changes, automatism,\n  cognitive disorder, confusional state, disturbance in attention,\n  encephalopathy, somnolence, lethargy, memory impairment, metabolic\n  encephalopathy and thinking abnormal.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dizziness includes\n  dizziness, presyncope and syncope.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Peripheral neuropathy\n  includes paraesthesia, peripheral sensory neuropathy, neuropathy peripheral,\n  hyperaesthesia and hypoaesthesia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tremor includes\n  dyskinesia and tremor.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Motor dysfunction\n  includes muscle spasms, muscle twitching, myoclonus and myopathy.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Seizure includes seizure,\n  generalised tonic\u2011clonic seizures and status epilepticus.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Speech disorders includes\n  speech disorders, dysarthria and aphasia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neuralgia includes\n  neuralgia and sciatica.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ataxia includes ataxia\n  and dysmetria.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Visual impairment\n  includes vision blurred and visual impairment.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;color:black'>Arrhythmia\n  includes atrial fibrillation, supraventricular tachycardia, </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tachycardia and\n  ventricular extrasystoles.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac failure includes\n  cardiac failure, left ventricular dysfunction, cardiac failure congestive and\n  right ventricular dysfunction.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>19)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypotension includes\n  hypotension and orthostatic hypotension.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>20)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombosis includes deep\n  vein thrombosis, embolism, pulmonary embolism, thrombosis, vena cava\n  thrombosis and venous thrombosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cough includes cough,\n  productive cough and upper\u2011airway cough syndrome.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Dyspnoea\n  includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory\n  failure.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>23)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oropharyngeal pain\n  includes oral pain and oropharyngeal pain.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>24)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pulmonary oedema includes\n  acute pulmonary oedema and pulmonary oedema</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>25)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Abdominal pain includes\n  abdominal pain, abdominal pain upper and abdominal discomfort.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>26)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Rash includes dermatitis,\n  dermatitis acneiform, dermatitis contact,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash maculo\u2011papular,\n  rash papular and rash pruritic.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>27)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute kidney injury\n  includes acute kidney injury, anuria, azotaemia, blood creatinine abnormal,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood creatinine\n  increased, renal failure, renal tubular dysfunction and renal tubular\n  necrosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>28)</span></sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fatigue includes fatigue\n  and malaise.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>29)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Oedema\n  includes oedema peripheral, generalised oedema, localised oedema, face oedema\n  and peripheral swelling.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>30)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pain includes pain and\n  pain in extremity.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\">*\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style='font-family:\n  \"Times New Roman\",serif'>Frequency is based on laboratory values. Patients\n  are counted only for the worst grade observed post baseline.</span></p>\n</td>\n</tr>\n</table>", "ID": "e367b44b-0512-45e9-97d6-1ffaeedafa0e", "Styles": "width:100.0%;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                     ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td rowspan=\"2\" style=\"width:17.86%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adverse drug reaction (MedDRA\n  system organ class)</span></b></p>\n</td>\n<td colspan=\"3\" style=\"width:82.14%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"82%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>Studies\n  B2202 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>N=</span></b><b><span lang=\"DE-CH\" style='font-family:\n  \"Times New Roman\",serif'>79) + C2201 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>N</span></b><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>=115)</span></b></p>\n</td>\n</tr>", "ID": "dfb2f310-e483-4af3-86d9-2665939db3a7", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td rowspan=\"2\" style=\"width:17.86%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adverse drug reaction (MedDRA\n  system organ class)</span></b></p>\n</td>", "ID": "fa7435bf-fd64-477a-bd52-67638961c903", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "dfb2f310-e483-4af3-86d9-2665939db3a7"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adverse drug reaction (MedDRA\n  system organ class)</span></b></p>", "ID": "e4277e66-fb3b-47ec-a180-5f17a99063b0", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "fa7435bf-fd64-477a-bd52-67638961c903"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adverse drug reaction (MedDRA\n  system organ class)</span></b>", "ID": "42b082aa-18db-492e-a4eb-cb322470b2cc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e4277e66-fb3b-47ec-a180-5f17a99063b0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Adverse drug reaction (MedDRA\n  system organ class)</span>", "ID": "6f8cb331-7be6-4f4e-91da-115c0fe061d4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Adverse drug reaction (MedDRA   system organ class)", "ParentId": "42b082aa-18db-492e-a4eb-cb322470b2cc"}, {"Element": "<td colspan=\"3\" style=\"width:82.14%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"82%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>Studies\n  B2202 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>N=</span></b><b><span lang=\"DE-CH\" style='font-family:\n  \"Times New Roman\",serif'>79) + C2201 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>N</span></b><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>=115)</span></b></p>\n</td>", "ID": "a7b6c11b-d13b-4ec2-bcab-fe34ad64b1d5", "Styles": "width:82.14%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "dfb2f310-e483-4af3-86d9-2665939db3a7"}, {"Element": "<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>Studies\n  B2202 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>N=</span></b><b><span lang=\"DE-CH\" style='font-family:\n  \"Times New Roman\",serif'>79) + C2201 (</span></b><b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>N</span></b><b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>=115)</span></b></p>", "ID": "16d44d03-2b73-460e-a9dd-24ab5a5d0aef", "Styles": "margin:0in;text-align:center;page-break-after:\n  avoid", "Classes": "['Table']", "Text": "", "ParentId": "a7b6c11b-d13b-4ec2-bcab-fe34ad64b1d5"}, {"Element": "<b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>Studies\n  B2202 (</span></b>", "ID": "f9185166-eee9-4ef4-8adb-232a6b44f48d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16d44d03-2b73-460e-a9dd-24ab5a5d0aef"}, {"Element": "<span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>Studies\n  B2202 (</span>", "ID": "33236308-7ead-4640-a991-0cdcf0abbb2f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Studies   B2202 (", "ParentId": "f9185166-eee9-4ef4-8adb-232a6b44f48d"}, {"Element": "<b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>N=</span></b>", "ID": "8070658d-6e4e-42ab-9963-62a6cbd87f70", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16d44d03-2b73-460e-a9dd-24ab5a5d0aef"}, {"Element": "<span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>N=</span>", "ID": "80d67751-8f7e-4128-90f6-7460762b0375", "Styles": "font-size:11.0pt;font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "N=", "ParentId": "8070658d-6e4e-42ab-9963-62a6cbd87f70"}, {"Element": "<b><span lang=\"DE-CH\" style='font-family:\n  \"Times New Roman\",serif'>79) + C2201 (</span></b>", "ID": "692202df-6194-48cc-829a-9a48d6193ecb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16d44d03-2b73-460e-a9dd-24ab5a5d0aef"}, {"Element": "<span lang=\"DE-CH\" style='font-family:\n  \"Times New Roman\",serif'>79) + C2201 (</span>", "ID": "a00f1ac7-dc01-4adf-8443-704f48310a0a", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "79) + C2201 (", "ParentId": "692202df-6194-48cc-829a-9a48d6193ecb"}, {"Element": "<b><span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>N</span></b>", "ID": "353285c8-2959-4d61-b783-45ef928f0863", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16d44d03-2b73-460e-a9dd-24ab5a5d0aef"}, {"Element": "<span lang=\"DE-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>N</span>", "ID": "3d312f12-9318-49be-b5b2-f9615368b23a", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "N", "ParentId": "353285c8-2959-4d61-b783-45ef928f0863"}, {"Element": "<b><span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>=115)</span></b>", "ID": "6926c4e3-50b7-4c6e-b79b-d2b52692a748", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16d44d03-2b73-460e-a9dd-24ab5a5d0aef"}, {"Element": "<span lang=\"DE-CH\" style='font-family:\"Times New Roman\",serif'>=115)</span>", "ID": "0ebd9498-7049-4f7b-b112-1c2b46816c79", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "=115)", "ParentId": "6926c4e3-50b7-4c6e-b79b-d2b52692a748"}, {"Element": "<tr>\n<td style=\"width:29.74%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"29%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very\n  common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/10)</span></b></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"28%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/100\n  to &lt;1/10)</span></b></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"24%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/1000\n  to &lt;1/100)</span></b></p>\n</td>\n</tr>", "ID": "d56cd7df-884a-4176-b93b-e3671a5fc0f9", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"29%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very\n  common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/10)</span></b></p>\n</td>", "ID": "fa2d3790-fee7-4715-8aac-59848c967db4", "Styles": "width:29.74%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "d56cd7df-884a-4176-b93b-e3671a5fc0f9"}, {"Element": "<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very\n  common</span></b></p>", "ID": "6fcff993-ed99-44e0-be15-cf0ee5217a3a", "Styles": "margin:0in;text-align:center;page-break-after:\n  avoid", "Classes": "['Table']", "Text": "", "ParentId": "fa2d3790-fee7-4715-8aac-59848c967db4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very\n  common</span></b>", "ID": "bdda8a80-ccb5-4e50-92a7-b99b5e5c132e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6fcff993-ed99-44e0-be15-cf0ee5217a3a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very\n  common</span>", "ID": "857888f5-06f5-430a-8d68-74cd2bd33872", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Very   common", "ParentId": "bdda8a80-ccb5-4e50-92a7-b99b5e5c132e"}, {"Element": "<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/10)</span></b></p>", "ID": "032a1381-b75a-428c-95b0-1b760a5a5f1b", "Styles": "margin:0in;text-align:center;page-break-after:\n  avoid", "Classes": "['Table']", "Text": "", "ParentId": "fa2d3790-fee7-4715-8aac-59848c967db4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/10)</span></b>", "ID": "de31dcbc-c48c-4d78-9d7a-0fa138766880", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "032a1381-b75a-428c-95b0-1b760a5a5f1b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/10)</span>", "ID": "e03e93ee-bd39-477f-840f-f9e4ec22acf4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(\u22651/10)", "ParentId": "de31dcbc-c48c-4d78-9d7a-0fa138766880"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"28%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/100\n  to &lt;1/10)</span></b></p>\n</td>", "ID": "0f1bcc6c-3327-4982-8371-3c68553a7513", "Styles": "width:28.32%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "d56cd7df-884a-4176-b93b-e3671a5fc0f9"}, {"Element": "<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></b></p>", "ID": "5341d983-4d2f-472c-b6eb-db867f0b9d9b", "Styles": "margin:0in;text-align:center;page-break-after:\n  avoid", "Classes": "['Table']", "Text": "", "ParentId": "0f1bcc6c-3327-4982-8371-3c68553a7513"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span></b>", "ID": "0ab24818-d7fb-4e95-98c8-d5a87db4bf46", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5341d983-4d2f-472c-b6eb-db867f0b9d9b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Common</span>", "ID": "73142e8e-934a-4e25-a997-f35fb8821900", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Common", "ParentId": "0ab24818-d7fb-4e95-98c8-d5a87db4bf46"}, {"Element": "<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/100\n  to &lt;1/10)</span></b></p>", "ID": "7e5e1431-120b-4340-a1b5-1d258545d46f", "Styles": "margin:0in;text-align:center;page-break-after:\n  avoid", "Classes": "['Table']", "Text": "", "ParentId": "0f1bcc6c-3327-4982-8371-3c68553a7513"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/100\n  to &lt;1/10)</span></b>", "ID": "c40477a5-0780-436a-8b71-4b830dc61a60", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7e5e1431-120b-4340-a1b5-1d258545d46f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/100\n  to &lt;1/10)</span>", "ID": "95db27e2-0aba-42e0-8c14-ab0ed191345b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(\u22651/100   to <1/10)", "ParentId": "c40477a5-0780-436a-8b71-4b830dc61a60"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"24%\">\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></b></p>\n<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/1000\n  to &lt;1/100)</span></b></p>\n</td>", "ID": "fe1967d4-74c4-4699-af73-fad0357c2d04", "Styles": "width:24.08%;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "d56cd7df-884a-4176-b93b-e3671a5fc0f9"}, {"Element": "<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></b></p>", "ID": "e89694c6-0320-47b7-b17b-4b2545e7f467", "Styles": "margin:0in;text-align:center;page-break-after:\n  avoid", "Classes": "['Table']", "Text": "", "ParentId": "fe1967d4-74c4-4699-af73-fad0357c2d04"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span></b>", "ID": "ff81aaec-d057-481d-85cf-0ba88212bf9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e89694c6-0320-47b7-b17b-4b2545e7f467"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Uncommon</span>", "ID": "61168db0-2c12-4c6d-93ca-0f2e39d859a7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Uncommon", "ParentId": "ff81aaec-d057-481d-85cf-0ba88212bf9e"}, {"Element": "<p align=\"center\" class=\"Table\" style=\"margin:0in;text-align:center;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/1000\n  to &lt;1/100)</span></b></p>", "ID": "8fef7249-b7db-43e6-ba94-c312c1106010", "Styles": "margin:0in;text-align:center;page-break-after:\n  avoid", "Classes": "['Table']", "Text": "", "ParentId": "fe1967d4-74c4-4699-af73-fad0357c2d04"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/1000\n  to &lt;1/100)</span></b>", "ID": "9a436ca4-a898-4765-a0ea-c81504beb7fc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8fef7249-b7db-43e6-ba94-c312c1106010"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>(\u22651/1000\n  to &lt;1/100)</span>", "ID": "17d4615b-ca37-4948-b191-94ed11b2b6a8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(\u22651/1000   to <1/100)", "ParentId": "9a436ca4-a898-4765-a0ea-c81504beb7fc"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Infections\n  and infestations<sup>1)</sup></span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infections \u2011 pathogen unspecified</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Viral infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Bacterial infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fungal infections</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "164daace-c5bc-4658-9eba-4313148b7630", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Infections\n  and infestations<sup>1)</sup></span></p>\n</td>", "ID": "d6735d1f-9954-40b9-bd24-5c199a32ed52", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "164daace-c5bc-4658-9eba-4313148b7630"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Infections\n  and infestations<sup>1)</sup></span></p>", "ID": "4f40ca41-ace8-450c-971f-68f27fb3dacc", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d6735d1f-9954-40b9-bd24-5c199a32ed52"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Infections\n  and infestations<sup>1)</sup></span>", "ID": "c38d01be-30ba-41ba-953e-8fd36ae8a748", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Infections   and infestations", "ParentId": "4f40ca41-ace8-450c-971f-68f27fb3dacc"}, {"Element": "<sup>1)</sup>", "ID": "1b6acb4d-04cb-46b3-9259-d079eb838ac8", "Styles": "None", "Classes": "None", "Text": "1)", "ParentId": "c38d01be-30ba-41ba-953e-8fd36ae8a748"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infections \u2011 pathogen unspecified</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Viral infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Bacterial infections</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fungal infections</span></p>\n</td>", "ID": "7454f455-7012-4fdd-8a2a-312364a54111", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "164daace-c5bc-4658-9eba-4313148b7630"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infections \u2011 pathogen unspecified</span></p>", "ID": "21a2ddbb-4059-4433-a57d-6d28c65a4d4f", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "7454f455-7012-4fdd-8a2a-312364a54111"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infections \u2011 pathogen unspecified</span>", "ID": "7497a843-c587-4c61-871f-558e6989ce81", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Infections \u2011 pathogen unspecified", "ParentId": "21a2ddbb-4059-4433-a57d-6d28c65a4d4f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Viral infections</span></p>", "ID": "df7910a4-4634-47de-97cb-6be2ab7c3710", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "7454f455-7012-4fdd-8a2a-312364a54111"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Viral infections</span>", "ID": "fc4f18a4-adc2-4744-98c2-6d3460168972", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Viral infections", "ParentId": "df7910a4-4634-47de-97cb-6be2ab7c3710"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Bacterial infections</span></p>", "ID": "21411ef3-f89b-40b1-8dd5-711484f61889", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "7454f455-7012-4fdd-8a2a-312364a54111"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Bacterial infections</span>", "ID": "d9fbc51d-a185-4e19-a8b6-5e004f266bda", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Bacterial infections", "ParentId": "21411ef3-f89b-40b1-8dd5-711484f61889"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fungal infections</span></p>", "ID": "bb51459a-9d92-4c3e-adcc-08bbbe774205", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "7454f455-7012-4fdd-8a2a-312364a54111"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fungal infections</span>", "ID": "dae94861-daf6-4533-94c5-df0576ce6e40", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Fungal infections", "ParentId": "bb51459a-9d92-4c3e-adcc-08bbbe774205"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "3d4f7be1-62c0-4580-a7de-7014c02b86bf", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "164daace-c5bc-4658-9eba-4313148b7630"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "898be3c7-c8ba-4974-b6a8-b5eb4462b6ea", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "3d4f7be1-62c0-4580-a7de-7014c02b86bf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "c1d854d6-d48a-41a6-b394-a25cd6c46605", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "898be3c7-c8ba-4974-b6a8-b5eb4462b6ea"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "a89f5d27-6cd8-414b-9b88-6f04e4a03d4e", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "164daace-c5bc-4658-9eba-4313148b7630"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "ea4c3936-8667-486c-a899-94468c607830", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "a89f5d27-6cd8-414b-9b88-6f04e4a03d4e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "80cb5975-308a-40dd-b3f1-99c7c4376a57", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "ea4c3936-8667-486c-a899-94468c607830"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood\n  and lymphatic system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemorrhage<sup>2)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Febrile neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombocytopenia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemophagocytic lymphohistiocytosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Leukopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pancytopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Coagulopathy</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphopenia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>B-cell aplasia</span></p>\n</td>\n</tr>", "ID": "6d23647b-6498-47a5-97ef-8b4f86fb5656", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood\n  and lymphatic system disorders</span></p>\n</td>", "ID": "cdce53c9-6fab-4b3b-a930-331e94703851", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6d23647b-6498-47a5-97ef-8b4f86fb5656"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood\n  and lymphatic system disorders</span></p>", "ID": "493e7767-5439-49a7-9dab-b632d1d2dad0", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "cdce53c9-6fab-4b3b-a930-331e94703851"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Blood\n  and lymphatic system disorders</span>", "ID": "a0ed71da-db68-42ea-9247-c1168bcdedad", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Blood   and lymphatic system disorders", "ParentId": "493e7767-5439-49a7-9dab-b632d1d2dad0"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemorrhage<sup>2)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Febrile neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutropenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombocytopenia</span></p>\n</td>", "ID": "6097fee0-2e87-4e3c-8dbc-8624c143abda", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "6d23647b-6498-47a5-97ef-8b4f86fb5656"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anaemia</span></p>", "ID": "7118df69-d489-40b3-b649-3e49b90c74e2", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6097fee0-2e87-4e3c-8dbc-8624c143abda"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anaemia</span>", "ID": "00fbe8d1-d287-4754-b352-6c0aac1c51e4", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Anaemia", "ParentId": "7118df69-d489-40b3-b649-3e49b90c74e2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemorrhage<sup>2)</sup></span></p>", "ID": "eb1d38a9-cc68-4b24-a2d0-6e9dbba7cf74", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6097fee0-2e87-4e3c-8dbc-8624c143abda"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemorrhage<sup>2)</sup></span>", "ID": "18dec2df-8c4c-4685-b601-d6f8251fc72f", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Haemorrhage", "ParentId": "eb1d38a9-cc68-4b24-a2d0-6e9dbba7cf74"}, {"Element": "<sup>2)</sup>", "ID": "833853b7-a135-44b0-9497-6275f11e054f", "Styles": "None", "Classes": "None", "Text": "2)", "ParentId": "18dec2df-8c4c-4685-b601-d6f8251fc72f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Febrile neutropenia</span></p>", "ID": "4646711d-587a-4065-ab21-57fa18fdbd01", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6097fee0-2e87-4e3c-8dbc-8624c143abda"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Febrile neutropenia</span>", "ID": "97e9564c-af22-4517-9ca9-81945ac988b1", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Febrile neutropenia", "ParentId": "4646711d-587a-4065-ab21-57fa18fdbd01"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutropenia</span></p>", "ID": "06e81434-5317-42d1-98c0-7a0ac6fd39bb", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6097fee0-2e87-4e3c-8dbc-8624c143abda"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutropenia</span>", "ID": "ccc55907-5b06-4a3c-972d-018d5d263a7d", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Neutropenia", "ParentId": "06e81434-5317-42d1-98c0-7a0ac6fd39bb"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombocytopenia</span></p>", "ID": "39bae771-bbd9-4066-8883-b8bab946ca28", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6097fee0-2e87-4e3c-8dbc-8624c143abda"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombocytopenia</span>", "ID": "982bead3-e260-43b7-a4df-874612a97eda", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Thrombocytopenia", "ParentId": "39bae771-bbd9-4066-8883-b8bab946ca28"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemophagocytic lymphohistiocytosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Leukopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pancytopenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Coagulopathy</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphopenia</span></p>\n</td>", "ID": "c3cf8a3d-43fe-4602-9739-2c3f7e47e710", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "6d23647b-6498-47a5-97ef-8b4f86fb5656"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemophagocytic lymphohistiocytosis</span></p>", "ID": "216044c0-068f-438c-9fb2-56ca568624db", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "c3cf8a3d-43fe-4602-9739-2c3f7e47e710"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemophagocytic lymphohistiocytosis</span>", "ID": "d11d3fb7-cd6a-4f04-afa2-812405ae9cfc", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Haemophagocytic lymphohistiocytosis", "ParentId": "216044c0-068f-438c-9fb2-56ca568624db"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Leukopenia</span></p>", "ID": "2055346f-0584-410c-a265-967d77b5c5e9", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "c3cf8a3d-43fe-4602-9739-2c3f7e47e710"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Leukopenia</span>", "ID": "9e688638-8f90-4c53-aa51-aace84607a44", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Leukopenia", "ParentId": "2055346f-0584-410c-a265-967d77b5c5e9"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pancytopenia</span></p>", "ID": "18dcca49-34c9-45f4-937b-da90c8251827", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "c3cf8a3d-43fe-4602-9739-2c3f7e47e710"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pancytopenia</span>", "ID": "73ac325e-8343-4796-b2ba-8063cabe732e", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Pancytopenia", "ParentId": "18dcca49-34c9-45f4-937b-da90c8251827"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Coagulopathy</span></p>", "ID": "5eb83fcb-89ee-4589-95ee-b56ca34daf5d", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "c3cf8a3d-43fe-4602-9739-2c3f7e47e710"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Coagulopathy</span>", "ID": "cc96f610-dc10-4ebe-b730-08841f75a652", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Coagulopathy", "ParentId": "5eb83fcb-89ee-4589-95ee-b56ca34daf5d"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphopenia</span></p>", "ID": "8fa6b56a-0a8f-4f6d-9b6f-d62db6e6edbd", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "c3cf8a3d-43fe-4602-9739-2c3f7e47e710"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphopenia</span>", "ID": "92034a64-73ce-462b-8f1d-a2b92322311b", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Lymphopenia", "ParentId": "8fa6b56a-0a8f-4f6d-9b6f-d62db6e6edbd"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>B-cell aplasia</span></p>\n</td>", "ID": "01313a9c-8c81-435b-9e1d-974632065955", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6d23647b-6498-47a5-97ef-8b4f86fb5656"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>B-cell aplasia</span></p>", "ID": "e3e56607-e96f-4647-8816-9194c1fa59b5", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "01313a9c-8c81-435b-9e1d-974632065955"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>B-cell aplasia</span>", "ID": "361e2300-7864-49bd-b718-ca6c1f4b9921", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "B-cell aplasia", "ParentId": "e3e56607-e96f-4647-8816-9194c1fa59b5"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune\n  system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cytokine release syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypogammaglobulinaemia<sup>3)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infusion\u2011related reaction</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Graft\u2011versus\u2011host disease</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "2c573fc9-e777-4d9e-818c-dce6c39f9445", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune\n  system disorders</span></p>\n</td>", "ID": "6e419fc1-d5bc-4b42-a1dd-f890d128af89", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2c573fc9-e777-4d9e-818c-dce6c39f9445"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune\n  system disorders</span></p>", "ID": "65b28ddf-33a0-4676-87da-89e5cf11f9a5", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6e419fc1-d5bc-4b42-a1dd-f890d128af89"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Immune\n  system disorders</span>", "ID": "8f1f37d5-95ad-4a57-8bad-c9cf2bf22371", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Immune   system disorders", "ParentId": "65b28ddf-33a0-4676-87da-89e5cf11f9a5"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cytokine release syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypogammaglobulinaemia<sup>3)</sup></span></p>\n</td>", "ID": "01f1970a-0a2f-4586-b437-a49576f6d771", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "2c573fc9-e777-4d9e-818c-dce6c39f9445"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cytokine release syndrome</span></p>", "ID": "7ca53d03-b98b-41c3-972a-25ec980e27b2", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "01f1970a-0a2f-4586-b437-a49576f6d771"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cytokine release syndrome</span>", "ID": "3786ed41-1171-4f73-9f84-19e660fe2031", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Cytokine release syndrome", "ParentId": "7ca53d03-b98b-41c3-972a-25ec980e27b2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypogammaglobulinaemia<sup>3)</sup></span></p>", "ID": "263438a8-e723-4759-8fec-dc01c657c0e5", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "01f1970a-0a2f-4586-b437-a49576f6d771"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypogammaglobulinaemia<sup>3)</sup></span>", "ID": "83b3e393-f0a5-4a83-95bd-7fac0b9c83e2", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypogammaglobulinaemia", "ParentId": "263438a8-e723-4759-8fec-dc01c657c0e5"}, {"Element": "<sup>3)</sup>", "ID": "0129449e-eabe-43de-b4be-55966d1b2c60", "Styles": "None", "Classes": "None", "Text": "3)", "ParentId": "83b3e393-f0a5-4a83-95bd-7fac0b9c83e2"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infusion\u2011related reaction</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Graft\u2011versus\u2011host disease</span></p>\n</td>", "ID": "eac7d672-5b14-4c89-b6bf-c82d74431e50", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "2c573fc9-e777-4d9e-818c-dce6c39f9445"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infusion\u2011related reaction</span></p>", "ID": "b9fb137f-ebef-418e-b39b-6be881fdaf49", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "eac7d672-5b14-4c89-b6bf-c82d74431e50"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Infusion\u2011related reaction</span>", "ID": "544cf016-e6e8-4fc3-9c90-e4ae2bd01226", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Infusion\u2011related reaction", "ParentId": "b9fb137f-ebef-418e-b39b-6be881fdaf49"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Graft\u2011versus\u2011host disease</span></p>", "ID": "3510d06e-48fb-48d5-9877-7fe8a113cdf2", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "eac7d672-5b14-4c89-b6bf-c82d74431e50"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Graft\u2011versus\u2011host disease</span>", "ID": "d88765d8-b7fb-4d93-a80e-7f22a220bfae", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Graft\u2011versus\u2011host disease", "ParentId": "3510d06e-48fb-48d5-9877-7fe8a113cdf2"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "f3dba7bf-db0d-425b-8f49-beeabd58c7b6", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2c573fc9-e777-4d9e-818c-dce6c39f9445"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "a3f8b40a-44c7-4002-b3ed-dffe5e41ba66", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "f3dba7bf-db0d-425b-8f49-beeabd58c7b6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "40b9f8fd-4974-47f7-8761-99672484f533", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "a3f8b40a-44c7-4002-b3ed-dffe5e41ba66"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism\n  and nutrition disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Decreased appetite</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypokalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypophosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypomagnesaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypocalcaemia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoalbuminaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperglycaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyponatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperuricaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fluid overload</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypercalcaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tumour lysis syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperkalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperphosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypernatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypermagnesaemia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "190a7907-d808-43ab-9fb0-340ade96ec4f", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism\n  and nutrition disorders</span></p>\n</td>", "ID": "91d9a763-3058-453b-acdf-61ed1b618d59", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "190a7907-d808-43ab-9fb0-340ade96ec4f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism\n  and nutrition disorders</span></p>", "ID": "53e7e465-22a0-4a27-bb31-5bdfa9f4cacc", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "91d9a763-3058-453b-acdf-61ed1b618d59"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Metabolism\n  and nutrition disorders</span>", "ID": "fa4b3e62-4339-4fe3-9c4e-d532d75ffd77", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Metabolism   and nutrition disorders", "ParentId": "53e7e465-22a0-4a27-bb31-5bdfa9f4cacc"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Decreased appetite</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypokalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypophosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypomagnesaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypocalcaemia</span></p>\n</td>", "ID": "bf8f66bd-3f89-483f-8fa8-30deb3a71448", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "190a7907-d808-43ab-9fb0-340ade96ec4f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Decreased appetite</span></p>", "ID": "8c81cd48-242d-4571-9b57-0b29ebcac627", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "bf8f66bd-3f89-483f-8fa8-30deb3a71448"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Decreased appetite</span>", "ID": "f3539a1a-f7bd-4453-b68c-1b4fa3761237", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Decreased appetite", "ParentId": "8c81cd48-242d-4571-9b57-0b29ebcac627"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypokalaemia</span></p>", "ID": "38fb7383-445d-4de0-b168-892cfb041a20", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "bf8f66bd-3f89-483f-8fa8-30deb3a71448"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypokalaemia</span>", "ID": "32b11599-f59b-45e2-8383-bf899df0a165", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypokalaemia", "ParentId": "38fb7383-445d-4de0-b168-892cfb041a20"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypophosphataemia</span></p>", "ID": "0f759f5f-2501-4f7c-9014-d6b72a538e4c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "bf8f66bd-3f89-483f-8fa8-30deb3a71448"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypophosphataemia</span>", "ID": "0958d778-4bfb-46b8-80ac-46559fa883a0", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypophosphataemia", "ParentId": "0f759f5f-2501-4f7c-9014-d6b72a538e4c"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypomagnesaemia</span></p>", "ID": "d357e4fc-4175-463c-9434-48066c2c75a6", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "bf8f66bd-3f89-483f-8fa8-30deb3a71448"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypomagnesaemia</span>", "ID": "ec950585-0a84-4162-a7a8-902ebac7c077", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypomagnesaemia", "ParentId": "d357e4fc-4175-463c-9434-48066c2c75a6"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypocalcaemia</span></p>", "ID": "608e6233-9bbb-4e80-a89d-1bac3fb5e6da", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "bf8f66bd-3f89-483f-8fa8-30deb3a71448"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypocalcaemia</span>", "ID": "8e5c1450-870a-4c6f-b5fe-61d49dc14df5", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypocalcaemia", "ParentId": "608e6233-9bbb-4e80-a89d-1bac3fb5e6da"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoalbuminaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperglycaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyponatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperuricaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fluid overload</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypercalcaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tumour lysis syndrome</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperkalaemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperphosphataemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypernatraemia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypermagnesaemia</span></p>\n</td>", "ID": "d9c59b5e-becc-4be2-a152-6ddae2f05696", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "            ", "ParentId": "190a7907-d808-43ab-9fb0-340ade96ec4f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoalbuminaemia</span></p>", "ID": "e1732221-4d8c-41e6-ab17-02d9c499c2ba", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoalbuminaemia</span>", "ID": "111df0b1-8d07-4304-9e59-534785af73d5", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypoalbuminaemia", "ParentId": "e1732221-4d8c-41e6-ab17-02d9c499c2ba"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperglycaemia</span></p>", "ID": "f1688335-a7cf-464c-9996-a68b8bf08af8", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperglycaemia</span>", "ID": "2c800334-ffe3-4543-a749-b897a6ba7fbd", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hyperglycaemia", "ParentId": "f1688335-a7cf-464c-9996-a68b8bf08af8"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyponatraemia</span></p>", "ID": "0dd238d6-33cc-4f6b-bb96-40ab4a60680b", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyponatraemia</span>", "ID": "3130b28e-b1ad-4a05-9801-82e21c20013f", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hyponatraemia", "ParentId": "0dd238d6-33cc-4f6b-bb96-40ab4a60680b"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperuricaemia</span></p>", "ID": "dcf3d72a-1b4b-4142-96cc-ae0324222eb6", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperuricaemia</span>", "ID": "3b2402df-9a21-4cef-aee9-4e44d4178c30", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hyperuricaemia", "ParentId": "dcf3d72a-1b4b-4142-96cc-ae0324222eb6"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fluid overload</span></p>", "ID": "e2d9c44c-042c-4828-8156-9941f320529e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fluid overload</span>", "ID": "d13c6094-7289-40e5-a2a6-fa7d060f3ca9", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Fluid overload", "ParentId": "e2d9c44c-042c-4828-8156-9941f320529e"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypercalcaemia</span></p>", "ID": "e4042834-cc4d-4a3b-9ef6-444cd5e6c35d", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypercalcaemia</span>", "ID": "0ace8ed5-711d-41d4-8c27-ea4026c48fb7", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypercalcaemia", "ParentId": "e4042834-cc4d-4a3b-9ef6-444cd5e6c35d"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tumour lysis syndrome</span></p>", "ID": "bb178f63-4612-458e-9236-90bdcb29eb7c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tumour lysis syndrome</span>", "ID": "3f23eb4f-5d3c-43ef-99e8-cf652e725667", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Tumour lysis syndrome", "ParentId": "bb178f63-4612-458e-9236-90bdcb29eb7c"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperkalaemia</span></p>", "ID": "098ddb7a-a760-40fc-89d0-953bb780f65c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperkalaemia</span>", "ID": "a0a65958-8b2a-4388-b8fa-3d0713e4023d", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hyperkalaemia", "ParentId": "098ddb7a-a760-40fc-89d0-953bb780f65c"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperphosphataemia</span></p>", "ID": "e8569fb6-d569-4025-a01f-20ea56975c46", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperphosphataemia</span>", "ID": "cfc9d83d-c4e3-4fd6-a010-55d0dc29a748", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hyperphosphataemia", "ParentId": "e8569fb6-d569-4025-a01f-20ea56975c46"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypernatraemia</span></p>", "ID": "ab63efe1-8225-4fd4-b738-43df817288a6", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypernatraemia</span>", "ID": "5eaea210-9183-461b-b13f-0ed3ea5c8bd1", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypernatraemia", "ParentId": "ab63efe1-8225-4fd4-b738-43df817288a6"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypermagnesaemia</span></p>", "ID": "db6e6c11-e415-4afe-b08c-f86690c3a7d5", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d9c59b5e-becc-4be2-a152-6ddae2f05696"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypermagnesaemia</span>", "ID": "83e47cea-3cb8-4626-8c8c-57fc0281cb67", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypermagnesaemia", "ParentId": "db6e6c11-e415-4afe-b08c-f86690c3a7d5"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "e60cfc51-7574-488f-b6d6-893ee8ab4ae7", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "190a7907-d808-43ab-9fb0-340ade96ec4f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "f1fa33d0-4adc-4d14-89e6-c88757920fe6", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e60cfc51-7574-488f-b6d6-893ee8ab4ae7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "86ae5085-dcfd-45ea-9a67-9996344b21f0", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "f1fa33d0-4adc-4d14-89e6-c88757920fe6"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anxiety</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Delirium<sup>4)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Sleep disorder<sup>5)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "21149168-08cb-4c3f-b4f3-0dd51a57438a", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric\n  disorders</span></p>\n</td>", "ID": "83236fe7-cca1-49d8-bb71-77ee044deb8f", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "21149168-08cb-4c3f-b4f3-0dd51a57438a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric\n  disorders</span></p>", "ID": "7a127c3c-87d4-4a5f-8b9a-534fb1b2c84d", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "83236fe7-cca1-49d8-bb71-77ee044deb8f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Psychiatric\n  disorders</span>", "ID": "a98b760b-559a-4eb9-9a96-3657b35bcad5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Psychiatric   disorders", "ParentId": "7a127c3c-87d4-4a5f-8b9a-534fb1b2c84d"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anxiety</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Delirium<sup>4)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Sleep disorder<sup>5)</sup></span></p>\n</td>", "ID": "44675cdb-17cd-4310-b15e-ab6be64519d2", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "21149168-08cb-4c3f-b4f3-0dd51a57438a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anxiety</span></p>", "ID": "bebbcdcd-eeab-42e7-ad9d-99150a09fee9", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "44675cdb-17cd-4310-b15e-ab6be64519d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Anxiety</span>", "ID": "8c771b72-db32-4f1b-85af-8cc6862f42a9", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Anxiety", "ParentId": "bebbcdcd-eeab-42e7-ad9d-99150a09fee9"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Delirium<sup>4)</sup></span></p>", "ID": "39557eb5-d543-4f2f-950f-7dec1c87bd1e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "44675cdb-17cd-4310-b15e-ab6be64519d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Delirium<sup>4)</sup></span>", "ID": "68e4aed8-9d74-4134-a014-0da510f296fc", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Delirium", "ParentId": "39557eb5-d543-4f2f-950f-7dec1c87bd1e"}, {"Element": "<sup>4)</sup>", "ID": "8b85bda8-fe59-48ee-8110-0991547e911a", "Styles": "None", "Classes": "None", "Text": "4)", "ParentId": "68e4aed8-9d74-4134-a014-0da510f296fc"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Sleep disorder<sup>5)</sup></span></p>", "ID": "688757aa-4456-409e-83ab-a1eb34c07670", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "44675cdb-17cd-4310-b15e-ab6be64519d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Sleep disorder<sup>5)</sup></span>", "ID": "a07f604c-dc68-4b81-ae1a-6eacb0298fe7", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Sleep disorder", "ParentId": "688757aa-4456-409e-83ab-a1eb34c07670"}, {"Element": "<sup>5)</sup>", "ID": "e138db96-d315-4d25-8d98-2a94c2d4a67e", "Styles": "None", "Classes": "None", "Text": "5)", "ParentId": "a07f604c-dc68-4b81-ae1a-6eacb0298fe7"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "e6554baa-308b-4a66-bbbc-15017515d7c8", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "21149168-08cb-4c3f-b4f3-0dd51a57438a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "190a92ed-069f-477d-9253-efced07efa6c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e6554baa-308b-4a66-bbbc-15017515d7c8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "9679088a-bc5f-48bd-bad6-8fa0f39e250b", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "190a92ed-069f-477d-9253-efced07efa6c"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "ec4ec260-88fc-40c3-a395-88f9cb866b4a", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "21149168-08cb-4c3f-b4f3-0dd51a57438a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "b69c3c7d-888f-4561-a648-b2f857962948", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "ec4ec260-88fc-40c3-a395-88f9cb866b4a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "55820f20-27be-42ed-9dfc-224790da55ff", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "b69c3c7d-888f-4561-a648-b2f857962948"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous\n  system disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Headache<sup>6)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Encephalopathy<sup>7)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dizziness<sup>8)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Peripheral neuropathy<sup>9)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tremor<sup>10)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Motor dysfunction<sup>11)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Seizure<sup>12)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Speech disorders<sup>13)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neuralgia<sup>14)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ataxia<sup>15)</sup></span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Ischaemic cerebral infarction</span></p>\n</td>\n</tr>", "ID": "d49104df-3026-48c0-b7ac-1ebb563da21b", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous\n  system disorders</span></p>\n</td>", "ID": "e77bdec7-453d-44ef-af8f-0b0d13547b9a", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d49104df-3026-48c0-b7ac-1ebb563da21b"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous\n  system disorders</span></p>", "ID": "d31ef278-b76f-48a2-b939-d8c2ab2adc98", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e77bdec7-453d-44ef-af8f-0b0d13547b9a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Nervous\n  system disorders</span>", "ID": "aaeb6033-bf8f-4e65-ba1e-ae5b2ba8f6e5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Nervous   system disorders", "ParentId": "d31ef278-b76f-48a2-b939-d8c2ab2adc98"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Headache<sup>6)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Encephalopathy<sup>7)</sup></span></p>\n</td>", "ID": "99d1995e-f075-4fa5-a990-0f34b642845e", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "d49104df-3026-48c0-b7ac-1ebb563da21b"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Headache<sup>6)</sup></span></p>", "ID": "726bc424-1b8e-46e6-947b-7ef53c12beeb", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "99d1995e-f075-4fa5-a990-0f34b642845e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Headache<sup>6)</sup></span>", "ID": "ae9be65b-9059-4b58-9b5b-7587f1c9ac41", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Headache", "ParentId": "726bc424-1b8e-46e6-947b-7ef53c12beeb"}, {"Element": "<sup>6)</sup>", "ID": "67f57d0b-3f0d-4f15-b10a-93a5730a31ae", "Styles": "None", "Classes": "None", "Text": "6)", "ParentId": "ae9be65b-9059-4b58-9b5b-7587f1c9ac41"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Encephalopathy<sup>7)</sup></span></p>", "ID": "e8118c91-88aa-421c-a124-0463c22faf3c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "99d1995e-f075-4fa5-a990-0f34b642845e"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Encephalopathy<sup>7)</sup></span>", "ID": "a3bed727-8d7d-4145-b17a-d0b915b1e8d0", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Encephalopathy", "ParentId": "e8118c91-88aa-421c-a124-0463c22faf3c"}, {"Element": "<sup>7)</sup>", "ID": "7bc4a34d-cccd-4059-bf14-45d300685877", "Styles": "None", "Classes": "None", "Text": "7)", "ParentId": "a3bed727-8d7d-4145-b17a-d0b915b1e8d0"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dizziness<sup>8)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Peripheral neuropathy<sup>9)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tremor<sup>10)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Motor dysfunction<sup>11)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Seizure<sup>12)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Speech disorders<sup>13)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neuralgia<sup>14)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ataxia<sup>15)</sup></span></p>\n</td>", "ID": "67eef9ac-2716-452f-ba82-67de39d2bae1", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "         ", "ParentId": "d49104df-3026-48c0-b7ac-1ebb563da21b"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dizziness<sup>8)</sup></span></p>", "ID": "34456bdd-9ee9-4025-8e60-cefbbaaa4e2e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dizziness<sup>8)</sup></span>", "ID": "f1b2223e-bcd2-4e2c-957c-f2c41775a866", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Dizziness", "ParentId": "34456bdd-9ee9-4025-8e60-cefbbaaa4e2e"}, {"Element": "<sup>8)</sup>", "ID": "18957f55-e05c-41e3-9977-cc05cd6a440f", "Styles": "None", "Classes": "None", "Text": "8)", "ParentId": "f1b2223e-bcd2-4e2c-957c-f2c41775a866"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Peripheral neuropathy<sup>9)</sup></span></p>", "ID": "a2718bb8-6a8c-4d8a-909f-1195f20591e6", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Peripheral neuropathy<sup>9)</sup></span>", "ID": "44329de2-8d41-467d-ba5b-d66d564d1ced", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Peripheral neuropathy", "ParentId": "a2718bb8-6a8c-4d8a-909f-1195f20591e6"}, {"Element": "<sup>9)</sup>", "ID": "ecaa7a6e-4110-4b5b-a4c1-e9b9033ce108", "Styles": "None", "Classes": "None", "Text": "9)", "ParentId": "44329de2-8d41-467d-ba5b-d66d564d1ced"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tremor<sup>10)</sup></span></p>", "ID": "b6cdc739-cd69-47e5-99dd-4b902601d3ab", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tremor<sup>10)</sup></span>", "ID": "af7e130f-170f-4a7d-be47-b88beb972f7f", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Tremor", "ParentId": "b6cdc739-cd69-47e5-99dd-4b902601d3ab"}, {"Element": "<sup>10)</sup>", "ID": "f38ad2ce-b89e-4054-9aa5-94856336900b", "Styles": "None", "Classes": "None", "Text": "10)", "ParentId": "af7e130f-170f-4a7d-be47-b88beb972f7f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Motor dysfunction<sup>11)</sup></span></p>", "ID": "8c7ae823-63d5-4c35-93a3-1e7a88344988", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Motor dysfunction<sup>11)</sup></span>", "ID": "a6d9b4c2-aa68-468d-8ab5-b900e3f75b14", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Motor dysfunction", "ParentId": "8c7ae823-63d5-4c35-93a3-1e7a88344988"}, {"Element": "<sup>11)</sup>", "ID": "cce5eaa8-13f6-41fb-b2fe-a3634b97b0dd", "Styles": "None", "Classes": "None", "Text": "11)", "ParentId": "a6d9b4c2-aa68-468d-8ab5-b900e3f75b14"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Seizure<sup>12)</sup></span></p>", "ID": "32d7d274-5ccf-40b0-b587-cc8f05c060de", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Seizure<sup>12)</sup></span>", "ID": "125e8e88-aa4f-4cb1-8c8f-a3fabe37e002", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Seizure", "ParentId": "32d7d274-5ccf-40b0-b587-cc8f05c060de"}, {"Element": "<sup>12)</sup>", "ID": "7f37c729-1596-44b7-aee5-280af843251c", "Styles": "None", "Classes": "None", "Text": "12)", "ParentId": "125e8e88-aa4f-4cb1-8c8f-a3fabe37e002"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Speech disorders<sup>13)</sup></span></p>", "ID": "5c874c6d-911e-44b2-8d65-7dfc06b52435", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Speech disorders<sup>13)</sup></span>", "ID": "9911b399-4112-4ee1-9946-45f17cfd7d6c", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Speech disorders", "ParentId": "5c874c6d-911e-44b2-8d65-7dfc06b52435"}, {"Element": "<sup>13)</sup>", "ID": "27607089-1f47-4902-8f9e-ffbae301cde2", "Styles": "None", "Classes": "None", "Text": "13)", "ParentId": "9911b399-4112-4ee1-9946-45f17cfd7d6c"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neuralgia<sup>14)</sup></span></p>", "ID": "084210bd-8678-4171-afe3-b7ca88914218", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neuralgia<sup>14)</sup></span>", "ID": "cb7ae898-7da7-4de3-b247-810b3051e2bf", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Neuralgia", "ParentId": "084210bd-8678-4171-afe3-b7ca88914218"}, {"Element": "<sup>14)</sup>", "ID": "25faa712-d1e3-443e-a220-11ba30330f95", "Styles": "None", "Classes": "None", "Text": "14)", "ParentId": "cb7ae898-7da7-4de3-b247-810b3051e2bf"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ataxia<sup>15)</sup></span></p>", "ID": "bf2d9ba9-aac5-4237-b6ea-7c13eb6087b4", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "67eef9ac-2716-452f-ba82-67de39d2bae1"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ataxia<sup>15)</sup></span>", "ID": "060f3038-8220-4a50-b560-a296c103f2f6", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Ataxia", "ParentId": "bf2d9ba9-aac5-4237-b6ea-7c13eb6087b4"}, {"Element": "<sup>15)</sup>", "ID": "9e0fb4eb-f05e-4c59-90fc-4b63ac9130c4", "Styles": "None", "Classes": "None", "Text": "15)", "ParentId": "060f3038-8220-4a50-b560-a296c103f2f6"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Ischaemic cerebral infarction</span></p>\n</td>", "ID": "da4bd9f3-0371-4322-8b87-e08ad8dfa3fa", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d49104df-3026-48c0-b7ac-1ebb563da21b"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Ischaemic cerebral infarction</span></p>", "ID": "980b7824-e6ae-4db9-a4dd-5ef993f6406b", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "da4bd9f3-0371-4322-8b87-e08ad8dfa3fa"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Ischaemic cerebral infarction</span>", "ID": "aec683eb-9758-415c-9ef2-d9afac641818", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Ischaemic cerebral infarction", "ParentId": "980b7824-e6ae-4db9-a4dd-5ef993f6406b"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Visual impairment<sup>16)</sup></span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "f2a00173-c146-4f7c-9740-d7b82a469809", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye\n  disorders</span></p>\n</td>", "ID": "70d12019-d282-49f7-b322-5c82b50999ac", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f2a00173-c146-4f7c-9740-d7b82a469809"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye\n  disorders</span></p>", "ID": "e6bfc42d-3493-4b3f-ab38-13890fc5a58f", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "70d12019-d282-49f7-b322-5c82b50999ac"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Eye\n  disorders</span>", "ID": "25e12ce7-1de8-408d-a41c-302ceb16a459", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Eye   disorders", "ParentId": "e6bfc42d-3493-4b3f-ab38-13890fc5a58f"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "6db95f27-54f4-44f6-9d4a-81d74fe40f48", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f2a00173-c146-4f7c-9740-d7b82a469809"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "d6309b90-f668-415d-93aa-234773fac3d7", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6db95f27-54f4-44f6-9d4a-81d74fe40f48"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "84773629-6839-4a9d-b01b-0df998ca668a", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "d6309b90-f668-415d-93aa-234773fac3d7"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Visual impairment<sup>16)</sup></span></p>\n</td>", "ID": "ee086ce8-d884-484a-b841-db7a1187bafb", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f2a00173-c146-4f7c-9740-d7b82a469809"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Visual impairment<sup>16)</sup></span></p>", "ID": "f1e97390-a50a-4189-b2d4-ec48e66292d1", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "ee086ce8-d884-484a-b841-db7a1187bafb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Visual impairment<sup>16)</sup></span>", "ID": "f4dc0ca8-e912-49e0-8ab8-189690ea1e52", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Visual impairment", "ParentId": "f1e97390-a50a-4189-b2d4-ec48e66292d1"}, {"Element": "<sup>16)</sup>", "ID": "b4520f63-bc3f-4a77-9666-d5c94a009557", "Styles": "None", "Classes": "None", "Text": "16)", "ParentId": "f4dc0ca8-e912-49e0-8ab8-189690ea1e52"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "5aeb3e2b-4891-4876-a84f-f349d60ef4c4", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f2a00173-c146-4f7c-9740-d7b82a469809"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "cbac1107-4ad4-457a-ab75-1db403abaae2", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "5aeb3e2b-4891-4876-a84f-f349d60ef4c4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "3050cd4d-2836-4ddf-b518-c57dfa6f1550", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "cbac1107-4ad4-457a-ab75-1db403abaae2"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arrhythmia<sup>17)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac failure<sup>18)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac arrest</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "31be1c26-81d0-45d3-802c-9a57232a73cf", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac\n  disorders</span></p>\n</td>", "ID": "0d891e22-8947-4393-92c2-bbb9d537e515", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "31be1c26-81d0-45d3-802c-9a57232a73cf"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac\n  disorders</span></p>", "ID": "824abad0-2b0a-46a1-8bfe-5a34cf86aaeb", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "0d891e22-8947-4393-92c2-bbb9d537e515"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Cardiac\n  disorders</span>", "ID": "32e41c19-a776-408b-9835-97953acb75ae", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Cardiac   disorders", "ParentId": "824abad0-2b0a-46a1-8bfe-5a34cf86aaeb"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arrhythmia<sup>17)</sup></span></p>\n</td>", "ID": "b9ea20a3-4ca8-4c73-a155-ff8fb67db9a2", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "31be1c26-81d0-45d3-802c-9a57232a73cf"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arrhythmia<sup>17)</sup></span></p>", "ID": "df137ae3-6328-48b4-88c4-6579a94d7c33", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "b9ea20a3-4ca8-4c73-a155-ff8fb67db9a2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arrhythmia<sup>17)</sup></span>", "ID": "130e5eac-23a4-42d0-bcf1-9a66fd953a18", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Arrhythmia", "ParentId": "df137ae3-6328-48b4-88c4-6579a94d7c33"}, {"Element": "<sup>17)</sup>", "ID": "9e6375b1-1655-49b8-be5b-05f8c02d41d7", "Styles": "None", "Classes": "None", "Text": "17)", "ParentId": "130e5eac-23a4-42d0-bcf1-9a66fd953a18"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac failure<sup>18)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac arrest</span></p>\n</td>", "ID": "6f73d873-76b4-43f0-ad92-d6697d0f2bd8", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "31be1c26-81d0-45d3-802c-9a57232a73cf"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac failure<sup>18)</sup></span></p>", "ID": "6d528629-5905-4442-a1d8-086a08fc7044", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6f73d873-76b4-43f0-ad92-d6697d0f2bd8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac failure<sup>18)</sup></span>", "ID": "c6d8d0ef-4c51-402f-b953-e368f49d45f3", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Cardiac failure", "ParentId": "6d528629-5905-4442-a1d8-086a08fc7044"}, {"Element": "<sup>18)</sup>", "ID": "b268cd0a-0cee-4d62-bd16-ff2a04eef07e", "Styles": "None", "Classes": "None", "Text": "18)", "ParentId": "c6d8d0ef-4c51-402f-b953-e368f49d45f3"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac arrest</span></p>", "ID": "a1f0b62a-5325-4b07-a4f3-5b75bba38d97", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "6f73d873-76b4-43f0-ad92-d6697d0f2bd8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cardiac arrest</span>", "ID": "f816351a-2104-43af-9b83-8db487be8327", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Cardiac arrest", "ParentId": "a1f0b62a-5325-4b07-a4f3-5b75bba38d97"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "8cf3f72b-d304-4007-b66c-afb86a4e0330", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "31be1c26-81d0-45d3-802c-9a57232a73cf"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "6748f42e-ab35-41c4-af31-a0f65ba201a7", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "8cf3f72b-d304-4007-b66c-afb86a4e0330"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "36da470b-059c-4897-8f68-95596e3ca4a1", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "6748f42e-ab35-41c4-af31-a0f65ba201a7"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypotension<sup>19)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypertension</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombosis<sup>20)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Capillary leak syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Flushing</span></p>\n</td>\n</tr>", "ID": "a3167908-5e49-45f2-b862-e04500e2b6b2", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular\n  disorders</span></p>\n</td>", "ID": "55237afd-83cf-48f2-8ef2-4513ef36783a", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a3167908-5e49-45f2-b862-e04500e2b6b2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular\n  disorders</span></p>", "ID": "b5928921-3794-45b1-849c-a7feff178111", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "55237afd-83cf-48f2-8ef2-4513ef36783a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Vascular\n  disorders</span>", "ID": "28f343f0-89d1-42f8-9c16-330fd3b0e9f6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Vascular   disorders", "ParentId": "b5928921-3794-45b1-849c-a7feff178111"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypotension<sup>19)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypertension</span></p>\n</td>", "ID": "ab058751-0800-4987-9141-0f0843de8340", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "a3167908-5e49-45f2-b862-e04500e2b6b2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypotension<sup>19)</sup></span></p>", "ID": "3b28661b-30d7-439f-b757-5d4fd02d9ee2", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "ab058751-0800-4987-9141-0f0843de8340"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypotension<sup>19)</sup></span>", "ID": "b77e3752-ed08-4935-bbfb-38f579cdc3e6", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypotension", "ParentId": "3b28661b-30d7-439f-b757-5d4fd02d9ee2"}, {"Element": "<sup>19)</sup>", "ID": "16d24da7-e82b-45ca-a994-128aeab445e4", "Styles": "None", "Classes": "None", "Text": "19)", "ParentId": "b77e3752-ed08-4935-bbfb-38f579cdc3e6"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypertension</span></p>", "ID": "5fea5256-edbc-42fb-933a-abdf5a6053c0", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "ab058751-0800-4987-9141-0f0843de8340"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypertension</span>", "ID": "e45c5c50-b8b2-4140-9d75-183545481945", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypertension", "ParentId": "5fea5256-edbc-42fb-933a-abdf5a6053c0"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombosis<sup>20)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Capillary leak syndrome</span></p>\n</td>", "ID": "cb9be13e-7b24-493c-af21-43ea559e0fc2", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "a3167908-5e49-45f2-b862-e04500e2b6b2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombosis<sup>20)</sup></span></p>", "ID": "53958601-68d2-481f-ade2-ec7e3aab715c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "cb9be13e-7b24-493c-af21-43ea559e0fc2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Thrombosis<sup>20)</sup></span>", "ID": "98b9656b-ecab-4a38-ba24-9584923ac7a1", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Thrombosis", "ParentId": "53958601-68d2-481f-ade2-ec7e3aab715c"}, {"Element": "<sup>20)</sup>", "ID": "3ab43eeb-5ec2-405b-9706-f72898fc7425", "Styles": "None", "Classes": "None", "Text": "20)", "ParentId": "98b9656b-ecab-4a38-ba24-9584923ac7a1"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Capillary leak syndrome</span></p>", "ID": "3748de72-4339-4a97-9976-3324b41c1ae5", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "cb9be13e-7b24-493c-af21-43ea559e0fc2"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Capillary leak syndrome</span>", "ID": "7b89952c-44ec-454d-9a65-30d37b64b4e0", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Capillary leak syndrome", "ParentId": "3748de72-4339-4a97-9976-3324b41c1ae5"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Flushing</span></p>\n</td>", "ID": "031dc2fb-2152-412e-bef4-4b8ae684db1d", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a3167908-5e49-45f2-b862-e04500e2b6b2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Flushing</span></p>", "ID": "1448e4a9-686b-4ee0-8db3-00037dcd8c4f", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "031dc2fb-2152-412e-bef4-4b8ae684db1d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Flushing</span>", "ID": "bffc0e76-43e5-4a8a-ad61-45cff130213f", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Flushing", "ParentId": "1448e4a9-686b-4ee0-8db3-00037dcd8c4f"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory,\n  thoracic and mediastinal disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cough<sup>21)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dyspnoea<sup>22)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoxia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oropharyngeal pain<sup>23)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pulmonary oedema<sup>24)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nasal congestion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pleural effusion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tachypnoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute respiratory distress syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lung infiltration</span></p>\n</td>\n</tr>", "ID": "4af3db58-9881-4453-9bec-44180418408a", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory,\n  thoracic and mediastinal disorders</span></p>\n</td>", "ID": "18f35f61-a1ec-4ad0-b06f-46e3d0765aff", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "4af3db58-9881-4453-9bec-44180418408a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory,\n  thoracic and mediastinal disorders</span></p>", "ID": "fb6144b8-4c00-4d59-8f1e-1cbe68b6713f", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "18f35f61-a1ec-4ad0-b06f-46e3d0765aff"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Respiratory,\n  thoracic and mediastinal disorders</span>", "ID": "7cf99f3e-bae3-4e03-9e19-e910c66de853", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Respiratory,   thoracic and mediastinal disorders", "ParentId": "fb6144b8-4c00-4d59-8f1e-1cbe68b6713f"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cough<sup>21)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dyspnoea<sup>22)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoxia</span></p>\n</td>", "ID": "5ecadc13-5239-4734-99bf-8637e2af13bf", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "4af3db58-9881-4453-9bec-44180418408a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cough<sup>21)</sup></span></p>", "ID": "a179c505-edc9-40e0-b6ac-f1c5bb75087e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "5ecadc13-5239-4734-99bf-8637e2af13bf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Cough<sup>21)</sup></span>", "ID": "5fa922fa-e8fd-4cbf-91ef-0a7592309e09", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Cough", "ParentId": "a179c505-edc9-40e0-b6ac-f1c5bb75087e"}, {"Element": "<sup>21)</sup>", "ID": "4c0c3bce-4ba7-4b5f-b729-9b0f86b8d5b7", "Styles": "None", "Classes": "None", "Text": "21)", "ParentId": "5fa922fa-e8fd-4cbf-91ef-0a7592309e09"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dyspnoea<sup>22)</sup></span></p>", "ID": "fe580195-8dad-488f-ab76-b320c8b01f62", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "5ecadc13-5239-4734-99bf-8637e2af13bf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dyspnoea<sup>22)</sup></span>", "ID": "ade492c0-de7c-474b-abf2-aad7c00b2c55", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Dyspnoea", "ParentId": "fe580195-8dad-488f-ab76-b320c8b01f62"}, {"Element": "<sup>22)</sup>", "ID": "43cdaf70-2f31-46c7-9f30-846078e8fc38", "Styles": "None", "Classes": "None", "Text": "22)", "ParentId": "ade492c0-de7c-474b-abf2-aad7c00b2c55"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoxia</span></p>", "ID": "66826e32-be20-485d-a163-3fba9c1aae63", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "5ecadc13-5239-4734-99bf-8637e2af13bf"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Hypoxia</span>", "ID": "92532c66-6009-48c3-a05e-6626e6a415a5", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hypoxia", "ParentId": "66826e32-be20-485d-a163-3fba9c1aae63"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oropharyngeal pain<sup>23)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pulmonary oedema<sup>24)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nasal congestion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pleural effusion</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tachypnoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute respiratory distress syndrome</span></p>\n</td>", "ID": "e5e06aa8-dbf8-43c2-8c86-fbdb663e0d2f", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "       ", "ParentId": "4af3db58-9881-4453-9bec-44180418408a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oropharyngeal pain<sup>23)</sup></span></p>", "ID": "f080fa41-8887-4729-91cb-ab687801cb3c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e5e06aa8-dbf8-43c2-8c86-fbdb663e0d2f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oropharyngeal pain<sup>23)</sup></span>", "ID": "a9e57f94-0c3e-4e0e-8ac2-ea2089eee8da", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Oropharyngeal pain", "ParentId": "f080fa41-8887-4729-91cb-ab687801cb3c"}, {"Element": "<sup>23)</sup>", "ID": "bcce0a38-f7f2-444e-966f-6a954bbb9a64", "Styles": "None", "Classes": "None", "Text": "23)", "ParentId": "a9e57f94-0c3e-4e0e-8ac2-ea2089eee8da"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pulmonary oedema<sup>24)</sup></span></p>", "ID": "a3e0af9f-9287-49ed-802d-6319bdbabfb3", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e5e06aa8-dbf8-43c2-8c86-fbdb663e0d2f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pulmonary oedema<sup>24)</sup></span>", "ID": "4207ac77-7b96-48a9-b244-4b5673b2cb17", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Pulmonary oedema", "ParentId": "a3e0af9f-9287-49ed-802d-6319bdbabfb3"}, {"Element": "<sup>24)</sup>", "ID": "cbf9a6ca-556f-428a-a8b1-2b52c1460e81", "Styles": "None", "Classes": "None", "Text": "24)", "ParentId": "4207ac77-7b96-48a9-b244-4b5673b2cb17"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nasal congestion</span></p>", "ID": "67e0832b-7948-419b-adf8-92183bc2c426", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e5e06aa8-dbf8-43c2-8c86-fbdb663e0d2f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nasal congestion</span>", "ID": "24e811db-3a69-441e-88b8-0123cde94bcc", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Nasal congestion", "ParentId": "67e0832b-7948-419b-adf8-92183bc2c426"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pleural effusion</span></p>", "ID": "faa10e70-153d-4b1d-89ed-2ef0ba85d3b9", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e5e06aa8-dbf8-43c2-8c86-fbdb663e0d2f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pleural effusion</span>", "ID": "50807fca-de60-42b9-bf80-350f015bea8a", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Pleural effusion", "ParentId": "faa10e70-153d-4b1d-89ed-2ef0ba85d3b9"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tachypnoea</span></p>", "ID": "b7611822-f021-4417-9bbc-b35f0d11e4a4", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e5e06aa8-dbf8-43c2-8c86-fbdb663e0d2f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Tachypnoea</span>", "ID": "f1e50f95-74a9-4216-a498-dee83a7e49eb", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Tachypnoea", "ParentId": "b7611822-f021-4417-9bbc-b35f0d11e4a4"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute respiratory distress syndrome</span></p>", "ID": "ff4b4127-a502-47be-8743-bb691695b080", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e5e06aa8-dbf8-43c2-8c86-fbdb663e0d2f"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute respiratory distress syndrome</span>", "ID": "9b270346-8f04-4fb5-af97-1d1438f3a292", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Acute respiratory distress syndrome", "ParentId": "ff4b4127-a502-47be-8743-bb691695b080"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lung infiltration</span></p>\n</td>", "ID": "de2a9bd4-ba96-4796-8d83-d960c2e4a951", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "4af3db58-9881-4453-9bec-44180418408a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lung infiltration</span></p>", "ID": "97029238-c2a9-4e1a-919c-d45120572944", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "de2a9bd4-ba96-4796-8d83-d960c2e4a951"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lung infiltration</span>", "ID": "efff2679-a86e-4a87-abb2-177e9711dc98", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Lung infiltration", "ParentId": "97029238-c2a9-4e1a-919c-d45120572944"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Diarrhoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nausea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Vomiting</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Constipation</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal pain<sup>25)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Stomatitis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal distension</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dry mouth</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ascites</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "2dc5e7c1-a9b6-4203-8a31-37543eb553ca", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>\n</td>", "ID": "d329f29a-6ba8-45dd-ab1a-496ff1c6734d", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2dc5e7c1-a9b6-4203-8a31-37543eb553ca"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span></p>", "ID": "8d142141-4657-4dc5-8c47-37de4e98d593", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "d329f29a-6ba8-45dd-ab1a-496ff1c6734d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Gastrointestinal\n  disorders</span>", "ID": "275b1d75-05a5-4c1c-b4c7-7c9238e3fc0e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Gastrointestinal   disorders", "ParentId": "8d142141-4657-4dc5-8c47-37de4e98d593"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Diarrhoea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nausea</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Vomiting</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Constipation</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal pain<sup>25)</sup></span></p>\n</td>", "ID": "b2725023-70cb-4189-bce6-27aa881f3538", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "2dc5e7c1-a9b6-4203-8a31-37543eb553ca"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Diarrhoea</span></p>", "ID": "51dd5f54-67d3-4cfb-b5d8-a342b6c29a18", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "b2725023-70cb-4189-bce6-27aa881f3538"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Diarrhoea</span>", "ID": "426f1155-4313-417a-8d62-041f28a522ef", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Diarrhoea", "ParentId": "51dd5f54-67d3-4cfb-b5d8-a342b6c29a18"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nausea</span></p>", "ID": "f8d73380-23fd-4f8a-846b-d6eba8f5a2df", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "b2725023-70cb-4189-bce6-27aa881f3538"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Nausea</span>", "ID": "7407c12f-46d5-4774-92eb-74bd74ee8054", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Nausea", "ParentId": "f8d73380-23fd-4f8a-846b-d6eba8f5a2df"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Vomiting</span></p>", "ID": "209a3193-5437-4553-82ce-1cbf52dce2c8", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "b2725023-70cb-4189-bce6-27aa881f3538"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Vomiting</span>", "ID": "093f9554-3fc9-457e-a06e-efb3ee2e5ef2", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Vomiting", "ParentId": "209a3193-5437-4553-82ce-1cbf52dce2c8"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Constipation</span></p>", "ID": "51fc4482-121c-461c-be66-805d24505aec", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "b2725023-70cb-4189-bce6-27aa881f3538"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Constipation</span>", "ID": "cd7cee24-f9eb-44f9-8aab-b52574826782", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Constipation", "ParentId": "51fc4482-121c-461c-be66-805d24505aec"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal pain<sup>25)</sup></span></p>", "ID": "235973c3-bdee-41f1-8951-2a269799ec98", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "b2725023-70cb-4189-bce6-27aa881f3538"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal pain<sup>25)</sup></span>", "ID": "3c8b3b6d-a8be-4629-b121-dae79811d8b5", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Abdominal pain", "ParentId": "235973c3-bdee-41f1-8951-2a269799ec98"}, {"Element": "<sup>25)</sup>", "ID": "a6b3298c-c0f6-46b5-9af6-70feb974beef", "Styles": "None", "Classes": "None", "Text": "25)", "ParentId": "3c8b3b6d-a8be-4629-b121-dae79811d8b5"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Stomatitis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal distension</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dry mouth</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ascites</span></p>\n</td>", "ID": "73ba0e20-a3c5-4086-bb71-6f667fc29b23", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "2dc5e7c1-a9b6-4203-8a31-37543eb553ca"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Stomatitis</span></p>", "ID": "114329ce-02d1-4a69-ba9d-4810bbfac984", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "73ba0e20-a3c5-4086-bb71-6f667fc29b23"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Stomatitis</span>", "ID": "aa89f4ac-de7c-4480-b100-c5022bd6b70a", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Stomatitis", "ParentId": "114329ce-02d1-4a69-ba9d-4810bbfac984"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal distension</span></p>", "ID": "02bf5c68-44d7-4843-bbde-f80f5a2da28a", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "73ba0e20-a3c5-4086-bb71-6f667fc29b23"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Abdominal distension</span>", "ID": "30074d0d-d47d-46bb-b43b-a5a558e6f24d", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Abdominal distension", "ParentId": "02bf5c68-44d7-4843-bbde-f80f5a2da28a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dry mouth</span></p>", "ID": "5e1259a0-c01c-4b97-b5d3-3bd3edb4b356", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "73ba0e20-a3c5-4086-bb71-6f667fc29b23"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Dry mouth</span>", "ID": "b2165c7e-3574-48fc-ba57-bc437d3ede65", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Dry mouth", "ParentId": "5e1259a0-c01c-4b97-b5d3-3bd3edb4b356"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ascites</span></p>", "ID": "14dfa780-efa7-4b72-b00c-f2a61cbe8b85", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "73ba0e20-a3c5-4086-bb71-6f667fc29b23"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Ascites</span>", "ID": "aaf404b8-d706-4a03-9fe0-6dc0427aa6c2", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Ascites", "ParentId": "14dfa780-efa7-4b72-b00c-f2a61cbe8b85"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "917dd63e-d125-451f-8c5f-ece4e8cfdc80", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2dc5e7c1-a9b6-4203-8a31-37543eb553ca"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "eacecce2-2619-45a8-9537-62398bed3ccd", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "917dd63e-d125-451f-8c5f-ece4e8cfdc80"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "00be516b-2336-43b7-9ba2-40793a553534", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "eacecce2-2619-45a8-9537-62398bed3ccd"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif'>Hepatobiliary\n  disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperbilirubinaemia</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "88d1d7f5-5f20-409a-81c8-4d33a2168f5f", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif'>Hepatobiliary\n  disorders</span></p>\n</td>", "ID": "cf3c6851-5e20-4802-a931-f65262248332", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "88d1d7f5-5f20-409a-81c8-4d33a2168f5f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif'>Hepatobiliary\n  disorders</span></p>", "ID": "3820e165-90d0-4d61-b77c-48310803c986", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "cf3c6851-5e20-4802-a931-f65262248332"}, {"Element": "<span style='font-family:\"Times New Roman\",serif'>Hepatobiliary\n  disorders</span>", "ID": "3cc0005d-fa9f-4080-a25e-57203fde031e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatobiliary   disorders", "ParentId": "3820e165-90d0-4d61-b77c-48310803c986"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "1bd2f027-fc8f-406c-8ac6-64216e26c6b0", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "88d1d7f5-5f20-409a-81c8-4d33a2168f5f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "7b3a029f-82d0-469e-a2ba-174ac055bbea", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "1bd2f027-fc8f-406c-8ac6-64216e26c6b0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "268dfeb8-e224-45e3-90d4-a5090018bbd9", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "7b3a029f-82d0-469e-a2ba-174ac055bbea"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperbilirubinaemia</span></p>\n</td>", "ID": "7d916111-c0e9-4b05-9056-f8eeb7db0fbb", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "88d1d7f5-5f20-409a-81c8-4d33a2168f5f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperbilirubinaemia</span></p>", "ID": "ed7576cb-dfda-4da1-8a7b-9708151556fd", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "7d916111-c0e9-4b05-9056-f8eeb7db0fbb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperbilirubinaemia</span>", "ID": "7e3a2319-6230-4911-9002-8727c65b7443", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hyperbilirubinaemia", "ParentId": "ed7576cb-dfda-4da1-8a7b-9708151556fd"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "ba660d3d-b05d-4c51-961b-d3e60b9a95a1", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "88d1d7f5-5f20-409a-81c8-4d33a2168f5f"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "f3f27b67-5b9f-4e90-8bc0-d2b8157b8a29", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "ba660d3d-b05d-4c51-961b-d3e60b9a95a1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "666b951d-b799-47a1-875b-5493ea05ddad", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "f3f27b67-5b9f-4e90-8bc0-d2b8157b8a29"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin\n  and subcutaneous tissue disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Rash<sup>26)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pruritus</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Erythema</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperhidrosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Night sweats</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "fa4c58e6-a908-4fa6-8b74-2d349ef3cff2", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin\n  and subcutaneous tissue disorders</span></p>\n</td>", "ID": "e3a649ab-a540-4f4a-a1f2-8e35b3937a8b", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fa4c58e6-a908-4fa6-8b74-2d349ef3cff2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin\n  and subcutaneous tissue disorders</span></p>", "ID": "3f237771-5bfa-4b21-82e2-846227a03f9e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e3a649ab-a540-4f4a-a1f2-8e35b3937a8b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Skin\n  and subcutaneous tissue disorders</span>", "ID": "567c1a16-d750-4f4c-8354-9b29f010ea6b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Skin   and subcutaneous tissue disorders", "ParentId": "3f237771-5bfa-4b21-82e2-846227a03f9e"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Rash<sup>26)</sup></span></p>\n</td>", "ID": "03cfe6d4-15fc-4b04-9adb-6e4b638a22e9", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fa4c58e6-a908-4fa6-8b74-2d349ef3cff2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Rash<sup>26)</sup></span></p>", "ID": "00c3cab8-fa54-4a7b-9fb2-30357f7368e7", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "03cfe6d4-15fc-4b04-9adb-6e4b638a22e9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Rash<sup>26)</sup></span>", "ID": "b9d322c8-cf83-4b4a-b258-e6b89eb6c99f", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Rash", "ParentId": "00c3cab8-fa54-4a7b-9fb2-30357f7368e7"}, {"Element": "<sup>26)</sup>", "ID": "6bff5a85-26ad-4989-946e-3f52cd2ac320", "Styles": "None", "Classes": "None", "Text": "26)", "ParentId": "b9d322c8-cf83-4b4a-b258-e6b89eb6c99f"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pruritus</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Erythema</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperhidrosis</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Night sweats</span></p>\n</td>", "ID": "fb1bb58d-a6b1-42db-b122-580c2135cad9", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "fa4c58e6-a908-4fa6-8b74-2d349ef3cff2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pruritus</span></p>", "ID": "6a94c863-feff-4eda-8c80-ec2bb8ef610a", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "fb1bb58d-a6b1-42db-b122-580c2135cad9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pruritus</span>", "ID": "3c1755a7-af10-41f8-9501-aecd8149216d", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Pruritus", "ParentId": "6a94c863-feff-4eda-8c80-ec2bb8ef610a"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Erythema</span></p>", "ID": "0f86af82-998a-49d0-a589-4b6cdd38fb50", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "fb1bb58d-a6b1-42db-b122-580c2135cad9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Erythema</span>", "ID": "a7e20f50-6130-40ec-a319-25443c2dd68d", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Erythema", "ParentId": "0f86af82-998a-49d0-a589-4b6cdd38fb50"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperhidrosis</span></p>", "ID": "2b796ca1-8710-4230-b409-306b45ec2cc1", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "fb1bb58d-a6b1-42db-b122-580c2135cad9"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Hyperhidrosis</span>", "ID": "204ca379-39da-4648-99f5-be3ec1dd33be", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Hyperhidrosis", "ParentId": "2b796ca1-8710-4230-b409-306b45ec2cc1"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Night sweats</span></p>", "ID": "3bfa0d9b-8098-4fa2-acf7-d64b22763cdc", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "fb1bb58d-a6b1-42db-b122-580c2135cad9"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Night sweats</span>", "ID": "b70b1a6c-26ac-405b-b56a-9385214295c0", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Night sweats", "ParentId": "3bfa0d9b-8098-4fa2-acf7-d64b22763cdc"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "e1988505-4617-48a8-b5eb-4061dd7d4142", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fa4c58e6-a908-4fa6-8b74-2d349ef3cff2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "c54f64d0-d87a-4363-a986-0d76aa5f0857", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "e1988505-4617-48a8-b5eb-4061dd7d4142"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "80e47c1a-18d0-4115-b28c-29c99cec90c8", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "c54f64d0-d87a-4363-a986-0d76aa5f0857"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal\n  and connective tissue disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arthralgia</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Back pain</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Myalgia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Musculoskeletal pain</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "42f661b8-ee99-4621-9a39-0d970ba5de47", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal\n  and connective tissue disorders</span></p>\n</td>", "ID": "2b9b6245-d63e-4fa1-8d62-5c4e6bce3b14", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "42f661b8-ee99-4621-9a39-0d970ba5de47"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal\n  and connective tissue disorders</span></p>", "ID": "2282c800-06cb-4aad-a4f3-c0580b665a0b", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "2b9b6245-d63e-4fa1-8d62-5c4e6bce3b14"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Musculoskeletal\n  and connective tissue disorders</span>", "ID": "d7617b35-b2f2-486f-94d8-a3d6eb1bfd79", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Musculoskeletal   and connective tissue disorders", "ParentId": "2282c800-06cb-4aad-a4f3-c0580b665a0b"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arthralgia</span></p>\n</td>", "ID": "35969d6c-05c1-43cc-ad66-4006df62b7c7", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "42f661b8-ee99-4621-9a39-0d970ba5de47"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arthralgia</span></p>", "ID": "1dcc0fd8-76d7-485d-a555-5458ce4f5034", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "35969d6c-05c1-43cc-ad66-4006df62b7c7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Arthralgia</span>", "ID": "07c9240a-b4a4-4fc6-ae65-7df2b830e923", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Arthralgia", "ParentId": "1dcc0fd8-76d7-485d-a555-5458ce4f5034"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Back pain</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Myalgia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Musculoskeletal pain</span></p>\n</td>", "ID": "4121566b-1438-45f6-94aa-7373d8d46a6c", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "42f661b8-ee99-4621-9a39-0d970ba5de47"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Back pain</span></p>", "ID": "bfe9dc08-6212-4d34-9946-a3b8c650ce67", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "4121566b-1438-45f6-94aa-7373d8d46a6c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Back pain</span>", "ID": "72fcdf74-4d5f-4acb-93ab-b980d005dda1", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Back pain", "ParentId": "bfe9dc08-6212-4d34-9946-a3b8c650ce67"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Myalgia</span></p>", "ID": "f5c0f35e-aaef-41f0-9850-c80bb6cd1c7b", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "4121566b-1438-45f6-94aa-7373d8d46a6c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Myalgia</span>", "ID": "afad8eaf-f85b-41e7-9b2e-1088783fa7d3", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Myalgia", "ParentId": "f5c0f35e-aaef-41f0-9850-c80bb6cd1c7b"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Musculoskeletal pain</span></p>", "ID": "e42507f6-8753-4ebb-b7ab-7cfdac015363", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "4121566b-1438-45f6-94aa-7373d8d46a6c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Musculoskeletal pain</span>", "ID": "3a2a591e-0186-401f-a4c1-18043570e2c0", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Musculoskeletal pain", "ParentId": "e42507f6-8753-4ebb-b7ab-7cfdac015363"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "edb8bb95-761f-488f-85f4-dba6c5f81530", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "42f661b8-ee99-4621-9a39-0d970ba5de47"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "15e0fbb7-0efb-4205-9144-61a48cf1aebd", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "edb8bb95-761f-488f-85f4-dba6c5f81530"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "baf33b4b-d4bc-4710-a17c-16e5cad43d14", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "15e0fbb7-0efb-4205-9144-61a48cf1aebd"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal\n  and urinary disorders</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute kidney injury<sup>27)</sup></span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "8f386430-ce6f-4699-a722-03247c148f56", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal\n  and urinary disorders</span></p>\n</td>", "ID": "537080ff-c762-41b9-a2e2-50f87f1714b0", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f386430-ce6f-4699-a722-03247c148f56"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal\n  and urinary disorders</span></p>", "ID": "9feaba1a-a41a-4666-b583-0116cdf7741f", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "537080ff-c762-41b9-a2e2-50f87f1714b0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Renal\n  and urinary disorders</span>", "ID": "392969ee-9dad-43de-8e58-5d220c4a4206", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Renal   and urinary disorders", "ParentId": "9feaba1a-a41a-4666-b583-0116cdf7741f"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute kidney injury<sup>27)</sup></span></p>\n</td>", "ID": "051e4b8b-fbd9-4e89-a5f9-2eda2ee0d4d4", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f386430-ce6f-4699-a722-03247c148f56"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute kidney injury<sup>27)</sup></span></p>", "ID": "7f94e89e-b438-4837-a948-e473f1089331", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "051e4b8b-fbd9-4e89-a5f9-2eda2ee0d4d4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Acute kidney injury<sup>27)</sup></span>", "ID": "237e677c-f37f-498b-8fab-2f008fa7f382", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Acute kidney injury", "ParentId": "7f94e89e-b438-4837-a948-e473f1089331"}, {"Element": "<sup>27)</sup>", "ID": "bff64059-30a6-47fb-8746-90bcaa970dfe", "Styles": "None", "Classes": "None", "Text": "27)", "ParentId": "237e677c-f37f-498b-8fab-2f008fa7f382"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "aac701a6-271c-4d17-acf5-33773a121072", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f386430-ce6f-4699-a722-03247c148f56"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "2813e1f0-6d61-4e72-b1c0-9dad23a42e06", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "aac701a6-271c-4d17-acf5-33773a121072"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "328f0c6a-63d9-4b28-a25f-379d66e8944e", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "2813e1f0-6d61-4e72-b1c0-9dad23a42e06"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "9d213bcc-af25-47c9-91d6-c914882a68c1", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8f386430-ce6f-4699-a722-03247c148f56"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "d8feb335-1f79-48df-a210-68bebb3b4a8e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "9d213bcc-af25-47c9-91d6-c914882a68c1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "8cee0037-6db8-4f44-929e-59c3f062eeef", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "d8feb335-1f79-48df-a210-68bebb3b4a8e"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General\n  disorders and administration site conditions</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pyrexia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fatigue<sup>28)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oedema<sup>29)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pain<sup>30)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Chills</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Influenza\u2011like illness</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Asthenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Multiple organ dysfunction syndrome</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "bd79d8cd-89c5-4586-9321-2b88e5e30fa7", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General\n  disorders and administration site conditions</span></p>\n</td>", "ID": "cce6ad0e-b671-4bd8-9a83-d955b8d37500", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bd79d8cd-89c5-4586-9321-2b88e5e30fa7"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General\n  disorders and administration site conditions</span></p>", "ID": "38fd022a-ceaf-4d32-b9ac-6f4399491abc", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "cce6ad0e-b671-4bd8-9a83-d955b8d37500"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>General\n  disorders and administration site conditions</span>", "ID": "8ba68c90-9411-4532-9638-cfa8f46a00e4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "General   disorders and administration site conditions", "ParentId": "38fd022a-ceaf-4d32-b9ac-6f4399491abc"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pyrexia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fatigue<sup>28)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oedema<sup>29)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pain<sup>30)</sup></span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Chills</span></p>\n</td>", "ID": "8f90fd74-5bcf-49af-b695-ea357ff19a24", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "bd79d8cd-89c5-4586-9321-2b88e5e30fa7"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pyrexia</span></p>", "ID": "3f8d87cb-d881-440b-a95e-001b5ba41a1c", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "8f90fd74-5bcf-49af-b695-ea357ff19a24"}, {"Element": "<span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pyrexia</span>", "ID": "67de6720-f886-4ba1-8d4f-90424a165b47", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Pyrexia", "ParentId": "3f8d87cb-d881-440b-a95e-001b5ba41a1c"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fatigue<sup>28)</sup></span></p>", "ID": "524bfe67-1f7f-4870-912c-2b289859ecf5", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "8f90fd74-5bcf-49af-b695-ea357ff19a24"}, {"Element": "<span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fatigue<sup>28)</sup></span>", "ID": "beb91e36-ec71-455a-bb7c-84d99bf9f386", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Fatigue", "ParentId": "524bfe67-1f7f-4870-912c-2b289859ecf5"}, {"Element": "<sup>28)</sup>", "ID": "22a8fa2a-ce09-445f-ad12-00d2e2e63b65", "Styles": "None", "Classes": "None", "Text": "28)", "ParentId": "beb91e36-ec71-455a-bb7c-84d99bf9f386"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oedema<sup>29)</sup></span></p>", "ID": "66f3aba2-7d88-496a-84b0-77ab1f9b6331", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "8f90fd74-5bcf-49af-b695-ea357ff19a24"}, {"Element": "<span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Oedema<sup>29)</sup></span>", "ID": "c9a89ff6-6dfd-4106-b129-51a911ec04e4", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Oedema", "ParentId": "66f3aba2-7d88-496a-84b0-77ab1f9b6331"}, {"Element": "<sup>29)</sup>", "ID": "a02178cd-4262-42cd-9d5a-3ed908193f12", "Styles": "None", "Classes": "None", "Text": "29)", "ParentId": "c9a89ff6-6dfd-4106-b129-51a911ec04e4"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pain<sup>30)</sup></span></p>", "ID": "778c6cf5-84bd-4802-a635-dd37d9c51c4e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "8f90fd74-5bcf-49af-b695-ea357ff19a24"}, {"Element": "<span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Pain<sup>30)</sup></span>", "ID": "cc3c3c10-254f-4189-841c-f683358c91c8", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Pain", "ParentId": "778c6cf5-84bd-4802-a635-dd37d9c51c4e"}, {"Element": "<sup>30)</sup>", "ID": "bd722d63-7836-46a5-b0af-29aadd4533bb", "Styles": "None", "Classes": "None", "Text": "30)", "ParentId": "cc3c3c10-254f-4189-841c-f683358c91c8"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Chills</span></p>", "ID": "bb1f9ac0-510a-4b46-87f0-22e6b8f49ce1", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "8f90fd74-5bcf-49af-b695-ea357ff19a24"}, {"Element": "<span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Chills</span>", "ID": "6575c651-286f-43d8-808a-21f5d418c8ca", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Chills", "ParentId": "bb1f9ac0-510a-4b46-87f0-22e6b8f49ce1"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Influenza\u2011like illness</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Asthenia</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Multiple organ dysfunction syndrome</span></p>\n</td>", "ID": "47c2aa2c-a7f1-4262-b140-04715d96b486", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "bd79d8cd-89c5-4586-9321-2b88e5e30fa7"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Influenza\u2011like illness</span></p>", "ID": "86d44036-d07f-4ce1-8b09-5b1e37e80edc", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "47c2aa2c-a7f1-4262-b140-04715d96b486"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Influenza\u2011like illness</span>", "ID": "08cc4857-5956-42fa-9855-5faeef197308", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Influenza\u2011like illness", "ParentId": "86d44036-d07f-4ce1-8b09-5b1e37e80edc"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Asthenia</span></p>", "ID": "77a72984-3162-4079-96ff-cf7ac3f2e9e4", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "47c2aa2c-a7f1-4262-b140-04715d96b486"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Asthenia</span>", "ID": "f775632a-736f-4827-a170-bb476c0a0cda", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Asthenia", "ParentId": "77a72984-3162-4079-96ff-cf7ac3f2e9e4"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Multiple organ dysfunction syndrome</span></p>", "ID": "ecb88593-c562-4e82-af85-2155d4713a37", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "47c2aa2c-a7f1-4262-b140-04715d96b486"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Multiple organ dysfunction syndrome</span>", "ID": "c85cbdbf-be5d-4ae5-8b86-4181a2a546de", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Multiple organ dysfunction syndrome", "ParentId": "ecb88593-c562-4e82-af85-2155d4713a37"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "a888ebdf-ad45-4e24-8379-01f900b495a3", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bd79d8cd-89c5-4586-9321-2b88e5e30fa7"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "16c14122-cee2-4155-974a-c986ffae978d", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "a888ebdf-ad45-4e24-8379-01f900b495a3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "e0d94561-0437-458d-9a58-48a0ab6cfdd5", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "16c14122-cee2-4155-974a-c986ffae978d"}, {"Element": "<tr>\n<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>\n<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphocyte count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>White blood cell count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemoglobin decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutrophil count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Platelet count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Aspartate aminotransferase increased</span></p>\n</td>\n<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Alanine aminotransferase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood bilirubin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Weight decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Serum ferritin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood fibrinogen decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>International normalised ratio increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fibrin D dimer increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Activated partial thromboplastin time prolonged</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood alkaline phosphatase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Prothrombin time prolonged</span></p>\n</td>\n<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "d6f8910c-42ec-4650-9b21-9c9ee3b1f902", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td style=\"width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>\n</td>", "ID": "c4c845ca-2338-4b94-88b6-c644ce03d3c2", "Styles": "width:17.86%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d6f8910c-42ec-4650-9b21-9c9ee3b1f902"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span></p>", "ID": "d2aa587e-ce1d-4294-afd3-e4c1380a6961", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "c4c845ca-2338-4b94-88b6-c644ce03d3c2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Investigations</span>", "ID": "4a44c423-baf3-4cb2-9e6b-b6d8c6ca9459", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Investigations", "ParentId": "d2aa587e-ce1d-4294-afd3-e4c1380a6961"}, {"Element": "<td style=\"width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"29%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphocyte count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>White blood cell count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemoglobin decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutrophil count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Platelet count decreased*</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Aspartate aminotransferase increased</span></p>\n</td>", "ID": "f7d32f93-d625-4b48-b112-d31e4bc036d2", "Styles": "width:29.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "       ", "ParentId": "d6f8910c-42ec-4650-9b21-9c9ee3b1f902"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphocyte count decreased*</span></p>", "ID": "b5f572a3-ab8b-4616-8396-168764f260ef", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "f7d32f93-d625-4b48-b112-d31e4bc036d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Lymphocyte count decreased*</span>", "ID": "0fba0145-422b-4fb4-b09c-f7685510f292", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Lymphocyte count decreased*", "ParentId": "b5f572a3-ab8b-4616-8396-168764f260ef"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>White blood cell count decreased*</span></p>", "ID": "98c04052-a7a1-4462-b9b4-e89bdd2ae7af", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "f7d32f93-d625-4b48-b112-d31e4bc036d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>White blood cell count decreased*</span>", "ID": "08983f6c-e7eb-4df7-8ce7-cd4d999e0d98", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "White blood cell count decreased*", "ParentId": "98c04052-a7a1-4462-b9b4-e89bdd2ae7af"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemoglobin decreased*</span></p>", "ID": "4699429c-dac5-495a-b8ee-d5b5f6bf9a4b", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "f7d32f93-d625-4b48-b112-d31e4bc036d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Haemoglobin decreased*</span>", "ID": "e9b13bca-7fb4-4f72-b18a-108677e61d0a", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Haemoglobin decreased*", "ParentId": "4699429c-dac5-495a-b8ee-d5b5f6bf9a4b"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutrophil count decreased*</span></p>", "ID": "987b7f1a-25b2-403d-b766-880fa366578e", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "f7d32f93-d625-4b48-b112-d31e4bc036d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Neutrophil count decreased*</span>", "ID": "f6ce2e99-590f-4495-a73d-293ab7166726", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Neutrophil count decreased*", "ParentId": "987b7f1a-25b2-403d-b766-880fa366578e"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Platelet count decreased*</span></p>", "ID": "a8743d01-a064-41c0-9e5b-5c5c487ab9b1", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "f7d32f93-d625-4b48-b112-d31e4bc036d2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Platelet count decreased*</span>", "ID": "8a84f8ab-7ab1-4b67-82bf-8e994e77f2a5", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Platelet count decreased*", "ParentId": "a8743d01-a064-41c0-9e5b-5c5c487ab9b1"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Aspartate aminotransferase increased</span></p>", "ID": "5f6e98ae-fd24-41ff-bf62-8c0ccc489b5d", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "f7d32f93-d625-4b48-b112-d31e4bc036d2"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Aspartate aminotransferase increased</span>", "ID": "4a6ab8e4-5e6d-4788-9e18-63f9e376c1a1", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Aspartate aminotransferase increased", "ParentId": "5f6e98ae-fd24-41ff-bf62-8c0ccc489b5d"}, {"Element": "<td style=\"width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"28%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Alanine aminotransferase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood bilirubin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Weight decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Serum ferritin increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood fibrinogen decreased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>International normalised ratio increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fibrin D dimer increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Activated partial thromboplastin time prolonged</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood alkaline phosphatase increased</span></p>\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Prothrombin time prolonged</span></p>\n</td>", "ID": "76cc0a58-2933-49f9-b864-6b48d5aa669d", "Styles": "width:28.32%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "           ", "ParentId": "d6f8910c-42ec-4650-9b21-9c9ee3b1f902"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Alanine aminotransferase increased</span></p>", "ID": "cbeb8b46-55f9-424e-8cea-cda5f693a947", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Alanine aminotransferase increased</span>", "ID": "2382de33-2987-48e5-804b-60aa745394a5", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Alanine aminotransferase increased", "ParentId": "cbeb8b46-55f9-424e-8cea-cda5f693a947"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood bilirubin increased</span></p>", "ID": "528851b8-c478-4601-83ee-c7e9acc59335", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood bilirubin increased</span>", "ID": "fba6b710-8177-41ce-8a79-43353bdd8db4", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Blood bilirubin increased", "ParentId": "528851b8-c478-4601-83ee-c7e9acc59335"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Weight decreased</span></p>", "ID": "664d48a2-298b-46a3-828f-caaf7fa25ad2", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Weight decreased</span>", "ID": "14355203-1b8e-4a9d-bdf5-3d280043dd16", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Weight decreased", "ParentId": "664d48a2-298b-46a3-828f-caaf7fa25ad2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Serum ferritin increased</span></p>", "ID": "3929c2c3-3dce-49ac-8e2a-b35d5388ccc5", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Serum ferritin increased</span>", "ID": "6e6d51c0-2f29-4f6d-8ad4-219215c96284", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Serum ferritin increased", "ParentId": "3929c2c3-3dce-49ac-8e2a-b35d5388ccc5"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood fibrinogen decreased</span></p>", "ID": "d373c5e8-1d4d-4497-9e6e-8cb45c5ef8b7", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood fibrinogen decreased</span>", "ID": "383e98db-3eb4-4fef-ba56-fcef9de3fdfb", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Blood fibrinogen decreased", "ParentId": "d373c5e8-1d4d-4497-9e6e-8cb45c5ef8b7"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>International normalised ratio increased</span></p>", "ID": "eb740ab5-ad10-44d9-870b-c4e5b3feb517", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>International normalised ratio increased</span>", "ID": "a0af8a7e-d7c6-476e-ad0a-741efa1d3170", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "International normalised ratio increased", "ParentId": "eb740ab5-ad10-44d9-870b-c4e5b3feb517"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fibrin D dimer increased</span></p>", "ID": "69e4685f-a513-48ab-9a2c-ccdefdbd9cc8", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Fibrin D dimer increased</span>", "ID": "3098a0ef-5732-4dcb-84e6-b76431c384af", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Fibrin D dimer increased", "ParentId": "69e4685f-a513-48ab-9a2c-ccdefdbd9cc8"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Activated partial thromboplastin time prolonged</span></p>", "ID": "4337a287-d08f-4dc0-8ed4-0434df486ad2", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Activated partial thromboplastin time prolonged</span>", "ID": "42b404a0-2296-4e68-abfa-566ef02fb8fb", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Activated partial thromboplastin time prolonged", "ParentId": "4337a287-d08f-4dc0-8ed4-0434df486ad2"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood alkaline phosphatase increased</span></p>", "ID": "de46c4b7-dcb5-46ac-8aa1-a630f4b78750", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;\n  color:black'>Blood alkaline phosphatase increased</span>", "ID": "d55b65f2-50bc-4e63-bbfe-5e1847ce1c20", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Blood alkaline phosphatase increased", "ParentId": "de46c4b7-dcb5-46ac-8aa1-a630f4b78750"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Prothrombin time prolonged</span></p>", "ID": "d91ac512-0bbb-4f88-a68c-774e9b19cc39", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "76cc0a58-2933-49f9-b864-6b48d5aa669d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>Prothrombin time prolonged</span>", "ID": "a90a518f-b3cd-4cd6-bc6b-24987f45a363", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "Prothrombin time prolonged", "ParentId": "d91ac512-0bbb-4f88-a68c-774e9b19cc39"}, {"Element": "<td style=\"width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"24%\">\n<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>\n</td>", "ID": "7dfae8bc-afea-4494-9886-705867c424f3", "Styles": "width:24.08%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d6f8910c-42ec-4650-9b21-9c9ee3b1f902"}, {"Element": "<p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span></p>", "ID": "1bfee8cd-3971-4e7a-95c5-55a49ab71ea0", "Styles": "margin:0in", "Classes": "['Table']", "Text": "", "ParentId": "7dfae8bc-afea-4494-9886-705867c424f3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;\n  color:black'>\u00a0</span>", "ID": "7786eb47-759a-4d5a-bc2b-5a7095ff5e8f", "Styles": "font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "1bfee8cd-3971-4e7a-95c5-55a49ab71ea0"}, {"Element": "<tr style=\"height:16.55pt\">\n<td colspan=\"4\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.55pt\" valign=\"top\" width=\"100%\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and\n  infestations presented reflect high\u2011level group terms.</span></p>\n<p class=\"Legend\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Haemorrhage\n  includes anal haemorrhage, blood urine present, catheter site haemorrhage,\n  cerebral haemorrhage, conjunctival haemorrhage, contusion, cystitis\n  haemorrhagic, duodenal ulcer haemorrhage, disseminated intravascular\n  coagulation, epistaxis, eye contusion, gastrointestinal haemorrhage, gingival\n  bleeding, haematochezia, haemarthrosis, haematemesis, haematuria,\n  haemoptysis, large intestinal haemorrhage, melaena, menorrhagia, mouth\n  haemorrhage, peritoneal haematoma, petechiae, pharyngeal haemorrhage, post\u2011procedural\n  haemorrhage, pulmonary haemorrhage, purpura, retinal haemorrhage, traumatic\n  haematoma, tumour haemorrhage, upper gastrointestinal haemorrhage and vaginal\n  haemorrhage.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypogammaglobulinaemia\n  includes immunoglobulins decreased, blood immunoglobulin A decreased, blood\n  immunoglobulin G decreased, blood immunoglobulin M decreased,\n  immunodeficiency, immunodeficiency common variable and\n  hypogammaglobulinaemia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Delirium includes\n  agitation, delirium, hallucination, hallucination visual, irritability and\n  restlessness.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sleep disorder includes\n  sleep disorder, insomnia and nightmare.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Headache includes\n  headache and migraine.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Encephalopathy includes\n  depressed level of consciousness, mental status changes, automatism,\n  cognitive disorder, confusional state, disturbance in attention,\n  encephalopathy, somnolence, lethargy, memory impairment, metabolic\n  encephalopathy and thinking abnormal.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dizziness includes\n  dizziness, presyncope and syncope.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Peripheral neuropathy\n  includes paraesthesia, peripheral sensory neuropathy, neuropathy peripheral,\n  hyperaesthesia and hypoaesthesia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tremor includes\n  dyskinesia and tremor.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Motor dysfunction\n  includes muscle spasms, muscle twitching, myoclonus and myopathy.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Seizure includes seizure,\n  generalised tonic\u2011clonic seizures and status epilepticus.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Speech disorders includes\n  speech disorders, dysarthria and aphasia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neuralgia includes\n  neuralgia and sciatica.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ataxia includes ataxia\n  and dysmetria.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Visual impairment\n  includes vision blurred and visual impairment.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;color:black'>Arrhythmia\n  includes atrial fibrillation, supraventricular tachycardia, </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tachycardia and\n  ventricular extrasystoles.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac failure includes\n  cardiac failure, left ventricular dysfunction, cardiac failure congestive and\n  right ventricular dysfunction.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>19)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypotension includes\n  hypotension and orthostatic hypotension.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>20)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombosis includes deep\n  vein thrombosis, embolism, pulmonary embolism, thrombosis, vena cava\n  thrombosis and venous thrombosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cough includes cough,\n  productive cough and upper\u2011airway cough syndrome.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Dyspnoea\n  includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory\n  failure.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>23)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oropharyngeal pain\n  includes oral pain and oropharyngeal pain.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>24)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pulmonary oedema includes\n  acute pulmonary oedema and pulmonary oedema</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>25)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Abdominal pain includes\n  abdominal pain, abdominal pain upper and abdominal discomfort.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>26)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Rash includes dermatitis,\n  dermatitis acneiform, dermatitis contact,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash maculo\u2011papular,\n  rash papular and rash pruritic.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>27)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute kidney injury\n  includes acute kidney injury, anuria, azotaemia, blood creatinine abnormal,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood creatinine\n  increased, renal failure, renal tubular dysfunction and renal tubular\n  necrosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>28)</span></sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fatigue includes fatigue\n  and malaise.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>29)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Oedema\n  includes oedema peripheral, generalised oedema, localised oedema, face oedema\n  and peripheral swelling.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>30)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pain includes pain and\n  pain in extremity.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\">*\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style='font-family:\n  \"Times New Roman\",serif'>Frequency is based on laboratory values. Patients\n  are counted only for the worst grade observed post baseline.</span></p>\n</td>\n</tr>", "ID": "cfd042ed-b794-4c0f-b15d-a5b7fe51c003", "Styles": "height:16.55pt", "Classes": "None", "Text": "  ", "ParentId": "e367b44b-0512-45e9-97d6-1ffaeedafa0e"}, {"Element": "<td colspan=\"4\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.55pt\" valign=\"top\" width=\"100%\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and\n  infestations presented reflect high\u2011level group terms.</span></p>\n<p class=\"Legend\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Haemorrhage\n  includes anal haemorrhage, blood urine present, catheter site haemorrhage,\n  cerebral haemorrhage, conjunctival haemorrhage, contusion, cystitis\n  haemorrhagic, duodenal ulcer haemorrhage, disseminated intravascular\n  coagulation, epistaxis, eye contusion, gastrointestinal haemorrhage, gingival\n  bleeding, haematochezia, haemarthrosis, haematemesis, haematuria,\n  haemoptysis, large intestinal haemorrhage, melaena, menorrhagia, mouth\n  haemorrhage, peritoneal haematoma, petechiae, pharyngeal haemorrhage, post\u2011procedural\n  haemorrhage, pulmonary haemorrhage, purpura, retinal haemorrhage, traumatic\n  haematoma, tumour haemorrhage, upper gastrointestinal haemorrhage and vaginal\n  haemorrhage.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypogammaglobulinaemia\n  includes immunoglobulins decreased, blood immunoglobulin A decreased, blood\n  immunoglobulin G decreased, blood immunoglobulin M decreased,\n  immunodeficiency, immunodeficiency common variable and\n  hypogammaglobulinaemia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Delirium includes\n  agitation, delirium, hallucination, hallucination visual, irritability and\n  restlessness.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sleep disorder includes\n  sleep disorder, insomnia and nightmare.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Headache includes\n  headache and migraine.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Encephalopathy includes\n  depressed level of consciousness, mental status changes, automatism,\n  cognitive disorder, confusional state, disturbance in attention,\n  encephalopathy, somnolence, lethargy, memory impairment, metabolic\n  encephalopathy and thinking abnormal.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dizziness includes\n  dizziness, presyncope and syncope.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Peripheral neuropathy\n  includes paraesthesia, peripheral sensory neuropathy, neuropathy peripheral,\n  hyperaesthesia and hypoaesthesia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tremor includes\n  dyskinesia and tremor.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Motor dysfunction\n  includes muscle spasms, muscle twitching, myoclonus and myopathy.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Seizure includes seizure,\n  generalised tonic\u2011clonic seizures and status epilepticus.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Speech disorders includes\n  speech disorders, dysarthria and aphasia.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neuralgia includes\n  neuralgia and sciatica.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ataxia includes ataxia\n  and dysmetria.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Visual impairment\n  includes vision blurred and visual impairment.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;color:black'>Arrhythmia\n  includes atrial fibrillation, supraventricular tachycardia, </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tachycardia and\n  ventricular extrasystoles.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac failure includes\n  cardiac failure, left ventricular dysfunction, cardiac failure congestive and\n  right ventricular dysfunction.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>19)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypotension includes\n  hypotension and orthostatic hypotension.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>20)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombosis includes deep\n  vein thrombosis, embolism, pulmonary embolism, thrombosis, vena cava\n  thrombosis and venous thrombosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cough includes cough,\n  productive cough and upper\u2011airway cough syndrome.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Dyspnoea\n  includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory\n  failure.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>23)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oropharyngeal pain\n  includes oral pain and oropharyngeal pain.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>24)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pulmonary oedema includes\n  acute pulmonary oedema and pulmonary oedema</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>25)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Abdominal pain includes\n  abdominal pain, abdominal pain upper and abdominal discomfort.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>26)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Rash includes dermatitis,\n  dermatitis acneiform, dermatitis contact,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash maculo\u2011papular,\n  rash papular and rash pruritic.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>27)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute kidney injury\n  includes acute kidney injury, anuria, azotaemia, blood creatinine abnormal,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood creatinine\n  increased, renal failure, renal tubular dysfunction and renal tubular\n  necrosis.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>28)</span></sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fatigue includes fatigue\n  and malaise.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>29)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Oedema\n  includes oedema peripheral, generalised oedema, localised oedema, face oedema\n  and peripheral swelling.</span></span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>30)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pain includes pain and\n  pain in extremity.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\">*\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style='font-family:\n  \"Times New Roman\",serif'>Frequency is based on laboratory values. Patients\n  are counted only for the worst grade observed post baseline.</span></p>\n</td>", "ID": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:16.55pt", "Classes": "None", "Text": "                                ", "ParentId": "cfd042ed-b794-4c0f-b15d-a5b7fe51c003"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and\n  infestations presented reflect high\u2011level group terms.</span></p>", "ID": "25af7585-2d12-45b1-88fb-23654f9472ad", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1)</span></sup>", "ID": "c362ffbd-4e52-4c6c-9e3f-445ee9532c34", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "25af7585-2d12-45b1-88fb-23654f9472ad"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>1)</span>", "ID": "ce7b62f8-5137-44cd-8b72-096600c1b5f8", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1)", "ParentId": "c362ffbd-4e52-4c6c-9e3f-445ee9532c34"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and\n  infestations presented reflect high\u2011level group terms.</span>", "ID": "e9ef1217-dd2f-4c78-a481-78410e5d1e8d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and   infestations presented reflect high\u2011level group terms.", "ParentId": "25af7585-2d12-45b1-88fb-23654f9472ad"}, {"Element": "<p class=\"Legend\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Haemorrhage\n  includes anal haemorrhage, blood urine present, catheter site haemorrhage,\n  cerebral haemorrhage, conjunctival haemorrhage, contusion, cystitis\n  haemorrhagic, duodenal ulcer haemorrhage, disseminated intravascular\n  coagulation, epistaxis, eye contusion, gastrointestinal haemorrhage, gingival\n  bleeding, haematochezia, haemarthrosis, haematemesis, haematuria,\n  haemoptysis, large intestinal haemorrhage, melaena, menorrhagia, mouth\n  haemorrhage, peritoneal haematoma, petechiae, pharyngeal haemorrhage, post\u2011procedural\n  haemorrhage, pulmonary haemorrhage, purpura, retinal haemorrhage, traumatic\n  haematoma, tumour haemorrhage, upper gastrointestinal haemorrhage and vaginal\n  haemorrhage.</span></p>", "ID": "a64f1ccb-e2ad-4c9c-95ea-6eeaba7f41a6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2)</span></sup>", "ID": "b73ed417-d4c5-41b5-978d-3c48dbdc27a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a64f1ccb-e2ad-4c9c-95ea-6eeaba7f41a6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>2)</span>", "ID": "629ec2f2-179a-4b8f-a789-a27426d06378", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2)", "ParentId": "b73ed417-d4c5-41b5-978d-3c48dbdc27a0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Haemorrhage\n  includes anal haemorrhage, blood urine present, catheter site haemorrhage,\n  cerebral haemorrhage, conjunctival haemorrhage, contusion, cystitis\n  haemorrhagic, duodenal ulcer haemorrhage, disseminated intravascular\n  coagulation, epistaxis, eye contusion, gastrointestinal haemorrhage, gingival\n  bleeding, haematochezia, haemarthrosis, haematemesis, haematuria,\n  haemoptysis, large intestinal haemorrhage, melaena, menorrhagia, mouth\n  haemorrhage, peritoneal haematoma, petechiae, pharyngeal haemorrhage, post\u2011procedural\n  haemorrhage, pulmonary haemorrhage, purpura, retinal haemorrhage, traumatic\n  haematoma, tumour haemorrhage, upper gastrointestinal haemorrhage and vaginal\n  haemorrhage.</span>", "ID": "acd757bc-2f9f-44ba-b20b-9a23ea4cdc98", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Haemorrhage   includes anal haemorrhage, blood urine present, catheter site haemorrhage,   cerebral haemorrhage, conjunctival haemorrhage, contusion, cystitis   haemorrhagic, duodenal ulcer haemorrhage, disseminated intravascular   coagulation, epistaxis, eye contusion, gastrointestinal haemorrhage, gingival   bleeding, haematochezia, haemarthrosis, haematemesis, haematuria,   haemoptysis, large intestinal haemorrhage, melaena, menorrhagia, mouth   haemorrhage, peritoneal haematoma, petechiae, pharyngeal haemorrhage, post\u2011procedural   haemorrhage, pulmonary haemorrhage, purpura, retinal haemorrhage, traumatic   haematoma, tumour haemorrhage, upper gastrointestinal haemorrhage and vaginal   haemorrhage.", "ParentId": "a64f1ccb-e2ad-4c9c-95ea-6eeaba7f41a6"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypogammaglobulinaemia\n  includes immunoglobulins decreased, blood immunoglobulin A decreased, blood\n  immunoglobulin G decreased, blood immunoglobulin M decreased,\n  immunodeficiency, immunodeficiency common variable and\n  hypogammaglobulinaemia.</span></p>", "ID": "1883ab54-924e-49df-a40e-b6ea7a4df52e", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup>", "ID": "846b2cdf-828f-49f9-ac86-bd356bd2324f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1883ab54-924e-49df-a40e-b6ea7a4df52e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "1c0e4a86-a008-471f-a291-87def2cf5d6e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "846b2cdf-828f-49f9-ac86-bd356bd2324f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Hypogammaglobulinaemia\n  includes immunoglobulins decreased, blood immunoglobulin A decreased, blood\n  immunoglobulin G decreased, blood immunoglobulin M decreased,\n  immunodeficiency, immunodeficiency common variable and\n  hypogammaglobulinaemia.</span>", "ID": "87253ddc-6b51-4cfd-a5a5-8478830a8216", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Hypogammaglobulinaemia   includes immunoglobulins decreased, blood immunoglobulin A decreased, blood   immunoglobulin G decreased, blood immunoglobulin M decreased,   immunodeficiency, immunodeficiency common variable and   hypogammaglobulinaemia.", "ParentId": "1883ab54-924e-49df-a40e-b6ea7a4df52e"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Delirium includes\n  agitation, delirium, hallucination, hallucination visual, irritability and\n  restlessness.</span></p>", "ID": "6ff4467e-1237-416b-8dbd-834fdec3fcd1", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4)</span></sup>", "ID": "a189b8fb-8086-4728-b54c-d3029acdaa22", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ff4467e-1237-416b-8dbd-834fdec3fcd1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>4)</span>", "ID": "90306372-55a2-432e-82d0-563647c80784", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "4)", "ParentId": "a189b8fb-8086-4728-b54c-d3029acdaa22"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Delirium includes\n  agitation, delirium, hallucination, hallucination visual, irritability and\n  restlessness.</span>", "ID": "2309903e-95d4-4ec4-8e08-b837fa02bcda", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Delirium includes   agitation, delirium, hallucination, hallucination visual, irritability and   restlessness.", "ParentId": "6ff4467e-1237-416b-8dbd-834fdec3fcd1"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sleep disorder includes\n  sleep disorder, insomnia and nightmare.</span></p>", "ID": "b305e2a0-775e-4d5a-a5c1-7673ee63e271", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5)</span></sup>", "ID": "eda0f95d-bad6-4f96-99d7-76723619a290", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b305e2a0-775e-4d5a-a5c1-7673ee63e271"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>5)</span>", "ID": "bd26132d-8c28-48f5-9f3f-9393fca7c3fe", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5)", "ParentId": "eda0f95d-bad6-4f96-99d7-76723619a290"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sleep disorder includes\n  sleep disorder, insomnia and nightmare.</span>", "ID": "c1c06c15-d1eb-4163-bedc-a4bb57fc6327", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Sleep disorder includes   sleep disorder, insomnia and nightmare.", "ParentId": "b305e2a0-775e-4d5a-a5c1-7673ee63e271"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Headache includes\n  headache and migraine.</span></p>", "ID": "a328a833-9f95-4f48-8a0d-c02a25444bd2", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6)</span></sup>", "ID": "0d4ec616-33a3-4816-b592-b23fff200cad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a328a833-9f95-4f48-8a0d-c02a25444bd2"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>6)</span>", "ID": "54b0b1c6-ef6e-40ec-b2c8-e41be0e45066", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6)", "ParentId": "0d4ec616-33a3-4816-b592-b23fff200cad"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Headache includes\n  headache and migraine.</span>", "ID": "dd0a7140-2828-44df-96f7-06a04bc53620", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Headache includes   headache and migraine.", "ParentId": "a328a833-9f95-4f48-8a0d-c02a25444bd2"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Encephalopathy includes\n  depressed level of consciousness, mental status changes, automatism,\n  cognitive disorder, confusional state, disturbance in attention,\n  encephalopathy, somnolence, lethargy, memory impairment, metabolic\n  encephalopathy and thinking abnormal.</span></p>", "ID": "eb3a748f-4b43-439d-a0ea-304f01518346", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7)</span></sup>", "ID": "064a89e9-1bbf-45d5-b90a-8c4009fe50df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb3a748f-4b43-439d-a0ea-304f01518346"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>7)</span>", "ID": "58cd8a9a-9323-4f0a-b74f-da98fb4b6222", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "7)", "ParentId": "064a89e9-1bbf-45d5-b90a-8c4009fe50df"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Encephalopathy includes\n  depressed level of consciousness, mental status changes, automatism,\n  cognitive disorder, confusional state, disturbance in attention,\n  encephalopathy, somnolence, lethargy, memory impairment, metabolic\n  encephalopathy and thinking abnormal.</span>", "ID": "7501ee17-f7d0-472d-8b98-433bf8ea014b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Encephalopathy includes   depressed level of consciousness, mental status changes, automatism,   cognitive disorder, confusional state, disturbance in attention,   encephalopathy, somnolence, lethargy, memory impairment, metabolic   encephalopathy and thinking abnormal.", "ParentId": "eb3a748f-4b43-439d-a0ea-304f01518346"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dizziness includes\n  dizziness, presyncope and syncope.</span></p>", "ID": "0dd4baec-43d4-41f5-8461-ba3e7711fdde", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8)</span></sup>", "ID": "5468a10a-a1e8-4d20-af90-1540a7211216", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0dd4baec-43d4-41f5-8461-ba3e7711fdde"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>8)</span>", "ID": "40212bfe-beb4-4bf7-94c7-e330481bd4d1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "8)", "ParentId": "5468a10a-a1e8-4d20-af90-1540a7211216"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dizziness includes\n  dizziness, presyncope and syncope.</span>", "ID": "c698ce1d-d400-4e00-a91c-4e071528ab6e", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Dizziness includes   dizziness, presyncope and syncope.", "ParentId": "0dd4baec-43d4-41f5-8461-ba3e7711fdde"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Peripheral neuropathy\n  includes paraesthesia, peripheral sensory neuropathy, neuropathy peripheral,\n  hyperaesthesia and hypoaesthesia.</span></p>", "ID": "3e4d81d5-3920-4dee-80c0-3eb4ed420675", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9)</span></sup>", "ID": "9eb69792-3b97-4976-b1bc-3be3cc149ca6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3e4d81d5-3920-4dee-80c0-3eb4ed420675"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>9)</span>", "ID": "e0f67d4a-e337-423c-80a2-d830df4496c4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "9)", "ParentId": "9eb69792-3b97-4976-b1bc-3be3cc149ca6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Peripheral neuropathy\n  includes paraesthesia, peripheral sensory neuropathy, neuropathy peripheral,\n  hyperaesthesia and hypoaesthesia.</span>", "ID": "b7b95e2c-63e9-4427-8e3a-0deaa4e0232c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Peripheral neuropathy   includes paraesthesia, peripheral sensory neuropathy, neuropathy peripheral,   hyperaesthesia and hypoaesthesia.", "ParentId": "3e4d81d5-3920-4dee-80c0-3eb4ed420675"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tremor includes\n  dyskinesia and tremor.</span></p>", "ID": "0877e471-4780-46aa-8a9c-4e57bef0f789", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10)</span></sup>", "ID": "659e17c0-a0d1-408a-8b6d-80204657f52d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0877e471-4780-46aa-8a9c-4e57bef0f789"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>10)</span>", "ID": "69811046-4526-4d9a-9fce-4d3668b6c125", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "10)", "ParentId": "659e17c0-a0d1-408a-8b6d-80204657f52d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tremor includes\n  dyskinesia and tremor.</span>", "ID": "3dc73a90-fac8-435b-b23b-b7f298a99e1c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Tremor includes   dyskinesia and tremor.", "ParentId": "0877e471-4780-46aa-8a9c-4e57bef0f789"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Motor dysfunction\n  includes muscle spasms, muscle twitching, myoclonus and myopathy.</span></p>", "ID": "6daa77fa-1a21-41c6-a83e-8e7d81d1cec0", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11)</span></sup>", "ID": "3b81db20-1fd8-4c5f-9438-8ea3235533c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6daa77fa-1a21-41c6-a83e-8e7d81d1cec0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>11)</span>", "ID": "24aec26f-e964-40eb-97e8-501d3447e610", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "11)", "ParentId": "3b81db20-1fd8-4c5f-9438-8ea3235533c0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Motor dysfunction\n  includes muscle spasms, muscle twitching, myoclonus and myopathy.</span>", "ID": "642f90f1-8f88-4724-8400-9997566a0814", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Motor dysfunction   includes muscle spasms, muscle twitching, myoclonus and myopathy.", "ParentId": "6daa77fa-1a21-41c6-a83e-8e7d81d1cec0"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Seizure includes seizure,\n  generalised tonic\u2011clonic seizures and status epilepticus.</span></p>", "ID": "f8fa5763-6b59-4138-934f-bcee7c5c8b15", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12)</span></sup>", "ID": "f4f300f0-9abc-43e6-b9db-6a50590618dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f8fa5763-6b59-4138-934f-bcee7c5c8b15"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>12)</span>", "ID": "b8039cf1-8cef-4c05-b454-08bb358581d3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "12)", "ParentId": "f4f300f0-9abc-43e6-b9db-6a50590618dc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Seizure includes seizure,\n  generalised tonic\u2011clonic seizures and status epilepticus.</span>", "ID": "c908bf10-ae59-4816-836e-d299fdf6d45d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Seizure includes seizure,   generalised tonic\u2011clonic seizures and status epilepticus.", "ParentId": "f8fa5763-6b59-4138-934f-bcee7c5c8b15"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Speech disorders includes\n  speech disorders, dysarthria and aphasia.</span></p>", "ID": "ef4aac36-e5f1-4d20-86d5-5e43138fd0fc", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13)</span></sup>", "ID": "98a71719-b40b-421b-8518-944097d59237", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ef4aac36-e5f1-4d20-86d5-5e43138fd0fc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>13)</span>", "ID": "75ffbae6-1b20-4d52-8483-2a3ac68fd877", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "13)", "ParentId": "98a71719-b40b-421b-8518-944097d59237"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Speech disorders includes\n  speech disorders, dysarthria and aphasia.</span>", "ID": "f2ddc637-a600-4866-aaac-ed891ddbe4eb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Speech disorders includes   speech disorders, dysarthria and aphasia.", "ParentId": "ef4aac36-e5f1-4d20-86d5-5e43138fd0fc"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neuralgia includes\n  neuralgia and sciatica.</span></p>", "ID": "9fe0654f-31b6-46c0-95c8-b68bd00bd306", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14)</span></sup>", "ID": "70662868-c0c1-4d35-b605-2c942bdfaacd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9fe0654f-31b6-46c0-95c8-b68bd00bd306"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>14)</span>", "ID": "8fd86ee2-cbc5-46bd-830f-9ca0d832952a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "14)", "ParentId": "70662868-c0c1-4d35-b605-2c942bdfaacd"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neuralgia includes\n  neuralgia and sciatica.</span>", "ID": "0094284d-8908-4190-9abb-8e81f4fe88aa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neuralgia includes   neuralgia and sciatica.", "ParentId": "9fe0654f-31b6-46c0-95c8-b68bd00bd306"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ataxia includes ataxia\n  and dysmetria.</span></p>", "ID": "1914a85e-645d-4f7f-ac2c-c74d93ee366a", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15)</span></sup>", "ID": "05527a9c-bfac-4aaf-b7da-64e5985e0336", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1914a85e-645d-4f7f-ac2c-c74d93ee366a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>15)</span>", "ID": "8efc5c26-565a-49d3-abf3-d9111de5f0f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "15)", "ParentId": "05527a9c-bfac-4aaf-b7da-64e5985e0336"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ataxia includes ataxia\n  and dysmetria.</span>", "ID": "c18e2e0d-dd2e-4900-8a44-9f6678b7c198", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ataxia includes ataxia   and dysmetria.", "ParentId": "1914a85e-645d-4f7f-ac2c-c74d93ee366a"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Visual impairment\n  includes vision blurred and visual impairment.</span></p>", "ID": "d454eecf-5e78-44ed-8af8-40c4ba356d37", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16)</span></sup>", "ID": "f3fd61ed-2320-4233-b116-a81dcceee5c6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d454eecf-5e78-44ed-8af8-40c4ba356d37"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>16)</span>", "ID": "5a81d8d1-f5a0-45e0-93e4-fec8b86ce06d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "16)", "ParentId": "f3fd61ed-2320-4233-b116-a81dcceee5c6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Visual impairment\n  includes vision blurred and visual impairment.</span>", "ID": "94245724-e082-409a-9913-06a2ceaf530c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Visual impairment   includes vision blurred and visual impairment.", "ParentId": "d454eecf-5e78-44ed-8af8-40c4ba356d37"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;color:black'>Arrhythmia\n  includes atrial fibrillation, supraventricular tachycardia, </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tachycardia and\n  ventricular extrasystoles.</span></p>", "ID": "82bcab70-9011-47e8-99ba-5682fae85d48", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup>", "ID": "51e86ee0-f750-471f-8087-4c71ca1b829f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "82bcab70-9011-47e8-99ba-5682fae85d48"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "14c2fcc9-a879-4a87-87fd-f6940b7e1883", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "17)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "51e86ee0-f750-471f-8087-4c71ca1b829f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif;color:black'>Arrhythmia\n  includes atrial fibrillation, supraventricular tachycardia, </span>", "ID": "14c470ce-1c56-4351-9b23-45c3d639c499", "Styles": "font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Arrhythmia   includes atrial fibrillation, supraventricular tachycardia, ", "ParentId": "82bcab70-9011-47e8-99ba-5682fae85d48"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>tachycardia and\n  ventricular extrasystoles.</span>", "ID": "aad8b762-7c97-4103-a74d-c1041b3aa9f2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "tachycardia and   ventricular extrasystoles.", "ParentId": "82bcab70-9011-47e8-99ba-5682fae85d48"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac failure includes\n  cardiac failure, left ventricular dysfunction, cardiac failure congestive and\n  right ventricular dysfunction.</span></p>", "ID": "d009cfab-5ad3-4660-80fe-64a7fbd8f16e", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18)</span></sup>", "ID": "fd0ea3ce-5c59-490e-94ec-e3d0d26fa9b3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d009cfab-5ad3-4660-80fe-64a7fbd8f16e"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>18)</span>", "ID": "639695b1-7f7b-427b-af90-1545badfd649", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "18)", "ParentId": "fd0ea3ce-5c59-490e-94ec-e3d0d26fa9b3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac failure includes\n  cardiac failure, left ventricular dysfunction, cardiac failure congestive and\n  right ventricular dysfunction.</span>", "ID": "ee0d1c16-61fb-4d9d-a701-055f4b7fa20a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac failure includes   cardiac failure, left ventricular dysfunction, cardiac failure congestive and   right ventricular dysfunction.", "ParentId": "d009cfab-5ad3-4660-80fe-64a7fbd8f16e"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>19)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypotension includes\n  hypotension and orthostatic hypotension.</span></p>", "ID": "ca99aa3d-bd2a-4f9e-827e-c3d1db34afa8", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>19)</span></sup>", "ID": "bc2e0856-3af0-4ce4-bc1d-1af05c27fda1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ca99aa3d-bd2a-4f9e-827e-c3d1db34afa8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>19)</span>", "ID": "a52106e5-9f6e-4583-a208-444b3d73b6b2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "19)", "ParentId": "bc2e0856-3af0-4ce4-bc1d-1af05c27fda1"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypotension includes\n  hypotension and orthostatic hypotension.</span>", "ID": "a752fb58-7837-464e-88bd-41312824c3cb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hypotension includes   hypotension and orthostatic hypotension.", "ParentId": "ca99aa3d-bd2a-4f9e-827e-c3d1db34afa8"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>20)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombosis includes deep\n  vein thrombosis, embolism, pulmonary embolism, thrombosis, vena cava\n  thrombosis and venous thrombosis.</span></p>", "ID": "8adaa847-c69d-4160-a39e-045723dbe913", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>20)</span></sup>", "ID": "5a98a438-e77e-47b2-b113-218ba72542fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8adaa847-c69d-4160-a39e-045723dbe913"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>20)</span>", "ID": "e820933a-3d50-4e60-a6da-8b58de11021c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "20)", "ParentId": "5a98a438-e77e-47b2-b113-218ba72542fb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombosis includes deep\n  vein thrombosis, embolism, pulmonary embolism, thrombosis, vena cava\n  thrombosis and venous thrombosis.</span>", "ID": "2d86e749-ef32-4f64-9ae6-13dc2bf33022", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Thrombosis includes deep   vein thrombosis, embolism, pulmonary embolism, thrombosis, vena cava   thrombosis and venous thrombosis.", "ParentId": "8adaa847-c69d-4160-a39e-045723dbe913"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cough includes cough,\n  productive cough and upper\u2011airway cough syndrome.</span></p>", "ID": "b67f46b2-c60a-4bdd-b08b-6acc13fcb2ed", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21)</span></sup>", "ID": "caa2427a-3a7a-4cb0-8315-afc195fbed65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b67f46b2-c60a-4bdd-b08b-6acc13fcb2ed"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>21)</span>", "ID": "70a97559-6dd4-4f86-95b8-1890f476be40", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "21)", "ParentId": "caa2427a-3a7a-4cb0-8315-afc195fbed65"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cough includes cough,\n  productive cough and upper\u2011airway cough syndrome.</span>", "ID": "15b037fd-6abc-46a1-b375-736f58d04a33", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cough includes cough,   productive cough and upper\u2011airway cough syndrome.", "ParentId": "b67f46b2-c60a-4bdd-b08b-6acc13fcb2ed"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Dyspnoea\n  includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory\n  failure.</span></span></p>", "ID": "d1f6a686-c20a-42a4-883c-a166a5da6a0a", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22)</span></sup>", "ID": "d9fd079c-0ae4-4133-838a-cb54838784eb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d1f6a686-c20a-42a4-883c-a166a5da6a0a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>22)</span>", "ID": "266e3f38-181e-4150-b037-329a6e1f6e4b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "22)", "ParentId": "d9fd079c-0ae4-4133-838a-cb54838784eb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Dyspnoea\n  includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory\n  failure.</span></span>", "ID": "b1c819b6-c502-461b-8eff-aa0e0b9036c0", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d1f6a686-c20a-42a4-883c-a166a5da6a0a"}, {"Element": "<span style=\"color:black\">Dyspnoea\n  includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory\n  failure.</span>", "ID": "94864dfc-76e0-49fc-9b9e-61730320490b", "Styles": "color:black", "Classes": "None", "Text": "Dyspnoea   includes dyspnoea, dyspnoea exertional, respiratory distress and respiratory   failure.", "ParentId": "b1c819b6-c502-461b-8eff-aa0e0b9036c0"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>23)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oropharyngeal pain\n  includes oral pain and oropharyngeal pain.</span></p>", "ID": "144052b1-b00c-4ee6-8187-5421b13abaaf", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>23)</span></sup>", "ID": "0a29ab3b-a1ab-4208-91c2-b3ebf5354455", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "144052b1-b00c-4ee6-8187-5421b13abaaf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>23)</span>", "ID": "b700fcc7-dfae-45d9-8a09-403e50c39168", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "23)", "ParentId": "0a29ab3b-a1ab-4208-91c2-b3ebf5354455"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oropharyngeal pain\n  includes oral pain and oropharyngeal pain.</span>", "ID": "5c6d7d68-d030-4b58-a874-b5120ee219e7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Oropharyngeal pain   includes oral pain and oropharyngeal pain.", "ParentId": "144052b1-b00c-4ee6-8187-5421b13abaaf"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>24)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pulmonary oedema includes\n  acute pulmonary oedema and pulmonary oedema</span></p>", "ID": "c26e463a-bbbf-4519-be5f-3dbc03bbb21f", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>24)</span></sup>", "ID": "349133fa-853a-40b5-a2d2-79f5c9b55a4c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c26e463a-bbbf-4519-be5f-3dbc03bbb21f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>24)</span>", "ID": "91a3cc25-4b7e-4704-9588-9b43dfd9beb2", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "24)", "ParentId": "349133fa-853a-40b5-a2d2-79f5c9b55a4c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pulmonary oedema includes\n  acute pulmonary oedema and pulmonary oedema</span>", "ID": "0a6346e8-739f-438b-8378-9b5f21688b66", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pulmonary oedema includes   acute pulmonary oedema and pulmonary oedema", "ParentId": "c26e463a-bbbf-4519-be5f-3dbc03bbb21f"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>25)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Abdominal pain includes\n  abdominal pain, abdominal pain upper and abdominal discomfort.</span></p>", "ID": "8c4978c0-97f2-4640-bc43-8378cb8ba636", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>25)</span></sup>", "ID": "37c3c1db-279f-468e-b263-b40609cf8971", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8c4978c0-97f2-4640-bc43-8378cb8ba636"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>25)</span>", "ID": "d311de5e-2a2f-4d6c-bc55-f5dd7434e0bd", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "25)", "ParentId": "37c3c1db-279f-468e-b263-b40609cf8971"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Abdominal pain includes\n  abdominal pain, abdominal pain upper and abdominal discomfort.</span>", "ID": "fd18883b-a042-4fbf-b25b-4338cc38c289", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Abdominal pain includes   abdominal pain, abdominal pain upper and abdominal discomfort.", "ParentId": "8c4978c0-97f2-4640-bc43-8378cb8ba636"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>26)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Rash includes dermatitis,\n  dermatitis acneiform, dermatitis contact,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash maculo\u2011papular,\n  rash papular and rash pruritic.</span></p>", "ID": "67bacebd-840f-4230-8adb-70f6951fe6ab", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>26)</span></sup>", "ID": "b699047c-7ff2-44ca-a50b-4e8c64754c3c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "67bacebd-840f-4230-8adb-70f6951fe6ab"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>26)</span>", "ID": "ab4d557b-5b5b-4dba-b168-dda3b5bc52fb", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "26)", "ParentId": "b699047c-7ff2-44ca-a50b-4e8c64754c3c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Rash includes dermatitis,\n  dermatitis acneiform, dermatitis contact,</span>", "ID": "8f7fca40-82dc-4200-beeb-7e2d782e0b47", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Rash includes dermatitis,   dermatitis acneiform, dermatitis contact,", "ParentId": "67bacebd-840f-4230-8adb-70f6951fe6ab"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span>", "ID": "a5ba06d0-71de-409e-87c8-294c90bc4084", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "67bacebd-840f-4230-8adb-70f6951fe6ab"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>rash, rash maculo\u2011papular,\n  rash papular and rash pruritic.</span>", "ID": "d550fbc6-3876-4090-9b58-4fe1bbb7a358", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "rash, rash maculo\u2011papular,   rash papular and rash pruritic.", "ParentId": "67bacebd-840f-4230-8adb-70f6951fe6ab"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>27)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute kidney injury\n  includes acute kidney injury, anuria, azotaemia, blood creatinine abnormal,</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood creatinine\n  increased, renal failure, renal tubular dysfunction and renal tubular\n  necrosis.</span></p>", "ID": "a4f99ec5-71d6-4134-81b9-270009818559", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>27)</span></sup>", "ID": "d257ab0b-2c39-497f-bf0f-b179c115c826", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a4f99ec5-71d6-4134-81b9-270009818559"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>27)</span>", "ID": "41c57e41-12f5-4412-84bb-25cd61c6388d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "27)", "ParentId": "d257ab0b-2c39-497f-bf0f-b179c115c826"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute kidney injury\n  includes acute kidney injury, anuria, azotaemia, blood creatinine abnormal,</span>", "ID": "e0e37b67-f4c0-43c7-ab63-1f354d104912", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Acute kidney injury   includes acute kidney injury, anuria, azotaemia, blood creatinine abnormal,", "ParentId": "a4f99ec5-71d6-4134-81b9-270009818559"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'> </span>", "ID": "9b658322-de3c-43c5-9c7d-323d3f6812c2", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "a4f99ec5-71d6-4134-81b9-270009818559"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>blood creatinine\n  increased, renal failure, renal tubular dysfunction and renal tubular\n  necrosis.</span>", "ID": "71efdd75-0ec5-4dab-b207-68bdb06a087d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "blood creatinine   increased, renal failure, renal tubular dysfunction and renal tubular   necrosis.", "ParentId": "a4f99ec5-71d6-4134-81b9-270009818559"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>28)</span></sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fatigue includes fatigue\n  and malaise.</span></p>", "ID": "a8443f1c-744b-4274-84a6-2f25547bcb84", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>28)</span></sup>", "ID": "b13319fb-c091-408f-a153-cb7a6bbcd0a4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a8443f1c-744b-4274-84a6-2f25547bcb84"}, {"Element": "<span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>28)</span>", "ID": "37d5de72-cdae-40bf-9bda-c04cbf49c703", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "28)", "ParentId": "b13319fb-c091-408f-a153-cb7a6bbcd0a4"}, {"Element": "<span lang=\"FR-CH\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fatigue includes fatigue\n  and malaise.</span>", "ID": "591321b9-56fb-476f-82fb-b2b59fd72685", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fatigue includes fatigue   and malaise.", "ParentId": "a8443f1c-744b-4274-84a6-2f25547bcb84"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>29)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Oedema\n  includes oedema peripheral, generalised oedema, localised oedema, face oedema\n  and peripheral swelling.</span></span></p>", "ID": "de886014-ac0e-4aae-89f6-adc6f015afcf", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>29)</span></sup>", "ID": "17f55fa0-364b-4b5a-b02e-d4e6b1ab8f7f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de886014-ac0e-4aae-89f6-adc6f015afcf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>29)</span>", "ID": "bdfea517-295d-472b-af61-97f03a43e1e7", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "29)", "ParentId": "17f55fa0-364b-4b5a-b02e-d4e6b1ab8f7f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"color:black\">Oedema\n  includes oedema peripheral, generalised oedema, localised oedema, face oedema\n  and peripheral swelling.</span></span>", "ID": "a5f9d8a8-88d9-4eb9-8c72-1317182f648a", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "de886014-ac0e-4aae-89f6-adc6f015afcf"}, {"Element": "<span style=\"color:black\">Oedema\n  includes oedema peripheral, generalised oedema, localised oedema, face oedema\n  and peripheral swelling.</span>", "ID": "b5a945ba-fa41-4e25-a4e4-30d0400b1f95", "Styles": "color:black", "Classes": "None", "Text": "Oedema   includes oedema peripheral, generalised oedema, localised oedema, face oedema   and peripheral swelling.", "ParentId": "a5f9d8a8-88d9-4eb9-8c72-1317182f648a"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt\"><sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>30)</span></sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pain includes pain and\n  pain in extremity.</span></p>", "ID": "d1b6fa79-7aea-4325-8bc8-dd6e96ba7632", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:30.05pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>30)</span></sup>", "ID": "9d93bdd8-9560-4346-92da-806d874726fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d1b6fa79-7aea-4325-8bc8-dd6e96ba7632"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>30)</span>", "ID": "996c88ed-5fb4-42dc-a112-90cbfd99124b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "30)", "ParentId": "9d93bdd8-9560-4346-92da-806d874726fb"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pain includes pain and\n  pain in extremity.</span>", "ID": "7825b504-489d-4366-9639-3eeb7fdf43ab", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pain includes pain and   pain in extremity.", "ParentId": "d1b6fa79-7aea-4325-8bc8-dd6e96ba7632"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt\">*\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style='font-family:\n  \"Times New Roman\",serif'>Frequency is based on laboratory values. Patients\n  are counted only for the worst grade observed post baseline.</span></p>", "ID": "84b457fa-564f-4358-bdad-aaefb23ae77e", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Legend']", "Text": "*\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "7fb1d7c2-4ba5-47ea-ad03-47bc080b2fd1"}, {"Element": "<span style='font-family:\n  \"Times New Roman\",serif'>Frequency is based on laboratory values. Patients\n  are counted only for the worst grade observed post baseline.</span>", "ID": "52680b5d-3ba8-403c-ad56-1364422ad4bb", "Styles": "font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "Frequency is based on laboratory values. Patients   are counted only for the worst grade observed post baseline.", "ParentId": "84b457fa-564f-4358-bdad-aaefb23ae77e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c9b19ba5-0d24-4693-89a7-dbff30764350", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "040ab1ee-be2c-4cd7-9ed7-4f3fc7c0b390", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c9b19ba5-0d24-4693-89a7-dbff30764350"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Description of selected adverse drug reactions</span></u></p>", "ID": "69aa5298-1639-4b3a-a747-6200837a7f73", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Description of selected adverse drug reactions</span></u>", "ID": "bee0ba89-6b78-4b8a-91eb-2233b089d269", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "69aa5298-1639-4b3a-a747-6200837a7f73"}, {"Element": "<span lang=\"EN-GB\">Description of selected adverse drug reactions</span>", "ID": "469735ba-c1b4-45c4-ab0b-63ce8216d265", "Styles": "None", "Classes": "None", "Text": "Description of selected adverse drug reactions", "ParentId": "bee0ba89-6b78-4b8a-91eb-2233b089d269"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ce050c87-5eb0-4021-a19e-d5e6dc268af6", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f6af43b7-8929-47f9-a777-42de916b3d58", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ce050c87-5eb0-4021-a19e-d5e6dc268af6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Cytokine release syndrome</span></u></i></p>", "ID": "ec98365b-cbff-41fc-a09f-41bd0375a6e0", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Cytokine release syndrome</span></u></i>", "ID": "7bb89bd3-8c4a-4820-9702-1f7fad45b2b4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec98365b-cbff-41fc-a09f-41bd0375a6e0"}, {"Element": "<u><span lang=\"EN-GB\">Cytokine release syndrome</span></u>", "ID": "c24dbbbe-b29c-4efc-9846-20660c97cfb5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7bb89bd3-8c4a-4820-9702-1f7fad45b2b4"}, {"Element": "<span lang=\"EN-GB\">Cytokine release syndrome</span>", "ID": "1c429373-4ce2-493e-ad9f-6470bd6f9606", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome", "ParentId": "c24dbbbe-b29c-4efc-9846-20660c97cfb5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the ongoing clinical study in paediatric and young adult B\u2011cell\nALL (N=79), </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> was reported in 77% of patients (48% with Grade\u00a03 or 4). Two\ndeaths occurred within 30\u00a0days of tisagenlecleucel infusion, including one\npatient, who died from progressive leukaemia in the setting of possible cytokine\nrelease syndrome and one patient who experienced fatal intracranial haemorrhage\nthat developed during the course of resolved </span><span lang=\"EN-GB\">cytokine\nrelease syndrome,</span><span lang=\"EN-GB\"> abdominal compartment syndrome,\ncoagulopathy and renal failure.</span></p>", "ID": "4af638db-d263-4d18-8cb0-9df5ab341d02", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In the ongoing clinical study in paediatric and young adult B\u2011cell\nALL (N=79), </span>", "ID": "4215c71d-16c0-42a9-93a1-22a75218194a", "Styles": "None", "Classes": "None", "Text": "In the ongoing clinical study in paediatric and young adult B\u2011cell ALL (N=79), ", "ParentId": "4af638db-d263-4d18-8cb0-9df5ab341d02"}, {"Element": "<span lang=\"EN-GB\">cytokine release syndrome</span>", "ID": "5e318534-bc90-43cf-8cbd-366e0b42b7df", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome", "ParentId": "4af638db-d263-4d18-8cb0-9df5ab341d02"}, {"Element": "<span lang=\"EN-GB\"> was reported in 77% of patients (48% with Grade\u00a03 or 4). Two\ndeaths occurred within 30\u00a0days of tisagenlecleucel infusion, including one\npatient, who died from progressive leukaemia in the setting of possible cytokine\nrelease syndrome and one patient who experienced fatal intracranial haemorrhage\nthat developed during the course of resolved </span>", "ID": "b0985327-472e-4f04-b203-0f3404112808", "Styles": "None", "Classes": "None", "Text": " was reported in 77% of patients (48% with Grade\u00a03 or 4). Two deaths occurred within 30\u00a0days of tisagenlecleucel infusion, including one patient, who died from progressive leukaemia in the setting of possible cytokine release syndrome and one patient who experienced fatal intracranial haemorrhage that developed during the course of resolved ", "ParentId": "4af638db-d263-4d18-8cb0-9df5ab341d02"}, {"Element": "<span lang=\"EN-GB\">cytokine\nrelease syndrome,</span>", "ID": "6abda757-049e-4877-98f1-0b88c920247d", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome,", "ParentId": "4af638db-d263-4d18-8cb0-9df5ab341d02"}, {"Element": "<span lang=\"EN-GB\"> abdominal compartment syndrome,\ncoagulopathy and renal failure.</span>", "ID": "23549fc5-5bdf-4164-9a3f-5132c273fc1b", "Styles": "None", "Classes": "None", "Text": " abdominal compartment syndrome, coagulopathy and renal failure.", "ParentId": "4af638db-d263-4d18-8cb0-9df5ab341d02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3854cc22-49ed-46e9-b47b-883e65d58d17", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6235ff03-3a44-4ccb-9f9b-e71a292c46fe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3854cc22-49ed-46e9-b47b-883e65d58d17"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the ongoing clinical study in DLBCL (N=115), </span><span lang=\"EN-GB\">cytokine release syndrome</span><span lang=\"EN-GB\"> was reported in 57%\nof patients (23% with Grade\u00a03 or 4).</span></p>", "ID": "f2445b37-131f-437c-b6e4-b34c271617ba", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In the ongoing clinical study in DLBCL (N=115), </span>", "ID": "e581eeca-eff9-42e1-b632-c9399e86b46f", "Styles": "None", "Classes": "None", "Text": "In the ongoing clinical study in DLBCL (N=115), ", "ParentId": "f2445b37-131f-437c-b6e4-b34c271617ba"}, {"Element": "<span lang=\"EN-GB\">cytokine release syndrome</span>", "ID": "30191780-4e87-4d89-b3dc-2ba8522b4d90", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome", "ParentId": "f2445b37-131f-437c-b6e4-b34c271617ba"}, {"Element": "<span lang=\"EN-GB\"> was reported in 57%\nof patients (23% with Grade\u00a03 or 4).</span>", "ID": "7fc4680d-6b2a-46c5-8feb-2bd7e734103e", "Styles": "None", "Classes": "None", "Text": " was reported in 57% of patients (23% with Grade\u00a03 or 4).", "ParentId": "f2445b37-131f-437c-b6e4-b34c271617ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "21d2dbdc-da63-4f7d-8a74-73a267aef87c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "15b66f97-fbf0-44fb-a9cb-f7339916d0ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "21d2dbdc-da63-4f7d-8a74-73a267aef87c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Cytokine release syndrome</span><span lang=\"EN-GB\"> was graded with\nthe Penn scale as follows: Grade\u00a01:\u00a0mild reactions, reactions\nrequiring supportive care; Grade\u00a02:\u00a0moderate reactions, reactions\nrequiring intravenous therapies; Grade\u00a03:\u00a0severe reactions, reactions\nrequiring low\u2011dose vasopressors or supplemental oxygen;\nGrade\u00a04:\u00a0life\u2011threatening reactions, those requiring high\u2011dose\nvasopressors or intubation; Grade\u00a05:\u00a0death.</span></p>", "ID": "4dbd1677-371e-42d2-a5dc-503cae1c8618", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Cytokine release syndrome</span>", "ID": "a7fa3baa-01cf-4f87-af3b-714ea43d22ef", "Styles": "None", "Classes": "None", "Text": "Cytokine release syndrome", "ParentId": "4dbd1677-371e-42d2-a5dc-503cae1c8618"}, {"Element": "<span lang=\"EN-GB\"> was graded with\nthe Penn scale as follows: Grade\u00a01:\u00a0mild reactions, reactions\nrequiring supportive care; Grade\u00a02:\u00a0moderate reactions, reactions\nrequiring intravenous therapies; Grade\u00a03:\u00a0severe reactions, reactions\nrequiring low\u2011dose vasopressors or supplemental oxygen;\nGrade\u00a04:\u00a0life\u2011threatening reactions, those requiring high\u2011dose\nvasopressors or intubation; Grade\u00a05:\u00a0death.</span>", "ID": "2552a156-2762-42ee-8cac-d952fcd783f7", "Styles": "None", "Classes": "None", "Text": " was graded with the Penn scale as follows: Grade\u00a01:\u00a0mild reactions, reactions requiring supportive care; Grade\u00a02:\u00a0moderate reactions, reactions requiring intravenous therapies; Grade\u00a03:\u00a0severe reactions, reactions requiring low\u2011dose vasopressors or supplemental oxygen; Grade\u00a04:\u00a0life\u2011threatening reactions, those requiring high\u2011dose vasopressors or intubation; Grade\u00a05:\u00a0death.", "ParentId": "4dbd1677-371e-42d2-a5dc-503cae1c8618"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "682a5da5-d489-471b-919d-d00f71cbb682", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a325c5c-0b02-4e7c-a31b-60ea1f6209cc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "682a5da5-d489-471b-919d-d00f71cbb682"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">For clinical management of </span><span lang=\"EN-GB\">cytokine release\nsyndrome</span><span lang=\"EN-GB\">, see section\u00a04.4 and Table\u00a01.</span></p>", "ID": "c0978837-ed6d-4618-9e73-38e14ecee400", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">For clinical management of </span>", "ID": "5529b64d-94af-4d02-a26c-9af8daf4a9ad", "Styles": "None", "Classes": "None", "Text": "For clinical management of ", "ParentId": "c0978837-ed6d-4618-9e73-38e14ecee400"}, {"Element": "<span lang=\"EN-GB\">cytokine release\nsyndrome</span>", "ID": "00c01d75-eb5e-42a0-bd20-5311d6fd563b", "Styles": "None", "Classes": "None", "Text": "cytokine release syndrome", "ParentId": "c0978837-ed6d-4618-9e73-38e14ecee400"}, {"Element": "<span lang=\"EN-GB\">, see section\u00a04.4 and Table\u00a01.</span>", "ID": "b929d7ff-7805-4f6d-9dda-18ad4c606310", "Styles": "None", "Classes": "None", "Text": ", see section\u00a04.4 and Table\u00a01.", "ParentId": "c0978837-ed6d-4618-9e73-38e14ecee400"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8295d0e0-2ca1-48f9-96ab-ab9c79efa540", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a7784a3-851e-401f-acf9-4e714439c97c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8295d0e0-2ca1-48f9-96ab-ab9c79efa540"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Infections and febrile neutropenia</span></u></i></p>", "ID": "e7eabce6-4bf6-41c2-ac64-b5abda03a33a", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Infections and febrile neutropenia</span></u></i>", "ID": "3dc16784-2c15-4c92-8f60-33e94c672c76", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e7eabce6-4bf6-41c2-ac64-b5abda03a33a"}, {"Element": "<u><span lang=\"EN-GB\">Infections and febrile neutropenia</span></u>", "ID": "786bd0d5-983b-4446-8743-fca5a78815a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3dc16784-2c15-4c92-8f60-33e94c672c76"}, {"Element": "<span lang=\"EN-GB\">Infections and febrile neutropenia</span>", "ID": "89792381-087a-487a-8a56-338dd5a348ef", "Styles": "None", "Classes": "None", "Text": "Infections and febrile neutropenia", "ParentId": "786bd0d5-983b-4446-8743-fca5a78815a9"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In B\u2011cell ALL\npatients severe infections (Grade\u00a03 and higher), which can be life\u2011threatening\nor fatal, occurred in 48% of patients after Kymriah infusion. The overall\nincidence (all grades) was 73% (unspecified 57%, viral 38%, bacterial 27% and\nfungal 15%) (see section\u00a04.4). 43% of the patients experienced an\ninfection of any type within 8\u00a0weeks after Kymriah infusion.</span></p>", "ID": "f5f16461-5c7f-4ca5-877c-a86f9e150a2f", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">In B\u2011cell ALL\npatients severe infections (Grade\u00a03 and higher), which can be life\u2011threatening\nor fatal, occurred in 48% of patients after Kymriah infusion. The overall\nincidence (all grades) was 73% (unspecified 57%, viral 38%, bacterial 27% and\nfungal 15%) (see section\u00a04.4). 43% of the patients experienced an\ninfection of any type within 8\u00a0weeks after Kymriah infusion.</span>", "ID": "590300b7-1a93-4722-b54d-5c374ed0d08d", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "In B\u2011cell ALL patients severe infections (Grade\u00a03 and higher), which can be life\u2011threatening or fatal, occurred in 48% of patients after Kymriah infusion. The overall incidence (all grades) was 73% (unspecified 57%, viral 38%, bacterial 27% and fungal 15%) (see section\u00a04.4). 43% of the patients experienced an infection of any type within 8\u00a0weeks after Kymriah infusion.", "ParentId": "f5f16461-5c7f-4ca5-877c-a86f9e150a2f"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "b0c23d32-4efe-4ccb-a1f5-5137ef8ff0e1", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "63bddcf5-fc6b-481d-9539-5c5bf7c91195", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "b0c23d32-4efe-4ccb-a1f5-5137ef8ff0e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">In DLBCL patients </span><span lang=\"EN-GB\" style=\"color:black\">severe </span><span lang=\"EN-GB\">infections (Grade\u00a03 and\nhigher), which can be life\u2011threatening or fatal, occurred in 34% of\npatients. The overall incidence (all grades) was 58% (unspecified 48%, bacterial\n15%, fungal 11% and viral 11%) (see section\u00a04.4). 37% of the patients\nexperienced an infection of any type within 8\u00a0weeks.</span></p>", "ID": "96778b39-ad0d-400e-93a7-94c68bef5f9d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">In DLBCL patients </span>", "ID": "92b90536-1be2-4967-bfcd-a17a8b867852", "Styles": "color:black", "Classes": "None", "Text": "In DLBCL patients ", "ParentId": "96778b39-ad0d-400e-93a7-94c68bef5f9d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">severe </span>", "ID": "7a323d15-9efe-44dc-a4be-8332637d4bea", "Styles": "color:black", "Classes": "None", "Text": "severe ", "ParentId": "96778b39-ad0d-400e-93a7-94c68bef5f9d"}, {"Element": "<span lang=\"EN-GB\">infections (Grade\u00a03 and\nhigher), which can be life\u2011threatening or fatal, occurred in 34% of\npatients. The overall incidence (all grades) was 58% (unspecified 48%, bacterial\n15%, fungal 11% and viral 11%) (see section\u00a04.4). 37% of the patients\nexperienced an infection of any type within 8\u00a0weeks.</span>", "ID": "c587f6cf-e77a-4c95-bd3a-a63cb25cfa18", "Styles": "None", "Classes": "None", "Text": "infections (Grade\u00a03 and higher), which can be life\u2011threatening or fatal, occurred in 34% of patients. The overall incidence (all grades) was 58% (unspecified 48%, bacterial 15%, fungal 11% and viral 11%) (see section\u00a04.4). 37% of the patients experienced an infection of any type within 8\u00a0weeks.", "ParentId": "96778b39-ad0d-400e-93a7-94c68bef5f9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "57180a8e-6348-4b40-9220-2c3a5cb173a6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "93aa8d41-fc4f-4783-a2b9-70eac823fd6e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "57180a8e-6348-4b40-9220-2c3a5cb173a6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Severe febrile neutropenia (Grade\u00a03 or 4) was observed in 34%\nof paediatric and young adult B\u2011cell ALL patients and 17% of DLBCL\npatients. See section\u00a04.4 for the management of febrile neutropenia before\nand after Kymriah infusion.</span></p>", "ID": "50b68a45-9267-41fb-b1bb-c94265514e0a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Severe febrile neutropenia (Grade\u00a03 or 4) was observed in 34%\nof paediatric and young adult B\u2011cell ALL patients and 17% of DLBCL\npatients. See section\u00a04.4 for the management of febrile neutropenia before\nand after Kymriah infusion.</span>", "ID": "8417e6ae-5d80-4b2d-82f5-431ff5a81682", "Styles": "None", "Classes": "None", "Text": "Severe febrile neutropenia (Grade\u00a03 or 4) was observed in 34% of paediatric and young adult B\u2011cell ALL patients and 17% of DLBCL patients. See section\u00a04.4 for the management of febrile neutropenia before and after Kymriah infusion.", "ParentId": "50b68a45-9267-41fb-b1bb-c94265514e0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5d974351-2aad-4196-aa58-d8dcc2af3a0d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "41f10f31-e1d3-4825-a79b-dbb4757f8fe1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5d974351-2aad-4196-aa58-d8dcc2af3a0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Prolonged cytopenias</span></u></i></p>", "ID": "06fc34c8-8c0d-4d83-9f52-0423a0ec5e09", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Prolonged cytopenias</span></u></i>", "ID": "3cc4d1e5-84b7-496e-8b68-a73fda6857e3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06fc34c8-8c0d-4d83-9f52-0423a0ec5e09"}, {"Element": "<u><span lang=\"EN-GB\">Prolonged cytopenias</span></u>", "ID": "6e9aff83-75b4-4950-824c-e09293bd9030", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3cc4d1e5-84b7-496e-8b68-a73fda6857e3"}, {"Element": "<span lang=\"EN-GB\">Prolonged cytopenias</span>", "ID": "f8c39375-94e6-49c3-9c2b-695c7e05f506", "Styles": "None", "Classes": "None", "Text": "Prolonged cytopenias", "ParentId": "6e9aff83-75b4-4950-824c-e09293bd9030"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Cytopenias are very common based on prior chemotherapies and Kymriah\ntherapy.</span></p>", "ID": "32d6f914-447d-4365-9913-a373c3fd2599", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Cytopenias are very common based on prior chemotherapies and Kymriah\ntherapy.</span>", "ID": "0ac7f801-55f0-4071-9ac4-9d71b7e499f7", "Styles": "None", "Classes": "None", "Text": "Cytopenias are very common based on prior chemotherapies and Kymriah therapy.", "ParentId": "32d6f914-447d-4365-9913-a373c3fd2599"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3dac6a68-451b-40b3-9aa6-9134c825d534", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dc1515a7-dd68-40b8-ad36-ccdaee59197a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3dac6a68-451b-40b3-9aa6-9134c825d534"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">All paediatric and young adult B\u2011cell ALL patients had a Grade\u00a03\nor 4 cytopenia at </span><span class=\"MsoCommentReference\"><span lang=\"EN-GB\">some</span></span><span lang=\"EN-GB\"> time after Kymriah infusion. Grade\u00a03 and 4 cytopenias not\nresolved by day\u00a028 after Kymriah infusion based on laboratory findings\nincluded decreased count of white blood cells (57%), neutrophils (54%), lymphocytes\n(44%), and thrombocytes (42%) and decreased haemoglobin (13%).</span></p>", "ID": "68532d40-0708-443f-bd99-3aed7fba0ab5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">All paediatric and young adult B\u2011cell ALL patients had a Grade\u00a03\nor 4 cytopenia at </span>", "ID": "91ad639b-fea0-4518-be3a-d278f65947b8", "Styles": "None", "Classes": "None", "Text": "All paediatric and young adult B\u2011cell ALL patients had a Grade\u00a03 or 4 cytopenia at ", "ParentId": "68532d40-0708-443f-bd99-3aed7fba0ab5"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"EN-GB\">some</span></span>", "ID": "2b4684a8-888f-41d2-a6d3-5e67f5c956cc", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "68532d40-0708-443f-bd99-3aed7fba0ab5"}, {"Element": "<span lang=\"EN-GB\">some</span>", "ID": "813cde6f-80ec-46e8-9ba6-513d2199d5b6", "Styles": "None", "Classes": "None", "Text": "some", "ParentId": "2b4684a8-888f-41d2-a6d3-5e67f5c956cc"}, {"Element": "<span lang=\"EN-GB\"> time after Kymriah infusion. Grade\u00a03 and 4 cytopenias not\nresolved by day\u00a028 after Kymriah infusion based on laboratory findings\nincluded decreased count of white blood cells (57%), neutrophils (54%), lymphocytes\n(44%), and thrombocytes (42%) and decreased haemoglobin (13%).</span>", "ID": "2c714c3d-fd06-4dd0-a7bc-41294a7697d5", "Styles": "None", "Classes": "None", "Text": " time after Kymriah infusion. Grade\u00a03 and 4 cytopenias not resolved by day\u00a028 after Kymriah infusion based on laboratory findings included decreased count of white blood cells (57%), neutrophils (54%), lymphocytes (44%), and thrombocytes (42%) and decreased haemoglobin (13%).", "ParentId": "68532d40-0708-443f-bd99-3aed7fba0ab5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4036e84a-4bd2-4342-b6c9-adb1c199c7ce", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a82fbb77-75f9-4277-9a6d-a7e5bad167dd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4036e84a-4bd2-4342-b6c9-adb1c199c7ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">All adult DLBCL patients had Grade\u00a03 and 4 cytopenias at some time\nafter Kymriah infusion. Grade\u00a03 and 4 cytopenias not resolved by day\u00a028\nbased on laboratory findings included decreased count of thrombocytes (39%),\nlymphocytes (29%), neutrophils (25%), and white blood cells (21%) and decreased\nhaemoglobin (14%).</span></p>", "ID": "bb054955-e701-4840-8bef-e7ab068471e0", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">All adult DLBCL patients had Grade\u00a03 and 4 cytopenias at some time\nafter Kymriah infusion. Grade\u00a03 and 4 cytopenias not resolved by day\u00a028\nbased on laboratory findings included decreased count of thrombocytes (39%),\nlymphocytes (29%), neutrophils (25%), and white blood cells (21%) and decreased\nhaemoglobin (14%).</span>", "ID": "a47564b4-2496-4a72-bf30-b0cdfd292ab5", "Styles": "None", "Classes": "None", "Text": "All adult DLBCL patients had Grade\u00a03 and 4 cytopenias at some time after Kymriah infusion. Grade\u00a03 and 4 cytopenias not resolved by day\u00a028 based on laboratory findings included decreased count of thrombocytes (39%), lymphocytes (29%), neutrophils (25%), and white blood cells (21%) and decreased haemoglobin (14%).", "ParentId": "bb054955-e701-4840-8bef-e7ab068471e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4a5c0a7f-b7fc-4ad3-9339-6c778be756c5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d2460f9-a5ce-45cf-b527-0a1903897c7a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4a5c0a7f-b7fc-4ad3-9339-6c778be756c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Neurological adverse reactions</span></u></i></p>", "ID": "08e420fc-21b6-4d1b-9549-88b0a6763601", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Neurological adverse reactions</span></u></i>", "ID": "eb773458-b360-4ffe-8d88-c399fb26df80", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "08e420fc-21b6-4d1b-9549-88b0a6763601"}, {"Element": "<u><span lang=\"EN-GB\">Neurological adverse reactions</span></u>", "ID": "5fa10873-3229-4d53-9141-4db5a5b8f0d9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb773458-b360-4ffe-8d88-c399fb26df80"}, {"Element": "<span lang=\"EN-GB\">Neurological adverse reactions</span>", "ID": "7ca70b4d-df86-4296-9a5b-d84962b7b74e", "Styles": "None", "Classes": "None", "Text": "Neurological adverse reactions", "ParentId": "5fa10873-3229-4d53-9141-4db5a5b8f0d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The majority of neurotoxic events occurred within 8\u00a0weeks\nfollowing infusion and were transient.</span></p>", "ID": "a09abb95-8774-4e88-85b4-8629c2530cf3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The majority of neurotoxic events occurred within 8\u00a0weeks\nfollowing infusion and were transient.</span>", "ID": "4e318a24-ff6e-4010-8aa1-08746268f106", "Styles": "None", "Classes": "None", "Text": "The majority of neurotoxic events occurred within 8\u00a0weeks following infusion and were transient.", "ParentId": "a09abb95-8774-4e88-85b4-8629c2530cf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d9afdf81-cfc4-4976-89c2-42b0dbfb0647", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f90bf456-ea37-4879-9deb-d8af86a54140", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d9afdf81-cfc4-4976-89c2-42b0dbfb0647"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In paediatric and young adult B\u2011cell ALL patients, manifestations\nof encephalopathy and/or delirium occurred in 39% of patients (10% were Grade\u00a03\nor 4) within 8\u00a0weeks after Kymriah infusion. In DLBCL patients, manifestations\nof encephalopathy and/or delirium occurred in 20% of patients (11% were Grade\u00a03\nor 4) within 8\u00a0weeks after Kymriah infusion.</span></p>", "ID": "de133d39-474d-4090-8793-a65144052299", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In paediatric and young adult B\u2011cell ALL patients, manifestations\nof encephalopathy and/or delirium occurred in 39% of patients (10% were Grade\u00a03\nor 4) within 8\u00a0weeks after Kymriah infusion. In DLBCL patients, manifestations\nof encephalopathy and/or delirium occurred in 20% of patients (11% were Grade\u00a03\nor 4) within 8\u00a0weeks after Kymriah infusion.</span>", "ID": "88f1ead9-7dd5-403e-b6c6-1167d43c8e45", "Styles": "None", "Classes": "None", "Text": "In paediatric and young adult B\u2011cell ALL patients, manifestations of encephalopathy and/or delirium occurred in 39% of patients (10% were Grade\u00a03 or 4) within 8\u00a0weeks after Kymriah infusion. In DLBCL patients, manifestations of encephalopathy and/or delirium occurred in 20% of patients (11% were Grade\u00a03 or 4) within 8\u00a0weeks after Kymriah infusion.", "ParentId": "de133d39-474d-4090-8793-a65144052299"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6a9e2161-9323-465f-83ea-499a3a8bcd06", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5be569ca-017c-4ecc-baff-d8594a87c288", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6a9e2161-9323-465f-83ea-499a3a8bcd06"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Hypogammaglobulinaemia</span></u></i></p>", "ID": "b18b5bd9-6966-4b83-8e3f-153223209721", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Hypogammaglobulinaemia</span></u></i>", "ID": "afdc6659-5bea-4108-8b6e-8634219f279d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b18b5bd9-6966-4b83-8e3f-153223209721"}, {"Element": "<u><span lang=\"EN-GB\">Hypogammaglobulinaemia</span></u>", "ID": "f381af84-db15-46e0-9e9d-49ac5d4383e4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "afdc6659-5bea-4108-8b6e-8634219f279d"}, {"Element": "<span lang=\"EN-GB\">Hypogammaglobulinaemia</span>", "ID": "76047aea-55ab-4e5d-934c-9c69263fde5f", "Styles": "None", "Classes": "None", "Text": "Hypogammaglobulinaemia", "ParentId": "f381af84-db15-46e0-9e9d-49ac5d4383e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Hypogammaglobulinaemia was reported in 53% of patients treated with\nKymriah for r/r ALL and 17% of patients with r/r DLBCL.</span></p>", "ID": "9546aba1-e0f5-4dbd-8d50-0bf9ca584eee", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Hypogammaglobulinaemia was reported in 53% of patients treated with\nKymriah for r/r ALL and 17% of patients with r/r DLBCL.</span>", "ID": "9af4df59-aaf1-4d54-aefe-fc0e21de4c7e", "Styles": "None", "Classes": "None", "Text": "Hypogammaglobulinaemia was reported in 53% of patients treated with Kymriah for r/r ALL and 17% of patients with r/r DLBCL.", "ParentId": "9546aba1-e0f5-4dbd-8d50-0bf9ca584eee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0a34c0c8-7bb3-44a9-8885-d75b7f1ac650", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ff168d6c-971a-47f2-84c5-5c967711cb53", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0a34c0c8-7bb3-44a9-8885-d75b7f1ac650"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Pregnant women who have received Kymriah may have\nhypogammaglobulinaemia. Immunoglobulin levels should be assessed in newborns of\nmothers treated with Kymriah.</span></p>", "ID": "a76cae75-b9d5-4138-a386-10e1314ffde8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Pregnant women who have received Kymriah may have\nhypogammaglobulinaemia. Immunoglobulin levels should be assessed in newborns of\nmothers treated with Kymriah.</span>", "ID": "37f98a0f-461c-4651-82d7-c39a1b6b440e", "Styles": "None", "Classes": "None", "Text": "Pregnant women who have received Kymriah may have hypogammaglobulinaemia. Immunoglobulin levels should be assessed in newborns of mothers treated with Kymriah.", "ParentId": "a76cae75-b9d5-4138-a386-10e1314ffde8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7508e3b4-11a8-42e8-8ef9-980bb61159f7", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "10ab672c-636c-42b3-b39c-2b7094e58751", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7508e3b4-11a8-42e8-8ef9-980bb61159f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Immunogenicity</span></u></i></p>", "ID": "ce4206c2-8333-4ec6-872a-627c8023727e", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Immunogenicity</span></u></i>", "ID": "4632956f-9128-4801-884d-b4df24634e89", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce4206c2-8333-4ec6-872a-627c8023727e"}, {"Element": "<u><span lang=\"EN-GB\">Immunogenicity</span></u>", "ID": "ca3789ce-72f5-4e37-be96-7774cacb9a77", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4632956f-9128-4801-884d-b4df24634e89"}, {"Element": "<span lang=\"EN-GB\">Immunogenicity</span>", "ID": "0c3e8285-6fe3-4bff-91ef-1fb7c94e0753", "Styles": "None", "Classes": "None", "Text": "Immunogenicity", "ParentId": "ca3789ce-72f5-4e37-be96-7774cacb9a77"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0d50ae9a-f840-4281-a49e-5cf0fdc17e5f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2146bbba-5363-47e0-9d24-d23b677f753f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d50ae9a-f840-4281-a49e-5cf0fdc17e5f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">In clinical studies, humoral immunogenicity of tisagenlecleucel was\nmeasured by determination of anti\u2011murine CAR19 antibodies (anti\u2011mCAR19)\nin serum pre\u2011 and post\u2011administration. The majority of patients\ntested positive for pre\u2011dose anti\u2011mCAR19 antibodies in paediatric\nand young adult ALL (B2202, 91.1%) and adult DLBCL (C2201, 93.9%) patients.</span></p>", "ID": "7a5a9c87-dfb6-45b1-80f1-a54108744fe4", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In clinical studies, humoral immunogenicity of tisagenlecleucel was\nmeasured by determination of anti\u2011murine CAR19 antibodies (anti\u2011mCAR19)\nin serum pre\u2011 and post\u2011administration. The majority of patients\ntested positive for pre\u2011dose anti\u2011mCAR19 antibodies in paediatric\nand young adult ALL (B2202, 91.1%) and adult DLBCL (C2201, 93.9%) patients.</span>", "ID": "3f2b5c07-636e-4325-a00e-60ee470af9d9", "Styles": "None", "Classes": "None", "Text": "In clinical studies, humoral immunogenicity of tisagenlecleucel was measured by determination of anti\u2011murine CAR19 antibodies (anti\u2011mCAR19) in serum pre\u2011 and post\u2011administration. The majority of patients tested positive for pre\u2011dose anti\u2011mCAR19 antibodies in paediatric and young adult ALL (B2202, 91.1%) and adult DLBCL (C2201, 93.9%) patients.", "ParentId": "7a5a9c87-dfb6-45b1-80f1-a54108744fe4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "71ef6003-ec9e-4728-b0bd-4a43f3623e91", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c64f8580-92bd-4da7-a00e-2b12943d1d09", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "71ef6003-ec9e-4728-b0bd-4a43f3623e91"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Treatment\u2011induced anti\u2011mCAR19 antibodies were found in 40.5%\nof paediatric and young adult ALL and 8.7% of adult DLBCL patients. Pre\u2011existing\nand treatment\u2011induced antibodies were not associated with an impact on\nclinical response nor did they have an impact on the expansion and persistence\nof tisagenlecleucel. There is no evidence that the presence of pre\u2011existing\nand treatment\u2011induced anti\u2011mCAR19 antibodies impacts the safety or\neffectiveness of Kymriah.</span></p>", "ID": "3a54caed-a104-41f0-96f6-38c79d7c7423", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Treatment\u2011induced anti\u2011mCAR19 antibodies were found in 40.5%\nof paediatric and young adult ALL and 8.7% of adult DLBCL patients. Pre\u2011existing\nand treatment\u2011induced antibodies were not associated with an impact on\nclinical response nor did they have an impact on the expansion and persistence\nof tisagenlecleucel. There is no evidence that the presence of pre\u2011existing\nand treatment\u2011induced anti\u2011mCAR19 antibodies impacts the safety or\neffectiveness of Kymriah.</span>", "ID": "12c17953-1a14-4792-ac1c-47cf8a6047c6", "Styles": "None", "Classes": "None", "Text": "Treatment\u2011induced anti\u2011mCAR19 antibodies were found in 40.5% of paediatric and young adult ALL and 8.7% of adult DLBCL patients. Pre\u2011existing and treatment\u2011induced antibodies were not associated with an impact on clinical response nor did they have an impact on the expansion and persistence of tisagenlecleucel. There is no evidence that the presence of pre\u2011existing and treatment\u2011induced anti\u2011mCAR19 antibodies impacts the safety or effectiveness of Kymriah.", "ParentId": "3a54caed-a104-41f0-96f6-38c79d7c7423"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "956b0ee8-1a9a-4ded-af27-047cb7272291", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b0725087-774b-4822-9c9d-f86ca34bdc9a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "956b0ee8-1a9a-4ded-af27-047cb7272291"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">T\u2011cell immunogenicity responses were not observed in paediatric\nand young adult B\u2011cell ALL and adult r/r DLBCL patients.</span></p>", "ID": "66a10223-b72e-40c1-a6b2-4a63475c1ded", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">T\u2011cell immunogenicity responses were not observed in paediatric\nand young adult B\u2011cell ALL and adult r/r DLBCL patients.</span>", "ID": "c7beda3f-8a86-40f5-a25a-389ac901404a", "Styles": "None", "Classes": "None", "Text": "T\u2011cell immunogenicity responses were not observed in paediatric and young adult B\u2011cell ALL and adult r/r DLBCL patients.", "ParentId": "66a10223-b72e-40c1-a6b2-4a63475c1ded"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "531b7eb7-f125-4f00-8fcc-2f1cb9163712", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c2acb894-9cff-4e5d-8658-f6a72309e87e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "531b7eb7-f125-4f00-8fcc-2f1cb9163712"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>", "ID": "c3891452-8c97-49ef-af51-26547e2c50a1", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u>", "ID": "ab629751-43ee-42f5-8675-4161599dcf54", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c3891452-8c97-49ef-af51-26547e2c50a1"}, {"Element": "<span lang=\"EN-GB\">Reporting of suspected adverse reactions</span>", "ID": "49e8b6d1-d9aa-4dac-aef5-6fe39f911e52", "Styles": "None", "Classes": "None", "Text": "Reporting of suspected adverse reactions", "ParentId": "ab629751-43ee-42f5-8675-4161599dcf54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9ec40a98-7a48-44e4-859f-d71154bcb0da", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dc2c34e3-2e45-447d-bd23-c47540a689cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ec40a98-7a48-44e4-859f-d71154bcb0da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\nmedicinal product is important. It allows continued monitoring of the\nbenefit/risk balance of the medicinal product. Healthcare professionals are\nasked to report any suspected adverse reactions via <span style=\"color:black;\nbackground:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span></p>", "ID": "9bc62bcf-3159-4004-8b21-5e314ab53c6f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\nmedicinal product is important. It allows continued monitoring of the\nbenefit/risk balance of the medicinal product. Healthcare professionals are\nasked to report any suspected adverse reactions via <span style=\"color:black;\nbackground:#D9D9D9\">the national reporting system listed in </span></span>", "ID": "70a9900f-b88a-4458-b8e9-0e0a80839b08", "Styles": "None", "Classes": "None", "Text": "Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via ", "ParentId": "9bc62bcf-3159-4004-8b21-5e314ab53c6f"}, {"Element": "<span style=\"color:black;\nbackground:#D9D9D9\">the national reporting system listed in </span>", "ID": "dc7925f3-c577-41f0-8bfe-04238131bc4f", "Styles": "color:black;\nbackground:#D9D9D9", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "70a9900f-b88a-4458-b8e9-0e0a80839b08"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span>", "ID": "6db74bbb-b416-4179-95f3-6b069ca69639", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9bc62bcf-3159-4004-8b21-5e314ab53c6f"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a>", "ID": "930776b5-3ab1-4d86-b122-8b17c52a3dec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6db74bbb-b416-4179-95f3-6b069ca69639"}, {"Element": "<span style=\"background:#D9D9D9\">Appendix V</span>", "ID": "66deba6c-f5f3-4ac0-a91c-bd915d04d846", "Styles": "background:#D9D9D9", "Classes": "None", "Text": "Appendix V", "ParentId": "930776b5-3ab1-4d86-b122-8b17c52a3dec"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "ecef0a85-39dd-4f17-9638-05ca17d5d270", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "9bc62bcf-3159-4004-8b21-5e314ab53c6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "559ce218-1695-42d6-bc83-7bdf10253134", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dba33559-bcb9-480f-b30d-b840c504623a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "559ce218-1695-42d6-bc83-7bdf10253134"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>", "ID": "811a74ee-6937-48f9-a99a-7ebf45c73a9f", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b>", "ID": "66baf013-a580-4c7f-a16a-a7ced95068cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "811a74ee-6937-48f9-a99a-7ebf45c73a9f"}, {"Element": "<span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span>", "ID": "1b4cd588-2685-4942-8fef-cc6a46d0bba8", "Styles": "None", "Classes": "None", "Text": "4.9\u00a0\u00a0\u00a0\u00a0 Overdose", "ParentId": "66baf013-a580-4c7f-a16a-a7ced95068cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "849f35f0-40b1-43fd-bf0a-cf376bfa2b28", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "58fef3f8-a42f-4a80-9b3c-ae7846e0b10f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "849f35f0-40b1-43fd-bf0a-cf376bfa2b28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not applicable.</span></p>", "ID": "9fb2db06-ec96-4517-bcee-9d9f2b696e8b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Not applicable.</span>", "ID": "e2c39662-6e9f-4fcb-946c-4b7dbb54f5ea", "Styles": "None", "Classes": "None", "Text": "Not applicable.", "ParentId": "9fb2db06-ec96-4517-bcee-9d9f2b696e8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9895193f-f76a-480c-aa0a-beac33dad863", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6cb62780-1c9a-4460-83a8-e3dbe8b2b26a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9895193f-f76a-480c-aa0a-beac33dad863"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1134d544-0ed7-47a9-98a9-1ec56ff2411f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3cffacc1-a4eb-463f-8243-a33176c5e68d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1134d544-0ed7-47a9-98a9-1ec56ff2411f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b></p>", "ID": "cfbbee17-8ba8-4c7b-b2d7-b62609ccd361", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span></b>", "ID": "65d15c1b-db8f-4320-bedf-aab359a44c73", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cfbbee17-8ba8-4c7b-b2d7-b62609ccd361"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL\nPROPERTIES</span>", "ID": "2e6ce6a1-7368-4965-a0e2-a5b507542a6f", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES", "ParentId": "65d15c1b-db8f-4320-bedf-aab359a44c73"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ef22529b-5c91-4493-a7b5-2b5c107d324f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9e58849f-58d6-4414-98fd-f9db2ec9b19c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ef22529b-5c91-4493-a7b5-2b5c107d324f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></b></p>", "ID": "79d59747-d860-4a36-a39f-fc1712541426", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span></b>", "ID": "cbfa7ed1-010c-4cd5-ad11-b028b5ca444a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "79d59747-d860-4a36-a39f-fc1712541426"}, {"Element": "<span lang=\"EN-GB\">5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic\nproperties</span>", "ID": "5cf3d555-a097-4694-b5ce-5780de16d228", "Styles": "None", "Classes": "None", "Text": "5.1\u00a0\u00a0\u00a0\u00a0 Pharmacodynamic properties", "ParentId": "cbfa7ed1-010c-4cd5-ad11-b028b5ca444a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7093afdb-a0dd-418b-87f3-2ea1214dcf35", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e73803db-1246-4be4-8d0f-d126fa89daf4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7093afdb-a0dd-418b-87f3-2ea1214dcf35"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: </span><span lang=\"EN-GB\">other\nantineoplastic agents, ATC code: L01XX71<span style=\"color:black;background:\n#D9D9D9\">.</span></span></p>", "ID": "483f0e44-1b2c-40fd-a172-eb407e715127", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Pharmacotherapeutic group: </span>", "ID": "08a32c7d-cf78-4fba-9dbb-17d91ac28be9", "Styles": "None", "Classes": "None", "Text": "Pharmacotherapeutic group: ", "ParentId": "483f0e44-1b2c-40fd-a172-eb407e715127"}, {"Element": "<span lang=\"EN-GB\">other\nantineoplastic agents, ATC code: L01XX71<span style=\"color:black;background:\n#D9D9D9\">.</span></span>", "ID": "168241ed-0973-471b-951c-27319a9adee0", "Styles": "None", "Classes": "None", "Text": "other antineoplastic agents, ATC code: L01XX71", "ParentId": "483f0e44-1b2c-40fd-a172-eb407e715127"}, {"Element": "<span style=\"color:black;background:\n#D9D9D9\">.</span>", "ID": "b97a6543-56cd-476f-b7d1-13f611edaced", "Styles": "color:black;background:\n#D9D9D9", "Classes": "None", "Text": ".", "ParentId": "168241ed-0973-471b-951c-27319a9adee0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "41c15f3c-6188-4846-b1ba-78ca07b617d4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "33df6522-0ffd-445d-8e7e-2555381ce129", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "41c15f3c-6188-4846-b1ba-78ca07b617d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>", "ID": "58c7fa30-8aa1-43fd-86c8-3fc615cac0e4", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Mechanism of action</span></u>", "ID": "985737ab-282a-4325-b5f1-0a475010e614", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58c7fa30-8aa1-43fd-86c8-3fc615cac0e4"}, {"Element": "<span lang=\"EN-GB\">Mechanism of action</span>", "ID": "63fd13b5-f576-4a4e-a9c2-db57f5b2c029", "Styles": "None", "Classes": "None", "Text": "Mechanism of action", "ParentId": "985737ab-282a-4325-b5f1-0a475010e614"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:#262626\">\u00a0</span></p>", "ID": "161e085e-7c88-4adc-a56c-5a8b3b5f8c71", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:#262626\">\u00a0</span>", "ID": "6fe2667a-23ec-4e18-8f5f-de202c1dfa0e", "Styles": "color:#262626", "Classes": "None", "Text": "\u00a0", "ParentId": "161e085e-7c88-4adc-a56c-5a8b3b5f8c71"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:#262626\">Tisagenlecleucel</span><span lang=\"EN-GB\"> is an\nautologous, immunocellular cancer therapy which involves reprogramming a\npatient\u2019s own T cells with a transgene encoding a chimeric antigen receptor\n(CAR) to identify and eliminate CD19 expressing cells. The CAR is comprised of\na murine single chain antibody fragment which recognises CD19 and is fused to\nintracellular signalling domains from 4\u20111BB (CD137) and CD3 zeta. The CD3\nzeta component is critical for initiating T\u2011cell activation and anti-tumour\nactivity, while 4\u20111BB enhances the expansion and persistence of tisagenlecleucel.\nUpon binding to CD19\u2011expressing cells, the CAR transmits a signal promoting\nT\u2011cell expansion and persistence of tisagenlecleucel.</span></p>", "ID": "9a283873-c3c6-49c9-bb4c-0dae637a454d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:#262626\">Tisagenlecleucel</span>", "ID": "d3bad800-d914-4930-8a8b-66ccb72a3422", "Styles": "color:#262626", "Classes": "None", "Text": "Tisagenlecleucel", "ParentId": "9a283873-c3c6-49c9-bb4c-0dae637a454d"}, {"Element": "<span lang=\"EN-GB\"> is an\nautologous, immunocellular cancer therapy which involves reprogramming a\npatient\u2019s own T cells with a transgene encoding a chimeric antigen receptor\n(CAR) to identify and eliminate CD19 expressing cells. The CAR is comprised of\na murine single chain antibody fragment which recognises CD19 and is fused to\nintracellular signalling domains from 4\u20111BB (CD137) and CD3 zeta. The CD3\nzeta component is critical for initiating T\u2011cell activation and anti-tumour\nactivity, while 4\u20111BB enhances the expansion and persistence of tisagenlecleucel.\nUpon binding to CD19\u2011expressing cells, the CAR transmits a signal promoting\nT\u2011cell expansion and persistence of tisagenlecleucel.</span>", "ID": "d0305e3f-9d86-4e97-ac84-022ba99c708e", "Styles": "None", "Classes": "None", "Text": " is an autologous, immunocellular cancer therapy which involves reprogramming a patient\u2019s own T cells with a transgene encoding a chimeric antigen receptor (CAR) to identify and eliminate CD19 expressing cells. The CAR is comprised of a murine single chain antibody fragment which recognises CD19 and is fused to intracellular signalling domains from 4\u20111BB (CD137) and CD3 zeta. The CD3 zeta component is critical for initiating T\u2011cell activation and anti-tumour activity, while 4\u20111BB enhances the expansion and persistence of tisagenlecleucel. Upon binding to CD19\u2011expressing cells, the CAR transmits a signal promoting T\u2011cell expansion and persistence of tisagenlecleucel.", "ParentId": "9a283873-c3c6-49c9-bb4c-0dae637a454d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9d977299-c0fb-4763-b83e-8e3d0114610b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c4be8435-5f47-466c-9033-01fe6ffc9cf8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9d977299-c0fb-4763-b83e-8e3d0114610b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>", "ID": "8bf02cbe-f4da-431d-b9c6-bba6ce894129", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u>", "ID": "287351a6-7dd4-41ff-a61a-978aba0d7c6c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8bf02cbe-f4da-431d-b9c6-bba6ce894129"}, {"Element": "<span lang=\"EN-GB\">Clinical efficacy and safety</span>", "ID": "0daabfcd-8220-41c7-897c-fa3d6964de90", "Styles": "None", "Classes": "None", "Text": "Clinical efficacy and safety", "ParentId": "287351a6-7dd4-41ff-a61a-978aba0d7c6c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "509f16a7-fb09-4598-b471-57d1825d91db", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "419bb9f7-27cc-4a7b-9164-e85a018cdc97", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "509f16a7-fb09-4598-b471-57d1825d91db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Acute lymphoblastic leukaemia (ALL)</span></u></i></p>", "ID": "1a7d67cf-c069-4660-b4f7-db738cd821d2", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Acute lymphoblastic leukaemia (ALL)</span></u></i>", "ID": "68bcf3e2-64b2-4088-9393-50a1d3cede71", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a7d67cf-c069-4660-b4f7-db738cd821d2"}, {"Element": "<u><span lang=\"EN-GB\">Acute lymphoblastic leukaemia (ALL)</span></u>", "ID": "da94808e-5980-4d41-8862-b1b154833ae1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68bcf3e2-64b2-4088-9393-50a1d3cede71"}, {"Element": "<span lang=\"EN-GB\">Acute lymphoblastic leukaemia (ALL)</span>", "ID": "bf1315d5-13a7-48e1-ae7b-cb3675579a1b", "Styles": "None", "Classes": "None", "Text": "Acute lymphoblastic leukaemia (ALL)", "ParentId": "da94808e-5980-4d41-8862-b1b154833ae1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of Kymriah treatment in paediatric and young\nadult patients up to and including 25\u00a0years of age, with relapsed or\nrefractory (r/r) B-cell ALL were evaluated in a total of 203\u00a0patients in\none pivotal (B2202, N=79) and two supportive (B2205J, N=64, and B2101J, N=60) open\u2011label,\nsingle\u2011arm phase I/II studies. All patients had leukapheresis products\ncollected and cryopreserved prior to or during study entry.</span></p>", "ID": "2ae16352-347b-45ab-9342-444c1a9f59c9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The safety and efficacy of Kymriah treatment in paediatric and young\nadult patients up to and including 25\u00a0years of age, with relapsed or\nrefractory (r/r) B-cell ALL were evaluated in a total of 203\u00a0patients in\none pivotal (B2202, N=79) and two supportive (B2205J, N=64, and B2101J, N=60) open\u2011label,\nsingle\u2011arm phase I/II studies. All patients had leukapheresis products\ncollected and cryopreserved prior to or during study entry.</span>", "ID": "9cf80abb-e140-42ac-a212-83a37abc1113", "Styles": "None", "Classes": "None", "Text": "The safety and efficacy of Kymriah treatment in paediatric and young adult patients up to and including 25\u00a0years of age, with relapsed or refractory (r/r) B-cell ALL were evaluated in a total of 203\u00a0patients in one pivotal (B2202, N=79) and two supportive (B2205J, N=64, and B2101J, N=60) open\u2011label, single\u2011arm phase I/II studies. All patients had leukapheresis products collected and cryopreserved prior to or during study entry.", "ParentId": "2ae16352-347b-45ab-9342-444c1a9f59c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f039ec9f-0b4e-4ba8-9d58-079cb6e4b5bf", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "106e07f4-5561-4414-85b4-1c05378ef765", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f039ec9f-0b4e-4ba8-9d58-079cb6e4b5bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The pivotal study B2202 (ELIANA) is a multicentre, single\u2011arm\nphase II study in paediatric and young adult patients with r/r B-cell ALL. Of 97\u00a0patients\nenrolled, 79 received infusion with Kymriah; for 8\u00a0patients (8%) Kymriah\ncould not be manufactured; reasons for discontinuation prior to Kymriah\ninfusion included death (n=7; 7%) or adverse events (n=3; 3%) while awaiting\nKymriah manufacturing in the clinical study. The median duration of study\nfollow-up defined as the time from Kymriah infusion to the date of completion\nor discontinuation from follow-up prior to the data cut-off date was 16.0\u00a0months\n(range: 0.4-34.4). The median time from Kymriah infusion to the data cut-off\ndate was 24.2\u00a0months (range: 4.5-35.1). The study is still ongoing.</span></p>", "ID": "4c390868-0846-4444-b14f-ecea65e9c3f9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The pivotal study B2202 (ELIANA) is a multicentre, single\u2011arm\nphase II study in paediatric and young adult patients with r/r B-cell ALL. Of 97\u00a0patients\nenrolled, 79 received infusion with Kymriah; for 8\u00a0patients (8%) Kymriah\ncould not be manufactured; reasons for discontinuation prior to Kymriah\ninfusion included death (n=7; 7%) or adverse events (n=3; 3%) while awaiting\nKymriah manufacturing in the clinical study. The median duration of study\nfollow-up defined as the time from Kymriah infusion to the date of completion\nor discontinuation from follow-up prior to the data cut-off date was 16.0\u00a0months\n(range: 0.4-34.4). The median time from Kymriah infusion to the data cut-off\ndate was 24.2\u00a0months (range: 4.5-35.1). The study is still ongoing.</span>", "ID": "119c55f7-f886-45ac-98de-8428847a0b7c", "Styles": "None", "Classes": "None", "Text": "The pivotal study B2202 (ELIANA) is a multicentre, single\u2011arm phase II study in paediatric and young adult patients with r/r B-cell ALL. Of 97\u00a0patients enrolled, 79 received infusion with Kymriah; for 8\u00a0patients (8%) Kymriah could not be manufactured; reasons for discontinuation prior to Kymriah infusion included death (n=7; 7%) or adverse events (n=3; 3%) while awaiting Kymriah manufacturing in the clinical study. The median duration of study follow-up defined as the time from Kymriah infusion to the date of completion or discontinuation from follow-up prior to the data cut-off date was 16.0\u00a0months (range: 0.4-34.4). The median time from Kymriah infusion to the data cut-off date was 24.2\u00a0months (range: 4.5-35.1). The study is still ongoing.", "ParentId": "4c390868-0846-4444-b14f-ecea65e9c3f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8cbc6be1-d6ed-4a3e-8e19-723fe999dedd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bda3d23a-5d30-44ae-93df-e2f6e6cdd145", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8cbc6be1-d6ed-4a3e-8e19-723fe999dedd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Key baseline information for enrolled and infused patients is\npresented in Table\u00a03. </span><span lang=\"EN-GB\">The majority of patients </span><span lang=\"EN-GB\">(69/79, 87%) </span><span lang=\"EN-GB\">received bridging therapy while\nwaiting for Kymriah. </span><span lang=\"EN-GB\">A total of 76 out of 79\u00a0patients\n(96%) who received Kymriah infusion also received lymphodepleting chemotherapy\nafter enrolment and prior to infusion of a single dose of Kymriah (see section\u00a04.2\nfor condition of lymphodepleting chemotherapy).</span></p>", "ID": "a2fc347d-11cc-4abe-8035-71cff6abbb51", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Key baseline information for enrolled and infused patients is\npresented in Table\u00a03. </span>", "ID": "0405d52f-0970-426d-b08c-a22a66cf7de5", "Styles": "None", "Classes": "None", "Text": "Key baseline information for enrolled and infused patients is presented in Table\u00a03. ", "ParentId": "a2fc347d-11cc-4abe-8035-71cff6abbb51"}, {"Element": "<span lang=\"EN-GB\">The majority of patients </span>", "ID": "538bf068-65b7-4546-bd1b-33ee76fbaca3", "Styles": "None", "Classes": "None", "Text": "The majority of patients ", "ParentId": "a2fc347d-11cc-4abe-8035-71cff6abbb51"}, {"Element": "<span lang=\"EN-GB\">(69/79, 87%) </span>", "ID": "779856e9-afd3-4db6-bb14-1677643791f1", "Styles": "None", "Classes": "None", "Text": "(69/79, 87%) ", "ParentId": "a2fc347d-11cc-4abe-8035-71cff6abbb51"}, {"Element": "<span lang=\"EN-GB\">received bridging therapy while\nwaiting for Kymriah. </span>", "ID": "9bd45982-c384-45fe-933c-e2412d39fce8", "Styles": "None", "Classes": "None", "Text": "received bridging therapy while waiting for Kymriah. ", "ParentId": "a2fc347d-11cc-4abe-8035-71cff6abbb51"}, {"Element": "<span lang=\"EN-GB\">A total of 76 out of 79\u00a0patients\n(96%) who received Kymriah infusion also received lymphodepleting chemotherapy\nafter enrolment and prior to infusion of a single dose of Kymriah (see section\u00a04.2\nfor condition of lymphodepleting chemotherapy).</span>", "ID": "5d7e851a-d571-4f68-959a-acf9986f2cf1", "Styles": "None", "Classes": "None", "Text": "A total of 76 out of 79\u00a0patients (96%) who received Kymriah infusion also received lymphodepleting chemotherapy after enrolment and prior to infusion of a single dose of Kymriah (see section\u00a04.2 for condition of lymphodepleting chemotherapy).", "ParentId": "a2fc347d-11cc-4abe-8035-71cff6abbb51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "55529871-57ba-4300-89dc-f1d3ab5851e3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "41c663a2-bad9-43ab-8764-748d38a08a95", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "55529871-57ba-4300-89dc-f1d3ab5851e3"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a03\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Baseline information across the enrolled and the infused patient\npopulation</span></b></p>", "ID": "ad9da23c-764f-419c-b2b7-90aba4f10cfb", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a03\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Baseline information across the enrolled and the infused patient\npopulation</span></b>", "ID": "3006d9d4-8241-4fee-ba57-17219d8687c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad9da23c-764f-419c-b2b7-90aba4f10cfb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a03\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Baseline information across the enrolled and the infused patient\npopulation</span>", "ID": "d838e60d-17d3-46bf-a757-e617dbbff594", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Table\u00a03\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study B2202: Baseline information across the enrolled and the infused patient population", "ParentId": "3006d9d4-8241-4fee-ba57-17219d8687c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e3cc428d-a639-42b9-9c8c-99a6ff61b2e5", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cddfb3ff-646e-46df-b227-b3a877c1403c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e3cc428d-a639-42b9-9c8c-99a6ff61b2e5"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse;border:none\" width=\"100%\">\n<thead>\n<tr style=\"height:29.4pt\">\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:25.72%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=97</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:25.74%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=79</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>\n</thead>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>\n<td style=\"width:25.72%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.48)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.38)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  27)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  24)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;10\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">32\n  (40.5)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226510\u00a0years\n  and &lt;18\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">33\n  (41.8)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226518\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">17 (17.5)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">14\n  (17.7)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (55.7)\n  </p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">45\n  (57.0)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">43 (44.3)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">34 (43)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary refractory<sup>1</sup></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">8 (8.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapsed disease<sup>2</sup></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">89 (91.8)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">73 (92.4)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Prior\n  stem-cell transplantation - n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">39 (40.2)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">31\n  (39.2)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">50 (51.5)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">42\n  (53.2)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">8 (8.2)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>\n</tr>\n<tr style=\"height:18.25pt\">\n<td colspan=\"3\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:18.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><sup>1</sup>Primary\n  refractory: Never had a morphologic complete remission (CR) prior to the\n  study;</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><sup>2</sup>Relapsed disease:\n  Had at least one relapse prior to the study</p>\n</td>\n</tr>\n</table>", "ID": "718157db-89e8-45ae-8466-63a7362232aa", "Styles": "width:100.0%;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                    ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<thead>\n<tr style=\"height:29.4pt\">\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:25.72%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=97</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:25.74%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=79</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>\n</thead>", "ID": "d439bbb9-bdcc-4bc4-96a5-a3edf5168756", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<tr style=\"height:29.4pt\">\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:25.72%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=97</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:25.74%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=79</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>", "ID": "3e7163f2-eb8d-4968-86e6-450ec0cfe177", "Styles": "height:29.4pt", "Classes": "None", "Text": "    ", "ParentId": "d439bbb9-bdcc-4bc4-96a5-a3edf5168756"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>", "ID": "38b94e8d-aca6-46c4-90d8-719d427a8f0f", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:29.4pt", "Classes": "None", "Text": "  ", "ParentId": "3e7163f2-eb8d-4968-86e6-450ec0cfe177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>", "ID": "e301401b-2f79-4c59-8177-233267ea05d6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "38b94e8d-aca6-46c4-90d8-719d427a8f0f"}, {"Element": "<b>\u00a0</b>", "ID": "34451edf-6493-4fa2-8b4e-af1945cec8ac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e301401b-2f79-4c59-8177-233267ea05d6"}, {"Element": "<td style=\"width:25.72%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=97</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>", "ID": "fe97a768-abba-4bb3-b247-4e7e12e54ffd", "Styles": "width:25.72%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt", "Classes": "None", "Text": "    ", "ParentId": "3e7163f2-eb8d-4968-86e6-450ec0cfe177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>", "ID": "aeea7ef5-726e-49d9-a6d8-9f91d9ed7e7d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fe97a768-abba-4bb3-b247-4e7e12e54ffd"}, {"Element": "<b>Enrolled</b>", "ID": "b9314c2c-a3b4-4901-850e-74ce512150bc", "Styles": "None", "Classes": "None", "Text": "Enrolled", "ParentId": "aeea7ef5-726e-49d9-a6d8-9f91d9ed7e7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=97</b></p>", "ID": "85b7281e-466e-48ec-b31a-8e70c230dcf9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fe97a768-abba-4bb3-b247-4e7e12e54ffd"}, {"Element": "<b>N=97</b>", "ID": "5cb57582-07ee-4ce0-bfc8-05eac877754b", "Styles": "None", "Classes": "None", "Text": "N=97", "ParentId": "85b7281e-466e-48ec-b31a-8e70c230dcf9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>", "ID": "66b2fc2b-8126-4aea-94e1-3baf35a6e02f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fe97a768-abba-4bb3-b247-4e7e12e54ffd"}, {"Element": "<b>n\n   (%)</b>", "ID": "5bc5712f-3cb2-4e64-8cd9-a96f0d5b8ddf", "Styles": "None", "Classes": "None", "Text": "n    (%)", "ParentId": "66b2fc2b-8126-4aea-94e1-3baf35a6e02f"}, {"Element": "<td style=\"width:25.74%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=79</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>", "ID": "3120c60e-557b-46c0-9e3a-1dc0b19e4e30", "Styles": "width:25.74%;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:29.4pt", "Classes": "None", "Text": "    ", "ParentId": "3e7163f2-eb8d-4968-86e6-450ec0cfe177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>", "ID": "01d4cb71-99bb-4882-8fd4-125ca632cf66", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3120c60e-557b-46c0-9e3a-1dc0b19e4e30"}, {"Element": "<b>Infused</b>", "ID": "a5a5c5f5-f2b5-44a2-9295-9c9b905f0eeb", "Styles": "None", "Classes": "None", "Text": "Infused", "ParentId": "01d4cb71-99bb-4882-8fd4-125ca632cf66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=79</b></p>", "ID": "92ee56d4-4921-44af-8959-01f04101ee08", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3120c60e-557b-46c0-9e3a-1dc0b19e4e30"}, {"Element": "<b>N=79</b>", "ID": "53ddb7c7-f78a-4b5a-97c6-241218ee4be1", "Styles": "None", "Classes": "None", "Text": "N=79", "ParentId": "92ee56d4-4921-44af-8959-01f04101ee08"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>", "ID": "d341d794-4035-4695-bb4d-ce7bcfaccd30", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3120c60e-557b-46c0-9e3a-1dc0b19e4e30"}, {"Element": "<b>n\n   (%)</b>", "ID": "dac524dd-7616-431f-9624-4382fc34ba26", "Styles": "None", "Classes": "None", "Text": "n    (%)", "ParentId": "d341d794-4035-4695-bb4d-ce7bcfaccd30"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>\n<td style=\"width:25.72%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "41ff031e-645d-41ac-91c8-477303a09045", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>", "ID": "b5c0b8f0-f172-4809-b188-f57eec20fbfd", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "41ff031e-645d-41ac-91c8-477303a09045"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>", "ID": "cb0ac945-33c1-4cfd-976b-46ee9c0a5274", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5c0b8f0-f172-4809-b188-f57eec20fbfd"}, {"Element": "<b>Age\n  (years)</b>", "ID": "a8fd3d0a-15e8-4fba-8548-96dd82b93362", "Styles": "None", "Classes": "None", "Text": "Age   (years)", "ParentId": "cb0ac945-33c1-4cfd-976b-46ee9c0a5274"}, {"Element": "<td style=\"width:25.72%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "c98ac6f2-7a9c-4867-ba54-c962d8d07077", "Styles": "width:25.72%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "41ff031e-645d-41ac-91c8-477303a09045"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "895a551a-3728-4c6e-9c83-8dd0b8aea2cf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "c98ac6f2-7a9c-4867-ba54-c962d8d07077"}, {"Element": "<td style=\"width:25.74%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "65d63c07-ea91-4241-9277-2080a8b06685", "Styles": "width:25.74%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "41ff031e-645d-41ac-91c8-477303a09045"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "e9447357-c843-4359-b1d2-35972fa66e0d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "65d63c07-ea91-4241-9277-2080a8b06685"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.48)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.38)</p>\n</td>\n</tr>", "ID": "1dbb2a94-6e6a-4658-9b3c-d54c8467e0ba", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>", "ID": "c864b06a-7be0-43d6-94c8-f87d13e08614", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1dbb2a94-6e6a-4658-9b3c-d54c8467e0ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>", "ID": "6bc258d7-594f-4813-8b8e-4d27f42f4148", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean   (standard deviation)", "ParentId": "c864b06a-7be0-43d6-94c8-f87d13e08614"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.48)</p>\n</td>", "ID": "f2052282-c13d-4a84-ac20-27d081b1039e", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1dbb2a94-6e6a-4658-9b3c-d54c8467e0ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.48)</p>", "ID": "4a99039a-6cfe-4e28-bd7e-441462f29e39", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "12 (5.48)", "ParentId": "f2052282-c13d-4a84-ac20-27d081b1039e"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.38)</p>\n</td>", "ID": "d9084b4a-d6af-433e-9b9d-f6c00ee8a0f3", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1dbb2a94-6e6a-4658-9b3c-d54c8467e0ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">12 (5.38)</p>", "ID": "e5cc2b0e-f303-492f-85a6-c16a3b52d318", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "12 (5.38)", "ParentId": "d9084b4a-d6af-433e-9b9d-f6c00ee8a0f3"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  27)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  24)</p>\n</td>\n</tr>", "ID": "d8af573c-f943-4e89-9610-59f025346e35", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>", "ID": "939e9149-9e53-47ff-8f29-654e9086c2b0", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8af573c-f943-4e89-9610-59f025346e35"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>", "ID": "1be963e1-a2bd-4d5c-bfa5-c8ce32229dc3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median   (minimum \u2013 maximum)", "ParentId": "939e9149-9e53-47ff-8f29-654e9086c2b0"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  27)</p>\n</td>", "ID": "fb38e229-c1ba-4ade-8255-9b41286c1622", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8af573c-f943-4e89-9610-59f025346e35"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  27)</p>", "ID": "b1ecfc9a-15f4-4979-93f0-f7f9dea32988", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "11 (3 \u2013   27)", "ParentId": "fb38e229-c1ba-4ade-8255-9b41286c1622"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  24)</p>\n</td>", "ID": "f6aa2dd6-9b39-4901-b751-52dda5be65e6", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d8af573c-f943-4e89-9610-59f025346e35"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">11 (3 \u2013\n  24)</p>", "ID": "154f32e2-9b87-4030-ab57-d71e97e2fb3e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "11 (3 \u2013   24)", "ParentId": "f6aa2dd6-9b39-4901-b751-52dda5be65e6"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "ab98aa26-40d0-4938-8fc7-9a0203fc0363", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>", "ID": "5a55ebba-8f57-497f-a310-f7c8036b119d", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ab98aa26-40d0-4938-8fc7-9a0203fc0363"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>", "ID": "0e44c34c-015a-4d3c-85e4-e496c115bf4f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a55ebba-8f57-497f-a310-f7c8036b119d"}, {"Element": "<b>Age\n  category (years) - n (%)</b>", "ID": "b9499bfa-6012-4faa-a6dd-3f69ed4dfc5c", "Styles": "None", "Classes": "None", "Text": "Age   category (years) - n (%)", "ParentId": "0e44c34c-015a-4d3c-85e4-e496c115bf4f"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "6a930314-7418-4954-9dd7-77f55456e9ef", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ab98aa26-40d0-4938-8fc7-9a0203fc0363"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "499189f9-6720-43d8-a85f-ba7638884cbe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "6a930314-7418-4954-9dd7-77f55456e9ef"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "10b1e90a-8ffe-4085-9a03-b7a6d5ece562", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ab98aa26-40d0-4938-8fc7-9a0203fc0363"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "302a3461-05ae-4884-824c-ab4cb78e40b5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "10b1e90a-8ffe-4085-9a03-b7a6d5ece562"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;10\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">32\n  (40.5)</p>\n</td>\n</tr>", "ID": "f8d0c0b8-fbfb-4f71-90e3-10e934122b66", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;10\u00a0years</p>\n</td>", "ID": "d7e4db23-1e28-4c8c-8156-54927b26dfc0", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f8d0c0b8-fbfb-4f71-90e3-10e934122b66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;10\u00a0years</p>", "ID": "7401a87c-1e20-41c5-9b7a-06d85f73c1be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <10\u00a0years", "ParentId": "d7e4db23-1e28-4c8c-8156-54927b26dfc0"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>", "ID": "3d81c6e8-2f26-4d8f-8781-5b60510b1cfd", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f8d0c0b8-fbfb-4f71-90e3-10e934122b66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>", "ID": "e3c6325e-9815-43cc-a332-4ebdcd12898e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "40   (41.2)", "ParentId": "3d81c6e8-2f26-4d8f-8781-5b60510b1cfd"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">32\n  (40.5)</p>\n</td>", "ID": "078f1bb1-7dd5-4a58-9e9d-9b96d5f3c546", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f8d0c0b8-fbfb-4f71-90e3-10e934122b66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">32\n  (40.5)</p>", "ID": "d841c9e7-cbf1-4944-9089-869686ebbd11", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "32   (40.5)", "ParentId": "078f1bb1-7dd5-4a58-9e9d-9b96d5f3c546"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226510\u00a0years\n  and &lt;18\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">33\n  (41.8)</p>\n</td>\n</tr>", "ID": "37eda168-8967-46c4-ba71-951423351293", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226510\u00a0years\n  and &lt;18\u00a0years</p>\n</td>", "ID": "5f99f11b-a325-4108-bd7f-3a6da960e65d", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "37eda168-8967-46c4-ba71-951423351293"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226510\u00a0years\n  and &lt;18\u00a0years</p>", "ID": "d335d4cd-cd86-4c6e-9ccb-8c1034baf685", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226510\u00a0years   and <18\u00a0years", "ParentId": "5f99f11b-a325-4108-bd7f-3a6da960e65d"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>\n</td>", "ID": "040f89a5-22c9-48fc-a09e-ddbab82ce817", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "37eda168-8967-46c4-ba71-951423351293"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">40\n  (41.2)</p>", "ID": "d36eabe2-1a7b-4d1a-a550-9c656b78354b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "40   (41.2)", "ParentId": "040f89a5-22c9-48fc-a09e-ddbab82ce817"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">33\n  (41.8)</p>\n</td>", "ID": "36a07e1b-7ab3-459e-9ff4-d5d83b72cfc6", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "37eda168-8967-46c4-ba71-951423351293"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">33\n  (41.8)</p>", "ID": "2c22e122-cb5b-4593-b4b0-94510cb278e1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "33   (41.8)", "ParentId": "36a07e1b-7ab3-459e-9ff4-d5d83b72cfc6"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226518\u00a0years</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">17 (17.5)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">14\n  (17.7)</p>\n</td>\n</tr>", "ID": "365d342f-18ca-4bdc-ac59-6f8002a6272f", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226518\u00a0years</p>\n</td>", "ID": "ec0bec37-4635-4f33-b808-117c0ed44cd8", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "365d342f-18ca-4bdc-ac59-6f8002a6272f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226518\u00a0years</p>", "ID": "89f927d5-4331-4e11-8018-6b848d213683", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226518\u00a0years", "ParentId": "ec0bec37-4635-4f33-b808-117c0ed44cd8"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">17 (17.5)</p>\n</td>", "ID": "eecb2b1f-e53a-4e47-b3b8-a2549e7d8c3d", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "365d342f-18ca-4bdc-ac59-6f8002a6272f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">17 (17.5)</p>", "ID": "d113668a-e3a3-4efb-ab5f-6d6b5466a94f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "17 (17.5)", "ParentId": "eecb2b1f-e53a-4e47-b3b8-a2549e7d8c3d"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">14\n  (17.7)</p>\n</td>", "ID": "ee558614-f11c-4117-b0b9-4ca4375468d5", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "365d342f-18ca-4bdc-ac59-6f8002a6272f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">14\n  (17.7)</p>", "ID": "2531a405-96cf-4a31-bd7a-2713fa116170", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "14   (17.7)", "ParentId": "ee558614-f11c-4117-b0b9-4ca4375468d5"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "59f34345-d674-4b2d-bf08-a16291fdcc13", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>", "ID": "57aeab8b-9ca9-49f1-8f89-1d751aeae7d4", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "59f34345-d674-4b2d-bf08-a16291fdcc13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>", "ID": "fb0a9998-9d7e-4b73-b52e-2e4a8483fd0b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "57aeab8b-9ca9-49f1-8f89-1d751aeae7d4"}, {"Element": "<b>Sex -\n  n (%)</b>", "ID": "34ea37af-3bf8-4a9b-ad6e-df3a1484302e", "Styles": "None", "Classes": "None", "Text": "Sex -   n (%)", "ParentId": "fb0a9998-9d7e-4b73-b52e-2e4a8483fd0b"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "68cd47ee-e173-4bf1-b72d-d4463598d044", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "59f34345-d674-4b2d-bf08-a16291fdcc13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "c4bbb453-336b-459c-91e1-e55350842eac", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "68cd47ee-e173-4bf1-b72d-d4463598d044"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "cfe98543-a438-4971-9a61-c646e92e0457", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "59f34345-d674-4b2d-bf08-a16291fdcc13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "ceab4c95-41dd-4797-b09e-455fdd36dc85", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "cfe98543-a438-4971-9a61-c646e92e0457"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (55.7)\n  </p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">45\n  (57.0)</p>\n</td>\n</tr>", "ID": "d21cc38d-9603-4dc2-8638-6b677b16fa2d", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>", "ID": "d45a8c17-57eb-43e4-98aa-ab0e180db8f0", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d21cc38d-9603-4dc2-8638-6b677b16fa2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>", "ID": "724f02a1-c762-4fc5-896c-f9f9cc1e7954", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male", "ParentId": "d45a8c17-57eb-43e4-98aa-ab0e180db8f0"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (55.7)\n  </p>\n</td>", "ID": "3c1ae532-d199-4a12-bd6e-59b9d21d7e18", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d21cc38d-9603-4dc2-8638-6b677b16fa2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (55.7)\n  </p>", "ID": "697d4338-ffd1-4334-a9af-63e0feeb7393", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "54 (55.7)   ", "ParentId": "3c1ae532-d199-4a12-bd6e-59b9d21d7e18"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">45\n  (57.0)</p>\n</td>", "ID": "cd09d6ef-0282-4ebb-9cd1-b1c7183ea542", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d21cc38d-9603-4dc2-8638-6b677b16fa2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">45\n  (57.0)</p>", "ID": "211544a5-39bf-4fc5-8ffc-08788921fe00", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "45   (57.0)", "ParentId": "cd09d6ef-0282-4ebb-9cd1-b1c7183ea542"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">43 (44.3)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">34 (43)</p>\n</td>\n</tr>", "ID": "d2c15820-e9ad-427d-96f0-734eeef6f3b3", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>", "ID": "3ff1c0ca-c498-4945-92d9-a4f0d7af3332", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d2c15820-e9ad-427d-96f0-734eeef6f3b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>", "ID": "272f2e00-555b-4e34-9100-b3b39e713b16", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female", "ParentId": "3ff1c0ca-c498-4945-92d9-a4f0d7af3332"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">43 (44.3)</p>\n</td>", "ID": "cac36ffa-8e26-4d86-8e9b-cfc3a868cf96", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d2c15820-e9ad-427d-96f0-734eeef6f3b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">43 (44.3)</p>", "ID": "5c486a92-6430-420b-aae9-893b913ca5db", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "43 (44.3)", "ParentId": "cac36ffa-8e26-4d86-8e9b-cfc3a868cf96"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">34 (43)</p>\n</td>", "ID": "d4f4e180-e016-4527-ad14-483a2f4a9ebe", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d2c15820-e9ad-427d-96f0-734eeef6f3b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">34 (43)</p>", "ID": "7e1e6771-52b2-4cae-9b2e-79783b247e7e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "34 (43)", "ParentId": "d4f4e180-e016-4527-ad14-483a2f4a9ebe"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "5bd921b6-5579-4550-84e2-bf39474935a3", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>", "ID": "a35a1566-bcd9-488b-9638-e358525fe530", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5bd921b6-5579-4550-84e2-bf39474935a3"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>", "ID": "9d2a3493-9821-4bed-afab-d5b2bb170cb3", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a35a1566-bcd9-488b-9638-e358525fe530"}, {"Element": "<b>Disease status (%)</b>", "ID": "60fa04b5-0e35-4d23-b963-f61c30d2c740", "Styles": "None", "Classes": "None", "Text": "Disease status (%)", "ParentId": "9d2a3493-9821-4bed-afab-d5b2bb170cb3"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "0c304e22-3729-4816-a732-a5384bcb0c3a", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5bd921b6-5579-4550-84e2-bf39474935a3"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "8c644ac9-6c9c-4554-9f70-e44a1a907be9", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "0c304e22-3729-4816-a732-a5384bcb0c3a"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "65632815-6c6b-4524-9032-8a95d2c05ac1", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5bd921b6-5579-4550-84e2-bf39474935a3"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "7710a58c-912c-41f0-9834-cab057c77368", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "65632815-6c6b-4524-9032-8a95d2c05ac1"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary refractory<sup>1</sup></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">8 (8.2)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>\n</tr>", "ID": "a6c04018-f901-41b5-9bab-955c15c17b1d", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary refractory<sup>1</sup></p>\n</td>", "ID": "28446c4e-85e3-403a-b534-dd644974097d", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a6c04018-f901-41b5-9bab-955c15c17b1d"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary refractory<sup>1</sup></p>", "ID": "831516d0-d728-4ff8-be81-29633efaea38", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Primary refractory", "ParentId": "28446c4e-85e3-403a-b534-dd644974097d"}, {"Element": "<sup>1</sup>", "ID": "0e3039f3-5010-4e92-a850-edb30d5149f9", "Styles": "None", "Classes": "None", "Text": "1", "ParentId": "831516d0-d728-4ff8-be81-29633efaea38"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">8 (8.2)</p>\n</td>", "ID": "bf851941-c15f-4614-b005-e4a1a5228528", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a6c04018-f901-41b5-9bab-955c15c17b1d"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">8 (8.2)</p>", "ID": "efc600da-7163-4de4-8495-44e62dfcdbb3", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "8 (8.2)", "ParentId": "bf851941-c15f-4614-b005-e4a1a5228528"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>", "ID": "247bb119-6273-4472-ab4f-4b9af4a171e6", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a6c04018-f901-41b5-9bab-955c15c17b1d"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">6 (7.6)</p>", "ID": "b08cd60d-1d40-4aa0-b71d-58759d77e414", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "6 (7.6)", "ParentId": "247bb119-6273-4472-ab4f-4b9af4a171e6"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapsed disease<sup>2</sup></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">89 (91.8)</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">73 (92.4)</p>\n</td>\n</tr>", "ID": "c011a198-a7e9-4f50-99cb-d21231bbd36e", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapsed disease<sup>2</sup></p>\n</td>", "ID": "a8d81810-27af-45b0-b57a-0b88ff723926", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c011a198-a7e9-4f50-99cb-d21231bbd36e"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapsed disease<sup>2</sup></p>", "ID": "0df65eee-a36f-43e1-b22f-9a022ad8d3b1", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapsed disease", "ParentId": "a8d81810-27af-45b0-b57a-0b88ff723926"}, {"Element": "<sup>2</sup>", "ID": "7d300235-bf4c-4b3c-ada8-dec47b245b97", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "0df65eee-a36f-43e1-b22f-9a022ad8d3b1"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">89 (91.8)</p>\n</td>", "ID": "5cbe00da-ba60-476d-96d3-ca11d7dcd7a8", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c011a198-a7e9-4f50-99cb-d21231bbd36e"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">89 (91.8)</p>", "ID": "0b6dd9c4-b98e-4c3e-b110-1f296ee8b59b", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "89 (91.8)", "ParentId": "5cbe00da-ba60-476d-96d3-ca11d7dcd7a8"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">73 (92.4)</p>\n</td>", "ID": "9d50bad3-fb12-469e-b084-b04af20b8c7e", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c011a198-a7e9-4f50-99cb-d21231bbd36e"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">73 (92.4)</p>", "ID": "4d8f25ae-a8c6-46fb-9d7b-5ad690967703", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "73 (92.4)", "ParentId": "9d50bad3-fb12-469e-b084-b04af20b8c7e"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Prior\n  stem-cell transplantation - n (%)</b></p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "694b51af-8cb5-48aa-8c00-22a9144bb277", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Prior\n  stem-cell transplantation - n (%)</b></p>\n</td>", "ID": "6928f2c2-68eb-4300-85d3-eb9c0f168a33", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "694b51af-8cb5-48aa-8c00-22a9144bb277"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Prior\n  stem-cell transplantation - n (%)</b></p>", "ID": "7a120576-b453-4bc6-8624-d113ebc820d7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6928f2c2-68eb-4300-85d3-eb9c0f168a33"}, {"Element": "<b>Prior\n  stem-cell transplantation - n (%)</b>", "ID": "54e1d540-128e-41c5-9875-4d4e6c609659", "Styles": "None", "Classes": "None", "Text": "Prior   stem-cell transplantation - n (%)", "ParentId": "7a120576-b453-4bc6-8624-d113ebc820d7"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "6d73736b-7fa3-45e4-9a49-196e8cd274a0", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "694b51af-8cb5-48aa-8c00-22a9144bb277"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "8740e028-7426-459b-aec2-3a94e1c9a072", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "6d73736b-7fa3-45e4-9a49-196e8cd274a0"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "18fefb83-e6a5-49bf-9ffb-196444a80efc", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "694b51af-8cb5-48aa-8c00-22a9144bb277"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "66611ce2-2efb-44e3-965d-ec9b9e2a99f6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "18fefb83-e6a5-49bf-9ffb-196444a80efc"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">39 (40.2)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">31\n  (39.2)</p>\n</td>\n</tr>", "ID": "ccfdd795-dd4a-41bb-8723-f23a69aaea05", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0</p>\n</td>", "ID": "249e8f8f-46e1-41d9-a493-5c0ebc3302e6", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ccfdd795-dd4a-41bb-8723-f23a69aaea05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0</p>", "ID": "cc31eae3-5139-4fdc-9c42-20dd3962eddb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 0", "ParentId": "249e8f8f-46e1-41d9-a493-5c0ebc3302e6"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">39 (40.2)</span></p>\n</td>", "ID": "93081f12-3883-4233-b735-6f441b747992", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ccfdd795-dd4a-41bb-8723-f23a69aaea05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">39 (40.2)</span></p>", "ID": "5bab0ddd-976b-4deb-bdd0-0c893874e85f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93081f12-3883-4233-b735-6f441b747992"}, {"Element": "<span lang=\"EN-GB\">39 (40.2)</span>", "ID": "8dfcba23-521e-40b3-992e-532bff1b94ee", "Styles": "None", "Classes": "None", "Text": "39 (40.2)", "ParentId": "5bab0ddd-976b-4deb-bdd0-0c893874e85f"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">31\n  (39.2)</p>\n</td>", "ID": "35a81dc6-c55f-48be-a2a7-91a8202c282d", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ccfdd795-dd4a-41bb-8723-f23a69aaea05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">31\n  (39.2)</p>", "ID": "a2c36a75-9289-4d01-9e62-bc30a1dc5b7f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "31   (39.2)", "ParentId": "35a81dc6-c55f-48be-a2a7-91a8202c282d"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">50 (51.5)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">42\n  (53.2)</p>\n</td>\n</tr>", "ID": "d81ceb11-0879-4139-9c57-5c5a682265a3", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</p>\n</td>", "ID": "7d2c4740-b3c4-477e-a58e-1518afb368e8", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d81ceb11-0879-4139-9c57-5c5a682265a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</p>", "ID": "964ad9db-8ed6-4b33-b884-6fd61f995eda", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1", "ParentId": "7d2c4740-b3c4-477e-a58e-1518afb368e8"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">50 (51.5)</span></p>\n</td>", "ID": "ccedca6e-abaa-40e8-9204-f32ee1af0633", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d81ceb11-0879-4139-9c57-5c5a682265a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">50 (51.5)</span></p>", "ID": "5655f6ff-4ca1-4eb3-b063-c5131d5d4186", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ccedca6e-abaa-40e8-9204-f32ee1af0633"}, {"Element": "<span lang=\"EN-GB\">50 (51.5)</span>", "ID": "95b8b22c-597f-49ff-9467-5300163d1b48", "Styles": "None", "Classes": "None", "Text": "50 (51.5)", "ParentId": "5655f6ff-4ca1-4eb3-b063-c5131d5d4186"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">42\n  (53.2)</p>\n</td>", "ID": "ca034391-cb26-4739-8cac-2453b587f36f", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d81ceb11-0879-4139-9c57-5c5a682265a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">42\n  (53.2)</p>", "ID": "2e6ef49c-536b-431d-a1a6-9869b9f84320", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "42   (53.2)", "ParentId": "ca034391-cb26-4739-8cac-2453b587f36f"}, {"Element": "<tr>\n<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</p>\n</td>\n<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">8 (8.2)</span></p>\n</td>\n<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>\n</tr>", "ID": "d3954951-44d5-402e-b471-40a1137a5062", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td style=\"width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"48%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</p>\n</td>", "ID": "02b0c245-ca8a-43cd-b110-c8231f773b2c", "Styles": "width:48.54%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d3954951-44d5-402e-b471-40a1137a5062"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</p>", "ID": "81f611f9-8a51-402d-a6f3-77aa2e350e45", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2", "ParentId": "02b0c245-ca8a-43cd-b110-c8231f773b2c"}, {"Element": "<td style=\"width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">8 (8.2)</span></p>\n</td>", "ID": "b7435ac6-1b16-4bb8-8a1f-f6360840efd1", "Styles": "width:25.72%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d3954951-44d5-402e-b471-40a1137a5062"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">8 (8.2)</span></p>", "ID": "525f14c1-4c0c-4c8b-9e0f-ba536b297315", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b7435ac6-1b16-4bb8-8a1f-f6360840efd1"}, {"Element": "<span lang=\"EN-GB\">8 (8.2)</span>", "ID": "176cc2b2-8959-4f66-ba3e-258b75c3c9fd", "Styles": "None", "Classes": "None", "Text": "8 (8.2)", "ParentId": "525f14c1-4c0c-4c8b-9e0f-ba536b297315"}, {"Element": "<td style=\"width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"25%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">6 (7.6)</p>\n</td>", "ID": "73d13dc1-4ca8-4f00-b121-6ece1fbf023f", "Styles": "width:25.74%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d3954951-44d5-402e-b471-40a1137a5062"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">6 (7.6)</p>", "ID": "7e9b6b52-c729-4c8e-8b1a-9549b6bb6d5c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "6 (7.6)", "ParentId": "73d13dc1-4ca8-4f00-b121-6ece1fbf023f"}, {"Element": "<tr style=\"height:18.25pt\">\n<td colspan=\"3\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:18.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><sup>1</sup>Primary\n  refractory: Never had a morphologic complete remission (CR) prior to the\n  study;</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><sup>2</sup>Relapsed disease:\n  Had at least one relapse prior to the study</p>\n</td>\n</tr>", "ID": "bcc2c0e7-8e23-4ef4-b627-d3c51101944f", "Styles": "height:18.25pt", "Classes": "None", "Text": "  ", "ParentId": "718157db-89e8-45ae-8466-63a7362232aa"}, {"Element": "<td colspan=\"3\" style=\"width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:18.25pt\" valign=\"top\" width=\"100%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><sup>1</sup>Primary\n  refractory: Never had a morphologic complete remission (CR) prior to the\n  study;</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><sup>2</sup>Relapsed disease:\n  Had at least one relapse prior to the study</p>\n</td>", "ID": "c1220aa4-7f25-4d0d-820d-479a912dff34", "Styles": "width:100.0%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:18.25pt", "Classes": "None", "Text": "   ", "ParentId": "bcc2c0e7-8e23-4ef4-b627-d3c51101944f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><sup>1</sup>Primary\n  refractory: Never had a morphologic complete remission (CR) prior to the\n  study;</p>", "ID": "ffdfd071-59cd-42c0-975d-f1e2e9a44e56", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "Primary   refractory: Never had a morphologic complete remission (CR) prior to the   study;", "ParentId": "c1220aa4-7f25-4d0d-820d-479a912dff34"}, {"Element": "<sup>1</sup>", "ID": "382eedea-2dc0-4d60-bc84-14373367c099", "Styles": "None", "Classes": "None", "Text": "1", "ParentId": "ffdfd071-59cd-42c0-975d-f1e2e9a44e56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><sup>2</sup>Relapsed disease:\n  Had at least one relapse prior to the study</p>", "ID": "65ea9dc4-1440-474f-b687-3770fd57bb93", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Relapsed disease:   Had at least one relapse prior to the study", "ParentId": "c1220aa4-7f25-4d0d-820d-479a912dff34"}, {"Element": "<sup>2</sup>", "ID": "6ee3df0c-9ef5-42cf-b550-6a99eeb0ba47", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "65ea9dc4-1440-474f-b687-3770fd57bb93"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be940a90-d6d9-47aa-a622-5d302c7bb4a0", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5eabd343-38ec-4fac-b914-f4aa5c1271ad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be940a90-d6d9-47aa-a622-5d302c7bb4a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Efficacy was established through the primary endpoint of overall\nremission rate (ORR), which includes best overall response as complete\nremission (CR) or complete remission with incomplete blood count recovery (CRi)\nwithin 3\u00a0months post infusion, as determined by Independent Review\nCommittee (IRC) assessment, as well as secondary endpoints including duration\nof remission (DOR) and the proportion of patients who achieved CR or CRi with\nminimal residual disease (MRD) &lt;0.01% by flow cytometry (MRD\u2011negative).</span><span lang=\"EN-GB\"> See Table\u00a04 for efficacy results from this study. ORR was\nconsistent across all subgroups. Eight </span><span lang=\"EN-GB\">patients (10.1%)\nwho achieved CR/CRi after Kymriah infusion went to haematopoietic stem cell transplant\nwhile in remission of which 6 of the patients (7.6%) proceeded to transplant\nwithin the first 6\u00a0months post\u2011infusion while in remission</span><span lang=\"EN-GB\">. Kymriah was administered in a qualified Kymriah treatment centre\nin an inpatient and outpatient setting.</span></p>", "ID": "2ab13269-29f9-4b06-a747-2ef21deb8d04", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Efficacy was established through the primary endpoint of overall\nremission rate (ORR), which includes best overall response as complete\nremission (CR) or complete remission with incomplete blood count recovery (CRi)\nwithin 3\u00a0months post infusion, as determined by Independent Review\nCommittee (IRC) assessment, as well as secondary endpoints including duration\nof remission (DOR) and the proportion of patients who achieved CR or CRi with\nminimal residual disease (MRD) &lt;0.01% by flow cytometry (MRD\u2011negative).</span>", "ID": "f53b8c97-2997-46a3-a656-fcd7c0fb02b3", "Styles": "None", "Classes": "None", "Text": "Efficacy was established through the primary endpoint of overall remission rate (ORR), which includes best overall response as complete remission (CR) or complete remission with incomplete blood count recovery (CRi) within 3\u00a0months post infusion, as determined by Independent Review Committee (IRC) assessment, as well as secondary endpoints including duration of remission (DOR) and the proportion of patients who achieved CR or CRi with minimal residual disease (MRD) <0.01% by flow cytometry (MRD\u2011negative).", "ParentId": "2ab13269-29f9-4b06-a747-2ef21deb8d04"}, {"Element": "<span lang=\"EN-GB\"> See Table\u00a04 for efficacy results from this study. ORR was\nconsistent across all subgroups. Eight </span>", "ID": "0262c57b-2dc3-44d3-a585-86caf5f4ca56", "Styles": "None", "Classes": "None", "Text": " See Table\u00a04 for efficacy results from this study. ORR was consistent across all subgroups. Eight ", "ParentId": "2ab13269-29f9-4b06-a747-2ef21deb8d04"}, {"Element": "<span lang=\"EN-GB\">patients (10.1%)\nwho achieved CR/CRi after Kymriah infusion went to haematopoietic stem cell transplant\nwhile in remission of which 6 of the patients (7.6%) proceeded to transplant\nwithin the first 6\u00a0months post\u2011infusion while in remission</span>", "ID": "77ed7019-ce17-4ea6-87df-f3abc045249c", "Styles": "None", "Classes": "None", "Text": "patients (10.1%) who achieved CR/CRi after Kymriah infusion went to haematopoietic stem cell transplant while in remission of which 6 of the patients (7.6%) proceeded to transplant within the first 6\u00a0months post\u2011infusion while in remission", "ParentId": "2ab13269-29f9-4b06-a747-2ef21deb8d04"}, {"Element": "<span lang=\"EN-GB\">. Kymriah was administered in a qualified Kymriah treatment centre\nin an inpatient and outpatient setting.</span>", "ID": "d3218b71-8778-450d-ab12-61d84107a3bf", "Styles": "None", "Classes": "None", "Text": ". Kymriah was administered in a qualified Kymriah treatment centre in an inpatient and outpatient setting.", "ParentId": "2ab13269-29f9-4b06-a747-2ef21deb8d04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ce63c311-af1a-4cb4-80ee-ff7f6c0076bd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b32428ae-7986-487e-a266-9bc5ede09af0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ce63c311-af1a-4cb4-80ee-ff7f6c0076bd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Table\u00a04\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Efficacy results in paediatric and young adult patients with\nrelapsed/refractory B\u2011cell acute lymphoblastic leukaemia (ALL)</span></b></p>", "ID": "2ff191b4-ccbd-495f-8120-e0d90e18aeba", "Styles": "margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a04\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Efficacy results in paediatric and young adult patients with\nrelapsed/refractory B\u2011cell acute lymphoblastic leukaemia (ALL)</span></b>", "ID": "adaf7969-ce32-437d-9676-c0311c23127b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ff191b4-ccbd-495f-8120-e0d90e18aeba"}, {"Element": "<span lang=\"EN-GB\">Table\u00a04\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nB2202: Efficacy results in paediatric and young adult patients with\nrelapsed/refractory B\u2011cell acute lymphoblastic leukaemia (ALL)</span>", "ID": "461aae50-700b-400f-b783-1c2a467a1a50", "Styles": "None", "Classes": "None", "Text": "Table\u00a04\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study B2202: Efficacy results in paediatric and young adult patients with relapsed/refractory B\u2011cell acute lymphoblastic leukaemia (ALL)", "ParentId": "adaf7969-ce32-437d-9676-c0311c23127b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "04728f3f-2071-41af-be79-b5ec53d36da5", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64076a89-a6fc-4fae-9fbf-79a7b9c0f061", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "04728f3f-2071-41af-be79-b5ec53d36da5"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr style=\"page-break-inside:avoid;height:12.9pt\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border:solid windowtext 1.0pt;border-left:\n  none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  remission rate (ORR)<sup>1,2</sup>, n (%)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>95% CI</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65 (67.0)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(56.7,\n  76.2)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65\n  (82.3)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(72.1,\n  90.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CR<sup>3</sup>,\n  n (%)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49 (50.5)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49\n  (62.0)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CRi<sup>4</sup>,\n  n (%)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (16.5)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (20.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Key secondary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>CR\n  or CRi with MRD negative bone marrow<sup>5,6</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">95% CI</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64 (66.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(55.7,\n  75.3)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">p&lt;0.0001</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64\n  (81.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(70.6,\n  89.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Duration of\n  remission (DOR)</span></b><sup><span style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>7</span></sup></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 18\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Median\n  (months) (95% CI)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE<sup>9</sup>)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  survival (OS)<sup>8</sup></span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 %\n  survival probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>69.8</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>76.4</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:14.2pt;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:\n  11.0pt;font-family:\"Times New Roman\",serif;color:black'>% survival probability\n  at 24\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>56.9</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 Median\n  (months) (95% CI)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (19.4, NE)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (28.2, NE)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>1</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requires remission\n  status to be maintained for at least 28\u00a0days without clinical evidence\n  of relapse.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: ORR \u226420% vs. Ha: ORR &gt;20%</span></p>\n<p class=\"MsoCommentText\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  page-break-after:avoid\"><sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">3</span></sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CR (complete remission) was defined as &lt;5% of blasts\n  in the bone marrow, circulating blasts in blood should be &lt;1%, no evidence\n  of extramedullary disease, and full recovery of peripheral blood counts\n  (platelets &gt;100,000/\u03bcL and absolute neutrophil counts [ANC]\n  &gt;1,000/\u03bcL) without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>4</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CRi (complete\n  remission with incomplete blood count recovery) was defined as &lt;5% of\n  blasts in the bone marrow, circulating blasts in blood should be &lt;1%, no\n  evidence of extramedullary disease, and without full recovery of peripheral\n  blood counts with or without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>5</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MRD (minimal\n  residual disease) negative was defined as MRD by flow cytometry &lt;0.01%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>6</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: Rate of MRD negative remission \u226415%\n  vs. Ha:\u00a0&gt;15%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>7</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOR was defined as\n  time since onset of CR or CRi to relapse or death due to underlying\n  indication, whichever is earlier (N=65).</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>8</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause for\n  infused patients and from time of date of enrolment to the date of death due\n  to any cause for enrolled patients.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  estimable</span></p>\n</td>\n</tr>\n</table>", "ID": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                 ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr style=\"page-break-inside:avoid;height:12.9pt\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border:solid windowtext 1.0pt;border-left:\n  none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>", "ID": "c940aab1-0ced-419b-bdce-1a107f2693a3", "Styles": "page-break-inside:avoid;height:12.9pt", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p>\n</td>", "ID": "cc124dae-dddf-459f-8143-be26f06063f0", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;padding:\n  0in 5.4pt 0in 5.4pt;height:12.9pt", "Classes": "None", "Text": "  ", "ParentId": "c940aab1-0ced-419b-bdce-1a107f2693a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p>", "ID": "ea1d8b5e-735e-4482-8ee3-dcb45cab77eb", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc124dae-dddf-459f-8143-be26f06063f0"}, {"Element": "<b><span lang=\"EN-GB\">Primary endpoint</span></b>", "ID": "ae2bdd97-5296-4d47-959a-954033b83862", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea1d8b5e-735e-4482-8ee3-dcb45cab77eb"}, {"Element": "<span lang=\"EN-GB\">Primary endpoint</span>", "ID": "5772b2a5-325f-4e85-84ae-9922940fc48c", "Styles": "None", "Classes": "None", "Text": "Primary endpoint", "ParentId": "ae2bdd97-5296-4d47-959a-954033b83862"}, {"Element": "<td style=\"width:113.85pt;border:solid windowtext 1.0pt;border-left:\n  none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>", "ID": "ff1187f2-cb54-47d5-a74d-fce143be4559", "Styles": "width:113.85pt;border:solid windowtext 1.0pt;border-left:\n  none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt", "Classes": "None", "Text": "   ", "ParentId": "c940aab1-0ced-419b-bdce-1a107f2693a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>", "ID": "41df5585-7e16-43de-93b1-5dec030e3777", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ff1187f2-cb54-47d5-a74d-fce143be4559"}, {"Element": "<b><span lang=\"EN-GB\">Enrolled patients</span></b>", "ID": "19a5f274-7234-40ce-994a-01f054bb2364", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "41df5585-7e16-43de-93b1-5dec030e3777"}, {"Element": "<span lang=\"EN-GB\">Enrolled patients</span>", "ID": "5237abc4-6cc8-4af2-b417-815da629a35c", "Styles": "None", "Classes": "None", "Text": "Enrolled patients", "ParentId": "19a5f274-7234-40ce-994a-01f054bb2364"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>", "ID": "c0557baa-9211-4791-972d-17a6e1ce260e", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ff1187f2-cb54-47d5-a74d-fce143be4559"}, {"Element": "<b><span lang=\"EN-GB\">N=97</span></b>", "ID": "0dae4425-81e2-4f34-bb7e-21804387d4b8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c0557baa-9211-4791-972d-17a6e1ce260e"}, {"Element": "<span lang=\"EN-GB\">N=97</span>", "ID": "d4947dce-c1a4-421a-acd2-f39e92845d98", "Styles": "None", "Classes": "None", "Text": "N=97", "ParentId": "0dae4425-81e2-4f34-bb7e-21804387d4b8"}, {"Element": "<td style=\"width:101.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>", "ID": "4f7d1682-7b23-4066-b423-a4eb726c3b78", "Styles": "width:101.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt;height:12.9pt", "Classes": "None", "Text": "   ", "ParentId": "c940aab1-0ced-419b-bdce-1a107f2693a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>", "ID": "7a0d0c89-735a-4450-8deb-69153ed3f14c", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4f7d1682-7b23-4066-b423-a4eb726c3b78"}, {"Element": "<b><span lang=\"EN-GB\">Infused patients</span></b>", "ID": "fbe5677b-6457-4db1-8bad-74224066fc47", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7a0d0c89-735a-4450-8deb-69153ed3f14c"}, {"Element": "<span lang=\"EN-GB\">Infused patients</span>", "ID": "fc715848-1e14-420a-8705-50175f76dd0a", "Styles": "None", "Classes": "None", "Text": "Infused patients", "ParentId": "fbe5677b-6457-4db1-8bad-74224066fc47"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>", "ID": "b5e1da57-f599-4396-90ef-45ab5a6ed178", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4f7d1682-7b23-4066-b423-a4eb726c3b78"}, {"Element": "<b><span lang=\"EN-GB\">N=79</span></b>", "ID": "24bfe1bf-b5fb-413e-b4d8-baafa6d2ab69", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5e1da57-f599-4396-90ef-45ab5a6ed178"}, {"Element": "<span lang=\"EN-GB\">N=79</span>", "ID": "eb67d17e-1bcc-46d5-b316-a55728873fe2", "Styles": "None", "Classes": "None", "Text": "N=79", "ParentId": "24bfe1bf-b5fb-413e-b4d8-baafa6d2ab69"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  remission rate (ORR)<sup>1,2</sup>, n (%)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>95% CI</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65 (67.0)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(56.7,\n  76.2)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65\n  (82.3)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(72.1,\n  90.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n</tr>", "ID": "dfbf2e50-f0f3-4ab3-a402-a0542eb9edd0", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  remission rate (ORR)<sup>1,2</sup>, n (%)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>95% CI</span></p>\n</td>", "ID": "9c771d11-9e3d-4205-814f-be4690af79b4", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "dfbf2e50-f0f3-4ab3-a402-a0542eb9edd0"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  remission rate (ORR)<sup>1,2</sup>, n (%)</span></b></p>", "ID": "44d09546-9c73-4fb8-822a-f254ad83f97c", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "9c771d11-9e3d-4205-814f-be4690af79b4"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  remission rate (ORR)<sup>1,2</sup>, n (%)</span></b>", "ID": "f99f02e0-2ce2-4253-a089-e2abdcda43fd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "44d09546-9c73-4fb8-822a-f254ad83f97c"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  remission rate (ORR)<sup>1,2</sup>, n (%)</span>", "ID": "1622fc62-fdae-42ba-afe1-95203f30a373", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Overall   remission rate (ORR), n (%)", "ParentId": "f99f02e0-2ce2-4253-a089-e2abdcda43fd"}, {"Element": "<sup>1,2</sup>", "ID": "a851a125-55bc-45d0-8dcf-ff4d5fdb3197", "Styles": "None", "Classes": "None", "Text": "1,2", "ParentId": "1622fc62-fdae-42ba-afe1-95203f30a373"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>95% CI</span></p>", "ID": "1b937391-c415-4b26-8782-93d3ddcc3c7d", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "9c771d11-9e3d-4205-814f-be4690af79b4"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>95% CI</span>", "ID": "aeec0455-a861-45e4-903b-46cddd55e660", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "95% CI", "ParentId": "1b937391-c415-4b26-8782-93d3ddcc3c7d"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65 (67.0)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(56.7,\n  76.2)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>", "ID": "6d96a926-6d66-49e8-b73f-f2a28628c824", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "dfbf2e50-f0f3-4ab3-a402-a0542eb9edd0"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65 (67.0)</span></b></p>", "ID": "8ae42a68-7f3e-428c-a386-903eca65e525", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6d96a926-6d66-49e8-b73f-f2a28628c824"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65 (67.0)</span></b>", "ID": "cb0b05dd-ca03-4e20-8384-7761297dd7b8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8ae42a68-7f3e-428c-a386-903eca65e525"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65 (67.0)</span>", "ID": "43f7db1d-7884-4beb-99aa-a0b4d4c15047", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "65 (67.0)", "ParentId": "cb0b05dd-ca03-4e20-8384-7761297dd7b8"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(56.7,\n  76.2)</span></p>", "ID": "a755ccd3-2bb2-4aa4-ace6-bb51759bb16b", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6d96a926-6d66-49e8-b73f-f2a28628c824"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(56.7,\n  76.2)</span>", "ID": "9de5d2c2-3727-4718-bc40-6f9df5cf7dd6", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "(56.7,   76.2)", "ParentId": "a755ccd3-2bb2-4aa4-ace6-bb51759bb16b"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>", "ID": "89483624-bb02-4373-8f2e-a81bc4421db3", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6d96a926-6d66-49e8-b73f-f2a28628c824"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span>", "ID": "61ed691b-cd81-4e3f-80bf-66ce1aff9031", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "p<0.0001", "ParentId": "89483624-bb02-4373-8f2e-a81bc4421db3"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65\n  (82.3)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(72.1,\n  90.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>", "ID": "aa9d81b8-1193-49f2-974a-fd633db0d31a", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "dfbf2e50-f0f3-4ab3-a402-a0542eb9edd0"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65\n  (82.3)</span></b></p>", "ID": "6f90d3c2-5b97-449a-bfb8-1951af4dee52", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "aa9d81b8-1193-49f2-974a-fd633db0d31a"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65\n  (82.3)</span></b>", "ID": "c90fac9e-0037-4883-9593-82eaf87ac5ce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6f90d3c2-5b97-449a-bfb8-1951af4dee52"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>65\n  (82.3)</span>", "ID": "bab4d543-c459-41f5-95e2-e2914c633c94", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "65   (82.3)", "ParentId": "c90fac9e-0037-4883-9593-82eaf87ac5ce"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(72.1,\n  90.0)</span></p>", "ID": "1863eeca-5af1-4cf7-87c8-4e5103d3fca5", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "aa9d81b8-1193-49f2-974a-fd633db0d31a"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(72.1,\n  90.0)</span>", "ID": "09430d9d-41ac-48b6-b5c9-d11e5a13f882", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "(72.1,   90.0)", "ParentId": "1863eeca-5af1-4cf7-87c8-4e5103d3fca5"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>", "ID": "8e8fefb3-0a7e-4877-aa61-4b2c1c159c74", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "aa9d81b8-1193-49f2-974a-fd633db0d31a"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span>", "ID": "44dad6da-fc21-4100-ba03-9e8e103e1764", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "p<0.0001", "ParentId": "8e8fefb3-0a7e-4877-aa61-4b2c1c159c74"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CR<sup>3</sup>,\n  n (%)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49 (50.5)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49\n  (62.0)</span></p>\n</td>\n</tr>", "ID": "86ef0c5a-66a2-4a24-be49-9b6da2562055", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CR<sup>3</sup>,\n  n (%)</span></p>\n</td>", "ID": "668b1a04-d438-4554-afe1-d82f00459aa7", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "86ef0c5a-66a2-4a24-be49-9b6da2562055"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CR<sup>3</sup>,\n  n (%)</span></p>", "ID": "fbb96d24-56f3-4bf3-9234-a38ffc2d2c6e", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "668b1a04-d438-4554-afe1-d82f00459aa7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CR<sup>3</sup>,\n  n (%)</span>", "ID": "bc96bf9b-71c7-4f47-ab56-06d41569bedc", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0 CR,   n (%)", "ParentId": "fbb96d24-56f3-4bf3-9234-a38ffc2d2c6e"}, {"Element": "<sup>3</sup>", "ID": "cae523e7-c1e9-4c41-a80c-6f27d9cf4995", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "bc96bf9b-71c7-4f47-ab56-06d41569bedc"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49 (50.5)</span></p>\n</td>", "ID": "b4f21f84-7b05-4a94-bde0-99b63f7a57cd", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "86ef0c5a-66a2-4a24-be49-9b6da2562055"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49 (50.5)</span></p>", "ID": "7e699baf-37ef-4848-abc4-e32787184a31", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b4f21f84-7b05-4a94-bde0-99b63f7a57cd"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49 (50.5)</span>", "ID": "716d4580-4dfc-4498-8bdb-da339d7e0209", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "49 (50.5)", "ParentId": "7e699baf-37ef-4848-abc4-e32787184a31"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49\n  (62.0)</span></p>\n</td>", "ID": "84926a80-d718-494e-935c-bbdbf4657649", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "86ef0c5a-66a2-4a24-be49-9b6da2562055"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49\n  (62.0)</span></p>", "ID": "4414a826-da19-4fd5-9b8c-ea6ecb010ea9", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "84926a80-d718-494e-935c-bbdbf4657649"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>49\n  (62.0)</span>", "ID": "939e89c2-9c94-4e4d-a700-e86096924579", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "49   (62.0)", "ParentId": "4414a826-da19-4fd5-9b8c-ea6ecb010ea9"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CRi<sup>4</sup>,\n  n (%)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (16.5)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (20.3)</span></p>\n</td>\n</tr>", "ID": "21b58d87-d0d4-4669-86f8-5c9a271fbe81", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CRi<sup>4</sup>,\n  n (%)</span></p>\n</td>", "ID": "f6615ab3-fe71-477d-b786-902aac13cbf2", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "21b58d87-d0d4-4669-86f8-5c9a271fbe81"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CRi<sup>4</sup>,\n  n (%)</span></p>", "ID": "b7be0c09-6058-419d-8c6c-6b23b5e07377", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "f6615ab3-fe71-477d-b786-902aac13cbf2"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0 CRi<sup>4</sup>,\n  n (%)</span>", "ID": "b60f0490-d52c-4586-b102-bae12de9b4fc", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0 CRi,   n (%)", "ParentId": "b7be0c09-6058-419d-8c6c-6b23b5e07377"}, {"Element": "<sup>4</sup>", "ID": "43033b40-2ffe-41cb-b23c-4c33c381bbae", "Styles": "None", "Classes": "None", "Text": "4", "ParentId": "b60f0490-d52c-4586-b102-bae12de9b4fc"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (16.5)</span></p>\n</td>", "ID": "5a33d512-4710-49da-b7d3-3f2d5d79f224", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "21b58d87-d0d4-4669-86f8-5c9a271fbe81"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (16.5)</span></p>", "ID": "36eab0f0-88ce-4be6-bd77-05c428fd1437", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "5a33d512-4710-49da-b7d3-3f2d5d79f224"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (16.5)</span>", "ID": "603904b6-b522-41cc-91a9-f7a35dd78544", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "16 (16.5)", "ParentId": "36eab0f0-88ce-4be6-bd77-05c428fd1437"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (20.3)</span></p>\n</td>", "ID": "10e99882-1898-4f88-be98-14664bb6a329", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "21b58d87-d0d4-4669-86f8-5c9a271fbe81"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (20.3)</span></p>", "ID": "5a86d41a-9f36-42f5-924e-23855212a88b", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "10e99882-1898-4f88-be98-14664bb6a329"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>16 (20.3)</span>", "ID": "2c5eda3a-e63b-4048-a9ef-fd572ad35626", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "16 (20.3)", "ParentId": "5a86d41a-9f36-42f5-924e-23855212a88b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Key secondary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>", "ID": "13603ffc-2430-41e9-b8c3-ab3be080cf91", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Key secondary endpoint</span></b></p>\n</td>", "ID": "083f5067-0abf-4f65-b403-13abcfb418f4", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "13603ffc-2430-41e9-b8c3-ab3be080cf91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Key secondary endpoint</span></b></p>", "ID": "264315f5-2162-4be7-bba5-a27422e443d0", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "083f5067-0abf-4f65-b403-13abcfb418f4"}, {"Element": "<b><span lang=\"EN-GB\">Key secondary endpoint</span></b>", "ID": "b98acf5e-0895-4177-8e95-581e5206adfa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "264315f5-2162-4be7-bba5-a27422e443d0"}, {"Element": "<span lang=\"EN-GB\">Key secondary endpoint</span>", "ID": "be168bc4-6e30-4013-9764-58729f8e339e", "Styles": "None", "Classes": "None", "Text": "Key secondary endpoint", "ParentId": "b98acf5e-0895-4177-8e95-581e5206adfa"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>", "ID": "b187b525-3cb6-43ab-be93-e6bf3d4d54c4", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "13603ffc-2430-41e9-b8c3-ab3be080cf91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>", "ID": "1e9858ef-9e46-41c7-98a2-a280bffd21dd", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b187b525-3cb6-43ab-be93-e6bf3d4d54c4"}, {"Element": "<b><span lang=\"EN-GB\">N=97</span></b>", "ID": "ab4d341b-2415-46cf-80e8-e2a54b0c1e7e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1e9858ef-9e46-41c7-98a2-a280bffd21dd"}, {"Element": "<span lang=\"EN-GB\">N=97</span>", "ID": "d45015e5-10ad-44a3-988d-0ea206c448bc", "Styles": "None", "Classes": "None", "Text": "N=97", "ParentId": "ab4d341b-2415-46cf-80e8-e2a54b0c1e7e"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>", "ID": "9f4264ee-1c1c-4d74-a680-dc8e49d0d8ca", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "13603ffc-2430-41e9-b8c3-ab3be080cf91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>", "ID": "b7f5242a-e7f3-4063-a655-767a70d7bfd9", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9f4264ee-1c1c-4d74-a680-dc8e49d0d8ca"}, {"Element": "<b><span lang=\"EN-GB\">N=79</span></b>", "ID": "572ab26a-7cc5-4b2b-b693-51b3d654b03c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b7f5242a-e7f3-4063-a655-767a70d7bfd9"}, {"Element": "<span lang=\"EN-GB\">N=79</span>", "ID": "8b2c2ca5-6a85-430b-bbca-787beda80800", "Styles": "None", "Classes": "None", "Text": "N=79", "ParentId": "572ab26a-7cc5-4b2b-b693-51b3d654b03c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>CR\n  or CRi with MRD negative bone marrow<sup>5,6</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">95% CI</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64 (66.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(55.7,\n  75.3)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">p&lt;0.0001</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64\n  (81.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(70.6,\n  89.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>\n</tr>", "ID": "a6e95e56-fc78-4ff1-90f3-e9efc48c7c30", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>CR\n  or CRi with MRD negative bone marrow<sup>5,6</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">95% CI</span></p>\n</td>", "ID": "927cf6f4-babc-4329-b60f-0edc204c0e7b", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "a6e95e56-fc78-4ff1-90f3-e9efc48c7c30"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>CR\n  or CRi with MRD negative bone marrow<sup>5,6</sup>, n (%)</span></p>", "ID": "9b7e012f-8ada-4ed7-8a47-d605c75e18ef", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "927cf6f4-babc-4329-b60f-0edc204c0e7b"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>CR\n  or CRi with MRD negative bone marrow<sup>5,6</sup>, n (%)</span>", "ID": "4f2732eb-d315-43cd-a53c-3805d44ab004", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "CR   or CRi with MRD negative bone marrow, n (%)", "ParentId": "9b7e012f-8ada-4ed7-8a47-d605c75e18ef"}, {"Element": "<sup>5,6</sup>", "ID": "32170c55-28b6-4be6-8202-1fe92de51666", "Styles": "None", "Classes": "None", "Text": "5,6", "ParentId": "4f2732eb-d315-43cd-a53c-3805d44ab004"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">95% CI</span></p>", "ID": "268353a4-fb51-4f23-bf3e-da04eda3d44e", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "927cf6f4-babc-4329-b60f-0edc204c0e7b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">95% CI</span>", "ID": "c8cd576e-e6fa-4a8d-aa0c-db7aa05cb531", "Styles": "color:black", "Classes": "None", "Text": "95% CI", "ParentId": "268353a4-fb51-4f23-bf3e-da04eda3d44e"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64 (66.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(55.7,\n  75.3)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">p&lt;0.0001</span></p>\n</td>", "ID": "50d6f932-c8ca-4ab6-82a0-507c6786d552", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "a6e95e56-fc78-4ff1-90f3-e9efc48c7c30"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64 (66.0)</span></p>", "ID": "b8ca21ef-e4af-4bdb-94da-f56b557e4c88", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "50d6f932-c8ca-4ab6-82a0-507c6786d552"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64 (66.0)</span>", "ID": "a62df41b-a51d-4b32-82c3-223929220235", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "64 (66.0)", "ParentId": "b8ca21ef-e4af-4bdb-94da-f56b557e4c88"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(55.7,\n  75.3)</span></p>", "ID": "8a5c6120-d7cb-4b52-a4b3-cdde5e8ebb18", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "50d6f932-c8ca-4ab6-82a0-507c6786d552"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(55.7,\n  75.3)</span>", "ID": "d659412e-cf6a-4bcd-a6c3-cd27fa3c2f97", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "(55.7,   75.3)", "ParentId": "8a5c6120-d7cb-4b52-a4b3-cdde5e8ebb18"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">p&lt;0.0001</span></p>", "ID": "e8916416-0637-4448-a3ec-4b66ab807b3a", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "50d6f932-c8ca-4ab6-82a0-507c6786d552"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">p&lt;0.0001</span>", "ID": "d0387b16-f9c6-4c93-ac6a-1ecd152b4e96", "Styles": "color:black", "Classes": "None", "Text": "p<0.0001", "ParentId": "e8916416-0637-4448-a3ec-4b66ab807b3a"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64\n  (81.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(70.6,\n  89.0)</span></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>\n</td>", "ID": "6bb45b22-2b25-4258-9a77-74a43dea2fc1", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "a6e95e56-fc78-4ff1-90f3-e9efc48c7c30"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64\n  (81.0)</span></p>", "ID": "6c911ce8-ea79-4fc4-954f-0635f722a4b0", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6bb45b22-2b25-4258-9a77-74a43dea2fc1"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>64\n  (81.0)</span>", "ID": "288736d4-4c32-484f-805a-8621b54aa71a", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "64   (81.0)", "ParentId": "6c911ce8-ea79-4fc4-954f-0635f722a4b0"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(70.6,\n  89.0)</span></p>", "ID": "3fdc3ac8-4482-47c0-be07-58535db26146", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6bb45b22-2b25-4258-9a77-74a43dea2fc1"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>(70.6,\n  89.0)</span>", "ID": "bfc92c9f-dfad-4e4e-b243-8438e1904fc7", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "(70.6,   89.0)", "ParentId": "3fdc3ac8-4482-47c0-be07-58535db26146"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span></p>", "ID": "0c9e7c9c-f00c-4787-a0a5-594c429b39b9", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6bb45b22-2b25-4258-9a77-74a43dea2fc1"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>p&lt;0.0001</span>", "ID": "544b67cb-cf95-4cfc-aa6d-078c3eb7bdbe", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "p<0.0001", "ParentId": "0c9e7c9c-f00c-4787-a0a5-594c429b39b9"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Duration of\n  remission (DOR)</span></b><sup><span style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>7</span></sup></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>\n</tr>", "ID": "4222a2c0-af96-49eb-b6a4-f4fe0ecbde44", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Duration of\n  remission (DOR)</span></b><sup><span style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>7</span></sup></p>\n</td>", "ID": "c0dc8068-47f3-4630-a75b-b039d0ccd658", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "4222a2c0-af96-49eb-b6a4-f4fe0ecbde44"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Duration of\n  remission (DOR)</span></b><sup><span style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>7</span></sup></p>", "ID": "e888c985-136f-414b-89b5-cafdb4738a72", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "c0dc8068-47f3-4630-a75b-b039d0ccd658"}, {"Element": "<b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Duration of\n  remission (DOR)</span></b>", "ID": "a72e7358-f7d9-4ec1-ada8-2fa8073633c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e888c985-136f-414b-89b5-cafdb4738a72"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Duration of\n  remission (DOR)</span>", "ID": "c0df17b2-bd6c-418b-b40d-50c802c006dc", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Duration of   remission (DOR)", "ParentId": "a72e7358-f7d9-4ec1-ada8-2fa8073633c3"}, {"Element": "<sup><span style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>7</span></sup>", "ID": "782b68d5-b62b-4d53-8564-a90a49cbae59", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e888c985-136f-414b-89b5-cafdb4738a72"}, {"Element": "<span style='font-size:11.0pt;font-family:\n  \"Times New Roman\",serif'>7</span>", "ID": "ab4dbfc1-877a-47aa-a6a8-c97f254e16b3", "Styles": "font-size:11.0pt;font-family:\n  \"Times New Roman\",serif", "Classes": "None", "Text": "7", "ParentId": "782b68d5-b62b-4d53-8564-a90a49cbae59"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>", "ID": "9c7227ef-b991-40bb-abda-9b1cc97688e0", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "4222a2c0-af96-49eb-b6a4-f4fe0ecbde44"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>", "ID": "b39025a5-57f2-4fb8-a0ac-2522d433ebee", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "9c7227ef-b991-40bb-abda-9b1cc97688e0"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b>", "ID": "fb7e5eb9-29b7-4b35-84d1-64d1f7a63ba6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b39025a5-57f2-4fb8-a0ac-2522d433ebee"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span>", "ID": "e9610e12-a1eb-4853-b9dd-493262a85ae9", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "N=65", "ParentId": "fb7e5eb9-29b7-4b35-84d1-64d1f7a63ba6"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>\n</td>", "ID": "0925be1d-7e33-4f4a-bdeb-00987902367c", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "4222a2c0-af96-49eb-b6a4-f4fe0ecbde44"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b></p>", "ID": "b01312e1-68e5-4422-a0a9-6712812e8718", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "0925be1d-7e33-4f4a-bdeb-00987902367c"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span></b>", "ID": "4b5e34c5-bd6b-4a80-b03a-413c2f72eb0b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b01312e1-68e5-4422-a0a9-6712812e8718"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>N=65</span>", "ID": "d87a0444-1bea-4aa3-95b2-8a5e830752fc", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "N=65", "ParentId": "4b5e34c5-bd6b-4a80-b03a-413c2f72eb0b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>", "ID": "0d273ef7-fc3b-4911-bad4-581ed2025a9f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 12\u00a0months</span></p>\n</td>", "ID": "64bd4042-aadf-4010-a52e-db4065727b35", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0d273ef7-fc3b-4911-bad4-581ed2025a9f"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 12\u00a0months</span></p>", "ID": "d79befec-45e1-48a7-ba00-05e29a5c6504", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "64bd4042-aadf-4010-a52e-db4065727b35"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 12\u00a0months</span>", "ID": "830c40e3-bfe1-46d5-9afe-bf1725fea73b", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "%   event free probability at 12\u00a0months", "ParentId": "d79befec-45e1-48a7-ba00-05e29a5c6504"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>", "ID": "451001be-ca4f-488f-8a1c-b0e6a3214525", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0d273ef7-fc3b-4911-bad4-581ed2025a9f"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>", "ID": "32857ec5-b814-4aa2-bd32-249d88264950", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "451001be-ca4f-488f-8a1c-b0e6a3214525"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span>", "ID": "187a705c-a5be-4aa4-83a1-5e839d6e15f2", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "66.3", "ParentId": "32857ec5-b814-4aa2-bd32-249d88264950"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>", "ID": "aff86ff9-36cd-4788-8f5c-0f30c0ef337b", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0d273ef7-fc3b-4911-bad4-581ed2025a9f"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>", "ID": "bc16caf8-93d9-4c02-b7e5-1de2952f80cd", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "aff86ff9-36cd-4788-8f5c-0f30c0ef337b"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span>", "ID": "f7da414c-9177-4764-ac95-0ca7382f9948", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "66.3", "ParentId": "bc16caf8-93d9-4c02-b7e5-1de2952f80cd"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 18\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>", "ID": "aaf28c36-cbcd-4cdb-9713-3af4178c1fec", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 18\u00a0months</span></p>\n</td>", "ID": "b9970bed-4ac1-478b-bd23-58ec022968b8", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aaf28c36-cbcd-4cdb-9713-3af4178c1fec"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 18\u00a0months</span></p>", "ID": "3e42591d-7e4a-4b9c-b2e3-e50a30937f50", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9970bed-4ac1-478b-bd23-58ec022968b8"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>%\n  event free probability at 18\u00a0months</span>", "ID": "9e312bbf-bd20-41b1-bb43-18e5961f05cb", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "%   event free probability at 18\u00a0months", "ParentId": "3e42591d-7e4a-4b9c-b2e3-e50a30937f50"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>", "ID": "c3e4f9a1-5904-484b-ae92-a6c5aedaadd1", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aaf28c36-cbcd-4cdb-9713-3af4178c1fec"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>", "ID": "8b938fcf-a481-4cc2-a301-500f9e438a72", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "c3e4f9a1-5904-484b-ae92-a6c5aedaadd1"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span>", "ID": "4bd0988b-3d38-4402-953c-3f0142ad628c", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "66.3", "ParentId": "8b938fcf-a481-4cc2-a301-500f9e438a72"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>", "ID": "6ba0a460-96e8-460e-b9a9-68dd21fd79c7", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aaf28c36-cbcd-4cdb-9713-3af4178c1fec"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>", "ID": "8ea5115c-6c90-4c2d-a5d5-58f7685ab339", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6ba0a460-96e8-460e-b9a9-68dd21fd79c7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span>", "ID": "c25f73a0-629b-4fba-a021-02ca2e1886c3", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "66.3", "ParentId": "8ea5115c-6c90-4c2d-a5d5-58f7685ab339"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Median\n  (months) (95% CI)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE<sup>9</sup>)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE)</span></p>\n</td>\n</tr>", "ID": "ddc70435-58d3-40ff-a7e2-64398a34db3d", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Median\n  (months) (95% CI)</span></p>\n</td>", "ID": "221bd9d1-039f-4e67-8a13-9a88364ad261", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ddc70435-58d3-40ff-a7e2-64398a34db3d"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Median\n  (months) (95% CI)</span></p>", "ID": "12a438af-80d9-49d3-8386-28fd4ae19136", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "221bd9d1-039f-4e67-8a13-9a88364ad261"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Median\n  (months) (95% CI)</span>", "ID": "acae24f9-ffd7-43c6-8576-acbf2cda5f10", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Median   (months) (95% CI)", "ParentId": "12a438af-80d9-49d3-8386-28fd4ae19136"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE<sup>9</sup>)</span></p>\n</td>", "ID": "97c7c80c-b1d9-4947-aa98-4c7849593581", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ddc70435-58d3-40ff-a7e2-64398a34db3d"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE<sup>9</sup>)</span></p>", "ID": "b1e5e0dd-36d9-4858-b55b-2d3c9e4bdd1b", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "97c7c80c-b1d9-4947-aa98-4c7849593581"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE<sup>9</sup>)</span>", "ID": "e9b59449-86cf-4c8a-be19-4a5366c81b6e", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Not   reached (20.0, NE)", "ParentId": "b1e5e0dd-36d9-4858-b55b-2d3c9e4bdd1b"}, {"Element": "<sup>9</sup>", "ID": "fa0d02a8-8e9e-4337-81b2-9c92509d1b1e", "Styles": "None", "Classes": "None", "Text": "9", "ParentId": "e9b59449-86cf-4c8a-be19-4a5366c81b6e"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE)</span></p>\n</td>", "ID": "182c8e6f-0d67-4d5c-aea0-993e7fec57d3", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ddc70435-58d3-40ff-a7e2-64398a34db3d"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE)</span></p>", "ID": "51ce3b82-97da-4e60-8f09-7ce1a8df1b64", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "182c8e6f-0d67-4d5c-aea0-993e7fec57d3"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (20.0, NE)</span>", "ID": "4c51ed33-35f2-40bc-b058-724a1f81d4af", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Not   reached (20.0, NE)", "ParentId": "51ce3b82-97da-4e60-8f09-7ce1a8df1b64"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoint</span></b></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>\n</tr>", "ID": "9273430d-7a3e-46e3-901d-29ba3f90106f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoint</span></b></p>\n</td>", "ID": "a8dde3bd-5805-48c2-8d29-52f51f2989d5", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9273430d-7a3e-46e3-901d-29ba3f90106f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoint</span></b></p>", "ID": "4aa8a5b6-e5bd-4068-a731-6c4453374660", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a8dde3bd-5805-48c2-8d29-52f51f2989d5"}, {"Element": "<b><span lang=\"EN-GB\">Other secondary endpoint</span></b>", "ID": "a6368907-2e98-4299-a401-11afde381ac3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4aa8a5b6-e5bd-4068-a731-6c4453374660"}, {"Element": "<span lang=\"EN-GB\">Other secondary endpoint</span>", "ID": "666b8d12-09bc-40fc-8daa-3587a2a053d5", "Styles": "None", "Classes": "None", "Text": "Other secondary endpoint", "ParentId": "a6368907-2e98-4299-a401-11afde381ac3"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>\n</td>", "ID": "28ca71c9-b918-406c-bc2d-265eb03f5694", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9273430d-7a3e-46e3-901d-29ba3f90106f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=97</span></b></p>", "ID": "d42df08f-c392-4f91-9349-bc44443d0187", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "28ca71c9-b918-406c-bc2d-265eb03f5694"}, {"Element": "<b><span lang=\"EN-GB\">N=97</span></b>", "ID": "cf413129-c409-4d18-a8df-943deee0a34c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d42df08f-c392-4f91-9349-bc44443d0187"}, {"Element": "<span lang=\"EN-GB\">N=97</span>", "ID": "c4f42076-38b0-40d0-a954-0d7220f89113", "Styles": "None", "Classes": "None", "Text": "N=97", "ParentId": "cf413129-c409-4d18-a8df-943deee0a34c"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>\n</td>", "ID": "bc97172a-7e9a-4bef-81f6-ad8f11f2cfeb", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9273430d-7a3e-46e3-901d-29ba3f90106f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=79</span></b></p>", "ID": "e0644331-133e-4b26-94af-8316b2b033bc", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bc97172a-7e9a-4bef-81f6-ad8f11f2cfeb"}, {"Element": "<b><span lang=\"EN-GB\">N=79</span></b>", "ID": "fa0737bb-6ca1-408a-9392-31f241063d0b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e0644331-133e-4b26-94af-8316b2b033bc"}, {"Element": "<span lang=\"EN-GB\">N=79</span>", "ID": "0652c4b2-0239-4005-9d7e-91589b5b5997", "Styles": "None", "Classes": "None", "Text": "N=79", "ParentId": "fa0737bb-6ca1-408a-9392-31f241063d0b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  survival (OS)<sup>8</sup></span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>\n</tr>", "ID": "7d7a93c3-9dc2-4557-b020-6b734e81f839", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  survival (OS)<sup>8</sup></span></p>\n</td>", "ID": "2bc3f116-bc7f-4cc1-9b3e-07ad2c8cbb6b", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d7a93c3-9dc2-4557-b020-6b734e81f839"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  survival (OS)<sup>8</sup></span></p>", "ID": "cfb85876-b773-4973-aae0-03f23a96c761", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "2bc3f116-bc7f-4cc1-9b3e-07ad2c8cbb6b"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Overall\n  survival (OS)<sup>8</sup></span>", "ID": "a2f978c8-6f05-4b52-8826-d3444068b16e", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Overall   survival (OS)", "ParentId": "cfb85876-b773-4973-aae0-03f23a96c761"}, {"Element": "<sup>8</sup>", "ID": "3f10715e-0b69-4be6-a828-27e24fa97bfb", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "a2f978c8-6f05-4b52-8826-d3444068b16e"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>", "ID": "ed701374-1b28-494a-87c4-c2c972798d30", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d7a93c3-9dc2-4557-b020-6b734e81f839"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>", "ID": "238eb4c0-30b5-4663-a542-316a8597dfcd", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "ed701374-1b28-494a-87c4-c2c972798d30"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span>", "ID": "bafde9a2-2196-4c4a-bc53-96698e31a3ce", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "238eb4c0-30b5-4663-a542-316a8597dfcd"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>\n</td>", "ID": "fd427cbe-3a46-401b-b015-e9f5160abd72", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7d7a93c3-9dc2-4557-b020-6b734e81f839"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span></p>", "ID": "33275786-1d02-4786-bf8c-7569d03c1f3e", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "fd427cbe-3a46-401b-b015-e9f5160abd72"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0</span>", "ID": "3c9b6de8-f294-457f-bf6d-2e2e9be2f7df", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "33275786-1d02-4786-bf8c-7569d03c1f3e"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 %\n  survival probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>69.8</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>76.4</span></p>\n</td>\n</tr>", "ID": "a2f27d6a-13cc-4016-a0db-1fe6eead8451", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 %\n  survival probability at 12\u00a0months</span></p>\n</td>", "ID": "846d0242-1734-4a69-abfd-891ae28e33c9", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a2f27d6a-13cc-4016-a0db-1fe6eead8451"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 %\n  survival probability at 12\u00a0months</span></p>", "ID": "035cebac-056f-4289-82a7-efa53dc653ab", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "846d0242-1734-4a69-abfd-891ae28e33c9"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 %\n  survival probability at 12\u00a0months</span>", "ID": "11c9d803-f021-4c1c-85a2-7e4c3bd1a737", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0 %   survival probability at 12\u00a0months", "ParentId": "035cebac-056f-4289-82a7-efa53dc653ab"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>69.8</span></p>\n</td>", "ID": "f2937a7e-4133-40dd-8759-f35f5dae3663", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a2f27d6a-13cc-4016-a0db-1fe6eead8451"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>69.8</span></p>", "ID": "1400d65a-1fc1-4e77-a633-9fbcf0d4a93d", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "f2937a7e-4133-40dd-8759-f35f5dae3663"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>69.8</span>", "ID": "8e76b39f-9d7d-4178-85ca-65524e1873a6", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "69.8", "ParentId": "1400d65a-1fc1-4e77-a633-9fbcf0d4a93d"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>76.4</span></p>\n</td>", "ID": "3dc6468c-f7e5-4ca4-8ba7-35624fcf22ed", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a2f27d6a-13cc-4016-a0db-1fe6eead8451"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>76.4</span></p>", "ID": "617ead14-a6fb-4f7c-b1ff-1ea17be28fc7", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "3dc6468c-f7e5-4ca4-8ba7-35624fcf22ed"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>76.4</span>", "ID": "d22b0b03-cdad-4eba-a636-bcf1479b2a6c", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "76.4", "ParentId": "617ead14-a6fb-4f7c-b1ff-1ea17be28fc7"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:14.2pt;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:\n  11.0pt;font-family:\"Times New Roman\",serif;color:black'>% survival probability\n  at 24\u00a0months</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>56.9</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>\n</tr>", "ID": "258d9c2f-fffd-421c-837f-5ccbe55aa49f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:14.2pt;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:\n  11.0pt;font-family:\"Times New Roman\",serif;color:black'>% survival probability\n  at 24\u00a0months</span></p>\n</td>", "ID": "45c87f35-d6d3-424b-a05d-5739b44f646c", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "258d9c2f-fffd-421c-837f-5ccbe55aa49f"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:14.2pt;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:\n  11.0pt;font-family:\"Times New Roman\",serif;color:black'>% survival probability\n  at 24\u00a0months</span></p>", "ID": "40ef6841-8950-4725-bee4-c639b15d97ae", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:14.2pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "45c87f35-d6d3-424b-a05d-5739b44f646c"}, {"Element": "<span lang=\"EN-GB\" style='font-size:\n  11.0pt;font-family:\"Times New Roman\",serif;color:black'>% survival probability\n  at 24\u00a0months</span>", "ID": "58b706f5-fcee-4170-9e7f-20db3fbcaebb", "Styles": "font-size:\n  11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "% survival probability   at 24\u00a0months", "ParentId": "40ef6841-8950-4725-bee4-c639b15d97ae"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>56.9</span></p>\n</td>", "ID": "1950fe8c-f830-42b4-8729-985026106bd2", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "258d9c2f-fffd-421c-837f-5ccbe55aa49f"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>56.9</span></p>", "ID": "3e7ee181-8a6e-4f37-be96-9d1e16fbc6bd", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "1950fe8c-f830-42b4-8729-985026106bd2"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>56.9</span>", "ID": "b2c93870-8c23-490f-bdb1-b8824fa5a3ad", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "56.9", "ParentId": "3e7ee181-8a6e-4f37-be96-9d1e16fbc6bd"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>\n</td>", "ID": "fd300faf-13c4-41df-ab3b-820d429796ee", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "258d9c2f-fffd-421c-837f-5ccbe55aa49f"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span></p>", "ID": "d456599f-e20c-4ca4-a14e-5631c7d2c2a6", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "fd300faf-13c4-41df-ab3b-820d429796ee"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>66.3</span>", "ID": "0280d81b-6b54-412b-8266-c1da0e5b4464", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "66.3", "ParentId": "d456599f-e20c-4ca4-a14e-5631c7d2c2a6"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 Median\n  (months) (95% CI)</span></p>\n</td>\n<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (19.4, NE)</span></p>\n</td>\n<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (28.2, NE)</span></p>\n</td>\n</tr>", "ID": "071bbf74-78c2-4666-81e1-7a649f05a7a9", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td style=\"width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"332\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 Median\n  (months) (95% CI)</span></p>\n</td>", "ID": "46375870-cf5c-40f8-95b3-5c56a8c487f5", "Styles": "width:249.15pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "071bbf74-78c2-4666-81e1-7a649f05a7a9"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 Median\n  (months) (95% CI)</span></p>", "ID": "f2564c5b-7488-4b77-9226-502ea055e4de", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "46375870-cf5c-40f8-95b3-5c56a8c487f5"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0 Median\n  (months) (95% CI)</span>", "ID": "9a9e5514-1e52-458c-851b-5230f7a36404", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0 Median   (months) (95% CI)", "ParentId": "f2564c5b-7488-4b77-9226-502ea055e4de"}, {"Element": "<td style=\"width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (19.4, NE)</span></p>\n</td>", "ID": "24f8e5c1-94bf-4977-8ad1-1ee01d4b0d8d", "Styles": "width:113.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "071bbf74-78c2-4666-81e1-7a649f05a7a9"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (19.4, NE)</span></p>", "ID": "60ec4f63-a233-4412-9e62-d10dea3e8347", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "24f8e5c1-94bf-4977-8ad1-1ee01d4b0d8d"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (19.4, NE)</span>", "ID": "43171a23-bbdb-49d9-a871-1067871754f2", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Not   reached (19.4, NE)", "ParentId": "60ec4f63-a233-4412-9e62-d10dea3e8347"}, {"Element": "<td style=\"width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (28.2, NE)</span></p>\n</td>", "ID": "689cb6b4-bab9-4c3c-973a-7f3c8c863e63", "Styles": "width:101.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "071bbf74-78c2-4666-81e1-7a649f05a7a9"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (28.2, NE)</span></p>", "ID": "141da73c-0aac-4717-96fc-4206b3070594", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "689cb6b4-bab9-4c3c-973a-7f3c8c863e63"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  reached (28.2, NE)</span>", "ID": "a8b9ad42-05f1-4b4b-8e3b-d4f20a70ccbc", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Not   reached (28.2, NE)", "ParentId": "141da73c-0aac-4717-96fc-4206b3070594"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>1</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requires remission\n  status to be maintained for at least 28\u00a0days without clinical evidence\n  of relapse.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: ORR \u226420% vs. Ha: ORR &gt;20%</span></p>\n<p class=\"MsoCommentText\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  page-break-after:avoid\"><sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">3</span></sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CR (complete remission) was defined as &lt;5% of blasts\n  in the bone marrow, circulating blasts in blood should be &lt;1%, no evidence\n  of extramedullary disease, and full recovery of peripheral blood counts\n  (platelets &gt;100,000/\u03bcL and absolute neutrophil counts [ANC]\n  &gt;1,000/\u03bcL) without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>4</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CRi (complete\n  remission with incomplete blood count recovery) was defined as &lt;5% of\n  blasts in the bone marrow, circulating blasts in blood should be &lt;1%, no\n  evidence of extramedullary disease, and without full recovery of peripheral\n  blood counts with or without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>5</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MRD (minimal\n  residual disease) negative was defined as MRD by flow cytometry &lt;0.01%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>6</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: Rate of MRD negative remission \u226415%\n  vs. Ha:\u00a0&gt;15%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>7</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOR was defined as\n  time since onset of CR or CRi to relapse or death due to underlying\n  indication, whichever is earlier (N=65).</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>8</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause for\n  infused patients and from time of date of enrolment to the date of death due\n  to any cause for enrolled patients.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  estimable</span></p>\n</td>\n</tr>", "ID": "0a63254e-4fd8-4eb9-9ed9-705258da4b97", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "f039ef8c-2f8f-4a0a-aa9f-806b4bbea36c"}, {"Element": "<td colspan=\"3\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>1</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requires remission\n  status to be maintained for at least 28\u00a0days without clinical evidence\n  of relapse.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: ORR \u226420% vs. Ha: ORR &gt;20%</span></p>\n<p class=\"MsoCommentText\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  page-break-after:avoid\"><sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">3</span></sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CR (complete remission) was defined as &lt;5% of blasts\n  in the bone marrow, circulating blasts in blood should be &lt;1%, no evidence\n  of extramedullary disease, and full recovery of peripheral blood counts\n  (platelets &gt;100,000/\u03bcL and absolute neutrophil counts [ANC]\n  &gt;1,000/\u03bcL) without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>4</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CRi (complete\n  remission with incomplete blood count recovery) was defined as &lt;5% of\n  blasts in the bone marrow, circulating blasts in blood should be &lt;1%, no\n  evidence of extramedullary disease, and without full recovery of peripheral\n  blood counts with or without blood transfusion.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>5</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MRD (minimal\n  residual disease) negative was defined as MRD by flow cytometry &lt;0.01%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>6</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: Rate of MRD negative remission \u226415%\n  vs. Ha:\u00a0&gt;15%.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>7</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOR was defined as\n  time since onset of CR or CRi to relapse or death due to underlying\n  indication, whichever is earlier (N=65).</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>8</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause for\n  infused patients and from time of date of enrolment to the date of death due\n  to any cause for enrolled patients.</span></p>\n<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  estimable</span></p>\n</td>", "ID": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "          ", "ParentId": "0a63254e-4fd8-4eb9-9ed9-705258da4b97"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>1</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requires remission\n  status to be maintained for at least 28\u00a0days without clinical evidence\n  of relapse.</span></p>", "ID": "184c98da-3ff2-4e14-949e-922b34810950", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>1</span></sup>", "ID": "3414ffb0-6c55-41e3-8a8c-66896fd1cabc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "184c98da-3ff2-4e14-949e-922b34810950"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>1</span>", "ID": "9d4a4e29-7d58-4c1c-b25e-a52e83ca65c2", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "1", "ParentId": "3414ffb0-6c55-41e3-8a8c-66896fd1cabc"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requires remission\n  status to be maintained for at least 28\u00a0days without clinical evidence\n  of relapse.</span>", "ID": "6d4dca9a-e82b-4c40-a053-3aee17ca53e7", "Styles": "font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Requires remission   status to be maintained for at least 28\u00a0days without clinical evidence   of relapse.", "ParentId": "184c98da-3ff2-4e14-949e-922b34810950"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: ORR \u226420% vs. Ha: ORR &gt;20%</span></p>", "ID": "78570299-2eac-4dc0-af11-53b3d08462a6", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>2</span></sup>", "ID": "0f67c6f5-01f7-4fcd-826b-949c0ff85ade", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "78570299-2eac-4dc0-af11-53b3d08462a6"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>2</span>", "ID": "3cc4b594-860c-474f-8e92-4b2f9ad358bf", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "2", "ParentId": "0f67c6f5-01f7-4fcd-826b-949c0ff85ade"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: ORR \u226420% vs. Ha: ORR &gt;20%</span>", "ID": "fe85dc3d-053f-43ac-9cfe-4d8bcb157249", "Styles": "font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided   exact p\u2011value based on H0: ORR \u226420% vs. Ha: ORR >20%", "ParentId": "78570299-2eac-4dc0-af11-53b3d08462a6"}, {"Element": "<p class=\"MsoCommentText\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  page-break-after:avoid\"><sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">3</span></sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CR (complete remission) was defined as &lt;5% of blasts\n  in the bone marrow, circulating blasts in blood should be &lt;1%, no evidence\n  of extramedullary disease, and full recovery of peripheral blood counts\n  (platelets &gt;100,000/\u03bcL and absolute neutrophil counts [ANC]\n  &gt;1,000/\u03bcL) without blood transfusion.</span></p>", "ID": "2503c074-b08a-4ecd-bd6c-9a6186b52430", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;\n  page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">3</span></sup>", "ID": "805a133c-c45f-46ed-849b-ed9e19ac7503", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2503c074-b08a-4ecd-bd6c-9a6186b52430"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">3</span>", "ID": "17015f58-8969-47e1-81d8-5b0dd67aabce", "Styles": "font-size:11.0pt;\n  color:black", "Classes": "None", "Text": "3", "ParentId": "805a133c-c45f-46ed-849b-ed9e19ac7503"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\n  color:black\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CR (complete remission) was defined as &lt;5% of blasts\n  in the bone marrow, circulating blasts in blood should be &lt;1%, no evidence\n  of extramedullary disease, and full recovery of peripheral blood counts\n  (platelets &gt;100,000/\u03bcL and absolute neutrophil counts [ANC]\n  &gt;1,000/\u03bcL) without blood transfusion.</span>", "ID": "edad8c24-ad22-4265-a22a-b1e477b44b52", "Styles": "font-size:11.0pt;\n  color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CR (complete remission) was defined as <5% of blasts   in the bone marrow, circulating blasts in blood should be <1%, no evidence   of extramedullary disease, and full recovery of peripheral blood counts   (platelets >100,000/\u03bcL and absolute neutrophil counts [ANC]   >1,000/\u03bcL) without blood transfusion.", "ParentId": "2503c074-b08a-4ecd-bd6c-9a6186b52430"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>4</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CRi (complete\n  remission with incomplete blood count recovery) was defined as &lt;5% of\n  blasts in the bone marrow, circulating blasts in blood should be &lt;1%, no\n  evidence of extramedullary disease, and without full recovery of peripheral\n  blood counts with or without blood transfusion.</span></p>", "ID": "dbe87ca5-1022-4f47-a9aa-cc67fd2fb233", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>4</span></sup>", "ID": "f7a378b7-e271-4104-8849-19d4ff65440c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dbe87ca5-1022-4f47-a9aa-cc67fd2fb233"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>4</span>", "ID": "b23d2a83-d091-42a4-ad99-e3713722ea18", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "4", "ParentId": "f7a378b7-e271-4104-8849-19d4ff65440c"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CRi (complete\n  remission with incomplete blood count recovery) was defined as &lt;5% of\n  blasts in the bone marrow, circulating blasts in blood should be &lt;1%, no\n  evidence of extramedullary disease, and without full recovery of peripheral\n  blood counts with or without blood transfusion.</span>", "ID": "6769adf8-10e1-489a-b601-3d43d5ddd11c", "Styles": "font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CRi (complete   remission with incomplete blood count recovery) was defined as <5% of   blasts in the bone marrow, circulating blasts in blood should be <1%, no   evidence of extramedullary disease, and without full recovery of peripheral   blood counts with or without blood transfusion.", "ParentId": "dbe87ca5-1022-4f47-a9aa-cc67fd2fb233"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>5</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MRD (minimal\n  residual disease) negative was defined as MRD by flow cytometry &lt;0.01%.</span></p>", "ID": "f3d09e1a-0e89-43a9-aaf4-a891d14350d7", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>5</span></sup>", "ID": "65e3ad7c-92c9-4f23-9b8d-faf881874d75", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f3d09e1a-0e89-43a9-aaf4-a891d14350d7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>5</span>", "ID": "7c07a601-8ddb-4d18-b468-28ee5cd6f599", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "5", "ParentId": "65e3ad7c-92c9-4f23-9b8d-faf881874d75"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MRD (minimal\n  residual disease) negative was defined as MRD by flow cytometry &lt;0.01%.</span>", "ID": "e7bc217a-d7d5-45b3-baa7-9e7e893794e2", "Styles": "font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MRD (minimal   residual disease) negative was defined as MRD by flow cytometry <0.01%.", "ParentId": "f3d09e1a-0e89-43a9-aaf4-a891d14350d7"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>6</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: Rate of MRD negative remission \u226415%\n  vs. Ha:\u00a0&gt;15%.</span></p>", "ID": "ad9c9aec-bdf5-471c-8308-0f9f2b391e74", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>6</span></sup>", "ID": "086289fe-0a59-49af-bbcf-6b00ff8b20b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad9c9aec-bdf5-471c-8308-0f9f2b391e74"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>6</span>", "ID": "51bc218c-ed6b-4d39-b4a4-1a0f60ef9dcf", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "6", "ParentId": "086289fe-0a59-49af-bbcf-6b00ff8b20b5"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided\n  exact p\u2011value based on H0: Rate of MRD negative remission \u226415%\n  vs. Ha:\u00a0&gt;15%.</span>", "ID": "7a95d595-c001-4c91-9107-4a30edb3b073", "Styles": "font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Nominal one\u2011sided   exact p\u2011value based on H0: Rate of MRD negative remission \u226415%   vs. Ha:\u00a0>15%.", "ParentId": "ad9c9aec-bdf5-471c-8308-0f9f2b391e74"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>7</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOR was defined as\n  time since onset of CR or CRi to relapse or death due to underlying\n  indication, whichever is earlier (N=65).</span></p>", "ID": "0d9cacc0-1984-4a55-b54b-24875f73ca99", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>7</span></sup>", "ID": "3fadfb8b-47df-4330-8060-3cdca52c5a9f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0d9cacc0-1984-4a55-b54b-24875f73ca99"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>7</span>", "ID": "61590642-2349-4ec3-9d77-3868166ab30d", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "7", "ParentId": "3fadfb8b-47df-4330-8060-3cdca52c5a9f"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOR was defined as\n  time since onset of CR or CRi to relapse or death due to underlying\n  indication, whichever is earlier (N=65).</span>", "ID": "d16e65b5-0c65-4af7-8284-334455f30547", "Styles": "font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DOR was defined as   time since onset of CR or CRi to relapse or death due to underlying   indication, whichever is earlier (N=65).", "ParentId": "0d9cacc0-1984-4a55-b54b-24875f73ca99"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>8</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause for\n  infused patients and from time of date of enrolment to the date of death due\n  to any cause for enrolled patients.</span></p>", "ID": "999344ca-a1c7-4f9a-890d-4bdc46cd9cf9", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>8</span></sup>", "ID": "5c2f76e4-10e8-4ba2-b49a-17977af1656f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "999344ca-a1c7-4f9a-890d-4bdc46cd9cf9"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>8</span>", "ID": "79c4ac02-3cf3-4aeb-965b-c049c1a5e347", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "8", "ParentId": "5c2f76e4-10e8-4ba2-b49a-17977af1656f"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause for\n  infused patients and from time of date of enrolment to the date of death due\n  to any cause for enrolled patients.</span>", "ID": "07b8a271-eacd-4e2e-91c7-758272701bdb", "Styles": "font-size:11.0pt;\n  font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OS was defined as   time from date of Kymriah infusion to the date of death due to any cause for   infused patients and from time of date of enrolment to the date of death due   to any cause for enrolled patients.", "ParentId": "999344ca-a1c7-4f9a-890d-4bdc46cd9cf9"}, {"Element": "<p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  estimable</span></p>", "ID": "f1e1a69e-77c8-4f05-99ba-368762742410", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b9a5f6ca-589b-4f93-a8d4-b8f5eb8b3d61"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup>", "ID": "b8fa87d0-f8c0-4a2c-bcf7-53dc57cc25c9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1e1a69e-77c8-4f05-99ba-368762742410"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black'>9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "e18d3ce4-176d-41a1-b971-5714c74b5ec5", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\n  color:black", "Classes": "None", "Text": "9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b8fa87d0-f8c0-4a2c-bcf7-53dc57cc25c9"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black'>Not\n  estimable</span>", "ID": "20a522dd-dca2-4af4-80cd-1b592448ca73", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "Not   estimable", "ParentId": "f1e1a69e-77c8-4f05-99ba-368762742410"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a36e9548-83e3-4ebc-b7a6-2725b62834e5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3c8a9d3f-086c-429a-8b1e-fdff6f8d446e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a36e9548-83e3-4ebc-b7a6-2725b62834e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Health\u2011related quality of life (HRQoL) was evaluated by PedsQL\nand EQ\u20115D questionnaires completed by patients aged 8\u00a0years and\nabove (n=61). Among patients responding (n=51), the mean</span><u><span lang=\"EN-GB\"> </span></u><span lang=\"EN-GB\">(SD) change from baseline in the PedsQL\ntotal score was 13.1 (13.45) at month\u00a03, 15.4 (16.81) at month\u00a06 and\n25.0 (19.09) at month\u00a012, and the mean (SD) change from baseline in the EQ\u20115D\nVAS score was 16.0 (16.45) at month\u00a03, 15.3 (18.33) at month\u00a06 and </span><span lang=\"EN-GB\" style=\"color:black\">21.7 (17.14) at month\u00a012</span><span lang=\"EN-GB\">, indicating overall clinically meaningful improvement in HRQoL </span><span lang=\"EN-GB\">following Kymriah infusion.</span></p>", "ID": "195400b2-6fe6-4c33-953c-3f4055d4f603", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Health\u2011related quality of life (HRQoL) was evaluated by PedsQL\nand EQ\u20115D questionnaires completed by patients aged 8\u00a0years and\nabove (n=61). Among patients responding (n=51), the mean</span>", "ID": "ecf58f31-e975-4cdc-b9a0-72d4080d978c", "Styles": "None", "Classes": "None", "Text": "Health\u2011related quality of life (HRQoL) was evaluated by PedsQL and EQ\u20115D questionnaires completed by patients aged 8\u00a0years and above (n=61). Among patients responding (n=51), the mean", "ParentId": "195400b2-6fe6-4c33-953c-3f4055d4f603"}, {"Element": "<u><span lang=\"EN-GB\"> </span></u>", "ID": "7f89142e-1fcd-4559-a723-a9143ba07409", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "195400b2-6fe6-4c33-953c-3f4055d4f603"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "95a750ea-c7b2-41c5-8e9e-fe947a729d64", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "7f89142e-1fcd-4559-a723-a9143ba07409"}, {"Element": "<span lang=\"EN-GB\">(SD) change from baseline in the PedsQL\ntotal score was 13.1 (13.45) at month\u00a03, 15.4 (16.81) at month\u00a06 and\n25.0 (19.09) at month\u00a012, and the mean (SD) change from baseline in the EQ\u20115D\nVAS score was 16.0 (16.45) at month\u00a03, 15.3 (18.33) at month\u00a06 and </span>", "ID": "0fcce601-8290-46a2-a85c-fe3fa4ca864c", "Styles": "None", "Classes": "None", "Text": "(SD) change from baseline in the PedsQL total score was 13.1 (13.45) at month\u00a03, 15.4 (16.81) at month\u00a06 and 25.0 (19.09) at month\u00a012, and the mean (SD) change from baseline in the EQ\u20115D VAS score was 16.0 (16.45) at month\u00a03, 15.3 (18.33) at month\u00a06 and ", "ParentId": "195400b2-6fe6-4c33-953c-3f4055d4f603"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">21.7 (17.14) at month\u00a012</span>", "ID": "d61b005a-a83c-4656-aa4e-e86be4a093dc", "Styles": "color:black", "Classes": "None", "Text": "21.7 (17.14) at month\u00a012", "ParentId": "195400b2-6fe6-4c33-953c-3f4055d4f603"}, {"Element": "<span lang=\"EN-GB\">, indicating overall clinically meaningful improvement in HRQoL </span>", "ID": "21da5fd4-49bc-46a0-921a-6ae73ef74559", "Styles": "None", "Classes": "None", "Text": ", indicating overall clinically meaningful improvement in HRQoL ", "ParentId": "195400b2-6fe6-4c33-953c-3f4055d4f603"}, {"Element": "<span lang=\"EN-GB\">following Kymriah infusion.</span>", "ID": "d018adaf-bcc5-4265-a161-7dce3c81fd06", "Styles": "None", "Classes": "None", "Text": "following Kymriah infusion.", "ParentId": "195400b2-6fe6-4c33-953c-3f4055d4f603"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8b0d84f8-26c7-41d9-8c53-b2f3c2229f13", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "88b435fd-4e1b-4a62-a5ed-038ef3c46f7f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8b0d84f8-26c7-41d9-8c53-b2f3c2229f13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The supportive study B2205J (ENSIGN) was a multicentre single-arm phase\u00a0II\nstudy in paediatric and young adult patients with r/r B\u2011cell ALL. The\nstudy had similar study design and enrolled comparable patient populations as\nthe pivotal study B2202. The main difference between the two studies was the\ndefinition of the primary efficacy endpoint ORR, which was measured within 6\u00a0months\nafter Kymriah infusion in study B2205J compared to 3\u00a0months in the pivotal\nstudy. Of 75\u00a0patients enrolled, 64 received infusion of Kymriah; for 5\u00a0patients\n(6.7%), Kymriah could not be manufactured and 6\u00a0patients (8.0%) died while\nawaiting Kymriah manufacturing in the clinical study. The median duration of\nstudy follow-up defined as the time from Kymriah infusion to the date of completion\nor discontinuation from follow-up prior to the data cut-off date in the final\nanalyses was 12.2\u00a0months (range: 0.4-49.3). The median time from Kymriah\ninfusion to the data cut-off date was 31.7\u00a0months (range: 17.6-56.0).</span></p>", "ID": "01239632-621a-4060-9676-0e86ed5b72cc", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The supportive study B2205J (ENSIGN) was a multicentre single-arm phase\u00a0II\nstudy in paediatric and young adult patients with r/r B\u2011cell ALL. The\nstudy had similar study design and enrolled comparable patient populations as\nthe pivotal study B2202. The main difference between the two studies was the\ndefinition of the primary efficacy endpoint ORR, which was measured within 6\u00a0months\nafter Kymriah infusion in study B2205J compared to 3\u00a0months in the pivotal\nstudy. Of 75\u00a0patients enrolled, 64 received infusion of Kymriah; for 5\u00a0patients\n(6.7%), Kymriah could not be manufactured and 6\u00a0patients (8.0%) died while\nawaiting Kymriah manufacturing in the clinical study. The median duration of\nstudy follow-up defined as the time from Kymriah infusion to the date of completion\nor discontinuation from follow-up prior to the data cut-off date in the final\nanalyses was 12.2\u00a0months (range: 0.4-49.3). The median time from Kymriah\ninfusion to the data cut-off date was 31.7\u00a0months (range: 17.6-56.0).</span>", "ID": "e9dac4b1-66cd-4349-a1eb-28e600ad5f78", "Styles": "None", "Classes": "None", "Text": "The supportive study B2205J (ENSIGN) was a multicentre single-arm phase\u00a0II study in paediatric and young adult patients with r/r B\u2011cell ALL. The study had similar study design and enrolled comparable patient populations as the pivotal study B2202. The main difference between the two studies was the definition of the primary efficacy endpoint ORR, which was measured within 6\u00a0months after Kymriah infusion in study B2205J compared to 3\u00a0months in the pivotal study. Of 75\u00a0patients enrolled, 64 received infusion of Kymriah; for 5\u00a0patients (6.7%), Kymriah could not be manufactured and 6\u00a0patients (8.0%) died while awaiting Kymriah manufacturing in the clinical study. The median duration of study follow-up defined as the time from Kymriah infusion to the date of completion or discontinuation from follow-up prior to the data cut-off date in the final analyses was 12.2\u00a0months (range: 0.4-49.3). The median time from Kymriah infusion to the data cut-off date was 31.7\u00a0months (range: 17.6-56.0).", "ParentId": "01239632-621a-4060-9676-0e86ed5b72cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0c9b075f-3d00-4872-a665-bbc315db2145", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c90e3d19-1d9b-4ec1-9b86-2d8537057bec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0c9b075f-3d00-4872-a665-bbc315db2145"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Among the patients infused, the median age was 12.5\u00a0years\n(range: 3 to 25), 34 (53.1%) were female and 30 (46.9%) were male, 10.9% had\nprimary refractory disease, 89.1% had relapsed disease, and 43.8% of patients\nhad at least one prior haematopoietic stem cell <span style=\"color:black\">transplant.\n</span></span><span lang=\"EN-GB\" style=\"color:black\">Baseline disease\ncharacteristics were similar in the enrolled patients with regard to age\n(median age 13.0\u00a0years, range: 3 to 25), gender (46.7% female and 53.3%\nmale), primary refractoriness (10.7%), and prior transplant history (42.7%).</span><span lang=\"EN-GB\" style=\"color:black\"> The </span><span lang=\"EN-GB\">majority of infused\npatients (57/64, 89.1%) received bridging chemotherapy while waiting for\nKymriah. A total of 60 out of 64\u00a0patients (93.8%) who received Kymriah\ninfusion also received lymphodepleting chemotherapy after enrolment and prior\nto infusion of a single dose of Kymriah.</span></p>", "ID": "daed21d7-0fd5-414d-8768-09083b088ecf", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Among the patients infused, the median age was 12.5\u00a0years\n(range: 3 to 25), 34 (53.1%) were female and 30 (46.9%) were male, 10.9% had\nprimary refractory disease, 89.1% had relapsed disease, and 43.8% of patients\nhad at least one prior haematopoietic stem cell <span style=\"color:black\">transplant.\n</span></span>", "ID": "38d4ce79-d97d-4ecc-800e-c76ddc0dd7d8", "Styles": "None", "Classes": "None", "Text": "Among the patients infused, the median age was 12.5\u00a0years (range: 3 to 25), 34 (53.1%) were female and 30 (46.9%) were male, 10.9% had primary refractory disease, 89.1% had relapsed disease, and 43.8% of patients had at least one prior haematopoietic stem cell ", "ParentId": "daed21d7-0fd5-414d-8768-09083b088ecf"}, {"Element": "<span style=\"color:black\">transplant.\n</span>", "ID": "d03f5f86-66ee-4ff4-8d12-75fce1feb5d9", "Styles": "color:black", "Classes": "None", "Text": "transplant. ", "ParentId": "38d4ce79-d97d-4ecc-800e-c76ddc0dd7d8"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Baseline disease\ncharacteristics were similar in the enrolled patients with regard to age\n(median age 13.0\u00a0years, range: 3 to 25), gender (46.7% female and 53.3%\nmale), primary refractoriness (10.7%), and prior transplant history (42.7%).</span>", "ID": "e00e4fe4-909c-431a-8e15-7bc095aae7d9", "Styles": "color:black", "Classes": "None", "Text": "Baseline disease characteristics were similar in the enrolled patients with regard to age (median age 13.0\u00a0years, range: 3 to 25), gender (46.7% female and 53.3% male), primary refractoriness (10.7%), and prior transplant history (42.7%).", "ParentId": "daed21d7-0fd5-414d-8768-09083b088ecf"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> The </span>", "ID": "b5cbb913-187c-465e-bcf2-e8b88caeb1d3", "Styles": "color:black", "Classes": "None", "Text": " The ", "ParentId": "daed21d7-0fd5-414d-8768-09083b088ecf"}, {"Element": "<span lang=\"EN-GB\">majority of infused\npatients (57/64, 89.1%) received bridging chemotherapy while waiting for\nKymriah. A total of 60 out of 64\u00a0patients (93.8%) who received Kymriah\ninfusion also received lymphodepleting chemotherapy after enrolment and prior\nto infusion of a single dose of Kymriah.</span>", "ID": "4b16c310-4e12-40da-b72f-9a1ad836aac0", "Styles": "None", "Classes": "None", "Text": "majority of infused patients (57/64, 89.1%) received bridging chemotherapy while waiting for Kymriah. A total of 60 out of 64\u00a0patients (93.8%) who received Kymriah infusion also received lymphodepleting chemotherapy after enrolment and prior to infusion of a single dose of Kymriah.", "ParentId": "daed21d7-0fd5-414d-8768-09083b088ecf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6f475031-721a-48b4-9d4a-830d63f14dc9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e6a4b89-418e-4b4e-88c0-a802495335ff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6f475031-721a-48b4-9d4a-830d63f14dc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Efficacy was established through the primary endpoint of ORR, which\nincluded best overall response as CR or CRi that were maintained for at least\n28\u00a0days within 6\u00a0months post\u2011infusion, as determined by IRC\nassessment, as well as secondary endpoints including DOR, proportion of\npatients who achieved CR or CRi with MRD\u2011negative disease status, and OS.\nAmong the patients infused, ORR was demonstrated in 45\u00a0patients (70.3%; 59.4%\nCR and 10.9% CRi). CR/CRi with MRD\u2011negative bone marrow was reported in 43\u00a0patients\n(67.2%). The median DOR was not reached and the event\u2011free probability at\n12\u00a0months was 70.5%. The survival probability at 24\u00a0months was 54.7%,\nand the median OS was estimated as 29.9\u00a0months (95% CI: 15.1, 42.4)<span style=\"color:black\">. The OS results were confirmed in an updated OS analyses\n(i.e. median OS 29.9\u00a0months [95% CI: 15.2, NE] with 57.6% survival\nprobability at 24\u00a0months; with a median follow\u2011up for OS of 25.9\u00a0months),\nwhich included patients transitioned to a separate long\u2011term follow\u2011up\nstudy. </span>Seven patients (10.9%) who achieved CR/CRi after Kymriah infusion\nproceeded to haematopoietic stem cell transplant while in remission during the\nstudy, of which 5 of the patients (7.8%) proceeded to transplant within the\nfirst 6\u00a0months post\u2011infusion.</span><span lang=\"EN-GB\" style=\"color:black\"> Efficacy results reported for the enrolled patients (n=75)\ndemonstrate an ORR of 60.0% (50.7% CR and 9.3% CRi; 57.3% with MRD\u2011negative\nbone marrow). The reported overall survival in the enrolled population is in accordance\nwith the infused population.</span></p>", "ID": "6a10d656-9dc1-45a1-a7b8-86e972b55cef", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Efficacy was established through the primary endpoint of ORR, which\nincluded best overall response as CR or CRi that were maintained for at least\n28\u00a0days within 6\u00a0months post\u2011infusion, as determined by IRC\nassessment, as well as secondary endpoints including DOR, proportion of\npatients who achieved CR or CRi with MRD\u2011negative disease status, and OS.\nAmong the patients infused, ORR was demonstrated in 45\u00a0patients (70.3%; 59.4%\nCR and 10.9% CRi). CR/CRi with MRD\u2011negative bone marrow was reported in 43\u00a0patients\n(67.2%). The median DOR was not reached and the event\u2011free probability at\n12\u00a0months was 70.5%. The survival probability at 24\u00a0months was 54.7%,\nand the median OS was estimated as 29.9\u00a0months (95% CI: 15.1, 42.4)<span style=\"color:black\">. The OS results were confirmed in an updated OS analyses\n(i.e. median OS 29.9\u00a0months [95% CI: 15.2, NE] with 57.6% survival\nprobability at 24\u00a0months; with a median follow\u2011up for OS of 25.9\u00a0months),\nwhich included patients transitioned to a separate long\u2011term follow\u2011up\nstudy. </span>Seven patients (10.9%) who achieved CR/CRi after Kymriah infusion\nproceeded to haematopoietic stem cell transplant while in remission during the\nstudy, of which 5 of the patients (7.8%) proceeded to transplant within the\nfirst 6\u00a0months post\u2011infusion.</span>", "ID": "fe252f70-6ba0-4298-8dc9-b9dac0d8f06d", "Styles": "None", "Classes": "None", "Text": "Efficacy was established through the primary endpoint of ORR, which included best overall response as CR or CRi that were maintained for at least 28\u00a0days within 6\u00a0months post\u2011infusion, as determined by IRC assessment, as well as secondary endpoints including DOR, proportion of patients who achieved CR or CRi with MRD\u2011negative disease status, and OS. Among the patients infused, ORR was demonstrated in 45\u00a0patients (70.3%; 59.4% CR and 10.9% CRi). CR/CRi with MRD\u2011negative bone marrow was reported in 43\u00a0patients (67.2%). The median DOR was not reached and the event\u2011free probability at 12\u00a0months was 70.5%. The survival probability at 24\u00a0months was 54.7%, and the median OS was estimated as 29.9\u00a0months (95% CI: 15.1, 42.4)Seven patients (10.9%) who achieved CR/CRi after Kymriah infusion proceeded to haematopoietic stem cell transplant while in remission during the study, of which 5 of the patients (7.8%) proceeded to transplant within the first 6\u00a0months post\u2011infusion.", "ParentId": "6a10d656-9dc1-45a1-a7b8-86e972b55cef"}, {"Element": "<span style=\"color:black\">. The OS results were confirmed in an updated OS analyses\n(i.e. median OS 29.9\u00a0months [95% CI: 15.2, NE] with 57.6% survival\nprobability at 24\u00a0months; with a median follow\u2011up for OS of 25.9\u00a0months),\nwhich included patients transitioned to a separate long\u2011term follow\u2011up\nstudy. </span>", "ID": "6f4e4b38-8236-4e6a-a6a3-61649a78f164", "Styles": "color:black", "Classes": "None", "Text": ". The OS results were confirmed in an updated OS analyses (i.e. median OS 29.9\u00a0months [95% CI: 15.2, NE] with 57.6% survival probability at 24\u00a0months; with a median follow\u2011up for OS of 25.9\u00a0months), which included patients transitioned to a separate long\u2011term follow\u2011up study. ", "ParentId": "fe252f70-6ba0-4298-8dc9-b9dac0d8f06d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\"> Efficacy results reported for the enrolled patients (n=75)\ndemonstrate an ORR of 60.0% (50.7% CR and 9.3% CRi; 57.3% with MRD\u2011negative\nbone marrow). The reported overall survival in the enrolled population is in accordance\nwith the infused population.</span>", "ID": "0918e311-a2e9-4a39-8f8b-66e543f68f9e", "Styles": "color:black", "Classes": "None", "Text": " Efficacy results reported for the enrolled patients (n=75) demonstrate an ORR of 60.0% (50.7% CR and 9.3% CRi; 57.3% with MRD\u2011negative bone marrow). The reported overall survival in the enrolled population is in accordance with the infused population.", "ParentId": "6a10d656-9dc1-45a1-a7b8-86e972b55cef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "11971f01-69d6-49cd-a3e4-79bd6ebac806", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e86151ad-699b-448a-99f7-1c177a148ad5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11971f01-69d6-49cd-a3e4-79bd6ebac806"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><span lang=\"EN-GB\">Special populations</span></i></p>", "ID": "a661381b-9960-48f7-965d-0e32466085a7", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\">Special populations</span></i>", "ID": "01ea6c0f-5696-4622-9ec4-d2c0a5758ae4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a661381b-9960-48f7-965d-0e32466085a7"}, {"Element": "<span lang=\"EN-GB\">Special populations</span>", "ID": "762a1598-9363-44a5-a3ee-612561b9279c", "Styles": "None", "Classes": "None", "Text": "Special populations", "ParentId": "01ea6c0f-5696-4622-9ec4-d2c0a5758ae4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">No differences in efficacy or safety were observed between different\nage subgroups.</span></p>", "ID": "4aeb5abf-5c76-459b-9758-bedb71d123b9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">No differences in efficacy or safety were observed between different\nage subgroups.</span>", "ID": "ff22ad54-d81e-4747-b66e-99b7c61a8910", "Styles": "None", "Classes": "None", "Text": "No differences in efficacy or safety were observed between different age subgroups.", "ParentId": "4aeb5abf-5c76-459b-9758-bedb71d123b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dc2a9b90-d480-4154-bf1f-7a5416797e09", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc5afdfd-28d8-41db-80f2-b7033498bbe9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc2a9b90-d480-4154-bf1f-7a5416797e09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Patients with active CNS leukaemia</span></i></p>", "ID": "a642221b-c5d6-4971-87d5-590978a0e46e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\">Patients with active CNS leukaemia</span></i>", "ID": "5998f9a4-3efd-4860-b067-6434c0217592", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a642221b-c5d6-4971-87d5-590978a0e46e"}, {"Element": "<span lang=\"EN-GB\">Patients with active CNS leukaemia</span>", "ID": "7957ecd8-019f-4496-8b3d-ce3765ab341d", "Styles": "None", "Classes": "None", "Text": "Patients with active CNS leukaemia", "ParentId": "5998f9a4-3efd-4860-b067-6434c0217592"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Of four patients with active CNS leukaemia (i.e. CNS\u20113)\nincluded in study B2101J, three experienced cytokine release syndrome\n(Grade\u00a02\u20114) and transient neurological abnormalities (Grade\u00a01\u20113)\nthat resolved within 1\u20113\u00a0months of infusion. One patient died due to\ndisease progression and the remaining three patients achieved a CR or CRi and\nremain alive 1.5\u20112\u00a0years after infusion.</span></p>", "ID": "b6267d76-3928-4fa7-b8f7-b11f7225c644", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Of four patients with active CNS leukaemia (i.e. CNS\u20113)\nincluded in study B2101J, three experienced cytokine release syndrome\n(Grade\u00a02\u20114) and transient neurological abnormalities (Grade\u00a01\u20113)\nthat resolved within 1\u20113\u00a0months of infusion. One patient died due to\ndisease progression and the remaining three patients achieved a CR or CRi and\nremain alive 1.5\u20112\u00a0years after infusion.</span>", "ID": "654294e8-4cc5-4065-8492-a43ab0fcff14", "Styles": "None", "Classes": "None", "Text": "Of four patients with active CNS leukaemia (i.e. CNS\u20113) included in study B2101J, three experienced cytokine release syndrome (Grade\u00a02\u20114) and transient neurological abnormalities (Grade\u00a01\u20113) that resolved within 1\u20113\u00a0months of infusion. One patient died due to disease progression and the remaining three patients achieved a CR or CRi and remain alive 1.5\u20112\u00a0years after infusion.", "ParentId": "b6267d76-3928-4fa7-b8f7-b11f7225c644"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "305df5f8-3e6f-458d-9ad2-fa8378b34df0", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8d51b1d7-2c89-40d7-9ef6-9cba9b194def", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "305df5f8-3e6f-458d-9ad2-fa8378b34df0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Diffuse large B\u2011cell lymphoma (DLBCL)</span></u></i></p>", "ID": "1ad136c0-b50d-441b-a2d6-212838f8aca1", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Diffuse large B\u2011cell lymphoma (DLBCL)</span></u></i>", "ID": "3cca3cae-d321-406e-ab21-509c92664765", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ad136c0-b50d-441b-a2d6-212838f8aca1"}, {"Element": "<u><span lang=\"EN-GB\">Diffuse large B\u2011cell lymphoma (DLBCL)</span></u>", "ID": "5d0f0388-3c01-466d-b150-2c9a68daf767", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3cca3cae-d321-406e-ab21-509c92664765"}, {"Element": "<span lang=\"EN-GB\">Diffuse large B\u2011cell lymphoma (DLBCL)</span>", "ID": "6f90111a-f489-41b1-8ea9-97d26ea9ead0", "Styles": "None", "Classes": "None", "Text": "Diffuse large B\u2011cell lymphoma (DLBCL)", "ParentId": "5d0f0388-3c01-466d-b150-2c9a68daf767"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of Kymriah treatment in adult patients with\nrelapsed or refractory (r/r) diffuse large B\u2011cell lymphoma (DLBCL) who\nreceived \u22652\u00a0lines of chemotherapy, including rituximab and\nanthracycline, or relapsed following autologous haematopoietic stem cell\ntransplantation (HSCT), was evaluated in an open\u2011label, pivotal, single\u2011arm\nstudy. Patients with T\u2011cell rich/histiocyte\u2011rich large B\u2011cell\nlymphoma (THRBCL), primary cutaneous large B\u2011cell lymphoma, primary\nmediastinal B\u2011cell lymphoma (PMBCL), EBV\u2011positive DLBCL of the\nelderly, Richter\u2019s transformation, and Burkitt lymphoma were not enrolled in\nstudy C2201.</span></p>", "ID": "e7dbdb92-e037-430a-ac29-9533b4d4bf3a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The safety and efficacy of Kymriah treatment in adult patients with\nrelapsed or refractory (r/r) diffuse large B\u2011cell lymphoma (DLBCL) who\nreceived \u22652\u00a0lines of chemotherapy, including rituximab and\nanthracycline, or relapsed following autologous haematopoietic stem cell\ntransplantation (HSCT), was evaluated in an open\u2011label, pivotal, single\u2011arm\nstudy. Patients with T\u2011cell rich/histiocyte\u2011rich large B\u2011cell\nlymphoma (THRBCL), primary cutaneous large B\u2011cell lymphoma, primary\nmediastinal B\u2011cell lymphoma (PMBCL), EBV\u2011positive DLBCL of the\nelderly, Richter\u2019s transformation, and Burkitt lymphoma were not enrolled in\nstudy C2201.</span>", "ID": "d4ad0d31-2f82-471f-9ede-306bc9015c1f", "Styles": "None", "Classes": "None", "Text": "The safety and efficacy of Kymriah treatment in adult patients with relapsed or refractory (r/r) diffuse large B\u2011cell lymphoma (DLBCL) who received \u22652\u00a0lines of chemotherapy, including rituximab and anthracycline, or relapsed following autologous haematopoietic stem cell transplantation (HSCT), was evaluated in an open\u2011label, pivotal, single\u2011arm study. Patients with T\u2011cell rich/histiocyte\u2011rich large B\u2011cell lymphoma (THRBCL), primary cutaneous large B\u2011cell lymphoma, primary mediastinal B\u2011cell lymphoma (PMBCL), EBV\u2011positive DLBCL of the elderly, Richter\u2019s transformation, and Burkitt lymphoma were not enrolled in study C2201.", "ParentId": "e7dbdb92-e037-430a-ac29-9533b4d4bf3a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "380b9fc9-3a1a-4f2f-84fa-b3833a31ed68", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ffb5a6e1-926d-49b7-bf19-e61f056a5872", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "380b9fc9-3a1a-4f2f-84fa-b3833a31ed68"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The pivotal study C2201 (JULIET) is a multicentre,\nsingle\u2011arm phase II study in adult patients with relapsed or refractory\nDLBCL. Of 167\u00a0patients enrolled, 115\u00a0patients received infusion with\nKymriah. Approximately 31% of patients discontinued the study prior to Kymriah infusion.\nFor 13\u00a0patients (8%) Kymriah could not be manufactured. Other reasons for\ndiscontinuation prior to Kymriah infusion included death (n=16; 10%), physician\ndecision/primary disease progression (n=16; 10%), patient decision (n=2; 1%),\nprotocol deviation (n=1; 1%) or adverse events (n=4; 2%) while awaiting Kymriah\nmanufacturing in the clinical study. </span><span style=\"font-size:11.0pt\">The\nmedian duration of study follow-up defined as the time from Kymriah infusion to\ndate of completion or discontinuation from follow-up prior to the data cut-off\ndate was 7.7\u00a0months (range: 0.4-35.6). The median time from Kymriah\ninfusion to the data cut-off date was 26.0\u00a0months (range: 9.7-38.2). The\nstudy is still ongoing.</span></p>", "ID": "0028bc0f-9127-480d-8848-7ca10ea40bc3", "Styles": "margin-top:0in;text-align:left", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The pivotal study C2201 (JULIET) is a multicentre,\nsingle\u2011arm phase II study in adult patients with relapsed or refractory\nDLBCL. Of 167\u00a0patients enrolled, 115\u00a0patients received infusion with\nKymriah. Approximately 31% of patients discontinued the study prior to Kymriah infusion.\nFor 13\u00a0patients (8%) Kymriah could not be manufactured. Other reasons for\ndiscontinuation prior to Kymriah infusion included death (n=16; 10%), physician\ndecision/primary disease progression (n=16; 10%), patient decision (n=2; 1%),\nprotocol deviation (n=1; 1%) or adverse events (n=4; 2%) while awaiting Kymriah\nmanufacturing in the clinical study. </span>", "ID": "01b6b335-ff5c-4795-8457-bd41a4e0d4b8", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The pivotal study C2201 (JULIET) is a multicentre, single\u2011arm phase II study in adult patients with relapsed or refractory DLBCL. Of 167\u00a0patients enrolled, 115\u00a0patients received infusion with Kymriah. Approximately 31% of patients discontinued the study prior to Kymriah infusion. For 13\u00a0patients (8%) Kymriah could not be manufactured. Other reasons for discontinuation prior to Kymriah infusion included death (n=16; 10%), physician decision/primary disease progression (n=16; 10%), patient decision (n=2; 1%), protocol deviation (n=1; 1%) or adverse events (n=4; 2%) while awaiting Kymriah manufacturing in the clinical study. ", "ParentId": "0028bc0f-9127-480d-8848-7ca10ea40bc3"}, {"Element": "<span style=\"font-size:11.0pt\">The\nmedian duration of study follow-up defined as the time from Kymriah infusion to\ndate of completion or discontinuation from follow-up prior to the data cut-off\ndate was 7.7\u00a0months (range: 0.4-35.6). The median time from Kymriah\ninfusion to the data cut-off date was 26.0\u00a0months (range: 9.7-38.2). The\nstudy is still ongoing.</span>", "ID": "62ddec97-930f-4242-b357-0b2cf41d7925", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The median duration of study follow-up defined as the time from Kymriah infusion to date of completion or discontinuation from follow-up prior to the data cut-off date was 7.7\u00a0months (range: 0.4-35.6). The median time from Kymriah infusion to the data cut-off date was 26.0\u00a0months (range: 9.7-38.2). The study is still ongoing.", "ParentId": "0028bc0f-9127-480d-8848-7ca10ea40bc3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "d77b398d-1bbd-4179-8f01-01aaa14e2342", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "9b5db4dc-5ca7-4f9c-b59a-598639059ef6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d77b398d-1bbd-4179-8f01-01aaa14e2342"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9aa1fefb-58cb-4047-be12-5af4bfaeefe9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9b5db4dc-5ca7-4f9c-b59a-598639059ef6"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Key baseline information for enrolled and\ninfused patients is presented in Table\u00a05. All patients had leukapheresis\nstarting material collected and cryopreserved prior to or during study entry.\nThe majority of patients (103/115, 90%) received bridging therapy for disease\nstabilisation. The type and duration of bridging therapy was left to the\ndiscretion of the physician. 107/115\u00a0patients (93%) received\nlymphodepleting chemotherapy prior to Kymriah infusion. Kymriah was given as a\nsingle\u2011dose (0.6\u20116.0\u00a0x\u00a010<sup>8</sup> CAR\u2011positive\nviable T cells) intravenous infusion in a qualified Kymriah treatment centre in\nan inpatient and outpatient setting.</span></p>", "ID": "4766e588-116e-4ff2-adc0-2cde9b591b97", "Styles": "margin-top:0in;text-align:left", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Key baseline information for enrolled and\ninfused patients is presented in Table\u00a05. All patients had leukapheresis\nstarting material collected and cryopreserved prior to or during study entry.\nThe majority of patients (103/115, 90%) received bridging therapy for disease\nstabilisation. The type and duration of bridging therapy was left to the\ndiscretion of the physician. 107/115\u00a0patients (93%) received\nlymphodepleting chemotherapy prior to Kymriah infusion. Kymriah was given as a\nsingle\u2011dose (0.6\u20116.0\u00a0x\u00a010<sup>8</sup> CAR\u2011positive\nviable T cells) intravenous infusion in a qualified Kymriah treatment centre in\nan inpatient and outpatient setting.</span>", "ID": "d9fb565f-28d4-4d7e-91ce-acd0f4686642", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Key baseline information for enrolled and infused patients is presented in Table\u00a05. All patients had leukapheresis starting material collected and cryopreserved prior to or during study entry. The majority of patients (103/115, 90%) received bridging therapy for disease stabilisation. The type and duration of bridging therapy was left to the discretion of the physician. 107/115\u00a0patients (93%) received lymphodepleting chemotherapy prior to Kymriah infusion. Kymriah was given as a single\u2011dose (0.6\u20116.0\u00a0x\u00a010 CAR\u2011positive viable T cells) intravenous infusion in a qualified Kymriah treatment centre in an inpatient and outpatient setting.", "ParentId": "4766e588-116e-4ff2-adc0-2cde9b591b97"}, {"Element": "<sup>8</sup>", "ID": "d41a93c2-a922-4483-b985-24f17d5d5976", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "d9fb565f-28d4-4d7e-91ce-acd0f4686642"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "ce41c282-4a4d-46b4-9ec0-fdc31ae399c8", "Styles": "margin-top:0in;text-align:left", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "ec2930fb-2b5a-4d14-870f-03e6e9690ca9", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "ce41c282-4a4d-46b4-9ec0-fdc31ae399c8"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a05\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nC2201: Baseline information across the enrolled and the infused patient\npopulations</span></b></p>", "ID": "d1c3d87b-255b-4e90-b046-775f69fbe282", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a05\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nC2201: Baseline information across the enrolled and the infused patient\npopulations</span></b>", "ID": "3882a6e9-23ad-4057-9865-c6c1648c399c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d1c3d87b-255b-4e90-b046-775f69fbe282"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Table\u00a05\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study\nC2201: Baseline information across the enrolled and the infused patient\npopulations</span>", "ID": "178a9a1b-6bb8-4de1-8225-7c0b7c985fc9", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Table\u00a05\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Study C2201: Baseline information across the enrolled and the infused patient populations", "ParentId": "3882a6e9-23ad-4057-9865-c6c1648c399c"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "fca8a67d-1e69-417c-9946-9f4f41fcbff3", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n0in;margin-left:56.7pt;margin-bottom:.0001pt;text-align:left;text-indent:-56.7pt;\npage-break-after:avoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "9261da1b-9ba5-44ee-a22f-1eab44a879b5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "fca8a67d-1e69-417c-9946-9f4f41fcbff3"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"606\">\n<thead>\n<tr style=\"height:41.05pt\">\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=167</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=115</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>\n</thead>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>\n<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56\n  (12.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (13.1)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">58 (22 -\n  76)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56 (22 -\n  76)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;65\u00a0years</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">120\n  (71.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">89\n  (77.4)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226565\u00a0years</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">47 (28.1)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">26\n  (22.6)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">105\n  (62.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">71\n  (61.7)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">62 (37.1)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">44\n  (38.3)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Prior haematopoietic stem cell transplant (SCT) - n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">93 (55.7)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">59 (51.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">74 (44.3)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">56 (48.7)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Stage III/IV disease at study entry - n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">36 (21.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">27 (23.5)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">131 (78.4)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">88 (76.5)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Number of prior\n  lines of antineoplastic therapy \u2013 n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>6 (3.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5 (4.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>73 (43.7)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>51 (44.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>52 (31.1)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (31.3)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u22654</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (21.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>23 (20.0)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refractory to last line\n  of therapy</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">98 (58.7)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">63 (54.8)</p>\n</td>\n</tr>\n<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapse to last line of therapy</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">69 (41.3)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">52 (45.2)</p>\n</td>\n</tr>\n</table>", "ID": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                         ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<thead>\n<tr style=\"height:41.05pt\">\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=167</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=115</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>\n</thead>", "ID": "8099f663-3e35-4bb7-bb70-07aea1ec8499", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<tr style=\"height:41.05pt\">\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=167</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=115</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>\n</tr>", "ID": "1ba2b936-fcc4-4842-9014-578e8f2a69d4", "Styles": "height:41.05pt", "Classes": "None", "Text": "    ", "ParentId": "8099f663-3e35-4bb7-bb70-07aea1ec8499"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>\n</td>", "ID": "94906cb7-e644-4cd7-b384-640d716ea7b0", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n   border-bottom:none;padding:0in 5.4pt 0in 5.4pt;height:41.05pt", "Classes": "None", "Text": "  ", "ParentId": "1ba2b936-fcc4-4842-9014-578e8f2a69d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>\u00a0</b></p>", "ID": "c7b1a9b8-c91d-4ad3-888f-d31af640cb28", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94906cb7-e644-4cd7-b384-640d716ea7b0"}, {"Element": "<b>\u00a0</b>", "ID": "8be5705f-ea72-44d5-b169-dd36da60eec6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c7b1a9b8-c91d-4ad3-888f-d31af640cb28"}, {"Element": "<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=167</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>", "ID": "4c29140b-9d76-4ac4-ad70-ec2a271da769", "Styles": "width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt", "Classes": "None", "Text": "    ", "ParentId": "1ba2b936-fcc4-4842-9014-578e8f2a69d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Enrolled</b></p>", "ID": "bca7551c-8ebf-43d1-b24f-372ad2dbbf04", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c29140b-9d76-4ac4-ad70-ec2a271da769"}, {"Element": "<b>Enrolled</b>", "ID": "a7cfd262-47d0-411f-9295-b154d2577ce4", "Styles": "None", "Classes": "None", "Text": "Enrolled", "ParentId": "bca7551c-8ebf-43d1-b24f-372ad2dbbf04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=167</b></p>", "ID": "25707fca-73f3-4f27-b5d3-c33e5ce40b64", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c29140b-9d76-4ac4-ad70-ec2a271da769"}, {"Element": "<b>N=167</b>", "ID": "a952b981-2896-4241-a9f3-bbb9ba2bf44c", "Styles": "None", "Classes": "None", "Text": "N=167", "ParentId": "25707fca-73f3-4f27-b5d3-c33e5ce40b64"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>", "ID": "d44f874f-1af4-449a-85bc-5f002147f871", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c29140b-9d76-4ac4-ad70-ec2a271da769"}, {"Element": "<b>n\n   (%)</b>", "ID": "34c570c8-f36b-4976-9c74-040163e3d90c", "Styles": "None", "Classes": "None", "Text": "n    (%)", "ParentId": "d44f874f-1af4-449a-85bc-5f002147f871"}, {"Element": "<td style=\"width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=115</b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>\n</td>", "ID": "6231b9b6-cb2e-4d28-8e32-038fbe244261", "Styles": "width:116.85pt;border-top:solid windowtext 1.0pt;\n   border-left:none;border-bottom:none;border-right:solid windowtext 1.0pt;\n   padding:0in 5.4pt 0in 5.4pt;height:41.05pt", "Classes": "None", "Text": "    ", "ParentId": "1ba2b936-fcc4-4842-9014-578e8f2a69d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Infused</b></p>", "ID": "fbb33725-5d6a-46e5-a59c-1c433b56ab3d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6231b9b6-cb2e-4d28-8e32-038fbe244261"}, {"Element": "<b>Infused</b>", "ID": "8f878e24-f910-4dfd-910a-d46d1e228655", "Styles": "None", "Classes": "None", "Text": "Infused", "ParentId": "fbb33725-5d6a-46e5-a59c-1c433b56ab3d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>N=115</b></p>", "ID": "97335f2d-8d4a-496a-9e91-a951e124538f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6231b9b6-cb2e-4d28-8e32-038fbe244261"}, {"Element": "<b>N=115</b>", "ID": "37ced667-71d5-4aa5-88db-097b0f101d1d", "Styles": "None", "Classes": "None", "Text": "N=115", "ParentId": "97335f2d-8d4a-496a-9e91-a951e124538f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>n\n   (%)</b></p>", "ID": "2bff1477-24d0-4e6f-9d80-1fe224276d96", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6231b9b6-cb2e-4d28-8e32-038fbe244261"}, {"Element": "<b>n\n   (%)</b>", "ID": "522afd6b-681f-4421-8081-43d8a89db2f0", "Styles": "None", "Classes": "None", "Text": "n    (%)", "ParentId": "2bff1477-24d0-4e6f-9d80-1fe224276d96"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>\n<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "478ee0b0-22b0-44a7-bd0a-0a5e3beb33ff", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>\n</td>", "ID": "d3a48db7-b974-4824-8bb5-306d4e39b499", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "478ee0b0-22b0-44a7-bd0a-0a5e3beb33ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  (years)</b></p>", "ID": "2808257b-0726-4fef-a922-914aa3e00b68", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d3a48db7-b974-4824-8bb5-306d4e39b499"}, {"Element": "<b>Age\n  (years)</b>", "ID": "2e1af1bd-28af-4a32-959e-a335b13693b8", "Styles": "None", "Classes": "None", "Text": "Age   (years)", "ParentId": "2808257b-0726-4fef-a922-914aa3e00b68"}, {"Element": "<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "52137fb7-9ee3-4d97-a8bc-eea67d92af24", "Styles": "width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "478ee0b0-22b0-44a7-bd0a-0a5e3beb33ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "c7607c00-9a78-4cc4-858c-74b57ab675e8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "52137fb7-9ee3-4d97-a8bc-eea67d92af24"}, {"Element": "<td style=\"width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "b6be2dff-8079-4b1e-a7d9-e8c68b9bce8c", "Styles": "width:116.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "478ee0b0-22b0-44a7-bd0a-0a5e3beb33ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "9e6620f8-5be6-4b9c-9e86-8e6fc16d690a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "b6be2dff-8079-4b1e-a7d9-e8c68b9bce8c"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56\n  (12.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (13.1)</p>\n</td>\n</tr>", "ID": "20283ff1-9355-4efc-8043-1fc397052505", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>\n</td>", "ID": "c05e4b2d-6b33-4a14-a4b1-06a12d3d97e6", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20283ff1-9355-4efc-8043-1fc397052505"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean\n  (standard deviation)</p>", "ID": "b45ff651-a7ac-4604-9cc2-964d80f3b757", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Mean   (standard deviation)", "ParentId": "c05e4b2d-6b33-4a14-a4b1-06a12d3d97e6"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56\n  (12.9)</p>\n</td>", "ID": "eb245010-1e2e-42d1-84b7-5105ffe1ab36", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20283ff1-9355-4efc-8043-1fc397052505"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56\n  (12.9)</p>", "ID": "bd4458d0-6aa2-45f6-aa35-d044fa28e727", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "56   (12.9)", "ParentId": "eb245010-1e2e-42d1-84b7-5105ffe1ab36"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (13.1)</p>\n</td>", "ID": "0851318d-d155-4949-8db4-c6af125cea8d", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "20283ff1-9355-4efc-8043-1fc397052505"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">54 (13.1)</p>", "ID": "3b583598-6f1f-48ae-9c1c-eebb7eb8e3c0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "54 (13.1)", "ParentId": "0851318d-d155-4949-8db4-c6af125cea8d"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">58 (22 -\n  76)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56 (22 -\n  76)</p>\n</td>\n</tr>", "ID": "50edd00d-d6c1-4ddc-837d-4959c4f6d180", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>\n</td>", "ID": "84cdbc33-19a3-4047-9225-2fa931d5a174", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "50edd00d-d6c1-4ddc-837d-4959c4f6d180"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median\n  (minimum \u2013 maximum)</p>", "ID": "bcf6b739-bf7e-4b95-a679-32b49763990d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Median   (minimum \u2013 maximum)", "ParentId": "84cdbc33-19a3-4047-9225-2fa931d5a174"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">58 (22 -\n  76)</p>\n</td>", "ID": "0183f200-ff79-4ede-9d0e-e449ba9b0c7f", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "50edd00d-d6c1-4ddc-837d-4959c4f6d180"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">58 (22 -\n  76)</p>", "ID": "121a49b9-3f5e-4fbd-8487-14479e1d8353", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "58 (22 -   76)", "ParentId": "0183f200-ff79-4ede-9d0e-e449ba9b0c7f"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56 (22 -\n  76)</p>\n</td>", "ID": "acbb1b2c-69b7-4958-86fc-a7ee471ce74b", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "50edd00d-d6c1-4ddc-837d-4959c4f6d180"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">56 (22 -\n  76)</p>", "ID": "6a77f6e4-004a-48c5-a9dc-3f922a830042", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "56 (22 -   76)", "ParentId": "acbb1b2c-69b7-4958-86fc-a7ee471ce74b"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "9931c25c-fe8a-4a60-a3a5-8d8b8f550a48", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>\n</td>", "ID": "b8b50273-841c-49b5-b64a-f58f0893c44c", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9931c25c-fe8a-4a60-a3a5-8d8b8f550a48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Age\n  category (years) - n (%)</b></p>", "ID": "327de0b7-6280-492d-b519-120d3021cfb4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b8b50273-841c-49b5-b64a-f58f0893c44c"}, {"Element": "<b>Age\n  category (years) - n (%)</b>", "ID": "f7f35475-291c-42e0-9aaa-56728cb90a16", "Styles": "None", "Classes": "None", "Text": "Age   category (years) - n (%)", "ParentId": "327de0b7-6280-492d-b519-120d3021cfb4"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "a65864d1-1b07-498b-badb-85e49a6fa5d6", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9931c25c-fe8a-4a60-a3a5-8d8b8f550a48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "58922be8-61fa-44c1-ba09-0e481b5043a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "a65864d1-1b07-498b-badb-85e49a6fa5d6"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "8f24ac67-fed4-4760-8c90-d64ba35ed86e", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9931c25c-fe8a-4a60-a3a5-8d8b8f550a48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "bf8df7a8-20b6-403b-9a03-07356eac49e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "8f24ac67-fed4-4760-8c90-d64ba35ed86e"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;65\u00a0years</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">120\n  (71.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">89\n  (77.4)</p>\n</td>\n</tr>", "ID": "f05bc1fc-d277-460a-be76-f90637c3b02c", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;65\u00a0years</p>\n</td>", "ID": "7233d915-71d2-43ba-900a-3c5f2c24c728", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f05bc1fc-d277-460a-be76-f90637c3b02c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &lt;65\u00a0years</p>", "ID": "5254e377-5acf-49a0-8df9-7e04191d3f41", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <65\u00a0years", "ParentId": "7233d915-71d2-43ba-900a-3c5f2c24c728"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">120\n  (71.9)</p>\n</td>", "ID": "ebcc046d-187a-4067-89f0-84ded15cf4c9", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f05bc1fc-d277-460a-be76-f90637c3b02c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">120\n  (71.9)</p>", "ID": "af89760a-045f-4cd7-b952-08ea5d4f48c0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "120   (71.9)", "ParentId": "ebcc046d-187a-4067-89f0-84ded15cf4c9"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">89\n  (77.4)</p>\n</td>", "ID": "a4649862-9a65-4a44-80c4-c22687be3ff2", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f05bc1fc-d277-460a-be76-f90637c3b02c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">89\n  (77.4)</p>", "ID": "dc6c1af4-5904-4e81-97e1-a6d2dd234ed6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "89   (77.4)", "ParentId": "a4649862-9a65-4a44-80c4-c22687be3ff2"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226565\u00a0years</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">47 (28.1)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">26\n  (22.6)</p>\n</td>\n</tr>", "ID": "92c4a1aa-404e-49b8-ab43-fb1f2b025fb9", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226565\u00a0years</p>\n</td>", "ID": "68f26043-0a9e-42dc-a869-59016c32c2ae", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "92c4a1aa-404e-49b8-ab43-fb1f2b025fb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226565\u00a0years</p>", "ID": "853cb792-a554-47a0-88db-36225853d255", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u226565\u00a0years", "ParentId": "68f26043-0a9e-42dc-a869-59016c32c2ae"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">47 (28.1)</p>\n</td>", "ID": "99ac3d67-9a39-4094-ad51-e5b7ec370cb9", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "92c4a1aa-404e-49b8-ab43-fb1f2b025fb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">47 (28.1)</p>", "ID": "3fbc6318-e762-4e2f-9081-7a6b25028a0c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "47 (28.1)", "ParentId": "99ac3d67-9a39-4094-ad51-e5b7ec370cb9"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">26\n  (22.6)</p>\n</td>", "ID": "490d7d7e-ea28-4767-affd-80ea572bfb5b", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "92c4a1aa-404e-49b8-ab43-fb1f2b025fb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">26\n  (22.6)</p>", "ID": "2dab579f-2603-491b-b445-1dc53e558c63", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "26   (22.6)", "ParentId": "490d7d7e-ea28-4767-affd-80ea572bfb5b"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "c2b35e40-2687-437e-9961-71e1bba2410a", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>\n</td>", "ID": "f1d108f6-8458-473b-81d9-551c23aaa5f5", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c2b35e40-2687-437e-9961-71e1bba2410a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Sex -\n  n (%)</b></p>", "ID": "ff373fd3-c24a-4a85-bf04-615093a7d7a4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f1d108f6-8458-473b-81d9-551c23aaa5f5"}, {"Element": "<b>Sex -\n  n (%)</b>", "ID": "14ab9940-bdea-4987-abd8-e81152acb407", "Styles": "None", "Classes": "None", "Text": "Sex -   n (%)", "ParentId": "ff373fd3-c24a-4a85-bf04-615093a7d7a4"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "70168435-af5e-482c-a432-06df39b4fb89", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c2b35e40-2687-437e-9961-71e1bba2410a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "4cfc8b64-6eb8-40e6-b73b-149966fc9541", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "70168435-af5e-482c-a432-06df39b4fb89"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "a25ceb37-6913-4e6a-acb8-0afc5ce13ce3", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c2b35e40-2687-437e-9961-71e1bba2410a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "48e10bff-8827-4dd0-bc9f-5574f8eddee8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "a25ceb37-6913-4e6a-acb8-0afc5ce13ce3"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">105\n  (62.9)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">71\n  (61.7)</p>\n</td>\n</tr>", "ID": "acfffa35-30cc-4add-8794-59f9172408a9", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>\n</td>", "ID": "11bf94d9-86d2-4b34-9fd9-38770686ccdf", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "acfffa35-30cc-4add-8794-59f9172408a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male</p>", "ID": "06e7f892-305f-4f1b-acb4-d171b41c3547", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Male", "ParentId": "11bf94d9-86d2-4b34-9fd9-38770686ccdf"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">105\n  (62.9)</p>\n</td>", "ID": "45656f33-ed9a-4d3f-b6fb-80a0d08ffa3a", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "acfffa35-30cc-4add-8794-59f9172408a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">105\n  (62.9)</p>", "ID": "5bd654c7-42d3-421b-bc81-c2cf16cf4316", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "105   (62.9)", "ParentId": "45656f33-ed9a-4d3f-b6fb-80a0d08ffa3a"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">71\n  (61.7)</p>\n</td>", "ID": "2bf4e0e5-6384-402d-b763-49e6e91de6c8", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "acfffa35-30cc-4add-8794-59f9172408a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">71\n  (61.7)</p>", "ID": "4fba2550-3ad3-400c-aade-116ecef5750f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "71   (61.7)", "ParentId": "2bf4e0e5-6384-402d-b763-49e6e91de6c8"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">62 (37.1)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">44\n  (38.3)</p>\n</td>\n</tr>", "ID": "dcda1529-f97e-4852-9cc0-204ab8dc02c9", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>\n</td>", "ID": "8aacea8c-0a95-4e34-9c42-a93d630a06a4", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "dcda1529-f97e-4852-9cc0-204ab8dc02c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female</p>", "ID": "00b206c9-8610-4a9f-b5db-2991dbd6e882", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Female", "ParentId": "8aacea8c-0a95-4e34-9c42-a93d630a06a4"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">62 (37.1)</p>\n</td>", "ID": "e5092ee7-4822-4001-99bc-3dd3addf0722", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "dcda1529-f97e-4852-9cc0-204ab8dc02c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">62 (37.1)</p>", "ID": "3643d8e4-a827-4217-8e55-376bf67e86d5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "62 (37.1)", "ParentId": "e5092ee7-4822-4001-99bc-3dd3addf0722"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">44\n  (38.3)</p>\n</td>", "ID": "cea88cde-da6b-4690-a137-52bcfba650b0", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "dcda1529-f97e-4852-9cc0-204ab8dc02c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">44\n  (38.3)</p>", "ID": "29efe759-7f98-4cde-b743-2a96989cba13", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "44   (38.3)", "ParentId": "cea88cde-da6b-4690-a137-52bcfba650b0"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Prior haematopoietic stem cell transplant (SCT) - n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "48720204-f005-4b30-9f72-6d6320899271", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Prior haematopoietic stem cell transplant (SCT) - n (%)</span></b></p>\n</td>", "ID": "2535665b-eced-4b0b-b06d-ddcdca9a0d94", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48720204-f005-4b30-9f72-6d6320899271"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Prior haematopoietic stem cell transplant (SCT) - n (%)</span></b></p>", "ID": "0c6b350e-0963-48f8-9503-630851c7d292", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2535665b-eced-4b0b-b06d-ddcdca9a0d94"}, {"Element": "<b><span lang=\"EN-GB\">Prior haematopoietic stem cell transplant (SCT) - n (%)</span></b>", "ID": "6ca406dd-fa6f-4e14-9a47-68b8d4f19fdb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c6b350e-0963-48f8-9503-630851c7d292"}, {"Element": "<span lang=\"EN-GB\">Prior haematopoietic stem cell transplant (SCT) - n (%)</span>", "ID": "63b59eee-919a-444e-9840-e76a3bb26da0", "Styles": "None", "Classes": "None", "Text": "Prior haematopoietic stem cell transplant (SCT) - n (%)", "ParentId": "6ca406dd-fa6f-4e14-9a47-68b8d4f19fdb"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "3be039ed-ec1c-4296-b54e-33096580c9ea", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48720204-f005-4b30-9f72-6d6320899271"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "739fa792-3b6f-4a4c-8aa8-3f1b819fd5ff", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "3be039ed-ec1c-4296-b54e-33096580c9ea"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "2ba57229-14ba-4b2f-9e06-260328442b20", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48720204-f005-4b30-9f72-6d6320899271"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "67ce77df-7f52-4b51-b9c6-3c95b61c0584", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "2ba57229-14ba-4b2f-9e06-260328442b20"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">93 (55.7)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">59 (51.3)</span></p>\n</td>\n</tr>", "ID": "eb8676d9-ff1b-4736-aedf-5adc1fc39b20", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>", "ID": "99d47f0b-7b80-408d-99c5-9e91ce8841ad", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "eb8676d9-ff1b-4736-aedf-5adc1fc39b20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>", "ID": "95a3719d-a291-41a9-89a4-6c22396e877c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "99d47f0b-7b80-408d-99c5-9e91ce8841ad"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span>", "ID": "dc5b759e-9a28-4895-9faa-c29fd1b1d010", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No", "ParentId": "95a3719d-a291-41a9-89a4-6c22396e877c"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">93 (55.7)</span></p>\n</td>", "ID": "41e03ddb-65eb-49e7-b6be-33136cc700e2", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "eb8676d9-ff1b-4736-aedf-5adc1fc39b20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">93 (55.7)</span></p>", "ID": "963f2753-5daf-4fa3-b1ee-2385ac7103a9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "41e03ddb-65eb-49e7-b6be-33136cc700e2"}, {"Element": "<span lang=\"EN-GB\">93 (55.7)</span>", "ID": "e9187917-7979-49d9-88d3-c4ec072ae060", "Styles": "None", "Classes": "None", "Text": "93 (55.7)", "ParentId": "963f2753-5daf-4fa3-b1ee-2385ac7103a9"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">59 (51.3)</span></p>\n</td>", "ID": "27ee7a12-7b37-4d70-93e1-02a1c09e820c", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "eb8676d9-ff1b-4736-aedf-5adc1fc39b20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">59 (51.3)</span></p>", "ID": "36053a3f-bdb5-4827-ace6-9fbd8e3e00ad", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27ee7a12-7b37-4d70-93e1-02a1c09e820c"}, {"Element": "<span lang=\"EN-GB\">59 (51.3)</span>", "ID": "4301a19f-26eb-4fba-afe5-916ca7ab2c07", "Styles": "None", "Classes": "None", "Text": "59 (51.3)", "ParentId": "36053a3f-bdb5-4827-ace6-9fbd8e3e00ad"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">74 (44.3)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">56 (48.7)</span></p>\n</td>\n</tr>", "ID": "35cb74b5-6f6e-4f73-8941-1a1583c00e43", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>", "ID": "256343e5-0f19-4f55-acd1-3de741510677", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "35cb74b5-6f6e-4f73-8941-1a1583c00e43"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>", "ID": "a87063d9-7f60-427f-a347-90a895f19c99", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "256343e5-0f19-4f55-acd1-3de741510677"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span>", "ID": "d1673bdf-68b5-473c-8e4e-c6f0baf22a76", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes", "ParentId": "a87063d9-7f60-427f-a347-90a895f19c99"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">74 (44.3)</span></p>\n</td>", "ID": "45901031-e568-479c-b12a-16d5aa29e9ea", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "35cb74b5-6f6e-4f73-8941-1a1583c00e43"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">74 (44.3)</span></p>", "ID": "d4de7103-fe0e-4b7a-8fb7-192faae489b8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "45901031-e568-479c-b12a-16d5aa29e9ea"}, {"Element": "<span lang=\"EN-GB\">74 (44.3)</span>", "ID": "2e3c65d3-38d0-4514-8eba-7a824488afd6", "Styles": "None", "Classes": "None", "Text": "74 (44.3)", "ParentId": "d4de7103-fe0e-4b7a-8fb7-192faae489b8"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">56 (48.7)</span></p>\n</td>", "ID": "ded785ee-128c-4252-ab7d-dd8b66704375", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "35cb74b5-6f6e-4f73-8941-1a1583c00e43"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">56 (48.7)</span></p>", "ID": "43b50780-e03f-4068-9787-fcb8b0480ba2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ded785ee-128c-4252-ab7d-dd8b66704375"}, {"Element": "<span lang=\"EN-GB\">56 (48.7)</span>", "ID": "5d9abe32-02d0-46f9-96f5-a7b43de130a5", "Styles": "None", "Classes": "None", "Text": "56 (48.7)", "ParentId": "43b50780-e03f-4068-9787-fcb8b0480ba2"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Stage III/IV disease at study entry - n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "a73017fb-08e6-400a-9e68-0396c8c661d4", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Stage III/IV disease at study entry - n (%)</span></b></p>\n</td>", "ID": "ced82ceb-ad4a-4bf2-8c8b-413e43e8700b", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a73017fb-08e6-400a-9e68-0396c8c661d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Stage III/IV disease at study entry - n (%)</span></b></p>", "ID": "e544f295-cb88-45d0-a424-4f7f1beb986b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ced82ceb-ad4a-4bf2-8c8b-413e43e8700b"}, {"Element": "<b><span lang=\"EN-GB\">Stage III/IV disease at study entry - n (%)</span></b>", "ID": "2aa28794-57c1-4ced-b9d3-df04f319a464", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e544f295-cb88-45d0-a424-4f7f1beb986b"}, {"Element": "<span lang=\"EN-GB\">Stage III/IV disease at study entry - n (%)</span>", "ID": "4d20dae2-4196-4513-b1b5-b01899ba0c07", "Styles": "None", "Classes": "None", "Text": "Stage III/IV disease at study entry - n (%)", "ParentId": "2aa28794-57c1-4ced-b9d3-df04f319a464"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "b9b83539-bc6e-45d1-ace7-d03231c73198", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a73017fb-08e6-400a-9e68-0396c8c661d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "afd38143-2244-463d-86ef-71123d40b1d6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "b9b83539-bc6e-45d1-ace7-d03231c73198"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "686b5228-e7fb-4f2e-b30c-14ba046c9601", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a73017fb-08e6-400a-9e68-0396c8c661d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "b4262bed-1612-4073-8b37-5ef7d3cdeee9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "686b5228-e7fb-4f2e-b30c-14ba046c9601"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">36 (21.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">27 (23.5)</span></p>\n</td>\n</tr>", "ID": "379d4253-af2e-49c1-82a8-3cea1462ca51", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>\n</td>", "ID": "62526aa4-f8ae-496e-af26-1dea97f5a818", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "379d4253-af2e-49c1-82a8-3cea1462ca51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span></p>", "ID": "37b60400-2d5c-49f1-b59d-897ac67f6aca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "62526aa4-f8ae-496e-af26-1dea97f5a818"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No</span>", "ID": "c3cbed3b-9c55-4f92-9bcc-643330392a12", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 No", "ParentId": "37b60400-2d5c-49f1-b59d-897ac67f6aca"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">36 (21.6)</span></p>\n</td>", "ID": "5b87df8f-b25f-4bea-a9cf-297981957b69", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "379d4253-af2e-49c1-82a8-3cea1462ca51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">36 (21.6)</span></p>", "ID": "183156df-8dbe-49e9-a450-185144774ecc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5b87df8f-b25f-4bea-a9cf-297981957b69"}, {"Element": "<span lang=\"EN-GB\">36 (21.6)</span>", "ID": "7b648c38-24a8-4d52-adc7-d5103db5cc1f", "Styles": "None", "Classes": "None", "Text": "36 (21.6)", "ParentId": "183156df-8dbe-49e9-a450-185144774ecc"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">27 (23.5)</span></p>\n</td>", "ID": "141f4e64-011c-43a3-89de-3199b6755534", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "379d4253-af2e-49c1-82a8-3cea1462ca51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">27 (23.5)</span></p>", "ID": "6b67efe4-ac3c-4667-bb6e-27cd7e3a3b47", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "141f4e64-011c-43a3-89de-3199b6755534"}, {"Element": "<span lang=\"EN-GB\">27 (23.5)</span>", "ID": "55eb5d14-dec5-46a2-af0a-a3e0a73fafab", "Styles": "None", "Classes": "None", "Text": "27 (23.5)", "ParentId": "6b67efe4-ac3c-4667-bb6e-27cd7e3a3b47"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">131 (78.4)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">88 (76.5)</span></p>\n</td>\n</tr>", "ID": "97118745-fe6f-4fac-bc4e-2c2d31282aa0", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>\n</td>", "ID": "40fe08ce-6140-4a75-8218-3d11e28b1379", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "97118745-fe6f-4fac-bc4e-2c2d31282aa0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span></p>", "ID": "c3dd8c75-0a06-43c5-b718-8fa63dd2f186", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "40fe08ce-6140-4a75-8218-3d11e28b1379"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes</span>", "ID": "ada7e6ba-a5fd-42e7-afdc-3ba3d3bfd599", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Yes", "ParentId": "c3dd8c75-0a06-43c5-b718-8fa63dd2f186"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">131 (78.4)</span></p>\n</td>", "ID": "7e4233c4-41c2-43c3-9113-0fab819611ac", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "97118745-fe6f-4fac-bc4e-2c2d31282aa0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">131 (78.4)</span></p>", "ID": "00513700-b798-4e6b-a1d3-7f0f8f12f636", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7e4233c4-41c2-43c3-9113-0fab819611ac"}, {"Element": "<span lang=\"EN-GB\">131 (78.4)</span>", "ID": "3f59a49b-9c89-461e-88d9-046962814fb4", "Styles": "None", "Classes": "None", "Text": "131 (78.4)", "ParentId": "00513700-b798-4e6b-a1d3-7f0f8f12f636"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">88 (76.5)</span></p>\n</td>", "ID": "823eebef-ef23-4012-a07b-42489d20028a", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "97118745-fe6f-4fac-bc4e-2c2d31282aa0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">88 (76.5)</span></p>", "ID": "77575381-4303-44ca-bc64-490bcbee5787", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "823eebef-ef23-4012-a07b-42489d20028a"}, {"Element": "<span lang=\"EN-GB\">88 (76.5)</span>", "ID": "9fe42e72-fb3e-4b0f-bbac-b93bc8562cce", "Styles": "None", "Classes": "None", "Text": "88 (76.5)", "ParentId": "77575381-4303-44ca-bc64-490bcbee5787"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Number of prior\n  lines of antineoplastic therapy \u2013 n (%)</span></b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>\n</tr>", "ID": "2e0c35f4-963b-408c-80ea-d405eafc538b", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Number of prior\n  lines of antineoplastic therapy \u2013 n (%)</span></b></p>\n</td>", "ID": "57cd4d83-472e-488a-a14d-9571513f7e4c", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2e0c35f4-963b-408c-80ea-d405eafc538b"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Number of prior\n  lines of antineoplastic therapy \u2013 n (%)</span></b></p>", "ID": "dc92d114-c24d-4c2e-895f-5f9bd8069050", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "57cd4d83-472e-488a-a14d-9571513f7e4c"}, {"Element": "<b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Number of prior\n  lines of antineoplastic therapy \u2013 n (%)</span></b>", "ID": "35457653-e316-405d-88f3-57eb0dcecaf3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc92d114-c24d-4c2e-895f-5f9bd8069050"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Number of prior\n  lines of antineoplastic therapy \u2013 n (%)</span>", "ID": "0616bf94-48f1-4fc0-b9e8-d98e90eee7d1", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Number of prior   lines of antineoplastic therapy \u2013 n (%)", "ParentId": "35457653-e316-405d-88f3-57eb0dcecaf3"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>", "ID": "2e1c9ff4-9b18-4b0c-aa70-4beffc64ca1d", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2e0c35f4-963b-408c-80ea-d405eafc538b"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "6ff1a25d-c685-4d4e-9a2b-7112b4310ca8", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "2e1c9ff4-9b18-4b0c-aa70-4beffc64ca1d"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "d09e9b63-3248-47ba-b917-89ade7386c54", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "6ff1a25d-c685-4d4e-9a2b-7112b4310ca8"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n</td>", "ID": "1e362e24-8fa8-498f-9acf-5e104e678c00", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2e0c35f4-963b-408c-80ea-d405eafc538b"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "85020492-8e59-4359-868d-41be0ce55671", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "1e362e24-8fa8-498f-9acf-5e104e678c00"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "4ab285ce-4276-4152-8265-90dc742e5655", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "85020492-8e59-4359-868d-41be0ce55671"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>6 (3.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5 (4.3)</span></p>\n</td>\n</tr>", "ID": "f66173ac-ff16-4e65-b64f-a4e0e394cd66", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</span></p>\n</td>", "ID": "314a9b4c-b812-4435-859d-e312d78a8499", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f66173ac-ff16-4e65-b64f-a4e0e394cd66"}, {"Element": "<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</span></p>", "ID": "fb4385bf-2a1f-4599-9a7e-119f7b3e9577", "Styles": "margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "314a9b4c-b812-4435-859d-e312d78a8499"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1</span>", "ID": "52850a28-ecb5-42b7-a3de-7025031d7107", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1", "ParentId": "fb4385bf-2a1f-4599-9a7e-119f7b3e9577"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>6 (3.6)</span></p>\n</td>", "ID": "7fd98162-dd8e-4bf7-8095-1ba55fa95946", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f66173ac-ff16-4e65-b64f-a4e0e394cd66"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>6 (3.6)</span></p>", "ID": "a31ee536-2244-4c91-94ce-78a5c69fcf0d", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "7fd98162-dd8e-4bf7-8095-1ba55fa95946"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>6 (3.6)</span>", "ID": "dfa89a60-c42f-498e-9998-9ed07d7913f7", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "6 (3.6)", "ParentId": "a31ee536-2244-4c91-94ce-78a5c69fcf0d"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5 (4.3)</span></p>\n</td>", "ID": "a18b3b77-6b01-4c88-a367-a31dfb4a5ec4", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f66173ac-ff16-4e65-b64f-a4e0e394cd66"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5 (4.3)</span></p>", "ID": "1eaafb2a-906a-4388-8c80-dbc80624bf31", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "a18b3b77-6b01-4c88-a367-a31dfb4a5ec4"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5 (4.3)</span>", "ID": "ad272520-ffe3-4407-8c01-f1e13eb9809b", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5 (4.3)", "ParentId": "1eaafb2a-906a-4388-8c80-dbc80624bf31"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>73 (43.7)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>51 (44.3)</span></p>\n</td>\n</tr>", "ID": "1b814f62-f1c8-4e18-8c39-e3cdb17b6bf4", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</span></p>\n</td>", "ID": "c9e1d88c-592e-4bcf-9812-2291d823cea0", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1b814f62-f1c8-4e18-8c39-e3cdb17b6bf4"}, {"Element": "<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</span></p>", "ID": "37bd01ac-804b-40f8-aacc-8afd07be167c", "Styles": "margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "c9e1d88c-592e-4bcf-9812-2291d823cea0"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2</span>", "ID": "84d0eff4-7bc6-4ef2-8540-ec79ccd7b5a9", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2", "ParentId": "37bd01ac-804b-40f8-aacc-8afd07be167c"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>73 (43.7)</span></p>\n</td>", "ID": "bc55c468-300b-4037-8928-cb0480d1f38a", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1b814f62-f1c8-4e18-8c39-e3cdb17b6bf4"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>73 (43.7)</span></p>", "ID": "9cd02bc9-3e9b-4a16-b72f-351c7eae5faa", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "bc55c468-300b-4037-8928-cb0480d1f38a"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>73 (43.7)</span>", "ID": "e7f6b510-4511-4df7-a54b-55aa02fe237e", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "73 (43.7)", "ParentId": "9cd02bc9-3e9b-4a16-b72f-351c7eae5faa"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>51 (44.3)</span></p>\n</td>", "ID": "b812b959-8982-4592-86ce-27ea6cde6132", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1b814f62-f1c8-4e18-8c39-e3cdb17b6bf4"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>51 (44.3)</span></p>", "ID": "d263945b-6662-4908-8b96-fc9ae3cbacc8", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "b812b959-8982-4592-86ce-27ea6cde6132"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>51 (44.3)</span>", "ID": "3308da7d-59f4-4a8a-b1bf-553f89d176be", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "51 (44.3)", "ParentId": "d263945b-6662-4908-8b96-fc9ae3cbacc8"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>52 (31.1)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (31.3)</span></p>\n</td>\n</tr>", "ID": "8d731fe9-cd5a-44c3-aabf-e3f4962bd7fb", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3</span></p>\n</td>", "ID": "d05ecf3e-e847-4778-ba5d-81fe60585131", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8d731fe9-cd5a-44c3-aabf-e3f4962bd7fb"}, {"Element": "<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3</span></p>", "ID": "05eb566c-01e2-40d3-8854-d7a1a6c47065", "Styles": "margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "d05ecf3e-e847-4778-ba5d-81fe60585131"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3</span>", "ID": "a4ba99ec-b060-4de5-bf3e-33706ef290bf", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3", "ParentId": "05eb566c-01e2-40d3-8854-d7a1a6c47065"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>52 (31.1)</span></p>\n</td>", "ID": "6f8d518b-d4eb-4f5a-b47f-8b5a551122e4", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8d731fe9-cd5a-44c3-aabf-e3f4962bd7fb"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>52 (31.1)</span></p>", "ID": "aebcc7c5-de87-4e1a-8a5f-1c0787707a65", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6f8d518b-d4eb-4f5a-b47f-8b5a551122e4"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>52 (31.1)</span>", "ID": "9f5a259c-6f28-45a5-a503-9174742ea9fa", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "52 (31.1)", "ParentId": "aebcc7c5-de87-4e1a-8a5f-1c0787707a65"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (31.3)</span></p>\n</td>", "ID": "7fccc016-95b3-466f-bcc4-119b23cede71", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8d731fe9-cd5a-44c3-aabf-e3f4962bd7fb"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (31.3)</span></p>", "ID": "2570a885-02fa-47b9-9d88-1790ba127a75", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "7fccc016-95b3-466f-bcc4-119b23cede71"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (31.3)</span>", "ID": "5892d8a4-50b1-4828-8827-567f9515602b", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "36 (31.3)", "ParentId": "2570a885-02fa-47b9-9d88-1790ba127a75"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u22654</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (21.6)</span></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>23 (20.0)</span></p>\n</td>\n</tr>", "ID": "2870794a-8afd-4bb2-b209-ab2645c32d11", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u22654</span></p>\n</td>", "ID": "7e7982e0-6a81-4e8d-a168-14c71550307b", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2870794a-8afd-4bb2-b209-ab2645c32d11"}, {"Element": "<p class=\"Table\" style=\"margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u22654</span></p>", "ID": "72b523c1-2ea6-412d-86b0-021a3e870d5f", "Styles": "margin:0in;text-align:justify;text-justify:inter-ideograph;\n  page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "7e7982e0-6a81-4e8d-a168-14c71550307b"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u22654</span>", "ID": "a9786a86-9848-49d7-81d2-fe44747f8c2f", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u22654", "ParentId": "72b523c1-2ea6-412d-86b0-021a3e870d5f"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (21.6)</span></p>\n</td>", "ID": "6a80c47b-4787-4aae-8e75-af6ba2f0a229", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2870794a-8afd-4bb2-b209-ab2645c32d11"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (21.6)</span></p>", "ID": "75630f80-9c84-41f9-bead-a5706cc3a7f7", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "6a80c47b-4787-4aae-8e75-af6ba2f0a229"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>36 (21.6)</span>", "ID": "a89b50eb-24ac-44d3-bbb1-d3c26a0e6a50", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "36 (21.6)", "ParentId": "75630f80-9c84-41f9-bead-a5706cc3a7f7"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>23 (20.0)</span></p>\n</td>", "ID": "8ac5cffd-8d36-4dd5-ae3d-b90de37853cd", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2870794a-8afd-4bb2-b209-ab2645c32d11"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>23 (20.0)</span></p>", "ID": "6cf8f9dd-ff7a-4df6-bf9f-dc8322b12754", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "8ac5cffd-8d36-4dd5-ae3d-b90de37853cd"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>23 (20.0)</span>", "ID": "d6593d6b-cc44-465b-9fd6-afcef7623ab8", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "23 (20.0)", "ParentId": "6cf8f9dd-ff7a-4df6-bf9f-dc8322b12754"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>\n</tr>", "ID": "430e6505-55bd-4c2a-8c54-6f635f3652b5", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>\n</td>", "ID": "f2c21ada-7cb5-4e19-bf4d-06e344097784", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "430e6505-55bd-4c2a-8c54-6f635f3652b5"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\"><b>Disease status (%)</b></p>", "ID": "eb7f1238-72e2-4306-a05f-6a2d70efcc5c", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f2c21ada-7cb5-4e19-bf4d-06e344097784"}, {"Element": "<b>Disease status (%)</b>", "ID": "6f8d058d-2ceb-48c4-b16e-584a47c39c82", "Styles": "None", "Classes": "None", "Text": "Disease status (%)", "ParentId": "eb7f1238-72e2-4306-a05f-6a2d70efcc5c"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "408f21d7-d3fd-4d58-8a8a-7453959532c9", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "430e6505-55bd-4c2a-8c54-6f635f3652b5"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "e9b6614b-aa3e-4142-8d33-7a3321b2241d", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "408f21d7-d3fd-4d58-8a8a-7453959532c9"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>\n</td>", "ID": "14c2cd98-339f-4f56-9c19-49510e5ef6a3", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "430e6505-55bd-4c2a-8c54-6f635f3652b5"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0</p>", "ID": "a7cf42f9-4f98-490e-8e8d-5e2a366083d1", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "14c2cd98-339f-4f56-9c19-49510e5ef6a3"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refractory to last line\n  of therapy</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">98 (58.7)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">63 (54.8)</p>\n</td>\n</tr>", "ID": "72c3a324-a571-4110-9b8f-4244c602bbdf", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refractory to last line\n  of therapy</p>\n</td>", "ID": "b44593d0-e231-4f86-a40f-acfc7d6b7f5b", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "72c3a324-a571-4110-9b8f-4244c602bbdf"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refractory to last line\n  of therapy</p>", "ID": "f33f76e1-228a-451d-b6c6-607f7fc44e62", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Refractory to last line   of therapy", "ParentId": "b44593d0-e231-4f86-a40f-acfc7d6b7f5b"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">98 (58.7)</p>\n</td>", "ID": "bd132b6a-be11-4528-9bbe-ae7f2da40a27", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "72c3a324-a571-4110-9b8f-4244c602bbdf"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">98 (58.7)</p>", "ID": "77168e14-d207-4ff5-8fac-0983b9b96c47", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "98 (58.7)", "ParentId": "bd132b6a-be11-4528-9bbe-ae7f2da40a27"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">63 (54.8)</p>\n</td>", "ID": "ef29e949-ca21-4c10-9a62-eec0ffec32bb", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "72c3a324-a571-4110-9b8f-4244c602bbdf"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid\">63 (54.8)</p>", "ID": "6d9eb46d-2e56-43df-98de-5565198f2b5a", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "63 (54.8)", "ParentId": "ef29e949-ca21-4c10-9a62-eec0ffec32bb"}, {"Element": "<tr>\n<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapse to last line of therapy</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">69 (41.3)</p>\n</td>\n<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">52 (45.2)</p>\n</td>\n</tr>", "ID": "ad669aee-bbe0-441e-9e37-8a3b88807c2c", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "b9bfafa0-a76c-4eb6-bfe0-d5632a42f63b"}, {"Element": "<td style=\"width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"294\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapse to last line of therapy</p>\n</td>", "ID": "99296f08-15b9-471a-a4a4-b4066032ee8b", "Styles": "width:220.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ad669aee-bbe0-441e-9e37-8a3b88807c2c"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapse to last line of therapy</p>", "ID": "3310fbf7-5a1c-4306-8773-82f684b6df9c", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Relapse to last line of therapy", "ParentId": "99296f08-15b9-471a-a4a4-b4066032ee8b"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">69 (41.3)</p>\n</td>", "ID": "33484a70-26c5-44e3-801e-520087c2465b", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ad669aee-bbe0-441e-9e37-8a3b88807c2c"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">69 (41.3)</p>", "ID": "d586863d-2eae-4edf-9c48-41ed8ac5682f", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "69 (41.3)", "ParentId": "33484a70-26c5-44e3-801e-520087c2465b"}, {"Element": "<td style=\"width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">52 (45.2)</p>\n</td>", "ID": "7b4e37e1-4554-48ff-9609-1f2c1c21fcbb", "Styles": "width:116.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ad669aee-bbe0-441e-9e37-8a3b88807c2c"}, {"Element": "<p class=\"MsoNormal\" style=\"text-align:justify;text-justify:inter-ideograph;\n  line-height:normal\">52 (45.2)</p>", "ID": "d7a97354-783b-44cb-99e8-4dff40f05a48", "Styles": "text-align:justify;text-justify:inter-ideograph;\n  line-height:normal", "Classes": "['MsoNormal']", "Text": "52 (45.2)", "ParentId": "7b4e37e1-4554-48ff-9609-1f2c1c21fcbb"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "6d25f645-c6cb-4836-a44a-f37114cb225a", "Styles": "margin-top:0in;text-align:left", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "11615264-d83b-4663-81d4-6eeded0186da", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "6d25f645-c6cb-4836-a44a-f37114cb225a"}, {"Element": "<p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The efficacy\nof Kymriah was evaluated through the primary endpoint of best overall response\nrate (ORR), which includes complete response (CR) and partial response (PR) as\ndetermined by Independent Review Committee (IRC) assessment as well as\nsecondary endpoints including duration of response (Table\u00a06).</span></p>", "ID": "716e45e8-9119-4be8-a732-e8f82f7cd7be", "Styles": "None", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The efficacy\nof Kymriah was evaluated through the primary endpoint of best overall response\nrate (ORR), which includes complete response (CR) and partial response (PR) as\ndetermined by Independent Review Committee (IRC) assessment as well as\nsecondary endpoints including duration of response (Table\u00a06).</span>", "ID": "b402d0bc-b6ed-4139-8d97-c3e19e918eaf", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The efficacy of Kymriah was evaluated through the primary endpoint of best overall response rate (ORR), which includes complete response (CR) and partial response (PR) as determined by Independent Review Committee (IRC) assessment as well as secondary endpoints including duration of response (Table\u00a06).", "ParentId": "716e45e8-9119-4be8-a732-e8f82f7cd7be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><a name=\"_hd6_Table_4_2_Best_overall27158\"></a><a name=\"_hd7_Figure_4_1_Kaplan_Meie31722\"></a><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ec7439a-3ab1-4caa-9577-00b834a09bdb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<a name=\"_hd6_Table_4_2_Best_overall27158\"></a>", "ID": "9a478801-959e-47a2-bef0-d90073a78e32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ec7439a-3ab1-4caa-9577-00b834a09bdb"}, {"Element": "<a name=\"_hd7_Figure_4_1_Kaplan_Meie31722\"></a>", "ID": "637523f5-a05c-4df4-abb6-94209f451e59", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ec7439a-3ab1-4caa-9577-00b834a09bdb"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a7a56343-663c-4c24-89b5-833ff3086c4a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ec7439a-3ab1-4caa-9577-00b834a09bdb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none\"><a name=\"_Toc488242409\"><b><span lang=\"EN-GB\">Table\u00a06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b></a><b><span lang=\"EN-GB\">Study C2201:\nEfficacy results in adult patients with relapsed or refractory diffuse large B\u2011cell\nlymphoma (DLBCL) after two or more lines of systemic therapy</span></b></p>", "ID": "cd33c4a9-1384-410b-bf26-ae4e8799a105", "Styles": "margin-left:56.7pt;text-indent:-56.7pt;line-height:\nnormal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<a name=\"_Toc488242409\"><b><span lang=\"EN-GB\">Table\u00a06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b></a>", "ID": "950cd9d0-ccf6-4dab-817f-d9ca710b381f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd33c4a9-1384-410b-bf26-ae4e8799a105"}, {"Element": "<b><span lang=\"EN-GB\">Table\u00a06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b>", "ID": "fbadab10-3599-4d84-9f98-6d19b4bd84a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "950cd9d0-ccf6-4dab-817f-d9ca710b381f"}, {"Element": "<span lang=\"EN-GB\">Table\u00a06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "4508305e-d486-478c-96fd-0320a872a5b7", "Styles": "None", "Classes": "None", "Text": "Table\u00a06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "fbadab10-3599-4d84-9f98-6d19b4bd84a1"}, {"Element": "<b><span lang=\"EN-GB\">Study C2201:\nEfficacy results in adult patients with relapsed or refractory diffuse large B\u2011cell\nlymphoma (DLBCL) after two or more lines of systemic therapy</span></b>", "ID": "8d02b5b7-f856-419c-bde5-1f9243bac153", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd33c4a9-1384-410b-bf26-ae4e8799a105"}, {"Element": "<span lang=\"EN-GB\">Study C2201:\nEfficacy results in adult patients with relapsed or refractory diffuse large B\u2011cell\nlymphoma (DLBCL) after two or more lines of systemic therapy</span>", "ID": "dc9b88c2-4224-4d45-8c12-716b5ddd0a3d", "Styles": "None", "Classes": "None", "Text": "Study C2201: Efficacy results in adult patients with relapsed or refractory diffuse large B\u2011cell lymphoma (DLBCL) after two or more lines of systemic therapy", "ParentId": "8d02b5b7-f856-419c-bde5-1f9243bac153"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "afaf1c97-57ae-452d-a61e-04597908c2bf", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8893b5a1-0004-4c33-82cd-40b9e36a8c58", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "afaf1c97-57ae-452d-a61e-04597908c2bf"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:487.35pt;border-collapse:collapse;border:none\" width=\"650\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>\n<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint<sup>1</sup></span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=147</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=99</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Overall response\n  rate</span></b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\n<b>(ORR)</b> (CR+PR)<sup>2</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">95% CI</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (36.1)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(28.3, 44.4)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (53.5)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(43.2, 63.6)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">CR, n (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40 (27.2)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40(40.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">PR, n (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (8.8)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (13.1)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">Response a</span><span lang=\"EN-GB\">t\n  month\u00a03</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (26.5)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (39.4)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Response at month\u00a06</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (21.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (31.3)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Duration of response (DOR)<sup>3</sup></span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 18\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoints</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Overall survival (OS)<sup>4</sup></span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">40.9</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">47.9</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 24\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">32.5</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39.1</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">8.2 (5.8, 11.7)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">10.3 <span style=\"color:black\">(6.6, 21.1)</span></span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:487.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"650\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\n  primary endpoint was analysed on all patients whose Kymriah was manufactured\n  at the Novartis US facility.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ORR\n  is the proportion of patients with best overall response (BOR) of CR or PR\n  based on the Lugano response criteria (Cheson 2014); non\u2011infused\n  patients were assigned BOR=Unknown (i.e. non\u2011responders).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>DOR\n  was defined as time from achievement of CR or PR to relapse or death due to\n  DLBCL, whichever occurs first.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal;page-break-after:avoid;text-autospace:none\"><sup><span lang=\"EN-GB\">4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\">OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause (N=115)\n  and time from date of enrolment to the date of death due to any cause for\n  enrolled patients (N=167).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5</span></sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not estimable.</span></p>\n</td>\n</tr>\n</table>", "ID": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46", "Styles": "width:487.35pt;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                      ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>\n<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>\n</tr>", "ID": "92106210-ca70-43dd-a201-3e76b537ff26", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "463da807-ff47-415f-964a-1bea2e104d84", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "92106210-ca70-43dd-a201-3e76b537ff26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "17db5d8c-3ef5-45f3-b735-282122d4e749", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "463da807-ff47-415f-964a-1bea2e104d84"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "3ac2d4f0-5233-4660-beb4-727368ab1235", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17db5d8c-3ef5-45f3-b735-282122d4e749"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c711df6e-ffd9-428f-83f1-a9d10b802db6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ac2d4f0-5233-4660-beb4-727368ab1235"}, {"Element": "<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>", "ID": "eb46ee92-8f00-4f7f-990e-98455fca11a4", "Styles": "width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "92106210-ca70-43dd-a201-3e76b537ff26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Enrolled patients</span></b></p>", "ID": "aadfbbbf-c083-4cec-8541-ab4a8ff9a358", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb46ee92-8f00-4f7f-990e-98455fca11a4"}, {"Element": "<b><span lang=\"EN-GB\">Enrolled patients</span></b>", "ID": "0c8cac49-a61d-4a18-915c-abc0325a45d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aadfbbbf-c083-4cec-8541-ab4a8ff9a358"}, {"Element": "<span lang=\"EN-GB\">Enrolled patients</span>", "ID": "caaf6963-711b-4737-b90c-ba2b2ce8bdb0", "Styles": "None", "Classes": "None", "Text": "Enrolled patients", "ParentId": "0c8cac49-a61d-4a18-915c-abc0325a45d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>", "ID": "5f414aa1-893e-4555-9c66-ac63c2fc6dac", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb46ee92-8f00-4f7f-990e-98455fca11a4"}, {"Element": "<b><span lang=\"EN-GB\">N=167</span></b>", "ID": "4772511c-1740-4ea5-b2f5-8ada29a0a649", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5f414aa1-893e-4555-9c66-ac63c2fc6dac"}, {"Element": "<span lang=\"EN-GB\">N=167</span>", "ID": "b0fc7732-e58e-41e5-a304-0e3d883cbccb", "Styles": "None", "Classes": "None", "Text": "N=167", "ParentId": "4772511c-1740-4ea5-b2f5-8ada29a0a649"}, {"Element": "<td style=\"width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>", "ID": "a2a57444-4a95-4afe-b012-725d3aef0208", "Styles": "width:120.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "92106210-ca70-43dd-a201-3e76b537ff26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Infused patients</span></b></p>", "ID": "945e5113-4b62-4449-9a43-9ed4b54db13b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2a57444-4a95-4afe-b012-725d3aef0208"}, {"Element": "<b><span lang=\"EN-GB\">Infused patients</span></b>", "ID": "ebbc9d97-a517-413a-911d-eec10c1c715b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "945e5113-4b62-4449-9a43-9ed4b54db13b"}, {"Element": "<span lang=\"EN-GB\">Infused patients</span>", "ID": "510d37dd-b6b0-465d-adce-c2d8d48c1de7", "Styles": "None", "Classes": "None", "Text": "Infused patients", "ParentId": "ebbc9d97-a517-413a-911d-eec10c1c715b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>", "ID": "09777b42-6bfe-4e7c-8dbe-bb24641adee7", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2a57444-4a95-4afe-b012-725d3aef0208"}, {"Element": "<b><span lang=\"EN-GB\">N=115</span></b>", "ID": "a5a31447-3426-43f5-9141-35be31fd306f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "09777b42-6bfe-4e7c-8dbe-bb24641adee7"}, {"Element": "<span lang=\"EN-GB\">N=115</span>", "ID": "2daf2343-40a6-40cf-8580-ef5e784bca56", "Styles": "None", "Classes": "None", "Text": "N=115", "ParentId": "a5a31447-3426-43f5-9141-35be31fd306f"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint<sup>1</sup></span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=147</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=99</span></b></p>\n</td>\n</tr>", "ID": "ffc64d2f-8541-4e5a-90a4-c132b409babe", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint<sup>1</sup></span></b></p>\n</td>", "ID": "2d87eba2-6af7-4091-a0f0-1627b9e5345a", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ffc64d2f-8541-4e5a-90a4-c132b409babe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint<sup>1</sup></span></b></p>", "ID": "4dca07a8-5f09-475c-a1cf-37a01b7e9d5d", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2d87eba2-6af7-4091-a0f0-1627b9e5345a"}, {"Element": "<b><span lang=\"EN-GB\">Primary endpoint<sup>1</sup></span></b>", "ID": "81c3f3e4-0b82-4b55-b231-746fe9e1df60", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4dca07a8-5f09-475c-a1cf-37a01b7e9d5d"}, {"Element": "<span lang=\"EN-GB\">Primary endpoint<sup>1</sup></span>", "ID": "1e42fb5b-2b93-4e42-b87b-1b10db1d1610", "Styles": "None", "Classes": "None", "Text": "Primary endpoint", "ParentId": "81c3f3e4-0b82-4b55-b231-746fe9e1df60"}, {"Element": "<sup>1</sup>", "ID": "2ec8e7df-d5e4-4e51-bc52-9dbab6ed03ae", "Styles": "None", "Classes": "None", "Text": "1", "ParentId": "1e42fb5b-2b93-4e42-b87b-1b10db1d1610"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=147</span></b></p>\n</td>", "ID": "16dd5f1b-5927-4957-a3f9-c771eb850ef1", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ffc64d2f-8541-4e5a-90a4-c132b409babe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=147</span></b></p>", "ID": "400eb8fb-ec0f-4497-8ba1-9942d567632e", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "16dd5f1b-5927-4957-a3f9-c771eb850ef1"}, {"Element": "<b><span lang=\"EN-GB\">N=147</span></b>", "ID": "6d16be0f-f274-4c94-9629-bbf2411dfd9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "400eb8fb-ec0f-4497-8ba1-9942d567632e"}, {"Element": "<span lang=\"EN-GB\">N=147</span>", "ID": "d6989a80-b69a-42c9-91b5-20f76e417a77", "Styles": "None", "Classes": "None", "Text": "N=147", "ParentId": "6d16be0f-f274-4c94-9629-bbf2411dfd9e"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=99</span></b></p>\n</td>", "ID": "3ee2e5cf-8bc2-48dc-9b17-61b9e7ed8d5e", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ffc64d2f-8541-4e5a-90a4-c132b409babe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=99</span></b></p>", "ID": "5b2f65ae-913e-4718-ab4e-cc0dd70ec0ed", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3ee2e5cf-8bc2-48dc-9b17-61b9e7ed8d5e"}, {"Element": "<b><span lang=\"EN-GB\">N=99</span></b>", "ID": "f1583249-89b6-445b-b820-d4178d94da51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5b2f65ae-913e-4718-ab4e-cc0dd70ec0ed"}, {"Element": "<span lang=\"EN-GB\">N=99</span>", "ID": "b056b16a-d98d-4d43-9c44-c24055403af5", "Styles": "None", "Classes": "None", "Text": "N=99", "ParentId": "f1583249-89b6-445b-b820-d4178d94da51"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Overall response\n  rate</span></b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\n<b>(ORR)</b> (CR+PR)<sup>2</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">95% CI</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (36.1)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(28.3, 44.4)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (53.5)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(43.2, 63.6)</span></p>\n</td>\n</tr>", "ID": "8aaf34f6-85b2-4443-b5c5-9ce761eb25d8", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Overall response\n  rate</span></b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\n<b>(ORR)</b> (CR+PR)<sup>2</sup>, n (%)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">95% CI</span></p>\n</td>", "ID": "ff050fe2-4672-4834-b9f4-c679cf6040c1", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "8aaf34f6-85b2-4443-b5c5-9ce761eb25d8"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Overall response\n  rate</span></b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\n<b>(ORR)</b> (CR+PR)<sup>2</sup>, n (%)</span></p>", "ID": "761f0335-fa4c-4e7c-86a2-f8bd55915944", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "ff050fe2-4672-4834-b9f4-c679cf6040c1"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Overall response\n  rate</span></b>", "ID": "643b3970-c11b-4dc6-8147-810116305c07", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "761f0335-fa4c-4e7c-86a2-f8bd55915944"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Overall response\n  rate</span>", "ID": "c49eb399-8d79-4dfb-b913-726bd43557ae", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Overall response   rate", "ParentId": "643b3970-c11b-4dc6-8147-810116305c07"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\n<b>(ORR)</b> (CR+PR)<sup>2</sup>, n (%)</span>", "ID": "5bf94de4-4634-40a9-9a3e-170bc4d104fe", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "  (CR+PR), n (%)", "ParentId": "761f0335-fa4c-4e7c-86a2-f8bd55915944"}, {"Element": "<b>(ORR)</b>", "ID": "2d8d2d57-10e1-4c54-88d4-dc5ab8525d21", "Styles": "None", "Classes": "None", "Text": "(ORR)", "ParentId": "5bf94de4-4634-40a9-9a3e-170bc4d104fe"}, {"Element": "<sup>2</sup>", "ID": "557bf513-f7ae-43da-aa14-2ee585392203", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "5bf94de4-4634-40a9-9a3e-170bc4d104fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">95% CI</span></p>", "ID": "9134d492-ff16-4b5d-8e4a-ebf62b63d29c", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ff050fe2-4672-4834-b9f4-c679cf6040c1"}, {"Element": "<span lang=\"EN-GB\">95% CI</span>", "ID": "1b44ae34-a92a-4904-a430-7688576f61b8", "Styles": "None", "Classes": "None", "Text": "95% CI", "ParentId": "9134d492-ff16-4b5d-8e4a-ebf62b63d29c"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (36.1)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(28.3, 44.4)</span></p>\n</td>", "ID": "d765983e-3c8e-4f31-ac3f-0fca60ebdc3b", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "8aaf34f6-85b2-4443-b5c5-9ce761eb25d8"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (36.1)</span></b></p>", "ID": "81546438-5a20-469b-8ee8-9d38e70a50c8", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "d765983e-3c8e-4f31-ac3f-0fca60ebdc3b"}, {"Element": "<b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (36.1)</span></b>", "ID": "03c31fbe-2032-4837-ab97-e9473d92ae0e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81546438-5a20-469b-8ee8-9d38e70a50c8"}, {"Element": "<span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (36.1)</span>", "ID": "f8e59e69-efaa-4614-aef6-f2637da8552f", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "53 (36.1)", "ParentId": "03c31fbe-2032-4837-ab97-e9473d92ae0e"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(28.3, 44.4)</span></p>", "ID": "9507d894-a1cd-49c2-9082-459bf3aba6d3", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "d765983e-3c8e-4f31-ac3f-0fca60ebdc3b"}, {"Element": "<span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(28.3, 44.4)</span>", "ID": "c4b1f118-7d6a-4f4c-b4dc-f924851a09bf", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(28.3, 44.4)", "ParentId": "9507d894-a1cd-49c2-9082-459bf3aba6d3"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (53.5)</span></b></p>\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(43.2, 63.6)</span></p>\n</td>", "ID": "baa7b314-8064-4662-85f3-6db8653dce95", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "8aaf34f6-85b2-4443-b5c5-9ce761eb25d8"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (53.5)</span></b></p>", "ID": "4182c23b-4b76-4a5a-a065-95c58d481f7f", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "baa7b314-8064-4662-85f3-6db8653dce95"}, {"Element": "<b><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (53.5)</span></b>", "ID": "c959ce56-21c3-42a2-84ec-0a80a1c74195", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4182c23b-4b76-4a5a-a065-95c58d481f7f"}, {"Element": "<span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>53 (53.5)</span>", "ID": "c2bc426d-8a19-48fa-be01-786ea8417eea", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "53 (53.5)", "ParentId": "c959ce56-21c3-42a2-84ec-0a80a1c74195"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(43.2, 63.6)</span></p>", "ID": "d01c8163-b195-4dcf-9734-ff2176cf0888", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "baa7b314-8064-4662-85f3-6db8653dce95"}, {"Element": "<span lang=\"FR-CH\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>(43.2, 63.6)</span>", "ID": "a2a87c5d-2bc3-4c48-9637-b3a27d4ffe0c", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(43.2, 63.6)", "ParentId": "d01c8163-b195-4dcf-9734-ff2176cf0888"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">CR, n (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40 (27.2)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40(40.4)</span></p>\n</td>\n</tr>", "ID": "84437343-3f11-48d6-8f6a-595c56003d77", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">CR, n (%)</span></p>\n</td>", "ID": "00fed366-dcf0-4c9e-b00d-8f633b289d00", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "84437343-3f11-48d6-8f6a-595c56003d77"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">CR, n (%)</span></p>", "ID": "2e2a2b83-6900-40ee-8db9-a39f4e0a8c0c", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "00fed366-dcf0-4c9e-b00d-8f633b289d00"}, {"Element": "<span lang=\"FR-CH\">CR, n (%)</span>", "ID": "f194e4d2-4daf-41a7-9460-abad5106bd10", "Styles": "None", "Classes": "None", "Text": "CR, n (%)", "ParentId": "2e2a2b83-6900-40ee-8db9-a39f4e0a8c0c"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40 (27.2)</span></p>\n</td>", "ID": "6918ea27-fc7b-45a1-b367-71da151dcc44", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "84437343-3f11-48d6-8f6a-595c56003d77"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40 (27.2)</span></p>", "ID": "effe0515-146f-4821-844f-1a218caba82a", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6918ea27-fc7b-45a1-b367-71da151dcc44"}, {"Element": "<span lang=\"FR-CH\">40 (27.2)</span>", "ID": "b0d9d8ec-6f8c-4674-8f5d-d374f836b130", "Styles": "None", "Classes": "None", "Text": "40 (27.2)", "ParentId": "effe0515-146f-4821-844f-1a218caba82a"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40(40.4)</span></p>\n</td>", "ID": "b5ede12a-803a-410d-ad53-05ee33ef6b5c", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "84437343-3f11-48d6-8f6a-595c56003d77"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">40(40.4)</span></p>", "ID": "965e561c-cd5a-4b50-be77-bc4b90e3ad5a", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b5ede12a-803a-410d-ad53-05ee33ef6b5c"}, {"Element": "<span lang=\"FR-CH\">40(40.4)</span>", "ID": "eb7313b7-2e49-43ee-83f2-517bfae50f64", "Styles": "None", "Classes": "None", "Text": "40(40.4)", "ParentId": "965e561c-cd5a-4b50-be77-bc4b90e3ad5a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">PR, n (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (8.8)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (13.1)</span></p>\n</td>\n</tr>", "ID": "886a063e-b3c2-44b7-b2e0-e99c07d17f48", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">PR, n (%)</span></p>\n</td>", "ID": "f3ed380f-c28e-443e-a141-ef90bcbbba4d", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "886a063e-b3c2-44b7-b2e0-e99c07d17f48"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"FR-CH\">PR, n (%)</span></p>", "ID": "5e838c96-aba3-455a-9242-9ac31ea5040c", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f3ed380f-c28e-443e-a141-ef90bcbbba4d"}, {"Element": "<span lang=\"FR-CH\">PR, n (%)</span>", "ID": "85c4633a-61a2-4833-9fee-d06b9416a35b", "Styles": "None", "Classes": "None", "Text": "PR, n (%)", "ParentId": "5e838c96-aba3-455a-9242-9ac31ea5040c"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (8.8)</span></p>\n</td>", "ID": "c252ee5e-f553-42cb-8fcd-31ac9f8dd7a0", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "886a063e-b3c2-44b7-b2e0-e99c07d17f48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (8.8)</span></p>", "ID": "405c3259-39d7-4139-8965-7d7fd81d0a94", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c252ee5e-f553-42cb-8fcd-31ac9f8dd7a0"}, {"Element": "<span lang=\"FR-CH\">13 (8.8)</span>", "ID": "f72b9946-ddc2-4623-834f-588a294ab420", "Styles": "None", "Classes": "None", "Text": "13 (8.8)", "ParentId": "405c3259-39d7-4139-8965-7d7fd81d0a94"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (13.1)</span></p>\n</td>", "ID": "8b5562d3-b981-4ca4-b0a0-6e3708609128", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "886a063e-b3c2-44b7-b2e0-e99c07d17f48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">13 (13.1)</span></p>", "ID": "bddd6382-58eb-49b7-9a0f-3080ab91785d", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b5562d3-b981-4ca4-b0a0-6e3708609128"}, {"Element": "<span lang=\"FR-CH\">13 (13.1)</span>", "ID": "89300d3e-1722-4442-a1b7-cd9db81232b4", "Styles": "None", "Classes": "None", "Text": "13 (13.1)", "ParentId": "bddd6382-58eb-49b7-9a0f-3080ab91785d"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">Response a</span><span lang=\"EN-GB\">t\n  month\u00a03</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>\n</tr>", "ID": "acb9f559-1e3f-4010-bec1-3d8f2d2b1f30", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">Response a</span><span lang=\"EN-GB\">t\n  month\u00a03</span></p>\n</td>", "ID": "46f2f6d2-ba58-4a6b-a7ac-dc0c4e84befb", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "acb9f559-1e3f-4010-bec1-3d8f2d2b1f30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"FR-CH\">Response a</span><span lang=\"EN-GB\">t\n  month\u00a03</span></p>", "ID": "4d9148cb-b7a1-4681-83ce-1ea6254bf950", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "46f2f6d2-ba58-4a6b-a7ac-dc0c4e84befb"}, {"Element": "<span lang=\"FR-CH\">Response a</span>", "ID": "ca5e39e6-863c-4fed-84fe-251d91373b7b", "Styles": "None", "Classes": "None", "Text": "Response a", "ParentId": "4d9148cb-b7a1-4681-83ce-1ea6254bf950"}, {"Element": "<span lang=\"EN-GB\">t\n  month\u00a03</span>", "ID": "a240980b-a750-4799-83e8-be00a0a3545d", "Styles": "None", "Classes": "None", "Text": "t   month\u00a03", "ParentId": "4d9148cb-b7a1-4681-83ce-1ea6254bf950"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>", "ID": "54ea6f64-6be6-4eb5-a56c-a478a651f7e7", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "acb9f559-1e3f-4010-bec1-3d8f2d2b1f30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>", "ID": "b234b110-a057-44ce-90c8-62a4962fa63b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "54ea6f64-6be6-4eb5-a56c-a478a651f7e7"}, {"Element": "<span lang=\"EN-GB\">N=147</span>", "ID": "dd24a2c1-0220-42a7-bebb-924ce65ae3e2", "Styles": "None", "Classes": "None", "Text": "N=147", "ParentId": "b234b110-a057-44ce-90c8-62a4962fa63b"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>", "ID": "c04937a6-280e-4eaa-add3-6a066bfa7400", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "acb9f559-1e3f-4010-bec1-3d8f2d2b1f30"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>", "ID": "948bffc1-4ad9-405f-bc4b-4a58bd1b8cc2", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c04937a6-280e-4eaa-add3-6a066bfa7400"}, {"Element": "<span lang=\"EN-GB\">N=99</span>", "ID": "e41b88e6-2991-49de-8a8d-266bc070f4d2", "Styles": "None", "Classes": "None", "Text": "N=99", "ParentId": "948bffc1-4ad9-405f-bc4b-4a58bd1b8cc2"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (26.5)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (39.4)</span></p>\n</td>\n</tr>", "ID": "5f205bc9-c7f4-428e-ad34-407f92e5623f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>", "ID": "7ed26dec-61a8-41bf-9975-eca1dfaa5031", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5f205bc9-c7f4-428e-ad34-407f92e5623f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>", "ID": "50cfb129-d467-4d7b-aa3f-bc1896dc5d48", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7ed26dec-61a8-41bf-9975-eca1dfaa5031"}, {"Element": "<span lang=\"EN-GB\">ORR (%)</span>", "ID": "98f11875-5efb-4c65-b313-e94f9da22625", "Styles": "None", "Classes": "None", "Text": "ORR (%)", "ParentId": "50cfb129-d467-4d7b-aa3f-bc1896dc5d48"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (26.5)</span></p>\n</td>", "ID": "373923a5-2ed6-4cd0-9e50-eef295ddca9d", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5f205bc9-c7f4-428e-ad34-407f92e5623f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (26.5)</span></p>", "ID": "fee40e7b-95c5-4def-96d9-fd3c2ad47f74", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "373923a5-2ed6-4cd0-9e50-eef295ddca9d"}, {"Element": "<span lang=\"EN-GB\">39 (26.5)</span>", "ID": "02df3981-d0cd-47d3-8df6-ad448dd0880c", "Styles": "None", "Classes": "None", "Text": "39 (26.5)", "ParentId": "fee40e7b-95c5-4def-96d9-fd3c2ad47f74"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (39.4)</span></p>\n</td>", "ID": "5224928a-f70e-4d7b-a654-914b2b8a7dc8", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5f205bc9-c7f4-428e-ad34-407f92e5623f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39 (39.4)</span></p>", "ID": "14f179e8-7eca-4726-a7d9-101e1024889b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5224928a-f70e-4d7b-a654-914b2b8a7dc8"}, {"Element": "<span lang=\"EN-GB\">39 (39.4)</span>", "ID": "76994b26-0457-42c5-a835-dc4f973e24ac", "Styles": "None", "Classes": "None", "Text": "39 (39.4)", "ParentId": "14f179e8-7eca-4726-a7d9-101e1024889b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>\n</tr>", "ID": "78f48468-6012-446f-b6ac-445587e43d5d", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>", "ID": "0322d4bd-4a8c-4464-8480-e7b8e14b1c74", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "78f48468-6012-446f-b6ac-445587e43d5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>", "ID": "918394eb-471f-43b7-85d6-11f627b6712b", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0322d4bd-4a8c-4464-8480-e7b8e14b1c74"}, {"Element": "<span lang=\"EN-GB\">CR (%)</span>", "ID": "bae8305b-ac63-460b-a0fe-bfcdb39934bb", "Styles": "None", "Classes": "None", "Text": "CR (%)", "ParentId": "918394eb-471f-43b7-85d6-11f627b6712b"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>", "ID": "d11481b5-b563-4780-885d-af47796fd696", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "78f48468-6012-446f-b6ac-445587e43d5d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>", "ID": "2a5b6eca-4dd1-402d-a27c-c15dec52a9ea", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d11481b5-b563-4780-885d-af47796fd696"}, {"Element": "<span lang=\"EN-GB\">34 (23.1)</span>", "ID": "6bee418b-6912-4d77-8fdd-addfcd647ef0", "Styles": "None", "Classes": "None", "Text": "34 (23.1)", "ParentId": "2a5b6eca-4dd1-402d-a27c-c15dec52a9ea"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>", "ID": "5a5effc6-1360-45fb-9827-ba846d9641a2", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "78f48468-6012-446f-b6ac-445587e43d5d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>", "ID": "28667687-7210-4b83-9ee7-cc0976c88ab9", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a5effc6-1360-45fb-9827-ba846d9641a2"}, {"Element": "<span lang=\"EN-GB\">34 (34.3)</span>", "ID": "1dac2c0c-345b-4abb-b694-a17561ae9720", "Styles": "None", "Classes": "None", "Text": "34 (34.3)", "ParentId": "28667687-7210-4b83-9ee7-cc0976c88ab9"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Response at month\u00a06</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>\n</tr>", "ID": "c1b2c4a1-75b3-4776-a984-e6f5aedf8226", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Response at month\u00a06</span></p>\n</td>", "ID": "148f962b-8432-4e7a-a8d1-abfb7eb4f81c", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c1b2c4a1-75b3-4776-a984-e6f5aedf8226"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Response at month\u00a06</span></p>", "ID": "fa21faed-8e8d-4847-9ab7-b7a7391a8b62", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "148f962b-8432-4e7a-a8d1-abfb7eb4f81c"}, {"Element": "<span lang=\"EN-GB\">Response at month\u00a06</span>", "ID": "9453d013-8355-45fa-b021-42c8871613e3", "Styles": "None", "Classes": "None", "Text": "Response at month\u00a06", "ParentId": "fa21faed-8e8d-4847-9ab7-b7a7391a8b62"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>\n</td>", "ID": "7753fd10-a86d-4015-85f5-c43c3426e0df", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c1b2c4a1-75b3-4776-a984-e6f5aedf8226"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=147</span></p>", "ID": "0f4fd9c4-b98a-4542-b5e8-d6cdaa7c7465", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7753fd10-a86d-4015-85f5-c43c3426e0df"}, {"Element": "<span lang=\"EN-GB\">N=147</span>", "ID": "40f44da8-e323-48dd-a682-592447f62aef", "Styles": "None", "Classes": "None", "Text": "N=147", "ParentId": "0f4fd9c4-b98a-4542-b5e8-d6cdaa7c7465"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>\n</td>", "ID": "72cae5af-95ae-4ce1-9081-1b586a6211cb", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c1b2c4a1-75b3-4776-a984-e6f5aedf8226"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">N=99</span></p>", "ID": "f5c91fb9-4220-48fe-89ad-75a3d3ccd9a5", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "72cae5af-95ae-4ce1-9081-1b586a6211cb"}, {"Element": "<span lang=\"EN-GB\">N=99</span>", "ID": "9902915c-4bb0-4109-91b7-7ba8c3f97ad7", "Styles": "None", "Classes": "None", "Text": "N=99", "ParentId": "f5c91fb9-4220-48fe-89ad-75a3d3ccd9a5"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>\n</tr>", "ID": "57037efd-192d-4eae-8ae8-5eec40cecc3a", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>\n</td>", "ID": "22d511d9-f653-4a9a-b36e-528fd5ba6770", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "57037efd-192d-4eae-8ae8-5eec40cecc3a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">ORR (%)</span></p>", "ID": "5b356182-f853-44d5-a66e-c281c563ea4d", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "22d511d9-f653-4a9a-b36e-528fd5ba6770"}, {"Element": "<span lang=\"EN-GB\">ORR (%)</span>", "ID": "0869f198-bf8f-4a75-8c8e-1ba5da0f0894", "Styles": "None", "Classes": "None", "Text": "ORR (%)", "ParentId": "5b356182-f853-44d5-a66e-c281c563ea4d"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>\n</td>", "ID": "3367bca1-1172-4fb9-805e-6ee13d7b9330", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "57037efd-192d-4eae-8ae8-5eec40cecc3a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (23.1)</span></p>", "ID": "2abe0135-fc67-423b-b18a-6bdfb6c8022d", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3367bca1-1172-4fb9-805e-6ee13d7b9330"}, {"Element": "<span lang=\"EN-GB\">34 (23.1)</span>", "ID": "aa87202b-df75-4e25-9c88-45f2b27d6dd4", "Styles": "None", "Classes": "None", "Text": "34 (23.1)", "ParentId": "2abe0135-fc67-423b-b18a-6bdfb6c8022d"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>\n</td>", "ID": "19e6d19a-b85f-4bf3-a805-545396255985", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "57037efd-192d-4eae-8ae8-5eec40cecc3a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">34 (34.3)</span></p>", "ID": "572e9690-7a74-40f4-ba5f-f28adf0bc178", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19e6d19a-b85f-4bf3-a805-545396255985"}, {"Element": "<span lang=\"EN-GB\">34 (34.3)</span>", "ID": "69199a9d-d970-4cb7-abf1-d3de8751eb7b", "Styles": "None", "Classes": "None", "Text": "34 (34.3)", "ParentId": "572e9690-7a74-40f4-ba5f-f28adf0bc178"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (21.1)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (31.3)</span></p>\n</td>\n</tr>", "ID": "75f5e4e4-f02b-4703-a4ff-810aa23f3ba4", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>\n</td>", "ID": "039ac2ef-5ee2-4633-9f32-3f7bc2a0b2ef", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "75f5e4e4-f02b-4703-a4ff-810aa23f3ba4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">CR (%)</span></p>", "ID": "cacf813a-513f-40cf-abf4-c0645709affa", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "039ac2ef-5ee2-4633-9f32-3f7bc2a0b2ef"}, {"Element": "<span lang=\"EN-GB\">CR (%)</span>", "ID": "f6d7b754-7870-4ba6-a0ff-6ae9b79c8005", "Styles": "None", "Classes": "None", "Text": "CR (%)", "ParentId": "cacf813a-513f-40cf-abf4-c0645709affa"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (21.1)</span></p>\n</td>", "ID": "f8018d80-1d8d-4da8-8109-4690f915004d", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "75f5e4e4-f02b-4703-a4ff-810aa23f3ba4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (21.1)</span></p>", "ID": "0ef6f427-a28c-4fa8-b19a-777faada3733", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8018d80-1d8d-4da8-8109-4690f915004d"}, {"Element": "<span lang=\"EN-GB\">31 (21.1)</span>", "ID": "8aadda47-3a23-48c8-a1ac-ce217f2fe30a", "Styles": "None", "Classes": "None", "Text": "31 (21.1)", "ParentId": "0ef6f427-a28c-4fa8-b19a-777faada3733"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (31.3)</span></p>\n</td>", "ID": "ab72f49c-289c-458d-b141-7b992d7ea6a2", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "75f5e4e4-f02b-4703-a4ff-810aa23f3ba4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">31 (31.3)</span></p>", "ID": "a5075887-c1b6-4d3c-aece-4a6cfedad95c", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab72f49c-289c-458d-b141-7b992d7ea6a2"}, {"Element": "<span lang=\"EN-GB\">31 (31.3)</span>", "ID": "598e0b76-e324-47b7-b9a4-9cb8b312bba7", "Styles": "None", "Classes": "None", "Text": "31 (31.3)", "ParentId": "a5075887-c1b6-4d3c-aece-4a6cfedad95c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Duration of response (DOR)<sup>3</sup></span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>\n</tr>", "ID": "913b9c04-e4b4-426e-a7e2-c3799cd6a464", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Duration of response (DOR)<sup>3</sup></span></b></p>\n</td>", "ID": "eb1bb571-463b-41ba-a761-c2e1fb8be268", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "913b9c04-e4b4-426e-a7e2-c3799cd6a464"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Duration of response (DOR)<sup>3</sup></span></b></p>", "ID": "fc21a83e-9392-4a09-92ca-8772e9e87d5d", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb1bb571-463b-41ba-a761-c2e1fb8be268"}, {"Element": "<b><span lang=\"EN-GB\">Duration of response (DOR)<sup>3</sup></span></b>", "ID": "8766ded4-a32b-4900-a4df-7947f84f8c87", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fc21a83e-9392-4a09-92ca-8772e9e87d5d"}, {"Element": "<span lang=\"EN-GB\">Duration of response (DOR)<sup>3</sup></span>", "ID": "fbda3308-9268-4576-86ed-5d149cae8390", "Styles": "None", "Classes": "None", "Text": "Duration of response (DOR)", "ParentId": "8766ded4-a32b-4900-a4df-7947f84f8c87"}, {"Element": "<sup>3</sup>", "ID": "c09cca1b-ff13-4541-bed8-02b006d2c6e8", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "fbda3308-9268-4576-86ed-5d149cae8390"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>", "ID": "8f6aa90c-441c-4fba-a344-959700a78070", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "913b9c04-e4b4-426e-a7e2-c3799cd6a464"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>", "ID": "6a63ae32-bde9-4b24-94d4-2705317b307b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8f6aa90c-441c-4fba-a344-959700a78070"}, {"Element": "<b><span lang=\"EN-GB\">N=53</span></b>", "ID": "23f9e9a1-c45e-453e-a8e9-6a84ab7c3e92", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a63ae32-bde9-4b24-94d4-2705317b307b"}, {"Element": "<span lang=\"EN-GB\">N=53</span>", "ID": "22600fe0-20fc-4b2c-8fb2-633fdf76712c", "Styles": "None", "Classes": "None", "Text": "N=53", "ParentId": "23f9e9a1-c45e-453e-a8e9-6a84ab7c3e92"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>\n</td>", "ID": "7f110fa9-17a0-489e-b126-da7e11e4550e", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "913b9c04-e4b4-426e-a7e2-c3799cd6a464"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=53</span></b></p>", "ID": "e4f74aef-8698-43e5-ab14-529597151056", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7f110fa9-17a0-489e-b126-da7e11e4550e"}, {"Element": "<b><span lang=\"EN-GB\">N=53</span></b>", "ID": "2039e635-bde3-4acb-b96c-a2a9fdc2452a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e4f74aef-8698-43e5-ab14-529597151056"}, {"Element": "<span lang=\"EN-GB\">N=53</span>", "ID": "7c97dad5-8263-4be6-9075-3a945eb5a9a5", "Styles": "None", "Classes": "None", "Text": "N=53", "ParentId": "2039e635-bde3-4acb-b96c-a2a9fdc2452a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>\n</tr>", "ID": "b69dc35f-1933-43b4-9a46-f0b12f55e501", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>", "ID": "bd7ff2cc-3dcf-48cb-b3b7-ee894c473c81", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b69dc35f-1933-43b4-9a46-f0b12f55e501"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>", "ID": "94bb8085-cecb-45c4-a80b-104aaef578a9", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bd7ff2cc-3dcf-48cb-b3b7-ee894c473c81"}, {"Element": "<span lang=\"EN-GB\">Median (months) (95% CI)</span>", "ID": "9dd2235c-b992-4462-bca8-38d063e6fc8a", "Styles": "None", "Classes": "None", "Text": "Median (months) (95% CI)", "ParentId": "94bb8085-cecb-45c4-a80b-104aaef578a9"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>", "ID": "080bd4e8-d5ab-4261-852d-59844f2ce7bd", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b69dc35f-1933-43b4-9a46-f0b12f55e501"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>", "ID": "b1d8cd0a-3d9a-440d-a663-e26bda315a69", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "080bd4e8-d5ab-4261-852d-59844f2ce7bd"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span>", "ID": "6525808e-c5a6-41d4-ae97-3e9ecab00e76", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Not reached   (10.0, NE)", "ParentId": "b1d8cd0a-3d9a-440d-a663-e26bda315a69"}, {"Element": "<sup>5</sup>", "ID": "4d2a60f9-fe87-40bd-94f6-344a2a8b2d6b", "Styles": "None", "Classes": "None", "Text": "5", "ParentId": "6525808e-c5a6-41d4-ae97-3e9ecab00e76"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>\n</td>", "ID": "2d471425-a2a8-4e4e-87aa-2df735e819ca", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b69dc35f-1933-43b4-9a46-f0b12f55e501"}, {"Element": "<p class=\"Table\" style=\"margin:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span></p>", "ID": "50fdd7ed-594b-4e4c-83fe-8dd646dbffe0", "Styles": "margin:0in;page-break-after:avoid", "Classes": "['Table']", "Text": "", "ParentId": "2d471425-a2a8-4e4e-87aa-2df735e819ca"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Not reached\n  (10.0, NE<sup>5</sup>)</span>", "ID": "22636b8b-2f4b-4650-a945-e5ca945d3574", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Not reached   (10.0, NE)", "ParentId": "50fdd7ed-594b-4e4c-83fe-8dd646dbffe0"}, {"Element": "<sup>5</sup>", "ID": "c4b6228d-42c0-461d-9f97-0fc634abf85a", "Styles": "None", "Classes": "None", "Text": "5", "ParentId": "22636b8b-2f4b-4650-a945-e5ca945d3574"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n</tr>", "ID": "aa10369f-d9c9-4ad2-8452-20ea03038c7f", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 12\u00a0months</span></p>\n</td>", "ID": "1f43c24b-c0c2-4b9f-b999-992466e99850", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aa10369f-d9c9-4ad2-8452-20ea03038c7f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 12\u00a0months</span></p>", "ID": "8de9579b-c9ed-4a77-93b6-a1900671f16b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1f43c24b-c0c2-4b9f-b999-992466e99850"}, {"Element": "<span lang=\"EN-GB\">% relapse free probability at 12\u00a0months</span>", "ID": "193e027b-29e4-4f50-98ea-32e5ecf05b27", "Styles": "None", "Classes": "None", "Text": "% relapse free probability at 12\u00a0months", "ParentId": "8de9579b-c9ed-4a77-93b6-a1900671f16b"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>", "ID": "f563ea6a-a64f-4b5d-8790-99aaf670aa10", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aa10369f-d9c9-4ad2-8452-20ea03038c7f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>", "ID": "16298725-8620-4894-95bd-79e8d0a24284", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f563ea6a-a64f-4b5d-8790-99aaf670aa10"}, {"Element": "<span lang=\"EN-GB\">63.2</span>", "ID": "25355b23-e9ab-403e-b3c8-84f4c0a3257a", "Styles": "None", "Classes": "None", "Text": "63.2", "ParentId": "16298725-8620-4894-95bd-79e8d0a24284"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>", "ID": "1e48a3a9-a2c7-4a49-a32c-c55283b79f45", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aa10369f-d9c9-4ad2-8452-20ea03038c7f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>", "ID": "622ad1ea-4945-498b-906f-72751c2e0dd8", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e48a3a9-a2c7-4a49-a32c-c55283b79f45"}, {"Element": "<span lang=\"EN-GB\">63.2</span>", "ID": "e7ed3b32-6a28-4d57-aabc-59f79cca4e00", "Styles": "None", "Classes": "None", "Text": "63.2", "ParentId": "622ad1ea-4945-498b-906f-72751c2e0dd8"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 18\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>\n</tr>", "ID": "63960b77-4249-42a0-87e1-824139ab9712", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 18\u00a0months</span></p>\n</td>", "ID": "65bcbecc-a4ec-4803-b0da-1dc35222e735", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "63960b77-4249-42a0-87e1-824139ab9712"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">% relapse free probability at 18\u00a0months</span></p>", "ID": "ef46e39e-b6d3-474b-bc93-407591dc696a", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "65bcbecc-a4ec-4803-b0da-1dc35222e735"}, {"Element": "<span lang=\"EN-GB\">% relapse free probability at 18\u00a0months</span>", "ID": "85a122cc-c168-46f0-b476-28f743309839", "Styles": "None", "Classes": "None", "Text": "% relapse free probability at 18\u00a0months", "ParentId": "ef46e39e-b6d3-474b-bc93-407591dc696a"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>", "ID": "57cb2b9c-4bac-4faa-96a0-6acc3e134701", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "63960b77-4249-42a0-87e1-824139ab9712"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>", "ID": "99dc84cb-c4e9-45b6-a75b-b206791e6d39", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "57cb2b9c-4bac-4faa-96a0-6acc3e134701"}, {"Element": "<span lang=\"EN-GB\">63.2</span>", "ID": "19b0e3f3-6683-46ad-80bb-a61280525ba4", "Styles": "None", "Classes": "None", "Text": "63.2", "ParentId": "99dc84cb-c4e9-45b6-a75b-b206791e6d39"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>\n</td>", "ID": "6405de26-8430-40b6-8dbd-482a753a2583", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "63960b77-4249-42a0-87e1-824139ab9712"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">63.2</span></p>", "ID": "d0095b26-1c2b-4d97-8664-efc189c5541c", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6405de26-8430-40b6-8dbd-482a753a2583"}, {"Element": "<span lang=\"EN-GB\">63.2</span>", "ID": "04775d3e-003e-4c39-9625-d955514b1cda", "Styles": "None", "Classes": "None", "Text": "63.2", "ParentId": "d0095b26-1c2b-4d97-8664-efc189c5541c"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoints</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>\n</tr>", "ID": "a4e7b806-7b38-4d84-88f9-7fe38d275dcb", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoints</span></b></p>\n</td>", "ID": "1d4eb39f-9d85-4003-b6a9-327fba650b51", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a4e7b806-7b38-4d84-88f9-7fe38d275dcb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Other secondary endpoints</span></b></p>", "ID": "fca87678-7f64-4ffd-a8cd-62b8e20e8c01", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1d4eb39f-9d85-4003-b6a9-327fba650b51"}, {"Element": "<b><span lang=\"EN-GB\">Other secondary endpoints</span></b>", "ID": "48865e03-1614-4367-a927-9eb02b702873", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fca87678-7f64-4ffd-a8cd-62b8e20e8c01"}, {"Element": "<span lang=\"EN-GB\">Other secondary endpoints</span>", "ID": "5ede085a-90f0-4117-b295-af95ab709292", "Styles": "None", "Classes": "None", "Text": "Other secondary endpoints", "ParentId": "48865e03-1614-4367-a927-9eb02b702873"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>\n</td>", "ID": "26c8b083-923a-49ce-8ba8-2a51824b4c52", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a4e7b806-7b38-4d84-88f9-7fe38d275dcb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=167</span></b></p>", "ID": "a31e4911-98e2-4eaf-a6e1-57eb698f700f", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "26c8b083-923a-49ce-8ba8-2a51824b4c52"}, {"Element": "<b><span lang=\"EN-GB\">N=167</span></b>", "ID": "c0f81604-c909-40cc-acd2-1299d2af8fca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a31e4911-98e2-4eaf-a6e1-57eb698f700f"}, {"Element": "<span lang=\"EN-GB\">N=167</span>", "ID": "6fbc56d6-b396-4477-ad04-98e0693db85a", "Styles": "None", "Classes": "None", "Text": "N=167", "ParentId": "c0f81604-c909-40cc-acd2-1299d2af8fca"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>\n</td>", "ID": "f5ef5d35-5fac-474f-b6a9-284e0c8fa307", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a4e7b806-7b38-4d84-88f9-7fe38d275dcb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">N=115</span></b></p>", "ID": "b5961235-334c-4e97-b3c6-c63dc81d1faa", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f5ef5d35-5fac-474f-b6a9-284e0c8fa307"}, {"Element": "<b><span lang=\"EN-GB\">N=115</span></b>", "ID": "7a337f7f-c684-45e1-8be4-2c90f1cf8935", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5961235-334c-4e97-b3c6-c63dc81d1faa"}, {"Element": "<span lang=\"EN-GB\">N=115</span>", "ID": "6c95978a-a13e-4cc7-8c87-8ac06d88d751", "Styles": "None", "Classes": "None", "Text": "N=115", "ParentId": "7a337f7f-c684-45e1-8be4-2c90f1cf8935"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Overall survival (OS)<sup>4</sup></span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "29cec1ce-98c9-4b75-a4ae-0832217ebede", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Overall survival (OS)<sup>4</sup></span></p>\n</td>", "ID": "50ba2d51-a9aa-4e19-92a0-7541c5c2b8c1", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "29cec1ce-98c9-4b75-a4ae-0832217ebede"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Overall survival (OS)<sup>4</sup></span></p>", "ID": "108e56ec-3f07-41d9-ae87-00fb62edd72b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "50ba2d51-a9aa-4e19-92a0-7541c5c2b8c1"}, {"Element": "<span lang=\"EN-GB\">Overall survival (OS)<sup>4</sup></span>", "ID": "8a2bf559-74ff-4bdd-851d-f437b354163f", "Styles": "None", "Classes": "None", "Text": "Overall survival (OS)", "ParentId": "108e56ec-3f07-41d9-ae87-00fb62edd72b"}, {"Element": "<sup>4</sup>", "ID": "2edcd388-5fe8-4407-8e2d-b33ce697a012", "Styles": "None", "Classes": "None", "Text": "4", "ParentId": "8a2bf559-74ff-4bdd-851d-f437b354163f"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "ee659bc8-76d5-401a-b191-85acd145f400", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "29cec1ce-98c9-4b75-a4ae-0832217ebede"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2f9ecc65-c77e-4b51-94aa-d53e9709cca5", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ee659bc8-76d5-401a-b191-85acd145f400"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "083d191c-8ff8-408f-9f36-224e9bd93cfa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2f9ecc65-c77e-4b51-94aa-d53e9709cca5"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "3e1e05ef-54ce-4f32-9d06-cceb6bc9a0e1", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "29cec1ce-98c9-4b75-a4ae-0832217ebede"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "64ada24e-8038-44f5-ad03-b0ab768f8a3b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3e1e05ef-54ce-4f32-9d06-cceb6bc9a0e1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a09d965-e456-4dde-ba4b-53b298d05350", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "64ada24e-8038-44f5-ad03-b0ab768f8a3b"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 12\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">40.9</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">47.9</span></p>\n</td>\n</tr>", "ID": "010a419b-24f7-4064-9e14-b43047f6de02", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 12\u00a0months</span></p>\n</td>", "ID": "74d362af-eade-4bf3-b7db-5c608c595d04", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "010a419b-24f7-4064-9e14-b43047f6de02"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 12\u00a0months</span></p>", "ID": "54814b48-3899-4c83-ad98-f1753fc6911e", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "74d362af-eade-4bf3-b7db-5c608c595d04"}, {"Element": "<span lang=\"EN-GB\">% survival probability at 12\u00a0months</span>", "ID": "a4dcc814-a5bf-44d9-9e68-561027de81fb", "Styles": "None", "Classes": "None", "Text": "% survival probability at 12\u00a0months", "ParentId": "54814b48-3899-4c83-ad98-f1753fc6911e"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">40.9</span></p>\n</td>", "ID": "2a78040b-c328-472c-a0ff-a1a2bc09b9a5", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "010a419b-24f7-4064-9e14-b43047f6de02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">40.9</span></p>", "ID": "0b4427f6-1b4e-40f6-960f-d45c80faa77c", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2a78040b-c328-472c-a0ff-a1a2bc09b9a5"}, {"Element": "<span lang=\"EN-GB\">40.9</span>", "ID": "70eb7c77-a65f-4568-8ac4-29295154f341", "Styles": "None", "Classes": "None", "Text": "40.9", "ParentId": "0b4427f6-1b4e-40f6-960f-d45c80faa77c"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">47.9</span></p>\n</td>", "ID": "a0391478-10bf-4153-b88b-be7a0a2e9432", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "010a419b-24f7-4064-9e14-b43047f6de02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">47.9</span></p>", "ID": "646ca4f4-2a09-4f73-a895-47511f25d5ad", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a0391478-10bf-4153-b88b-be7a0a2e9432"}, {"Element": "<span lang=\"EN-GB\">47.9</span>", "ID": "d190fac4-fc63-4ec9-a936-d4af5b66b1c3", "Styles": "None", "Classes": "None", "Text": "47.9", "ParentId": "646ca4f4-2a09-4f73-a895-47511f25d5ad"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 24\u00a0months</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">32.5</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39.1</span></p>\n</td>\n</tr>", "ID": "50617694-2a34-4314-9141-f739c733ec6b", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 24\u00a0months</span></p>\n</td>", "ID": "50281d2a-2e12-470b-906b-5d19a59b8a2a", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "50617694-2a34-4314-9141-f739c733ec6b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">% survival probability at 24\u00a0months</span></p>", "ID": "660af5a6-7f99-42e3-bced-80ce855966b6", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "50281d2a-2e12-470b-906b-5d19a59b8a2a"}, {"Element": "<span lang=\"EN-GB\">% survival probability at 24\u00a0months</span>", "ID": "afeb1177-9f0b-4599-9232-a45e1ad17e7a", "Styles": "None", "Classes": "None", "Text": "% survival probability at 24\u00a0months", "ParentId": "660af5a6-7f99-42e3-bced-80ce855966b6"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">32.5</span></p>\n</td>", "ID": "8762602b-68b2-4390-92bf-b432ca689af4", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "50617694-2a34-4314-9141-f739c733ec6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">32.5</span></p>", "ID": "cee01c07-6276-42be-9e26-393b738b81aa", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8762602b-68b2-4390-92bf-b432ca689af4"}, {"Element": "<span lang=\"EN-GB\">32.5</span>", "ID": "7fb53b18-1c28-44b2-b807-12a7e2a6d55d", "Styles": "None", "Classes": "None", "Text": "32.5", "ParentId": "cee01c07-6276-42be-9e26-393b738b81aa"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39.1</span></p>\n</td>", "ID": "89ecda45-38c3-42bd-8614-6752da9ce973", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "50617694-2a34-4314-9141-f739c733ec6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">39.1</span></p>", "ID": "b7d82668-9cfa-4885-b63b-032bf73e8f65", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89ecda45-38c3-42bd-8614-6752da9ce973"}, {"Element": "<span lang=\"EN-GB\">39.1</span>", "ID": "03cae38b-d746-43e0-9ca5-13a0d13442c2", "Styles": "None", "Classes": "None", "Text": "39.1", "ParentId": "b7d82668-9cfa-4885-b63b-032bf73e8f65"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">8.2 (5.8, 11.7)</span></p>\n</td>\n<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">10.3 <span style=\"color:black\">(6.6, 21.1)</span></span></p>\n</td>\n</tr>", "ID": "934b8081-3793-4a5e-8a91-752a90a92fd7", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "    ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td style=\"width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"328\">\n<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>\n</td>", "ID": "d8984bd3-77ea-4543-972d-aa9307869cd5", "Styles": "width:246.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "934b8081-3793-4a5e-8a91-752a90a92fd7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\">Median (months) (95% CI)</span></p>", "ID": "ac3a1135-9488-49be-8816-5e92a5b89f70", "Styles": "margin-left:.25in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d8984bd3-77ea-4543-972d-aa9307869cd5"}, {"Element": "<span lang=\"EN-GB\">Median (months) (95% CI)</span>", "ID": "0639ca8e-1b6a-4c35-bd04-7bf566245490", "Styles": "None", "Classes": "None", "Text": "Median (months) (95% CI)", "ParentId": "ac3a1135-9488-49be-8816-5e92a5b89f70"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">8.2 (5.8, 11.7)</span></p>\n</td>", "ID": "b7414813-b044-45a3-a3c0-cb5ffd40ed78", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "934b8081-3793-4a5e-8a91-752a90a92fd7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">8.2 (5.8, 11.7)</span></p>", "ID": "0709e12e-25f0-4057-aae9-3b9fe59142a8", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b7414813-b044-45a3-a3c0-cb5ffd40ed78"}, {"Element": "<span lang=\"EN-GB\">8.2 (5.8, 11.7)</span>", "ID": "b0d091ee-913e-4c1c-ba8e-1b22b49bbaf9", "Styles": "None", "Classes": "None", "Text": "8.2 (5.8, 11.7)", "ParentId": "0709e12e-25f0-4057-aae9-3b9fe59142a8"}, {"Element": "<td style=\"width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"161\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">10.3 <span style=\"color:black\">(6.6, 21.1)</span></span></p>\n</td>", "ID": "523400d8-d055-4a38-afd0-35ee407a5dbe", "Styles": "width:120.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "934b8081-3793-4a5e-8a91-752a90a92fd7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">10.3 <span style=\"color:black\">(6.6, 21.1)</span></span></p>", "ID": "18a85cda-e626-4a3e-b12d-695959543363", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "523400d8-d055-4a38-afd0-35ee407a5dbe"}, {"Element": "<span lang=\"EN-GB\">10.3 <span style=\"color:black\">(6.6, 21.1)</span></span>", "ID": "1ea68d32-3c0e-4bbd-a3da-2f1e91531974", "Styles": "None", "Classes": "None", "Text": "10.3 ", "ParentId": "18a85cda-e626-4a3e-b12d-695959543363"}, {"Element": "<span style=\"color:black\">(6.6, 21.1)</span>", "ID": "22eb50dc-c5ad-48a3-90ae-8c4e067de3c3", "Styles": "color:black", "Classes": "None", "Text": "(6.6, 21.1)", "ParentId": "1ea68d32-3c0e-4bbd-a3da-2f1e91531974"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td colspan=\"3\" style=\"width:487.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"650\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\n  primary endpoint was analysed on all patients whose Kymriah was manufactured\n  at the Novartis US facility.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ORR\n  is the proportion of patients with best overall response (BOR) of CR or PR\n  based on the Lugano response criteria (Cheson 2014); non\u2011infused\n  patients were assigned BOR=Unknown (i.e. non\u2011responders).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>DOR\n  was defined as time from achievement of CR or PR to relapse or death due to\n  DLBCL, whichever occurs first.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal;page-break-after:avoid;text-autospace:none\"><sup><span lang=\"EN-GB\">4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\">OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause (N=115)\n  and time from date of enrolment to the date of death due to any cause for\n  enrolled patients (N=167).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5</span></sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not estimable.</span></p>\n</td>\n</tr>", "ID": "ff2ce67f-465c-488a-9f13-266a4f593fd4", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "  ", "ParentId": "6cc143cc-4e36-42d9-bba2-11d1b4d93f46"}, {"Element": "<td colspan=\"3\" style=\"width:487.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"650\">\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\n  primary endpoint was analysed on all patients whose Kymriah was manufactured\n  at the Novartis US facility.</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ORR\n  is the proportion of patients with best overall response (BOR) of CR or PR\n  based on the Lugano response criteria (Cheson 2014); non\u2011infused\n  patients were assigned BOR=Unknown (i.e. non\u2011responders).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>DOR\n  was defined as time from achievement of CR or PR to relapse or death due to\n  DLBCL, whichever occurs first.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal;page-break-after:avoid;text-autospace:none\"><sup><span lang=\"EN-GB\">4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\">OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause (N=115)\n  and time from date of enrolment to the date of death due to any cause for\n  enrolled patients (N=167).</span></p>\n<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5</span></sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not estimable.</span></p>\n</td>", "ID": "e9a80cf2-cf8a-401b-91d2-01cf6ed652aa", "Styles": "width:487.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "ff2ce67f-465c-488a-9f13-266a4f593fd4"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\n  primary endpoint was analysed on all patients whose Kymriah was manufactured\n  at the Novartis US facility.</span></p>", "ID": "64c7abfd-0629-419e-8810-4d4edc938fe6", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Legend']", "Text": "", "ParentId": "e9a80cf2-cf8a-401b-91d2-01cf6ed652aa"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup>", "ID": "5ac407c8-93cc-4f20-9af2-ded3988efb56", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "64c7abfd-0629-419e-8810-4d4edc938fe6"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "8932972a-f8a9-4a25-be06-407480e9d134", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "1\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5ac407c8-93cc-4f20-9af2-ded3988efb56"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\n  primary endpoint was analysed on all patients whose Kymriah was manufactured\n  at the Novartis US facility.</span>", "ID": "287d1822-7d8e-4f89-beba-d43c4cf8fa23", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The   primary endpoint was analysed on all patients whose Kymriah was manufactured   at the Novartis US facility.", "ParentId": "64c7abfd-0629-419e-8810-4d4edc938fe6"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>2</span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ORR\n  is the proportion of patients with best overall response (BOR) of CR or PR\n  based on the Lugano response criteria (Cheson 2014); non\u2011infused\n  patients were assigned BOR=Unknown (i.e. non\u2011responders).</span></p>", "ID": "c3b03b33-c29e-4c41-9f01-4588f05ed906", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Legend']", "Text": "", "ParentId": "e9a80cf2-cf8a-401b-91d2-01cf6ed652aa"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>2</span></sup>", "ID": "acd69e46-ef9a-4af9-9d6b-641d0c037038", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c3b03b33-c29e-4c41-9f01-4588f05ed906"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>2</span>", "ID": "5766c2b5-b21c-4ee6-98e1-48ce420ab50c", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "2", "ParentId": "acd69e46-ef9a-4af9-9d6b-641d0c037038"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ORR\n  is the proportion of patients with best overall response (BOR) of CR or PR\n  based on the Lugano response criteria (Cheson 2014); non\u2011infused\n  patients were assigned BOR=Unknown (i.e. non\u2011responders).</span>", "ID": "a6744078-f29d-4286-a01b-7bd7a344c691", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ORR   is the proportion of patients with best overall response (BOR) of CR or PR   based on the Lugano response criteria (Cheson 2014); non\u2011infused   patients were assigned BOR=Unknown (i.e. non\u2011responders).", "ParentId": "c3b03b33-c29e-4c41-9f01-4588f05ed906"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>DOR\n  was defined as time from achievement of CR or PR to relapse or death due to\n  DLBCL, whichever occurs first.</span></p>", "ID": "5cdd5be0-1058-40cf-8d2e-617695ebc9fc", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Legend']", "Text": "", "ParentId": "e9a80cf2-cf8a-401b-91d2-01cf6ed652aa"}, {"Element": "<sup><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup>", "ID": "6ae5f9ba-19fd-4c89-8844-55be0c97fb17", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5cdd5be0-1058-40cf-8d2e-617695ebc9fc"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "58fa3053-7a52-4410-9a83-0ce0d1fb6432", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6ae5f9ba-19fd-4c89-8844-55be0c97fb17"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>DOR\n  was defined as time from achievement of CR or PR to relapse or death due to\n  DLBCL, whichever occurs first.</span>", "ID": "ed8ab8c7-9260-425c-9e16-344c580523c6", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "DOR   was defined as time from achievement of CR or PR to relapse or death due to   DLBCL, whichever occurs first.", "ParentId": "5cdd5be0-1058-40cf-8d2e-617695ebc9fc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal;page-break-after:avoid;text-autospace:none\"><sup><span lang=\"EN-GB\">4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup><span lang=\"EN-GB\">OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause (N=115)\n  and time from date of enrolment to the date of death due to any cause for\n  enrolled patients (N=167).</span></p>", "ID": "3a1821cc-03c6-4451-b1cd-233bb5c7f642", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;\n  line-height:normal;page-break-after:avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a80cf2-cf8a-401b-91d2-01cf6ed652aa"}, {"Element": "<sup><span lang=\"EN-GB\">4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></sup>", "ID": "c90b2dd0-4e4a-401a-894e-e75f7145287a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3a1821cc-03c6-4451-b1cd-233bb5c7f642"}, {"Element": "<span lang=\"EN-GB\">4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "cc7b6690-c51e-40cd-ada1-8f2e5be3e2fc", "Styles": "None", "Classes": "None", "Text": "4\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c90b2dd0-4e4a-401a-894e-e75f7145287a"}, {"Element": "<span lang=\"EN-GB\">OS was defined as\n  time from date of Kymriah infusion to the date of death due to any cause (N=115)\n  and time from date of enrolment to the date of death due to any cause for\n  enrolled patients (N=167).</span>", "ID": "65c02e8c-2440-4460-8838-533a676304fd", "Styles": "None", "Classes": "None", "Text": "OS was defined as   time from date of Kymriah infusion to the date of death due to any cause (N=115)   and time from date of enrolment to the date of death due to any cause for   enrolled patients (N=167).", "ParentId": "3a1821cc-03c6-4451-b1cd-233bb5c7f642"}, {"Element": "<p class=\"Legend\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid\"><sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5</span></sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not estimable.</span></p>", "ID": "6a30e010-f756-4a9a-947b-960feacc5030", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;\n  margin-left:28.35pt;text-indent:-28.35pt;page-break-after:avoid", "Classes": "['Legend']", "Text": "", "ParentId": "e9a80cf2-cf8a-401b-91d2-01cf6ed652aa"}, {"Element": "<sup><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5</span></sup>", "ID": "3765361d-05bf-4460-a249-cdb0b8fc5633", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a30e010-f756-4a9a-947b-960feacc5030"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>5</span>", "ID": "97ba9487-41c7-460d-83b8-a93464230732", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "5", "ParentId": "3765361d-05bf-4460-a249-cdb0b8fc5633"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not estimable.</span>", "ID": "3c7b026a-91b4-4bd9-b469-b7fd64f46729", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Not estimable.", "ParentId": "6a30e010-f756-4a9a-947b-960feacc5030"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><a name=\"_Toc485048491\"></a><a name=\"_Toc488242412\"><span lang=\"EN-GB\">\u00a0</span></a></p>", "ID": "286e915a-7314-463d-a413-c870d91500a0", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<a name=\"_Toc485048491\"></a>", "ID": "b0b8b46f-3868-4c10-9653-8e53b7d774c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "286e915a-7314-463d-a413-c870d91500a0"}, {"Element": "<a name=\"_Toc488242412\"><span lang=\"EN-GB\">\u00a0</span></a>", "ID": "e62e030d-7205-4f02-bfff-04b747e6e350", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "286e915a-7314-463d-a413-c870d91500a0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2c048e5e-8c1d-4259-8d5b-876697a51eaa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e62e030d-7205-4f02-bfff-04b747e6e350"}, {"Element": "<p class=\"MsoCommentText\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Among the 40\u00a0patients\nwho achieved CR, 15\u00a0patients initially had an overall disease response of\nPR which improved to CR over time; most patients (13/15) achieved PR to CR\nconversion within 6\u00a0months post-tisagenlecleucel infusion. ORR was consistent\nacross subgroups.</span></p>", "ID": "4a135c7d-b397-4989-beec-d507dd70e791", "Styles": "None", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Among the 40\u00a0patients\nwho achieved CR, 15\u00a0patients initially had an overall disease response of\nPR which improved to CR over time; most patients (13/15) achieved PR to CR\nconversion within 6\u00a0months post-tisagenlecleucel infusion. ORR was consistent\nacross subgroups.</span>", "ID": "9643f050-8a8c-4031-86be-8b408b2c76e5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Among the 40\u00a0patients who achieved CR, 15\u00a0patients initially had an overall disease response of PR which improved to CR over time; most patients (13/15) achieved PR to CR conversion within 6\u00a0months post-tisagenlecleucel infusion. ORR was consistent across subgroups.", "ParentId": "4a135c7d-b397-4989-beec-d507dd70e791"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2bbc4892-eb95-4c24-a9af-8db382ae4b02", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "33332360-372d-417a-aed7-e7fee11edfee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2bbc4892-eb95-4c24-a9af-8db382ae4b02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>", "ID": "7bcc7d9e-2ef2-4fb6-b6b6-6fa5767c1d84", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Special populations</span></u>", "ID": "86ab4748-f125-439b-a769-3e136914c77f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7bcc7d9e-2ef2-4fb6-b6b6-6fa5767c1d84"}, {"Element": "<span lang=\"EN-GB\">Special populations</span>", "ID": "840dcaf5-3443-4a36-9fb7-dc9ddab5824a", "Styles": "None", "Classes": "None", "Text": "Special populations", "ParentId": "86ab4748-f125-439b-a769-3e136914c77f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f852993b-cc94-48c1-8a86-e18bd46ad38c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "80c25d04-22ee-4752-bcd7-f50761c7f293", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f852993b-cc94-48c1-8a86-e18bd46ad38c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are not\nenough data to determine whether there are any differences in efficacy or\nsafety between different age subgroups, although the clinical benefit and\nsafety experience in elderly patients with DLBCL above the age of 65\u00a0years\n(23% of the study population) were comparable to the overall population.</span></p>", "ID": "c8c29892-7e57-47e6-b54b-6fc4b7e8b2d8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There are not\nenough data to determine whether there are any differences in efficacy or\nsafety between different age subgroups, although the clinical benefit and\nsafety experience in elderly patients with DLBCL above the age of 65\u00a0years\n(23% of the study population) were comparable to the overall population.</span>", "ID": "43b9c339-28bf-4e1f-8486-c28db5cacce7", "Styles": "None", "Classes": "None", "Text": "There are not enough data to determine whether there are any differences in efficacy or safety between different age subgroups, although the clinical benefit and safety experience in elderly patients with DLBCL above the age of 65\u00a0years (23% of the study population) were comparable to the overall population.", "ParentId": "c8c29892-7e57-47e6-b54b-6fc4b7e8b2d8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b9e7efb0-f246-46ec-a057-d319082a4aa4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "515fcfd5-43ce-42d1-a9c4-24e3668072c6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b9e7efb0-f246-46ec-a057-d319082a4aa4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>", "ID": "92a738eb-51f4-42bf-8a8b-0d69d24b59b7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Paediatric population</span></u>", "ID": "6c8f9e6e-7c69-49cc-8430-cb6f4c19d1c4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92a738eb-51f4-42bf-8a8b-0d69d24b59b7"}, {"Element": "<span lang=\"EN-GB\">Paediatric population</span>", "ID": "a19ec71c-e2d1-44b1-8a21-8c1140c9c131", "Styles": "None", "Classes": "None", "Text": "Paediatric population", "ParentId": "6c8f9e6e-7c69-49cc-8430-cb6f4c19d1c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5b319f0c-c67f-43c8-9556-486fb44c4304", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "67b6ce2e-f720-42c5-b4c1-19e7e7d4ef15", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5b319f0c-c67f-43c8-9556-486fb44c4304"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European\nMedicines Agency has deferred the obligation to submit the results of studies\nwith Kymriah</span><span lang=\"EN-GB\" style=\"color:#00B050\"> </span><span lang=\"EN-GB\">in one or more subsets of the paediatric population in the following\nconditions: a)\u00a0treatment of B\u2011cell lymphoblastic lymphoma, and b)\u00a0treatment\nof mature B\u2011cell neoplasms (see section\u00a04.2 for information on\npaediatric use).</span></p>", "ID": "038263c2-585d-4fe8-a99e-d404f79ae113", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The European\nMedicines Agency has deferred the obligation to submit the results of studies\nwith Kymriah</span>", "ID": "205abcde-d9ec-49ba-b729-bb8b22ae9960", "Styles": "None", "Classes": "None", "Text": "The European Medicines Agency has deferred the obligation to submit the results of studies with Kymriah", "ParentId": "038263c2-585d-4fe8-a99e-d404f79ae113"}, {"Element": "<span lang=\"EN-GB\" style=\"color:#00B050\"> </span>", "ID": "a207ff1a-c2d2-4702-967f-15eaea18b78d", "Styles": "color:#00B050", "Classes": "None", "Text": " ", "ParentId": "038263c2-585d-4fe8-a99e-d404f79ae113"}, {"Element": "<span lang=\"EN-GB\">in one or more subsets of the paediatric population in the following\nconditions: a)\u00a0treatment of B\u2011cell lymphoblastic lymphoma, and b)\u00a0treatment\nof mature B\u2011cell neoplasms (see section\u00a04.2 for information on\npaediatric use).</span>", "ID": "0895d1b9-1240-4af2-b2c8-ea5da91e69c4", "Styles": "None", "Classes": "None", "Text": "in one or more subsets of the paediatric population in the following conditions: a)\u00a0treatment of B\u2011cell lymphoblastic lymphoma, and b)\u00a0treatment of mature B\u2011cell neoplasms (see section\u00a04.2 for information on paediatric use).", "ParentId": "038263c2-585d-4fe8-a99e-d404f79ae113"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "28c37c8b-50ad-4e23-a1e0-dfb370aea597", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7cad587a-bce8-4834-af55-5d1236244f56", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "28c37c8b-50ad-4e23-a1e0-dfb370aea597"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b></p>", "ID": "f6f2e4a2-cdf9-461b-bd0f-dc8ed336b4fd", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span></b>", "ID": "4f4a858d-9530-4ff9-a6e8-dc7695d9bbf5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f6f2e4a2-cdf9-461b-bd0f-dc8ed336b4fd"}, {"Element": "<span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic\nproperties</span>", "ID": "1676b97b-0275-4f9b-86d3-2e455d7512a1", "Styles": "None", "Classes": "None", "Text": "5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties", "ParentId": "4f4a858d-9530-4ff9-a6e8-dc7695d9bbf5"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d61cdebf-f5a4-492c-8cc3-1841260c02f4", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2978d942-11a4-4232-9f3f-74fc994c2f6a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d61cdebf-f5a4-492c-8cc3-1841260c02f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Following infusion of Kymriah into paediatric and young adult r/r B\u2011cell\nALL and r/r DLBCL patients, tisagenlecleucel typically exhibited an initial\nrapid expansion followed by a slower bi\u2011exponential decline.</span></p>", "ID": "820d2f18-958d-4438-8d0f-38538aedf8de", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Following infusion of Kymriah into paediatric and young adult r/r B\u2011cell\nALL and r/r DLBCL patients, tisagenlecleucel typically exhibited an initial\nrapid expansion followed by a slower bi\u2011exponential decline.</span>", "ID": "07f32690-86fe-4bcb-b118-59f3f68b08b0", "Styles": "None", "Classes": "None", "Text": "Following infusion of Kymriah into paediatric and young adult r/r B\u2011cell ALL and r/r DLBCL patients, tisagenlecleucel typically exhibited an initial rapid expansion followed by a slower bi\u2011exponential decline.", "ParentId": "820d2f18-958d-4438-8d0f-38538aedf8de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "90487bd9-2b65-4bc9-8863-02498d1436df", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "e669ef56-3985-43b6-85d9-0c56548a1a84", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "90487bd9-2b65-4bc9-8863-02498d1436df"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "57e49e25-2c02-4459-ac9b-9ac771788a6c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e669ef56-3985-43b6-85d9-0c56548a1a84"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "30cf3a0f-fe44-4def-8014-d574f6cd021d", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "57e49e25-2c02-4459-ac9b-9ac771788a6c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cellular kinetics in paediatric and young adult B\u2011cell ALL\npatients</span></u></p>", "ID": "947ab269-717b-40be-bded-deb6cdc1c33c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Cellular kinetics in paediatric and young adult B\u2011cell ALL\npatients</span></u>", "ID": "11e8e212-c7f4-4e5c-894c-91a27002ea35", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "947ab269-717b-40be-bded-deb6cdc1c33c"}, {"Element": "<span lang=\"EN-GB\">Cellular kinetics in paediatric and young adult B\u2011cell ALL\npatients</span>", "ID": "166e6104-f2a3-426e-ba8a-3e89ab23f59d", "Styles": "None", "Classes": "None", "Text": "Cellular kinetics in paediatric and young adult B\u2011cell ALL patients", "ParentId": "11e8e212-c7f4-4e5c-894c-91a27002ea35"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be8f0a35-5ad1-4be2-a86d-80cfd34052f7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cd03b694-b0a4-4d09-9c44-3c91b0af743a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be8f0a35-5ad1-4be2-a86d-80cfd34052f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">A summary of cellular kinetic parameters of tisagenlecleucel in\npaediatric and young adult B\u2011cell ALL patients is provided in Table\u00a07\nbelow. The maximal expansion (C<sub>max</sub>) was approximately 1.6\u2011fold\nhigher in CR/CRi patients (n=103) compared with non\u2011responding (NR)\npatients (n=10) as measured by qPCR. Delayed and lower expansion was observed\nin NR patients compared to CR/CRi patients.</span></p>", "ID": "edec455a-2368-4bca-9ba3-16be19c3af1d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">A summary of cellular kinetic parameters of tisagenlecleucel in\npaediatric and young adult B\u2011cell ALL patients is provided in Table\u00a07\nbelow. The maximal expansion (C<sub>max</sub>) was approximately 1.6\u2011fold\nhigher in CR/CRi patients (n=103) compared with non\u2011responding (NR)\npatients (n=10) as measured by qPCR. Delayed and lower expansion was observed\nin NR patients compared to CR/CRi patients.</span>", "ID": "f1fcb72b-6158-4e50-ba5a-3c097eb2be4e", "Styles": "None", "Classes": "None", "Text": "A summary of cellular kinetic parameters of tisagenlecleucel in paediatric and young adult B\u2011cell ALL patients is provided in Table\u00a07 below. The maximal expansion (C) was approximately 1.6\u2011fold higher in CR/CRi patients (n=103) compared with non\u2011responding (NR) patients (n=10) as measured by qPCR. Delayed and lower expansion was observed in NR patients compared to CR/CRi patients.", "ParentId": "edec455a-2368-4bca-9ba3-16be19c3af1d"}, {"Element": "<sub>max</sub>", "ID": "7bfc82b3-8b06-4415-b6ae-2120b913de2a", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "f1fcb72b-6158-4e50-ba5a-3c097eb2be4e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "f1ee5750-688c-4600-9f36-c9858f176289", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "bc2e2671-7374-479f-aa8f-0e25ea452c54", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f1ee5750-688c-4600-9f36-c9858f176289"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "854ea202-e5e8-433b-9772-aea2c693c912", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc2e2671-7374-479f-aa8f-0e25ea452c54"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "bf91e479-c962-4e22-bec9-5714daf4cf1e", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "854ea202-e5e8-433b-9772-aea2c693c912"}, {"Element": "<h6 style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:56.7pt;\ntext-indent:-56.7pt\"><a name=\"_Toc491696953\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a07\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of\ntisagenlecleucel in paediatric and young adult r/r B\u2011cell ALL</span></a><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> (Studies B2202 and\nB2205J)</span></h6>", "ID": "5559e467-f53d-4544-8469-a81749289554", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:56.7pt;\ntext-indent:-56.7pt", "Classes": "None", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<a name=\"_Toc491696953\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a07\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of\ntisagenlecleucel in paediatric and young adult r/r B\u2011cell ALL</span></a>", "ID": "55db9dba-e087-4f83-a61c-216f5ae7189b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5559e467-f53d-4544-8469-a81749289554"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a07\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of\ntisagenlecleucel in paediatric and young adult r/r B\u2011cell ALL</span>", "ID": "42ae3efa-5b89-4693-b3cc-7c67ac99bff1", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Table\u00a07\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of tisagenlecleucel in paediatric and young adult r/r B\u2011cell ALL", "ParentId": "55db9dba-e087-4f83-a61c-216f5ae7189b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'> (Studies B2202 and\nB2205J)</span>", "ID": "9787308a-ad46-426d-ad42-6753cb5e97dc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " (Studies B2202 and B2205J)", "ParentId": "5559e467-f53d-4544-8469-a81749289554"}, {"Element": "<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "42cb4565-3432-49a9-9b3c-87b411a6e9c9", "Styles": "margin-top:0in;page-break-after:avoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "75d17216-dfea-4dac-ae0f-42d49e90574f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "42cb4565-3432-49a9-9b3c-87b411a6e9c9"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>\n<td style=\"width:112.3pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>\n<td style=\"width:115.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients (CR/CRi)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=105</span></p>\n</td>\n<td style=\"width:116.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients (NR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:black\">N</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">=12</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">35,300 (154.0), 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">21,900 (80.7), 10</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub><sup>\u2021</sup> (day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.83 [5.70; 27.8], 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">20.1 [12.6; 62.7], 10</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">309,000 (178.1), 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">232,000 (104.5), 8</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">25.2 (307.8), 71</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">3.80 (182.4), 4</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">166 [20.9; 916], 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">28.8 [26.7; 742], 9</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n</td>\n</tr>\n</table>", "ID": "e40786c3-8791-4857-ae70-f7b9f4fab5d1", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "        ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>\n<td style=\"width:112.3pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>\n<td style=\"width:115.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients (CR/CRi)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=105</span></p>\n</td>\n<td style=\"width:116.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients (NR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:black\">N</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">=12</span></p>\n</td>\n</tr>", "ID": "2f25996a-24a3-42e6-8754-1dcb26980f33", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e40786c3-8791-4857-ae70-f7b9f4fab5d1"}, {"Element": "<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>", "ID": "b6e207b2-4f75-4817-a732-8a4e0f6f2dd5", "Styles": "width:119.5pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2f25996a-24a3-42e6-8754-1dcb26980f33"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>", "ID": "125937bd-5f39-4909-b5ff-6f5386c2f3d1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "b6e207b2-4f75-4817-a732-8a4e0f6f2dd5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span>", "ID": "47afea4a-1c48-4076-a913-c7b811c3fb3e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Parameter", "ParentId": "125937bd-5f39-4909-b5ff-6f5386c2f3d1"}, {"Element": "<td style=\"width:112.3pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>", "ID": "63a1d67d-16bb-4635-bb8c-3230186643d6", "Styles": "width:112.3pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "2f25996a-24a3-42e6-8754-1dcb26980f33"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>", "ID": "44156ccb-1bfc-4d0b-9e94-300f9ba1a821", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "63a1d67d-16bb-4635-bb8c-3230186643d6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span>", "ID": "3926a87f-6dad-418f-9dbd-819731ce8bcb", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Summary statistics", "ParentId": "44156ccb-1bfc-4d0b-9e94-300f9ba1a821"}, {"Element": "<td style=\"width:115.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients (CR/CRi)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=105</span></p>\n</td>", "ID": "ae24595d-4b6e-4e60-897b-f54317a31415", "Styles": "width:115.85pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "2f25996a-24a3-42e6-8754-1dcb26980f33"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients (CR/CRi)</span></p>", "ID": "d6b5fde4-da11-4b8e-8332-6ac99ec78367", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "ae24595d-4b6e-4e60-897b-f54317a31415"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients (CR/CRi)</span>", "ID": "b24768ad-17d0-4654-871d-0cd5a20489b5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Responding patients (CR/CRi)", "ParentId": "d6b5fde4-da11-4b8e-8332-6ac99ec78367"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=105</span></p>", "ID": "9f67b8c3-955f-4894-b866-85fad1ef7992", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "ae24595d-4b6e-4e60-897b-f54317a31415"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=105</span>", "ID": "b1ae6356-d54d-4ce8-a82b-8b648145cfe7", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "N=105", "ParentId": "9f67b8c3-955f-4894-b866-85fad1ef7992"}, {"Element": "<td style=\"width:116.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients (NR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:black\">N</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">=12</span></p>\n</td>", "ID": "87ceb649-820f-4ed9-8788-ffc548b67100", "Styles": "width:116.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "2f25996a-24a3-42e6-8754-1dcb26980f33"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients (NR)</span></p>", "ID": "34a7eef5-198e-41f7-9727-1f4fc3469f7d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "87ceb649-820f-4ed9-8788-ffc548b67100"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients (NR)</span>", "ID": "114be46d-fd1f-4fef-8ebb-7ecde99c8bba", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Non\u2011responding patients (NR)", "ParentId": "34a7eef5-198e-41f7-9727-1f4fc3469f7d"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:black\">N</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">=12</span></p>", "ID": "edaf38d6-24dd-4578-b11c-356be4a91836", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "87ceb649-820f-4ed9-8788-ffc548b67100"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:black\">N</span>", "ID": "7070fa62-e4ec-4a67-a03a-a9745d7a5f40", "Styles": "font-size:11.0pt;color:black", "Classes": "None", "Text": "N", "ParentId": "edaf38d6-24dd-4578-b11c-356be4a91836"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">=12</span>", "ID": "564ee069-0432-4aed-b8a2-552b742ed45c", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "=12", "ParentId": "edaf38d6-24dd-4578-b11c-356be4a91836"}, {"Element": "<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">35,300 (154.0), 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">21,900 (80.7), 10</span></p>\n</td>\n</tr>", "ID": "e25037c0-7ac5-4cd5-aa64-5af8cceae800", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e40786c3-8791-4857-ae70-f7b9f4fab5d1"}, {"Element": "<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>", "ID": "8e7fd6f5-e469-41b9-b1c0-ba983848af7c", "Styles": "width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e25037c0-7ac5-4cd5-aa64-5af8cceae800"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>", "ID": "2f0bcc80-13fb-4901-a2fe-e92a646a2afd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "8e7fd6f5-e469-41b9-b1c0-ba983848af7c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span>", "ID": "faf9082d-2a5e-410a-90cd-c8f72e63ff26", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "C (copies/", "ParentId": "2f0bcc80-13fb-4901-a2fe-e92a646a2afd"}, {"Element": "<sub>max</sub>", "ID": "f251f56b-2166-499b-8219-ffaaa36dc9ce", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "faf9082d-2a5e-410a-90cd-c8f72e63ff26"}, {"Element": "<span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span>", "ID": "54841c92-025e-49c4-870e-c9fbffc53d16", "Styles": "None", "Classes": "['st1']", "Text": "", "ParentId": "2f0bcc80-13fb-4901-a2fe-e92a646a2afd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span>", "ID": "968010c9-85c5-4372-be57-20c4cabfe0c4", "Styles": "font-size:11.0pt;color:#545454", "Classes": "None", "Text": "\u03bc", "ParentId": "54841c92-025e-49c4-870e-c9fbffc53d16"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span>", "ID": "6d58f1aa-c03a-492f-9e03-342818195361", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "g)", "ParentId": "2f0bcc80-13fb-4901-a2fe-e92a646a2afd"}, {"Element": "<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>", "ID": "d191a0d2-ad41-40d8-be61-1055217d0dc0", "Styles": "width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e25037c0-7ac5-4cd5-aa64-5af8cceae800"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>", "ID": "0914983b-ad18-42ea-8a7b-de429ec391e7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "d191a0d2-ad41-40d8-be61-1055217d0dc0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span>", "ID": "f01b371b-8ff0-48b0-bf7f-8a49803f2dbc", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Geometric mean (CV%), n", "ParentId": "0914983b-ad18-42ea-8a7b-de429ec391e7"}, {"Element": "<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">35,300 (154.0), 103</span></p>\n</td>", "ID": "0bf02368-f6ac-4880-ab75-a61d607f6309", "Styles": "width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e25037c0-7ac5-4cd5-aa64-5af8cceae800"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">35,300 (154.0), 103</span></p>", "ID": "476cc50d-92a3-4f4f-9030-e192576504c4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "0bf02368-f6ac-4880-ab75-a61d607f6309"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">35,300 (154.0), 103</span>", "ID": "345fb534-1c62-4fe1-a985-c0e46fa31906", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "35,300 (154.0), 103", "ParentId": "476cc50d-92a3-4f4f-9030-e192576504c4"}, {"Element": "<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">21,900 (80.7), 10</span></p>\n</td>", "ID": "9de00133-5ffb-4a73-9e5c-dd641c935b12", "Styles": "width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e25037c0-7ac5-4cd5-aa64-5af8cceae800"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">21,900 (80.7), 10</span></p>", "ID": "20a51cfc-cf90-4400-a8a4-b6982bd841fd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "9de00133-5ffb-4a73-9e5c-dd641c935b12"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">21,900 (80.7), 10</span>", "ID": "263d1c9c-0e53-44b7-94a5-faca550dc306", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "21,900 (80.7), 10", "ParentId": "20a51cfc-cf90-4400-a8a4-b6982bd841fd"}, {"Element": "<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub><sup>\u2021</sup> (day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.83 [5.70; 27.8], 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">20.1 [12.6; 62.7], 10</span></p>\n</td>\n</tr>", "ID": "e1dd371f-861c-424c-aa9a-6b230fd11624", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e40786c3-8791-4857-ae70-f7b9f4fab5d1"}, {"Element": "<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub><sup>\u2021</sup> (day)</span></p>\n</td>", "ID": "11170acb-0b7b-46c1-886c-462498b225fd", "Styles": "width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e1dd371f-861c-424c-aa9a-6b230fd11624"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub><sup>\u2021</sup> (day)</span></p>", "ID": "54159589-9af4-4384-a875-4e32925cfcbe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "11170acb-0b7b-46c1-886c-462498b225fd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub><sup>\u2021</sup> (day)</span>", "ID": "4bfa1b60-3751-4d90-91fd-2dbb634546c9", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "T (day)", "ParentId": "54159589-9af4-4384-a875-4e32925cfcbe"}, {"Element": "<sub>max</sub>", "ID": "29f9f6ce-d269-47d3-8b6f-b5b7a76a2438", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "4bfa1b60-3751-4d90-91fd-2dbb634546c9"}, {"Element": "<sup>\u2021</sup>", "ID": "2b1a936b-4382-422e-b558-c4602b48369d", "Styles": "None", "Classes": "None", "Text": "\u2021", "ParentId": "4bfa1b60-3751-4d90-91fd-2dbb634546c9"}, {"Element": "<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>", "ID": "4c2c99bb-81b7-4b14-b24c-b834f503d7cc", "Styles": "width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e1dd371f-861c-424c-aa9a-6b230fd11624"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>", "ID": "fee852fc-618a-40c3-89ec-6e07fde00b08", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "4c2c99bb-81b7-4b14-b24c-b834f503d7cc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span>", "ID": "74f6ac1c-a853-4e68-b8f6-a90566e56916", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Median [min;max], n", "ParentId": "fee852fc-618a-40c3-89ec-6e07fde00b08"}, {"Element": "<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.83 [5.70; 27.8], 103</span></p>\n</td>", "ID": "37df3282-623f-4129-86ef-3f308da4e6f5", "Styles": "width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e1dd371f-861c-424c-aa9a-6b230fd11624"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.83 [5.70; 27.8], 103</span></p>", "ID": "5f7e604f-1187-4e81-8a72-778ee0301a79", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "37df3282-623f-4129-86ef-3f308da4e6f5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.83 [5.70; 27.8], 103</span>", "ID": "58adab65-8511-4823-9cf7-e009feacb76d", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "9.83 [5.70; 27.8], 103", "ParentId": "5f7e604f-1187-4e81-8a72-778ee0301a79"}, {"Element": "<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">20.1 [12.6; 62.7], 10</span></p>\n</td>", "ID": "f90c49fb-a000-4f1b-bd75-a5cafde0314e", "Styles": "width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e1dd371f-861c-424c-aa9a-6b230fd11624"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">20.1 [12.6; 62.7], 10</span></p>", "ID": "c5c54f5a-bb0e-4d54-b111-435d612175fe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "f90c49fb-a000-4f1b-bd75-a5cafde0314e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">20.1 [12.6; 62.7], 10</span>", "ID": "bd54817d-358f-47e2-b362-8b90cb10bc96", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "20.1 [12.6; 62.7], 10", "ParentId": "c5c54f5a-bb0e-4d54-b111-435d612175fe"}, {"Element": "<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">309,000 (178.1), 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">232,000 (104.5), 8</span></p>\n</td>\n</tr>", "ID": "86b667ff-fffb-4592-9e52-b2ee0bf7eaeb", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e40786c3-8791-4857-ae70-f7b9f4fab5d1"}, {"Element": "<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>", "ID": "afdc565f-9d3e-4bd1-a27a-546f329e2c68", "Styles": "width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "86b667ff-fffb-4592-9e52-b2ee0bf7eaeb"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>", "ID": "9f668ab7-df3f-497a-90f9-adbc3f371914", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "afdc565f-9d3e-4bd1-a27a-546f329e2c68"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span>", "ID": "3d5fcf65-01cb-4153-847c-6a07a03af0da", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "AUC(copies/", "ParentId": "9f668ab7-df3f-497a-90f9-adbc3f371914"}, {"Element": "<sub>0\u201128d </sub>", "ID": "22f6e920-5e53-4b88-8bc4-3e9170502ed9", "Styles": "None", "Classes": "None", "Text": "0\u201128d ", "ParentId": "3d5fcf65-01cb-4153-847c-6a07a03af0da"}, {"Element": "<span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span>", "ID": "f9603632-4d4a-4d37-80c5-0d769ab321b8", "Styles": "None", "Classes": "['st1']", "Text": "", "ParentId": "9f668ab7-df3f-497a-90f9-adbc3f371914"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span>", "ID": "3cc999aa-7d3b-4a6a-ae5e-b919eae31258", "Styles": "font-size:11.0pt;color:#545454", "Classes": "None", "Text": "\u03bc", "ParentId": "f9603632-4d4a-4d37-80c5-0d769ab321b8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span>", "ID": "517d54ee-1f3c-4d20-a5de-573b5e440c96", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "g*day)", "ParentId": "9f668ab7-df3f-497a-90f9-adbc3f371914"}, {"Element": "<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>", "ID": "4055285c-cef9-468f-b884-7711e92f723e", "Styles": "width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "86b667ff-fffb-4592-9e52-b2ee0bf7eaeb"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>", "ID": "60ac84d5-429f-4eb9-b584-7e0d527fc3a3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "4055285c-cef9-468f-b884-7711e92f723e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span>", "ID": "54ee21f8-d47b-49a2-baad-39bf4a9ba3bf", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Geometric mean (CV%), n", "ParentId": "60ac84d5-429f-4eb9-b584-7e0d527fc3a3"}, {"Element": "<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">309,000 (178.1), 103</span></p>\n</td>", "ID": "f67c4203-ad90-4bba-b305-36762cd3cc84", "Styles": "width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "86b667ff-fffb-4592-9e52-b2ee0bf7eaeb"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">309,000 (178.1), 103</span></p>", "ID": "e6856eb6-f244-4af8-ad90-8717881ff6f3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "f67c4203-ad90-4bba-b305-36762cd3cc84"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">309,000 (178.1), 103</span>", "ID": "3867fb5c-742d-4154-8acf-898b04987e18", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "309,000 (178.1), 103", "ParentId": "e6856eb6-f244-4af8-ad90-8717881ff6f3"}, {"Element": "<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">232,000 (104.5), 8</span></p>\n</td>", "ID": "3cc9f869-a625-4e63-b72a-be98d58a1359", "Styles": "width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "86b667ff-fffb-4592-9e52-b2ee0bf7eaeb"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">232,000 (104.5), 8</span></p>", "ID": "9cd5b26d-3da3-4192-b8c8-035d22664e1f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "3cc9f869-a625-4e63-b72a-be98d58a1359"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">232,000 (104.5), 8</span>", "ID": "05407ca6-c40e-4b3e-a4c1-dde058e8ca18", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "232,000 (104.5), 8", "ParentId": "9cd5b26d-3da3-4192-b8c8-035d22664e1f"}, {"Element": "<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">25.2 (307.8), 71</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">3.80 (182.4), 4</span></p>\n</td>\n</tr>", "ID": "0987def5-0ba7-46c2-a7b4-48ca07e3c323", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e40786c3-8791-4857-ae70-f7b9f4fab5d1"}, {"Element": "<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>", "ID": "8df79d1f-fddd-4996-828d-e66c1aca8ac0", "Styles": "width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0987def5-0ba7-46c2-a7b4-48ca07e3c323"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>", "ID": "46be4335-26a3-4473-932f-65a2ccabc2e9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "8df79d1f-fddd-4996-828d-e66c1aca8ac0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span>", "ID": "c27cd698-01ba-4235-b5f9-d7ac8a74ac6f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "T (day)", "ParentId": "46be4335-26a3-4473-932f-65a2ccabc2e9"}, {"Element": "<sub>\u00bd</sub>", "ID": "a9b57a75-5496-4316-a38d-4b9b54791709", "Styles": "None", "Classes": "None", "Text": "\u00bd", "ParentId": "c27cd698-01ba-4235-b5f9-d7ac8a74ac6f"}, {"Element": "<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>", "ID": "e601a462-d9a1-488b-88b5-07c857919517", "Styles": "width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0987def5-0ba7-46c2-a7b4-48ca07e3c323"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>", "ID": "37a393c6-7fbf-4bf5-a384-fedac02f9cee", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "e601a462-d9a1-488b-88b5-07c857919517"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span>", "ID": "d374ab8b-3a55-453f-9f7d-e5aef8e4005f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Geometric mean (CV%), n", "ParentId": "37a393c6-7fbf-4bf5-a384-fedac02f9cee"}, {"Element": "<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">25.2 (307.8), 71</span></p>\n</td>", "ID": "d3cf78a3-982c-4f9a-95bb-4973624cf023", "Styles": "width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0987def5-0ba7-46c2-a7b4-48ca07e3c323"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">25.2 (307.8), 71</span></p>", "ID": "d8f22880-4fc5-4ad6-9b96-c2211ddb6920", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "d3cf78a3-982c-4f9a-95bb-4973624cf023"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">25.2 (307.8), 71</span>", "ID": "5d87f8b9-caf7-4534-a585-130106543f48", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "25.2 (307.8), 71", "ParentId": "d8f22880-4fc5-4ad6-9b96-c2211ddb6920"}, {"Element": "<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">3.80 (182.4), 4</span></p>\n</td>", "ID": "5029de61-e098-4ad0-aedb-324aedbf94d6", "Styles": "width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0987def5-0ba7-46c2-a7b4-48ca07e3c323"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">3.80 (182.4), 4</span></p>", "ID": "943fd172-ad03-4f02-8c20-ed567f63f0b8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "5029de61-e098-4ad0-aedb-324aedbf94d6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">3.80 (182.4), 4</span>", "ID": "665b40b5-48bf-480e-a00b-2a7976e55f4b", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "3.80 (182.4), 4", "ParentId": "943fd172-ad03-4f02-8c20-ed567f63f0b8"}, {"Element": "<tr>\n<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>\n<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">166 [20.9; 916], 103</span></p>\n</td>\n<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">28.8 [26.7; 742], 9</span></p>\n</td>\n</tr>", "ID": "c5dfc60a-02c5-4acf-96e0-3fbd38650504", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e40786c3-8791-4857-ae70-f7b9f4fab5d1"}, {"Element": "<td style=\"width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"159\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>", "ID": "1f239cc2-731e-4d18-88ae-bd0efc9275f7", "Styles": "width:119.5pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c5dfc60a-02c5-4acf-96e0-3fbd38650504"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>", "ID": "5eb1f96c-1192-45bf-a1ed-32ce519153ba", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "1f239cc2-731e-4d18-88ae-bd0efc9275f7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span>", "ID": "bd1f3494-65ab-4b2e-88d4-0b80af076242", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "T", "ParentId": "5eb1f96c-1192-45bf-a1ed-32ce519153ba"}, {"Element": "<sub>last</sub>", "ID": "32bcab0a-1979-45e1-8c38-ea4abd62f2e8", "Styles": "None", "Classes": "None", "Text": "last", "ParentId": "bd1f3494-65ab-4b2e-88d4-0b80af076242"}, {"Element": "<td style=\"width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>", "ID": "d3e105c7-f6b7-4b5f-8d96-8537cdd6ffe5", "Styles": "width:112.3pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c5dfc60a-02c5-4acf-96e0-3fbd38650504"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>", "ID": "33cf835f-fdd7-47fe-aff8-6907f7b71547", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "d3e105c7-f6b7-4b5f-8d96-8537cdd6ffe5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span>", "ID": "3042cedb-68cd-4328-b838-d0cf3cb1927c", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Median [min;max], n", "ParentId": "33cf835f-fdd7-47fe-aff8-6907f7b71547"}, {"Element": "<td style=\"width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">166 [20.9; 916], 103</span></p>\n</td>", "ID": "29d4027a-e2db-4a72-937f-ca73e50c02c5", "Styles": "width:115.85pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c5dfc60a-02c5-4acf-96e0-3fbd38650504"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">166 [20.9; 916], 103</span></p>", "ID": "8554a17c-7c65-47dd-97f1-65262dd05f99", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "29d4027a-e2db-4a72-937f-ca73e50c02c5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">166 [20.9; 916], 103</span>", "ID": "2bc1e2b3-3589-4079-b2ad-0d60ab83ea79", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "166 [20.9; 916], 103", "ParentId": "8554a17c-7c65-47dd-97f1-65262dd05f99"}, {"Element": "<td style=\"width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"156\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">28.8 [26.7; 742], 9</span></p>\n</td>", "ID": "79ccfda2-e911-434a-84ff-e011c1d2dbd6", "Styles": "width:116.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c5dfc60a-02c5-4acf-96e0-3fbd38650504"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">28.8 [26.7; 742], 9</span></p>", "ID": "d72084bd-dede-41bc-8f20-4364a2e620be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "79ccfda2-e911-434a-84ff-e011c1d2dbd6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">28.8 [26.7; 742], 9</span>", "ID": "30162b76-6139-4718-af8b-0fe99f541615", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "28.8 [26.7; 742], 9", "ParentId": "d72084bd-dede-41bc-8f20-4364a2e620be"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n</td>\n</tr>", "ID": "344734c8-e78d-43fd-ae86-2aa41be0bb6c", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e40786c3-8791-4857-ae70-f7b9f4fab5d1"}, {"Element": "<td colspan=\"4\" style=\"width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"619\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n</td>", "ID": "e467eb73-25d6-41f2-b42f-5ed45fa9a5df", "Styles": "width:464.35pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "344734c8-e78d-43fd-ae86-2aa41be0bb6c"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "138d3d34-45a4-464f-bc23-eccd312f3081", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "e467eb73-25d6-41f2-b42f-5ed45fa9a5df"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "302d02bc-0271-40bd-b847-be82d8edf091", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "138d3d34-45a4-464f-bc23-eccd312f3081"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1681d3ad-2fba-4666-b612-743c16048332", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "38bac805-ebca-4055-9672-4d2975984fbc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1681d3ad-2fba-4666-b612-743c16048332"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Cellular kinetics in adult DLBCL patients</span></u></p>", "ID": "4ae02500-e512-4e9d-b407-2392b3b928d0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Cellular kinetics in adult DLBCL patients</span></u>", "ID": "d53a959c-0871-4948-94f9-3429025995fd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ae02500-e512-4e9d-b407-2392b3b928d0"}, {"Element": "<span lang=\"EN-GB\">Cellular kinetics in adult DLBCL patients</span>", "ID": "472c8a8e-82f2-4f83-8961-6608bc62c7c6", "Styles": "None", "Classes": "None", "Text": "Cellular kinetics in adult DLBCL patients", "ParentId": "d53a959c-0871-4948-94f9-3429025995fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f35edbcf-a243-42bc-846f-3fa85fefcaae", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4b804a2-5b34-4e13-a927-4ff84a36f0c6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f35edbcf-a243-42bc-846f-3fa85fefcaae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A summary of\ncellular kinetic parameters of tisagenlecleucel in DLBCL patients is provided\nin Table\u00a08 below.</span></p>", "ID": "ef1fa603-15ed-4b1c-a482-db2356d7fe5d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">A summary of\ncellular kinetic parameters of tisagenlecleucel in DLBCL patients is provided\nin Table\u00a08 below.</span>", "ID": "f1a827a5-a945-402b-847f-345996f6a6bf", "Styles": "None", "Classes": "None", "Text": "A summary of cellular kinetic parameters of tisagenlecleucel in DLBCL patients is provided in Table\u00a08 below.", "ParentId": "ef1fa603-15ed-4b1c-a482-db2356d7fe5d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e3dab0e-0a83-4cc4-9391-62fd730716d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2997fa2f-4907-4301-9413-f617790b0871", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e3dab0e-0a83-4cc4-9391-62fd730716d0"}, {"Element": "<h6 style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:56.7pt;\ntext-indent:-56.7pt\"><a name=\"_Toc491696954\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a08\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of tisagenlecleucel\nin r/r DLBCL patients</span></a></h6>", "ID": "e600a265-71d0-40f6-ba79-4b5eaecaa500", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:56.7pt;\ntext-indent:-56.7pt", "Classes": "None", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<a name=\"_Toc491696954\"><span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a08\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of tisagenlecleucel\nin r/r DLBCL patients</span></a>", "ID": "dfd16ac0-30ea-49f2-84d2-4df8648f13dd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e600a265-71d0-40f6-ba79-4b5eaecaa500"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\n\"Times New Roman\",serif'>Table\u00a08\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of tisagenlecleucel\nin r/r DLBCL patients</span>", "ID": "48a9fdce-3edd-4e89-89e3-1099c9b6379c", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Table\u00a08\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cellular kinetic parameters of tisagenlecleucel in r/r DLBCL patients", "ParentId": "dfd16ac0-30ea-49f2-84d2-4df8648f13dd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a0d96a51-7618-4056-8174-6b5a2aaa4314", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "94609ae2-4d5a-480b-8d22-f1278493a80e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0d96a51-7618-4056-8174-6b5a2aaa4314"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>\n<td style=\"width:110.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>\n<td style=\"width:113.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(CR and PR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=43</span></p>\n</td>\n<td style=\"width:122.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(SD/PD/Unknown)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=72</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,840 (254.3), 43</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,460 (326.89), 65</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub> (day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.00 [5.78; 19.8], 35</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">8.84 [3.04; 27.7], 65</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61,200 (177.7), 40</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">67,000 (275.2), 56</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">129 (199.2), 33</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">14.7 (147.1), 44</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">551 [17.1; 1030], 43</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61.4 [19.8; 685], 56</span></p>\n</td>\n</tr>\n</table>", "ID": "2a1a4778-cc6f-4f5a-85d6-595f5e944c14", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>\n<td style=\"width:110.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>\n<td style=\"width:113.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(CR and PR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=43</span></p>\n</td>\n<td style=\"width:122.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(SD/PD/Unknown)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=72</span></p>\n</td>\n</tr>", "ID": "5e7752bd-89d4-47d9-824a-c7e8862b9c93", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "2a1a4778-cc6f-4f5a-85d6-595f5e944c14"}, {"Element": "<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>\n</td>", "ID": "beba359b-91b0-420a-9a14-9bf60b1ed9f1", "Styles": "width:118.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5e7752bd-89d4-47d9-824a-c7e8862b9c93"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span></p>", "ID": "e1a3f13e-a053-4385-a287-6cf3ed037530", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "beba359b-91b0-420a-9a14-9bf60b1ed9f1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Parameter</span>", "ID": "0df2a66a-d638-4dfc-afaf-2e0326d4bdd8", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Parameter", "ParentId": "e1a3f13e-a053-4385-a287-6cf3ed037530"}, {"Element": "<td style=\"width:110.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>\n</td>", "ID": "3b8862d3-a35b-45b2-b6c5-ca8870fd99f6", "Styles": "width:110.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5e7752bd-89d4-47d9-824a-c7e8862b9c93"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span></p>", "ID": "6c8632d7-be56-4991-ae15-45987a554763", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "3b8862d3-a35b-45b2-b6c5-ca8870fd99f6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Summary statistics</span>", "ID": "8de14862-72e9-4a65-8684-f47689583295", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Summary statistics", "ParentId": "6c8632d7-be56-4991-ae15-45987a554763"}, {"Element": "<td style=\"width:113.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(CR and PR)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=43</span></p>\n</td>", "ID": "93cd1c92-57c2-4c88-ac49-478ea0d9147a", "Styles": "width:113.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "5e7752bd-89d4-47d9-824a-c7e8862b9c93"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients</span></p>", "ID": "685c6fed-40b4-47ae-a103-ff7679ea1bdf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "93cd1c92-57c2-4c88-ac49-478ea0d9147a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Responding patients</span>", "ID": "64d1fc76-5462-4d17-9478-5ae484923279", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Responding patients", "ParentId": "685c6fed-40b4-47ae-a103-ff7679ea1bdf"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(CR and PR)</span></p>", "ID": "732e67be-cdf2-41ca-a35e-c4c72b2e1046", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "93cd1c92-57c2-4c88-ac49-478ea0d9147a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">(CR and PR)</span>", "ID": "f305db1e-6aab-48fc-926a-bf90bbff11c4", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "(CR and PR)", "ParentId": "732e67be-cdf2-41ca-a35e-c4c72b2e1046"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=43</span></p>", "ID": "1122a6b0-e77b-4b22-8f2d-1da7180334b3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "93cd1c92-57c2-4c88-ac49-478ea0d9147a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=43</span>", "ID": "bd3c4d3b-3ce2-4f4d-aff5-d7372f044d12", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "N=43", "ParentId": "1122a6b0-e77b-4b22-8f2d-1da7180334b3"}, {"Element": "<td style=\"width:122.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(SD/PD/Unknown)</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=72</span></p>\n</td>", "ID": "2845e1f7-4db5-45ce-af9b-93dc6996d134", "Styles": "width:122.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "5e7752bd-89d4-47d9-824a-c7e8862b9c93"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients</span></p>", "ID": "82a4c7cb-67ee-4d4d-8354-160625c8b468", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "2845e1f7-4db5-45ce-af9b-93dc6996d134"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Non\u2011responding patients</span>", "ID": "5f6c3d29-0355-4064-b1b5-696c84ea18dd", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Non\u2011responding patients", "ParentId": "82a4c7cb-67ee-4d4d-8354-160625c8b468"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">(SD/PD/Unknown)</span></p>", "ID": "017fe194-48da-4b56-afb2-c0272c3ed424", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "2845e1f7-4db5-45ce-af9b-93dc6996d134"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">(SD/PD/Unknown)</span>", "ID": "0732b6fe-69c8-436e-86cd-8fd5760366b5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "(SD/PD/Unknown)", "ParentId": "017fe194-48da-4b56-afb2-c0272c3ed424"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=72</span></p>", "ID": "fd4a75cb-b336-4f98-8026-fb5296bfb150", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "2845e1f7-4db5-45ce-af9b-93dc6996d134"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">N=72</span>", "ID": "9e28797b-63a6-469a-885f-6784dd0af6a8", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "N=72", "ParentId": "fd4a75cb-b336-4f98-8026-fb5296bfb150"}, {"Element": "<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,840 (254.3), 43</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,460 (326.89), 65</span></p>\n</td>\n</tr>", "ID": "1370ac7f-2319-4e0e-bec6-2540a37449b6", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "2a1a4778-cc6f-4f5a-85d6-595f5e944c14"}, {"Element": "<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>\n</td>", "ID": "5c3228de-7ca4-4364-a16b-d4a7316996de", "Styles": "width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1370ac7f-2319-4e0e-bec6-2540a37449b6"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span></p>", "ID": "4eb20448-c9ed-4a85-84ea-938006595743", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "5c3228de-7ca4-4364-a16b-d4a7316996de"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">C<sub>max</sub> (copies/</span>", "ID": "a4ded656-ff95-4a63-8fd9-7bb89ffda485", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "C (copies/", "ParentId": "4eb20448-c9ed-4a85-84ea-938006595743"}, {"Element": "<sub>max</sub>", "ID": "ddc964a7-2ffa-4611-8dc4-6e4869ec187d", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "a4ded656-ff95-4a63-8fd9-7bb89ffda485"}, {"Element": "<span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span>", "ID": "a23f26cd-ee82-4fa9-be42-0f48e3c725cd", "Styles": "None", "Classes": "['st1']", "Text": "", "ParentId": "4eb20448-c9ed-4a85-84ea-938006595743"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span>", "ID": "3d382fac-af77-4799-917d-1b35497f8999", "Styles": "font-size:11.0pt;color:#545454", "Classes": "None", "Text": "\u03bc", "ParentId": "a23f26cd-ee82-4fa9-be42-0f48e3c725cd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">g)</span>", "ID": "a514381a-6149-48c1-8536-11f49dc2f1fb", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "g)", "ParentId": "4eb20448-c9ed-4a85-84ea-938006595743"}, {"Element": "<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>", "ID": "031be55e-635d-4a84-bb08-6d2c9981dd66", "Styles": "width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1370ac7f-2319-4e0e-bec6-2540a37449b6"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>", "ID": "5c59f8f7-a284-4569-befb-12d1cf1ac923", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "031be55e-635d-4a84-bb08-6d2c9981dd66"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span>", "ID": "ffe1bae8-32c5-4f04-9282-e27240a10c32", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Geometric mean (CV%), n", "ParentId": "5c59f8f7-a284-4569-befb-12d1cf1ac923"}, {"Element": "<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,840 (254.3), 43</span></p>\n</td>", "ID": "db858b04-9fed-4f03-83a0-2c1868439354", "Styles": "width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1370ac7f-2319-4e0e-bec6-2540a37449b6"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,840 (254.3), 43</span></p>", "ID": "9132a21e-613b-4464-9a7b-cebdef540540", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "db858b04-9fed-4f03-83a0-2c1868439354"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,840 (254.3), 43</span>", "ID": "dbf4c4a5-8675-427b-91bd-28a56fad35b3", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "5,840 (254.3), 43", "ParentId": "9132a21e-613b-4464-9a7b-cebdef540540"}, {"Element": "<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,460 (326.89), 65</span></p>\n</td>", "ID": "cb6962b3-6fee-4638-8490-3742dbd48a6a", "Styles": "width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1370ac7f-2319-4e0e-bec6-2540a37449b6"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,460 (326.89), 65</span></p>", "ID": "c1ad3d49-bd96-4692-8c1e-16c7dd83fad5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "cb6962b3-6fee-4638-8490-3742dbd48a6a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">5,460 (326.89), 65</span>", "ID": "47624e5b-da70-4cd7-83f9-fcf025dc7dac", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "5,460 (326.89), 65", "ParentId": "c1ad3d49-bd96-4692-8c1e-16c7dd83fad5"}, {"Element": "<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub> (day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.00 [5.78; 19.8], 35</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">8.84 [3.04; 27.7], 65</span></p>\n</td>\n</tr>", "ID": "197d729f-e076-49a1-8e21-ef5e45d139c1", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "2a1a4778-cc6f-4f5a-85d6-595f5e944c14"}, {"Element": "<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub> (day)</span></p>\n</td>", "ID": "aa8fc9fa-cff7-427c-8f4d-9096b5f8a206", "Styles": "width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "197d729f-e076-49a1-8e21-ef5e45d139c1"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub> (day)</span></p>", "ID": "e1e81a6f-15e5-40de-9e44-dcd413d5944d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "aa8fc9fa-cff7-427c-8f4d-9096b5f8a206"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>max</sub> (day)</span>", "ID": "219716c7-c75c-47c2-ba67-fd920e924d7e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "T (day)", "ParentId": "e1e81a6f-15e5-40de-9e44-dcd413d5944d"}, {"Element": "<sub>max</sub>", "ID": "6ab92a4f-0432-43b4-9642-3cb9f7c5c81f", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "219716c7-c75c-47c2-ba67-fd920e924d7e"}, {"Element": "<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>", "ID": "c50d7f46-5aaf-4317-b6c5-c52b8ec1b848", "Styles": "width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "197d729f-e076-49a1-8e21-ef5e45d139c1"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>", "ID": "c708ac6b-a9fc-4024-8557-6fae77c80c2e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "c50d7f46-5aaf-4317-b6c5-c52b8ec1b848"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span>", "ID": "1d987d7d-a02b-46d0-996a-b14aaa2ce9e9", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Median [min;max], n", "ParentId": "c708ac6b-a9fc-4024-8557-6fae77c80c2e"}, {"Element": "<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.00 [5.78; 19.8], 35</span></p>\n</td>", "ID": "026bab2f-53ee-405a-8898-13959e4b86c0", "Styles": "width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "197d729f-e076-49a1-8e21-ef5e45d139c1"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.00 [5.78; 19.8], 35</span></p>", "ID": "18fa077a-275f-4dfe-b1fe-ee01aed47679", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "026bab2f-53ee-405a-8898-13959e4b86c0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">9.00 [5.78; 19.8], 35</span>", "ID": "7fbd8fc0-a69b-48bd-b7be-dcf690e6f20a", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "9.00 [5.78; 19.8], 35", "ParentId": "18fa077a-275f-4dfe-b1fe-ee01aed47679"}, {"Element": "<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">8.84 [3.04; 27.7], 65</span></p>\n</td>", "ID": "2e6fa6e3-735f-4a8c-a85f-24708da3cf96", "Styles": "width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "197d729f-e076-49a1-8e21-ef5e45d139c1"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">8.84 [3.04; 27.7], 65</span></p>", "ID": "42493ce2-7601-4682-babf-681a809ecd84", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "2e6fa6e3-735f-4a8c-a85f-24708da3cf96"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">8.84 [3.04; 27.7], 65</span>", "ID": "bde8096b-e0b3-4620-a484-8b511d5933ad", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "8.84 [3.04; 27.7], 65", "ParentId": "42493ce2-7601-4682-babf-681a809ecd84"}, {"Element": "<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61,200 (177.7), 40</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">67,000 (275.2), 56</span></p>\n</td>\n</tr>", "ID": "1542a0db-90df-47d4-a429-b9ea0362aa55", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "2a1a4778-cc6f-4f5a-85d6-595f5e944c14"}, {"Element": "<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>\n</td>", "ID": "cf756ecc-7abf-4787-a07b-3439fd342155", "Styles": "width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1542a0db-90df-47d4-a429-b9ea0362aa55"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span><span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span></p>", "ID": "be3c8eb2-79ae-45aa-8bbe-6899ae6a1e13", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "cf756ecc-7abf-4787-a07b-3439fd342155"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">AUC<sub>0\u201128d </sub>(copies/</span>", "ID": "cbd12cb4-2ea0-41ac-a77f-514cf5374a3f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "AUC(copies/", "ParentId": "be3c8eb2-79ae-45aa-8bbe-6899ae6a1e13"}, {"Element": "<sub>0\u201128d </sub>", "ID": "9886f345-8a88-419d-b6c9-374522788105", "Styles": "None", "Classes": "None", "Text": "0\u201128d ", "ParentId": "cbd12cb4-2ea0-41ac-a77f-514cf5374a3f"}, {"Element": "<span class=\"st1\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span></span>", "ID": "64e74367-61fb-479a-b48a-d1bd8c17ee84", "Styles": "None", "Classes": "['st1']", "Text": "", "ParentId": "be3c8eb2-79ae-45aa-8bbe-6899ae6a1e13"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:#545454\">\u03bc</span>", "ID": "5213d1d5-0104-40c6-97c7-1d4d5d6dd131", "Styles": "font-size:11.0pt;color:#545454", "Classes": "None", "Text": "\u03bc", "ParentId": "64e74367-61fb-479a-b48a-d1bd8c17ee84"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">g*day)</span>", "ID": "4863893b-5e0f-44fe-8b6c-d75625178309", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "g*day)", "ParentId": "be3c8eb2-79ae-45aa-8bbe-6899ae6a1e13"}, {"Element": "<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>", "ID": "9c57fe4d-6978-487a-8ec2-90eb1cdb9ad7", "Styles": "width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1542a0db-90df-47d4-a429-b9ea0362aa55"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>", "ID": "c26bb5a9-9671-430c-a05b-5659eb9152df", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "9c57fe4d-6978-487a-8ec2-90eb1cdb9ad7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span>", "ID": "d04fd807-792d-4fb3-abea-d40d0e8cb9e5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Geometric mean (CV%), n", "ParentId": "c26bb5a9-9671-430c-a05b-5659eb9152df"}, {"Element": "<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61,200 (177.7), 40</span></p>\n</td>", "ID": "5e310dcd-ef6c-4d1d-91fc-01e593b7093c", "Styles": "width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1542a0db-90df-47d4-a429-b9ea0362aa55"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61,200 (177.7), 40</span></p>", "ID": "396cdb2c-b36f-4753-8bd2-79ddc9b0f18b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "5e310dcd-ef6c-4d1d-91fc-01e593b7093c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">61,200 (177.7), 40</span>", "ID": "eb54041f-6681-45c3-b216-64f8633dcf64", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "61,200 (177.7), 40", "ParentId": "396cdb2c-b36f-4753-8bd2-79ddc9b0f18b"}, {"Element": "<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">67,000 (275.2), 56</span></p>\n</td>", "ID": "dc304246-fa3c-45a0-b1b2-c1ba83bf79ae", "Styles": "width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1542a0db-90df-47d4-a429-b9ea0362aa55"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">67,000 (275.2), 56</span></p>", "ID": "b7c8c01c-cd11-46cd-84f0-a7aefa7fe0e8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "dc304246-fa3c-45a0-b1b2-c1ba83bf79ae"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">67,000 (275.2), 56</span>", "ID": "6366ea9d-48f0-4c3b-a04b-ced3c38144a5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "67,000 (275.2), 56", "ParentId": "b7c8c01c-cd11-46cd-84f0-a7aefa7fe0e8"}, {"Element": "<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">129 (199.2), 33</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">14.7 (147.1), 44</span></p>\n</td>\n</tr>", "ID": "b69d6599-f72e-4aa8-b24e-693cd35bfd6b", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "2a1a4778-cc6f-4f5a-85d6-595f5e944c14"}, {"Element": "<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>\n</td>", "ID": "410f1e0d-a35e-4b99-8d64-841112d101d2", "Styles": "width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b69d6599-f72e-4aa8-b24e-693cd35bfd6b"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span></p>", "ID": "2ad21002-033d-46ce-9ac4-9e024c3632f4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "410f1e0d-a35e-4b99-8d64-841112d101d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>\u00bd</sub> (day)</span>", "ID": "a21d72d1-9773-44cb-abe4-b78b612d6a01", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "T (day)", "ParentId": "2ad21002-033d-46ce-9ac4-9e024c3632f4"}, {"Element": "<sub>\u00bd</sub>", "ID": "05054569-f64b-43f1-92b3-47fb6a5b18b0", "Styles": "None", "Classes": "None", "Text": "\u00bd", "ParentId": "a21d72d1-9773-44cb-abe4-b78b612d6a01"}, {"Element": "<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>\n</td>", "ID": "39563446-906b-4c06-ae07-2003bf8b8702", "Styles": "width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b69d6599-f72e-4aa8-b24e-693cd35bfd6b"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span></p>", "ID": "a133937f-8a5c-4a90-bbd4-7da5251b2e31", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "39563446-906b-4c06-ae07-2003bf8b8702"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Geometric mean (CV%), n</span>", "ID": "c8b633f9-eb9a-4cd4-b2a4-e60408b62bbd", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Geometric mean (CV%), n", "ParentId": "a133937f-8a5c-4a90-bbd4-7da5251b2e31"}, {"Element": "<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">129 (199.2), 33</span></p>\n</td>", "ID": "21ed4b03-2096-449c-bfa6-fd1937473171", "Styles": "width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b69d6599-f72e-4aa8-b24e-693cd35bfd6b"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">129 (199.2), 33</span></p>", "ID": "10c8dcbe-9abe-4ec5-b8fb-d1737e690307", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "21ed4b03-2096-449c-bfa6-fd1937473171"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">129 (199.2), 33</span>", "ID": "ae421d48-0758-401e-9c4e-41eb2e3c1314", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "129 (199.2), 33", "ParentId": "10c8dcbe-9abe-4ec5-b8fb-d1737e690307"}, {"Element": "<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">14.7 (147.1), 44</span></p>\n</td>", "ID": "8566b0f1-2dfc-4d3b-a52b-0df432e030f8", "Styles": "width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b69d6599-f72e-4aa8-b24e-693cd35bfd6b"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">14.7 (147.1), 44</span></p>", "ID": "53273295-77a1-470e-94c8-dd0e4b235634", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "8566b0f1-2dfc-4d3b-a52b-0df432e030f8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">14.7 (147.1), 44</span>", "ID": "c123ab3d-a97e-46f5-8b26-1b7a69df7857", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "14.7 (147.1), 44", "ParentId": "53273295-77a1-470e-94c8-dd0e4b235634"}, {"Element": "<tr>\n<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>\n<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>\n<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">551 [17.1; 1030], 43</span></p>\n</td>\n<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61.4 [19.8; 685], 56</span></p>\n</td>\n</tr>", "ID": "d6807cac-3122-427e-a170-0abbb04b515f", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "2a1a4778-cc6f-4f5a-85d6-595f5e944c14"}, {"Element": "<td style=\"width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"157\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>\n</td>", "ID": "95dcc883-11a3-4b02-91cb-79448d59d5bc", "Styles": "width:118.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d6807cac-3122-427e-a170-0abbb04b515f"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span></p>", "ID": "d0cfdf32-3f9d-47be-a727-2b6753feeef3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "95dcc883-11a3-4b02-91cb-79448d59d5bc"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">T<sub>last</sub></span>", "ID": "61109d1b-00ed-4b12-a437-1d8de70dc5c1", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "T", "ParentId": "d0cfdf32-3f9d-47be-a727-2b6753feeef3"}, {"Element": "<sub>last</sub>", "ID": "86d1b028-7bf5-44dc-b66c-d39a5eed0655", "Styles": "None", "Classes": "None", "Text": "last", "ParentId": "61109d1b-00ed-4b12-a437-1d8de70dc5c1"}, {"Element": "<td style=\"width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"147\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>\n</td>", "ID": "3c56b455-03e3-4be7-be55-70d95f13e6ed", "Styles": "width:110.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d6807cac-3122-427e-a170-0abbb04b515f"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span></p>", "ID": "ad874813-a145-48eb-8901-2720fd7a5909", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "3c56b455-03e3-4be7-be55-70d95f13e6ed"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Median [min;max], n</span>", "ID": "ba840f77-da87-497a-94a4-24f1fbc0454e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Median [min;max], n", "ParentId": "ad874813-a145-48eb-8901-2720fd7a5909"}, {"Element": "<td style=\"width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"152\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">551 [17.1; 1030], 43</span></p>\n</td>", "ID": "48661f2b-0331-42d2-a65c-e32a17e709d2", "Styles": "width:113.9pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d6807cac-3122-427e-a170-0abbb04b515f"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">551 [17.1; 1030], 43</span></p>", "ID": "0c6ce24f-89aa-4fde-bac6-e9a24cdf1805", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "48661f2b-0331-42d2-a65c-e32a17e709d2"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">551 [17.1; 1030], 43</span>", "ID": "843993c4-39ac-4bbd-93d3-fa596ee0fdb5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "551 [17.1; 1030], 43", "ParentId": "0c6ce24f-89aa-4fde-bac6-e9a24cdf1805"}, {"Element": "<td style=\"width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"163\">\n<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61.4 [19.8; 685], 56</span></p>\n</td>", "ID": "512fd1d6-988d-43b1-83d6-a16a9e53d074", "Styles": "width:122.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d6807cac-3122-427e-a170-0abbb04b515f"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">61.4 [19.8; 685], 56</span></p>", "ID": "863d432b-6d91-481a-9789-325c8249fbed", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "512fd1d6-988d-43b1-83d6-a16a9e53d074"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">61.4 [19.8; 685], 56</span>", "ID": "00a62914-6425-48f3-86f8-7f33c713f8f3", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "61.4 [19.8; 685], 56", "ParentId": "863d432b-6d91-481a-9789-325c8249fbed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "3ac4797a-f698-4630-9a3b-6393d809610e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u>Dis<span lang=\"EN-GB\">tribution</span></u></p>", "ID": "c534aba5-74e2-4e24-84dd-d2829bc86da0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u>Dis<span lang=\"EN-GB\">tribution</span></u>", "ID": "16c6af96-2e5c-4669-863b-d1ad01afb0db", "Styles": "None", "Classes": "None", "Text": "Dis", "ParentId": "c534aba5-74e2-4e24-84dd-d2829bc86da0"}, {"Element": "<span lang=\"EN-GB\">tribution</span>", "ID": "432d9821-7503-49ba-81bf-22a123409a54", "Styles": "None", "Classes": "None", "Text": "tribution", "ParentId": "16c6af96-2e5c-4669-863b-d1ad01afb0db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa64b200-e69b-4fc9-8a06-b49884660624", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7350e8e-5347-47dd-9bf6-326b7686e720", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa64b200-e69b-4fc9-8a06-b49884660624"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">In paediatric and young adult B\u2011cell ALL patients, tisagenlecleucel\nhas been shown to be present in the blood and bone marrow beyond 2\u00a0years. The\nblood to bone marrow partitioning of tisagenlecleucel in bone marrow was 47.2% of\nthat present in blood at day\u00a028 while at months\u00a03 and 6 it distributes\nat 68.3% and 69%, respectively (</span><span lang=\"EN-GB\">Studies\u00a0B2202 and\nB2205J)</span><span lang=\"EN-GB\">. </span><span lang=\"EN-GB\">T</span><span lang=\"EN-GB\">isagenlecleucel also traffics and persists in cerebrospinal fluid in\npaediatric and young adult B\u2011cell ALL patients (Study B2101J) for up to\n1\u00a0year.</span></p>", "ID": "66156f4f-c1ad-4369-95ed-d69e03b8a564", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In paediatric and young adult B\u2011cell ALL patients, tisagenlecleucel\nhas been shown to be present in the blood and bone marrow beyond 2\u00a0years. The\nblood to bone marrow partitioning of tisagenlecleucel in bone marrow was 47.2% of\nthat present in blood at day\u00a028 while at months\u00a03 and 6 it distributes\nat 68.3% and 69%, respectively (</span>", "ID": "a83e31f2-6eac-48c2-989e-bf6f9c43f08a", "Styles": "None", "Classes": "None", "Text": "In paediatric and young adult B\u2011cell ALL patients, tisagenlecleucel has been shown to be present in the blood and bone marrow beyond 2\u00a0years. The blood to bone marrow partitioning of tisagenlecleucel in bone marrow was 47.2% of that present in blood at day\u00a028 while at months\u00a03 and 6 it distributes at 68.3% and 69%, respectively (", "ParentId": "66156f4f-c1ad-4369-95ed-d69e03b8a564"}, {"Element": "<span lang=\"EN-GB\">Studies\u00a0B2202 and\nB2205J)</span>", "ID": "1402f98f-9e7b-4312-af7f-7fe19ea485c6", "Styles": "None", "Classes": "None", "Text": "Studies\u00a0B2202 and B2205J)", "ParentId": "66156f4f-c1ad-4369-95ed-d69e03b8a564"}, {"Element": "<span lang=\"EN-GB\">. </span>", "ID": "d2229b60-5e7f-4f1f-b405-f34da7f521ce", "Styles": "None", "Classes": "None", "Text": ". ", "ParentId": "66156f4f-c1ad-4369-95ed-d69e03b8a564"}, {"Element": "<span lang=\"EN-GB\">T</span>", "ID": "128dd8d7-b627-42e0-8098-a3d6239489f6", "Styles": "None", "Classes": "None", "Text": "T", "ParentId": "66156f4f-c1ad-4369-95ed-d69e03b8a564"}, {"Element": "<span lang=\"EN-GB\">isagenlecleucel also traffics and persists in cerebrospinal fluid in\npaediatric and young adult B\u2011cell ALL patients (Study B2101J) for up to\n1\u00a0year.</span>", "ID": "5bcabf0e-5624-47c3-9ce8-e4049ff8eb9d", "Styles": "None", "Classes": "None", "Text": "isagenlecleucel also traffics and persists in cerebrospinal fluid in paediatric and young adult B\u2011cell ALL patients (Study B2101J) for up to 1\u00a0year.", "ParentId": "66156f4f-c1ad-4369-95ed-d69e03b8a564"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "351a778f-d860-48af-8187-8e478448b61c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c1c68a0a-32f3-4336-9b56-3158dcf6a3cd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "351a778f-d860-48af-8187-8e478448b61c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">In adult DLBCL patients (Study C2201), tisagenlecleucel has been\ndetected for up to 3\u00a0years in peripheral blood and up to month\u00a09 in\nbone marrow for complete responder patients. The blood to bone marrow\npartitioning in bone marrow was nearly 70% of that present in blood at day\u00a028\nand 50% at month\u00a03 in both responder and non\u2011responder patients.</span></p>", "ID": "fb326d06-4278-4b33-b500-31d37f357266", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In adult DLBCL patients (Study C2201), tisagenlecleucel has been\ndetected for up to 3\u00a0years in peripheral blood and up to month\u00a09 in\nbone marrow for complete responder patients. The blood to bone marrow\npartitioning in bone marrow was nearly 70% of that present in blood at day\u00a028\nand 50% at month\u00a03 in both responder and non\u2011responder patients.</span>", "ID": "f3ed78e4-7964-4bc4-8189-86f1c26ad7fd", "Styles": "None", "Classes": "None", "Text": "In adult DLBCL patients (Study C2201), tisagenlecleucel has been detected for up to 3\u00a0years in peripheral blood and up to month\u00a09 in bone marrow for complete responder patients. The blood to bone marrow partitioning in bone marrow was nearly 70% of that present in blood at day\u00a028 and 50% at month\u00a03 in both responder and non\u2011responder patients.", "ParentId": "fb326d06-4278-4b33-b500-31d37f357266"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "22091ae1-c249-40be-adf2-00a811a00090", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c4d1eadc-d877-440f-91a5-e6aac625b00e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "22091ae1-c249-40be-adf2-00a811a00090"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>", "ID": "ea3e1939-c05f-45d6-8630-8d0870481bad", "Styles": "margin-right:-.1pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Elimination</span></u>", "ID": "99cc3f32-a445-4b80-8a4a-9a9504e86054", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea3e1939-c05f-45d6-8630-8d0870481bad"}, {"Element": "<span lang=\"EN-GB\">Elimination</span>", "ID": "4ad44794-502d-4ec3-b9ae-5d75fadda602", "Styles": "None", "Classes": "None", "Text": "Elimination", "ParentId": "99cc3f32-a445-4b80-8a4a-9a9504e86054"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5604e13a-8100-4256-a025-eda1d6fc4d07", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a54e4286-b340-4220-afe2-843827d095fc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5604e13a-8100-4256-a025-eda1d6fc4d07"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The elimination profile of Kymriah includes a bi\u2011exponential\ndecline in peripheral blood and bone marrow.</span></p>", "ID": "c921740f-c331-4211-ba4a-556c2cc4791c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The elimination profile of Kymriah includes a bi\u2011exponential\ndecline in peripheral blood and bone marrow.</span>", "ID": "f9847001-4c81-4b1b-99d8-a119a0f81b1f", "Styles": "None", "Classes": "None", "Text": "The elimination profile of Kymriah includes a bi\u2011exponential decline in peripheral blood and bone marrow.", "ParentId": "c921740f-c331-4211-ba4a-556c2cc4791c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a591235c-ae64-4f55-9a56-4207e311697a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "757fa858-4fc4-473f-ba62-32824c70e6fa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a591235c-ae64-4f55-9a56-4207e311697a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><u><span lang=\"EN-GB\">Linearity/non\u2011linearity</span></u></p>", "ID": "3c11c16e-305a-405f-a485-381443f47b0e", "Styles": "margin-right:-.1pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Linearity/non\u2011linearity</span></u>", "ID": "4a614491-b06c-4821-845f-89095f6ffd7c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3c11c16e-305a-405f-a485-381443f47b0e"}, {"Element": "<span lang=\"EN-GB\">Linearity/non\u2011linearity</span>", "ID": "b26a1e70-d3c6-494c-9fdd-61ca6fd62230", "Styles": "None", "Classes": "None", "Text": "Linearity/non\u2011linearity", "ParentId": "4a614491-b06c-4821-845f-89095f6ffd7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "05233014-a272-4bc3-a828-56b7c9f6c932", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "66faf701-e69c-49de-930b-bd19304dd86f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "05233014-a272-4bc3-a828-56b7c9f6c932"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">There is no apparent relationship between dose and AUC<sub>0\u201128d</sub>\nor C<sub>max</sub>.</span></p>", "ID": "52d655ea-f274-4a6b-8b71-49cc620c3855", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There is no apparent relationship between dose and AUC<sub>0\u201128d</sub>\nor C<sub>max</sub>.</span>", "ID": "d33fbc20-76a3-4a97-bba5-e12a390b8d00", "Styles": "None", "Classes": "None", "Text": "There is no apparent relationship between dose and AUC or C.", "ParentId": "52d655ea-f274-4a6b-8b71-49cc620c3855"}, {"Element": "<sub>0\u201128d</sub>", "ID": "347877c2-b95f-4026-bdd6-089aeb4e41b8", "Styles": "None", "Classes": "None", "Text": "0\u201128d", "ParentId": "d33fbc20-76a3-4a97-bba5-e12a390b8d00"}, {"Element": "<sub>max</sub>", "ID": "97dd0c0d-3753-4c1d-a88a-ac1e3b14f187", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "d33fbc20-76a3-4a97-bba5-e12a390b8d00"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60d1be69-fb3d-45d9-acc3-ec7620cd05d9", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "54bd3b89-609c-4130-b62d-eafb03d7b3a9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60d1be69-fb3d-45d9-acc3-ec7620cd05d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Special populations</span></u></p>", "ID": "8f43de81-5c4e-4ce0-8eff-3f650b139366", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Special populations</span></u>", "ID": "8a2d4283-d79a-4064-a1ba-6f7d01c1c53e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f43de81-5c4e-4ce0-8eff-3f650b139366"}, {"Element": "<span lang=\"EN-GB\">Special populations</span>", "ID": "41a22d08-3807-4417-8b07-0e0790067c53", "Styles": "None", "Classes": "None", "Text": "Special populations", "ParentId": "8a2d4283-d79a-4064-a1ba-6f7d01c1c53e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e19142b5-3421-4543-8e2e-26e9d26d2bbc", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e57b93bd-f362-4f09-a09b-4d64a298c309", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e19142b5-3421-4543-8e2e-26e9d26d2bbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Elderly</span></u></i></p>", "ID": "f87dabfe-ac09-41d9-aa47-1f9984b85a9f", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Elderly</span></u></i>", "ID": "e987b5f0-8c57-4676-b351-301ace8d1a8d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f87dabfe-ac09-41d9-aa47-1f9984b85a9f"}, {"Element": "<u><span lang=\"EN-GB\">Elderly</span></u>", "ID": "80824164-02e4-492d-b2e8-2af392ef4cce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e987b5f0-8c57-4676-b351-301ace8d1a8d"}, {"Element": "<span lang=\"EN-GB\">Elderly</span>", "ID": "9ec69827-c659-4829-a223-4bb9dbf22c1c", "Styles": "None", "Classes": "None", "Text": "Elderly", "ParentId": "80824164-02e4-492d-b2e8-2af392ef4cce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The scatter\nplots of cellular kinetic parameters versus age (22\u201176\u00a0years)\nrevealed no relevant relationship between cellular kinetic parameters (AUC<sub>0\u201128d</sub>\nand C<sub>max</sub>) with age.</span></p>", "ID": "26ec2da6-a0cc-434d-b0ac-e295139efb8d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The scatter\nplots of cellular kinetic parameters versus age (22\u201176\u00a0years)\nrevealed no relevant relationship between cellular kinetic parameters (AUC<sub>0\u201128d</sub>\nand C<sub>max</sub>) with age.</span>", "ID": "c96c147f-64c3-41f8-86a8-b918dbe18d34", "Styles": "None", "Classes": "None", "Text": "The scatter plots of cellular kinetic parameters versus age (22\u201176\u00a0years) revealed no relevant relationship between cellular kinetic parameters (AUC and C) with age.", "ParentId": "26ec2da6-a0cc-434d-b0ac-e295139efb8d"}, {"Element": "<sub>0\u201128d</sub>", "ID": "3912bce9-49e8-4761-a195-992a2090004f", "Styles": "None", "Classes": "None", "Text": "0\u201128d", "ParentId": "c96c147f-64c3-41f8-86a8-b918dbe18d34"}, {"Element": "<sub>max</sub>", "ID": "06f45045-7776-4fef-802f-9de035797b97", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "c96c147f-64c3-41f8-86a8-b918dbe18d34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ee07dcca-021d-4171-a000-a32792327572", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "acc59292-ad92-4d85-b089-eb1af6399dad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ee07dcca-021d-4171-a000-a32792327572"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Gender</span></u></i></p>", "ID": "dc196e0b-99f5-4f6d-8c64-59c12497cf11", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Gender</span></u></i>", "ID": "b237e916-3fa3-46a9-a6de-4f3bf81f2e77", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc196e0b-99f5-4f6d-8c64-59c12497cf11"}, {"Element": "<u><span lang=\"EN-GB\">Gender</span></u>", "ID": "fb8df008-1fee-4a58-bb3c-06d4f96fb2fd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b237e916-3fa3-46a9-a6de-4f3bf81f2e77"}, {"Element": "<span lang=\"EN-GB\">Gender</span>", "ID": "ab7d4517-275e-4b78-873a-36958ff8f943", "Styles": "None", "Classes": "None", "Text": "Gender", "ParentId": "fb8df008-1fee-4a58-bb3c-06d4f96fb2fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gender is not a significant characteristic influencing tisagenlecleucel\nexpansion in B\u2011cell ALL and DLBCL patients. In Study B2202, there were 43%\nfemale and 57% male patients and in Study C2201 38% female and 62% male\npatients who received Kymriah.</span></p>", "ID": "bd48136c-a492-418f-aee8-a77ea55c3750", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Gender is not a significant characteristic influencing tisagenlecleucel\nexpansion in B\u2011cell ALL and DLBCL patients. In Study B2202, there were 43%\nfemale and 57% male patients and in Study C2201 38% female and 62% male\npatients who received Kymriah.</span>", "ID": "850e6cd7-525c-4c36-bc5b-b9f63e400bc8", "Styles": "None", "Classes": "None", "Text": "Gender is not a significant characteristic influencing tisagenlecleucel expansion in B\u2011cell ALL and DLBCL patients. In Study B2202, there were 43% female and 57% male patients and in Study C2201 38% female and 62% male patients who received Kymriah.", "ParentId": "bd48136c-a492-418f-aee8-a77ea55c3750"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c833ed4d-f984-43fd-a2d9-d0786c1cb98a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a59d2607-bcba-428b-90db-9dfd55f09b34", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c833ed4d-f984-43fd-a2d9-d0786c1cb98a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Race/ethnicity</span></u></i></p>", "ID": "b4fe9f04-030a-4eb1-9037-c8cc8792c642", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Race/ethnicity</span></u></i>", "ID": "7e8df33b-4ee1-4d7e-967a-d2bea3fe532e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b4fe9f04-030a-4eb1-9037-c8cc8792c642"}, {"Element": "<u><span lang=\"EN-GB\">Race/ethnicity</span></u>", "ID": "43857726-1e32-44cb-8142-f2799ebb6fd3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7e8df33b-4ee1-4d7e-967a-d2bea3fe532e"}, {"Element": "<span lang=\"EN-GB\">Race/ethnicity</span>", "ID": "436c0c97-d7ac-45ce-bbef-6fdad2fe16c4", "Styles": "None", "Classes": "None", "Text": "Race/ethnicity", "ParentId": "43857726-1e32-44cb-8142-f2799ebb6fd3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is limited\nevidence that race/ethnicity impact the expansion of Kymriah in paediatric and\nyoung adult ALL and DLBCL patients. In Study B2202 there were 73.4% Caucasian, 12.7%\nAsian and 13.9% other ethnic patients. In Study C2201 there were 85% Caucasian,\n9% Asian, 4% Black or African American patients, and 3\u00a0patients (3%) of\nunknown race.</span></p>", "ID": "869c42f2-09de-4719-a100-d740b8a781ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There is limited\nevidence that race/ethnicity impact the expansion of Kymriah in paediatric and\nyoung adult ALL and DLBCL patients. In Study B2202 there were 73.4% Caucasian, 12.7%\nAsian and 13.9% other ethnic patients. In Study C2201 there were 85% Caucasian,\n9% Asian, 4% Black or African American patients, and 3\u00a0patients (3%) of\nunknown race.</span>", "ID": "7c244ae5-9988-4922-b99b-ad674a42d857", "Styles": "None", "Classes": "None", "Text": "There is limited evidence that race/ethnicity impact the expansion of Kymriah in paediatric and young adult ALL and DLBCL patients. In Study B2202 there were 73.4% Caucasian, 12.7% Asian and 13.9% other ethnic patients. In Study C2201 there were 85% Caucasian, 9% Asian, 4% Black or African American patients, and 3\u00a0patients (3%) of unknown race.", "ParentId": "869c42f2-09de-4719-a100-d740b8a781ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "36ca5b65-8edf-4570-a0cc-ed9d37465939", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fe6d0261-2fde-478c-827e-6753e521410a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "36ca5b65-8edf-4570-a0cc-ed9d37465939"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Body weight</span></u></i></p>", "ID": "a5e68655-2d6e-4539-a0ba-3485e75bbef4", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Body weight</span></u></i>", "ID": "8a5483a8-b707-4188-a2f4-cce393fafd23", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a5e68655-2d6e-4539-a0ba-3485e75bbef4"}, {"Element": "<u><span lang=\"EN-GB\">Body weight</span></u>", "ID": "3abfc8d1-539a-4d4a-bfcc-a16b1c51de7e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8a5483a8-b707-4188-a2f4-cce393fafd23"}, {"Element": "<span lang=\"EN-GB\">Body weight</span>", "ID": "66bd5b6f-e5a6-49fe-aa84-67b8ac4a784a", "Styles": "None", "Classes": "None", "Text": "Body weight", "ParentId": "3abfc8d1-539a-4d4a-bfcc-a16b1c51de7e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In ALL and DLBCL patients, across the weight ranges (ALL; 14.4 to\n137\u00a0kg; DLBCL: 38.4 to 186.7\u00a0kg), the scatter plots of qPCR cellular\nkinetic parameters versus weight revealed no apparent relationship between\ncellular kinetic parameters with weight.</span></p>", "ID": "a270012d-b689-49ac-9f77-ff49b3834416", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In ALL and DLBCL patients, across the weight ranges (ALL; 14.4 to\n137\u00a0kg; DLBCL: 38.4 to 186.7\u00a0kg), the scatter plots of qPCR cellular\nkinetic parameters versus weight revealed no apparent relationship between\ncellular kinetic parameters with weight.</span>", "ID": "54cc7a1e-3e84-4730-a895-e199c3ea998f", "Styles": "None", "Classes": "None", "Text": "In ALL and DLBCL patients, across the weight ranges (ALL; 14.4 to 137\u00a0kg; DLBCL: 38.4 to 186.7\u00a0kg), the scatter plots of qPCR cellular kinetic parameters versus weight revealed no apparent relationship between cellular kinetic parameters with weight.", "ParentId": "a270012d-b689-49ac-9f77-ff49b3834416"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0ea424cd-3987-43ec-bc23-7cdf01178592", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "83292a0c-d38e-4d8f-8119-98df9d41e30e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0ea424cd-3987-43ec-bc23-7cdf01178592"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Prior transplantation</span></u></i></p>", "ID": "70e85a1b-b8c3-4897-b758-0f4345a3b964", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><u><span lang=\"EN-GB\">Prior transplantation</span></u></i>", "ID": "ffdc1ece-502b-476b-b04c-875775dae774", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "70e85a1b-b8c3-4897-b758-0f4345a3b964"}, {"Element": "<u><span lang=\"EN-GB\">Prior transplantation</span></u>", "ID": "f166e5ee-031c-4420-bf70-081fd547b7fe", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ffdc1ece-502b-476b-b04c-875775dae774"}, {"Element": "<span lang=\"EN-GB\">Prior transplantation</span>", "ID": "02f5e7a3-cd2b-4a33-a058-e55bb3b4c6a3", "Styles": "None", "Classes": "None", "Text": "Prior transplantation", "ParentId": "f166e5ee-031c-4420-bf70-081fd547b7fe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Prior transplantation did not impact the expansion/persistence of Kymriah\nin paediatric and young adult B\u2011Cell ALL patients or DLBCL patients.</span></p>", "ID": "a854951c-e2cc-4e44-a280-7b682456e7c3", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Prior transplantation did not impact the expansion/persistence of Kymriah\nin paediatric and young adult B\u2011Cell ALL patients or DLBCL patients.</span>", "ID": "89ab5d76-e288-4d16-9579-911ad62d2d82", "Styles": "None", "Classes": "None", "Text": "Prior transplantation did not impact the expansion/persistence of Kymriah in paediatric and young adult B\u2011Cell ALL patients or DLBCL patients.", "ParentId": "a854951c-e2cc-4e44-a280-7b682456e7c3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c5e29730-35e7-487b-bf17-df22889b7d5a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e315165b-4ae4-4594-ba7b-947efb596d9e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c5e29730-35e7-487b-bf17-df22889b7d5a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety\ndata</span></b></p>", "ID": "4856b673-da57-443e-92e2-ffc7c3652d2c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety\ndata</span></b>", "ID": "de6ab552-e231-4200-92a4-5c8d0df38a28", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4856b673-da57-443e-92e2-ffc7c3652d2c"}, {"Element": "<span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety\ndata</span>", "ID": "42b607c2-38c4-48e9-9d10-3f2f6c29afb1", "Styles": "None", "Classes": "None", "Text": "5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data", "ParentId": "de6ab552-e231-4200-92a4-5c8d0df38a28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4c3b45c6-23f1-470e-99a9-d9e55f6ff3f2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "17f1c13d-ced0-4bec-9c9d-ee2fefedab47", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4c3b45c6-23f1-470e-99a9-d9e55f6ff3f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Non\u2011clinical\nsafety assessment of Kymriah addressed the safety concerns of potential\nuncontrolled cell growth of transduced T cells <i>in vitro</i> and <i>in vivo</i>\nas well as dose\u2011related toxicity, biodistribution and persistence. No\nsuch risks were identified based on these studies.</span></p>", "ID": "f2bb7dee-1bf4-41f0-9e0b-a7b7fa8a25db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Non\u2011clinical\nsafety assessment of Kymriah addressed the safety concerns of potential\nuncontrolled cell growth of transduced T cells <i>in vitro</i> and <i>in vivo</i>\nas well as dose\u2011related toxicity, biodistribution and persistence. No\nsuch risks were identified based on these studies.</span>", "ID": "306aae80-d90d-4c6d-baee-52e25552a2a7", "Styles": "None", "Classes": "None", "Text": "Non\u2011clinical safety assessment of Kymriah addressed the safety concerns of potential uncontrolled cell growth of transduced T cells  and  as well as dose\u2011related toxicity, biodistribution and persistence. No such risks were identified based on these studies.", "ParentId": "f2bb7dee-1bf4-41f0-9e0b-a7b7fa8a25db"}, {"Element": "<i>in vitro</i>", "ID": "b897f51e-fcbc-4aac-a00f-9f6abc87aca9", "Styles": "None", "Classes": "None", "Text": "in vitro", "ParentId": "306aae80-d90d-4c6d-baee-52e25552a2a7"}, {"Element": "<i>in vivo</i>", "ID": "ad6a020f-2698-4a6e-aed3-dd6cbc827d8a", "Styles": "None", "Classes": "None", "Text": "in vivo", "ParentId": "306aae80-d90d-4c6d-baee-52e25552a2a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "91f66017-0c04-4d17-aaea-97ffba769ba8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "194c8abb-663a-4af2-9d9a-31e1bd3a9e44", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "91f66017-0c04-4d17-aaea-97ffba769ba8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Carcinogenicity and mutagenicity</span></u></p>", "ID": "83cafc8b-6c6f-4c87-a02f-b87287a7c888", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Carcinogenicity and mutagenicity</span></u>", "ID": "9611e3cd-7e68-4f7d-8e9d-d00187e9a8e5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "83cafc8b-6c6f-4c87-a02f-b87287a7c888"}, {"Element": "<span lang=\"EN-GB\">Carcinogenicity and mutagenicity</span>", "ID": "18bacfe9-3570-4464-ac48-d3e71ede2c43", "Styles": "None", "Classes": "None", "Text": "Carcinogenicity and mutagenicity", "ParentId": "9611e3cd-7e68-4f7d-8e9d-d00187e9a8e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8d819072-2d66-44ad-95da-9bfa14d1ed50", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2dd51b4a-3969-473d-a8ac-5f45e2069fc3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8d819072-2d66-44ad-95da-9bfa14d1ed50"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Genotoxicity\nassays and carcinogenicity studies in rodents are not appropriate to assess the\nrisk of insertional mutagenesis for genetically\u2011modified cell therapy\nproducts. No alternative adequate animal models are available.</span></p>", "ID": "481edab0-db22-4f47-b3da-134b0d0d2883", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Genotoxicity\nassays and carcinogenicity studies in rodents are not appropriate to assess the\nrisk of insertional mutagenesis for genetically\u2011modified cell therapy\nproducts. No alternative adequate animal models are available.</span>", "ID": "449ac395-d96a-4e17-8514-26c69e809b2d", "Styles": "None", "Classes": "None", "Text": "Genotoxicity assays and carcinogenicity studies in rodents are not appropriate to assess the risk of insertional mutagenesis for genetically\u2011modified cell therapy products. No alternative adequate animal models are available.", "ParentId": "481edab0-db22-4f47-b3da-134b0d0d2883"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6faea9de-6851-436d-b8d8-67226fb733b7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ba0ee1bf-8cfe-4425-ae4f-11681eb75bf0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6faea9de-6851-436d-b8d8-67226fb733b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">In vitro</span></i><span lang=\"EN-GB\"> expansion studies with CAR\u2011positive T cells (Kymriah) from\nhealthy donors and patients showed no evidence for transformation and/or\nimmortalisation of T cells. <i>In vivo</i> studies in immunocompromised mice\ndid not show signs of abnormal cell growth or signs of clonal cell expansion\nfor up to 7\u00a0months, which represents the longest meaningful observation\nperiod for immunocompromised mouse models. A genomic insertion site analysis of\nthe lentiviral vector was performed on Kymriah products from 14\u00a0individual\ndonors (12\u00a0patients and 2\u00a0healthy volunteers). There was no evidence\nfor preferential </span><span lang=\"EN-GB\">integration near genes of concern or\npreferential outgrowth of cells harbouring integration sites of concern</span><span lang=\"EN-GB\">.</span></p>", "ID": "16eecbee-d8c0-4ffe-9aa9-21259e7d5c02", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<i><span lang=\"EN-GB\">In vitro</span></i>", "ID": "3df6dea1-deb2-4dca-afe6-0ae925a05c99", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16eecbee-d8c0-4ffe-9aa9-21259e7d5c02"}, {"Element": "<span lang=\"EN-GB\">In vitro</span>", "ID": "3f4660c2-1a09-40c7-bd2a-8a74daa824b9", "Styles": "None", "Classes": "None", "Text": "In vitro", "ParentId": "3df6dea1-deb2-4dca-afe6-0ae925a05c99"}, {"Element": "<span lang=\"EN-GB\"> expansion studies with CAR\u2011positive T cells (Kymriah) from\nhealthy donors and patients showed no evidence for transformation and/or\nimmortalisation of T cells. <i>In vivo</i> studies in immunocompromised mice\ndid not show signs of abnormal cell growth or signs of clonal cell expansion\nfor up to 7\u00a0months, which represents the longest meaningful observation\nperiod for immunocompromised mouse models. A genomic insertion site analysis of\nthe lentiviral vector was performed on Kymriah products from 14\u00a0individual\ndonors (12\u00a0patients and 2\u00a0healthy volunteers). There was no evidence\nfor preferential </span>", "ID": "54e59efb-05ea-4a5c-b369-8fae4232d1d4", "Styles": "None", "Classes": "None", "Text": " expansion studies with CAR\u2011positive T cells (Kymriah) from healthy donors and patients showed no evidence for transformation and/or immortalisation of T cells.  studies in immunocompromised mice did not show signs of abnormal cell growth or signs of clonal cell expansion for up to 7\u00a0months, which represents the longest meaningful observation period for immunocompromised mouse models. A genomic insertion site analysis of the lentiviral vector was performed on Kymriah products from 14\u00a0individual donors (12\u00a0patients and 2\u00a0healthy volunteers). There was no evidence for preferential ", "ParentId": "16eecbee-d8c0-4ffe-9aa9-21259e7d5c02"}, {"Element": "<i>In vivo</i>", "ID": "30a8a9f9-ce54-440c-b1d7-f8cfc0921d05", "Styles": "None", "Classes": "None", "Text": "In vivo", "ParentId": "54e59efb-05ea-4a5c-b369-8fae4232d1d4"}, {"Element": "<span lang=\"EN-GB\">integration near genes of concern or\npreferential outgrowth of cells harbouring integration sites of concern</span>", "ID": "94350ae7-62db-4b1a-a230-852641f2a4dc", "Styles": "None", "Classes": "None", "Text": "integration near genes of concern or preferential outgrowth of cells harbouring integration sites of concern", "ParentId": "16eecbee-d8c0-4ffe-9aa9-21259e7d5c02"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "ad31efdc-5d1c-4568-997f-ed0ddfdb8e29", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "16eecbee-d8c0-4ffe-9aa9-21259e7d5c02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bd758f08-3738-45db-a471-6cb70754a769", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6c4d5200-7bb3-454e-b3fc-16ac47442414", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd758f08-3738-45db-a471-6cb70754a769"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reproductive toxicity</span></u></p>", "ID": "84099bd4-2b86-4d22-93a0-6f4f3d199ad1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Reproductive toxicity</span></u>", "ID": "c9f743e2-343a-428b-8378-200930a35a73", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84099bd4-2b86-4d22-93a0-6f4f3d199ad1"}, {"Element": "<span lang=\"EN-GB\">Reproductive toxicity</span>", "ID": "24f57268-f6af-4eb9-afb9-f909b3d93da8", "Styles": "None", "Classes": "None", "Text": "Reproductive toxicity", "ParentId": "c9f743e2-343a-428b-8378-200930a35a73"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1b76d065-ea42-4d18-8867-cf68045b7c41", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6eb8bb9-2a28-4908-9524-e24a64de0206", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1b76d065-ea42-4d18-8867-cf68045b7c41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No non\u2011clinical\nreproductive safety studies were conducted as no adequate animal model is\navailable.</span></p>", "ID": "2a150261-93ff-4741-83e5-9df93bd9f5ff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">No non\u2011clinical\nreproductive safety studies were conducted as no adequate animal model is\navailable.</span>", "ID": "25b33c7c-7ccf-4a8d-ac1f-c36f3abcb317", "Styles": "None", "Classes": "None", "Text": "No non\u2011clinical reproductive safety studies were conducted as no adequate animal model is available.", "ParentId": "2a150261-93ff-4741-83e5-9df93bd9f5ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58165bbd-0172-47ce-9dc1-c13a2104abbc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1ed425cb-8500-4e8a-bf28-1d7b1e5a42e2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58165bbd-0172-47ce-9dc1-c13a2104abbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Juvenile animal studies</span></u></p>", "ID": "948eed34-e369-47e4-be99-3322096606c5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Juvenile animal studies</span></u>", "ID": "848511b5-ad1f-474a-b233-8397799201bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "948eed34-e369-47e4-be99-3322096606c5"}, {"Element": "<span lang=\"EN-GB\">Juvenile animal studies</span>", "ID": "1f3551c7-9f86-45c3-a880-d3c6e8712875", "Styles": "None", "Classes": "None", "Text": "Juvenile animal studies", "ParentId": "848511b5-ad1f-474a-b233-8397799201bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c793f52f-09b8-4dfa-92f9-5d7c90db7eed", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e52f912e-eb48-44ba-b5af-1388b49f9da5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c793f52f-09b8-4dfa-92f9-5d7c90db7eed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Juvenile\ntoxicity studies were not conducted.</span></p>", "ID": "50990fe6-7fd5-4747-9485-4819a70543a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Juvenile\ntoxicity studies were not conducted.</span>", "ID": "c41fce4b-cf15-4cc6-b7c1-20ea4a99a177", "Styles": "None", "Classes": "None", "Text": "Juvenile toxicity studies were not conducted.", "ParentId": "50990fe6-7fd5-4747-9485-4819a70543a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "79d68184-3309-40e2-b072-78d1352b32a6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e2ad8cb2-be54-47ac-93e0-dd5a47219964", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "79d68184-3309-40e2-b072-78d1352b32a6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6af51786-79fb-4261-b91e-3d67148f2190", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "57592f51-83b4-4f71-b2ac-fea0f17700c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6af51786-79fb-4261-b91e-3d67148f2190"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b></p>", "ID": "496a7581-2b41-437d-8111-b27be39c9edc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span></b>", "ID": "b75aa452-ebb7-451c-b885-0476c79f478a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "496a7581-2b41-437d-8111-b27be39c9edc"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nPARTICULARS</span>", "ID": "4d8e45d4-3d82-40ef-8b50-430795a33e51", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS", "ParentId": "b75aa452-ebb7-451c-b885-0476c79f478a"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f7c3eece-7fd0-478e-bb42-a6b490f8934f", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8af25cbd-85f2-49c2-bfa6-5f2746de9f59", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f7c3eece-7fd0-478e-bb42-a6b490f8934f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>", "ID": "ea1fd9dd-f42b-49eb-9333-db8e71c52870", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b>", "ID": "1b82c25a-3cc2-4491-8a49-74f397f7f9bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea1fd9dd-f42b-49eb-9333-db8e71c52870"}, {"Element": "<span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span>", "ID": "0d4f9582-2df0-4b7c-b7a8-f444bad9fd6c", "Styles": "None", "Classes": "None", "Text": "6.1\u00a0\u00a0\u00a0\u00a0 List of excipients", "ParentId": "1b82c25a-3cc2-4491-8a49-74f397f7f9bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3b8e62df-d2c4-43f0-baa8-b9653f94022f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8eb1bda1-74ae-4dec-ada0-461e4b851105", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3b8e62df-d2c4-43f0-baa8-b9653f94022f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Glucose</span></p>", "ID": "2200ea1d-ff24-412b-b441-da657645e6df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Glucose</span>", "ID": "639ee687-eb57-45ca-9fc5-35632833cfc8", "Styles": "None", "Classes": "None", "Text": "Glucose", "ParentId": "2200ea1d-ff24-412b-b441-da657645e6df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium chloride</span></p>", "ID": "be4cc016-f713-4b21-8640-a9ab46677a0e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Sodium chloride</span>", "ID": "3b0badae-d8df-41b1-a05a-1c0f8a26b99e", "Styles": "None", "Classes": "None", "Text": "Sodium chloride", "ParentId": "be4cc016-f713-4b21-8640-a9ab46677a0e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Human albumin\nsolution</span></p>", "ID": "8a49869d-9180-4fa2-b036-20c82df11c74", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Human albumin\nsolution</span>", "ID": "ebd283b1-0516-4048-887e-aaf6bdbda47e", "Styles": "None", "Classes": "None", "Text": "Human albumin solution", "ParentId": "8a49869d-9180-4fa2-b036-20c82df11c74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dextran 40 for\ninjection</span></p>", "ID": "48d700b4-ace1-411e-944f-43d64b9b7db3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Dextran 40 for\ninjection</span>", "ID": "381a794b-78c0-477f-a28f-467a7b1c52b1", "Styles": "None", "Classes": "None", "Text": "Dextran 40 for injection", "ParentId": "48d700b4-ace1-411e-944f-43d64b9b7db3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dimethylsulfoxide</span></p>", "ID": "3c00b036-d50a-4b87-ab2f-3222ce78521b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Dimethylsulfoxide</span>", "ID": "ad708e97-8135-42db-9a9f-17e3631a50fd", "Styles": "None", "Classes": "None", "Text": "Dimethylsulfoxide", "ParentId": "3c00b036-d50a-4b87-ab2f-3222ce78521b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium gluconate</span></p>", "ID": "dd34494e-f75e-4cea-bb49-b0c5646cd535", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Sodium gluconate</span>", "ID": "b5a21d43-86ed-4bde-80bb-026cab0897df", "Styles": "None", "Classes": "None", "Text": "Sodium gluconate", "ParentId": "dd34494e-f75e-4cea-bb49-b0c5646cd535"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium acetate</span></p>", "ID": "bcf65d21-b2a9-4384-807c-6c9a74cbda8b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Sodium acetate</span>", "ID": "d2b329e2-34e2-4818-b380-f1b9e0628b6c", "Styles": "None", "Classes": "None", "Text": "Sodium acetate", "ParentId": "bcf65d21-b2a9-4384-807c-6c9a74cbda8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Potassium\nchloride</span></p>", "ID": "484990ba-0fc2-4753-bec0-574ad5737dc2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Potassium\nchloride</span>", "ID": "beb40b1b-ab26-4d09-a0c7-7215dfdacbca", "Styles": "None", "Classes": "None", "Text": "Potassium chloride", "ParentId": "484990ba-0fc2-4753-bec0-574ad5737dc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Magnesium\nchloride</span></p>", "ID": "639b3166-ad15-4ecd-b63d-3cca5450baa9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Magnesium\nchloride</span>", "ID": "7fe853cb-a2ed-498b-9c61-2dd1ec93cd73", "Styles": "None", "Classes": "None", "Text": "Magnesium chloride", "ParentId": "639b3166-ad15-4ecd-b63d-3cca5450baa9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium\u2011N\u2011acetyltryptophanate</span></p>", "ID": "42e513ed-d290-41b7-aa9d-aa231c30b7a3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Sodium\u2011N\u2011acetyltryptophanate</span>", "ID": "335085e0-d520-4ee6-a61e-d88ce101d459", "Styles": "None", "Classes": "None", "Text": "Sodium\u2011N\u2011acetyltryptophanate", "ParentId": "42e513ed-d290-41b7-aa9d-aa231c30b7a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sodium caprylate</span></p>", "ID": "7ff06212-4791-48b5-9930-3b7715189717", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Sodium caprylate</span>", "ID": "8c8d620f-4ecd-4281-a38f-98421fe28837", "Styles": "None", "Classes": "None", "Text": "Sodium caprylate", "ParentId": "7ff06212-4791-48b5-9930-3b7715189717"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Aluminium</span></p>", "ID": "a532637b-55f9-4a62-bd31-3aea2faaa41a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Aluminium</span>", "ID": "daf3bc0c-a6af-44c4-b8b3-18b8f21b9876", "Styles": "None", "Classes": "None", "Text": "Aluminium", "ParentId": "a532637b-55f9-4a62-bd31-3aea2faaa41a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for\ninjections</span></p>", "ID": "191e4493-7aca-46e0-9266-0d67a81ce2d2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Water for\ninjections</span>", "ID": "bc758df7-16dc-4638-8fdc-a93f2b7db810", "Styles": "None", "Classes": "None", "Text": "Water for injections", "ParentId": "191e4493-7aca-46e0-9266-0d67a81ce2d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0748b6e1-a836-4c48-9c9b-8c30dc8142f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b69e1030-c824-47b3-a071-87198d86cea9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0748b6e1-a836-4c48-9c9b-8c30dc8142f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>", "ID": "6c456067-4657-4cff-9586-eb67da03baa2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b>", "ID": "db2d9821-f59c-4735-af7b-0bcccd8f5727", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6c456067-4657-4cff-9586-eb67da03baa2"}, {"Element": "<span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span>", "ID": "1deffdd3-180b-44fc-9e1d-596ac85b7bcc", "Styles": "None", "Classes": "None", "Text": "6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities", "ParentId": "db2d9821-f59c-4735-af7b-0bcccd8f5727"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "274104cb-7296-4472-a709-0c91db7d79dc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2e9dd048-637e-47cc-961a-a8fff1ca3dbc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "274104cb-7296-4472-a709-0c91db7d79dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the absence\nof compatibility studies, this medicinal product must not be mixed with other\nmedicinal products.</span></p>", "ID": "3249082c-2688-489d-87a7-2d8119a7f9aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In the absence\nof compatibility studies, this medicinal product must not be mixed with other\nmedicinal products.</span>", "ID": "f948542c-3560-492e-ba5a-dc59a30a7d7e", "Styles": "None", "Classes": "None", "Text": "In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.", "ParentId": "3249082c-2688-489d-87a7-2d8119a7f9aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4aa7fe22-7024-49ad-a596-82733ceb1c61", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "076ce35e-a237-404b-8d02-5b635dea00fa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4aa7fe22-7024-49ad-a596-82733ceb1c61"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>", "ID": "9e867a59-643f-4ddf-81f8-729fab65169d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b>", "ID": "3d919570-a467-40e0-96cd-fbeef0cb22dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e867a59-643f-4ddf-81f8-729fab65169d"}, {"Element": "<span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span>", "ID": "1afc145a-e476-43ef-9cf5-a984f06294d5", "Styles": "None", "Classes": "None", "Text": "6.3\u00a0\u00a0\u00a0\u00a0 Shelf life", "ParentId": "3d919570-a467-40e0-96cd-fbeef0cb22dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5210c2c7-5e08-4f8c-9ca1-3fc897fbec76", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f0c65865-9924-4e75-9aa9-5381b2f271a0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5210c2c7-5e08-4f8c-9ca1-3fc897fbec76"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">9\u00a0months.</span></p>", "ID": "62969e52-b9e9-4af7-b40a-43837bc18e34", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">9\u00a0months.</span>", "ID": "8895936d-aaca-4a21-9c14-8404edc866c7", "Styles": "None", "Classes": "None", "Text": "9\u00a0months.", "ParentId": "62969e52-b9e9-4af7-b40a-43837bc18e34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "178c60ec-3813-40ba-9b95-3cd5506caac9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "baf6de29-5287-460c-8c66-f6cbc31a1174", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "178c60ec-3813-40ba-9b95-3cd5506caac9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The product\nshould be administered immediately after thawing. After thawing, the product\nshould be kept at room temperature (20\u00b0C\u201125\u00b0C) and infused within 30\u00a0minutes\nto maintain maximum product viability, including any interruption during the infusion.</span></p>", "ID": "e207333c-8288-4f24-a756-b396aa5d8aca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The product\nshould be administered immediately after thawing. After thawing, the product\nshould be kept at room temperature (20\u00b0C\u201125\u00b0C) and infused within 30\u00a0minutes\nto maintain maximum product viability, including any interruption during the infusion.</span>", "ID": "fb04cb10-cbae-4717-b301-25a4c915154d", "Styles": "None", "Classes": "None", "Text": "The product should be administered immediately after thawing. After thawing, the product should be kept at room temperature (20\u00b0C\u201125\u00b0C) and infused within 30\u00a0minutes to maintain maximum product viability, including any interruption during the infusion.", "ParentId": "e207333c-8288-4f24-a756-b396aa5d8aca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e18589e2-8a1a-43c9-ad66-f76deebe03cb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d226adb-b008-4335-b163-c1951bb41c75", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e18589e2-8a1a-43c9-ad66-f76deebe03cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span></b></p>", "ID": "634a74de-b2b6-4cad-a5df-96c569279712", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span></b>", "ID": "c2ec219a-aa61-43fd-9fa9-ff1c187fbc46", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "634a74de-b2b6-4cad-a5df-96c569279712"}, {"Element": "<span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span>", "ID": "79f33463-d181-417f-b87d-828b2f0c27d3", "Styles": "None", "Classes": "None", "Text": "6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage", "ParentId": "c2ec219a-aa61-43fd-9fa9-ff1c187fbc46"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67c9f9a9-3982-42cf-9f80-c5778ff7f491", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "88d5dd25-9cac-425a-85be-3c08a0297a47", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67c9f9a9-3982-42cf-9f80-c5778ff7f491"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store and\ntransport below \u2011120\u00b0C, e.g. in a container for cryogenic storage (Dewar)\nin the vapour phase of liquid nitrogen.</span></p>", "ID": "6e99eb6b-1eda-461f-bf1a-46daad09668d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Store and\ntransport below \u2011120\u00b0C, e.g. in a container for cryogenic storage (Dewar)\nin the vapour phase of liquid nitrogen.</span>", "ID": "87f6ee3c-ab64-4949-920d-6c27fed579b3", "Styles": "None", "Classes": "None", "Text": "Store and transport below \u2011120\u00b0C, e.g. in a container for cryogenic storage (Dewar) in the vapour phase of liquid nitrogen.", "ParentId": "6e99eb6b-1eda-461f-bf1a-46daad09668d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6b90752d-a2ea-4cc9-93e1-b04245b53b60", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "273c907e-71a9-4635-a467-e5aeefcbfbe8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6b90752d-a2ea-4cc9-93e1-b04245b53b60"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in the\noriginal protective envelope (Tyvek) containing the cassette protecting the infusion\nbag.</span></p>", "ID": "4e8bd485-7708-4103-a124-ed08dfc954d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Store in the\noriginal protective envelope (Tyvek) containing the cassette protecting the infusion\nbag.</span>", "ID": "86af4c72-90c5-40d0-a900-bc62c2a8d6f4", "Styles": "None", "Classes": "None", "Text": "Store in the original protective envelope (Tyvek) containing the cassette protecting the infusion bag.", "ParentId": "4e8bd485-7708-4103-a124-ed08dfc954d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9fbfb4b4-5c5f-41f5-9241-1e54d50ab9e6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "400d0ea4-3924-41ad-a96a-a3a5aab10dbe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9fbfb4b4-5c5f-41f5-9241-1e54d50ab9e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage\nconditions after thawing of the medicinal product, see section\u00a06.3.</span></p>", "ID": "b72a33ed-cd12-455c-8728-1a1da4c2272f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">For storage\nconditions after thawing of the medicinal product, see section\u00a06.3.</span>", "ID": "9ef6255a-4d61-4430-9dcf-2b4f80778d20", "Styles": "None", "Classes": "None", "Text": "For storage conditions after thawing of the medicinal product, see section\u00a06.3.", "ParentId": "b72a33ed-cd12-455c-8728-1a1da4c2272f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c025808c-9224-4103-8ddd-26011ad502bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "84a1fb7f-5810-410a-9f58-7a59f984815e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c025808c-9224-4103-8ddd-26011ad502bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents\nof container and special equipment for use, administration or implantation</span></b></p>", "ID": "bfc77314-40c5-42f0-87d6-a79d81b55eb5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents\nof container and special equipment for use, administration or implantation</span></b>", "ID": "19e9c2a0-278d-495d-92ee-67682c32a839", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bfc77314-40c5-42f0-87d6-a79d81b55eb5"}, {"Element": "<span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents\nof container and special equipment for use, administration or implantation</span>", "ID": "360b2cb7-6d80-4c7a-8618-37e82f48419b", "Styles": "None", "Classes": "None", "Text": "6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container and special equipment for use, administration or implantation", "ParentId": "19e9c2a0-278d-495d-92ee-67682c32a839"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58fc7f47-d880-41ef-b896-d2376b68de54", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "649c2f58-bb14-434c-ab81-f06f03beb31d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58fc7f47-d880-41ef-b896-d2376b68de54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ethylene vinyl\nacetate (EVA) infusion bag with polyvinyl chloride (PVC) tubing and a luer\nspike interconnector closed by a luer\u2011lock cap containing either\n10\u201330\u00a0mL (50\u00a0mL bags) or 30\u201350\u00a0mL (250\u00a0mL bags) cell\ndispersion.</span></p>", "ID": "5728cb17-a2e7-4cb1-9d46-fb2783f77007", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Ethylene vinyl\nacetate (EVA) infusion bag with polyvinyl chloride (PVC) tubing and a luer\nspike interconnector closed by a luer\u2011lock cap containing either\n10\u201330\u00a0mL (50\u00a0mL bags) or 30\u201350\u00a0mL (250\u00a0mL bags) cell\ndispersion.</span>", "ID": "92a32a51-94e8-4314-b18d-5ddd30abe118", "Styles": "None", "Classes": "None", "Text": "Ethylene vinyl acetate (EVA) infusion bag with polyvinyl chloride (PVC) tubing and a luer spike interconnector closed by a luer\u2011lock cap containing either 10\u201330\u00a0mL (50\u00a0mL bags) or 30\u201350\u00a0mL (250\u00a0mL bags) cell dispersion.", "ParentId": "5728cb17-a2e7-4cb1-9d46-fb2783f77007"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "500e368c-eba9-4b32-a482-9614f397309c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f1fc1913-31f1-4338-a484-ae3b9c3b3577", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "500e368c-eba9-4b32-a482-9614f397309c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Each infusion bag is placed into\nan aluminum cassette, then put in a plastic overwrap bag with absorbent sheets\nand sealed in a protective envelope (Tyvek).</p>", "ID": "e9d598c5-d56d-4e0b-919f-3366cd5049d4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Each infusion bag is placed into an aluminum cassette, then put in a plastic overwrap bag with absorbent sheets and sealed in a protective envelope (Tyvek).", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "3e3061bf-e445-4c10-8fde-c98d94940b71", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">One individual treatment dose comprises\n1 or more infusion bags.</p>", "ID": "b6a3806f-0a6d-465d-81c0-b30e6a093092", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "One individual treatment dose comprises 1 or more infusion bags.", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f4adcb55-f152-49ea-8486-6c7d9fab4874", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0defacc4-62f4-4b9d-b80f-ffcc817c7fe1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f4adcb55-f152-49ea-8486-6c7d9fab4874"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b></a></p>", "ID": "d2cc6352-a082-4cf9-91d6-09f11318a4ac", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b></a>", "ID": "ce7df4ac-653c-4bb6-8eec-1efcacca20e1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d2cc6352-a082-4cf9-91d6-09f11318a4ac"}, {"Element": "<b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b>", "ID": "dcaba02d-6658-4d39-be89-c464b5cd618c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce7df4ac-653c-4bb6-8eec-1efcacca20e1"}, {"Element": "<span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span>", "ID": "5ee9f249-07c7-45ed-9bd5-9716316796be", "Styles": "None", "Classes": "None", "Text": "6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for disposal and other handling", "ParentId": "dcaba02d-6658-4d39-be89-c464b5cd618c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "41484487-a32b-4208-951d-944dbf8a6367", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ec0ad5e6-42f1-4791-ab2c-04363cdc0920", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "41484487-a32b-4208-951d-944dbf8a6367"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Inspection and thawing of the infusion bag(s)</span></u></p>", "ID": "2fb3d072-b25d-4e5a-95d7-541a87eeb762", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Inspection and thawing of the infusion bag(s)</span></u>", "ID": "70053c05-c9d0-4d38-9ea4-3865f29d28eb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2fb3d072-b25d-4e5a-95d7-541a87eeb762"}, {"Element": "<span lang=\"EN-GB\">Inspection and thawing of the infusion bag(s)</span>", "ID": "9c9ef970-adf6-4c99-9d82-6786601dc248", "Styles": "None", "Classes": "None", "Text": "Inspection and thawing of the infusion bag(s)", "ParentId": "70053c05-c9d0-4d38-9ea4-3865f29d28eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9812cb62-748d-45ab-80f9-b24764b78ee6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "46bb1bfd-daf3-4ff8-acd2-a0a58e472320", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9812cb62-748d-45ab-80f9-b24764b78ee6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not thaw the\nproduct until it is ready to be used.</span></p>", "ID": "97d8a0bc-01f4-45b1-8d3f-e999fb8b641b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Do not thaw the\nproduct until it is ready to be used.</span>", "ID": "c64d8818-5d80-406a-a71e-fd992c978267", "Styles": "None", "Classes": "None", "Text": "Do not thaw the product until it is ready to be used.", "ParentId": "97d8a0bc-01f4-45b1-8d3f-e999fb8b641b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f361ae88-1ffa-4271-ad9e-a92f1940af48", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3cba8c64-1c1c-4a67-9cf4-8a8e91a096e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f361ae88-1ffa-4271-ad9e-a92f1940af48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The infusion bag\nshould be placed inside a second sterile bag during thawing to protect ports\nfrom contamination and avoid spills in the unlikely event of the bag leaking. </span><span lang=\"EN-GB\">Kymriah should be thawed at 37\u00b0C using either a water bath or dry\nthaw method until there is no visible ice in the infusion bag. The bag should\nbe removed immediately from the thawing device and kept at room temperature (20\u00b0C\u201125\u00b0C)\nuntil infusion. If more than one infusion bag has been received for the\ntreatment dose, the next bag should only be thawed after the contents of the preceding\nbag have been infused.</span></p>", "ID": "1b20791a-3652-422a-b418-a916df0123fa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The infusion bag\nshould be placed inside a second sterile bag during thawing to protect ports\nfrom contamination and avoid spills in the unlikely event of the bag leaking. </span>", "ID": "ed0ec450-cf4c-42b4-928f-0056a34d7633", "Styles": "None", "Classes": "None", "Text": "The infusion bag should be placed inside a second sterile bag during thawing to protect ports from contamination and avoid spills in the unlikely event of the bag leaking. ", "ParentId": "1b20791a-3652-422a-b418-a916df0123fa"}, {"Element": "<span lang=\"EN-GB\">Kymriah should be thawed at 37\u00b0C using either a water bath or dry\nthaw method until there is no visible ice in the infusion bag. The bag should\nbe removed immediately from the thawing device and kept at room temperature (20\u00b0C\u201125\u00b0C)\nuntil infusion. If more than one infusion bag has been received for the\ntreatment dose, the next bag should only be thawed after the contents of the preceding\nbag have been infused.</span>", "ID": "a2640100-dc1c-4cc7-b09a-ea44d7d921f7", "Styles": "None", "Classes": "None", "Text": "Kymriah should be thawed at 37\u00b0C using either a water bath or dry thaw method until there is no visible ice in the infusion bag. The bag should be removed immediately from the thawing device and kept at room temperature (20\u00b0C\u201125\u00b0C) until infusion. If more than one infusion bag has been received for the treatment dose, the next bag should only be thawed after the contents of the preceding bag have been infused.", "ParentId": "1b20791a-3652-422a-b418-a916df0123fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bd95f3f0-05cc-413b-8808-1a5f9981cd28", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d10935c2-0452-4228-b54c-56e3001daee3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd95f3f0-05cc-413b-8808-1a5f9981cd28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah should <u>not</u>\nbe manipulated. For example, Kymriah should not be washed (spun down and\nresuspended in new media) prior to infusion.</span></p>", "ID": "474395d3-1108-4887-801b-c5e60b41ec4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah should <u>not</u>\nbe manipulated. For example, Kymriah should not be washed (spun down and\nresuspended in new media) prior to infusion.</span>", "ID": "ba422c0f-d3fd-4050-9937-0e5d3cde819f", "Styles": "None", "Classes": "None", "Text": "Kymriah should  be manipulated. For example, Kymriah should not be washed (spun down and resuspended in new media) prior to infusion.", "ParentId": "474395d3-1108-4887-801b-c5e60b41ec4e"}, {"Element": "<u>not</u>", "ID": "d78e8b2f-d622-4e83-ad87-e80a9979dd5d", "Styles": "None", "Classes": "None", "Text": "not", "ParentId": "ba422c0f-d3fd-4050-9937-0e5d3cde819f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "37b221f5-e389-46f9-b09e-2ce8170df6b7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a1b5f179-c4ae-4d20-99ff-f6fdb59b170c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "37b221f5-e389-46f9-b09e-2ce8170df6b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The infusion bag(s)\nshould be examined for any breaks or cracks prior to thawing. If the infusion bag\nappears to have been damaged or to be leaking, it should not be infused and\nshould be disposed of according to local procedures on handling of biological\nwaste (see section\u00a04.2.).</span></p>", "ID": "be447901-738b-4936-b542-f17ac5b7da2c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The infusion bag(s)\nshould be examined for any breaks or cracks prior to thawing. If the infusion bag\nappears to have been damaged or to be leaking, it should not be infused and\nshould be disposed of according to local procedures on handling of biological\nwaste (see section\u00a04.2.).</span>", "ID": "80b1561b-b559-48b5-8c21-762e260f583c", "Styles": "None", "Classes": "None", "Text": "The infusion bag(s) should be examined for any breaks or cracks prior to thawing. If the infusion bag appears to have been damaged or to be leaking, it should not be infused and should be disposed of according to local procedures on handling of biological waste (see section\u00a04.2.).", "ParentId": "be447901-738b-4936-b542-f17ac5b7da2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4a0bdfa7-acbc-4ad3-8b6d-18375bea3df2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "31036bba-be8e-4963-bceb-62cc8bb54ca7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4a0bdfa7-acbc-4ad3-8b6d-18375bea3df2"}, {"Element": "<p class=\"MsoHeader\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Precautions\nto be taken for transport and disposal of the medicinal product</span></u></p>", "ID": "50b9f03c-5418-49ec-b603-c0abea32638e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoHeader']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Precautions\nto be taken for transport and disposal of the medicinal product</span></u>", "ID": "55d05a39-06db-472c-9118-56ca869ce43b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "50b9f03c-5418-49ec-b603-c0abea32638e"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Precautions\nto be taken for transport and disposal of the medicinal product</span>", "ID": "2196b93c-c22a-427d-ad9a-f545ed9f8d7b", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Precautions to be taken for transport and disposal of the medicinal product", "ParentId": "55d05a39-06db-472c-9118-56ca869ce43b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7130c8d7-0e54-490f-bb5a-6690d021f880", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ef449ac1-4081-422c-91cc-6e80380476bd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7130c8d7-0e54-490f-bb5a-6690d021f880"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah should\nbe transported within the facility in closed, break\u2011proof, leak\u2011proof\ncontainers.</span></p>", "ID": "9c63bc86-967c-4c33-9acc-e6c2c4149d8b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah should\nbe transported within the facility in closed, break\u2011proof, leak\u2011proof\ncontainers.</span>", "ID": "2d830178-1034-45fc-8e33-c611959aacac", "Styles": "None", "Classes": "None", "Text": "Kymriah should be transported within the facility in closed, break\u2011proof, leak\u2011proof containers.", "ParentId": "9c63bc86-967c-4c33-9acc-e6c2c4149d8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "03f48243-ed2c-4f72-837d-1f181b9041e7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "33b84d40-3f40-4a60-9493-89b7a1b65537", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03f48243-ed2c-4f72-837d-1f181b9041e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah contains\ngenetically\u2011modified human blood cells. Local guidelines on handling of\nbiological waste should be followed for unused medicinal product or waste\nmaterial. All material that has been in contact with Kymriah (solid and liquid\nwaste) should be handled and disposed in accordance with local guidelines on\nhandling of biological waste.</span></p>", "ID": "6354b36a-69bb-46d5-9539-17435bafda10", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah contains\ngenetically\u2011modified human blood cells. Local guidelines on handling of\nbiological waste should be followed for unused medicinal product or waste\nmaterial. All material that has been in contact with Kymriah (solid and liquid\nwaste) should be handled and disposed in accordance with local guidelines on\nhandling of biological waste.</span>", "ID": "1612b64d-2814-4e94-a833-9165640f613f", "Styles": "None", "Classes": "None", "Text": "Kymriah contains genetically\u2011modified human blood cells. Local guidelines on handling of biological waste should be followed for unused medicinal product or waste material. All material that has been in contact with Kymriah (solid and liquid waste) should be handled and disposed in accordance with local guidelines on handling of biological waste.", "ParentId": "6354b36a-69bb-46d5-9539-17435bafda10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4b512d71-b2c7-4ed0-932d-37b515bbbe81", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8b24a2d1-93f1-469b-8ea3-a95be2009710", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4b512d71-b2c7-4ed0-932d-37b515bbbe81"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8c2bfc9c-bd70-46c1-8cd9-72d8c8a554f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1240063e-7461-4e44-919d-257353612916", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8c2bfc9c-bd70-46c1-8cd9-72d8c8a554f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "d2ec2245-c8f8-4634-82e1-253e4e577185", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "c7f2b689-2422-410f-a0cd-d67ca26af27d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d2ec2245-c8f8-4634-82e1-253e4e577185"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION HOLDER</span>", "ID": "1d5d6016-6b6e-432f-a0e7-3fc26deb7c25", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION HOLDER", "ParentId": "c7f2b689-2422-410f-a0cd-d67ca26af27d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "109607fc-b455-41f2-bc44-10e017c2f022", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3e8906b1-774c-404b-b7ab-f11200da4dd5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "109607fc-b455-41f2-bc44-10e017c2f022"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Novartis Europharm Limited</span></p>", "ID": "13543a51-efad-43e4-833b-5062b40ef8da", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Novartis Europharm Limited</span>", "ID": "30e23533-7cf6-4973-848c-da433fe6a26d", "Styles": "color:black", "Classes": "None", "Text": "Novartis Europharm Limited", "ParentId": "13543a51-efad-43e4-833b-5062b40ef8da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black\">Vista Building</span></p>", "ID": "c1db6f5d-c118-4d69-af01-f7299b690c1c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black\">Vista Building</span>", "ID": "cd438de3-4d93-4f2b-a14d-05c300d385d6", "Styles": "color:black", "Classes": "None", "Text": "Vista Building", "ParentId": "c1db6f5d-c118-4d69-af01-f7299b690c1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black\">Elm Park, Merrion Road</span></p>", "ID": "0e39ad7c-19e9-485d-a9b0-fc4900c9970e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black\">Elm Park, Merrion Road</span>", "ID": "7d2b9055-fadd-49bc-8db5-97f15df23868", "Styles": "color:black", "Classes": "None", "Text": "Elm Park, Merrion Road", "ParentId": "0e39ad7c-19e9-485d-a9b0-fc4900c9970e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black\">Dublin 4</span></p>", "ID": "d7073ec8-d292-47a9-bdfc-bc685c8448df", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black\">Dublin 4</span>", "ID": "8184e425-2c0d-4832-b226-43448e691e59", "Styles": "color:black", "Classes": "None", "Text": "Dublin 4", "ParentId": "d7073ec8-d292-47a9-bdfc-bc685c8448df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black\">Ireland</span></p>", "ID": "be82a5a3-fcfb-4d0f-ab42-5fd2e38c5864", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black\">Ireland</span>", "ID": "7cde0a9c-058b-404d-bcc0-8b8ba8aa192f", "Styles": "color:black", "Classes": "None", "Text": "Ireland", "ParentId": "be82a5a3-fcfb-4d0f-ab42-5fd2e38c5864"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "07675948-9ecd-4ca2-85b9-f6fecf3bfed1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "918c19b9-f292-41d3-b0a7-767f7be578bd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "07675948-9ecd-4ca2-85b9-f6fecf3bfed1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6e0ba723-fc6b-490a-ad7e-8bec5098db33", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f988e35b-3eb4-4fa7-9d89-5b9d75ced6d0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6e0ba723-fc6b-490a-ad7e-8bec5098db33"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>", "ID": "7d879e21-4ac7-4eab-bf84-253d6e0bcba6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b>", "ID": "ecacd2e5-0a2c-42aa-bd88-95cdcf168cc2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7d879e21-4ac7-4eab-bf84-253d6e0bcba6"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span>", "ID": "b9201132-7893-4db0-aab3-c6888db5d61a", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S)", "ParentId": "ecacd2e5-0a2c-42aa-bd88-95cdcf168cc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "96dad83b-594a-4929-8451-07944b29a57c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "775d8793-02fe-4f88-b27d-09a93015148f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "96dad83b-594a-4929-8451-07944b29a57c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/18/1297/001</span></p>", "ID": "977f9aca-6a7e-4754-96d2-8495e3816bee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">EU/1/18/1297/001</span>", "ID": "9d154375-422b-4f29-b8dc-da523bcf2937", "Styles": "None", "Classes": "None", "Text": "EU/1/18/1297/001", "ParentId": "977f9aca-6a7e-4754-96d2-8495e3816bee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3649c0e1-f487-4d4c-ae33-affac4915e1c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "19ac93ac-7ed4-4cef-8913-08713bdb2978", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3649c0e1-f487-4d4c-ae33-affac4915e1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ecd12d3c-f129-4896-9a28-0f81eb6b04cb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cecc4ac8-78a1-4db6-8d79-d2b7cf422b93", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ecd12d3c-f129-4896-9a28-0f81eb6b04cb"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>", "ID": "a8f4948e-2e46-421e-971e-bcc5d58cd847", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b>", "ID": "18984c62-45e2-4b00-a0a6-8f994d02e1df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a8f4948e-2e46-421e-971e-bcc5d58cd847"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span>", "ID": "99fc27c4-7c51-46a4-afec-5aa2aefb2ea9", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION", "ParentId": "18984c62-45e2-4b00-a0a6-8f994d02e1df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4ae4ce4c-629d-4c2f-8824-eaa66c40809b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "250b4c10-e85d-49c5-85ca-21a4b30f9359", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4ae4ce4c-629d-4c2f-8824-eaa66c40809b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">23 August 2018</span></p>", "ID": "1b08142d-cd16-486d-8788-089479670875", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">23 August 2018</span>", "ID": "c7da3152-db13-4a24-b5d4-f110acf5127b", "Styles": "None", "Classes": "None", "Text": "23 August 2018", "ParentId": "1b08142d-cd16-486d-8788-089479670875"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "074731da-54df-4354-ad99-cac710887c09", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f6a5d612-79e8-41d7-8152-c64ad6a7bdfd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "074731da-54df-4354-ad99-cac710887c09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3a8c194-eee5-4f71-a1da-86295c4f72f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e300b90-85b5-4bc0-b462-142b6a8d51c6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3a8c194-eee5-4f71-a1da-86295c4f72f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span></b></p>", "ID": "b566e6aa-5b9f-4def-879d-c8c878d31b0a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span></b>", "ID": "f33e4528-c8ae-44cf-b5a7-55363ea5e327", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b566e6aa-5b9f-4def-879d-c8c878d31b0a"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span>", "ID": "503b52a0-1900-4732-b3a7-6afc6d948861", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT", "ParentId": "f33e4528-c8ae-44cf-b5a7-55363ea5e327"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0505cc91-7094-4ace-b9ab-46ba7a819de8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "195002db-29af-455e-86ac-ee4ddd3ad72d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0505cc91-7094-4ace-b9ab-46ba7a819de8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4ce2c283-f726-4261-92e8-61000a7430e8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7567baa9-1b2f-42a9-914a-5056890a269e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4ce2c283-f726-4261-92e8-61000a7430e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency <a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span></p>", "ID": "237c2476-63d5-4525-b22b-49b774608d3c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency <a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span>", "ID": "cea07a67-e136-41d4-a2b2-b578f29c966b", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency ", "ParentId": "237c2476-63d5-4525-b22b-49b774608d3c"}, {"Element": "<a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a>", "ID": "0d8aa22d-a25e-41e2-b7e9-f3ea96019bf9", "Styles": "None", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "cea07a67-e136-41d4-a2b2-b578f29c966b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ddbf1635-482b-430b-b9ed-dfabc8029bc8", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ca2f6e96-78d6-43a6-993f-442c64ee85cd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ddbf1635-482b-430b-b9ed-dfabc8029bc8"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "0059721e-ace2-4708-8842-8c586e165afe", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "30070d76-a2bb-423a-857b-ec5b722fd5fc", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "0059721e-ace2-4708-8842-8c586e165afe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7dc206d1-f56a-4000-870a-ff4efe10a7d7", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b8329c8-ba4b-49ed-bf5d-75751b372f20", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7dc206d1-f56a-4000-870a-ff4efe10a7d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "729b7f45-f244-478a-8a51-56dcfb3786ed", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "deff357f-62de-4a05-b013-5c0c896cee83", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "729b7f45-f244-478a-8a51-56dcfb3786ed"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8bacf02c-bc86-4168-a708-c00aee77a92f", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "98aa154f-01f3-4c19-9d8e-b66ccf9ce3d1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8bacf02c-bc86-4168-a708-c00aee77a92f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bf6e1097-dfcd-4bae-8628-aa3ea66f0d83", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1e691f6c-ba73-4648-8bb6-99c1eb34cb66", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bf6e1097-dfcd-4bae-8628-aa3ea66f0d83"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fafc739f-e76c-4e5e-8c89-dbe05accfd2e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "054cd0f5-5da0-4f39-997d-d203c15ef9fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fafc739f-e76c-4e5e-8c89-dbe05accfd2e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2f398991-8af4-47c1-95b7-a33ec88eee5b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1b41f1d7-068a-4800-8738-938ef8f0ba19", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2f398991-8af4-47c1-95b7-a33ec88eee5b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2c954a3-73a3-4082-8707-8c0c87049c6f", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "68d5f7a7-3cb6-417a-8803-1a977e9b1258", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2c954a3-73a3-4082-8707-8c0c87049c6f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e12cf02f-d0da-42e8-9f8d-4fab74169795", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "358c4b67-cedd-4ea0-ab00-058e4a552fe9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e12cf02f-d0da-42e8-9f8d-4fab74169795"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3efc8f97-bea5-4169-aad5-5db3a7be47a7", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bdf18acf-42f6-4351-8f9b-8902c3dd8d36", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3efc8f97-bea5-4169-aad5-5db3a7be47a7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1855c951-2db1-40cd-bc2d-9b9166d51e85", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dc2e4289-aa94-454b-9944-3683f1eae5f4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1855c951-2db1-40cd-bc2d-9b9166d51e85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ac7630e4-3b30-4f2a-92c5-dc7e3de388e8", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dbb75326-207e-4c93-b6f7-949268924887", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ac7630e4-3b30-4f2a-92c5-dc7e3de388e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1014b977-4b79-4167-a9c4-7a1246273b70", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b738efdc-1719-44b0-844b-7f25f646279d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1014b977-4b79-4167-a9c4-7a1246273b70"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "31642595-f6ac-4697-b094-b6d487e80e14", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "af793622-566b-4ef3-befc-117aceb5594a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "31642595-f6ac-4697-b094-b6d487e80e14"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9526746d-6915-4d2f-bbe0-a912535d64b0", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b669c9c-a467-44b3-ba89-ac676d90c58d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9526746d-6915-4d2f-bbe0-a912535d64b0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4e2841d7-31bf-4d41-b120-f3f023651239", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cc7199fc-365f-4ebe-b4ae-c59ace2ba4b0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4e2841d7-31bf-4d41-b120-f3f023651239"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "11b08df7-8331-4d30-8138-8831bf8ff2b8", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6e89d0f4-73df-4044-b1d9-58018a8593d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11b08df7-8331-4d30-8138-8831bf8ff2b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c01ba51-5910-4099-9e7a-c89b583b7180", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "142fa6c0-a21d-4714-9cc9-caf17c60bd21", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c01ba51-5910-4099-9e7a-c89b583b7180"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bf953aef-2c39-4682-8b16-c4ecb39e9361", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "60188d54-3e55-486e-b197-c5545584c860", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bf953aef-2c39-4682-8b16-c4ecb39e9361"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3875b710-1f5b-4c0f-8078-c3305641478c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f516a668-7ff9-453a-b1b8-b486a35bcbbb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3875b710-1f5b-4c0f-8078-c3305641478c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e5e62cf1-62d0-41f3-b6d9-e270646e472a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a8936737-eb22-4586-9fa9-8f23ea2f5d35", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e5e62cf1-62d0-41f3-b6d9-e270646e472a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "82550333-cd87-42b9-ae36-2a39aa6af5fd", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8001ce1a-132a-4f72-82ed-57d791cfcd59", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "82550333-cd87-42b9-ae36-2a39aa6af5fd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba7d5e03-48f3-4202-8594-e832643a1faa", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6619bcc1-6d09-4b8d-a5fe-1c12e16c3ff5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba7d5e03-48f3-4202-8594-e832643a1faa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "89b99cef-e867-4d85-b307-28f494cc5b9d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2cf167fd-1ca8-411b-b151-2ebfbff3df0a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "89b99cef-e867-4d85-b307-28f494cc5b9d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"margin-right:-.1pt;text-align:center;\nline-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p>", "ID": "16992fa3-235d-4c9c-9a4e-7c633ce3c6a1", "Styles": "margin-right:-.1pt;text-align:center;\nline-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX II</span></b>", "ID": "7f1fcecc-1b7a-415c-8119-f9290bc4a77a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16992fa3-235d-4c9c-9a4e-7c633ce3c6a1"}, {"Element": "<span lang=\"EN-GB\">ANNEX II</span>", "ID": "3308b28d-1646-4452-80e6-f26e25b64219", "Styles": "None", "Classes": "None", "Text": "ANNEX II", "ParentId": "7f1fcecc-1b7a-415c-8119-f9290bc4a77a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "980a5945-c71f-4248-b411-f2583973e66c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b9a950aa-ad6f-4e6d-a9b5-83d09b6be1a1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "980a5945-c71f-4248-b411-f2583973e66c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE\nAND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span></b></p>", "ID": "cd394443-c3fe-4ae7-a15f-dfddf105133c", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE\nAND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span></b>", "ID": "6f214e84-1e4e-42bd-98ef-fd3ad35e02f0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd394443-c3fe-4ae7-a15f-dfddf105133c"}, {"Element": "<span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE\nAND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span>", "ID": "f3a877f8-5b59-4d62-b5a5-7053fb9042ef", "Styles": "None", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE", "ParentId": "6f214e84-1e4e-42bd-98ef-fd3ad35e02f0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aa357d9f-f433-4fce-aa78-dff82ec063b8", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2fa204be-a6a1-4bcf-85a3-6ebc360ee72f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa357d9f-f433-4fce-aa78-dff82ec063b8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY\nAND USE</span></b></p>", "ID": "e24fbc72-50af-4e02-8a15-c4b27df4bcd6", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY\nAND USE</span></b>", "ID": "4bd11f95-89c1-4ce6-aa1a-850c05471c89", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e24fbc72-50af-4e02-8a15-c4b27df4bcd6"}, {"Element": "<span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY\nAND USE</span>", "ID": "2a508d02-65ad-4af5-a4da-0b6330c2cef6", "Styles": "None", "Classes": "None", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "4bd11f95-89c1-4ce6-aa1a-850c05471c89"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5ca61118-a530-456e-bcca-d523964cbad7", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d2bca834-147e-4c81-bc85-912531d038ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5ca61118-a530-456e-bcca-d523964cbad7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span></b></p>", "ID": "6ef0b8b2-85a9-4c5e-9ce8-2e06d7d55f35", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span></b>", "ID": "ca7042b4-0ace-4da7-8417-c272e6466cb8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ef0b8b2-85a9-4c5e-9ce8-2e06d7d55f35"}, {"Element": "<span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span>", "ID": "a5deb2c0-de87-4362-bcbd-3ce4cd84a391", "Styles": "None", "Classes": "None", "Text": "C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION", "ParentId": "ca7042b4-0ace-4da7-8417-c272e6466cb8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a228002c-7e69-4f69-b9a7-5bc70cc49918", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0a45b81a-885a-4699-9b79-0c7ef091c27b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a228002c-7e69-4f69-b9a7-5bc70cc49918"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions\nor restrictions with regard to the safe and effective use of the medicinal\nproduct</span></span></b></p>", "ID": "94e334ae-324f-498f-a8ee-ca34f828b54e", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions\nor restrictions with regard to the safe and effective use of the medicinal\nproduct</span></span></b>", "ID": "9308c447-b0b0-4a88-9f63-b981e06a0e29", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "94e334ae-324f-498f-a8ee-ca34f828b54e"}, {"Element": "<span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions\nor restrictions with regard to the safe and effective use of the medicinal\nproduct</span></span>", "ID": "7d3f9c1c-d96f-48be-9c97-609d876972dc", "Styles": "None", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "9308c447-b0b0-4a88-9f63-b981e06a0e29"}, {"Element": "<span style=\"text-transform:uppercase\">conditions\nor restrictions with regard to the safe and effective use of the medicinal\nproduct</span>", "ID": "bed43fb4-6f33-4b50-9128-91866f6f81eb", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "conditions or restrictions with regard to the safe and effective use of the medicinal product", "ParentId": "7d3f9c1c-d96f-48be-9c97-609d876972dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a3e0fec3-713a-41b8-88cb-965aba54a128", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bb474729-7a16-4e03-9775-52f76e87afae", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a3e0fec3-713a-41b8-88cb-965aba54a128"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "a399aa13-2c12-474d-b469-8459ea21ec1f", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "7304610e-4fb6-48d2-bc1b-8c273701950b", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "a399aa13-2c12-474d-b469-8459ea21ec1f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE\nSUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span></b></p>", "ID": "c5f92ddb-8fdf-4046-802b-6afcd717bf0a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE\nSUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span></b>", "ID": "65c38ed3-7b9d-45db-896c-d28d3bf85fa6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c5f92ddb-8fdf-4046-802b-6afcd717bf0a"}, {"Element": "<span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE\nSUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE</span>", "ID": "9a33f1fc-19c2-459a-9d55-761572efa3e7", "Styles": "None", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE", "ParentId": "65c38ed3-7b9d-45db-896c-d28d3bf85fa6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0b0dbac7-7892-4514-ab09-48b1411df2d1", "Styles": "margin-right:70.8pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d6449a4-8de5-4b52-a007-3f9b6abd1974", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0b0dbac7-7892-4514-ab09-48b1411df2d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Name and\naddress of the manufacturers of the biological active substance</span></u></p>", "ID": "93acbcb7-a8b3-4b0b-b99b-d21943d2c215", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Name and\naddress of the manufacturers of the biological active substance</span></u>", "ID": "919eacdf-fb5f-4ceb-a3f8-9ee3ac29041c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "93acbcb7-a8b3-4b0b-b99b-d21943d2c215"}, {"Element": "<span lang=\"EN-GB\">Name and\naddress of the manufacturers of the biological active substance</span>", "ID": "d9ed9111-4175-42a5-b23a-684bb629c80b", "Styles": "None", "Classes": "None", "Text": "Name and address of the manufacturers of the biological active substance", "ParentId": "919eacdf-fb5f-4ceb-a3f8-9ee3ac29041c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c83d4af5-c17f-4df2-b78a-daf44d072ee0", "Styles": "margin-right:70.8pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "accd53a2-5999-42e3-9fab-507fcfce0967", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c83d4af5-c17f-4df2-b78a-daf44d072ee0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Fraunhofer\nInstitut f\u00fcr Zelltherapie und Immunologie</span></p>", "ID": "4693d84b-8fd4-4469-86d6-91d0b9bb2976", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">Fraunhofer\nInstitut f\u00fcr Zelltherapie und Immunologie</span>", "ID": "023563ed-23f9-408c-aed6-1575e7aca96d", "Styles": "None", "Classes": "None", "Text": "Fraunhofer Institut f\u00fcr Zelltherapie und Immunologie", "ParentId": "4693d84b-8fd4-4469-86d6-91d0b9bb2976"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Perlickstrasse 1</span></p>", "ID": "1b6dc4ec-55e8-488b-b2ea-b58d7cca1055", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">Perlickstrasse 1</span>", "ID": "c246e87f-bca4-435b-99e8-c615fc81bfa4", "Styles": "None", "Classes": "None", "Text": "Perlickstrasse 1", "ParentId": "1b6dc4ec-55e8-488b-b2ea-b58d7cca1055"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Hauptgeb\u00e4ude und\nErweiterungsbau 1</span></p>", "ID": "1d705352-2f5c-4483-85d3-c4d4bf0ddcf3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">Hauptgeb\u00e4ude und\nErweiterungsbau 1</span>", "ID": "84ff01d1-6fb3-4ab3-89f5-4ecd0adfa8c5", "Styles": "None", "Classes": "None", "Text": "Hauptgeb\u00e4ude und Erweiterungsbau 1", "ParentId": "1d705352-2f5c-4483-85d3-c4d4bf0ddcf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">D-04103 Leipzig</span></p>", "ID": "2dfe5b6c-e131-4359-9507-6a3796f7b840", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">D-04103 Leipzig</span>", "ID": "e31b6b54-0b89-4309-be03-7f02d06d98fb", "Styles": "None", "Classes": "None", "Text": "D-04103 Leipzig", "ParentId": "2dfe5b6c-e131-4359-9507-6a3796f7b840"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Germany</span></p>", "ID": "bd5d1d5e-cbcf-4425-8853-4757109ecf23", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Germany</span>", "ID": "75e1a64c-80ed-4706-8105-ddb6cbb269d6", "Styles": "None", "Classes": "None", "Text": "Germany", "ParentId": "bd5d1d5e-cbcf-4425-8853-4757109ecf23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34f6a20b-93bf-444b-ad5a-ed4debbe6751", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "467982e5-603f-49dd-b0dd-6eccbcc189a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34f6a20b-93bf-444b-ad5a-ed4debbe6751"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\nPharmaceutical Corporation</span></p>", "ID": "e0a8ef3f-fc47-4fed-bd45-8059bd2dde9d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Novartis\nPharmaceutical Corporation</span>", "ID": "d694005b-0373-453b-8e8d-2df4ab1cb0a4", "Styles": "None", "Classes": "None", "Text": "Novartis Pharmaceutical Corporation", "ParentId": "e0a8ef3f-fc47-4fed-bd45-8059bd2dde9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">220 East Hanover\nAvenue</span></p>", "ID": "1e732c11-f04d-480e-9677-bfe62f4848a3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">220 East Hanover\nAvenue</span>", "ID": "3da9f561-112f-4139-a75d-3e04a9035f79", "Styles": "None", "Classes": "None", "Text": "220 East Hanover Avenue", "ParentId": "1e732c11-f04d-480e-9677-bfe62f4848a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Morris Plains</span></p>", "ID": "9e565351-ffce-4292-b368-d332da9f6b55", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Morris Plains</span>", "ID": "b26a984e-5499-4b1c-8b22-f4beca218c66", "Styles": "None", "Classes": "None", "Text": "Morris Plains", "ParentId": "9e565351-ffce-4292-b368-d332da9f6b55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">New Jersey</span></p>", "ID": "73b99965-b8f1-4438-aa80-2ac8517d8a62", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">New Jersey</span>", "ID": "4e9f32bf-8c61-42aa-8893-d071813e10ba", "Styles": "None", "Classes": "None", "Text": "New Jersey", "ParentId": "73b99965-b8f1-4438-aa80-2ac8517d8a62"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NJ07950</span></p>", "ID": "1f276a13-603d-4fce-9b10-c694c08eaaf8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">NJ07950</span>", "ID": "75a54d7b-70c3-4030-ba10-82a552f2fc98", "Styles": "None", "Classes": "None", "Text": "NJ07950", "ParentId": "1f276a13-603d-4fce-9b10-c694c08eaaf8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">United States</span></p>", "ID": "45db6ad8-e2f9-45f2-b160-f419e3bd2695", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">United States</span>", "ID": "8854bdf0-9959-43d8-ad40-b4d665d0092c", "Styles": "None", "Classes": "None", "Text": "United States", "ParentId": "45db6ad8-e2f9-45f2-b160-f419e3bd2695"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "453b9fc9-05b8-43ff-8c13-6067acebae61", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8878b74c-f4ab-4903-9fa4-97b3edd47532", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "453b9fc9-05b8-43ff-8c13-6067acebae61"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis Pharma\nStein AG</span></p>", "ID": "653379d8-3d98-4d3b-aea8-98769164c604", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">Novartis Pharma\nStein AG</span>", "ID": "58d20fd6-82f4-432f-81b2-66f5f976e951", "Styles": "None", "Classes": "None", "Text": "Novartis Pharma Stein AG", "ParentId": "653379d8-3d98-4d3b-aea8-98769164c604"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis Technical\nOperations Schweiz</span></p>", "ID": "578adc0e-1d48-4372-800c-4106f9fdcf41", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">Novartis Technical\nOperations Schweiz</span>", "ID": "18ec250d-e1b0-4006-a970-ab825658fbbb", "Styles": "None", "Classes": "None", "Text": "Novartis Technical Operations Schweiz", "ParentId": "578adc0e-1d48-4372-800c-4106f9fdcf41"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Stein Cell and\nGene Therapy,</span></p>", "ID": "901707b7-16ed-4dfb-aa79-58a97cda8640", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">Stein Cell and\nGene Therapy,</span>", "ID": "ea6f0b93-348e-425f-9215-cf22accff127", "Styles": "None", "Classes": "None", "Text": "Stein Cell and Gene Therapy,", "ParentId": "901707b7-16ed-4dfb-aa79-58a97cda8640"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Schaffhauserstrasse</span></p>", "ID": "bfc76fdc-8b0b-4888-82d6-f23fc7839d32", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"DE-CH\">Schaffhauserstrasse</span>", "ID": "a9922c6c-0cb3-40f5-b9be-d5156ec36708", "Styles": "None", "Classes": "None", "Text": "Schaffhauserstrasse", "ParentId": "bfc76fdc-8b0b-4888-82d6-f23fc7839d32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">4332 Stein</span></p>", "ID": "274498f1-c9db-4db3-a137-dd8e4e9b4348", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">4332 Stein</span>", "ID": "bae910f5-7d56-4211-9764-8d587796e37a", "Styles": "None", "Classes": "None", "Text": "4332 Stein", "ParentId": "274498f1-c9db-4db3-a137-dd8e4e9b4348"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Switzerland</span></p>", "ID": "c96b0a09-016a-43c3-b5bc-c7f9a8f651bf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">Switzerland</span>", "ID": "b54f0002-d60d-4b61-a1a9-f09481aa0680", "Styles": "None", "Classes": "None", "Text": "Switzerland", "ParentId": "c96b0a09-016a-43c3-b5bc-c7f9a8f651bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>", "ID": "4327f810-c566-4213-84cb-d2e59d70955c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">\u00a0</span>", "ID": "53399ee6-e249-473e-9770-6d0287d615b8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4327f810-c566-4213-84cb-d2e59d70955c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">CELLFORCURE</span></p>", "ID": "66c29ffe-af31-40cf-b7ba-f76956d1f654", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">CELLFORCURE</span>", "ID": "93d3add3-3183-44c1-9394-673dc844dbbe", "Styles": "None", "Classes": "None", "Text": "CELLFORCURE", "ParentId": "66c29ffe-af31-40cf-b7ba-f76956d1f654"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">ZA de Courtab\u0153uf</span></p>", "ID": "cf00186c-afe9-4c8a-aec6-0cd22ad643bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">ZA de Courtab\u0153uf</span>", "ID": "19cfe9ac-442b-41d8-b1ba-cb794f77e484", "Styles": "None", "Classes": "None", "Text": "ZA de Courtab\u0153uf", "ParentId": "cf00186c-afe9-4c8a-aec6-0cd22ad643bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">11 avenue des\nTropiques</span></p>", "ID": "e9cd4a42-bc04-4212-acce-dcd754724177", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">11 avenue des\nTropiques</span>", "ID": "73a78ea0-a56b-4940-a022-28a00d28d9fc", "Styles": "None", "Classes": "None", "Text": "11 avenue des Tropiques", "ParentId": "e9cd4a42-bc04-4212-acce-dcd754724177"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">91940 Les Ulis</span></p>", "ID": "30b7de36-0e10-4a47-8795-ca470f4d37a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">91940 Les Ulis</span>", "ID": "a3c8f1ec-aaec-463a-91e5-24f2361b9187", "Styles": "None", "Classes": "None", "Text": "91940 Les Ulis", "ParentId": "30b7de36-0e10-4a47-8795-ca470f4d37a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">France</span></p>", "ID": "15a710ce-fa67-4c13-ba5f-afdd2e9afd80", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">France</span>", "ID": "ca7bf4d2-d887-48f5-bd99-f12088006e0d", "Styles": "None", "Classes": "None", "Text": "France", "ParentId": "15a710ce-fa67-4c13-ba5f-afdd2e9afd80"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>", "ID": "0d386b74-f319-434a-b983-441f537a83b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">\u00a0</span>", "ID": "145a3d6d-bd07-4083-bcbe-c649964e115e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d386b74-f319-434a-b983-441f537a83b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span></u></p>", "ID": "bb658ff0-cf9d-4703-9933-735930e2a1da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span></u>", "ID": "62c7de58-04a5-44e7-917f-3ed1b85d1d1f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bb658ff0-cf9d-4703-9933-735930e2a1da"}, {"Element": "<span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span>", "ID": "5b17f0fc-562f-47c4-b577-c260d748149e", "Styles": "None", "Classes": "None", "Text": "Name and address of the manufacturers responsible for batch release", "ParentId": "62c7de58-04a5-44e7-917f-3ed1b85d1d1f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ad069c87-f4e6-44c6-a921-ea1d4fc1e3f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3d59c45d-6411-4618-9564-df7b6acf111c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ad069c87-f4e6-44c6-a921-ea1d4fc1e3f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis Pharma\nGmbH</span></p>", "ID": "f7764fb1-eccd-498a-a02d-ab2be413f728", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">Novartis Pharma\nGmbH</span>", "ID": "28bff6be-8951-4383-97b4-bd429e72be9f", "Styles": "None", "Classes": "None", "Text": "Novartis Pharma GmbH", "ParentId": "f7764fb1-eccd-498a-a02d-ab2be413f728"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Roonstrasse 25</span></p>", "ID": "1a669c13-7fb0-4aa6-b865-9715b0f37a38", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">Roonstrasse 25</span>", "ID": "6358a7bc-d732-4331-9d3f-a7d6a39c6a4d", "Styles": "None", "Classes": "None", "Text": "Roonstrasse 25", "ParentId": "1a669c13-7fb0-4aa6-b865-9715b0f37a38"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">D-90429\nNuremberg</span></p>", "ID": "f280638c-87af-4a34-897b-1b495a2f4899", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">D-90429\nNuremberg</span>", "ID": "7b018236-1599-4f1b-8d6c-350068b79fef", "Styles": "None", "Classes": "None", "Text": "D-90429 Nuremberg", "ParentId": "f280638c-87af-4a34-897b-1b495a2f4899"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Germany</span></p>", "ID": "5c98033d-6a25-446f-8d49-7531e801f022", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">Germany</span>", "ID": "edc29d5a-3bd7-4856-909c-1d4c07f17226", "Styles": "None", "Classes": "None", "Text": "Germany", "ParentId": "5c98033d-6a25-446f-8d49-7531e801f022"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>", "ID": "738733f0-67bf-4949-9094-d1ce71ce839a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">\u00a0</span>", "ID": "5f56dee0-e026-421d-8a94-92e27514a588", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "738733f0-67bf-4949-9094-d1ce71ce839a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">CELLFORCURE</span></p>", "ID": "96ee0075-15b6-4082-827c-4a7889962275", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">CELLFORCURE</span>", "ID": "aad735e4-f4ee-443d-94ab-9d89c3f16177", "Styles": "None", "Classes": "None", "Text": "CELLFORCURE", "ParentId": "96ee0075-15b6-4082-827c-4a7889962275"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">ZA de Courtab\u0153uf</span></p>", "ID": "2229f61f-c1fb-4b2f-b078-a39b9708c2af", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">ZA de Courtab\u0153uf</span>", "ID": "f86d7e5e-3b67-4a26-b9af-48bbbb8390b3", "Styles": "None", "Classes": "None", "Text": "ZA de Courtab\u0153uf", "ParentId": "2229f61f-c1fb-4b2f-b078-a39b9708c2af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">11 avenue des\nTropiques</span></p>", "ID": "9eb9d713-4af4-4e32-85ba-a84678a8514e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">11 avenue des\nTropiques</span>", "ID": "94b377ef-9680-4503-adec-d984af281345", "Styles": "None", "Classes": "None", "Text": "11 avenue des Tropiques", "ParentId": "9eb9d713-4af4-4e32-85ba-a84678a8514e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">91940 Les Ulis</span></p>", "ID": "37ff2cc2-4e56-43ed-9647-77b380b74798", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR\">91940 Les Ulis</span>", "ID": "18fd2e23-50f7-4db3-b979-6c2e90bc820f", "Styles": "None", "Classes": "None", "Text": "91940 Les Ulis", "ParentId": "37ff2cc2-4e56-43ed-9647-77b380b74798"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">France</span></p>", "ID": "371de302-4b3c-4e68-8255-da6f3f3019ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR\">France</span>", "ID": "fef5810a-8a65-41c8-b0f4-69e5752074ce", "Styles": "None", "Classes": "None", "Text": "France", "ParentId": "371de302-4b3c-4e68-8255-da6f3f3019ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">\u00a0</span></p>", "ID": "6795fd3f-1a34-403f-a8e1-2a2edfe59abe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR\">\u00a0</span>", "ID": "ed19a2c9-9314-43fe-b8d1-382e2ff682e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6795fd3f-1a34-403f-a8e1-2a2edfe59abe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The printed\npackage leaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span></p>", "ID": "d5420eb3-219f-4a95-96c6-bf9ea51e8832", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The printed\npackage leaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span>", "ID": "550b1c5b-6bc5-4075-acb1-e0a29a74f945", "Styles": "None", "Classes": "None", "Text": "The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.", "ParentId": "d5420eb3-219f-4a95-96c6-bf9ea51e8832"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a7ff8968-25ea-42ef-a4b8-7328381314f5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "69378143-b11d-48e5-b920-2b77ddd0c733", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a7ff8968-25ea-42ef-a4b8-7328381314f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "dece4113-c1a1-449d-baf6-84e96907d64e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\">B.</span></b></a><b><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>", "ID": "6e486cf5-0059-44d4-bd9e-62a9d6a3f23d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\">B.</span></b></a>", "ID": "156699a9-0f19-4daf-a244-5eaf62348206", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6e486cf5-0059-44d4-bd9e-62a9d6a3f23d"}, {"Element": "<b><span lang=\"EN-GB\">B.</span></b>", "ID": "7ff0d095-63bc-41d8-bf8b-501e6278949e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "156699a9-0f19-4daf-a244-5eaf62348206"}, {"Element": "<span lang=\"EN-GB\">B.</span>", "ID": "4de77127-f71c-446d-b784-a50816c05b35", "Styles": "None", "Classes": "None", "Text": "B.", "ParentId": "7ff0d095-63bc-41d8-bf8b-501e6278949e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b>", "ID": "e1abcd80-b790-4b18-8605-9c80417d15f7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6e486cf5-0059-44d4-bd9e-62a9d6a3f23d"}, {"Element": "<span lang=\"EN-GB\">\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span>", "ID": "a3db3607-765e-4b58-a3b0-8c7a9acea1b1", "Styles": "None", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "e1abcd80-b790-4b18-8605-9c80417d15f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42b89ec2-adc3-4d2b-ad86-0f772ec16768", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e548705a-dcb9-4344-9dd1-9e002af4c19e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42b89ec2-adc3-4d2b-ad86-0f772ec16768"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex I: Summary of\nProduct Characteristics, section\u00a04.2).</span></p>", "ID": "322b9c73-51ee-40ff-aaef-1494c948eef3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex I: Summary of\nProduct Characteristics, section\u00a04.2).</span>", "ID": "c82d1d15-6770-4c76-91d9-6de23bbbfca7", "Styles": "None", "Classes": "None", "Text": "Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section\u00a04.2).", "ParentId": "322b9c73-51ee-40ff-aaef-1494c948eef3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "659e8f65-c67f-42df-a56f-a2e3030aef23", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d46e644e-6f88-4b04-bf10-b530c7db3923", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "659e8f65-c67f-42df-a56f-a2e3030aef23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e750488d-2e30-4b0b-809a-c18c427fea32", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0adb1afb-1023-44de-aa9d-1e560851b949", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e750488d-2e30-4b0b-809a-c18c427fea32"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span></b></p>", "ID": "f21c5ef2-a27e-4f22-9526-9a9964791fc9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span></b>", "ID": "964123f7-a8a9-4779-b904-fc09172cedd9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f21c5ef2-a27e-4f22-9526-9a9964791fc9"}, {"Element": "<span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE\nMARKETING AUTHORISATION</span>", "ID": "0aecd42c-5ce1-4bc3-8b6d-1c64508e70d8", "Styles": "None", "Classes": "None", "Text": "C.\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION", "ParentId": "964123f7-a8a9-4779-b904-fc09172cedd9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "02933fde-4d59-42b4-85d6-455712501b1e", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c6dcb42c-2a0a-4444-a8d5-dbc82e0a86f6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "02933fde-4d59-42b4-85d6-455712501b1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b></p>", "ID": "1dd4040c-56f4-4cf1-a7c4-59c0a16dba26", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "44177a7a-5096-4195-ba7a-5353f1ce33d8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "1dd4040c-56f4-4cf1-a7c4-59c0a16dba26"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "034db534-d1c4-449c-a02d-52516028bc45", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "44177a7a-5096-4195-ba7a-5353f1ce33d8"}, {"Element": "<b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b>", "ID": "14a5267c-d37c-463d-aa71-0bfbc71a461c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1dd4040c-56f4-4cf1-a7c4-59c0a16dba26"}, {"Element": "<span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span>", "ID": "0b7b9f48-5d94-4512-8e66-cffa412b1916", "Styles": "None", "Classes": "None", "Text": "Periodic safety update reports (PSURs)", "ParentId": "14a5267c-d37c-463d-aa71-0bfbc71a461c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "50da3815-a599-42b5-928d-fb3ca9937b5b", "Styles": "margin-right:28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b75f43e7-8453-4e09-94af-eba7d03e2b88", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50da3815-a599-42b5-928d-fb3ca9937b5b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The requirements for submission of </span><span lang=\"EN-GB\">PSURs</span><span lang=\"EN-GB\"> for this medicinal product are set out in the list of Union\nreference dates (EURD list) </span><span lang=\"EN-GB\">provided for under Article\n107c(7) of Directive 2001/83</span><span lang=\"EN-GB\">/EC</span><span lang=\"EN-GB\">\nand </span><span lang=\"EN-GB\">any subsequent updates published on the European\nmedicines web-portal.</span></p>", "ID": "f6e204e9-25f4-4e43-925e-cea03d962bd9", "Styles": "margin-right:28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The requirements for submission of </span>", "ID": "873b1403-54ae-4558-b2e4-ed5b1885e3f1", "Styles": "None", "Classes": "None", "Text": "The requirements for submission of ", "ParentId": "f6e204e9-25f4-4e43-925e-cea03d962bd9"}, {"Element": "<span lang=\"EN-GB\">PSURs</span>", "ID": "7475b862-02d7-4eb5-a5f5-99fdd6fb4816", "Styles": "None", "Classes": "None", "Text": "PSURs", "ParentId": "f6e204e9-25f4-4e43-925e-cea03d962bd9"}, {"Element": "<span lang=\"EN-GB\"> for this medicinal product are set out in the list of Union\nreference dates (EURD list) </span>", "ID": "c0e620d3-f687-4c8f-adeb-37f79eeb2ae5", "Styles": "None", "Classes": "None", "Text": " for this medicinal product are set out in the list of Union reference dates (EURD list) ", "ParentId": "f6e204e9-25f4-4e43-925e-cea03d962bd9"}, {"Element": "<span lang=\"EN-GB\">provided for under Article\n107c(7) of Directive 2001/83</span>", "ID": "3082231e-4014-41f0-9feb-ca9b2db0ea5d", "Styles": "None", "Classes": "None", "Text": "provided for under Article 107c(7) of Directive 2001/83", "ParentId": "f6e204e9-25f4-4e43-925e-cea03d962bd9"}, {"Element": "<span lang=\"EN-GB\">/EC</span>", "ID": "0a8935fa-72c1-4fef-a9af-5cec743ba84a", "Styles": "None", "Classes": "None", "Text": "/EC", "ParentId": "f6e204e9-25f4-4e43-925e-cea03d962bd9"}, {"Element": "<span lang=\"EN-GB\">\nand </span>", "ID": "9864e467-2240-4b04-aec9-a8abb48cc7db", "Styles": "None", "Classes": "None", "Text": " and ", "ParentId": "f6e204e9-25f4-4e43-925e-cea03d962bd9"}, {"Element": "<span lang=\"EN-GB\">any subsequent updates published on the European\nmedicines web-portal.</span>", "ID": "a6345d47-e524-4324-a5fa-a4a5d46bf06e", "Styles": "None", "Classes": "None", "Text": "any subsequent updates published on the European medicines web-portal.", "ParentId": "f6e204e9-25f4-4e43-925e-cea03d962bd9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eb49dcfa-cb70-4eaa-87f0-babfb418a21f", "Styles": "margin-right:28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "67b61ac4-457c-43e4-88d9-d126222c416a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eb49dcfa-cb70-4eaa-87f0-babfb418a21f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\nauthorisation holder (MAH) shall submit the first PSUR for this product within\n6\u00a0months following authorisation.</span></p>", "ID": "31cd037c-786f-4d1d-8252-54df0acf8970", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The marketing\nauthorisation holder (MAH) shall submit the first PSUR for this product within\n6\u00a0months following authorisation.</span>", "ID": "c6e41067-ebcf-4e18-a53c-15108d81e62e", "Styles": "None", "Classes": "None", "Text": "The marketing authorisation holder (MAH) shall submit the first PSUR for this product within 6\u00a0months following authorisation.", "ParentId": "31cd037c-786f-4d1d-8252-54df0acf8970"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fcd52661-75c2-443b-8cbe-7a9c16bb80fe", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2e0283af-96e3-41fe-9369-612b1e1bdab1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fcd52661-75c2-443b-8cbe-7a9c16bb80fe"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "28084d5b-2415-44b4-88e1-5cfff9669b2f", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a580c1a8-0fce-4855-bc57-c8df0a2e4745", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "28084d5b-2415-44b4-88e1-5cfff9669b2f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "7e0ef6fe-4201-4071-9a49-31ccd5097e69", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b>", "ID": "cad9cb40-c1ba-4260-b069-7a89fc68c02b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7e0ef6fe-4201-4071-9a49-31ccd5097e69"}, {"Element": "<span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR\nRESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span>", "ID": "2c6bf75f-6e7d-4ef3-b915-5b7c5fa3b3b1", "Styles": "None", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT", "ParentId": "cad9cb40-c1ba-4260-b069-7a89fc68c02b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "977f2319-2e8f-4f71-8ea0-8cc56fb84e65", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1b9bfc3e-6f32-4a0c-9c91-6fac1286ee69", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "977f2319-2e8f-4f71-8ea0-8cc56fb84e65"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b></p>", "ID": "953ae617-fcfb-48ff-b303-b1dcb16f5046", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d80037a5-d695-4e4d-a8bc-ce33a8d2c64b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "953ae617-fcfb-48ff-b303-b1dcb16f5046"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "20f6700f-d50b-41e9-b7c2-4f53552d12b6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d80037a5-d695-4e4d-a8bc-ce33a8d2c64b"}, {"Element": "<b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b>", "ID": "a80f0e70-5010-4a14-842f-168c7d1f42f5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "953ae617-fcfb-48ff-b303-b1dcb16f5046"}, {"Element": "<span lang=\"EN-GB\">Risk management plan (RMP)</span>", "ID": "5d795b78-07eb-4c86-90ea-bb5c1cf80628", "Styles": "None", "Classes": "None", "Text": "Risk management plan (RMP)", "ParentId": "a80f0e70-5010-4a14-842f-168c7d1f42f5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3494b6a-4772-4914-a254-d6eb4a125ece", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bef2a83f-0f2c-4ace-8c04-a687df12a294", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3494b6a-4772-4914-a254-d6eb4a125ece"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The marketing authorisation holder (MAH) shall perform the required\npharmacovigilance activities and interventions detailed in the agreed RMP\npresented in Module 1.8.2 of the marketing authorisation and any agreed\nsubsequent updates of the RMP.</span></p>", "ID": "61b2903e-d3ef-4263-8140-b7305e54e961", "Styles": "margin-right:28.35pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The marketing authorisation holder (MAH) shall perform the required\npharmacovigilance activities and interventions detailed in the agreed RMP\npresented in Module 1.8.2 of the marketing authorisation and any agreed\nsubsequent updates of the RMP.</span>", "ID": "d774a0c1-916d-42df-a63f-95d76d181944", "Styles": "None", "Classes": "None", "Text": "The marketing authorisation holder (MAH) shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.", "ParentId": "61b2903e-d3ef-4263-8140-b7305e54e961"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4cba1ab1-6c0a-4b31-8640-ce6beb0f61c3", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "66480e34-34e5-4fcc-af12-da59fc8382cc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4cba1ab1-6c0a-4b31-8640-ce6beb0f61c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An updated RMP should be submitted:</span></p>", "ID": "01595cd4-d8db-4361-b3ea-83463a2a086b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">An updated RMP should be submitted:</span>", "ID": "2ae73a21-a352-47ae-b1d2-050a7ebf0e94", "Styles": "None", "Classes": "None", "Text": "An updated RMP should be submitted:", "ParentId": "01595cd4-d8db-4361-b3ea-83463a2a086b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p>", "ID": "1a45c288-5127-476e-915e-8956c3cc00f6", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5fbacddd-8f30-42b1-8c76-49351ff1e0bb", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "1a45c288-5127-476e-915e-8956c3cc00f6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "841202e8-f74a-4856-b02f-5605f3b33df5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5fbacddd-8f30-42b1-8c76-49351ff1e0bb"}, {"Element": "<span lang=\"EN-GB\">At the request of the European Medicines Agency;</span>", "ID": "d8e5904a-0c3a-455d-b6e0-070d0905a93e", "Styles": "None", "Classes": "None", "Text": "At the request of the European Medicines Agency;", "ParentId": "1a45c288-5127-476e-915e-8956c3cc00f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached.</span></p>", "ID": "d1cf9909-eb18-4e11-862c-1ed61444c21d", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6bd35ecb-152d-47ab-b681-2710d543ae66", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d1cf9909-eb18-4e11-862c-1ed61444c21d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ae421b95-6055-430d-8ec6-304af3f5d09e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6bd35ecb-152d-47ab-b681-2710d543ae66"}, {"Element": "<span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached.</span>", "ID": "83c5e172-e3c6-4d34-87c8-377b7c9fc9de", "Styles": "None", "Classes": "None", "Text": "Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.", "ParentId": "d1cf9909-eb18-4e11-862c-1ed61444c21d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "27052074-14f5-4ff8-a003-2997c68016fa", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "945e1245-4a73-4a24-a07b-a40c55c9382b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "27052074-14f5-4ff8-a003-2997c68016fa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Additional risk minimisation measures</span></b></p>", "ID": "74586ea9-34e2-42c2-91d8-046657fec203", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ea6dfa1e-7a82-4587-8338-207686ea5f45", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "74586ea9-34e2-42c2-91d8-046657fec203"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f63e1dfa-204d-4bb4-b19e-ee64f236473e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ea6dfa1e-7a82-4587-8338-207686ea5f45"}, {"Element": "<b><span lang=\"EN-GB\">Additional risk minimisation measures</span></b>", "ID": "6ceeb8d9-43ed-4cc6-b465-08ca2fc7467f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "74586ea9-34e2-42c2-91d8-046657fec203"}, {"Element": "<span lang=\"EN-GB\">Additional risk minimisation measures</span>", "ID": "48c834d3-3a14-4a86-89fa-a79044095002", "Styles": "None", "Classes": "None", "Text": "Additional risk minimisation measures", "ParentId": "6ceeb8d9-43ed-4cc6-b465-08ca2fc7467f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1be4f2ef-50c6-4889-b9af-a35f3c05ec7b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c81ea366-a6c9-41d7-b722-b9b9d97f5624", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1be4f2ef-50c6-4889-b9af-a35f3c05ec7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Key elements:</span></b></p>", "ID": "70b2704e-f634-4826-a0df-209a28974d2a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Key elements:</span></b>", "ID": "5e94e2d8-e026-42e0-a956-7e4da66ce86b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "70b2704e-f634-4826-a0df-209a28974d2a"}, {"Element": "<span lang=\"EN-GB\">Key elements:</span>", "ID": "dbccaf76-4d89-4e95-97dc-59f926a9ded7", "Styles": "None", "Classes": "None", "Text": "Key elements:", "ParentId": "5e94e2d8-e026-42e0-a956-7e4da66ce86b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b7740886-28c6-4e62-b0d5-345c774bc74a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "648e276f-56db-4f87-9fab-3d04bfebc5c0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b7740886-28c6-4e62-b0d5-345c774bc74a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Availability of tocilizumab and site qualification</span></u></p>", "ID": "4bb9316c-740e-4057-85e7-8cd521f429af", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Availability of tocilizumab and site qualification</span></u>", "ID": "7c05647d-990f-48aa-b254-74e34b5df6d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4bb9316c-740e-4057-85e7-8cd521f429af"}, {"Element": "<span lang=\"EN-GB\">Availability of tocilizumab and site qualification</span>", "ID": "fa6144f7-6d4a-4d68-9c5c-f16dc9285f29", "Styles": "None", "Classes": "None", "Text": "Availability of tocilizumab and site qualification", "ParentId": "7c05647d-990f-48aa-b254-74e34b5df6d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a850cbef-248e-4999-a39f-33df64b56d7d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75c18bad-ccca-4e23-b0c0-e9634a3b1ae8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a850cbef-248e-4999-a39f-33df64b56d7d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">To minimise the risks associated with KYMRIAH treatment, the MAH\nmust ensure that hospitals and their associated centres that dispense KYMRIAH\nare specially qualified in accordance with the agreed control distribution\nprogramme.</span></p>", "ID": "c9587ebb-d66b-4d04-a148-960932217e32", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">To minimise the risks associated with KYMRIAH treatment, the MAH\nmust ensure that hospitals and their associated centres that dispense KYMRIAH\nare specially qualified in accordance with the agreed control distribution\nprogramme.</span>", "ID": "b6865c7d-bcc6-43cf-aff3-85d76d39b5d3", "Styles": "None", "Classes": "None", "Text": "To minimise the risks associated with KYMRIAH treatment, the MAH must ensure that hospitals and their associated centres that dispense KYMRIAH are specially qualified in accordance with the agreed control distribution programme.", "ParentId": "c9587ebb-d66b-4d04-a148-960932217e32"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "392cb8cd-2a27-4efb-a12b-1c240d9bb42d", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1070676c-3d0c-48f2-9e83-477fa3725111", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "392cb8cd-2a27-4efb-a12b-1c240d9bb42d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">The MAH must ensure on\u2011site, immediate access to tocilizumab\nfor each patient as CRS management medication prior to treating patients. </span><span lang=\"EN-GB\">Hospitals should have access to additional doses of tocilizumab\nwithin 8\u00a0hours.</span></p>", "ID": "4c6a29e2-975c-4712-8e2a-4ab46db16f42", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The MAH must ensure on\u2011site, immediate access to tocilizumab\nfor each patient as CRS management medication prior to treating patients. </span>", "ID": "480012e2-6629-48f7-9287-0a1660e9ec58", "Styles": "None", "Classes": "None", "Text": "The MAH must ensure on\u2011site, immediate access to tocilizumab for each patient as CRS management medication prior to treating patients. ", "ParentId": "4c6a29e2-975c-4712-8e2a-4ab46db16f42"}, {"Element": "<span lang=\"EN-GB\">Hospitals should have access to additional doses of tocilizumab\nwithin 8\u00a0hours.</span>", "ID": "4d71968d-109a-434f-bcf2-d33ec6cb064b", "Styles": "None", "Classes": "None", "Text": "Hospitals should have access to additional doses of tocilizumab within 8\u00a0hours.", "ParentId": "4c6a29e2-975c-4712-8e2a-4ab46db16f42"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b2c11f29-bb65-4fec-bfa4-2d8e3d519287", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0df452e8-2611-4ee6-8c88-732777ec304c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b2c11f29-bb65-4fec-bfa4-2d8e3d519287"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">KYMRIAH will only be supplied to hospitals and associated centres that\nare qualified and only if the healthcare professionals involved in the\ntreatment of a patient have completed the educational programme.</span></p>", "ID": "ae133958-098d-4fae-b378-bc041398f0de", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">KYMRIAH will only be supplied to hospitals and associated centres that\nare qualified and only if the healthcare professionals involved in the\ntreatment of a patient have completed the educational programme.</span>", "ID": "e9c65447-b74f-49e9-91bf-666102cce141", "Styles": "None", "Classes": "None", "Text": "KYMRIAH will only be supplied to hospitals and associated centres that are qualified and only if the healthcare professionals involved in the treatment of a patient have completed the educational programme.", "ParentId": "ae133958-098d-4fae-b378-bc041398f0de"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "758efb23-9a50-4f1e-82a1-6f4a38a11a7f", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "57121e2d-b409-409a-91ef-c079642c6f58", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "758efb23-9a50-4f1e-82a1-6f4a38a11a7f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Educational programme</span></u></p>", "ID": "8d137249-b87b-4d42-a831-146e76712781", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Educational programme</span></u>", "ID": "5784c1c0-8cda-4eae-891c-2d88c809bc0b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d137249-b87b-4d42-a831-146e76712781"}, {"Element": "<span lang=\"EN-GB\">Educational programme</span>", "ID": "b9b1a9d5-b1c9-4c8a-a33d-e4738a5dcace", "Styles": "None", "Classes": "None", "Text": "Educational programme", "ParentId": "5784c1c0-8cda-4eae-891c-2d88c809bc0b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d6a7974a-8d3c-43ab-87ee-cf996e2a5b6a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ff414c41-e870-43a1-ae4c-831fbcc5822c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d6a7974a-8d3c-43ab-87ee-cf996e2a5b6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">Prior to the launch of KYMRIAH in each Member State, the MAH must\nagree about the content and format of the educational materials with the\nNational Competent Authority.</span></p>", "ID": "2e7a3bf7-82fe-42e1-9f34-aa175390835e", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Prior to the launch of KYMRIAH in each Member State, the MAH must\nagree about the content and format of the educational materials with the\nNational Competent Authority.</span>", "ID": "468a433a-55ea-478a-9f6a-aa62f6dfc808", "Styles": "None", "Classes": "None", "Text": "Prior to the launch of KYMRIAH in each Member State, the MAH must agree about the content and format of the educational materials with the National Competent Authority.", "ParentId": "2e7a3bf7-82fe-42e1-9f34-aa175390835e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fd4a8dc7-b33c-454b-84a8-3d67081d2028", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "debaf5de-b743-472a-8045-df0f0a9a9627", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fd4a8dc7-b33c-454b-84a8-3d67081d2028"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">HCP educational programme</span></p>", "ID": "1d4d7852-c39d-482c-b826-ca9cf5575ed5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">HCP educational programme</span>", "ID": "fe583970-d44f-49b7-8acf-7acbe95f62be", "Styles": "None", "Classes": "None", "Text": "HCP educational programme", "ParentId": "1d4d7852-c39d-482c-b826-ca9cf5575ed5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2f4aa74e-225b-4f5b-86aa-7545c282c1b0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c4776eaa-0e54-4936-8476-aa342ccecf99", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2f4aa74e-225b-4f5b-86aa-7545c282c1b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The MAH shall ensure that in each Member State where KYMRIAH is\nmarketed, all HCPs who are expected to prescribe, dispense annd administer\nKYMRIAH shall be provided with a guidance document to:</span></p>", "ID": "4c219aed-be66-4b01-ae42-221fca8de918", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The MAH shall ensure that in each Member State where KYMRIAH is\nmarketed, all HCPs who are expected to prescribe, dispense annd administer\nKYMRIAH shall be provided with a guidance document to:</span>", "ID": "f0cee1db-2300-43e7-9bc8-c853f1883638", "Styles": "None", "Classes": "None", "Text": "The MAH shall ensure that in each Member State where KYMRIAH is marketed, all HCPs who are expected to prescribe, dispense annd administer KYMRIAH shall be provided with a guidance document to:", "ParentId": "4c219aed-be66-4b01-ae42-221fca8de918"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">facilitate identification of CRS and serious\nneurological adverse reactions</span></p>", "ID": "9021b2d3-6a50-482f-9fa9-d304f2152329", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a812378f-ca8e-4153-9294-6479f56ae94f", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "9021b2d3-6a50-482f-9fa9-d304f2152329"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6f96d215-bf15-48c4-acdb-5b02881a9688", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a812378f-ca8e-4153-9294-6479f56ae94f"}, {"Element": "<span lang=\"EN-GB\">facilitate identification of CRS and serious\nneurological adverse reactions</span>", "ID": "a8a94da7-07fb-4922-b859-6c70fd44c25d", "Styles": "None", "Classes": "None", "Text": "facilitate identification of CRS and serious neurological adverse reactions", "ParentId": "9021b2d3-6a50-482f-9fa9-d304f2152329"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">facilitate management of the CRS and serious\nneurological adverse reactions</span></p>", "ID": "b9a35e85-bb9b-4013-a5e0-51f1a425db64", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6e7df1de-e415-4577-9c37-3b375b83971d", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "b9a35e85-bb9b-4013-a5e0-51f1a425db64"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "52d77636-3fc5-473a-be2d-332489526e8d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6e7df1de-e415-4577-9c37-3b375b83971d"}, {"Element": "<span lang=\"EN-GB\">facilitate management of the CRS and serious\nneurological adverse reactions</span>", "ID": "230f8326-19fc-4f24-b35c-c57de336e10f", "Styles": "None", "Classes": "None", "Text": "facilitate management of the CRS and serious neurological adverse reactions", "ParentId": "b9a35e85-bb9b-4013-a5e0-51f1a425db64"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">ensure adequate monitoring of CRS and serious\nneurological adverse reactions</span></p>", "ID": "b9b0542b-5e47-4827-b9e9-2738075b395f", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8479a688-d62b-49ba-b9ef-46cadba87892", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "b9b0542b-5e47-4827-b9e9-2738075b395f"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "eb638ce2-bfb5-4e1a-ade8-54dc9a9535e6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8479a688-d62b-49ba-b9ef-46cadba87892"}, {"Element": "<span lang=\"EN-GB\">ensure adequate monitoring of CRS and serious\nneurological adverse reactions</span>", "ID": "c0d4ca4d-b01a-434d-a050-875c39f8e68d", "Styles": "None", "Classes": "None", "Text": "ensure adequate monitoring of CRS and serious neurological adverse reactions", "ParentId": "b9b0542b-5e47-4827-b9e9-2738075b395f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">facilitate provision of all relevant information\nto patients</span></p>", "ID": "dd3077b4-129d-446b-b6be-5d72f0b52ee5", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a8121059-1305-4644-85e4-c6ed7e3878bf", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "dd3077b4-129d-446b-b6be-5d72f0b52ee5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "061e90e1-8e44-4284-a537-28b54b4a585d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a8121059-1305-4644-85e4-c6ed7e3878bf"}, {"Element": "<span lang=\"EN-GB\">facilitate provision of all relevant information\nto patients</span>", "ID": "e8854e9b-b6cb-4b65-b9f0-4ea114dc21de", "Styles": "None", "Classes": "None", "Text": "facilitate provision of all relevant information to patients", "ParentId": "dd3077b4-129d-446b-b6be-5d72f0b52ee5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">ensure that adverse reactions are adequately and\nappropriately reported</span></p>", "ID": "ba9db251-6b07-4e0d-91b3-637c598ce077", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "00f2e493-2570-4bee-a278-ffc2642af1b2", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "ba9db251-6b07-4e0d-91b3-637c598ce077"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "bf5836e8-6690-4734-a1ed-34bbd112ef47", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "00f2e493-2570-4bee-a278-ffc2642af1b2"}, {"Element": "<span lang=\"EN-GB\">ensure that adverse reactions are adequately and\nappropriately reported</span>", "ID": "86de9f09-6664-40ce-8789-3aa5cec921f3", "Styles": "None", "Classes": "None", "Text": "ensure that adverse reactions are adequately and appropriately reported", "ParentId": "ba9db251-6b07-4e0d-91b3-637c598ce077"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">ensure that detailed instructions about the\nthawing procedure are provided</span></p>", "ID": "061207eb-e87f-4db3-af80-b2eae9fd12d8", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ffec5c23-2c39-48eb-9c01-258f9c736f94", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "061207eb-e87f-4db3-af80-b2eae9fd12d8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "30592b28-ecbb-43ad-8d67-f35e75849079", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ffec5c23-2c39-48eb-9c01-258f9c736f94"}, {"Element": "<span lang=\"EN-GB\">ensure that detailed instructions about the\nthawing procedure are provided</span>", "ID": "3e7bb449-b28d-4db2-a842-61e300a4b50a", "Styles": "None", "Classes": "None", "Text": "ensure that detailed instructions about the thawing procedure are provided", "ParentId": "061207eb-e87f-4db3-af80-b2eae9fd12d8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">before treating a patient, ensure that\ntocilizumab for each patient are available on site</span></p>", "ID": "8ca11500-50b0-4102-acd5-9ebe118ad025", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f24b4b26-6a91-4aa9-9d35-c30987343b5d", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "8ca11500-50b0-4102-acd5-9ebe118ad025"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5251f39e-f203-4096-90c3-6962f6e82ca6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f24b4b26-6a91-4aa9-9d35-c30987343b5d"}, {"Element": "<span lang=\"EN-GB\">before treating a patient, ensure that\ntocilizumab for each patient are available on site</span>", "ID": "01529ee5-949b-4919-a1c3-11c1d204d8f9", "Styles": "None", "Classes": "None", "Text": "before treating a patient, ensure that tocilizumab for each patient are available on site", "ParentId": "8ca11500-50b0-4102-acd5-9ebe118ad025"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "02fa7c05-1b77-41f2-8b9d-4a1a5d819806", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0678f68e-ffdb-4264-9d40-dde243405535", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "02fa7c05-1b77-41f2-8b9d-4a1a5d819806"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient educational programme</span></p>", "ID": "6764aec7-ec79-45b9-adf5-8e171e3dd3f5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Patient educational programme</span>", "ID": "365caff0-30d5-4044-b5d7-16659d561607", "Styles": "None", "Classes": "None", "Text": "Patient educational programme", "ParentId": "6764aec7-ec79-45b9-adf5-8e171e3dd3f5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a3812a8b-2a41-4c10-9414-756c61f2bfb8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc832958-4c60-49f0-b765-7f780bede820", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a3812a8b-2a41-4c10-9414-756c61f2bfb8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">To inform and explain to patients:</span></p>", "ID": "b5770472-5200-48ee-aa5f-a2c42a826a1c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">To inform and explain to patients:</span>", "ID": "b454a19a-cf4e-426a-a138-3ac23417f20a", "Styles": "None", "Classes": "None", "Text": "To inform and explain to patients:", "ParentId": "b5770472-5200-48ee-aa5f-a2c42a826a1c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the risks of CRS and serious neurological\nadverse reactions associated with KYMRIAH</span></p>", "ID": "3da810c7-66b3-4ae2-b822-5acf3f015418", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8b46577e-97ab-463c-ba8d-3cf59daf8d2e", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "3da810c7-66b3-4ae2-b822-5acf3f015418"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a928c6ee-56aa-46e8-bac3-56940d8183d9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8b46577e-97ab-463c-ba8d-3cf59daf8d2e"}, {"Element": "<span lang=\"EN-GB\">the risks of CRS and serious neurological\nadverse reactions associated with KYMRIAH</span>", "ID": "27ba3aa7-ce1e-4e50-9c50-d401b0eda2e7", "Styles": "None", "Classes": "None", "Text": "the risks of CRS and serious neurological adverse reactions associated with KYMRIAH", "ParentId": "3da810c7-66b3-4ae2-b822-5acf3f015418"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the need to report the symptoms to their\ntreating doctor immediately</span></p>", "ID": "d29447cd-64e9-4809-92e5-240553f374fd", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0b5e6928-b5ee-441a-86c6-579f8f969264", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "d29447cd-64e9-4809-92e5-240553f374fd"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "91d80cbf-b333-4949-8ee1-8dbcaaa1b403", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0b5e6928-b5ee-441a-86c6-579f8f969264"}, {"Element": "<span lang=\"EN-GB\">the need to report the symptoms to their\ntreating doctor immediately</span>", "ID": "f4b410d4-b0a2-44b7-9157-bff73b9046c6", "Styles": "None", "Classes": "None", "Text": "the need to report the symptoms to their treating doctor immediately", "ParentId": "d29447cd-64e9-4809-92e5-240553f374fd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the need to remain in the proximity of the\nlocation where KYMRIAH was received for at least 4\u00a0weeks following KYMRIAH\ninfusion</span></p>", "ID": "bab6ae96-4730-4de9-85ca-592871c6c49e", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f11a54c7-5c02-474b-9e77-0781b01d52ae", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "bab6ae96-4730-4de9-85ca-592871c6c49e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c61cf596-f7ae-4965-b143-5c4f99c5bae6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f11a54c7-5c02-474b-9e77-0781b01d52ae"}, {"Element": "<span lang=\"EN-GB\">the need to remain in the proximity of the\nlocation where KYMRIAH was received for at least 4\u00a0weeks following KYMRIAH\ninfusion</span>", "ID": "e1d9d2c0-5368-4892-ab42-13b7194ac545", "Styles": "None", "Classes": "None", "Text": "the need to remain in the proximity of the location where KYMRIAH was received for at least 4\u00a0weeks following KYMRIAH infusion", "ParentId": "bab6ae96-4730-4de9-85ca-592871c6c49e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">the need to carry the patient alert card at all\ntimes</span></p>", "ID": "485f29be-ff16-4c44-ae8e-66bed7d5a7ca", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "4d6c438c-c2d9-41b3-9715-93c256fce273", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "485f29be-ff16-4c44-ae8e-66bed7d5a7ca"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0de9915f-45f7-4128-a757-69d09ad49c8c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "4d6c438c-c2d9-41b3-9715-93c256fce273"}, {"Element": "<span lang=\"EN-GB\">the need to carry the patient alert card at all\ntimes</span>", "ID": "f838f0e5-046d-48f2-9608-a3f3d4d0ea86", "Styles": "None", "Classes": "None", "Text": "the need to carry the patient alert card at all times", "ParentId": "485f29be-ff16-4c44-ae8e-66bed7d5a7ca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cf072c26-d64f-4ca1-8558-71484bee6a30", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d715c1b0-13d2-4ea7-bd9b-a1b7940b7026", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cf072c26-d64f-4ca1-8558-71484bee6a30"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span></b></p>", "ID": "74f266ac-f365-47f5-aa15-f5ded74168c6", "Styles": "margin-top:0in;margin-right:-.05pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8140ec30-a388-45d6-af76-d203ab0e2a67", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "74f266ac-f365-47f5-aa15-f5ded74168c6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2b36253a-1ffe-46f5-925f-9fe1db155166", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8140ec30-a388-45d6-af76-d203ab0e2a67"}, {"Element": "<b><span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span></b>", "ID": "42f8bfd4-6323-4b67-a402-c5ca0ff98eda", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "74f266ac-f365-47f5-aa15-f5ded74168c6"}, {"Element": "<span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span>", "ID": "2ac71fb3-d412-4ed9-9f0b-c31f24e5a0a6", "Styles": "None", "Classes": "None", "Text": "Obligation to conduct post\u2011authorisation measures", "ParentId": "42f8bfd4-6323-4b67-a402-c5ca0ff98eda"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e0642d80-9091-4fee-bf6c-050ef94be94b", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7f5122b3-b1b7-4c9a-afb2-1950eaabdb84", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e0642d80-9091-4fee-bf6c-050ef94be94b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe,\nthe below measures:</span></p>", "ID": "914468eb-4120-4b8d-9143-93e7a42a20d7", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe,\nthe below measures:</span>", "ID": "9147e09e-c32e-40a5-8411-1e809eb5d299", "Styles": "None", "Classes": "None", "Text": "The MAH shall complete, within the stated timeframe, the below measures:", "ParentId": "914468eb-4120-4b8d-9143-93e7a42a20d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "485d3885-f83e-4200-9ab0-2fc07f7528c3", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7137f152-20b3-44a9-b062-4f84e1399368", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "485d3885-f83e-4200-9ab0-2fc07f7528c3"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:100.0%;border-collapse:collapse;border:none\" width=\"100%\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:30.4%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Non\u2011interventional post\u2011authorisation\n  safety study (PASS): In order to further characterise the safety \u2013 including\n  long\u2011term safety \u2013 of Kymriah, the applicant should conduct and submit\n  a study based on data from a disease registry in ALL and DLBCL patients.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Annual safety reports and 5\u2011yearly interim\n  reports</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report of study results:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">December 2038</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In\n  order to further evaluate the efficacy and safety of Kymriah in ALL patients\n  below the age of 3\u00a0years, the applicant should conduct and submit a\n  study based on data from a disease registry in ALL patients.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Included as part of the annual reports of the non\u2011interventional\n  PASS</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report: December 2023</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further evaluate the efficacy of Kymriah in patients with relapsed/refractory\n  DLBCL, the applicant should conduct and submit a prospective, observational\n  study in patients with r/r DLBCL based on data from registry with efficacy\n  outcome measures in line with study C2201, including details of the\n  manufacturing turnaround time (i.e. time from last relapse or confirmed\n  refractory status, time from decision to treat, and time from leukapheresis\n  to infusion).</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the 24\u00a0months\n  follow\u2011up of all infused patients from study C2201. In addition the\n  applicant should submit the final CSR including 5\u00a0years of follow\u2011up.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Updated report:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">November 2020</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Final CSR: August 2023</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the results of study\n  CCTL019H2301 \u2013 open\u2011label, Phase III study of Kymriah versus standard\n  of care in adult patients with relapsed or refractory aggressive B\u2011cell\n  non\u2011Hodgkin lymphoma.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>\n</tr>\n</table>", "ID": "d6666d2a-09b2-4626-9934-130fcf0aef7d", "Styles": "width:100.0%;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "       ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:30.4%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>\n</tr>", "ID": "6722815f-3095-4b3d-9767-5b2d7f32676e", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "d6666d2a-09b2-4626-9934-130fcf0aef7d"}, {"Element": "<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>", "ID": "2b876d5f-0c1e-4183-91e8-0c985fed1e32", "Styles": "width:69.6%;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6722815f-3095-4b3d-9767-5b2d7f32676e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>", "ID": "2eacc8fa-6af8-43ef-ba52-438709a2e6df", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2b876d5f-0c1e-4183-91e8-0c985fed1e32"}, {"Element": "<b><span lang=\"EN-GB\">Description</span></b>", "ID": "dea33f38-25f2-4efd-aa8c-d6d21daec94b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2eacc8fa-6af8-43ef-ba52-438709a2e6df"}, {"Element": "<span lang=\"EN-GB\">Description</span>", "ID": "27a081ab-ed7c-40e2-b276-ca7d89036e22", "Styles": "None", "Classes": "None", "Text": "Description", "ParentId": "dea33f38-25f2-4efd-aa8c-d6d21daec94b"}, {"Element": "<td style=\"width:30.4%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>\n</td>", "ID": "d5d5f1af-3db2-4e6a-973e-a58bf34362a7", "Styles": "width:30.4%;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6722815f-3095-4b3d-9767-5b2d7f32676e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p>", "ID": "6934c7f4-5802-4b6d-9c70-912a13896b06", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d5d5f1af-3db2-4e6a-973e-a58bf34362a7"}, {"Element": "<b><span lang=\"EN-GB\">Due date</span></b>", "ID": "9b095d47-8054-475a-a4b2-aa039e685ecd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6934c7f4-5802-4b6d-9c70-912a13896b06"}, {"Element": "<span lang=\"EN-GB\">Due date</span>", "ID": "03543e52-7dcc-427e-9ecd-e766ffd8edc7", "Styles": "None", "Classes": "None", "Text": "Due date", "ParentId": "9b095d47-8054-475a-a4b2-aa039e685ecd"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Non\u2011interventional post\u2011authorisation\n  safety study (PASS): In order to further characterise the safety \u2013 including\n  long\u2011term safety \u2013 of Kymriah, the applicant should conduct and submit\n  a study based on data from a disease registry in ALL and DLBCL patients.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Annual safety reports and 5\u2011yearly interim\n  reports</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report of study results:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">December 2038</span></p>\n</td>\n</tr>", "ID": "635662d5-484f-4379-ba8d-5c67acf5e806", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "d6666d2a-09b2-4626-9934-130fcf0aef7d"}, {"Element": "<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Non\u2011interventional post\u2011authorisation\n  safety study (PASS): In order to further characterise the safety \u2013 including\n  long\u2011term safety \u2013 of Kymriah, the applicant should conduct and submit\n  a study based on data from a disease registry in ALL and DLBCL patients.</span></p>\n</td>", "ID": "c5cd45a7-acd8-40f2-a0a6-e466ca497d0f", "Styles": "width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "635662d5-484f-4379-ba8d-5c67acf5e806"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Non\u2011interventional post\u2011authorisation\n  safety study (PASS): In order to further characterise the safety \u2013 including\n  long\u2011term safety \u2013 of Kymriah, the applicant should conduct and submit\n  a study based on data from a disease registry in ALL and DLBCL patients.</span></p>", "ID": "c30c7649-fa5a-4dbe-a709-6e59506488a7", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c5cd45a7-acd8-40f2-a0a6-e466ca497d0f"}, {"Element": "<span lang=\"EN-GB\">Non\u2011interventional post\u2011authorisation\n  safety study (PASS): In order to further characterise the safety \u2013 including\n  long\u2011term safety \u2013 of Kymriah, the applicant should conduct and submit\n  a study based on data from a disease registry in ALL and DLBCL patients.</span>", "ID": "a1773a03-0095-4023-a1b4-4a5a44ac8b66", "Styles": "None", "Classes": "None", "Text": "Non\u2011interventional post\u2011authorisation   safety study (PASS): In order to further characterise the safety \u2013 including   long\u2011term safety \u2013 of Kymriah, the applicant should conduct and submit   a study based on data from a disease registry in ALL and DLBCL patients.", "ParentId": "c30c7649-fa5a-4dbe-a709-6e59506488a7"}, {"Element": "<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Annual safety reports and 5\u2011yearly interim\n  reports</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report of study results:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">December 2038</span></p>\n</td>", "ID": "89949429-ef43-4808-aa4d-741b88475df3", "Styles": "width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "635662d5-484f-4379-ba8d-5c67acf5e806"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>", "ID": "45bc6e5b-9057-4e9f-81ee-f7b161adf91c", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89949429-ef43-4808-aa4d-741b88475df3"}, {"Element": "<span lang=\"EN-GB\">Update reports:</span>", "ID": "1b8514c6-d769-4b16-aab5-594a3f09d7c9", "Styles": "None", "Classes": "None", "Text": "Update reports:", "ParentId": "45bc6e5b-9057-4e9f-81ee-f7b161adf91c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Annual safety reports and 5\u2011yearly interim\n  reports</span></p>", "ID": "87b6faae-828d-4736-90d8-7ef188c243c9", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89949429-ef43-4808-aa4d-741b88475df3"}, {"Element": "<span lang=\"EN-GB\">Annual safety reports and 5\u2011yearly interim\n  reports</span>", "ID": "51547aa4-727f-49bc-b355-034ee81c1cf6", "Styles": "None", "Classes": "None", "Text": "Annual safety reports and 5\u2011yearly interim   reports", "ParentId": "87b6faae-828d-4736-90d8-7ef188c243c9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fef8daea-7bc9-4184-ae0e-bdbad27ca1aa", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89949429-ef43-4808-aa4d-741b88475df3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "738cdc6a-ff8c-47a1-8222-e510e69bce27", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fef8daea-7bc9-4184-ae0e-bdbad27ca1aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report of study results:</span></p>", "ID": "6426b4d1-55ab-4f08-970f-2e77e8c1c131", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89949429-ef43-4808-aa4d-741b88475df3"}, {"Element": "<span lang=\"EN-GB\">Final report of study results:</span>", "ID": "63b02b74-dd13-43c4-87cf-afa0b24c905b", "Styles": "None", "Classes": "None", "Text": "Final report of study results:", "ParentId": "6426b4d1-55ab-4f08-970f-2e77e8c1c131"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">December 2038</span></p>", "ID": "06dfc3d9-6fe0-4b3a-a414-d48c237e1f10", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89949429-ef43-4808-aa4d-741b88475df3"}, {"Element": "<span lang=\"EN-GB\">December 2038</span>", "ID": "d0d47d13-7521-42e5-a919-23f305215a82", "Styles": "None", "Classes": "None", "Text": "December 2038", "ParentId": "06dfc3d9-6fe0-4b3a-a414-d48c237e1f10"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In\n  order to further evaluate the efficacy and safety of Kymriah in ALL patients\n  below the age of 3\u00a0years, the applicant should conduct and submit a\n  study based on data from a disease registry in ALL patients.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Included as part of the annual reports of the non\u2011interventional\n  PASS</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report: December 2023</span></p>\n</td>\n</tr>", "ID": "650ab606-5b7e-4dd0-ba79-41b66014f2d0", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "d6666d2a-09b2-4626-9934-130fcf0aef7d"}, {"Element": "<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In\n  order to further evaluate the efficacy and safety of Kymriah in ALL patients\n  below the age of 3\u00a0years, the applicant should conduct and submit a\n  study based on data from a disease registry in ALL patients.</span></p>\n</td>", "ID": "5e20765e-7ee7-442e-a263-50cef3139769", "Styles": "width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "650ab606-5b7e-4dd0-ba79-41b66014f2d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In\n  order to further evaluate the efficacy and safety of Kymriah in ALL patients\n  below the age of 3\u00a0years, the applicant should conduct and submit a\n  study based on data from a disease registry in ALL patients.</span></p>", "ID": "2fc50862-83da-4107-9df1-2899453ebd00", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5e20765e-7ee7-442e-a263-50cef3139769"}, {"Element": "<span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In\n  order to further evaluate the efficacy and safety of Kymriah in ALL patients\n  below the age of 3\u00a0years, the applicant should conduct and submit a\n  study based on data from a disease registry in ALL patients.</span>", "ID": "5c759f8f-8bc1-4a87-9b47-c8be206f53da", "Styles": "None", "Classes": "None", "Text": "Post\u2011authorisation efficacy study (PAES): In   order to further evaluate the efficacy and safety of Kymriah in ALL patients   below the age of 3\u00a0years, the applicant should conduct and submit a   study based on data from a disease registry in ALL patients.", "ParentId": "2fc50862-83da-4107-9df1-2899453ebd00"}, {"Element": "<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Included as part of the annual reports of the non\u2011interventional\n  PASS</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report: December 2023</span></p>\n</td>", "ID": "f8b9eb19-9567-4cbf-a282-1cc7db38f59f", "Styles": "width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "650ab606-5b7e-4dd0-ba79-41b66014f2d0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Update reports:</span></p>", "ID": "0fe24b63-cf13-4473-8e50-45242da15e18", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8b9eb19-9567-4cbf-a282-1cc7db38f59f"}, {"Element": "<span lang=\"EN-GB\">Update reports:</span>", "ID": "5a9ef227-d686-4ec4-a95e-f9f875489e21", "Styles": "None", "Classes": "None", "Text": "Update reports:", "ParentId": "0fe24b63-cf13-4473-8e50-45242da15e18"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Included as part of the annual reports of the non\u2011interventional\n  PASS</span></p>", "ID": "e53f0589-7bd3-4b6a-ad54-3de0544b0d03", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8b9eb19-9567-4cbf-a282-1cc7db38f59f"}, {"Element": "<span lang=\"EN-GB\">Included as part of the annual reports of the non\u2011interventional\n  PASS</span>", "ID": "956e2d0e-90ae-4092-8a41-9034fb882cb1", "Styles": "None", "Classes": "None", "Text": "Included as part of the annual reports of the non\u2011interventional   PASS", "ParentId": "e53f0589-7bd3-4b6a-ad54-3de0544b0d03"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e5042e30-d161-414c-a8a9-f712b4200748", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8b9eb19-9567-4cbf-a282-1cc7db38f59f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "35360933-9819-41b2-b1da-e3600d24f371", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e5042e30-d161-414c-a8a9-f712b4200748"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid\"><span lang=\"EN-GB\">Final report: December 2023</span></p>", "ID": "cd6b0596-778a-4b57-80d2-9c362f48fc36", "Styles": "margin-right:-.05pt;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8b9eb19-9567-4cbf-a282-1cc7db38f59f"}, {"Element": "<span lang=\"EN-GB\">Final report: December 2023</span>", "ID": "bea09007-cfb0-4a91-b634-57a037679089", "Styles": "None", "Classes": "None", "Text": "Final report: December 2023", "ParentId": "cd6b0596-778a-4b57-80d2-9c362f48fc36"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further evaluate the efficacy of Kymriah in patients with relapsed/refractory\n  DLBCL, the applicant should conduct and submit a prospective, observational\n  study in patients with r/r DLBCL based on data from registry with efficacy\n  outcome measures in line with study C2201, including details of the\n  manufacturing turnaround time (i.e. time from last relapse or confirmed\n  refractory status, time from decision to treat, and time from leukapheresis\n  to infusion).</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>\n</tr>", "ID": "61ceb6b3-c25e-4be0-8769-1835f1c9c5c4", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "d6666d2a-09b2-4626-9934-130fcf0aef7d"}, {"Element": "<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further evaluate the efficacy of Kymriah in patients with relapsed/refractory\n  DLBCL, the applicant should conduct and submit a prospective, observational\n  study in patients with r/r DLBCL based on data from registry with efficacy\n  outcome measures in line with study C2201, including details of the\n  manufacturing turnaround time (i.e. time from last relapse or confirmed\n  refractory status, time from decision to treat, and time from leukapheresis\n  to infusion).</span></p>\n</td>", "ID": "e2938bc4-b6f4-4562-a4f2-a03a683588d4", "Styles": "width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "61ceb6b3-c25e-4be0-8769-1835f1c9c5c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further evaluate the efficacy of Kymriah in patients with relapsed/refractory\n  DLBCL, the applicant should conduct and submit a prospective, observational\n  study in patients with r/r DLBCL based on data from registry with efficacy\n  outcome measures in line with study C2201, including details of the\n  manufacturing turnaround time (i.e. time from last relapse or confirmed\n  refractory status, time from decision to treat, and time from leukapheresis\n  to infusion).</span></p>", "ID": "f83aed4e-63c3-40c1-a0a4-46002bbe4051", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e2938bc4-b6f4-4562-a4f2-a03a683588d4"}, {"Element": "<span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further evaluate the efficacy of Kymriah in patients with relapsed/refractory\n  DLBCL, the applicant should conduct and submit a prospective, observational\n  study in patients with r/r DLBCL based on data from registry with efficacy\n  outcome measures in line with study C2201, including details of the\n  manufacturing turnaround time (i.e. time from last relapse or confirmed\n  refractory status, time from decision to treat, and time from leukapheresis\n  to infusion).</span>", "ID": "56dbe28e-b092-4962-b942-52185d49eeb1", "Styles": "None", "Classes": "None", "Text": "Post\u2011authorisation efficacy study (PAES): In order to   further evaluate the efficacy of Kymriah in patients with relapsed/refractory   DLBCL, the applicant should conduct and submit a prospective, observational   study in patients with r/r DLBCL based on data from registry with efficacy   outcome measures in line with study C2201, including details of the   manufacturing turnaround time (i.e. time from last relapse or confirmed   refractory status, time from decision to treat, and time from leukapheresis   to infusion).", "ParentId": "f83aed4e-63c3-40c1-a0a4-46002bbe4051"}, {"Element": "<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>", "ID": "5050dd82-9fe4-4435-86b3-fed26c2d7209", "Styles": "width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "61ceb6b3-c25e-4be0-8769-1835f1c9c5c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>", "ID": "802d06ec-9700-4217-ac02-aeb78b302f96", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5050dd82-9fe4-4435-86b3-fed26c2d7209"}, {"Element": "<span lang=\"EN-GB\">June 2022</span>", "ID": "66d0f44b-56dc-4e51-b14f-773e7b7d4a60", "Styles": "None", "Classes": "None", "Text": "June 2022", "ParentId": "802d06ec-9700-4217-ac02-aeb78b302f96"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the 24\u00a0months\n  follow\u2011up of all infused patients from study C2201. In addition the\n  applicant should submit the final CSR including 5\u00a0years of follow\u2011up.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Updated report:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">November 2020</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Final CSR: August 2023</span></p>\n</td>\n</tr>", "ID": "60932be0-df07-478c-ad28-f7838962bb05", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "d6666d2a-09b2-4626-9934-130fcf0aef7d"}, {"Element": "<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the 24\u00a0months\n  follow\u2011up of all infused patients from study C2201. In addition the\n  applicant should submit the final CSR including 5\u00a0years of follow\u2011up.</span></p>\n</td>", "ID": "eda0c66a-a94c-40a3-aee4-c32f6369d7d3", "Styles": "width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "60932be0-df07-478c-ad28-f7838962bb05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the 24\u00a0months\n  follow\u2011up of all infused patients from study C2201. In addition the\n  applicant should submit the final CSR including 5\u00a0years of follow\u2011up.</span></p>", "ID": "71410b74-50c1-43d9-b9b9-73da300780ec", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eda0c66a-a94c-40a3-aee4-c32f6369d7d3"}, {"Element": "<span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the 24\u00a0months\n  follow\u2011up of all infused patients from study C2201. In addition the\n  applicant should submit the final CSR including 5\u00a0years of follow\u2011up.</span>", "ID": "0b1ab123-3fe7-4175-ab84-803abae8be94", "Styles": "None", "Classes": "None", "Text": "Post\u2011authorisation efficacy study (PAES): In order to   further characterise the long\u2011term efficacy and safety of Kymriah in   relapsed/refractory DLBCL, the applicant should submit the 24\u00a0months   follow\u2011up of all infused patients from study C2201. In addition the   applicant should submit the final CSR including 5\u00a0years of follow\u2011up.", "ParentId": "71410b74-50c1-43d9-b9b9-73da300780ec"}, {"Element": "<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Updated report:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">November 2020</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Final CSR: August 2023</span></p>\n</td>", "ID": "bedbeeca-b377-4765-96f7-3b3c3bcf0685", "Styles": "width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "60932be0-df07-478c-ad28-f7838962bb05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Updated report:</span></p>", "ID": "bdfb10a6-9d3b-4ea2-bdac-c524ae885098", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bedbeeca-b377-4765-96f7-3b3c3bcf0685"}, {"Element": "<span lang=\"EN-GB\">Updated report:</span>", "ID": "7e1a9615-bae7-4358-8e04-f7e1b215f315", "Styles": "None", "Classes": "None", "Text": "Updated report:", "ParentId": "bdfb10a6-9d3b-4ea2-bdac-c524ae885098"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">November 2020</span></p>", "ID": "7d444845-3b39-46f4-8e81-f0581c51aea9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bedbeeca-b377-4765-96f7-3b3c3bcf0685"}, {"Element": "<span lang=\"EN-GB\">November 2020</span>", "ID": "7fd29a47-a3c8-47c8-8013-ab7f654f7667", "Styles": "None", "Classes": "None", "Text": "November 2020", "ParentId": "7d444845-3b39-46f4-8e81-f0581c51aea9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "770b206c-b8e4-431e-a7a3-948095f573c1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bedbeeca-b377-4765-96f7-3b3c3bcf0685"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6781d996-510c-46ec-b5ee-40c3f4df4a1c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "770b206c-b8e4-431e-a7a3-948095f573c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Final CSR: August 2023</span></p>", "ID": "b37eda74-1f6b-43bc-a4ea-aca18ddd9309", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bedbeeca-b377-4765-96f7-3b3c3bcf0685"}, {"Element": "<span lang=\"EN-GB\">Final CSR: August 2023</span>", "ID": "f4d87743-c974-4198-bb36-4476e64f44c6", "Styles": "None", "Classes": "None", "Text": "Final CSR: August 2023", "ParentId": "b37eda74-1f6b-43bc-a4ea-aca18ddd9309"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the results of study\n  CCTL019H2301 \u2013 open\u2011label, Phase III study of Kymriah versus standard\n  of care in adult patients with relapsed or refractory aggressive B\u2011cell\n  non\u2011Hodgkin lymphoma.</span></p>\n</td>\n<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>\n</tr>", "ID": "96ee2324-038e-4046-8eaa-cf13a5ffeaba", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "d6666d2a-09b2-4626-9934-130fcf0aef7d"}, {"Element": "<td style=\"width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the results of study\n  CCTL019H2301 \u2013 open\u2011label, Phase III study of Kymriah versus standard\n  of care in adult patients with relapsed or refractory aggressive B\u2011cell\n  non\u2011Hodgkin lymphoma.</span></p>\n</td>", "ID": "fc96ee35-86fc-430f-878d-a0f3d88fa6ed", "Styles": "width:69.6%;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "96ee2324-038e-4046-8eaa-cf13a5ffeaba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the results of study\n  CCTL019H2301 \u2013 open\u2011label, Phase III study of Kymriah versus standard\n  of care in adult patients with relapsed or refractory aggressive B\u2011cell\n  non\u2011Hodgkin lymphoma.</span></p>", "ID": "e1062b81-ab84-4280-96a3-5ff52cd73f94", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fc96ee35-86fc-430f-878d-a0f3d88fa6ed"}, {"Element": "<span lang=\"EN-GB\">Post\u2011authorisation efficacy study (PAES): In order to\n  further characterise the long\u2011term efficacy and safety of Kymriah in\n  relapsed/refractory DLBCL, the applicant should submit the results of study\n  CCTL019H2301 \u2013 open\u2011label, Phase III study of Kymriah versus standard\n  of care in adult patients with relapsed or refractory aggressive B\u2011cell\n  non\u2011Hodgkin lymphoma.</span>", "ID": "adcdaeeb-b28a-4958-8cb5-f304fdc80671", "Styles": "None", "Classes": "None", "Text": "Post\u2011authorisation efficacy study (PAES): In order to   further characterise the long\u2011term efficacy and safety of Kymriah in   relapsed/refractory DLBCL, the applicant should submit the results of study   CCTL019H2301 \u2013 open\u2011label, Phase III study of Kymriah versus standard   of care in adult patients with relapsed or refractory aggressive B\u2011cell   non\u2011Hodgkin lymphoma.", "ParentId": "e1062b81-ab84-4280-96a3-5ff52cd73f94"}, {"Element": "<td style=\"width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"30%\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>\n</td>", "ID": "5a3bb560-4a5e-4ea9-9075-c95359342e52", "Styles": "width:30.4%;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "96ee2324-038e-4046-8eaa-cf13a5ffeaba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">June 2022</span></p>", "ID": "e41f8845-5c70-40cc-9a4d-04b2a5ddce03", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5a3bb560-4a5e-4ea9-9075-c95359342e52"}, {"Element": "<span lang=\"EN-GB\">June 2022</span>", "ID": "b3cf5427-b643-4a67-ac4e-d92d5c0566d9", "Styles": "None", "Classes": "None", "Text": "June 2022", "ParentId": "e41f8845-5c70-40cc-9a4d-04b2a5ddce03"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9ac483f7-3242-4625-87c8-7f1669c81ee5", "Styles": "margin-right:-.05pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a048a7ce-afdd-4da5-a280-b1e659545c12", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ac483f7-3242-4625-87c8-7f1669c81ee5"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "12e51d35-abaa-4870-a6c4-94fe6281fe9a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "aaeba976-fcc5-4c81-a45f-a3ca7c793184", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "12e51d35-abaa-4870-a6c4-94fe6281fe9a"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "7a7e3d4c-e69b-4110-8c9b-91d122fa920b", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "aaeba976-fcc5-4c81-a45f-a3ca7c793184"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ab3229eb-eefe-4461-aca0-b2552fcb6ea5", "Styles": "margin-right:28.3pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d7e3bf45-4b41-4712-9481-5d1a354a37e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ab3229eb-eefe-4461-aca0-b2552fcb6ea5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5a4b7a11-3b67-4733-936b-77e3cc9741cd", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e26ad749-aa5f-4eb7-bdea-9d9c711f8360", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5a4b7a11-3b67-4733-936b-77e3cc9741cd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:28.3pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c89b216-3ab7-4f47-b673-f894f7bddb8a", "Styles": "margin-right:28.3pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3d75b3df-2b74-42c5-b39f-245c931d749d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c89b216-3ab7-4f47-b673-f894f7bddb8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "76cb193a-520b-4d3e-ae8d-5414db69a98f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2eee69c2-5823-4450-8159-74468bca73f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "76cb193a-520b-4d3e-ae8d-5414db69a98f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c2951a63-d2ca-4243-a14a-c604f7bce877", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "859cf977-20b8-4403-b629-cda94d389b3a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c2951a63-d2ca-4243-a14a-c604f7bce877"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "184d2c38-0815-4ef3-94b0-729811ade454", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "96540cd0-f358-4c45-8150-331e33384f1f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "184d2c38-0815-4ef3-94b0-729811ade454"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ee33049c-3741-4966-a35a-e0e30d24c555", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b7eb5cf-35e5-4cfe-ab10-98dc9899e420", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ee33049c-3741-4966-a35a-e0e30d24c555"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bbb52e02-4458-43ab-8c9f-d86e467eb8d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "91171a05-39d7-455e-86d4-801229378c7d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bbb52e02-4458-43ab-8c9f-d86e467eb8d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "53dc7378-94cb-4886-9260-6592065101db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65d99fde-aa90-4157-ba22-8a8396d0d3d6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "53dc7378-94cb-4886-9260-6592065101db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cd764873-59c5-409c-a558-4cfaf39e6000", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7fe0420-ce96-420b-8fd2-14f931676409", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cd764873-59c5-409c-a558-4cfaf39e6000"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26e27c66-9111-4bdc-b9c8-53cdf9fe0c50", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45b98679-efa7-4136-a4e1-fa8c67ddfe88", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26e27c66-9111-4bdc-b9c8-53cdf9fe0c50"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f91f7d45-4e1a-4f72-8018-285a7971aadb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bd8ddbc6-8c44-42bd-916d-40bdd0208078", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f91f7d45-4e1a-4f72-8018-285a7971aadb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e22e489-3612-4d5c-a59b-96378e80d657", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d6a1d5e-d8d3-477d-8118-3185ed844f81", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e22e489-3612-4d5c-a59b-96378e80d657"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df5eb9e1-c247-46fc-a734-453ca8dd3a13", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "299b975c-9e9b-4322-9bf0-88e12b075c77", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df5eb9e1-c247-46fc-a734-453ca8dd3a13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "40f6316e-b32b-44fb-b78d-5a690df04e64", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7fa63d72-9bde-4ea5-b97e-c300e722fe3a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "40f6316e-b32b-44fb-b78d-5a690df04e64"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2817e2d3-7386-46c2-9a43-43fd5afcebcf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "566183a0-6e1a-4b69-a6fd-3aa91f9bc395", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2817e2d3-7386-46c2-9a43-43fd5afcebcf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "980f5aa6-6a31-46b3-bd65-e4617b3a27bd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cb466d86-2a0b-484b-836c-e73ca912ec72", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "980f5aa6-6a31-46b3-bd65-e4617b3a27bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4dd60b06-6708-47ba-b3e7-005923eecc0a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e58c1028-d735-4c2d-a297-895d6360ccbe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4dd60b06-6708-47ba-b3e7-005923eecc0a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f688afe1-c001-4649-b601-ad834e51d16e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "87a25b20-6644-4c90-ad8e-1b31ba90c6ae", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f688afe1-c001-4649-b601-ad834e51d16e"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1be5cedf-f202-4bb3-837c-9298aee5e3f8", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "606b627c-a755-4436-8549-4b9f3902552e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1be5cedf-f202-4bb3-837c-9298aee5e3f8"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1b459051-9a4f-4ee4-897c-4842c7bf2a40", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df043d34-09ee-43ee-b8fb-70d3a59b64f0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1b459051-9a4f-4ee4-897c-4842c7bf2a40"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6efa17ce-d607-4443-8fa6-6d14f51bcac9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d948995e-a212-45ee-aa49-cf37f46cc97d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6efa17ce-d607-4443-8fa6-6d14f51bcac9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7acbd863-c889-450d-ab46-b0c18545cf67", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d5d01b5f-be34-40e5-aa3c-dc94402cbd86", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7acbd863-c889-450d-ab46-b0c18545cf67"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a5875524-1d35-48e7-b74a-12555cc8ce71", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ed3af4b6-6a9c-4477-9046-1bfb1e599e38", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a5875524-1d35-48e7-b74a-12555cc8ce71"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7091b0ef-c0ae-498d-b758-29dcc099ddb3", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "600c0f01-6ace-4b37-afc7-a52b86772677", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7091b0ef-c0ae-498d-b758-29dcc099ddb3"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>", "ID": "9779a46a-fee8-4d63-a1e9-c5ca381a465d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX III</span></b>", "ID": "23966d96-7d2e-4a02-8740-b6412c85ad8f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9779a46a-fee8-4d63-a1e9-c5ca381a465d"}, {"Element": "<span lang=\"EN-GB\">ANNEX III</span>", "ID": "376a7ff8-c4c1-49a9-a08e-041078b734db", "Styles": "None", "Classes": "None", "Text": "ANNEX III", "ParentId": "23966d96-7d2e-4a02-8740-b6412c85ad8f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9a0a6ed2-ff27-4616-b641-f6da111c20ab", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "6537e44e-467f-4278-be3a-c554a8af943e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a0a6ed2-ff27-4616-b641-f6da111c20ab"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8610e77b-b25b-401f-bb30-a587cbb25fbc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6537e44e-467f-4278-be3a-c554a8af943e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>", "ID": "356f5658-5431-4f00-8997-c506f8edf337", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b>", "ID": "e9d5af02-621a-4ef8-8555-ac57c39cafdd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "356f5658-5431-4f00-8997-c506f8edf337"}, {"Element": "<span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span>", "ID": "d456a35d-971d-498d-b9df-bddbbfcd3c71", "Styles": "None", "Classes": "None", "Text": "LABELLING AND PACKAGE LEAFLET", "ParentId": "e9d5af02-621a-4ef8-8555-ac57c39cafdd"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "a29b4a88-33e4-41ff-a237-8e29c6b2eeca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "89d42d44-4904-4596-8d44-f0df491c4c62", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "a29b4a88-33e4-41ff-a237-8e29c6b2eeca"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "daa33e52-ee50-45fe-ae89-11f0a0715a54", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "89d42d44-4904-4596-8d44-f0df491c4c62"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "70be35bf-861c-44da-b2be-62e9b43db8a4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "455683d2-a204-497d-ae9a-1b8523099b27", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "70be35bf-861c-44da-b2be-62e9b43db8a4"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6b2b0d38-be0e-40a7-b82a-25f29cf9fb41", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4994e286-1ef8-407f-8a77-249755359d45", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6b2b0d38-be0e-40a7-b82a-25f29cf9fb41"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44954e6d-9956-44a9-9587-186c5effb8bb", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f4fe951a-3e54-42ef-9811-5f104213ccbc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44954e6d-9956-44a9-9587-186c5effb8bb"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "92f546ff-fcd7-43f9-be67-97c5a31a7865", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0f0c9b39-3a59-458b-aac0-23de785cf0d1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "92f546ff-fcd7-43f9-be67-97c5a31a7865"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60dd548f-e563-4ce3-8bc3-77def2fea828", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5e6210f1-1183-4546-baf9-f233e0d236e9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60dd548f-e563-4ce3-8bc3-77def2fea828"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "48ae99c3-1535-4be8-946d-86d441171398", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d1b1b51-973a-4db5-a5f1-623962fd90d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "48ae99c3-1535-4be8-946d-86d441171398"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0d05b540-eba2-4207-a269-518dce7510b9", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dd3e7688-0c5e-4775-95e0-f78fd8cad18b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d05b540-eba2-4207-a269-518dce7510b9"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58e5bea2-b5ba-4a9f-958c-fc4a6b8e225d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "892d78b6-7e9a-4aa8-9556-87c1ebeec54e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58e5bea2-b5ba-4a9f-958c-fc4a6b8e225d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "75f16e54-a253-46b6-b806-6d137bdaeff7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "523dd49b-e7be-4be7-84d5-64bd40554dfd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "75f16e54-a253-46b6-b806-6d137bdaeff7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e464f2ce-8be0-42fe-b799-2fb15c99bccd", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78687704-237b-499b-9fc2-1dc6b7ef6934", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e464f2ce-8be0-42fe-b799-2fb15c99bccd"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d3df059-969d-4525-af15-b6a62b2c966d", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4bd4c281-8a50-4e38-93fa-29393fcf5416", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d3df059-969d-4525-af15-b6a62b2c966d"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60b2b197-bdd7-4bf6-8063-c4330f429fab", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fc360423-939b-4d7a-a504-502302fcf166", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60b2b197-bdd7-4bf6-8063-c4330f429fab"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "27751e23-abf8-4ebd-b411-32529fbe5fe7", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bbfa24b5-41cb-4a53-91bd-586fe13ee931", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "27751e23-abf8-4ebd-b411-32529fbe5fe7"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ce8a152e-b0ae-419c-adeb-ac03a39338f5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1a8f5f22-fbd2-4727-a9ef-e5c240ef0545", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ce8a152e-b0ae-419c-adeb-ac03a39338f5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ae4f8871-b392-405d-b44a-8ff60293f52b", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ae95d08b-cd0d-4424-afd7-d606d189c33d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ae4f8871-b392-405d-b44a-8ff60293f52b"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f2f44803-cb08-493c-b323-3591cccbc3d1", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2a8d94dd-6347-41d1-8326-63fff47ea52a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f2f44803-cb08-493c-b323-3591cccbc3d1"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1bc658db-dd28-471e-b317-5c571d1ffe07", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9144da81-43de-4c99-aa74-37692972993f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1bc658db-dd28-471e-b317-5c571d1ffe07"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1ae7414d-d210-423b-8593-625d7eff3808", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9d2cad9c-5028-4ff1-bd39-170e03b82ef4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1ae7414d-d210-423b-8593-625d7eff3808"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fe0e72ef-4a22-4416-945f-37e4cc19bda5", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8c1e7de3-3421-499c-ab66-5330f3182174", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fe0e72ef-4a22-4416-945f-37e4cc19bda5"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "321e8f88-a043-4485-9bc4-971841877a50", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1dfa6313-03fa-45d6-a739-0efa8dc94812", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "321e8f88-a043-4485-9bc4-971841877a50"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fc52ece8-ee56-415d-92dd-0bafdb3be1ce", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "951bdf67-221b-4c6b-86d2-5900b8afcb46", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fc52ece8-ee56-415d-92dd-0bafdb3be1ce"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3be0677e-979f-4689-9c6f-5fe5f028055a", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aed8df91-20d8-4bfa-b0a3-5ed9b3cbbc1f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3be0677e-979f-4689-9c6f-5fe5f028055a"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42914cb8-b764-49ce-ae11-b463db575118", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aea0113e-e50f-40a6-ae63-5b4559698347", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42914cb8-b764-49ce-ae11-b463db575118"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c866afd0-331a-4a61-8e6c-2bbcbe2f79a4", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "809444da-4681-43d8-b722-edb4eb42dde5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c866afd0-331a-4a61-8e6c-2bbcbe2f79a4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">A. LABELLING</span></b></p>", "ID": "4e2d55b5-2171-4845-98a0-c33767d0e729", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">A. LABELLING</span></b>", "ID": "0d87200e-4dd1-4b1d-be56-8b84bc7946de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e2d55b5-2171-4845-98a0-c33767d0e729"}, {"Element": "<span lang=\"EN-GB\">A. LABELLING</span>", "ID": "7b1f2227-2df8-441a-8fdf-905e27305ef1", "Styles": "None", "Classes": "None", "Text": "A. LABELLING", "ParentId": "0d87200e-4dd1-4b1d-be56-8b84bc7946de"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "8c381bd6-bf4c-406f-a954-3596ee5e25c0", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "6e87f535-dbe7-4499-86dc-0c760a55c73c", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "8c381bd6-bf4c-406f-a954-3596ee5e25c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c97ea08-d22f-46f4-b2e4-79b27def446a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e6aeba9-ed99-4652-84a6-2ac03ef90a1f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c97ea08-d22f-46f4-b2e4-79b27def446a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "18f31004-221d-42eb-b1c2-23097a85734e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "268fe995-7555-410e-8f90-e26a557ec2fa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "18f31004-221d-42eb-b1c2-23097a85734e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">INFUSION BAG LABEL</span></b></p>\n</div>", "ID": "315dee9f-11ce-46e0-892d-96f8e034f073", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING</span></b></p>", "ID": "33fa9393-1baa-4dd3-bd99-92b12228f942", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "315dee9f-11ce-46e0-892d-96f8e034f073"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING</span></b>", "ID": "4e08e752-2e4e-4f04-abd2-cc81e3924e93", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33fa9393-1baa-4dd3-bd99-92b12228f942"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING</span>", "ID": "a55aaff3-d654-4538-8a4d-7fcb215d0679", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING", "ParentId": "4e08e752-2e4e-4f04-abd2-cc81e3924e93"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "62c6712f-cf7a-4e4b-b680-9d46aecc34df", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "315dee9f-11ce-46e0-892d-96f8e034f073"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cf7db95d-cb07-4760-9606-4a420a70fb96", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "62c6712f-cf7a-4e4b-b680-9d46aecc34df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">INFUSION BAG LABEL</span></b></p>", "ID": "c0aa9b2f-4ecc-4e4a-bf20-14fe92d291f9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "315dee9f-11ce-46e0-892d-96f8e034f073"}, {"Element": "<b><span lang=\"EN-GB\">INFUSION BAG LABEL</span></b>", "ID": "9d650e19-35d5-4b8a-9553-012bac45484c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c0aa9b2f-4ecc-4e4a-bf20-14fe92d291f9"}, {"Element": "<span lang=\"EN-GB\">INFUSION BAG LABEL</span>", "ID": "ebf3a664-bf66-4889-959f-b5bc4b493e1f", "Styles": "None", "Classes": "None", "Text": "INFUSION BAG LABEL", "ParentId": "9d650e19-35d5-4b8a-9553-012bac45484c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bf6f89ca-e1d0-472e-b672-e0c57142f473", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "beacc54d-1a34-439f-b941-4c7cfe69a08e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bf6f89ca-e1d0-472e-b672-e0c57142f473"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8c83d706-4f5d-47f7-881a-28c5ee1098fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb8291e4-0712-4841-a161-4dcea57b56dc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8c83d706-4f5d-47f7-881a-28c5ee1098fd"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE\nMEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "ebd90041-358f-4484-9e87-ca42cc62aea0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE\nMEDICINAL PRODUCT</span></b></p>", "ID": "92e56893-78c9-4fec-a998-83730dc24fd0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebd90041-358f-4484-9e87-ca42cc62aea0"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE\nMEDICINAL PRODUCT</span></b>", "ID": "5dce7e05-9985-483f-afce-4673a76e9fac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92e56893-78c9-4fec-a998-83730dc24fd0"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE\nMEDICINAL PRODUCT</span>", "ID": "bf46c950-729a-48f7-9527-43d89cf94a5f", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "5dce7e05-9985-483f-afce-4673a76e9fac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d26f3e74-12df-4d93-bdfb-abf128f249c6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d3971f58-df44-43ab-9d82-705cd9adc588", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d26f3e74-12df-4d93-bdfb-abf128f249c6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Kymriah 1.</span><span lang=\"FR-CH\">2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells</span><span lang=\"FR-CH\"> dispersion for infusion</span></p>", "ID": "68862dd3-c6a5-4180-a207-151626e5fac2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">Kymriah 1.</span>", "ID": "8f857f12-2887-4bdf-ae89-204552d0877d", "Styles": "None", "Classes": "None", "Text": "Kymriah 1.", "ParentId": "68862dd3-c6a5-4180-a207-151626e5fac2"}, {"Element": "<span lang=\"FR-CH\">2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells</span>", "ID": "0b56bb15-6b02-41ab-bf94-13d3bf580a6a", "Styles": "None", "Classes": "None", "Text": "2\u00a0x\u00a010\u00a0\u2013\u00a06\u00a0x\u00a010 cells", "ParentId": "68862dd3-c6a5-4180-a207-151626e5fac2"}, {"Element": "<sup>6</sup>", "ID": "ddda77f2-164d-476e-ba93-8b3473e4c65b", "Styles": "None", "Classes": "None", "Text": "6", "ParentId": "0b56bb15-6b02-41ab-bf94-13d3bf580a6a"}, {"Element": "<sup>8</sup>", "ID": "661f1228-8f89-4d05-9bcd-18cde4c9ff2a", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "0b56bb15-6b02-41ab-bf94-13d3bf580a6a"}, {"Element": "<span lang=\"FR-CH\"> dispersion for infusion</span>", "ID": "19e3f7fd-a7a4-4046-a92a-4b79bfa9e6e6", "Styles": "None", "Classes": "None", "Text": " dispersion for infusion", "ParentId": "68862dd3-c6a5-4180-a207-151626e5fac2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">tisagenlecleucel\n(CAR+ viable T cells)</span></p>", "ID": "7c12c7b2-4f3d-4740-8232-0c3ea8209ac6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">tisagenlecleucel\n(CAR+ viable T cells)</span>", "ID": "d74b5320-114a-4b3f-b5b3-4d51aee6ccf7", "Styles": "None", "Classes": "None", "Text": "tisagenlecleucel (CAR+ viable T cells)", "ParentId": "7c12c7b2-4f3d-4740-8232-0c3ea8209ac6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>", "ID": "1d77c9c4-61bc-470d-91a7-c3bceee8a44c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">\u00a0</span>", "ID": "31a30b75-047d-459b-9cc5-d843637a3ce3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1d77c9c4-61bc-470d-91a7-c3bceee8a44c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>", "ID": "972597d6-beb1-4ae6-818c-66ca2c46fe9a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">\u00a0</span>", "ID": "c02a971e-e02b-402d-9307-f385aa74a12e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "972597d6-beb1-4ae6-818c-66ca2c46fe9a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF\nACTIVE SUBSTANCE(S)</span></b></p>\n</div>", "ID": "4296c7f8-2f00-47d3-80b8-334220ce2681", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF\nACTIVE SUBSTANCE(S)</span></b></p>", "ID": "aa36ab72-ae5c-49b0-b1f1-0897ad3faa07", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4296c7f8-2f00-47d3-80b8-334220ce2681"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF\nACTIVE SUBSTANCE(S)</span></b>", "ID": "ca7c936d-83dc-4bde-a3da-13d36593b1ba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa36ab72-ae5c-49b0-b1f1-0897ad3faa07"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF\nACTIVE SUBSTANCE(S)</span>", "ID": "36058e36-b643-4d80-87c3-41eee85725b0", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "ca7c936d-83dc-4bde-a3da-13d36593b1ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e0d805ca-88a6-4b28-881b-8016e05fc0bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ebbebaac-99b2-4b29-9c82-135b0d4d1cf1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e0d805ca-88a6-4b28-881b-8016e05fc0bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Autologous human\nT cells genetically modified <i>ex vivo</i> using a lentiviral vector encoding\nan anti\u2011CD19 chimeric antigen receptor (CAR).</span></p>", "ID": "df7a3a3a-506f-47e4-8d8c-b3b73b3f2a51", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Autologous human\nT cells genetically modified <i>ex vivo</i> using a lentiviral vector encoding\nan anti\u2011CD19 chimeric antigen receptor (CAR).</span>", "ID": "9278c187-b7d6-4efe-a083-1aea4143a81a", "Styles": "None", "Classes": "None", "Text": "Autologous human T cells genetically modified  using a lentiviral vector encoding an anti\u2011CD19 chimeric antigen receptor (CAR).", "ParentId": "df7a3a3a-506f-47e4-8d8c-b3b73b3f2a51"}, {"Element": "<i>ex vivo</i>", "ID": "4f1a667c-c168-4e51-a170-af8aaff2a4a7", "Styles": "None", "Classes": "None", "Text": "ex vivo", "ParentId": "9278c187-b7d6-4efe-a083-1aea4143a81a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Contains 1.2\u00a0x\u00a010<sup>6</sup>\nto 6\u00a0x\u00a010<sup>8</sup> CAR+ viable T cells.</span></p>", "ID": "de058d58-24ba-4894-8660-1bf86fdd9a9f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Contains 1.2\u00a0x\u00a010<sup>6</sup>\nto 6\u00a0x\u00a010<sup>8</sup> CAR+ viable T cells.</span>", "ID": "0df03c9f-a6e6-4b3a-af10-7e3d17adb4d5", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Contains 1.2\u00a0x\u00a010 to 6\u00a0x\u00a010 CAR+ viable T cells.", "ParentId": "de058d58-24ba-4894-8660-1bf86fdd9a9f"}, {"Element": "<sup>6</sup>", "ID": "f8d00213-561b-4fa8-a7bd-31025f944ae7", "Styles": "None", "Classes": "None", "Text": "6", "ParentId": "0df03c9f-a6e6-4b3a-af10-7e3d17adb4d5"}, {"Element": "<sup>8</sup>", "ID": "3e7a3f0d-51b3-421c-a112-8a26711e0a51", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "0df03c9f-a6e6-4b3a-af10-7e3d17adb4d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dcaace2e-c0e7-46ff-93b6-cdd4f2fe43b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b443efae-e6ff-416b-bd60-5b6a14a3a994", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dcaace2e-c0e7-46ff-93b6-cdd4f2fe43b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e51e67a-1de2-4f15-932c-e0fb58f0fdde", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b109ee06-4d39-421c-bff8-46ea6764b99f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e51e67a-1de2-4f15-932c-e0fb58f0fdde"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "1343224d-28c1-4d28-bdcd-c3acf2afb5ee", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "938ba8f0-5f0e-4c30-9310-6e93abcbe808", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1343224d-28c1-4d28-bdcd-c3acf2afb5ee"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "fc48f4aa-f01f-47ae-9a2d-b007694114bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "938ba8f0-5f0e-4c30-9310-6e93abcbe808"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "da31b212-8c0f-441e-af6a-56e5773474bd", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "fc48f4aa-f01f-47ae-9a2d-b007694114bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7bff6d2d-b5c5-4603-8823-47d5a6909607", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "abfb1509-b23a-41e3-b051-214f8c8d131c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7bff6d2d-b5c5-4603-8823-47d5a6909607"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Also contains:\nglucose, sodium chloride, human albumin solution, dextran 40 for injection,\ndimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride,\nmagnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate,\naluminium, water for injections. <span style=\"color:black;background:#D9D9D9\">See\nleaflet for further information.</span></span></p>", "ID": "6f73a0a9-eb3a-4a7d-90c1-f82f0b05f577", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Also contains:\nglucose, sodium chloride, human albumin solution, dextran 40 for injection,\ndimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride,\nmagnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate,\naluminium, water for injections. <span style=\"color:black;background:#D9D9D9\">See\nleaflet for further information.</span></span>", "ID": "9f65a654-b04a-473f-aeac-9e33d609b427", "Styles": "None", "Classes": "None", "Text": "Also contains: glucose, sodium chloride, human albumin solution, dextran 40 for injection, dimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate, aluminium, water for injections. ", "ParentId": "6f73a0a9-eb3a-4a7d-90c1-f82f0b05f577"}, {"Element": "<span style=\"color:black;background:#D9D9D9\">See\nleaflet for further information.</span>", "ID": "fc0d0256-5fb4-42e6-8bed-af2c57a1093f", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "See leaflet for further information.", "ParentId": "9f65a654-b04a-473f-aeac-9e33d609b427"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "737fb315-e302-4dcb-9e69-78c2c4a7893f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3e82b357-40aa-4ea3-b746-7490d8bd8ba2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "737fb315-e302-4dcb-9e69-78c2c4a7893f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e1e6b7ff-0507-4405-af8f-c29196c76928", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a7706770-c348-4910-a4a4-ff32c8843c8a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e1e6b7ff-0507-4405-af8f-c29196c76928"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>\n</div>", "ID": "49aa7c3c-2d6a-48c5-80d6-bbfe3b1825ec", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b></p>", "ID": "63f6f49c-ca14-4aee-9b71-e012796c6124", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "49aa7c3c-2d6a-48c5-80d6-bbfe3b1825ec"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span></b>", "ID": "31417e79-36bd-45ce-809f-e2c623e10f95", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "63f6f49c-ca14-4aee-9b71-e012796c6124"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL\nFORM AND CONTENTS</span>", "ID": "4f0dd667-90f6-456e-be4a-d533a14417f2", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "31417e79-36bd-45ce-809f-e2c623e10f95"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e6431151-8b00-4ee3-9333-acfe88f2c67c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4c710bf2-6ee7-4354-a5d2-04fead68ab89", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e6431151-8b00-4ee3-9333-acfe88f2c67c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Dispersion for infusion</span></p>", "ID": "168ede48-15c8-4edc-b554-4eccac0a5b7d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Dispersion for infusion</span>", "ID": "c9a36c8b-15c8-4ed5-8ed2-4152d6d9ef70", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Dispersion for infusion", "ParentId": "168ede48-15c8-4edc-b554-4eccac0a5b7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10\u00a0mL\u00a0\u2011\u00a050\u00a0mL\nper bag.</span></p>", "ID": "21a91294-4944-42e0-85e3-7fa15c2655d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">10\u00a0mL\u00a0\u2011\u00a050\u00a0mL\nper bag.</span>", "ID": "f7448b17-2df2-442c-9aaa-0b504253fbf4", "Styles": "None", "Classes": "None", "Text": "10\u00a0mL\u00a0\u2011\u00a050\u00a0mL per bag.", "ParentId": "21a91294-4944-42e0-85e3-7fa15c2655d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3e19926-d27f-464e-965a-c6c524c6cdb6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b698cc56-611e-42a2-b36d-31f2726ae3f3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3e19926-d27f-464e-965a-c6c524c6cdb6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2212c74f-05a4-434c-a390-1efc3cce26ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "be1be371-970c-4686-909b-988bac3c84f6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2212c74f-05a4-434c-a390-1efc3cce26ba"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND\nROUTE(S) OF ADMINISTRATION</span></b></p>\n</div>", "ID": "2ba8ef3e-391d-4fda-9997-8d1feacc2254", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND\nROUTE(S) OF ADMINISTRATION</span></b></p>", "ID": "fbbc21c3-cf13-45b5-b784-3707de15ad3b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2ba8ef3e-391d-4fda-9997-8d1feacc2254"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND\nROUTE(S) OF ADMINISTRATION</span></b>", "ID": "dc675d7f-b877-4bc5-98fc-da07e906162b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbbc21c3-cf13-45b5-b784-3707de15ad3b"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND\nROUTE(S) OF ADMINISTRATION</span>", "ID": "c8065f85-20a6-47d7-9124-398b4482a8ff", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "dc675d7f-b877-4bc5-98fc-da07e906162b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "82a89bb4-6a55-4f94-bdd9-3448336b7ea2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f39084d-256e-413f-878f-92a428e3aebb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "82a89bb4-6a55-4f94-bdd9-3448336b7ea2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Intravenous use</span></p>", "ID": "d57beb7f-afeb-4293-b9d1-593ab2596aeb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Intravenous use</span>", "ID": "4e818043-7d24-403f-823b-946b0867af9d", "Styles": "None", "Classes": "None", "Text": "Intravenous use", "ParentId": "d57beb7f-afeb-4293-b9d1-593ab2596aeb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use\nleukocyte depleting filter.</span></p>", "ID": "f2ab1630-014d-4d55-9ed0-c4d7e0e5797c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Do not use\nleukocyte depleting filter.</span>", "ID": "619e3867-27f0-4482-8518-c273dc9c23cd", "Styles": "None", "Classes": "None", "Text": "Do not use leukocyte depleting filter.", "ParentId": "f2ab1630-014d-4d55-9ed0-c4d7e0e5797c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2bf67ade-4dd6-435f-9c82-bd3c90e73463", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1046abd5-570a-400a-8232-c13a9ab80fa4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2bf67ade-4dd6-435f-9c82-bd3c90e73463"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "78a7e8ad-74d6-4b41-98e3-a1d6400308ff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7d92af5-2b4a-4147-a90f-6981d4af41ee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "78a7e8ad-74d6-4b41-98e3-a1d6400308ff"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING\nTHAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>\n</div>", "ID": "6283eb59-0dbf-4280-bf71-a79b76f5a547", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING\nTHAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b></p>", "ID": "77c362c0-fe67-4083-ac9e-a09ca96a26a7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6283eb59-0dbf-4280-bf71-a79b76f5a547"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING\nTHAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span></b>", "ID": "dc59577b-ea61-4dcb-a258-4f219cc7cb97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "77c362c0-fe67-4083-ac9e-a09ca96a26a7"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING\nTHAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF\nCHILDREN</span>", "ID": "fd3b3201-025d-420d-a837-627a80308b1d", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "dc59577b-ea61-4dcb-a258-4f219cc7cb97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "31cf12c6-1cc8-4726-ac0d-3f4644e28fe9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "838d870c-2dac-40bd-b347-63e02f6d5d61", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "31cf12c6-1cc8-4726-ac0d-3f4644e28fe9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Keep out of the sight and reach of\nchildren.</span></p>", "ID": "4014c082-e4ad-45a5-9ef6-93e69caf2a9d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Keep out of the sight and reach of\nchildren.</span>", "ID": "aceb3a24-6fb2-4213-be0a-d568cb63583c", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Keep out of the sight and reach of children.", "ParentId": "4014c082-e4ad-45a5-9ef6-93e69caf2a9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3aff67ee-ce2d-48aa-9641-b2604af20090", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "68b42b15-e04e-4c5a-ac26-00fc8bea291d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3aff67ee-ce2d-48aa-9641-b2604af20090"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7691a096-adff-4617-8fab-ad304893518a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b2b9249-d59c-4a12-9c06-5e807b2015df", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7691a096-adff-4617-8fab-ad304893518a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL\nWARNING(S), IF NECESSARY</span></b></p>\n</div>", "ID": "5b259b10-782a-46f2-af1d-75003aaf7fa2", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL\nWARNING(S), IF NECESSARY</span></b></p>", "ID": "2ce752bf-c0d2-4f3c-974d-a8f00ef3ead9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5b259b10-782a-46f2-af1d-75003aaf7fa2"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL\nWARNING(S), IF NECESSARY</span></b>", "ID": "22d32dde-6052-40ae-8bde-665a0c7ec74b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ce752bf-c0d2-4f3c-974d-a8f00ef3ead9"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL\nWARNING(S), IF NECESSARY</span>", "ID": "d5ee5c06-1826-4fda-8d39-75f9de60e2cb", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "22d32dde-6052-40ae-8bde-665a0c7ec74b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d477e640-3245-4486-b581-e299b17379ea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f5dea431-dcb4-4b42-9074-d9d3422791a3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d477e640-3245-4486-b581-e299b17379ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For autologous\nuse only.</span></p>", "ID": "f46da377-5de4-4997-ab38-d670675b876c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">For autologous\nuse only.</span>", "ID": "1313ae7b-2d74-49ed-a109-2045861262cf", "Styles": "None", "Classes": "None", "Text": "For autologous use only.", "ParentId": "f46da377-5de4-4997-ab38-d670675b876c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d91b1697-1385-48b0-8065-c67b1e0cdb7c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bb997325-f88d-46c8-97a2-18ee1ad84f96", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d91b1697-1385-48b0-8065-c67b1e0cdb7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d4b9bf84-c07b-4137-bfb2-df6507ab523f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "66521d2f-cfa3-434a-bf9d-5b2d9a2c0c72", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d4b9bf84-c07b-4137-bfb2-df6507ab523f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>\n</div>", "ID": "07bd94d0-9908-47ae-a13b-551ce859d2c1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b></p>", "ID": "9b281706-e026-40c3-96b0-a6d5e177f673", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "07bd94d0-9908-47ae-a13b-551ce859d2c1"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span></b>", "ID": "2502c52b-a4e1-4ac9-87c5-c6747e256c3f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b281706-e026-40c3-96b0-a6d5e177f673"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY\nDATE</span>", "ID": "72d7f451-7945-404d-a64a-929d5ca84e13", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "2502c52b-a4e1-4ac9-87c5-c6747e256c3f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8b4396d7-e1f0-4593-92b6-31829a356988", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9c89c96f-ce34-428b-8391-4fba8883b845", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8b4396d7-e1f0-4593-92b6-31829a356988"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "a5b228af-db94-4cba-afa1-9ec74331e993", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "3d832870-1c58-435a-a9fc-8e0afde6fac4", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "a5b228af-db94-4cba-afa1-9ec74331e993"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9811b21c-8e34-4310-82d6-2cccaa91a091", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8ada078e-32ee-4b55-acd4-d92ff8ae4160", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9811b21c-8e34-4310-82d6-2cccaa91a091"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "00ae266d-5d5a-4597-97dc-04c6a9561f8e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1019f23b-c74f-4d46-b654-c98921b41a6d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "00ae266d-5d5a-4597-97dc-04c6a9561f8e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "a2473761-5ad1-4d07-b68a-78efd4df8473", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "9af9395f-b8bb-4aa2-bafb-1c4b23fc14fc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2473761-5ad1-4d07-b68a-78efd4df8473"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "8e8bcd4b-0c76-498e-97ac-f0c10303e9cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9af9395f-b8bb-4aa2-bafb-1c4b23fc14fc"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "40c0e165-bd2f-4516-8b31-7e56f0491d34", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "8e8bcd4b-0c76-498e-97ac-f0c10303e9cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "efe5ac70-2700-4f91-aa7c-396333daaf12", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "420e9f01-6bc9-4080-8b38-c61dc0ac0cc2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "efe5ac70-2700-4f91-aa7c-396333daaf12"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Store and transport below \u2011120\u00b0C; do not thaw the product\nuntil use.</span></p>", "ID": "a30df9d8-6510-4f78-8ddb-a09671e749d2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Store and transport below \u2011120\u00b0C; do not thaw the product\nuntil use.</span>", "ID": "9cc32fdc-d965-49ec-886b-acf8c57eeb89", "Styles": "None", "Classes": "None", "Text": "Store and transport below \u2011120\u00b0C; do not thaw the product until use.", "ParentId": "a30df9d8-6510-4f78-8ddb-a09671e749d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6f7f0f7a-83de-4c71-8ed4-9445c6fcaa70", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ebafb8b7-d4c9-4d80-b6f2-633d0af9c320", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6f7f0f7a-83de-4c71-8ed4-9445c6fcaa70"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df15fc03-5817-4636-823b-4f29d1b1a831", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "46a0dfca-5727-4728-97fb-5283f42a5158", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df15fc03-5817-4636-823b-4f29d1b1a831"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS\nFOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "7aee533d-772b-4634-b712-d02c06e4da39", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS\nFOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "53e3a076-fdf2-4bbd-b122-4f3115839848", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7aee533d-772b-4634-b712-d02c06e4da39"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS\nFOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "93db1202-5723-4cf2-9192-07a9ea138535", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "53e3a076-fdf2-4bbd-b122-4f3115839848"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS\nFOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "b9bd4b56-da8d-44fd-9c73-9f3d1ffefcff", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "93db1202-5723-4cf2-9192-07a9ea138535"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6eb25ceb-bfca-4e28-a948-3cd2ced37ff6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ceaa4f2c-a050-499e-942c-0418dc9c9d56", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6eb25ceb-bfca-4e28-a948-3cd2ced37ff6"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Contains genetically\u2011modified\ncells.</span></p>", "ID": "30de73e9-c78b-45f8-82d5-6e78772db15d", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Contains genetically\u2011modified\ncells.</span>", "ID": "4ef316f4-4b42-462b-87bc-db576edd7cd5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Contains genetically\u2011modified cells.", "ParentId": "30de73e9-c78b-45f8-82d5-6e78772db15d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dispose of as\nper local guideline on handling of biological waste.</span></p>", "ID": "6cc40e2d-b140-4418-836c-6188c5494967", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Dispose of as\nper local guideline on handling of biological waste.</span>", "ID": "175665c7-f7f3-4279-9e42-7cf9c1043f61", "Styles": "None", "Classes": "None", "Text": "Dispose of as per local guideline on handling of biological waste.", "ParentId": "6cc40e2d-b140-4418-836c-6188c5494967"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e9fe9300-0000-4116-9001-f6adcbaa4113", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "96e00969-e716-4148-b135-4254ff080225", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e9fe9300-0000-4116-9001-f6adcbaa4113"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8ca41dce-92fe-49a5-9544-f5d6d347827b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c68d0959-19a9-4e86-a3d8-dcfa01e35628", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8ca41dce-92fe-49a5-9544-f5d6d347827b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "84e4672d-625e-4427-b912-7b1c2aec9404", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "cad53c8b-7cc9-4eb5-9e36-888eadbb1453", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84e4672d-625e-4427-b912-7b1c2aec9404"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "5a7093e8-46d0-493c-888b-b621ec3a97ae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cad53c8b-7cc9-4eb5-9e36-888eadbb1453"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME\nAND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "2ae5d476-b099-487d-9d86-efb85b0b9554", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "5a7093e8-46d0-493c-888b-b621ec3a97ae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cf89fce6-6c54-4ea8-9fda-a30132cafb9c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64a0960b-9b65-41bf-b72e-3dda9af194cb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cf89fce6-6c54-4ea8-9fda-a30132cafb9c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Novartis Europharm Limited</span></p>", "ID": "cb985299-8343-404b-a2c0-7bbecff954d2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Novartis Europharm Limited</span>", "ID": "e228de5d-5750-4d5c-aa91-f8570d381053", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Novartis Europharm Limited", "ParentId": "cb985299-8343-404b-a2c0-7bbecff954d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">Vista Building</span></p>", "ID": "83f38b74-a7c7-4cb7-8c2e-d45f44847cc9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black;background:#D9D9D9\">Vista Building</span>", "ID": "467fb948-e301-4f33-ad08-92718aea81f4", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Vista Building", "ParentId": "83f38b74-a7c7-4cb7-8c2e-d45f44847cc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">Elm Park, Merrion Road</span></p>", "ID": "48c2f22c-0bc3-44e4-a45f-475cf93638a2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black;background:#D9D9D9\">Elm Park, Merrion Road</span>", "ID": "98bacd68-486d-42c7-b2bf-5cff5674ca3f", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Elm Park, Merrion Road", "ParentId": "48c2f22c-0bc3-44e4-a45f-475cf93638a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">Dublin 4</span></p>", "ID": "2940103f-c7d9-4a61-a8b1-4e73f3ea8370", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black;background:#D9D9D9\">Dublin 4</span>", "ID": "3eb04c98-fcfe-47af-adef-839be212a89c", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Dublin 4", "ParentId": "2940103f-c7d9-4a61-a8b1-4e73f3ea8370"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"color:black;\nbackground:#D9D9D9\">Ireland</span></p>", "ID": "584fd68d-2f98-4f2b-bdef-985976e7fe37", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black;\nbackground:#D9D9D9\">Ireland</span>", "ID": "5d9771a1-c737-46d4-b986-46d6fc76a986", "Styles": "color:black;\nbackground:#D9D9D9", "Classes": "None", "Text": "Ireland", "ParentId": "584fd68d-2f98-4f2b-bdef-985976e7fe37"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "69549e6e-c193-41dc-a45b-2e552681efac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3bf25e23-5ef0-45b1-884c-ebed3a8e86e4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "69549e6e-c193-41dc-a45b-2e552681efac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d785b29f-25d5-428b-ad66-661996ff6e42", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "72701f55-4efd-4a25-bf9c-fc7ca88eba8d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d785b29f-25d5-428b-ad66-661996ff6e42"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>\n</div>", "ID": "aea84465-115f-4d13-a906-6b93ddd91178", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b></p>", "ID": "c7f9c3f2-d5c2-48fb-b705-49373a8d3f3b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aea84465-115f-4d13-a906-6b93ddd91178"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span></b>", "ID": "d7f0bd7d-88ce-435c-b8de-75be00e0cced", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c7f9c3f2-d5c2-48fb-b705-49373a8d3f3b"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING\nAUTHORISATION NUMBER(S)</span>", "ID": "2a73da55-77e3-4fc7-84cb-416b1804472e", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S)", "ParentId": "d7f0bd7d-88ce-435c-b8de-75be00e0cced"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b0ee4cb-ceea-4e37-94e2-5ec7eacd047c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "543901b8-ddc7-45c0-9ac0-7677edcf63eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b0ee4cb-ceea-4e37-94e2-5ec7eacd047c"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse\">\n<tr>\n<td style=\"width:232.15pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/18/1297/001</span></p>\n</td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">10 \u2013 50\u00a0ml</span></p>\n</td>\n</tr>\n</table>", "ID": "be05e046-9fbd-443e-b7fb-b73a58ac857e", "Styles": "border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr>\n<td style=\"width:232.15pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/18/1297/001</span></p>\n</td>\n<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">10 \u2013 50\u00a0ml</span></p>\n</td>\n</tr>", "ID": "0f5afddd-b3d4-49f2-84b7-e3f1f5213b98", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "be05e046-9fbd-443e-b7fb-b73a58ac857e"}, {"Element": "<td style=\"width:232.15pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/18/1297/001</span></p>\n</td>", "ID": "9f2e1e98-fa03-437c-a0e1-618611ccb577", "Styles": "width:232.15pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0f5afddd-b3d4-49f2-84b7-e3f1f5213b98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/18/1297/001</span></p>", "ID": "055724c1-7b87-4b4f-ac42-45986bb93372", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9f2e1e98-fa03-437c-a0e1-618611ccb577"}, {"Element": "<span lang=\"EN-GB\">EU/1/18/1297/001</span>", "ID": "29c3d096-a30f-4f91-8855-e280dc277f6f", "Styles": "None", "Classes": "None", "Text": "EU/1/18/1297/001", "ParentId": "055724c1-7b87-4b4f-ac42-45986bb93372"}, {"Element": "<td style=\"width:232.2pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"310\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">10 \u2013 50\u00a0ml</span></p>\n</td>", "ID": "46232daa-ff36-4eba-b881-2c99bad76204", "Styles": "width:232.2pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0f5afddd-b3d4-49f2-84b7-e3f1f5213b98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">10 \u2013 50\u00a0ml</span></p>", "ID": "252c9429-1905-4dfc-8aee-47f1c0e497b1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "46232daa-ff36-4eba-b881-2c99bad76204"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">10 \u2013 50\u00a0ml</span>", "ID": "79647ef1-2b10-4952-908a-dcf7f277cf37", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "10 \u2013 50\u00a0ml", "ParentId": "252c9429-1905-4dfc-8aee-47f1c0e497b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "525670ce-e23f-47fe-96f9-e917c018f3c8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2cdbdf19-a2c9-47a8-b8f8-d2a0fcb29a76", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "525670ce-e23f-47fe-96f9-e917c018f3c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "564fe4f6-3a95-48d9-bb7c-d07b129fd785", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6895565d-6125-4ac1-93a5-6333477c6702", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "564fe4f6-3a95-48d9-bb7c-d07b129fd785"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER,\nDONATION AND PRODUCT CODES</span></b></p>\n</div>", "ID": "09795240-03ad-44f9-941a-f68750b20e12", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER,\nDONATION AND PRODUCT CODES</span></b></p>", "ID": "b88a3edb-d04c-412b-855c-455eb4bb71bb", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "09795240-03ad-44f9-941a-f68750b20e12"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER,\nDONATION AND PRODUCT CODES</span></b>", "ID": "0da25114-dfc6-4414-b76c-49e0506ab259", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b88a3edb-d04c-412b-855c-455eb4bb71bb"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER,\nDONATION AND PRODUCT CODES</span>", "ID": "0faa0d88-c161-4632-a3bf-52d88277e006", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER, DONATION AND PRODUCT CODES", "ParentId": "0da25114-dfc6-4414-b76c-49e0506ab259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "83e37286-1ada-4667-b020-4d14faa58d15", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8df65d71-888a-4677-a861-f58f4561df94", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "83e37286-1ada-4667-b020-4d14faa58d15"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Name:</span></p>", "ID": "aefd148c-1357-4091-9931-e55c53d6f4cf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Name:</span>", "ID": "a3aca860-a704-48ef-86bd-64f099b830cb", "Styles": "None", "Classes": "None", "Text": "Name:", "ParentId": "aefd148c-1357-4091-9931-e55c53d6f4cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of birth: <span style=\"color:black;background:#D9D9D9\">{DD MMM YYYY}</span></span></p>", "ID": "637efc05-79f4-449f-b633-f8e9dc3b70c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Date of birth: <span style=\"color:black;background:#D9D9D9\">{DD MMM YYYY}</span></span>", "ID": "93706c79-27c1-400c-8222-c550ad29f242", "Styles": "None", "Classes": "None", "Text": "Date of birth: ", "ParentId": "637efc05-79f4-449f-b633-f8e9dc3b70c0"}, {"Element": "<span style=\"color:black;background:#D9D9D9\">{DD MMM YYYY}</span>", "ID": "a44abef9-bace-4cf5-bc3b-acf075aa970a", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "{DD MMM YYYY}", "ParentId": "93706c79-27c1-400c-8222-c550ad29f242"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Aph ID/DIN:</span></p>", "ID": "373d6e7e-159c-493e-bcaa-696645cf8fed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Aph ID/DIN:</span>", "ID": "baf15933-b435-4c16-8ec6-69fff110bafb", "Styles": "None", "Classes": "None", "Text": "Aph ID/DIN:", "ParentId": "373d6e7e-159c-493e-bcaa-696645cf8fed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Batch:</span></p>", "ID": "f554e4f1-5e8f-4252-bf76-fcab558b4cc0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Batch:</span>", "ID": "e50f551c-13f3-49c9-ab5b-13075fd1f90a", "Styles": "None", "Classes": "None", "Text": "Batch:", "ParentId": "f554e4f1-5e8f-4252-bf76-fcab558b4cc0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Bag <span style=\"color:black;background:#D9D9D9\">x</span></span></p>", "ID": "9aba6486-c0f6-4fb6-8461-82d3ca4cfdfc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Bag <span style=\"color:black;background:#D9D9D9\">x</span></span>", "ID": "e5774470-84fe-4616-a7b6-202c855d4899", "Styles": "None", "Classes": "None", "Text": "Bag ", "ParentId": "9aba6486-c0f6-4fb6-8461-82d3ca4cfdfc"}, {"Element": "<span style=\"color:black;background:#D9D9D9\">x</span>", "ID": "c2298225-8551-485c-a543-664e9745aff0", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "x", "ParentId": "e5774470-84fe-4616-a7b6-202c855d4899"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3f3e4424-01a4-40cb-9d41-7c4763ed73b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cdf909fb-9ac1-4d62-9c40-8758cb11659a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3f3e4424-01a4-40cb-9d41-7c4763ed73b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "128d9f33-1f8e-446c-8635-46a8fe053a9a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6205e2f2-02f3-420d-96c2-0e396c23cf90", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "128d9f33-1f8e-446c-8635-46a8fe053a9a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "4aa147cb-5ff2-46da-9eb2-b5a4979c106c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "32ed75d5-ecb9-49ed-a693-a6293b7d72e9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4aa147cb-5ff2-46da-9eb2-b5a4979c106c"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span></b>", "ID": "ae8f1c1d-b73d-4b65-98cc-66e9a494b3ce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "32ed75d5-ecb9-49ed-a693-a6293b7d72e9"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL\nCLASSIFICATION FOR SUPPLY</span>", "ID": "8810bc4e-f4d0-4c72-9886-b4ab9b0655f7", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "ae8f1c1d-b73d-4b65-98cc-66e9a494b3ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d6f34c2-c9cb-48da-b779-25e662e209b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bdde2c24-e3d3-42cd-8d8a-d30b40dd0cf7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d6f34c2-c9cb-48da-b779-25e662e209b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "618ee5c9-f4f5-46c1-9111-443cc1367db8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "70aac764-ebfd-40ce-beea-9241a4936196", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "618ee5c9-f4f5-46c1-9111-443cc1367db8"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "44f2abb3-bd78-4b5d-b82f-df2c3b3b49f0", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "949c11bf-f7a9-42b1-b251-a29140613d90", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44f2abb3-bd78-4b5d-b82f-df2c3b3b49f0"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "d8e78782-692e-43d2-a8b3-3155727107da", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "949c11bf-f7a9-42b1-b251-a29140613d90"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "c4ce0955-b675-4286-a775-ff89d89ede9a", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "d8e78782-692e-43d2-a8b3-3155727107da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c0e3d70a-7e49-4a12-b7c3-396aecee234a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "30ca97cf-2298-4073-8183-e3ab866c1de9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c0e3d70a-7e49-4a12-b7c3-396aecee234a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f526b8cf-73d9-493f-a744-0d468400f9b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "50665f24-0411-418f-aa11-eaa564046d0d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f526b8cf-73d9-493f-a744-0d468400f9b5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN\nBRAILLE</span></b></p>\n</div>", "ID": "a254a373-ed95-45ad-aec8-06e7468cd006", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN\nBRAILLE</span></b></p>", "ID": "163f5906-047a-4b09-b323-cac50af3d5ae", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a254a373-ed95-45ad-aec8-06e7468cd006"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN\nBRAILLE</span></b>", "ID": "d4279a46-3c06-4445-a157-ad62a94e2d90", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "163f5906-047a-4b09-b323-cac50af3d5ae"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN\nBRAILLE</span>", "ID": "65349bbf-5e8e-4a4c-8e78-68828c0a4c9f", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "d4279a46-3c06-4445-a157-ad62a94e2d90"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26220643-af92-4c73-98ad-991183e56eab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05122d0f-92bc-4f70-ab37-0c76d5b815bf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26220643-af92-4c73-98ad-991183e56eab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Justification for not including Braille\naccepted.</span></p>", "ID": "4c94f6aa-7706-4fa9-9570-20902459be7f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Justification for not including Braille\naccepted.</span>", "ID": "2df9a0cb-67a9-4469-a30b-b896f53fea0f", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Justification for not including Braille accepted.", "ParentId": "4c94f6aa-7706-4fa9-9570-20902459be7f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "9d22be74-09a3-4e2e-87af-65756e95456c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "62abaad4-0d56-43ff-98ec-705394122442", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "9d22be74-09a3-4e2e-87af-65756e95456c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "3b8384f3-dd60-4648-88e6-4e8a97f78f28", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "4c448ff9-3c7c-4066-93fc-01f5ad2b1c96", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "3b8384f3-dd60-4648-88e6-4e8a97f78f28"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "b29ed3a0-31b0-4c7a-a5af-77290fa4328f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "7270900c-df73-467b-881f-577bc3dc7ac9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b29ed3a0-31b0-4c7a-a5af-77290fa4328f"}, {"Element": "<b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "3592ad22-5aad-46c0-9597-4e38cc4a8cdb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7270900c-df73-467b-881f-577bc3dc7ac9"}, {"Element": "<span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2013 2D BARCODE</span>", "ID": "d2a29e85-69b6-482e-9ecd-bb054d97ddb9", "Styles": "None", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "3592ad22-5aad-46c0-9597-4e38cc4a8cdb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>", "ID": "6e8b1881-01cc-4edc-a9b3-ee66885851f1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span>", "ID": "57d83deb-0acd-4cc2-a592-74e81afdfbca", "Styles": "background:#D9D9D9", "Classes": "None", "Text": "\u00a0", "ParentId": "6e8b1881-01cc-4edc-a9b3-ee66885851f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Not applicable</span></p>", "ID": "1033b8b4-2011-496c-9724-e031e7c03e65", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Not applicable</span>", "ID": "e5fce1f9-672b-45a9-8e19-2c4f71eaf930", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Not applicable", "ParentId": "1033b8b4-2011-496c-9724-e031e7c03e65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "ccf70b61-1969-45d1-91f3-a97ec23f5abb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "dafc667f-9708-48f6-941b-c54f419a9a4d", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "ccf70b61-1969-45d1-91f3-a97ec23f5abb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "de38fb59-9520-493e-86e9-5d4f1ce132ea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8d796415-4edd-40f7-8a93-2d3acc6a95b8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "de38fb59-9520-493e-86e9-5d4f1ce132ea"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2011 HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "b434211b-5f46-4bce-a0f8-34f62ae75369", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2011 HUMAN READABLE DATA</span></b></p>", "ID": "ea78b2ee-6a87-4c5b-bac0-93bc0dcda920", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b434211b-5f46-4bce-a0f8-34f62ae75369"}, {"Element": "<b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2011 HUMAN READABLE DATA</span></b>", "ID": "d06b0183-bd90-4566-8758-998936e79afa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea78b2ee-6a87-4c5b-bac0-93bc0dcda920"}, {"Element": "<span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE\nIDENTIFIER \u2011 HUMAN READABLE DATA</span>", "ID": "5fafe226-5aa1-4d16-984e-4f3fd98cef7f", "Styles": "None", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2011 HUMAN READABLE DATA", "ParentId": "d06b0183-bd90-4566-8758-998936e79afa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>", "ID": "c003dd9c-1c5d-414e-bc0a-2a2819dc665a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span>", "ID": "bf870035-e879-4094-a101-11ce964e845b", "Styles": "background:#D9D9D9", "Classes": "None", "Text": "\u00a0", "ParentId": "c003dd9c-1c5d-414e-bc0a-2a2819dc665a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Not applicable</span><span lang=\"EN-GB\"><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></p>", "ID": "742491b6-61d8-4f92-b3f1-9c6ea7f5d8a3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Not applicable</span>", "ID": "670ffd22-5ae8-40ed-89d3-6a5802891662", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Not applicable", "ParentId": "742491b6-61d8-4f92-b3f1-9c6ea7f5d8a3"}, {"Element": "<span lang=\"EN-GB\"><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "7f8bd166-b144-45b6-8cc7-753d1665d78b", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "742491b6-61d8-4f92-b3f1-9c6ea7f5d8a3"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "34161d09-871e-4e00-af80-393e00ed0ba4", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "7f8bd166-b144-45b6-8cc7-753d1665d78b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c5cc9971-3019-4662-a68b-8a8e6578517b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aebf5baf-a6f8-4f3f-8c78-33882102ef6b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c5cc9971-3019-4662-a68b-8a8e6578517b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df6be11d-94db-49e7-ad18-b455e6ef716d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bddf7ab2-588c-4245-87a4-d5fb32174bd9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df6be11d-94db-49e7-ad18-b455e6ef716d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f47989a3-d9d0-4c05-9568-0d8e1b2721bb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e2a71172-8390-4b81-ae2a-977930f7446e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f47989a3-d9d0-4c05-9568-0d8e1b2721bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ed72f3e6-d971-4b6e-9336-dc6a102ffb83", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "924029c5-a480-429b-9c6d-7634b4d7cd60", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed72f3e6-d971-4b6e-9336-dc6a102ffb83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "330b9c4e-f599-43ed-972a-0b38dd90bb19", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ee236712-6c34-4f8c-888a-627a0e26f554", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "330b9c4e-f599-43ed-972a-0b38dd90bb19"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e17df44e-0f23-44bf-b948-eaf462e3e083", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "837edd74-1d3f-4f6e-b1ca-e24385ae7813", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e17df44e-0f23-44bf-b948-eaf462e3e083"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "134e37c6-0730-4145-a580-71864d729c17", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f57bee3c-af0a-4cfc-b079-3a99ad12c9dd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "134e37c6-0730-4145-a580-71864d729c17"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3301b7e5-f223-40e0-9c55-b2845bd08dc4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b36bbbb8-48cf-4032-8f18-f5003d0b4c13", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3301b7e5-f223-40e0-9c55-b2845bd08dc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba9bdcf4-7ad9-4446-a9bd-c8df86ca4eba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "80f709bc-c159-4416-b296-1fdbc17f434d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba9bdcf4-7ad9-4446-a9bd-c8df86ca4eba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "38351932-e252-4d1b-9455-5cb2898b4bc1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e83cd4b5-739a-4b10-8619-65df4396d55c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "38351932-e252-4d1b-9455-5cb2898b4bc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b1d20091-e154-431e-a6c7-e756d05ac026", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e6a07bda-2d3e-4d36-beeb-95e052c4daae", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b1d20091-e154-431e-a6c7-e756d05ac026"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1b650d3a-e6ee-469b-8f49-6798ea80a6c6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b6a937c-3fa9-41c0-81dc-d60a06f37c44", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1b650d3a-e6ee-469b-8f49-6798ea80a6c6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "79383949-514f-409e-b767-6a018f35ad5a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3c583e91-c529-4879-8c46-2194d4374f2e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "79383949-514f-409e-b767-6a018f35ad5a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7840e81f-4fb2-42b0-9606-fa2a83d6dc54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "55ef678d-27a2-4b4a-a4cc-b226317d227c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7840e81f-4fb2-42b0-9606-fa2a83d6dc54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4aed0400-7d2b-49e9-8d6d-da52f3842321", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "35a277b6-fef1-4e70-be67-cad0fac0c65c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4aed0400-7d2b-49e9-8d6d-da52f3842321"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7ab08738-1712-42d8-9faf-6b5a374127e7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5a7cfffc-49ea-43e0-a8ea-1a55de70b163", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7ab08738-1712-42d8-9faf-6b5a374127e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "918b2974-5358-4c0a-9f32-f9e42192ac57", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cb2ad6cf-0bfa-486c-943a-80d19adbe937", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "918b2974-5358-4c0a-9f32-f9e42192ac57"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "02642e1c-78c6-4560-8911-797dd30eb86e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6c9bcba8-6f0b-493c-85bc-3da87a0a3568", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "02642e1c-78c6-4560-8911-797dd30eb86e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0fbd2ea5-5bbb-47c3-adc3-519d12901c11", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "86b97380-897a-42c2-8ddf-7e2105cff66f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0fbd2ea5-5bbb-47c3-adc3-519d12901c11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e9e2770-b9c4-4bad-aa14-90faf74a8d34", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fe644a61-6c2a-4a17-858a-823bcff5329a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e9e2770-b9c4-4bad-aa14-90faf74a8d34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1e81fc70-2bdb-4390-b132-1b8b18292b89", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "58a3e1ac-eb43-4a67-8f02-53fbb19f667d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1e81fc70-2bdb-4390-b132-1b8b18292b89"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f1ff6d03-82c5-461e-ab96-32ddc2c31215", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "091842bf-7b54-4c5b-8359-f2860b14381d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f1ff6d03-82c5-461e-ab96-32ddc2c31215"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></b></p>", "ID": "eed9a5ba-5f8d-453b-83b5-525d41b1fb07", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></b>", "ID": "38f3d039-8b33-4e87-bc3a-4149ecae0ba0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eed9a5ba-5f8d-453b-83b5-525d41b1fb07"}, {"Element": "<span lang=\"EN-GB\">B. PACKAGE LEAFLET</span>", "ID": "edaed2e1-cac5-4a6f-8b13-d3321c6c1c03", "Styles": "None", "Classes": "None", "Text": "B. PACKAGE LEAFLET", "ParentId": "38f3d039-8b33-4e87-bc3a-4149ecae0ba0"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "e6f01a1e-9dd2-40c7-8271-fae314135d98", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "f94a77c3-8e85-42a9-b300-64d375f0e625", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "e6f01a1e-9dd2-40c7-8271-fae314135d98"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the patient or carer</span></b></p>", "ID": "4a42c085-2b9a-4e88-8497-60251c523065", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Package leaflet: Information for the patient or carer</span></b>", "ID": "fdb1e471-f577-4e4f-9711-0c1e191fb633", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4a42c085-2b9a-4e88-8497-60251c523065"}, {"Element": "<span lang=\"EN-GB\">Package leaflet: Information for the patient or carer</span>", "ID": "d5768b70-bb7f-49d0-b9af-15dd6737c67a", "Styles": "None", "Classes": "None", "Text": "Package leaflet: Information for the patient or carer", "ParentId": "fdb1e471-f577-4e4f-9711-0c1e191fb633"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1844efb6-26fe-45d7-81ee-fece3d2ef544", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9902b082-a5c9-4926-b556-c309f0986127", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1844efb6-26fe-45d7-81ee-fece3d2ef544"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"FR-CH\">Kymriah 1.</span></b><b><span lang=\"FR-CH\">2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells</span></b><b><span lang=\"FR-CH\"> dispersion for infusion</span></b></p>", "ID": "81696c0c-40d6-4699-89ca-9cd61967229a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"FR-CH\">Kymriah 1.</span></b>", "ID": "c52e9e04-5c8f-4369-8e41-07974fa57d36", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81696c0c-40d6-4699-89ca-9cd61967229a"}, {"Element": "<span lang=\"FR-CH\">Kymriah 1.</span>", "ID": "572fbce4-691a-4025-acc9-e0124290034e", "Styles": "None", "Classes": "None", "Text": "Kymriah 1.", "ParentId": "c52e9e04-5c8f-4369-8e41-07974fa57d36"}, {"Element": "<b><span lang=\"FR-CH\">2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells</span></b>", "ID": "fd6b7dc7-e168-4c0c-b7ea-caa4f647fbcf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81696c0c-40d6-4699-89ca-9cd61967229a"}, {"Element": "<span lang=\"FR-CH\">2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8</sup>\ncells</span>", "ID": "23589668-83d4-4d91-b7c1-378223f4ce40", "Styles": "None", "Classes": "None", "Text": "2\u00a0x\u00a010\u00a0\u2013\u00a06\u00a0x\u00a010 cells", "ParentId": "fd6b7dc7-e168-4c0c-b7ea-caa4f647fbcf"}, {"Element": "<sup>6</sup>", "ID": "28c9b85e-ba15-447d-bda5-04fddca24cba", "Styles": "None", "Classes": "None", "Text": "6", "ParentId": "23589668-83d4-4d91-b7c1-378223f4ce40"}, {"Element": "<sup>8</sup>", "ID": "2a31c2c6-752d-4f8d-a1cb-f12e59fc57a2", "Styles": "None", "Classes": "None", "Text": "8", "ParentId": "23589668-83d4-4d91-b7c1-378223f4ce40"}, {"Element": "<b><span lang=\"FR-CH\"> dispersion for infusion</span></b>", "ID": "fbd3315a-dcca-4d27-ac22-d822d9819c93", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81696c0c-40d6-4699-89ca-9cd61967229a"}, {"Element": "<span lang=\"FR-CH\"> dispersion for infusion</span>", "ID": "56a06f2e-ff93-4428-bf6a-1f470aad54a3", "Styles": "None", "Classes": "None", "Text": " dispersion for infusion", "ParentId": "fbd3315a-dcca-4d27-ac22-d822d9819c93"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"FR-CH\">tisagenlecleucel (CAR+ viable T cells)</span></p>", "ID": "3a761647-54f8-4ed9-a901-611d323ed820", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">tisagenlecleucel (CAR+ viable T cells)</span>", "ID": "684c49bd-a248-4606-bfa6-76451d4ce8f0", "Styles": "None", "Classes": "None", "Text": "tisagenlecleucel (CAR+ viable T cells)", "ParentId": "3a761647-54f8-4ed9-a901-611d323ed820"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>", "ID": "fa73c3c4-384f-4db6-8b28-27766fde4510", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\">\u00a0</span>", "ID": "8e23f914-4e9c-482f-a182-63532a1a5330", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa73c3c4-384f-4db6-8b28-27766fde4510"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Picture 1\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image002.gif\" width=\"21\"/></span><span lang=\"EN-GB\">This medicine is subject to\nadditional monitoring. This will allow quick identification of new safety\ninformation. You can help by reporting any side effects you may get. See the\nend of section\u00a04 for how to report side effects.</span></p>", "ID": "a61ad07b-fba2-412f-a99c-920e4c2dc13e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Picture 1\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image002.gif\" width=\"21\"/></span>", "ID": "fb826d2d-0e5b-4ddf-b54f-9acdef1d2430", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a61ad07b-fba2-412f-a99c-920e4c2dc13e"}, {"Element": "<img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Picture 1\" src=\"Kymriah%20II-30%20-%20EN%20PI%20clean_files/image002.gif\" width=\"21\"/>", "ID": "49713166-547e-48b8-9ddc-c609baec1710", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fb826d2d-0e5b-4ddf-b54f-9acdef1d2430"}, {"Element": "<span lang=\"EN-GB\">This medicine is subject to\nadditional monitoring. This will allow quick identification of new safety\ninformation. You can help by reporting any side effects you may get. See the\nend of section\u00a04 for how to report side effects.</span>", "ID": "45e44e72-6794-4a6c-af21-85e321da0eac", "Styles": "None", "Classes": "None", "Text": "This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section\u00a04 for how to report side effects.", "ParentId": "a61ad07b-fba2-412f-a99c-920e4c2dc13e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d349005f-73f2-4705-82dc-9c64045a7a11", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "42f053f4-d7cd-4401-b4cd-3a446c0378f3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d349005f-73f2-4705-82dc-9c64045a7a11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you (or your child) are given this medicine\nbecause it contains important information.</span></b></p>", "ID": "94523e87-eb49-4b14-94b2-2a77f90887fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you (or your child) are given this medicine\nbecause it contains important information.</span></b>", "ID": "8926c410-d80d-4f88-acfb-97f8d20370c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "94523e87-eb49-4b14-94b2-2a77f90887fd"}, {"Element": "<span lang=\"EN-GB\">Read all of\nthis leaflet carefully before you (or your child) are given this medicine\nbecause it contains important information.</span>", "ID": "0769d57f-2cbd-4377-9dbe-d003822ea840", "Styles": "None", "Classes": "None", "Text": "Read all of this leaflet carefully before you (or your child) are given this medicine because it contains important information.", "ParentId": "8926c410-d80d-4f88-acfb-97f8d20370c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain.</span></p>", "ID": "d84c811f-0510-476b-9e63-d30e7bdc05e7", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c3924f65-09d4-440d-a9f2-b20477db202a", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "d84c811f-0510-476b-9e63-d30e7bdc05e7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6e63d1cb-bb6f-4b29-8a23-69ad6d34fc12", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c3924f65-09d4-440d-a9f2-b20477db202a"}, {"Element": "<span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain.</span>", "ID": "593b004e-336a-4c5c-9c65-fc4d75b13acd", "Styles": "None", "Classes": "None", "Text": "Keep this leaflet. You may need to read it again.", "ParentId": "d84c811f-0510-476b-9e63-d30e7bdc05e7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor.</span></p>", "ID": "3a3d86d1-501d-47ac-b0c1-0b3cb2d5d92c", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3c2b62e7-d896-4115-a185-a243eda1dd6c", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "3a3d86d1-501d-47ac-b0c1-0b3cb2d5d92c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4b7084b1-78f3-4d7c-8a79-96cc79994574", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3c2b62e7-d896-4115-a185-a243eda1dd6c"}, {"Element": "<span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor.</span>", "ID": "0aae46bb-32d9-462e-890c-efd488e7895f", "Styles": "None", "Classes": "None", "Text": "If you have any further questions, ask your doctor.", "ParentId": "3a3d86d1-501d-47ac-b0c1-0b3cb2d5d92c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you get any side effects, talk to your\ndoctor.</span><span lang=\"EN-GB\" style=\"color:red\"> </span><span lang=\"EN-GB\">This\nincludes any possible side effects not listed in this leaflet. See section\u00a04.</span></p>", "ID": "8b925852-5d36-497a-8cbd-a97090529478", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f3d8e635-b3d9-49e5-b1d4-ebeb9217bb22", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "8b925852-5d36-497a-8cbd-a97090529478"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ea4f4c79-bf35-4d13-92cd-fa60d26d7a98", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f3d8e635-b3d9-49e5-b1d4-ebeb9217bb22"}, {"Element": "<span lang=\"EN-GB\">If you get any side effects, talk to your\ndoctor.</span>", "ID": "1e2ed532-14f0-429a-bac0-264c4952054f", "Styles": "None", "Classes": "None", "Text": "If you get any side effects, talk to your doctor.", "ParentId": "8b925852-5d36-497a-8cbd-a97090529478"}, {"Element": "<span lang=\"EN-GB\" style=\"color:red\"> </span>", "ID": "83ae46dd-b25b-424f-8117-9bff3b3403c6", "Styles": "color:red", "Classes": "None", "Text": " ", "ParentId": "8b925852-5d36-497a-8cbd-a97090529478"}, {"Element": "<span lang=\"EN-GB\">This\nincludes any possible side effects not listed in this leaflet. See section\u00a04.</span>", "ID": "d11f5bda-2747-45fc-97de-85ec108f675b", "Styles": "None", "Classes": "None", "Text": "This includes any possible side effects not listed in this leaflet. See section\u00a04.", "ParentId": "8b925852-5d36-497a-8cbd-a97090529478"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will give you a Patient Alert Card.\nRead it carefully and follow the instructions on it.</span></p>", "ID": "93c0f57b-a0c0-4dad-a2fa-16949075e4c2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d82d0687-a551-4e2f-bb02-cb4eaeba4508", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "93c0f57b-a0c0-4dad-a2fa-16949075e4c2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "11bb1918-b351-464b-92c5-bda120b2d30f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d82d0687-a551-4e2f-bb02-cb4eaeba4508"}, {"Element": "<span lang=\"EN-GB\">Your doctor will give you a Patient Alert Card.\nRead it carefully and follow the instructions on it.</span>", "ID": "a35e93f7-7aba-4989-86e9-fca797937a55", "Styles": "None", "Classes": "None", "Text": "Your doctor will give you a Patient Alert Card. Read it carefully and follow the instructions on it.", "ParentId": "93c0f57b-a0c0-4dad-a2fa-16949075e4c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Always show the Patient Alert Card to the doctor\nor nurse when you see them or if you go to hospital.</span></p>", "ID": "5a0e7515-750f-4a99-a30f-be41cb4c7947", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0e462e12-7241-4415-932b-fd277370e369", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "5a0e7515-750f-4a99-a30f-be41cb4c7947"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "eb206131-8465-415d-8539-c0122c1dcd33", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0e462e12-7241-4415-932b-fd277370e369"}, {"Element": "<span lang=\"EN-GB\">Always show the Patient Alert Card to the doctor\nor nurse when you see them or if you go to hospital.</span>", "ID": "c20f7e8c-7fcf-4ed3-9704-83c8771d53bd", "Styles": "None", "Classes": "None", "Text": "Always show the Patient Alert Card to the doctor or nurse when you see them or if you go to hospital.", "ParentId": "5a0e7515-750f-4a99-a30f-be41cb4c7947"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The information in this leaflet is for you or\nyour child \u2013 but in the leaflet it will just say \u201cyou\u201d.</span></p>", "ID": "33addc35-4cd8-484e-95c3-3b1ea8b2b15a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d31ef202-e7f3-4bf4-ac52-7c8c08fc8af3", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "33addc35-4cd8-484e-95c3-3b1ea8b2b15a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "62f9bfb4-891a-4af6-93f0-69e200912acc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d31ef202-e7f3-4bf4-ac52-7c8c08fc8af3"}, {"Element": "<span lang=\"EN-GB\">The information in this leaflet is for you or\nyour child \u2013 but in the leaflet it will just say \u201cyou\u201d.</span>", "ID": "a3891ec6-a56c-417f-8263-7d13c25e28ab", "Styles": "None", "Classes": "None", "Text": "The information in this leaflet is for you or your child \u2013 but in the leaflet it will just say \u201cyou\u201d.", "ParentId": "33addc35-4cd8-484e-95c3-3b1ea8b2b15a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d983e2f5-72eb-4d31-bda6-fc1cce0f3ac0", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e7c90c16-b626-4dff-8c95-b796aa349cff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d983e2f5-72eb-4d31-bda6-fc1cce0f3ac0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p>", "ID": "3775e3f3-5f34-4087-a7c5-ae76b006029c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">What is in this leaflet</span></b>", "ID": "0b2aea40-215f-48a3-9961-2bace7cf30f7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3775e3f3-5f34-4087-a7c5-ae76b006029c"}, {"Element": "<span lang=\"EN-GB\">What is in this leaflet</span>", "ID": "bccd336b-7245-43da-9471-6cdd906c3ddd", "Styles": "None", "Classes": "None", "Text": "What is in this leaflet", "ParentId": "0b2aea40-215f-48a3-9961-2bace7cf30f7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and what it is used for</span></p>", "ID": "96248fd8-9e68-473c-b854-adc9e2b6258e", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and what it is used for</span>", "ID": "4cd06966-192c-49d5-a80a-d52274c4601d", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and what it is used for", "ParentId": "96248fd8-9e68-473c-b854-adc9e2b6258e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you are given Kymriah</span></p>", "ID": "4ebbf782-2797-4557-9b93-704213246012", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you are given Kymriah</span>", "ID": "e78fc535-43a7-4d1c-8d64-061c7c7b4b80", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you are given Kymriah", "ParentId": "4ebbf782-2797-4557-9b93-704213246012"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is given</span></p>", "ID": "966bb75c-820d-405a-bb86-f3cfecb4b7db", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is given</span>", "ID": "5f786ec3-ae1f-45aa-bfb2-8569042146f8", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is given", "ParentId": "966bb75c-820d-405a-bb86-f3cfecb4b7db"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects</span></p>", "ID": "16c8b25e-2855-488a-9665-de03d57e3376", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects</span>", "ID": "f98e1a7a-a43b-4732-bdba-093359d01c99", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "16c8b25e-2855-488a-9665-de03d57e3376"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Kymriah</span></p>", "ID": "5f0d698e-436e-40e0-bce5-5d449323ab37", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Kymriah</span>", "ID": "12f942a3-ec04-46c8-a13f-3501a20f1f8c", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Kymriah", "ParentId": "5f0d698e-436e-40e0-bce5-5d449323ab37"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information</span></p>", "ID": "8ebb5e5e-39d9-4a4b-b32e-c216d0f81043", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information</span>", "ID": "2391f761-3513-40a3-ba89-0931696b6bdd", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information", "ParentId": "8ebb5e5e-39d9-4a4b-b32e-c216d0f81043"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "48572f64-b464-461a-8871-7d109d6d50a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7df451ac-fdb8-4afc-a121-fa5cfad5e4a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "48572f64-b464-461a-8871-7d109d6d50a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bf209fb6-6585-4a88-a09d-3b2b8d9ac4d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ef1b3a5f-7dfd-4c4e-91eb-cf4d12106be5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bf209fb6-6585-4a88-a09d-3b2b8d9ac4d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and\nwhat it is used for</span></b></p>", "ID": "963ad331-9dea-447c-b109-3da877ee94d7", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and\nwhat it is used for</span></b>", "ID": "7a028147-83aa-44af-91f9-c0b4b5138c1d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "963ad331-9dea-447c-b109-3da877ee94d7"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and\nwhat it is used for</span>", "ID": "54bccfa0-a01b-4bff-945c-696c6d483b39", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What Kymriah is and what it is used for", "ParentId": "7a028147-83aa-44af-91f9-c0b4b5138c1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60be7679-9636-4403-92f7-8c5d261fd253", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4172764a-88e6-490b-981d-c78a9af5c095", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60be7679-9636-4403-92f7-8c5d261fd253"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What </span></b><b><span lang=\"EN-GB\">Kymriah is</span></b></p>", "ID": "26fbbff0-d258-4e2b-b7d2-d053caece1d3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">What </span></b>", "ID": "77d612d0-cffb-4698-85b7-f184e84fcd41", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26fbbff0-d258-4e2b-b7d2-d053caece1d3"}, {"Element": "<span lang=\"EN-GB\">What </span>", "ID": "6111e03e-7e82-450d-8c01-90574c8d443c", "Styles": "None", "Classes": "None", "Text": "What ", "ParentId": "77d612d0-cffb-4698-85b7-f184e84fcd41"}, {"Element": "<b><span lang=\"EN-GB\">Kymriah is</span></b>", "ID": "0974f04b-c199-4d03-9beb-576510456d5e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26fbbff0-d258-4e2b-b7d2-d053caece1d3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is</span>", "ID": "b352d2a2-eac9-4e97-b6c6-ce000752e667", "Styles": "None", "Classes": "None", "Text": "Kymriah is", "ParentId": "0974f04b-c199-4d03-9beb-576510456d5e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah, also\nknown as tisagenlecleucel, is made from some of your own white blood</span><span lang=\"EN-GB\"> cells</span> called T cells. T cells <span lang=\"EN-GB\">are important\nfor your immune system (the body\u2019s defences) to work properly.</span></p>", "ID": "c37d3069-952f-46da-9554-21709c9f6d84", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": " called T cells. T cells ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah, also\nknown as tisagenlecleucel, is made from some of your own white blood</span>", "ID": "579e6b9b-7833-4812-805d-a3d4dc2f33ca", "Styles": "None", "Classes": "None", "Text": "Kymriah, also known as tisagenlecleucel, is made from some of your own white blood", "ParentId": "c37d3069-952f-46da-9554-21709c9f6d84"}, {"Element": "<span lang=\"EN-GB\"> cells</span>", "ID": "2ec97d7d-c24f-4cae-bfc4-493627ad4f85", "Styles": "None", "Classes": "None", "Text": " cells", "ParentId": "c37d3069-952f-46da-9554-21709c9f6d84"}, {"Element": "<span lang=\"EN-GB\">are important\nfor your immune system (the body\u2019s defences) to work properly.</span>", "ID": "c0584a46-cf9e-4965-8d85-dc4b6222d353", "Styles": "None", "Classes": "None", "Text": "are important for your immune system (the body\u2019s defences) to work properly.", "ParentId": "c37d3069-952f-46da-9554-21709c9f6d84"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33077b74-f9b4-4ead-b51a-b0206a26d28f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "31fa849e-1c51-4fc9-a66f-455164fefd87", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33077b74-f9b4-4ead-b51a-b0206a26d28f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How does Kymriah work?</span></b></p>", "ID": "c9c41b6a-3186-436d-afcc-a499ec7c109c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">How does Kymriah work?</span></b>", "ID": "70f5cb6e-3f41-46ac-907c-00714ca77f33", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c9c41b6a-3186-436d-afcc-a499ec7c109c"}, {"Element": "<span lang=\"EN-GB\">How does Kymriah work?</span>", "ID": "ba4733b6-1e38-4714-9b14-e7498ad92acb", "Styles": "None", "Classes": "None", "Text": "How does Kymriah work?", "ParentId": "70f5cb6e-3f41-46ac-907c-00714ca77f33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The T cells are\ntaken</span><span lang=\"EN-GB\"> from your blood and a new gene is put into the T\ncells so that they can target the cancer cells in your body. When Kymriah is\ninfused into your blood, the modified T cells will find and kill the cancer cells.</span></p>", "ID": "d5ad1893-67ca-4891-8295-19e6da9abedb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The T cells are\ntaken</span>", "ID": "d5f650a8-476b-456c-9c06-20c5d78e9bd7", "Styles": "None", "Classes": "None", "Text": "The T cells are taken", "ParentId": "d5ad1893-67ca-4891-8295-19e6da9abedb"}, {"Element": "<span lang=\"EN-GB\"> from your blood and a new gene is put into the T\ncells so that they can target the cancer cells in your body. When Kymriah is\ninfused into your blood, the modified T cells will find and kill the cancer cells.</span>", "ID": "7534847e-8a76-45f5-9e4f-226d66492b33", "Styles": "None", "Classes": "None", "Text": " from your blood and a new gene is put into the T cells so that they can target the cancer cells in your body. When Kymriah is infused into your blood, the modified T cells will find and kill the cancer cells.", "ParentId": "d5ad1893-67ca-4891-8295-19e6da9abedb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "157d7cbf-71b1-45e0-8bb9-a97b9cd03ec9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7acd31fc-d299-4edd-9bd2-e5d302bcee99", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "157d7cbf-71b1-45e0-8bb9-a97b9cd03ec9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Kymriah is used for</span></b></p>", "ID": "d756f9b3-ad67-4854-8ae1-ba315d95fb2b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">What Kymriah is used for</span></b>", "ID": "5a8e0abd-ef84-4a94-9e06-66dd46e4f890", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d756f9b3-ad67-4854-8ae1-ba315d95fb2b"}, {"Element": "<span lang=\"EN-GB\">What Kymriah is used for</span>", "ID": "cbffab05-bd4f-4561-90b6-8814cb4310a1", "Styles": "None", "Classes": "None", "Text": "What Kymriah is used for", "ParentId": "5a8e0abd-ef84-4a94-9e06-66dd46e4f890"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Kymriah is used to treat:</span></p>", "ID": "685809f8-6415-4b03-9543-9f20dbf5eb14", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is used to treat:</span>", "ID": "770e2272-7651-4033-8ade-c811ce2f5215", "Styles": "None", "Classes": "None", "Text": "Kymriah is used to treat:", "ParentId": "685809f8-6415-4b03-9543-9f20dbf5eb14"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">B\u2011cell acute lymphoblastic leukaemia (B\u2011cell\nALL)</span></b><span lang=\"EN-GB\"> \u2011 a form of cancer that affects some other\ntypes of white blood cells. The medicine can be used in children and young\nadults up to and including 25\u00a0years of age with this cancer.</span></p>", "ID": "675cda35-d1e8-44b9-922e-78f9aff01dff", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2920bdcd-18f5-4b6b-aed0-c30ca5d9aa81", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "675cda35-d1e8-44b9-922e-78f9aff01dff"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0abef62c-ff5d-423d-878e-3e4686b9032f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2920bdcd-18f5-4b6b-aed0-c30ca5d9aa81"}, {"Element": "<b><span lang=\"EN-GB\">B\u2011cell acute lymphoblastic leukaemia (B\u2011cell\nALL)</span></b>", "ID": "861925f1-2e5b-4deb-9862-efa2db9daac9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "675cda35-d1e8-44b9-922e-78f9aff01dff"}, {"Element": "<span lang=\"EN-GB\">B\u2011cell acute lymphoblastic leukaemia (B\u2011cell\nALL)</span>", "ID": "e0262000-55b5-4cf6-a2ab-96878675ef66", "Styles": "None", "Classes": "None", "Text": "B\u2011cell acute lymphoblastic leukaemia (B\u2011cell ALL)", "ParentId": "861925f1-2e5b-4deb-9862-efa2db9daac9"}, {"Element": "<span lang=\"EN-GB\"> \u2011 a form of cancer that affects some other\ntypes of white blood cells. The medicine can be used in children and young\nadults up to and including 25\u00a0years of age with this cancer.</span>", "ID": "ecd209cb-46cf-4bd1-9530-364b60ca6942", "Styles": "None", "Classes": "None", "Text": " \u2011 a form of cancer that affects some other types of white blood cells. The medicine can be used in children and young adults up to and including 25\u00a0years of age with this cancer.", "ParentId": "675cda35-d1e8-44b9-922e-78f9aff01dff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Diffuse</span></b><b><span lang=\"EN-GB\"> large\nB\u2011cell lymphoma (DLBCL)</span></b><span lang=\"EN-GB\"> \u2011</span><span lang=\"EN-GB\"> another form of cancer that affects some types of white blood\ncells, mostly in the lymph nodes. The medicine can be used in adults\n(18\u00a0years of age or older) with this cancer.</span></p>", "ID": "e5fe6c23-6ca8-44ae-b585-a898c5fb928e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "38208ed3-c6cb-4941-b1ce-df6a0b92b581", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e5fe6c23-6ca8-44ae-b585-a898c5fb928e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "37b824b1-0657-401a-afce-65c4b455d6d3", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "38208ed3-c6cb-4941-b1ce-df6a0b92b581"}, {"Element": "<b><span lang=\"EN-GB\">Diffuse</span></b>", "ID": "dc0cf3fe-1e1d-47b6-aa91-2135f87dc4d9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e5fe6c23-6ca8-44ae-b585-a898c5fb928e"}, {"Element": "<span lang=\"EN-GB\">Diffuse</span>", "ID": "f407a169-64fe-4c2f-b89e-e3d732517b98", "Styles": "None", "Classes": "None", "Text": "Diffuse", "ParentId": "dc0cf3fe-1e1d-47b6-aa91-2135f87dc4d9"}, {"Element": "<b><span lang=\"EN-GB\"> large\nB\u2011cell lymphoma (DLBCL)</span></b>", "ID": "3bbd9a61-b754-4001-8ad4-4e1ff7155671", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e5fe6c23-6ca8-44ae-b585-a898c5fb928e"}, {"Element": "<span lang=\"EN-GB\"> large\nB\u2011cell lymphoma (DLBCL)</span>", "ID": "551307a3-71d7-4dc3-8ee9-22d61c3ad6be", "Styles": "None", "Classes": "None", "Text": " large B\u2011cell lymphoma (DLBCL)", "ParentId": "3bbd9a61-b754-4001-8ad4-4e1ff7155671"}, {"Element": "<span lang=\"EN-GB\"> \u2011</span>", "ID": "445f03ae-880d-441f-888c-7cb71ae08653", "Styles": "None", "Classes": "None", "Text": " \u2011", "ParentId": "e5fe6c23-6ca8-44ae-b585-a898c5fb928e"}, {"Element": "<span lang=\"EN-GB\"> another form of cancer that affects some types of white blood\ncells, mostly in the lymph nodes. The medicine can be used in adults\n(18\u00a0years of age or older) with this cancer.</span>", "ID": "14a4e6d9-a392-4742-998b-8e28e8ccad51", "Styles": "None", "Classes": "None", "Text": " another form of cancer that affects some types of white blood cells, mostly in the lymph nodes. The medicine can be used in adults (18\u00a0years of age or older) with this cancer.", "ParentId": "e5fe6c23-6ca8-44ae-b585-a898c5fb928e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33722b9d-7e7d-4fc6-b75e-5b7a8c5702c1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f285583a-4cd1-4346-a2ff-7a39653f5c24", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33722b9d-7e7d-4fc6-b75e-5b7a8c5702c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any\nquestions about how Kymriah works or why this medicine has been prescribed for\nyou, ask your doctor.</span></p>", "ID": "2b61911d-29f0-4b68-b1c1-0da95cfb5820", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If you have any\nquestions about how Kymriah works or why this medicine has been prescribed for\nyou, ask your doctor.</span>", "ID": "b02429dd-f1af-4c26-9e68-9642427c8239", "Styles": "None", "Classes": "None", "Text": "If you have any questions about how Kymriah works or why this medicine has been prescribed for you, ask your doctor.", "ParentId": "2b61911d-29f0-4b68-b1c1-0da95cfb5820"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "23136f1c-f1fd-47d0-965c-75b5e3d5e0f6", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "adc452e7-65c9-438e-82c2-faee97b193a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "23136f1c-f1fd-47d0-965c-75b5e3d5e0f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fb3887e5-c85b-4681-b983-4f7edf7935b5", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b87124db-4e6b-465b-8842-511d5cad78cb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fb3887e5-c85b-4681-b983-4f7edf7935b5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to\nknow before you are given Kymriah</span></b></p>", "ID": "07501e95-c0d4-4a80-af81-b88e45dd355e", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to\nknow before you are given Kymriah</span></b>", "ID": "c568397a-c316-4b98-87a7-045411dd5803", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07501e95-c0d4-4a80-af81-b88e45dd355e"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to\nknow before you are given Kymriah</span>", "ID": "18572fbe-dd97-463d-96cb-c8317d3851ee", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you are given Kymriah", "ParentId": "c568397a-c316-4b98-87a7-045411dd5803"}, {"Element": "<p class=\"MsoNormal\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7795a9d9-897b-4679-a915-bfc5937d2667", "Styles": "page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4a7d454-992f-4e46-9ea1-6568d53a1494", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7795a9d9-897b-4679-a915-bfc5937d2667"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">You should not be given Kymriah:</span></b></p>", "ID": "ed479c4b-3432-4d33-99ab-2e9fd4291aa5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">You should not be given Kymriah:</span></b>", "ID": "82e6f282-fc9c-4e41-bb22-456fbceb907c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed479c4b-3432-4d33-99ab-2e9fd4291aa5"}, {"Element": "<span lang=\"EN-GB\">You should not be given Kymriah:</span>", "ID": "4d0417fc-3ee9-4998-80ea-2d94be779383", "Styles": "None", "Classes": "None", "Text": "You should not be given Kymriah:", "ParentId": "82e6f282-fc9c-4e41-bb22-456fbceb907c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">if you are allergic to any of the ingredients of\nthis medicine (listed in section\u00a06).</span><span lang=\"EN-GB\"> If you think\nyou may be allergic, ask your doctor for advice.</span></p>", "ID": "61e3cad8-666c-43c3-8f29-2b8a6cb754fa", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d2ebde22-bc65-4bee-9ea3-ae6329d71a08", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "61e3cad8-666c-43c3-8f29-2b8a6cb754fa"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "09335961-f3a5-453c-9cd3-3a9a09f1c0d1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d2ebde22-bc65-4bee-9ea3-ae6329d71a08"}, {"Element": "<span lang=\"EN-GB\">if you are allergic to any of the ingredients of\nthis medicine (listed in section\u00a06).</span>", "ID": "980fd334-a39f-4c28-87e2-2f263abbddde", "Styles": "None", "Classes": "None", "Text": "if you are allergic to any of the ingredients of this medicine (listed in section\u00a06).", "ParentId": "61e3cad8-666c-43c3-8f29-2b8a6cb754fa"}, {"Element": "<span lang=\"EN-GB\"> If you think\nyou may be allergic, ask your doctor for advice.</span>", "ID": "39c59aae-eb83-4ea5-8b4b-cc59d13652ef", "Styles": "None", "Classes": "None", "Text": " If you think you may be allergic, ask your doctor for advice.", "ParentId": "61e3cad8-666c-43c3-8f29-2b8a6cb754fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "de1d5a82-2332-4bb3-b18d-0ce2f40b6b07", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "13bc1cf5-a8bb-48e0-89fd-391b84315371", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "de1d5a82-2332-4bb3-b18d-0ce2f40b6b07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p>", "ID": "48c94422-5371-4df5-b440-4834f2c12678", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Warnings and precautions</span></b>", "ID": "c1e4522f-a704-452d-934c-666737e67cf2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "48c94422-5371-4df5-b440-4834f2c12678"}, {"Element": "<span lang=\"EN-GB\">Warnings and precautions</span>", "ID": "5629ffe7-b801-4889-bbee-785cd8e02ba1", "Styles": "None", "Classes": "None", "Text": "Warnings and precautions", "ParentId": "c1e4522f-a704-452d-934c-666737e67cf2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is made\nfrom your own white blood cells and should only be given to you.</span></p>", "ID": "4cea7af7-7835-479a-9d5a-04cb2161511f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is made\nfrom your own white blood cells and should only be given to you.</span>", "ID": "4c6b9189-8136-4d49-af51-88541da74e3d", "Styles": "None", "Classes": "None", "Text": "Kymriah is made from your own white blood cells and should only be given to you.", "ParentId": "4cea7af7-7835-479a-9d5a-04cb2161511f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "427e8be1-3167-4655-8bba-74b7c03159d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "16eb3548-d30b-4c4a-847f-7f11ca03b9fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "427e8be1-3167-4655-8bba-74b7c03159d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Before you are given Kymriah you should tell your doctor if:</span></b></p>", "ID": "46ea568e-0797-4534-9811-5ac1c575ed97", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Before you are given Kymriah you should tell your doctor if:</span></b>", "ID": "88f4e207-a663-4a38-9acd-ef6859f629d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46ea568e-0797-4534-9811-5ac1c575ed97"}, {"Element": "<span lang=\"EN-GB\">Before you are given Kymriah you should tell your doctor if:</span>", "ID": "c20a3181-6a96-4c1d-a1e7-4d0bbf38033d", "Styles": "None", "Classes": "None", "Text": "Before you are given Kymriah you should tell your doctor if:", "ParentId": "88f4e207-a663-4a38-9acd-ef6859f629d4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have had a stem cell transplant in the last 4\u00a0months.\nYour doctor will check if you have signs or symptoms of graft\u2011versus\u2011host\ndisease. This happens when transplanted cells attack your body, causing\nsymptoms such as rash, nausea, vomiting, diarrhoea and bloody stools.</span></p>", "ID": "cadb2b1d-d154-4782-a6e6-5e004c0906af", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "25707353-530a-495c-883e-0402695cd642", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cadb2b1d-d154-4782-a6e6-5e004c0906af"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "3b2649c0-90c2-4249-9fd5-a4f91ed4bf39", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "25707353-530a-495c-883e-0402695cd642"}, {"Element": "<span lang=\"EN-GB\">You have had a stem cell transplant in the last 4\u00a0months.\nYour doctor will check if you have signs or symptoms of graft\u2011versus\u2011host\ndisease. This happens when transplanted cells attack your body, causing\nsymptoms such as rash, nausea, vomiting, diarrhoea and bloody stools.</span>", "ID": "cea4e31d-0fdb-4428-a62c-2b451f42892b", "Styles": "None", "Classes": "None", "Text": "You have had a stem cell transplant in the last 4\u00a0months. Your doctor will check if you have signs or symptoms of graft\u2011versus\u2011host disease. This happens when transplanted cells attack your body, causing symptoms such as rash, nausea, vomiting, diarrhoea and bloody stools.", "ParentId": "cadb2b1d-d154-4782-a6e6-5e004c0906af"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have any lung, heart or blood pressure (low\nor raised) problems.</span></p>", "ID": "54ce3133-3167-408b-89dd-0cc62d17f724", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b5a11532-fb0e-4c5d-804d-02580a8f9f2c", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "54ce3133-3167-408b-89dd-0cc62d17f724"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8a805201-4cc5-434b-95f1-8fe153c54ddf", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b5a11532-fb0e-4c5d-804d-02580a8f9f2c"}, {"Element": "<span lang=\"EN-GB\">You have any lung, heart or blood pressure (low\nor raised) problems.</span>", "ID": "a0763551-5428-46a5-acb8-83ada26a57c8", "Styles": "None", "Classes": "None", "Text": "You have any lung, heart or blood pressure (low or raised) problems.", "ParentId": "54ce3133-3167-408b-89dd-0cc62d17f724"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You notice the symptoms of your cancer are\ngetting worse. If you have leukaemia this might include fever, feeling weak,\nbleeding gums, bruising. If you have lymphoma, this might include unexplained\nfever, feeling weak, night sweats, sudden weight loss.</span></p>", "ID": "7033744d-b774-475f-8d4e-4eec94179877", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ec6b3337-1785-44b9-aaa5-0751f436de06", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7033744d-b774-475f-8d4e-4eec94179877"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b99a2923-28fe-4be4-bb2d-b3ba41efcf2d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ec6b3337-1785-44b9-aaa5-0751f436de06"}, {"Element": "<span lang=\"EN-GB\">You notice the symptoms of your cancer are\ngetting worse. If you have leukaemia this might include fever, feeling weak,\nbleeding gums, bruising. If you have lymphoma, this might include unexplained\nfever, feeling weak, night sweats, sudden weight loss.</span>", "ID": "f31cdf4e-5c64-4a73-921b-79f6065a9fa3", "Styles": "None", "Classes": "None", "Text": "You notice the symptoms of your cancer are getting worse. If you have leukaemia this might include fever, feeling weak, bleeding gums, bruising. If you have lymphoma, this might include unexplained fever, feeling weak, night sweats, sudden weight loss.", "ParentId": "7033744d-b774-475f-8d4e-4eec94179877"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have an infection. The infection will be\ntreated before the Kymriah infusion.</span></p>", "ID": "a2b013e3-01b4-445f-a572-2c33ae5bf73e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "987f7762-92f5-4d76-9b9e-d8877e9c0ad1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a2b013e3-01b4-445f-a572-2c33ae5bf73e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a9d0207b-29e5-4c62-b097-67dd1c09e285", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "987f7762-92f5-4d76-9b9e-d8877e9c0ad1"}, {"Element": "<span lang=\"EN-GB\">You have an infection. The infection will be\ntreated before the Kymriah infusion.</span>", "ID": "6cbb4c72-f8ba-404f-bec1-6d38a05d17cb", "Styles": "None", "Classes": "None", "Text": "You have an infection. The infection will be treated before the Kymriah infusion.", "ParentId": "a2b013e3-01b4-445f-a572-2c33ae5bf73e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You have had hepatitis B, hepatitis C or human\nimmunodeficiency virus (HIV) infection.</span></p>", "ID": "8f530483-c5fd-4d23-afa8-28ce2fb481bf", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "daa979c9-9b02-47a2-b014-ca14c1c686c5", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8f530483-c5fd-4d23-afa8-28ce2fb481bf"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "156028f0-b524-457f-91ef-d76887551c66", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "daa979c9-9b02-47a2-b014-ca14c1c686c5"}, {"Element": "<span lang=\"EN-GB\">You have had hepatitis B, hepatitis C or human\nimmunodeficiency virus (HIV) infection.</span>", "ID": "e3a31ef3-7208-43d2-99b6-17a1c48bb112", "Styles": "None", "Classes": "None", "Text": "You have had hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.", "ParentId": "8f530483-c5fd-4d23-afa8-28ce2fb481bf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You are pregnant, think you may be pregnant, or\nplan to become pregnant (see sections \u201cPregnancy and breast\u2011feeding\u201d and \u201cContraception\nfor women and men\u201d below).</span></p>", "ID": "f82c7d23-e30d-4d54-9596-f397892ab905", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f1b66553-14e6-40ef-b213-8bad4a17c6c2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f82c7d23-e30d-4d54-9596-f397892ab905"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0dc663e0-36a9-4a0e-aadd-934d2a79006c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f1b66553-14e6-40ef-b213-8bad4a17c6c2"}, {"Element": "<span lang=\"EN-GB\">You are pregnant, think you may be pregnant, or\nplan to become pregnant (see sections \u201cPregnancy and breast\u2011feeding\u201d and \u201cContraception\nfor women and men\u201d below).</span>", "ID": "c8c3775a-e807-4c24-abcf-a007e1c6ebc9", "Styles": "None", "Classes": "None", "Text": "You are pregnant, think you may be pregnant, or plan to become pregnant (see sections \u201cPregnancy and breast\u2011feeding\u201d and \u201cContraception for women and men\u201d below).", "ParentId": "f82c7d23-e30d-4d54-9596-f397892ab905"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You had a vaccination in the previous\n6\u00a0weeks or are planning to have one in the next few months.</span></p>", "ID": "8a58c8cb-7a4c-4ce4-855f-c7c7fca8b331", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "eac4ecd1-56d8-46ca-b5d6-261bbcc93e2a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8a58c8cb-7a4c-4ce4-855f-c7c7fca8b331"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "70d90ea6-f75b-4188-8b38-6ce2be528f0c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "eac4ecd1-56d8-46ca-b5d6-261bbcc93e2a"}, {"Element": "<span lang=\"EN-GB\">You had a vaccination in the previous\n6\u00a0weeks or are planning to have one in the next few months.</span>", "ID": "21776dee-183a-49a5-a1e9-add3475f816d", "Styles": "None", "Classes": "None", "Text": "You had a vaccination in the previous 6\u00a0weeks or are planning to have one in the next few months.", "ParentId": "8a58c8cb-7a4c-4ce4-855f-c7c7fca8b331"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If any of the\nabove apply to you (or you are not sure), talk to your doctor before being\ngiven Kymriah.</span></p>", "ID": "c7306957-64a8-46e3-8e75-10723b31f55e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If any of the\nabove apply to you (or you are not sure), talk to your doctor before being\ngiven Kymriah.</span>", "ID": "4b80f89c-ca92-4ecb-96e9-c563ca3a5adc", "Styles": "None", "Classes": "None", "Text": "If any of the above apply to you (or you are not sure), talk to your doctor before being given Kymriah.", "ParentId": "c7306957-64a8-46e3-8e75-10723b31f55e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ece0b7d5-79ed-462b-896f-2f8b409043e6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "73420875-2a4c-4038-86ab-b18f0ce591b9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ece0b7d5-79ed-462b-896f-2f8b409043e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Test and checks</span></b></p>", "ID": "8d2a4e8b-5936-47c9-826e-5ab9c34144dc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Test and checks</span></b>", "ID": "c7f0477f-a2de-4e0a-9927-e62d380c6b5a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d2a4e8b-5936-47c9-826e-5ab9c34144dc"}, {"Element": "<span lang=\"EN-GB\">Test and checks</span>", "ID": "d2a11e9c-5625-46be-8735-dbab1e80618e", "Styles": "None", "Classes": "None", "Text": "Test and checks", "ParentId": "c7f0477f-a2de-4e0a-9927-e62d380c6b5a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Before you are given Kymriah</span></b><span lang=\"EN-GB\"> <b>your\ndoctor will:</b></span></p>", "ID": "eac31c16-2375-48f3-8193-653c9d3ad33b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Before you are given Kymriah</span></b>", "ID": "85fc18ab-6051-4cba-a4d9-431b030512f3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eac31c16-2375-48f3-8193-653c9d3ad33b"}, {"Element": "<span lang=\"EN-GB\">Before you are given Kymriah</span>", "ID": "0ffd5565-109b-4e71-b917-0001126bd971", "Styles": "None", "Classes": "None", "Text": "Before you are given Kymriah", "ParentId": "85fc18ab-6051-4cba-a4d9-431b030512f3"}, {"Element": "<span lang=\"EN-GB\"> <b>your\ndoctor will:</b></span>", "ID": "9b4e9f7f-cb6a-4866-83bf-68c6e97d5852", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "eac31c16-2375-48f3-8193-653c9d3ad33b"}, {"Element": "<b>your\ndoctor will:</b>", "ID": "28b00cc8-0d99-405d-a109-3aff6e1e0aaf", "Styles": "None", "Classes": "None", "Text": "your doctor will:", "ParentId": "9b4e9f7f-cb6a-4866-83bf-68c6e97d5852"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Check your lungs, heart and blood pressure.</span></p>", "ID": "97e44871-f114-4b03-9600-68eb16b252dc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ca1b3fcb-9ce8-45a9-bcda-2c8c9b3710d8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "97e44871-f114-4b03-9600-68eb16b252dc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "081cbd99-897e-45a8-b37e-c595c1428c4b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ca1b3fcb-9ce8-45a9-bcda-2c8c9b3710d8"}, {"Element": "<span lang=\"EN-GB\">Check your lungs, heart and blood pressure.</span>", "ID": "0d3cd0f6-4094-4411-a3c0-1bf44a431a24", "Styles": "None", "Classes": "None", "Text": "Check your lungs, heart and blood pressure.", "ParentId": "97e44871-f114-4b03-9600-68eb16b252dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Look for signs of infection; any infection will\nbe treated before you are given Kymriah.</span></p>", "ID": "4abde534-0b0e-4f1f-bb08-b39f55e0787d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ac3cbee8-6329-44b4-8067-643e5c60d707", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "4abde534-0b0e-4f1f-bb08-b39f55e0787d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "79ac2d44-5690-4573-8887-51583a0abfa2", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ac3cbee8-6329-44b4-8067-643e5c60d707"}, {"Element": "<span lang=\"EN-GB\">Look for signs of infection; any infection will\nbe treated before you are given Kymriah.</span>", "ID": "2b924aa0-c813-4b64-8722-b0a91139a420", "Styles": "None", "Classes": "None", "Text": "Look for signs of infection; any infection will be treated before you are given Kymriah.", "ParentId": "4abde534-0b0e-4f1f-bb08-b39f55e0787d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Check if your lymphoma or leukaemia is getting\nworse.</span></p>", "ID": "f790dfb2-dd71-4910-9b6a-4455d3745015", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "dd875702-61da-4375-a1c4-224622f72a52", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f790dfb2-dd71-4910-9b6a-4455d3745015"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "89563214-ce76-4c7f-a85d-e3f67c1767c3", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "dd875702-61da-4375-a1c4-224622f72a52"}, {"Element": "<span lang=\"EN-GB\">Check if your lymphoma or leukaemia is getting\nworse.</span>", "ID": "d2c672b2-b290-410c-872f-c4ebf2816f9b", "Styles": "None", "Classes": "None", "Text": "Check if your lymphoma or leukaemia is getting worse.", "ParentId": "f790dfb2-dd71-4910-9b6a-4455d3745015"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Look for signs of graft\u2011versus\u2011host disease\nthat can happen after a transplant.</span></p>", "ID": "f04a6d7e-87cd-49d6-afcf-689ff86cd522", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d4165f3f-f395-47ac-b07e-1f4d747bd380", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f04a6d7e-87cd-49d6-afcf-689ff86cd522"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a173f2a7-398e-4e45-8802-54c7ee902fbc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d4165f3f-f395-47ac-b07e-1f4d747bd380"}, {"Element": "<span lang=\"EN-GB\">Look for signs of graft\u2011versus\u2011host disease\nthat can happen after a transplant.</span>", "ID": "984d0fad-356d-4bf4-aece-7d84e9654ba2", "Styles": "None", "Classes": "None", "Text": "Look for signs of graft\u2011versus\u2011host disease that can happen after a transplant.", "ParentId": "f04a6d7e-87cd-49d6-afcf-689ff86cd522"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><s><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></s><span lang=\"EN-GB\">Check your blood for uric acid and for how\nmany cancer cells there are in your blood. This will show if you are likely to\ndevelop a condition called tumour lysis syndrome. You may be given medicines to\nhelp prevent the condition.</span></p>", "ID": "2e65bac3-95bd-4d4f-bca3-062865852153", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<s><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span></s>", "ID": "e9af82db-92d1-403a-8635-249779470d40", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2e65bac3-95bd-4d4f-bca3-062865852153"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0dc288a6-f207-4cf8-8d4a-2fee23a9d3e7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e9af82db-92d1-403a-8635-249779470d40"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c1777bbf-a662-4a59-ac57-af193f25f083", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0dc288a6-f207-4cf8-8d4a-2fee23a9d3e7"}, {"Element": "<span lang=\"EN-GB\">Check your blood for uric acid and for how\nmany cancer cells there are in your blood. This will show if you are likely to\ndevelop a condition called tumour lysis syndrome. You may be given medicines to\nhelp prevent the condition.</span>", "ID": "a0dd5df5-f1ee-4523-a875-3b69769c0a50", "Styles": "None", "Classes": "None", "Text": "Check your blood for uric acid and for how many cancer cells there are in your blood. This will show if you are likely to develop a condition called tumour lysis syndrome. You may be given medicines to help prevent the condition.", "ParentId": "2e65bac3-95bd-4d4f-bca3-062865852153"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Check for hepatitis B, hepatitis C or HIV infection.</span></p>", "ID": "30c8ac48-e7f5-4691-a917-595f8131648d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "98917fab-4fab-4b21-ad6c-77dbd28cb63c", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "30c8ac48-e7f5-4691-a917-595f8131648d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c6b216e9-f70c-4f5c-a9c4-ac9c52b930a4", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "98917fab-4fab-4b21-ad6c-77dbd28cb63c"}, {"Element": "<span lang=\"EN-GB\">Check for hepatitis B, hepatitis C or HIV infection.</span>", "ID": "691563fb-0a5a-42a4-b8c0-38946f3f87fa", "Styles": "None", "Classes": "None", "Text": "Check for hepatitis B, hepatitis C or HIV infection.", "ParentId": "30c8ac48-e7f5-4691-a917-595f8131648d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "82863e91-227b-4e64-b348-2139374faed7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4239f8b2-ec76-416a-8ee0-dae8a835c30f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "82863e91-227b-4e64-b348-2139374faed7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">After you have been given Kymriah</span></b></p>", "ID": "10e76ed5-2d47-4e7a-a0ea-1a7512e293b1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">After you have been given Kymriah</span></b>", "ID": "856f7e5f-d964-47c8-a861-78ababb27c66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10e76ed5-2d47-4e7a-a0ea-1a7512e293b1"}, {"Element": "<span lang=\"EN-GB\">After you have been given Kymriah</span>", "ID": "ff61bb29-b878-459d-8792-66bb7a6a7e44", "Styles": "None", "Classes": "None", "Text": "After you have been given Kymriah", "ParentId": "856f7e5f-d964-47c8-a861-78ababb27c66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor or nurse immediately if you have any of the\nfollowing:</span></b></p>", "ID": "7f4a4b8d-3730-4828-bed4-1199dfdc7225", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Tell your doctor or nurse immediately if you have any of the\nfollowing:</span></b>", "ID": "7303c528-9f59-4d1e-a8e4-53e6e2672ac4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7f4a4b8d-3730-4828-bed4-1199dfdc7225"}, {"Element": "<span lang=\"EN-GB\">Tell your doctor or nurse immediately if you have any of the\nfollowing:</span>", "ID": "0f67cd7f-4a81-489d-a556-fc253bb122a0", "Styles": "None", "Classes": "None", "Text": "Tell your doctor or nurse immediately if you have any of the following:", "ParentId": "7303c528-9f59-4d1e-a8e4-53e6e2672ac4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Fever, which may be a symptom of an infection.\nYour doctor will regularly check your blood counts as the number of blood cells\nand other blood components may decrease.</span></p>", "ID": "0807d1f0-ba02-4bda-8688-829f26d361f5", "Styles": "margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5090d2c5-dcac-406c-993f-940b884c3cfc", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0807d1f0-ba02-4bda-8688-829f26d361f5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2047c30f-31dd-46da-8920-dcefb1cd99cc", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5090d2c5-dcac-406c-993f-940b884c3cfc"}, {"Element": "<span lang=\"EN-GB\">Fever, which may be a symptom of an infection.\nYour doctor will regularly check your blood counts as the number of blood cells\nand other blood components may decrease.</span>", "ID": "0ac280e7-f877-4a5c-b6a7-b9b55c96e38a", "Styles": "None", "Classes": "None", "Text": "Fever, which may be a symptom of an infection. Your doctor will regularly check your blood counts as the number of blood cells and other blood components may decrease.", "ParentId": "0807d1f0-ba02-4bda-8688-829f26d361f5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Take your temperature twice a day for 3\u20114\u00a0weeks\nafter treatment with Kymriah. If your temperature is high, see your doctor\nimmediately.</span></p>", "ID": "fa7f842b-a2c6-4cae-9cea-270f090cd086", "Styles": "margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "59202936-693d-4c7e-bc2f-1415366567ff", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "fa7f842b-a2c6-4cae-9cea-270f090cd086"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a81b106f-ae18-46eb-991c-596c17a51196", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "59202936-693d-4c7e-bc2f-1415366567ff"}, {"Element": "<span lang=\"EN-GB\">Take your temperature twice a day for 3\u20114\u00a0weeks\nafter treatment with Kymriah. If your temperature is high, see your doctor\nimmediately.</span>", "ID": "8903ba84-04f8-4ce6-9971-406944280d9e", "Styles": "None", "Classes": "None", "Text": "Take your temperature twice a day for 3\u20114\u00a0weeks after treatment with Kymriah. If your temperature is high, see your doctor immediately.", "ParentId": "fa7f842b-a2c6-4cae-9cea-270f090cd086"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Extreme tiredness, weakness and shortness of\nbreath, which may be symptoms of a lack of red blood cells.</span></p>", "ID": "7a46c719-b6e2-47af-a48d-64655e930f45", "Styles": "margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "429e767e-1f1f-4fe3-8d20-780544b18555", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7a46c719-b6e2-47af-a48d-64655e930f45"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e6fc0203-6885-49ae-a7a3-96cbab6cf26b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "429e767e-1f1f-4fe3-8d20-780544b18555"}, {"Element": "<span lang=\"EN-GB\">Extreme tiredness, weakness and shortness of\nbreath, which may be symptoms of a lack of red blood cells.</span>", "ID": "cab3ddc8-21ab-4ac9-8c5a-78825bab4658", "Styles": "None", "Classes": "None", "Text": "Extreme tiredness, weakness and shortness of breath, which may be symptoms of a lack of red blood cells.", "ParentId": "7a46c719-b6e2-47af-a48d-64655e930f45"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Bleeding or bruising more easily, which may be\nsymptoms of low levels of cells in the blood known as platelets.</span></p>", "ID": "353cf973-7335-4c05-ab75-831793d6b0db", "Styles": "margin-left:28.4pt;text-indent:-28.4pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "4ebbcd1d-81d3-4d91-84e8-c2f91cfdbdfa", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "353cf973-7335-4c05-ab75-831793d6b0db"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "958b60d0-98b3-4ea8-8ec7-5a89f8493218", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "4ebbcd1d-81d3-4d91-84e8-c2f91cfdbdfa"}, {"Element": "<span lang=\"EN-GB\">Bleeding or bruising more easily, which may be\nsymptoms of low levels of cells in the blood known as platelets.</span>", "ID": "325525dc-c601-445a-96e9-1fe2fe40ac45", "Styles": "None", "Classes": "None", "Text": "Bleeding or bruising more easily, which may be symptoms of low levels of cells in the blood known as platelets.", "ParentId": "353cf973-7335-4c05-ab75-831793d6b0db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a1faf7d9-0532-41c0-a1a9-90eb28fe96ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b665a73-acc7-4faa-a210-d2232fb605b0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a1faf7d9-0532-41c0-a1a9-90eb28fe96ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There may be an\neffect on the results of some types of HIV test \u2013 ask your doctor about this.</span></p>", "ID": "0e751283-e6b6-40a4-ae11-fd9a7badc2d5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">There may be an\neffect on the results of some types of HIV test \u2013 ask your doctor about this.</span>", "ID": "d1ffa523-3a70-4be9-b9de-e7e19238885c", "Styles": "None", "Classes": "None", "Text": "There may be an effect on the results of some types of HIV test \u2013 ask your doctor about this.", "ParentId": "0e751283-e6b6-40a4-ae11-fd9a7badc2d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "16a4b66e-d6d6-421e-8083-3156b9ebc2fa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "70cf49cc-8d7f-4cce-8f62-5f0ce1a9e1a6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "16a4b66e-d6d6-421e-8083-3156b9ebc2fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor will\nregularly monitor your blood counts after you receive Kymriah as you may\nexperience a reduction in the number of blood cells and other blood components.</span></p>", "ID": "51beb234-bcae-4bea-8572-f11b660103fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Your doctor will\nregularly monitor your blood counts after you receive Kymriah as you may\nexperience a reduction in the number of blood cells and other blood components.</span>", "ID": "e3487ce2-ddda-4096-bfd0-915f37f2b2e5", "Styles": "None", "Classes": "None", "Text": "Your doctor will regularly monitor your blood counts after you receive Kymriah as you may experience a reduction in the number of blood cells and other blood components.", "ParentId": "51beb234-bcae-4bea-8572-f11b660103fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "753ba38b-4407-4415-a337-a83028950f29", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7129a7d0-b0b5-4c44-9a6d-654ce5377929", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "753ba38b-4407-4415-a337-a83028950f29"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not donate\nblood, organs, tissues or cells.</span></p>", "ID": "544fbdec-627f-4d59-90cf-1c778fbf6396", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Do not donate\nblood, organs, tissues or cells.</span>", "ID": "c1c8c2c4-6aa6-4e10-8874-2d3ac02eed94", "Styles": "None", "Classes": "None", "Text": "Do not donate blood, organs, tissues or cells.", "ParentId": "544fbdec-627f-4d59-90cf-1c778fbf6396"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f195078c-bc41-49ef-bdc7-4f4ecf3b5e44", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c22c628-10f5-4a17-82cf-b878318bad33", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f195078c-bc41-49ef-bdc7-4f4ecf3b5e44"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p>", "ID": "26b1e200-7d49-4e8b-8927-8c9c0b1e152e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Children and adolescents</span></b>", "ID": "21bcc944-ccee-41a6-a149-6e4af23eccae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26b1e200-7d49-4e8b-8927-8c9c0b1e152e"}, {"Element": "<span lang=\"EN-GB\">Children and adolescents</span>", "ID": "71a7158d-8280-485e-b5eb-936180ef091d", "Styles": "None", "Classes": "None", "Text": "Children and adolescents", "ParentId": "21bcc944-ccee-41a6-a149-6e4af23eccae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">No formal studies have been performed in paediatric\npatients below 3\u00a0years of age in B\u2011cell ALL.</span></p>", "ID": "2a6ea839-cb6c-48a2-aa07-b81047f00ac2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "252cab33-ff5e-485c-8eb9-00184c2602aa", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2a6ea839-cb6c-48a2-aa07-b81047f00ac2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5a06b5fd-af18-4c01-81a8-e0108bc450b7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "252cab33-ff5e-485c-8eb9-00184c2602aa"}, {"Element": "<span lang=\"EN-GB\">No formal studies have been performed in paediatric\npatients below 3\u00a0years of age in B\u2011cell ALL.</span>", "ID": "39c3d01a-ae17-4ef6-aeda-bd0f257d34bc", "Styles": "None", "Classes": "None", "Text": "No formal studies have been performed in paediatric patients below 3\u00a0years of age in B\u2011cell ALL.", "ParentId": "2a6ea839-cb6c-48a2-aa07-b81047f00ac2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Kymriah should not be used in children and adolescents\nbelow 18\u00a0years of age to treat DLBCL</span><span lang=\"EN-GB\">. This is\nbecause Kymriah has</span><span lang=\"EN-GB\"> not been studied in this age group.</span></p>", "ID": "3eab4f0f-4642-4bb1-874a-266e3c6731c1", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d2379710-c71e-49ed-b497-b3814f6c9521", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3eab4f0f-4642-4bb1-874a-266e3c6731c1"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "272fb3b7-f72f-4112-a2fc-184045451039", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d2379710-c71e-49ed-b497-b3814f6c9521"}, {"Element": "<span lang=\"EN-GB\">Kymriah should not be used in children and adolescents\nbelow 18\u00a0years of age to treat DLBCL</span>", "ID": "6908e781-98c7-4963-82a0-f33ac5ddc16c", "Styles": "None", "Classes": "None", "Text": "Kymriah should not be used in children and adolescents below 18\u00a0years of age to treat DLBCL", "ParentId": "3eab4f0f-4642-4bb1-874a-266e3c6731c1"}, {"Element": "<span lang=\"EN-GB\">. This is\nbecause Kymriah has</span>", "ID": "40a0369b-67c6-49bc-a74d-fa5a881e1b41", "Styles": "None", "Classes": "None", "Text": ". This is because Kymriah has", "ParentId": "3eab4f0f-4642-4bb1-874a-266e3c6731c1"}, {"Element": "<span lang=\"EN-GB\"> not been studied in this age group.</span>", "ID": "6b78255e-218d-425f-a129-48cbf61f1a12", "Styles": "None", "Classes": "None", "Text": " not been studied in this age group.", "ParentId": "3eab4f0f-4642-4bb1-874a-266e3c6731c1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fd64b148-0211-4dab-aaed-e826aee4631c", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aa7b1865-45cf-4e83-96dc-2d463798fd61", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fd64b148-0211-4dab-aaed-e826aee4631c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other medicines and Kymriah</span></b></p>", "ID": "2084d3ba-ce55-44bc-8724-b60c21da751a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Other medicines and Kymriah</span></b>", "ID": "490f2ab1-c634-4e04-ae97-2d2cea7ea1d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2084d3ba-ce55-44bc-8724-b60c21da751a"}, {"Element": "<span lang=\"EN-GB\">Other medicines and Kymriah</span>", "ID": "bccc5629-4cae-4757-89f9-54de37cc43da", "Styles": "None", "Classes": "None", "Text": "Other medicines and Kymriah", "ParentId": "490f2ab1-c634-4e04-ae97-2d2cea7ea1d6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Tell your doctor if you are taking, have recently taken or might\ntake any other medicines, including medicines obtained without a prescription.\nThis is because other medicines can affect the way Kymriah works.</span></p>", "ID": "98d45676-9be7-452f-ab0d-2cb958862881", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Tell your doctor if you are taking, have recently taken or might\ntake any other medicines, including medicines obtained without a prescription.\nThis is because other medicines can affect the way Kymriah works.</span>", "ID": "18fbdd1a-d391-4b59-8f9f-2b073d66b30f", "Styles": "None", "Classes": "None", "Text": "Tell your doctor if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is because other medicines can affect the way Kymriah works.", "ParentId": "98d45676-9be7-452f-ab0d-2cb958862881"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be12731e-4613-4117-be9b-79e5da364b9e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "911db4f3-7b2d-41d5-b8bf-939bd654fe79", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be12731e-4613-4117-be9b-79e5da364b9e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">In particular, you must not be given certain vaccines called live\nvaccines:</span></p>", "ID": "27085d27-a169-43d5-8601-cb240de70657", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">In particular, you must not be given certain vaccines called live\nvaccines:</span>", "ID": "702156b3-ba24-4d2a-9b64-fe1db9413fac", "Styles": "None", "Classes": "None", "Text": "In particular, you must not be given certain vaccines called live vaccines:", "ParentId": "27085d27-a169-43d5-8601-cb240de70657"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">in the 6\u00a0weeks before you are given the\nshort course of chemotherapy (called lymphodepleting chemotherapy) to prepare\nyour body for the Kymriah cells.</span></p>", "ID": "59fad0ee-057e-4306-97ce-29e83eb7ebbc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "696af3c9-3b14-44aa-a104-cd612c1e9aff", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "59fad0ee-057e-4306-97ce-29e83eb7ebbc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f04ca88c-acfc-446a-9673-4ec40903b365", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "696af3c9-3b14-44aa-a104-cd612c1e9aff"}, {"Element": "<span lang=\"EN-GB\">in the 6\u00a0weeks before you are given the\nshort course of chemotherapy (called lymphodepleting chemotherapy) to prepare\nyour body for the Kymriah cells.</span>", "ID": "374ee477-5dc6-4110-bd9f-190cd01fccdf", "Styles": "None", "Classes": "None", "Text": "in the 6\u00a0weeks before you are given the short course of chemotherapy (called lymphodepleting chemotherapy) to prepare your body for the Kymriah cells.", "ParentId": "59fad0ee-057e-4306-97ce-29e83eb7ebbc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">during Kymriah treatment.</span></p>", "ID": "e7a01d0a-c822-47eb-af2e-c82ba7f54edd", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "584eb703-7d01-4832-a2a0-3809688860eb", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e7a01d0a-c822-47eb-af2e-c82ba7f54edd"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "94be38a2-3e42-400a-bb95-79c59a0b6b8a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "584eb703-7d01-4832-a2a0-3809688860eb"}, {"Element": "<span lang=\"EN-GB\">during Kymriah treatment.</span>", "ID": "014a71e8-114a-4ab2-89e8-f34dbff2fe42", "Styles": "None", "Classes": "None", "Text": "during Kymriah treatment.", "ParentId": "e7a01d0a-c822-47eb-af2e-c82ba7f54edd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">after treatment while the immune system is\nrecovering.</span></p>", "ID": "a035c0a1-5ce7-40e3-a564-1618ae5a22bb", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "96e43c3a-6a38-4159-8b82-9a91f03d4609", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a035c0a1-5ce7-40e3-a564-1618ae5a22bb"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d3bdac44-143d-4665-9c15-28aa968c2997", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "96e43c3a-6a38-4159-8b82-9a91f03d4609"}, {"Element": "<span lang=\"EN-GB\">after treatment while the immune system is\nrecovering.</span>", "ID": "a71acb32-4795-47bf-af57-0f790e21fa79", "Styles": "None", "Classes": "None", "Text": "after treatment while the immune system is recovering.", "ParentId": "a035c0a1-5ce7-40e3-a564-1618ae5a22bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Talk to your\ndoctor if you need to have any vaccinations.</span></p>", "ID": "23b41879-e642-4252-93f8-e57849795b5c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Talk to your\ndoctor if you need to have any vaccinations.</span>", "ID": "684e1378-77c6-4a5b-a7cf-e7908acb34c4", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor if you need to have any vaccinations.", "ParentId": "23b41879-e642-4252-93f8-e57849795b5c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:1.4pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b546b440-ea8e-464d-9e45-3da3dc4f5559", "Styles": "margin-right:1.4pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7ea82df4-8fbf-4095-8546-64ce5f955189", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b546b440-ea8e-464d-9e45-3da3dc4f5559"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:1.4pt;line-height:normal\"><span lang=\"EN-GB\">Before<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>ou<span style=\"letter-spacing:-.3pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>given<span style=\"letter-spacing:-.25pt\"> </span>Kymriah<span style=\"letter-spacing:-.3pt\"> </span>tell<span style=\"letter-spacing:-.2pt\"> </span>your<span style=\"letter-spacing:-.25pt\"> </span>doctor<span style=\"letter-spacing:-.25pt\">\n</span>or<span style=\"letter-spacing:-.3pt\"> </span>nurse<span style=\"letter-spacing:-.3pt\"> </span>if<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>ou<span style=\"letter-spacing:-.25pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>taking<span style=\"letter-spacing:-.25pt\">\n</span>any<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:\n-.1pt\">m</span>edicines<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:.05pt\">t</span>hat we<span style=\"letter-spacing:-.05pt\">a</span>ken<span style=\"letter-spacing:-.35pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>our\n<span style=\"letter-spacing:.05pt\">i</span>m<span style=\"letter-spacing:-.15pt\">m</span>une<span style=\"letter-spacing:-.35pt\"> </span>s<span style=\"letter-spacing:.05pt\">y</span>stem<span style=\"letter-spacing:-.35pt\"> </span>such<span style=\"letter-spacing:-.3pt\"> </span>as<span style=\"letter-spacing:-.35pt\"> </span>co<span style=\"letter-spacing:.05pt\">r</span>ticosteroids,<span style=\"letter-spacing:-.35pt\"> </span>since<span style=\"letter-spacing:-.35pt\">\n</span>these<span style=\"letter-spacing:-.3pt\"> </span>medicines<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:-.1pt\">m</span>ay<span style=\"letter-spacing:-.3pt\"> </span>interfere<span style=\"letter-spacing:-.35pt\">\n</span>with<span style=\"letter-spacing:-.3pt\"> </span>the effe<span style=\"letter-spacing:-.05pt\">c</span>t<span style=\"letter-spacing:-.55pt\"> </span>of<span style=\"letter-spacing:-.5pt\"> </span>Kymriah.</span></p>", "ID": "d4cd4f5a-ecf6-49a4-bf4d-7b7a613ac5d8", "Styles": "margin-right:1.4pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Before<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>ou<span style=\"letter-spacing:-.3pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>given<span style=\"letter-spacing:-.25pt\"> </span>Kymriah<span style=\"letter-spacing:-.3pt\"> </span>tell<span style=\"letter-spacing:-.2pt\"> </span>your<span style=\"letter-spacing:-.25pt\"> </span>doctor<span style=\"letter-spacing:-.25pt\">\n</span>or<span style=\"letter-spacing:-.3pt\"> </span>nurse<span style=\"letter-spacing:-.3pt\"> </span>if<span style=\"letter-spacing:-.3pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>ou<span style=\"letter-spacing:-.25pt\"> </span>are<span style=\"letter-spacing:-.3pt\"> </span>taking<span style=\"letter-spacing:-.25pt\">\n</span>any<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:\n-.1pt\">m</span>edicines<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:.05pt\">t</span>hat we<span style=\"letter-spacing:-.05pt\">a</span>ken<span style=\"letter-spacing:-.35pt\"> </span><span style=\"letter-spacing:.05pt\">y</span>our\n<span style=\"letter-spacing:.05pt\">i</span>m<span style=\"letter-spacing:-.15pt\">m</span>une<span style=\"letter-spacing:-.35pt\"> </span>s<span style=\"letter-spacing:.05pt\">y</span>stem<span style=\"letter-spacing:-.35pt\"> </span>such<span style=\"letter-spacing:-.3pt\"> </span>as<span style=\"letter-spacing:-.35pt\"> </span>co<span style=\"letter-spacing:.05pt\">r</span>ticosteroids,<span style=\"letter-spacing:-.35pt\"> </span>since<span style=\"letter-spacing:-.35pt\">\n</span>these<span style=\"letter-spacing:-.3pt\"> </span>medicines<span style=\"letter-spacing:-.25pt\"> </span><span style=\"letter-spacing:-.1pt\">m</span>ay<span style=\"letter-spacing:-.3pt\"> </span>interfere<span style=\"letter-spacing:-.35pt\">\n</span>with<span style=\"letter-spacing:-.3pt\"> </span>the effe<span style=\"letter-spacing:-.05pt\">c</span>t<span style=\"letter-spacing:-.55pt\"> </span>of<span style=\"letter-spacing:-.5pt\"> </span>Kymriah.</span>", "ID": "8bbaba46-ca8a-4578-94b8-a85577815f57", "Styles": "None", "Classes": "None", "Text": "BeforeouaregivenKymriahtellyourdoctorornurseifouaretakinganyedicineshat wekenour munesstemsuchascoticosteroids,sincethesemedicinesayinterferewiththe effetofKymriah.", "ParentId": "d4cd4f5a-ecf6-49a4-bf4d-7b7a613ac5d8"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "0fe94422-59dd-4d04-b0eb-a44fbabc8d4d", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:.05pt\">y</span>", "ID": "f051ed39-83f0-4970-9398-3aaae71c057d", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "y", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "3633342b-a41d-4dfa-a230-72ab7ffdbefb", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "e667c985-fc1c-496a-96ce-9161c04534a6", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "489c8222-2cf0-4f7a-a681-bd374ef99652", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "a9943afb-c87f-4ad2-b12b-8ecb2a41b8d1", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.2pt\"> </span>", "ID": "7cc843fe-e82c-47b8-bea9-b56d8bc59f1d", "Styles": "letter-spacing:-.2pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "b2235332-036b-4a34-a680-002bf81d9f39", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\">\n</span>", "ID": "98099af7-9fb6-4a3a-b640-321453ed7651", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "b1b34b50-4bed-4a72-931d-0a479b71213a", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "007a2af0-2c07-4358-a1b2-a6a44be62887", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "25aede2a-972d-4bf3-822d-73a3e744ed7f", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:.05pt\">y</span>", "ID": "a2974cf9-5a20-4e04-b4b4-5ebd7db31de9", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "y", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "ae1465a3-0774-4bb1-8e50-e5c49fc39bd3", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "c1ca7082-e119-4718-adf3-8a48bd85ceb5", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\">\n</span>", "ID": "92f1ebb3-3935-420d-a7ad-ae54ef775a4c", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "eba89c75-8b56-4d32-b78d-f787c5eac206", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:\n-.1pt\">m</span>", "ID": "61e8ac43-c0f3-44dd-88bb-92d0d03b9eac", "Styles": "letter-spacing:\n-.1pt", "Classes": "None", "Text": "m", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "4c6853c0-e126-435b-9987-8633855532ff", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:.05pt\">t</span>", "ID": "ab84471f-cb9c-4eb0-bc73-4a7c399e42b7", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "t", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.05pt\">a</span>", "ID": "1cab9518-0197-4662-8d0c-8609d145cbdf", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "a", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.35pt\"> </span>", "ID": "48f38dfc-2475-4ce4-bd99-85bbc9cf108d", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:.05pt\">y</span>", "ID": "8e380571-e190-4404-a10f-5e871dd2a3e4", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "y", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:.05pt\">i</span>", "ID": "0f7a4435-d4d8-4194-894b-0f4a3fb0ca94", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "i", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.15pt\">m</span>", "ID": "f89fd3b9-98f5-4095-b704-7a0c671e761d", "Styles": "letter-spacing:-.15pt", "Classes": "None", "Text": "m", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.35pt\"> </span>", "ID": "eb1b22c4-182b-4558-bde1-29c57037eec2", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:.05pt\">y</span>", "ID": "6b884d46-4e44-4c83-b3ce-bc54e9750f15", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "y", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.35pt\"> </span>", "ID": "f5ce6cba-b376-43df-8da0-2ff046239bb7", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "6522ce25-cc13-4b43-8413-3298c3ef9077", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.35pt\"> </span>", "ID": "bc5af90d-8626-43d8-83aa-37392439dbae", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:.05pt\">r</span>", "ID": "6be22536-0da7-4f4e-841c-4a8cc86e81fc", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "r", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.35pt\"> </span>", "ID": "868e9af6-0339-4cb4-9a31-68f2a6ec0ed7", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.35pt\">\n</span>", "ID": "4a0754c5-3318-488d-a2fd-f4212cb2e440", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "74c3fc62-5f9a-44b8-8dff-1a87d3de304b", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.25pt\"> </span>", "ID": "857e8768-7118-40a7-823c-a9ad57bce6d8", "Styles": "letter-spacing:-.25pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.1pt\">m</span>", "ID": "985b2b66-6091-4c23-854e-4fe80a813924", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "m", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "820aa4cb-d437-42f4-8a9d-b2146528b3da", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.35pt\">\n</span>", "ID": "b27baf4e-5a4c-40a6-89ef-b957bae8aca0", "Styles": "letter-spacing:-.35pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.3pt\"> </span>", "ID": "7aa238a2-9f49-4614-836c-8a18c25efa17", "Styles": "letter-spacing:-.3pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.05pt\">c</span>", "ID": "3a4ec2ef-eebd-4b6a-9669-d0324a9217a6", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "c", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.55pt\"> </span>", "ID": "8a8350a7-3268-4f22-847b-55b615798314", "Styles": "letter-spacing:-.55pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<span style=\"letter-spacing:-.5pt\"> </span>", "ID": "d873ac16-6969-413b-bdc0-570d642b7187", "Styles": "letter-spacing:-.5pt", "Classes": "None", "Text": " ", "ParentId": "8bbaba46-ca8a-4578-94b8-a85577815f57"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0d9aaca3-6edf-448c-8f96-130fbd2b363d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9884121e-1323-42cb-b889-95abf8808205", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d9aaca3-6edf-448c-8f96-130fbd2b363d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span></b></p>", "ID": "b31b4753-13e0-4803-a163-13173b8c45bd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span></b>", "ID": "16afc43c-e9cb-46e1-b3aa-d22cb22039a2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b31b4753-13e0-4803-a163-13173b8c45bd"}, {"Element": "<span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span>", "ID": "2a6580de-adf4-42f8-8f02-5dde6a3de53f", "Styles": "None", "Classes": "None", "Text": "Pregnancy and breast\u2011feeding", "ParentId": "16afc43c-e9cb-46e1-b3aa-d22cb22039a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If you are pregnant or breast\u2011feeding, think you may be\npregnant or are planning to have a baby, ask your doctor for advice before being\ngiven this medicine. This is because the effects of Kymriah in pregnant or\nbreast\u2011feeding women are not known, and it may harm your unborn baby or\nyour newborn/infant.</span></p>", "ID": "a4e7f8dd-11f8-4839-b239-9d8d683eb206", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If you are pregnant or breast\u2011feeding, think you may be\npregnant or are planning to have a baby, ask your doctor for advice before being\ngiven this medicine. This is because the effects of Kymriah in pregnant or\nbreast\u2011feeding women are not known, and it may harm your unborn baby or\nyour newborn/infant.</span>", "ID": "7d052c66-500e-4847-ae09-a4ef3ba2c33f", "Styles": "None", "Classes": "None", "Text": "If you are pregnant or breast\u2011feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before being given this medicine. This is because the effects of Kymriah in pregnant or breast\u2011feeding women are not known, and it may harm your unborn baby or your newborn/infant.", "ParentId": "a4e7f8dd-11f8-4839-b239-9d8d683eb206"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If</span><span lang=\"EN-GB\"> you become pregnant\nor think you may be pregnant after treatment with Kymriah, talk your doctor\nimmediately.</span></p>", "ID": "c26a6804-6c97-4c64-85f6-edbfc4bafcd8", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "fc7aa36f-9534-45c9-9afb-40ab9bb7e248", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c26a6804-6c97-4c64-85f6-edbfc4bafcd8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2d8f3306-e6e9-418a-a068-f62e68b93005", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "fc7aa36f-9534-45c9-9afb-40ab9bb7e248"}, {"Element": "<span lang=\"EN-GB\">If</span>", "ID": "5edc6ba2-4504-480f-a316-3b6ce22a156b", "Styles": "None", "Classes": "None", "Text": "If", "ParentId": "c26a6804-6c97-4c64-85f6-edbfc4bafcd8"}, {"Element": "<span lang=\"EN-GB\"> you become pregnant\nor think you may be pregnant after treatment with Kymriah, talk your doctor\nimmediately.</span>", "ID": "a1d199c7-c0d9-40d6-98b0-31f75c5052a4", "Styles": "None", "Classes": "None", "Text": " you become pregnant or think you may be pregnant after treatment with Kymriah, talk your doctor immediately.", "ParentId": "c26a6804-6c97-4c64-85f6-edbfc4bafcd8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">You will be given a pregnancy test before\ntreatment starts. Kymriah should only be given if the result shows you are not\npregnant.</span></p>", "ID": "a29f424a-656c-419d-90c0-abbe3c113ea6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ca595487-7729-4070-9160-f297684d11fd", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a29f424a-656c-419d-90c0-abbe3c113ea6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "3ddb67e4-a833-499a-8f3c-d92a038a146e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ca595487-7729-4070-9160-f297684d11fd"}, {"Element": "<span lang=\"EN-GB\">You will be given a pregnancy test before\ntreatment starts. Kymriah should only be given if the result shows you are not\npregnant.</span>", "ID": "89a17cca-6393-48b1-a1ab-c4802019743d", "Styles": "None", "Classes": "None", "Text": "You will be given a pregnancy test before treatment starts. Kymriah should only be given if the result shows you are not pregnant.", "ParentId": "a29f424a-656c-419d-90c0-abbe3c113ea6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "202972ff-ed27-432f-8750-044f73d4bfc8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2fca6e77-09a6-4b25-aab4-b7ba2e59367c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "202972ff-ed27-432f-8750-044f73d4bfc8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Contraception for women and men</span></b></p>", "ID": "9d749d89-e56d-4c8f-8861-9f321ea76f1c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Contraception for women and men</span></b>", "ID": "f418a9bc-2a83-4da4-8f5d-07d2be92108b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9d749d89-e56d-4c8f-8861-9f321ea76f1c"}, {"Element": "<span lang=\"EN-GB\">Contraception for women and men</span>", "ID": "8c9a6cbd-e181-4e12-bb31-d65853ed11bd", "Styles": "None", "Classes": "None", "Text": "Contraception for women and men", "ParentId": "f418a9bc-2a83-4da4-8f5d-07d2be92108b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discuss\npregnancy with your doctor if you have received Kymriah.</span></p>", "ID": "e79cecac-ab2f-406f-a395-d05f1dc41629", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Discuss\npregnancy with your doctor if you have received Kymriah.</span>", "ID": "7df2a34d-3bc4-439f-b81a-01c3a0f687b2", "Styles": "None", "Classes": "None", "Text": "Discuss pregnancy with your doctor if you have received Kymriah.", "ParentId": "e79cecac-ab2f-406f-a395-d05f1dc41629"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d329f882-5721-4133-9165-675c6f6a8c01", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c2fad346-dfbd-4546-bbc1-6d30c9d9fbe6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d329f882-5721-4133-9165-675c6f6a8c01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>", "ID": "d8a73666-9a4d-4b16-9a29-0e8ab8b35e02", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Driving and using machines</span></b>", "ID": "013104cd-383c-49fb-821a-af69dcb3547d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d8a73666-9a4d-4b16-9a29-0e8ab8b35e02"}, {"Element": "<span lang=\"EN-GB\">Driving and using machines</span>", "ID": "c45ca21a-d7fb-4d6f-8b4f-4c8ed092a3c2", "Styles": "None", "Classes": "None", "Text": "Driving and using machines", "ParentId": "013104cd-383c-49fb-821a-af69dcb3547d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not drive, use machines, or take part in activities that need you\nto be alert for. Kymriah can cause problems such as altered or decreased\nconsciousness, confusion and seizures (fits) in the 8\u00a0weeks following\ninfusion.</span></p>", "ID": "91f4855a-ccd6-41ec-b838-82295f6cffb6", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Do not drive, use machines, or take part in activities that need you\nto be alert for. Kymriah can cause problems such as altered or decreased\nconsciousness, confusion and seizures (fits) in the 8\u00a0weeks following\ninfusion.</span>", "ID": "be6de6a5-34ef-4c17-b9fe-439007181190", "Styles": "None", "Classes": "None", "Text": "Do not drive, use machines, or take part in activities that need you to be alert for. Kymriah can cause problems such as altered or decreased consciousness, confusion and seizures (fits) in the 8\u00a0weeks following infusion.", "ParentId": "91f4855a-ccd6-41ec-b838-82295f6cffb6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f90febf3-6fdc-4455-a92f-ca26d4b48833", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6bb7bff8-a706-4de2-a4d8-65b374dbe52b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f90febf3-6fdc-4455-a92f-ca26d4b48833"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Kymriah contains sodium, dimethylsulfoxide (DMSO) and dextran 40.</span></b></p>", "ID": "d6710fb1-10a1-4b5a-a7d0-e9a9cd04ee1f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Kymriah contains sodium, dimethylsulfoxide (DMSO) and dextran 40.</span></b>", "ID": "59b9f915-29b6-45f9-91d1-7148c5c37856", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d6710fb1-10a1-4b5a-a7d0-e9a9cd04ee1f"}, {"Element": "<span lang=\"EN-GB\">Kymriah contains sodium, dimethylsulfoxide (DMSO) and dextran 40.</span>", "ID": "7e422f92-dddf-4b98-abda-c6d898a5163d", "Styles": "None", "Classes": "None", "Text": "Kymriah contains sodium, dimethylsulfoxide (DMSO) and dextran 40.", "ParentId": "59b9f915-29b6-45f9-91d1-7148c5c37856"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">This medicine contains 24.3 to 121.5\u00a0mg sodium per dose. This\nis equivalent to 1 to 6% of the recommended maximum daily dietary intake of 2\u00a0g\nsodium for an adult. If you have not been previously exposed to dextran or DMSO\nyou should be observed closely during the first minutes of the infusion period.</span></p>", "ID": "6005df9e-a3d3-49f8-9385-b537089d18c5", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">This medicine contains 24.3 to 121.5\u00a0mg sodium per dose. This\nis equivalent to 1 to 6% of the recommended maximum daily dietary intake of 2\u00a0g\nsodium for an adult. If you have not been previously exposed to dextran or DMSO\nyou should be observed closely during the first minutes of the infusion period.</span>", "ID": "ae545d68-4aca-4e90-8f4a-977c03d57b59", "Styles": "None", "Classes": "None", "Text": "This medicine contains 24.3 to 121.5\u00a0mg sodium per dose. This is equivalent to 1 to 6% of the recommended maximum daily dietary intake of 2\u00a0g sodium for an adult. If you have not been previously exposed to dextran or DMSO you should be observed closely during the first minutes of the infusion period.", "ParentId": "6005df9e-a3d3-49f8-9385-b537089d18c5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5e3865b6-c953-45d3-9342-7ca9313169f6", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "405ead6e-cce8-4925-b98c-1e12f6d809af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5e3865b6-c953-45d3-9342-7ca9313169f6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "86e898a9-53bb-4af0-9d3b-c360170efbf7", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb6301dd-1879-4028-9aa9-c789bcc95a26", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "86e898a9-53bb-4af0-9d3b-c360170efbf7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is\ngiven</span></b></p>", "ID": "603e9a4f-dd1e-4fa4-99f2-85f940862a3f", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is\ngiven</span></b>", "ID": "64e84e59-5d6d-43dd-85a1-302de19bb6c2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "603e9a4f-dd1e-4fa4-99f2-85f940862a3f"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is\ngiven</span>", "ID": "f3bec81b-15e8-4b6f-a827-c2f787629cdd", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How Kymriah is given", "ParentId": "64e84e59-5d6d-43dd-85a1-302de19bb6c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "06836c4f-6d64-44f4-b872-2d86667da632", "Styles": "margin-right:-.1pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "68d5477f-53d4-4027-8f86-6c6cd20d0353", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "06836c4f-6d64-44f4-b872-2d86667da632"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">Kymriah will always be given to you by a doctor in a\nqualified treatment centre.</span></p>", "ID": "7ddf4db4-440b-4777-ab49-ee86876ff8fa", "Styles": "margin-right:-.1pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah will always be given to you by a doctor in a\nqualified treatment centre.</span>", "ID": "d84a6d02-17e4-4c29-ba24-e459239a721c", "Styles": "None", "Classes": "None", "Text": "Kymriah will always be given to you by a doctor in a qualified treatment centre.", "ParentId": "7ddf4db4-440b-4777-ab49-ee86876ff8fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "144c5c63-5b38-4124-bbbb-b6b334a7ae7b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b430e6c0-ef26-4158-b526-a62ffa5e6a41", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "144c5c63-5b38-4124-bbbb-b6b334a7ae7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah contains\nhuman blood cells. Your doctor handling Kymriah will therefore take appropriate\nprecautions (wearing gloves and glasses) to avoid potential transmission of\ninfectious diseases.</span></p>", "ID": "057bc965-3206-43a9-9575-90434a5f6ef9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah contains\nhuman blood cells. Your doctor handling Kymriah will therefore take appropriate\nprecautions (wearing gloves and glasses) to avoid potential transmission of\ninfectious diseases.</span>", "ID": "18a77ca9-96f1-4b78-8426-083f9a384cb2", "Styles": "None", "Classes": "None", "Text": "Kymriah contains human blood cells. Your doctor handling Kymriah will therefore take appropriate precautions (wearing gloves and glasses) to avoid potential transmission of infectious diseases.", "ParentId": "057bc965-3206-43a9-9575-90434a5f6ef9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d6ec6ef7-e08e-4a29-8a56-795b5e527035", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "722ae1fe-ad18-48b2-af3d-0dc3c20d21fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d6ec6ef7-e08e-4a29-8a56-795b5e527035"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><b><span lang=\"EN-GB\">Giving blood to make Kymriah</span></b></p>", "ID": "ba1c780e-8cc1-4297-ab33-ea25c0173676", "Styles": "margin-right:-.1pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Giving blood to make Kymriah</span></b>", "ID": "ebfd6a87-0c30-458c-bad9-d7c040de4dfd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ba1c780e-8cc1-4297-ab33-ea25c0173676"}, {"Element": "<span lang=\"EN-GB\">Giving blood to make Kymriah</span>", "ID": "bc6d6b83-547a-4031-a0df-272f19a6773e", "Styles": "None", "Classes": "None", "Text": "Giving blood to make Kymriah", "ParentId": "ebfd6a87-0c30-458c-bad9-d7c040de4dfd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Kymriah is made from your own white blood cells.</span></p>", "ID": "0559f464-b640-4985-9014-0571bc09b5dc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is made from your own white blood cells.</span>", "ID": "9de335c8-cafa-4631-8a16-6bfcbb9e3491", "Styles": "None", "Classes": "None", "Text": "Kymriah is made from your own white blood cells.", "ParentId": "0559f464-b640-4985-9014-0571bc09b5dc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will take some of your blood using a\ncatheter placed in your vein (a procedure called leukapheresis). Some of your\nwhite blood cells are separated from your blood and the rest of your blood is\nreturned to your vein. This can take 3 to 6\u00a0hours and may need to be\nrepeated.</span></p>", "ID": "67b6389f-5251-4a85-8b06-194a5fa404e2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d17343d3-d4da-41f2-bb14-4127043dbc37", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "67b6389f-5251-4a85-8b06-194a5fa404e2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7f7c4291-c73b-4e0d-a946-e783f19d6e88", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d17343d3-d4da-41f2-bb14-4127043dbc37"}, {"Element": "<span lang=\"EN-GB\">Your doctor will take some of your blood using a\ncatheter placed in your vein (a procedure called leukapheresis). Some of your\nwhite blood cells are separated from your blood and the rest of your blood is\nreturned to your vein. This can take 3 to 6\u00a0hours and may need to be\nrepeated.</span>", "ID": "f007d65b-3823-4c08-a268-72301c811db7", "Styles": "None", "Classes": "None", "Text": "Your doctor will take some of your blood using a catheter placed in your vein (a procedure called leukapheresis). Some of your white blood cells are separated from your blood and the rest of your blood is returned to your vein. This can take 3 to 6\u00a0hours and may need to be repeated.", "ParentId": "67b6389f-5251-4a85-8b06-194a5fa404e2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your white blood cells are frozen and sent away\nto make Kymriah. It usually takes about 3 to 4\u00a0weeks to make Kymriah but\nthe time may vary.</span></p>", "ID": "d195703e-c83a-4e68-94be-9818bcfb0026", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d839acd0-f564-44c0-9cdc-3dd01f1247a9", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d195703e-c83a-4e68-94be-9818bcfb0026"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "782f6032-72d8-4403-8a21-2f5f886a52d5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d839acd0-f564-44c0-9cdc-3dd01f1247a9"}, {"Element": "<span lang=\"EN-GB\">Your white blood cells are frozen and sent away\nto make Kymriah. It usually takes about 3 to 4\u00a0weeks to make Kymriah but\nthe time may vary.</span>", "ID": "8ee576c7-c68d-4c18-83af-01acbd3faef5", "Styles": "None", "Classes": "None", "Text": "Your white blood cells are frozen and sent away to make Kymriah. It usually takes about 3 to 4\u00a0weeks to make Kymriah but the time may vary.", "ParentId": "d195703e-c83a-4e68-94be-9818bcfb0026"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Kymriah is a treatment that is manufactured\nspecifically for you. There are situations where Kymriah cannot be successfully\nmanufactured and be given to you. In some cases, a second manufacturing of\nKymriah may be attempted.</span></p>", "ID": "9b750c06-1aad-456f-ab6b-129ae0c46b2e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "81b71bd5-f75b-479f-98d6-ef8d8cc63d36", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9b750c06-1aad-456f-ab6b-129ae0c46b2e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7607f7d6-a33a-4e14-a074-77cdb12a77d9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "81b71bd5-f75b-479f-98d6-ef8d8cc63d36"}, {"Element": "<span lang=\"EN-GB\">Kymriah is a treatment that is manufactured\nspecifically for you. There are situations where Kymriah cannot be successfully\nmanufactured and be given to you. In some cases, a second manufacturing of\nKymriah may be attempted.</span>", "ID": "cba1df84-170c-4502-b880-ccbbc75df48a", "Styles": "None", "Classes": "None", "Text": "Kymriah is a treatment that is manufactured specifically for you. There are situations where Kymriah cannot be successfully manufactured and be given to you. In some cases, a second manufacturing of Kymriah may be attempted.", "ParentId": "9b750c06-1aad-456f-ab6b-129ae0c46b2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Before you are\ngiven Kymriah, your doctor may give you a type of treatment called\nlymphodepleting chemotherapy for a few days to prepare your body.</span></p>", "ID": "e276ea5d-e808-4e9d-b455-ca732979461f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Before you are\ngiven Kymriah, your doctor may give you a type of treatment called\nlymphodepleting chemotherapy for a few days to prepare your body.</span>", "ID": "4accc052-bf57-4fc8-9ac2-18315e4098a5", "Styles": "None", "Classes": "None", "Text": "Before you are given Kymriah, your doctor may give you a type of treatment called lymphodepleting chemotherapy for a few days to prepare your body.", "ParentId": "e276ea5d-e808-4e9d-b455-ca732979461f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a5136b7a-cf60-47ad-9985-8c58eb302b0b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7dde72d2-82e4-46a2-bf7a-49a1310fb19e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a5136b7a-cf60-47ad-9985-8c58eb302b0b"}, {"Element": "<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:\navoid\"><b><span style=\"font-size:11.0pt\">Cancer treatment while Kymriah is\nbeing made</span></b></p>", "ID": "6ca56002-9118-44af-9690-5ae846c75f87", "Styles": "margin-top:0in;text-align:left;page-break-after:\navoid", "Classes": "['Text']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span style=\"font-size:11.0pt\">Cancer treatment while Kymriah is\nbeing made</span></b>", "ID": "7e971604-9bda-4c9e-adb7-71c282601593", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ca56002-9118-44af-9690-5ae846c75f87"}, {"Element": "<span style=\"font-size:11.0pt\">Cancer treatment while Kymriah is\nbeing made</span>", "ID": "1f43b8cb-11f7-4153-9f24-72dee028d50b", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Cancer treatment while Kymriah is being made", "ParentId": "7e971604-9bda-4c9e-adb7-71c282601593"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">During the period while Kymriah is being made, your </span><span lang=\"EN-GB\">lymphoma or leukaemia may get worse and your doctor may decide to\nuse an additional treatment (a type of chemotherapy known as \u201cbridging\ntherapy\u201d) to stabilise your cancer </span><span lang=\"EN-GB\">by stopping new\ncancer cells from developing</span><span lang=\"EN-GB\">. This t</span><span lang=\"EN-GB\">reatment </span><span lang=\"EN-GB\">may lead to side effects and these\nmay be severe or life-threatening. Your doctor will inform you of the potential\nside effects of this treatment.</span></p>", "ID": "8a1ca908-3a19-4f53-bf56-e512a4ae4d81", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">During the period while Kymriah is being made, your </span>", "ID": "c86ed77a-ad03-4121-8de9-7bac7803ddc0", "Styles": "None", "Classes": "None", "Text": "During the period while Kymriah is being made, your ", "ParentId": "8a1ca908-3a19-4f53-bf56-e512a4ae4d81"}, {"Element": "<span lang=\"EN-GB\">lymphoma or leukaemia may get worse and your doctor may decide to\nuse an additional treatment (a type of chemotherapy known as \u201cbridging\ntherapy\u201d) to stabilise your cancer </span>", "ID": "eb2d29d3-31f6-4d6a-bf8f-945ec840a426", "Styles": "None", "Classes": "None", "Text": "lymphoma or leukaemia may get worse and your doctor may decide to use an additional treatment (a type of chemotherapy known as \u201cbridging therapy\u201d) to stabilise your cancer ", "ParentId": "8a1ca908-3a19-4f53-bf56-e512a4ae4d81"}, {"Element": "<span lang=\"EN-GB\">by stopping new\ncancer cells from developing</span>", "ID": "8a9f85c9-3ea5-4912-89b8-02616dfded87", "Styles": "None", "Classes": "None", "Text": "by stopping new cancer cells from developing", "ParentId": "8a1ca908-3a19-4f53-bf56-e512a4ae4d81"}, {"Element": "<span lang=\"EN-GB\">. This t</span>", "ID": "0bad3ca1-c87c-489a-99bd-2ca48a65e69d", "Styles": "None", "Classes": "None", "Text": ". This t", "ParentId": "8a1ca908-3a19-4f53-bf56-e512a4ae4d81"}, {"Element": "<span lang=\"EN-GB\">reatment </span>", "ID": "e69858e4-b4ac-45fd-beb5-2f0fab0e8fe1", "Styles": "None", "Classes": "None", "Text": "reatment ", "ParentId": "8a1ca908-3a19-4f53-bf56-e512a4ae4d81"}, {"Element": "<span lang=\"EN-GB\">may lead to side effects and these\nmay be severe or life-threatening. Your doctor will inform you of the potential\nside effects of this treatment.</span>", "ID": "e6c99625-8f35-4238-a37a-4dc7bca90cb8", "Styles": "None", "Classes": "None", "Text": "may lead to side effects and these may be severe or life-threatening. Your doctor will inform you of the potential side effects of this treatment.", "ParentId": "8a1ca908-3a19-4f53-bf56-e512a4ae4d81"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aa347110-24cb-4547-836e-c99ffc6e7a6b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b055e1b6-3afc-418d-8068-dcfb9236b3ce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa347110-24cb-4547-836e-c99ffc6e7a6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Medicines given immediately before Kymriah treatment</span></b></p>", "ID": "2bd4d387-f675-4968-be8b-035429be86aa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Medicines given immediately before Kymriah treatment</span></b>", "ID": "51b2d39f-56b6-4fa7-a5a3-a0c1bbb3eecd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2bd4d387-f675-4968-be8b-035429be86aa"}, {"Element": "<span lang=\"EN-GB\">Medicines given immediately before Kymriah treatment</span>", "ID": "264617f9-ad21-416b-81c8-f010f23135a2", "Styles": "None", "Classes": "None", "Text": "Medicines given immediately before Kymriah treatment", "ParentId": "51b2d39f-56b6-4fa7-a5a3-a0c1bbb3eecd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">During the 30 to 60\u00a0minutes before you are given Kymriah you\nmay be given other medicines. This is to help prevent infusion reactions and\nfever. These other medicines may include:</span></p>", "ID": "e7855f31-3e48-40fa-af30-3b1a9f71f62a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">During the 30 to 60\u00a0minutes before you are given Kymriah you\nmay be given other medicines. This is to help prevent infusion reactions and\nfever. These other medicines may include:</span>", "ID": "62856ff8-08e7-4222-b2fb-f5b9a22509fb", "Styles": "None", "Classes": "None", "Text": "During the 30 to 60\u00a0minutes before you are given Kymriah you may be given other medicines. This is to help prevent infusion reactions and fever. These other medicines may include:", "ParentId": "e7855f31-3e48-40fa-af30-3b1a9f71f62a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Paracetamol</span></p>", "ID": "6dc0bad9-5e5b-428e-92ab-232abb2d2a6b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2f494ba1-4c5c-4fb3-a470-f7f262fc1e54", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6dc0bad9-5e5b-428e-92ab-232abb2d2a6b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c9e050d3-d0e6-4214-ba16-f54e3ff65e39", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2f494ba1-4c5c-4fb3-a470-f7f262fc1e54"}, {"Element": "<span lang=\"EN-GB\">Paracetamol</span>", "ID": "95b8a0b7-75d4-47b8-b1e2-9dc681b31bcb", "Styles": "None", "Classes": "None", "Text": "Paracetamol", "ParentId": "6dc0bad9-5e5b-428e-92ab-232abb2d2a6b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">An antihistamine such as diphenhydramine.</span></p>", "ID": "dde05ea1-327b-4df6-9b24-1b0bfbf783b0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8ac87a1a-9363-4cf2-b1f1-a66fa3c59d6e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "dde05ea1-327b-4df6-9b24-1b0bfbf783b0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "761064b5-c85e-4d0b-a278-15891b5fbefb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8ac87a1a-9363-4cf2-b1f1-a66fa3c59d6e"}, {"Element": "<span lang=\"EN-GB\">An antihistamine such as diphenhydramine.</span>", "ID": "c6397636-f082-46f1-aa6b-e2446930de82", "Styles": "None", "Classes": "None", "Text": "An antihistamine such as diphenhydramine.", "ParentId": "dde05ea1-327b-4df6-9b24-1b0bfbf783b0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1ca41702-17c8-4c2a-9b63-917ff3097e7d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fee85acb-0af4-4e47-a329-be8d417b1da5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1ca41702-17c8-4c2a-9b63-917ff3097e7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How you are given Kymriah</span></b></p>", "ID": "aa56b8c0-822d-4df1-a3b1-b9add8011a18", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">How you are given Kymriah</span></b>", "ID": "2f23aeeb-36f3-4c63-ab3f-703e241afb2b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa56b8c0-822d-4df1-a3b1-b9add8011a18"}, {"Element": "<span lang=\"EN-GB\">How you are given Kymriah</span>", "ID": "59b0c9e3-2d9d-44c0-8dc2-5630046f7a43", "Styles": "None", "Classes": "None", "Text": "How you are given Kymriah", "ParentId": "2f23aeeb-36f3-4c63-ab3f-703e241afb2b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will check that the individual\npatient identifiers on the Kymriah infusion bag match up to you.</span></p>", "ID": "588c3064-4728-4c67-a3d0-a11f0d93450d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ac7fbe2e-17f8-4f93-a91e-acb7de2960d6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "588c3064-4728-4c67-a3d0-a11f0d93450d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4b529495-8c14-49a6-bb51-fb764e2b20c1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ac7fbe2e-17f8-4f93-a91e-acb7de2960d6"}, {"Element": "<span lang=\"EN-GB\">Your doctor will check that the individual\npatient identifiers on the Kymriah infusion bag match up to you.</span>", "ID": "f3698b6f-b3a0-4b88-baff-c5437b1d6585", "Styles": "None", "Classes": "None", "Text": "Your doctor will check that the individual patient identifiers on the Kymriah infusion bag match up to you.", "ParentId": "588c3064-4728-4c67-a3d0-a11f0d93450d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Your doctor will give you Kymriah by infusion,\nwhich means it will be given as a drip through a tube in your vein. This\nusually takes less than 1\u00a0hour.</span></p>", "ID": "e7a75b4c-d528-4a8a-a9f6-5f7e0b906d26", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "de963119-7112-4d2c-a363-b1b1a699dff1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e7a75b4c-d528-4a8a-a9f6-5f7e0b906d26"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8ea3aa81-44e9-4c9a-a387-69f6caf0a7f0", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "de963119-7112-4d2c-a363-b1b1a699dff1"}, {"Element": "<span lang=\"EN-GB\">Your doctor will give you Kymriah by infusion,\nwhich means it will be given as a drip through a tube in your vein. This\nusually takes less than 1\u00a0hour.</span>", "ID": "e47d1496-a5c1-4739-b655-9f37f725da83", "Styles": "None", "Classes": "None", "Text": "Your doctor will give you Kymriah by infusion, which means it will be given as a drip through a tube in your vein. This usually takes less than 1\u00a0hour.", "ParentId": "e7a75b4c-d528-4a8a-a9f6-5f7e0b906d26"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Kymriah is a one\u2011time treatment.</span></p>", "ID": "6977a92f-723a-4ef3-b1e9-b5837ffb1a95", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "85534bc9-c5c6-4899-a6ba-9113d52c0619", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "6977a92f-723a-4ef3-b1e9-b5837ffb1a95"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "87b4a49d-c1d2-499a-9c07-edf0a781e901", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "85534bc9-c5c6-4899-a6ba-9113d52c0619"}, {"Element": "<span lang=\"EN-GB\">Kymriah is a one\u2011time treatment.</span>", "ID": "1f4636a0-87ff-4aec-a690-4fb9e78a036d", "Styles": "None", "Classes": "None", "Text": "Kymriah is a one\u2011time treatment.", "ParentId": "6977a92f-723a-4ef3-b1e9-b5837ffb1a95"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1e127504-b231-4a83-a74a-e52b33c2bac0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "56d9c4b7-f983-4fdc-b2ff-e47549f590d7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1e127504-b231-4a83-a74a-e52b33c2bac0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">After you are given Kymriah</span></b></p>", "ID": "bb8e8acc-928c-45d3-b6a4-d842648ca70c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">After you are given Kymriah</span></b>", "ID": "4be4d8fc-896b-4782-8db7-a3e0d6a51177", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bb8e8acc-928c-45d3-b6a4-d842648ca70c"}, {"Element": "<span lang=\"EN-GB\">After you are given Kymriah</span>", "ID": "0233138f-d9b8-4d32-8198-7cb8553bdf78", "Styles": "None", "Classes": "None", "Text": "After you are given Kymriah", "ParentId": "4be4d8fc-896b-4782-8db7-a3e0d6a51177"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Plan to stay within 2\u00a0hours\u2019 travel from\nthe hospital where you were treated for at least 4\u00a0weeks after you have\nbeen given Kymriah. Your doctor will recommend that you return to the hospital daily\nfor at least 10\u00a0days and will consider whether you need to stay at the hospital\nas an in\u2011patient for the first 10\u00a0days after infusion. This is so\nyour doctor can check if your treatment is working and help you if you have any\nside effects.</span></p>", "ID": "a6bb584e-bf37-4004-9bc5-4ae707d65232", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6a5058ef-290a-46ef-b7e2-8c13ebe458db", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a6bb584e-bf37-4004-9bc5-4ae707d65232"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a31a6bf6-be0e-4655-838c-21149c2404c0", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6a5058ef-290a-46ef-b7e2-8c13ebe458db"}, {"Element": "<span lang=\"EN-GB\">Plan to stay within 2\u00a0hours\u2019 travel from\nthe hospital where you were treated for at least 4\u00a0weeks after you have\nbeen given Kymriah. Your doctor will recommend that you return to the hospital daily\nfor at least 10\u00a0days and will consider whether you need to stay at the hospital\nas an in\u2011patient for the first 10\u00a0days after infusion. This is so\nyour doctor can check if your treatment is working and help you if you have any\nside effects.</span>", "ID": "fe5d754b-01a3-48e0-a253-8b21ffe75fee", "Styles": "None", "Classes": "None", "Text": "Plan to stay within 2\u00a0hours\u2019 travel from the hospital where you were treated for at least 4\u00a0weeks after you have been given Kymriah. Your doctor will recommend that you return to the hospital daily for at least 10\u00a0days and will consider whether you need to stay at the hospital as an in\u2011patient for the first 10\u00a0days after infusion. This is so your doctor can check if your treatment is working and help you if you have any side effects.", "ParentId": "a6bb584e-bf37-4004-9bc5-4ae707d65232"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "96cdbba3-19d8-493e-8338-25c3bb132625", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e8fa9e0f-06c1-45aa-b9fa-f155ed7bc703", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "96cdbba3-19d8-493e-8338-25c3bb132625"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">If you miss an appointment, call your doctor or the hospital as soon\nas possible to reschedule.</span></p>", "ID": "bba0253a-55e1-485b-88d1-b121f57b9ddf", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If you miss an appointment, call your doctor or the hospital as soon\nas possible to reschedule.</span>", "ID": "fb2e6e89-6c4d-4e00-9614-81199af1d32d", "Styles": "None", "Classes": "None", "Text": "If you miss an appointment, call your doctor or the hospital as soon as possible to reschedule.", "ParentId": "bba0253a-55e1-485b-88d1-b121f57b9ddf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1cfc1d2f-6b21-4d10-b323-d4d0f47c9d5b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a4b76966-b63f-44c8-9b3b-bc5cd28b0295", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1cfc1d2f-6b21-4d10-b323-d4d0f47c9d5b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a172e4fc-1a6d-48c7-9b01-5668f9972e72", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e93266bc-1237-4504-93d4-2f5b5a6193c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a172e4fc-1a6d-48c7-9b01-5668f9972e72"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b></p>", "ID": "a80b7ac9-8f4e-47b6-a64b-a41664f44f6c", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b>", "ID": "8edf1dae-5716-4088-82f2-88fb9d9cd44b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a80b7ac9-8f4e-47b6-a64b-a41664f44f6c"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span>", "ID": "c8812926-504b-4346-9fc1-6c1ce240772c", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "8edf1dae-5716-4088-82f2-88fb9d9cd44b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ae6d4108-f3eb-4b07-b02d-a608590dfe27", "Styles": "margin-right:-1.45pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3cb62d4a-a1a9-482a-be9a-3e1df9d64b80", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ae6d4108-f3eb-4b07-b02d-a608590dfe27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">Like all medicines, this medicine can cause side\neffects, although not everybody gets them.</span></p>", "ID": "9681db20-0841-4db6-b8b3-4fcfada16b1b", "Styles": "margin-right:-1.45pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Like all medicines, this medicine can cause side\neffects, although not everybody gets them.</span>", "ID": "fa0cc62a-8382-423b-a383-21fd860c3b54", "Styles": "None", "Classes": "None", "Text": "Like all medicines, this medicine can cause side effects, although not everybody gets them.", "ParentId": "9681db20-0841-4db6-b8b3-4fcfada16b1b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be3ca817-ae53-452e-ab9f-2bb421a3f4f2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cb65e2ec-01c2-4f96-a405-8bb2b9477b78", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be3ca817-ae53-452e-ab9f-2bb421a3f4f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor immediately</span></b><span lang=\"EN-GB\"> if you get\nany of the following side effects after the Kymriah infusion. They usually\nhappen in the first 8\u00a0weeks after the infusion, but can also develop later:</span></p>", "ID": "0c25b524-eee2-4dd6-863d-1dabbd12b060", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Tell your doctor immediately</span></b>", "ID": "0eedad66-abaf-4e59-a73d-114b9adc43ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c25b524-eee2-4dd6-863d-1dabbd12b060"}, {"Element": "<span lang=\"EN-GB\">Tell your doctor immediately</span>", "ID": "cdffce2f-8431-43c8-9a81-29cc1f2b2667", "Styles": "None", "Classes": "None", "Text": "Tell your doctor immediately", "ParentId": "0eedad66-abaf-4e59-a73d-114b9adc43ad"}, {"Element": "<span lang=\"EN-GB\"> if you get\nany of the following side effects after the Kymriah infusion. They usually\nhappen in the first 8\u00a0weeks after the infusion, but can also develop later:</span>", "ID": "54d7b559-052b-419b-82ab-63d5b024bdee", "Styles": "None", "Classes": "None", "Text": " if you get any of the following side effects after the Kymriah infusion. They usually happen in the first 8\u00a0weeks after the infusion, but can also develop later:", "ParentId": "0c25b524-eee2-4dd6-863d-1dabbd12b060"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2e23c8c-3f1e-4b77-b733-90655c9844ee", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "672bf36b-f356-4e4a-96d1-d9de23c0b45e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2e23c8c-3f1e-4b77-b733-90655c9844ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Very common: may affect more than 1 in 10\u00a0people</span></b></p>", "ID": "3dc66d29-9f82-41e6-9a74-6fa82e244487", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Very common: may affect more than 1 in 10\u00a0people</span></b>", "ID": "5d24a714-7fa0-4748-8d3b-88719e72a776", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3dc66d29-9f82-41e6-9a74-6fa82e244487"}, {"Element": "<span lang=\"EN-GB\">Very common: may affect more than 1 in 10\u00a0people</span>", "ID": "3d7cd9eb-3046-417b-b4a8-fd0fecd67b65", "Styles": "None", "Classes": "None", "Text": "Very common: may affect more than 1 in 10\u00a0people", "ParentId": "5d24a714-7fa0-4748-8d3b-88719e72a776"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">high fever and chills. These may be symptoms of\na serious condition called cytokine release syndrome which </span><span lang=\"EN-GB\">may be life-threatening or fatal</span><span lang=\"EN-GB\">. Other\nsymptoms of cytokine release syndrome are difficulty breathing, nausea,\nvomiting, diarrhoea, loss of appetite, fatigue, muscle pain, joint pain, swelling,\nlow blood pressure, headache, heart, lung and kidney failure and liver injury.\nThese symptoms almost always occur </span><span lang=\"EN-GB\">within the first\n10\u00a0days after infusion.</span></p>", "ID": "109c7f70-c0a8-4784-808b-fc0f4cbb7bcf", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b6899cd0-7fd6-40a7-896d-937dc31dddf9", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "109c7f70-c0a8-4784-808b-fc0f4cbb7bcf"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c156e243-e5e0-41f5-bad8-8812eeb2c69e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b6899cd0-7fd6-40a7-896d-937dc31dddf9"}, {"Element": "<span lang=\"EN-GB\">high fever and chills. These may be symptoms of\na serious condition called cytokine release syndrome which </span>", "ID": "b5f66e0d-c4c6-43cf-97a2-bd3a868ed299", "Styles": "None", "Classes": "None", "Text": "high fever and chills. These may be symptoms of a serious condition called cytokine release syndrome which ", "ParentId": "109c7f70-c0a8-4784-808b-fc0f4cbb7bcf"}, {"Element": "<span lang=\"EN-GB\">may be life-threatening or fatal</span>", "ID": "73efbc4b-815c-492e-95ed-74fa558952a8", "Styles": "None", "Classes": "None", "Text": "may be life-threatening or fatal", "ParentId": "109c7f70-c0a8-4784-808b-fc0f4cbb7bcf"}, {"Element": "<span lang=\"EN-GB\">. Other\nsymptoms of cytokine release syndrome are difficulty breathing, nausea,\nvomiting, diarrhoea, loss of appetite, fatigue, muscle pain, joint pain, swelling,\nlow blood pressure, headache, heart, lung and kidney failure and liver injury.\nThese symptoms almost always occur </span>", "ID": "361e0341-8ec3-4279-a2d8-bfb6aee3c630", "Styles": "None", "Classes": "None", "Text": ". Other symptoms of cytokine release syndrome are difficulty breathing, nausea, vomiting, diarrhoea, loss of appetite, fatigue, muscle pain, joint pain, swelling, low blood pressure, headache, heart, lung and kidney failure and liver injury. These symptoms almost always occur ", "ParentId": "109c7f70-c0a8-4784-808b-fc0f4cbb7bcf"}, {"Element": "<span lang=\"EN-GB\">within the first\n10\u00a0days after infusion.</span>", "ID": "eb7eebea-7adc-476a-8ed8-a264257a4ee1", "Styles": "None", "Classes": "None", "Text": "within the first 10\u00a0days after infusion.", "ParentId": "109c7f70-c0a8-4784-808b-fc0f4cbb7bcf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">problems such as altered thinking or decreased\nconsciousness, loss of contact with reality, confusion, agitation, seizures,\ndifficulty speaking and understanding speech, difficulty walking.</span></p>", "ID": "23aa2d29-4e24-434b-9b8f-b200b966e9e4", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "70555ee1-fef0-41ad-9352-9680cd25efc8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "23aa2d29-4e24-434b-9b8f-b200b966e9e4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e836ec1a-5ce9-4fa5-9d7e-d2f2c3c8f71c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "70555ee1-fef0-41ad-9352-9680cd25efc8"}, {"Element": "<span lang=\"EN-GB\">problems such as altered thinking or decreased\nconsciousness, loss of contact with reality, confusion, agitation, seizures,\ndifficulty speaking and understanding speech, difficulty walking.</span>", "ID": "7e1b6c58-6f64-43b9-aa10-2c4a27dd8e71", "Styles": "None", "Classes": "None", "Text": "problems such as altered thinking or decreased consciousness, loss of contact with reality, confusion, agitation, seizures, difficulty speaking and understanding speech, difficulty walking.", "ParentId": "23aa2d29-4e24-434b-9b8f-b200b966e9e4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">feeling warm, fever, chills or shivering, sore\nthroat or mouth ulcers may be signs of an infection. </span><span lang=\"EN-GB\">Some\ninfections may be life-threatening or fatal.</span></p>", "ID": "0a89eb52-534b-433e-b972-6e7fb2933bad", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "96dc37db-0030-4139-b509-2126bfd1ea1b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0a89eb52-534b-433e-b972-6e7fb2933bad"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "eee6520e-3f52-4c5f-bf75-b3d7512e08c7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "96dc37db-0030-4139-b509-2126bfd1ea1b"}, {"Element": "<span lang=\"EN-GB\">feeling warm, fever, chills or shivering, sore\nthroat or mouth ulcers may be signs of an infection. </span>", "ID": "d961c50f-4dd2-416f-9c7e-7a67e3b75b4c", "Styles": "None", "Classes": "None", "Text": "feeling warm, fever, chills or shivering, sore throat or mouth ulcers may be signs of an infection. ", "ParentId": "0a89eb52-534b-433e-b972-6e7fb2933bad"}, {"Element": "<span lang=\"EN-GB\">Some\ninfections may be life-threatening or fatal.</span>", "ID": "3e5ad072-4b84-4bfc-abb9-bb4ade769cef", "Styles": "None", "Classes": "None", "Text": "Some infections may be life-threatening or fatal.", "ParentId": "0a89eb52-534b-433e-b972-6e7fb2933bad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "591cd7e7-1ef1-4943-98af-4036a65014ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f746191b-6383-4571-86f2-b040b2a6532d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "591cd7e7-1ef1-4943-98af-4036a65014ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Common: may affect up to 1 in 10\u00a0people</span></b></p>", "ID": "1b9e4b7c-af10-449a-9d29-ec01bfee5cf0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Common: may affect up to 1 in 10\u00a0people</span></b>", "ID": "68e1d80c-3ef9-4c58-8dfa-6119a0445db3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b9e4b7c-af10-449a-9d29-ec01bfee5cf0"}, {"Element": "<span lang=\"EN-GB\">Common: may affect up to 1 in 10\u00a0people</span>", "ID": "755361a9-0866-4ac3-b52a-5d017634ca07", "Styles": "None", "Classes": "None", "Text": "Common: may affect up to 1 in 10\u00a0people", "ParentId": "68e1d80c-3ef9-4c58-8dfa-6119a0445db3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Rapid breakdown of tumour cells causing release\nof their contents into the bloodstream. This can interfere with the workings of\nvarious body organs, especially the kidneys, heart and nervous system</span><span lang=\"EN-GB\"> </span>(tumour lysis syndrome).</p>", "ID": "e8677e69-95cc-47a5-9488-e047ed2b83ae", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "(tumour lysis syndrome).", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "82b96451-4273-4868-ba9e-1c3af6c34bc2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e8677e69-95cc-47a5-9488-e047ed2b83ae"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "113a3738-91cb-43ba-974a-4740cf5fa58d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "82b96451-4273-4868-ba9e-1c3af6c34bc2"}, {"Element": "<span lang=\"EN-GB\">Rapid breakdown of tumour cells causing release\nof their contents into the bloodstream. This can interfere with the workings of\nvarious body organs, especially the kidneys, heart and nervous system</span>", "ID": "7f75c285-65d1-4b96-856f-205e60c4ae4a", "Styles": "None", "Classes": "None", "Text": "Rapid breakdown of tumour cells causing release of their contents into the bloodstream. This can interfere with the workings of various body organs, especially the kidneys, heart and nervous system", "ParentId": "e8677e69-95cc-47a5-9488-e047ed2b83ae"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "692c6b2a-8456-4636-befe-cd896e082acb", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "e8677e69-95cc-47a5-9488-e047ed2b83ae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.4pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e1dde213-7db6-438d-bd6e-5780c7b02ae4", "Styles": "margin-right:-1.4pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8b7cc047-9168-4369-97c7-37ae476de0f3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e1dde213-7db6-438d-bd6e-5780c7b02ae4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><b><span lang=\"EN-GB\">Other possible side effects</span></b></p>", "ID": "83313cb2-39b5-4cde-87dc-bfc82998c672", "Styles": "margin-right:-1.45pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Other possible side effects</span></b>", "ID": "8951b4de-a88a-4326-b99d-a0e719c41856", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "83313cb2-39b5-4cde-87dc-bfc82998c672"}, {"Element": "<span lang=\"EN-GB\">Other possible side effects</span>", "ID": "ede799ba-6776-4e14-9d46-8eaa5864d8d9", "Styles": "None", "Classes": "None", "Text": "Other possible side effects", "ParentId": "8951b4de-a88a-4326-b99d-a0e719c41856"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">Other side effects are listed below. If these side\neffects become severe or serious, tell your doctor immediately.</span></p>", "ID": "5946bc7e-94f8-4f4f-9ff2-6f4ee1b30473", "Styles": "margin-right:-1.45pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Other side effects are listed below. If these side\neffects become severe or serious, tell your doctor immediately.</span>", "ID": "0981fceb-01a3-4632-859c-626616cc1402", "Styles": "None", "Classes": "None", "Text": "Other side effects are listed below. If these side effects become severe or serious, tell your doctor immediately.", "ParentId": "5946bc7e-94f8-4f4f-9ff2-6f4ee1b30473"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0ddf542b-9a80-4d41-aea3-5173b2e9dd88", "Styles": "margin-right:-1.45pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eb74e61d-ad89-4fa2-a6f9-39e1d5e7476f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0ddf542b-9a80-4d41-aea3-5173b2e9dd88"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Very common:</span></b><span lang=\"EN-GB\"> <i>may affect more than 1\nin 10\u00a0people</i></span></p>", "ID": "678253b4-3eee-4548-8e75-c06e73e61ac0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Very common:</span></b>", "ID": "1ed5f60e-9aa7-460b-b175-5447811ba265", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "678253b4-3eee-4548-8e75-c06e73e61ac0"}, {"Element": "<span lang=\"EN-GB\">Very common:</span>", "ID": "8b7c8324-e5f9-4170-af5a-c5e48fe143cc", "Styles": "None", "Classes": "None", "Text": "Very common:", "ParentId": "1ed5f60e-9aa7-460b-b175-5447811ba265"}, {"Element": "<span lang=\"EN-GB\"> <i>may affect more than 1\nin 10\u00a0people</i></span>", "ID": "c82f1469-e4f3-498e-9de7-cf27631f7f93", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "678253b4-3eee-4548-8e75-c06e73e61ac0"}, {"Element": "<i>may affect more than 1\nin 10\u00a0people</i>", "ID": "f329d3f3-e9c8-4f53-bcad-c324db952123", "Styles": "None", "Classes": "None", "Text": "may affect more than 1 in 10\u00a0people", "ParentId": "c82f1469-e4f3-498e-9de7-cf27631f7f93"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Pale skin, weakness, breathlessness due to low\nnumber of red blood cells or low haemoglobin</span></p>", "ID": "bfeb6879-8732-4128-9289-049342e834d7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c079a7ef-6295-4d37-92fc-7a1346715b53", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "bfeb6879-8732-4128-9289-049342e834d7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5f8a0db6-1f56-4b87-a032-d11903f89daa", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c079a7ef-6295-4d37-92fc-7a1346715b53"}, {"Element": "<span lang=\"EN-GB\">Pale skin, weakness, breathlessness due to low\nnumber of red blood cells or low haemoglobin</span>", "ID": "a15f7e4a-b5fc-4934-813b-fb543012ede5", "Styles": "None", "Classes": "None", "Text": "Pale skin, weakness, breathlessness due to low number of red blood cells or low haemoglobin", "ParentId": "bfeb6879-8732-4128-9289-049342e834d7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Excessive or prolonged bleeding or bruising due\nto l</span><span lang=\"EN-GB\" style=\"color:black;background:white\">ow number of\nplatelets</span></p>", "ID": "dbe7de63-1995-4117-b2f1-335df3e2a9ab", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b9ed9636-f6ba-41de-8bf3-7849f195afc4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "dbe7de63-1995-4117-b2f1-335df3e2a9ab"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7f33d14d-35cb-492d-a8fb-f39ff7c2bb50", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b9ed9636-f6ba-41de-8bf3-7849f195afc4"}, {"Element": "<span lang=\"EN-GB\">Excessive or prolonged bleeding or bruising due\nto l</span>", "ID": "1cd08193-a5a8-4d52-8454-62983a692e92", "Styles": "None", "Classes": "None", "Text": "Excessive or prolonged bleeding or bruising due to l", "ParentId": "dbe7de63-1995-4117-b2f1-335df3e2a9ab"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:white\">ow number of\nplatelets</span>", "ID": "40546892-6b6d-46f8-bff6-ba8c2088b004", "Styles": "color:black;background:white", "Classes": "None", "Text": "ow number of platelets", "ParentId": "dbe7de63-1995-4117-b2f1-335df3e2a9ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black;background:white\">Fever with dangerously\nlow white blood cell count</span></p>", "ID": "68c58db8-fa19-4dfe-a2a8-9f6f455c4bdd", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "86e3acb9-6687-4200-90cf-f9d4814539ae", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "68c58db8-fa19-4dfe-a2a8-9f6f455c4bdd"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f7177365-77f9-48c0-85bc-d5c5b060b861", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "86e3acb9-6687-4200-90cf-f9d4814539ae"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:white\">Fever with dangerously\nlow white blood cell count</span>", "ID": "2f6dd9a3-52d2-4e76-8309-39b944a15a65", "Styles": "color:black;background:white", "Classes": "None", "Text": "Fever with dangerously low white blood cell count", "ParentId": "68c58db8-fa19-4dfe-a2a8-9f6f455c4bdd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black;background:white\">Increased\nrisk of infection due to abnormally low number of white blood cells</span></p>", "ID": "c551f8bd-795f-4c64-990f-44e115164aab", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b2e0d340-eb7f-41d1-8fc0-cfcacafd39fd", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c551f8bd-795f-4c64-990f-44e115164aab"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9a731f3c-526d-42e9-9819-61ea58c80683", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b2e0d340-eb7f-41d1-8fc0-cfcacafd39fd"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:white\">Increased\nrisk of infection due to abnormally low number of white blood cells</span>", "ID": "f5e08ab1-f4a7-4d5a-a725-23ca8d3ee392", "Styles": "color:black;background:white", "Classes": "None", "Text": "Increased risk of infection due to abnormally low number of white blood cells", "ParentId": "c551f8bd-795f-4c64-990f-44e115164aab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"letter-spacing:-.05pt\">Frequent</span><span lang=\"EN-GB\" style=\"letter-spacing:.3pt\"> </span><span lang=\"EN-GB\">and<span style=\"letter-spacing:1.35pt\"> </span><span style=\"letter-spacing:-.05pt\">persistent\ninfections due to decreased</span><span style=\"letter-spacing:.3pt\"> </span>antibodies\nin<span style=\"letter-spacing:.45pt\"> </span><span style=\"letter-spacing:-.1pt\">your</span><span style=\"letter-spacing:.4pt\"> </span>blood</span></p>", "ID": "c8e71646-eb41-4f61-a307-f9824982eae1", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "80703291-cdaa-42af-aaa0-9eedb62cd1e1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c8e71646-eb41-4f61-a307-f9824982eae1"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7a21630f-1358-444e-acf3-1873f39fcb45", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "80703291-cdaa-42af-aaa0-9eedb62cd1e1"}, {"Element": "<span lang=\"EN-GB\" style=\"letter-spacing:-.05pt\">Frequent</span>", "ID": "59c1e393-58f7-4f8b-88df-88ed5307019c", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "Frequent", "ParentId": "c8e71646-eb41-4f61-a307-f9824982eae1"}, {"Element": "<span lang=\"EN-GB\" style=\"letter-spacing:.3pt\"> </span>", "ID": "a4f276e9-fe25-441d-831a-c91fc919d3ee", "Styles": "letter-spacing:.3pt", "Classes": "None", "Text": " ", "ParentId": "c8e71646-eb41-4f61-a307-f9824982eae1"}, {"Element": "<span lang=\"EN-GB\">and<span style=\"letter-spacing:1.35pt\"> </span><span style=\"letter-spacing:-.05pt\">persistent\ninfections due to decreased</span><span style=\"letter-spacing:.3pt\"> </span>antibodies\nin<span style=\"letter-spacing:.45pt\"> </span><span style=\"letter-spacing:-.1pt\">your</span><span style=\"letter-spacing:.4pt\"> </span>blood</span>", "ID": "7101b321-7533-4705-aeb0-8184def73436", "Styles": "None", "Classes": "None", "Text": "andantibodies inblood", "ParentId": "c8e71646-eb41-4f61-a307-f9824982eae1"}, {"Element": "<span style=\"letter-spacing:1.35pt\"> </span>", "ID": "eecc7b9a-7627-4f5b-9ae9-602740fe14c6", "Styles": "letter-spacing:1.35pt", "Classes": "None", "Text": " ", "ParentId": "7101b321-7533-4705-aeb0-8184def73436"}, {"Element": "<span style=\"letter-spacing:-.05pt\">persistent\ninfections due to decreased</span>", "ID": "671a55fa-926b-4308-9fad-b47797de8604", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "persistent infections due to decreased", "ParentId": "7101b321-7533-4705-aeb0-8184def73436"}, {"Element": "<span style=\"letter-spacing:.3pt\"> </span>", "ID": "6e659dbf-b57a-4d42-8a8e-7127b7b67c69", "Styles": "letter-spacing:.3pt", "Classes": "None", "Text": " ", "ParentId": "7101b321-7533-4705-aeb0-8184def73436"}, {"Element": "<span style=\"letter-spacing:.45pt\"> </span>", "ID": "c98c1a4c-7b67-4c78-a8c7-1affe6ab33ec", "Styles": "letter-spacing:.45pt", "Classes": "None", "Text": " ", "ParentId": "7101b321-7533-4705-aeb0-8184def73436"}, {"Element": "<span style=\"letter-spacing:-.1pt\">your</span>", "ID": "28114fca-bd4f-4c5e-9d1e-b6a93f51dc33", "Styles": "letter-spacing:-.1pt", "Classes": "None", "Text": "your", "ParentId": "7101b321-7533-4705-aeb0-8184def73436"}, {"Element": "<span style=\"letter-spacing:.4pt\"> </span>", "ID": "2aa967fd-c362-4f65-bbe3-b2100e958c8f", "Styles": "letter-spacing:.4pt", "Classes": "None", "Text": " ", "ParentId": "7101b321-7533-4705-aeb0-8184def73436"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Weakness, abnormal heart rhythms, muscle\nspasms/cramping due to abnormal low level of blood salts including </span><span lang=\"EN-GB\">phosphorus</span><span lang=\"EN-GB\">, calcium, potassium, magnesium</span></p>", "ID": "2e33321c-0c28-4090-963a-08d02cb72559", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "11dddd3b-61ab-4700-94f6-303c76f94d1b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2e33321c-0c28-4090-963a-08d02cb72559"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "bb7d8b6f-4f65-4a74-8e04-6800ed2c3968", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "11dddd3b-61ab-4700-94f6-303c76f94d1b"}, {"Element": "<span lang=\"EN-GB\">Weakness, abnormal heart rhythms, muscle\nspasms/cramping due to abnormal low level of blood salts including </span>", "ID": "518f9f58-2faa-41dd-9784-25bb6f6ff825", "Styles": "None", "Classes": "None", "Text": "Weakness, abnormal heart rhythms, muscle spasms/cramping due to abnormal low level of blood salts including ", "ParentId": "2e33321c-0c28-4090-963a-08d02cb72559"}, {"Element": "<span lang=\"EN-GB\">phosphorus</span>", "ID": "b9ff5d46-2885-4b16-90a1-38d3b5aa138a", "Styles": "None", "Classes": "None", "Text": "phosphorus", "ParentId": "2e33321c-0c28-4090-963a-08d02cb72559"}, {"Element": "<span lang=\"EN-GB\">, calcium, potassium, magnesium</span>", "ID": "8d301a7c-ebac-4eea-aa5e-d4975b868c1b", "Styles": "None", "Classes": "None", "Text": ", calcium, potassium, magnesium", "ParentId": "2e33321c-0c28-4090-963a-08d02cb72559"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">High levels of liver enzymes or creatinine in\nthe blood that show that your liver or kidneys are not working normally</span></p>", "ID": "f49aba0a-9d62-4473-b6e0-b439e71e986a", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2496e54b-2425-4e60-867c-8bb1737c67d2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f49aba0a-9d62-4473-b6e0-b439e71e986a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e6fc9718-945d-4bc4-a73e-e7bb938140dd", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2496e54b-2425-4e60-867c-8bb1737c67d2"}, {"Element": "<span lang=\"EN-GB\">High levels of liver enzymes or creatinine in\nthe blood that show that your liver or kidneys are not working normally</span>", "ID": "d274478e-5a2e-4e53-bfe8-ebe4730b0ea5", "Styles": "None", "Classes": "None", "Text": "High levels of liver enzymes or creatinine in the blood that show that your liver or kidneys are not working normally", "ParentId": "f49aba0a-9d62-4473-b6e0-b439e71e986a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Anxiety, irritability</span></p>", "ID": "a05b5bce-7315-4c65-84f0-c05fdc96020f", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e8026566-21f6-46df-94b2-1d30fef12f9b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a05b5bce-7315-4c65-84f0-c05fdc96020f"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9faf74eb-86ad-4a35-b0da-9ac2b58d19ca", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e8026566-21f6-46df-94b2-1d30fef12f9b"}, {"Element": "<span lang=\"EN-GB\">Anxiety, irritability</span>", "ID": "80ad1994-d7cb-4ed7-96e1-afda928ae737", "Styles": "None", "Classes": "None", "Text": "Anxiety, irritability", "ParentId": "a05b5bce-7315-4c65-84f0-c05fdc96020f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Fast or irregular heart beat</span></p>", "ID": "1d0617a6-e545-457e-b38e-20a7a24ad771", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6b9452cb-c58b-4f9d-9c2a-58eb0deb3764", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "1d0617a6-e545-457e-b38e-20a7a24ad771"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "38b95556-195b-42c2-8ee8-3db6d7bc55df", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6b9452cb-c58b-4f9d-9c2a-58eb0deb3764"}, {"Element": "<span lang=\"EN-GB\">Fast or irregular heart beat</span>", "ID": "8ffd9d6b-1949-4461-b922-63b3b70c49a3", "Styles": "None", "Classes": "None", "Text": "Fast or irregular heart beat", "ParentId": "1d0617a6-e545-457e-b38e-20a7a24ad771"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Raised blood pressure</span></p>", "ID": "a7177542-52f1-4120-9bfb-9b22063e531b", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "50ba478c-680a-42e6-b920-8cfe8a2f206e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a7177542-52f1-4120-9bfb-9b22063e531b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "e7d95547-8885-4ac7-8a7a-c68959f74036", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "50ba478c-680a-42e6-b920-8cfe8a2f206e"}, {"Element": "<span lang=\"EN-GB\">Raised blood pressure</span>", "ID": "e65e1893-43e0-4e1a-9fb8-d2c7a7924245", "Styles": "None", "Classes": "None", "Text": "Raised blood pressure", "ParentId": "a7177542-52f1-4120-9bfb-9b22063e531b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Shortness of breath, laboured breathing, rapid\nbreathing, fluid in the lungs</span></p>", "ID": "abcc4a3d-fb1a-4720-803b-83017cbbd986", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e0b84bca-c560-44e2-b3f2-25faebb8273b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "abcc4a3d-fb1a-4720-803b-83017cbbd986"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c6daaf71-6a63-4d4a-a533-648382985c93", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e0b84bca-c560-44e2-b3f2-25faebb8273b"}, {"Element": "<span lang=\"EN-GB\">Shortness of breath, laboured breathing, rapid\nbreathing, fluid in the lungs</span>", "ID": "772a57d4-9167-4940-a20b-2b3c9fefc237", "Styles": "None", "Classes": "None", "Text": "Shortness of breath, laboured breathing, rapid breathing, fluid in the lungs", "ParentId": "abcc4a3d-fb1a-4720-803b-83017cbbd986"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Cough</span></p>", "ID": "ade9488a-f74d-4d6b-b419-b346bdafd0e9", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "23bdd253-5ab8-48b5-a2e0-c422b010146f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ade9488a-f74d-4d6b-b419-b346bdafd0e9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "285dc0ad-12b5-437d-9839-e26717b6b5d7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "23bdd253-5ab8-48b5-a2e0-c422b010146f"}, {"Element": "<span lang=\"EN-GB\">Cough</span>", "ID": "f39cc284-c1df-4c9f-a294-4d87820a40c3", "Styles": "None", "Classes": "None", "Text": "Cough", "ParentId": "ade9488a-f74d-4d6b-b419-b346bdafd0e9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Abdominal pain, constipation</span></p>", "ID": "768be42c-375d-48cb-a9e4-45cb9a866ac4", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "fa5df600-1ffa-46c7-b9a9-da6e6b20c71d", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "768be42c-375d-48cb-a9e4-45cb9a866ac4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "3a61da03-c525-45ae-9838-6b00b28ad7cd", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "fa5df600-1ffa-46c7-b9a9-da6e6b20c71d"}, {"Element": "<span lang=\"EN-GB\">Abdominal pain, constipation</span>", "ID": "b58c96bb-55f9-4d43-966a-b3ae2ef6d066", "Styles": "None", "Classes": "None", "Text": "Abdominal pain, constipation", "ParentId": "768be42c-375d-48cb-a9e4-45cb9a866ac4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Skin rash</span></p>", "ID": "22108457-0bde-4653-8fe1-8f40df62d67b", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "bce1ddc5-a415-48ea-b008-45a822bbc3c6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "22108457-0bde-4653-8fe1-8f40df62d67b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f3e86d06-46f0-4e41-8abe-be6eb5b285be", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "bce1ddc5-a415-48ea-b008-45a822bbc3c6"}, {"Element": "<span lang=\"EN-GB\">Skin rash</span>", "ID": "40dcef24-cd60-40e8-bc6a-34310ab61506", "Styles": "None", "Classes": "None", "Text": "Skin rash", "ParentId": "22108457-0bde-4653-8fe1-8f40df62d67b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Difficulty sleeping</span></p>", "ID": "e20ce0f3-bf76-4532-8713-454ce7ba486a", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "db7c266d-9bc5-441a-b93b-f1e7a29194b2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e20ce0f3-bf76-4532-8713-454ce7ba486a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8f27370a-3b67-4437-9013-9fe5d008f3b4", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "db7c266d-9bc5-441a-b93b-f1e7a29194b2"}, {"Element": "<span lang=\"EN-GB\">Difficulty sleeping</span>", "ID": "450319f1-bbdd-4cbd-950c-1428c42549d7", "Styles": "None", "Classes": "None", "Text": "Difficulty sleeping", "ParentId": "e20ce0f3-bf76-4532-8713-454ce7ba486a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swollen ankles, limbs and face</span></p>", "ID": "43c53d9f-f973-4a07-b513-6f294c6fa4c5", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "58986b66-202f-43ce-9e82-178af1bba882", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "43c53d9f-f973-4a07-b513-6f294c6fa4c5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "da3f9490-0a8b-4ef4-9cbd-85cbe494243d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "58986b66-202f-43ce-9e82-178af1bba882"}, {"Element": "<span lang=\"EN-GB\">Swollen ankles, limbs and face</span>", "ID": "afa649a9-530f-419f-b291-85f01e63ba94", "Styles": "None", "Classes": "None", "Text": "Swollen ankles, limbs and face", "ParentId": "43c53d9f-f973-4a07-b513-6f294c6fa4c5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b2c9770-72ab-4eab-838b-036a6e21964a", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d3848b9-ce20-459f-8861-af834b78779a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b2c9770-72ab-4eab-838b-036a6e21964a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Common:</span></b><span lang=\"EN-GB\"> <i>may affect up to 1 in 10\u00a0people</i></span></p>", "ID": "289df544-6d75-4ed3-b10d-f9cad88abfa4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Common:</span></b>", "ID": "3c4c909d-8c73-4f65-9cd8-d059e7b31a14", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "289df544-6d75-4ed3-b10d-f9cad88abfa4"}, {"Element": "<span lang=\"EN-GB\">Common:</span>", "ID": "5a9a6aae-5fa3-4592-8e76-7f638741b02f", "Styles": "None", "Classes": "None", "Text": "Common:", "ParentId": "3c4c909d-8c73-4f65-9cd8-d059e7b31a14"}, {"Element": "<span lang=\"EN-GB\"> <i>may affect up to 1 in 10\u00a0people</i></span>", "ID": "a782ccad-a24c-4990-88e3-a4f230ac4a4c", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "289df544-6d75-4ed3-b10d-f9cad88abfa4"}, {"Element": "<i>may affect up to 1 in 10\u00a0people</i>", "ID": "5f976755-4537-487b-96f2-c669ab3499d2", "Styles": "None", "Classes": "None", "Text": "may affect up to 1 in 10\u00a0people", "ParentId": "a782ccad-a24c-4990-88e3-a4f230ac4a4c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">F</span><span lang=\"EN-GB\">ever, malaise, enlarged\nliver, yellow colour of your skin and eyes, low blood cell counts due to severe\nimmune activation</span></p>", "ID": "47a00e56-e9f7-4e31-a8ff-202f6eb424da", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "38df0680-7f54-406d-a0b5-a876adfd6c48", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "47a00e56-e9f7-4e31-a8ff-202f6eb424da"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "330971af-514c-4b76-bf80-2c43cba9e085", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "38df0680-7f54-406d-a0b5-a876adfd6c48"}, {"Element": "<span lang=\"EN-GB\">F</span>", "ID": "31fdc057-a5dc-44b3-af81-a7b7eb3aec3d", "Styles": "None", "Classes": "None", "Text": "F", "ParentId": "47a00e56-e9f7-4e31-a8ff-202f6eb424da"}, {"Element": "<span lang=\"EN-GB\">ever, malaise, enlarged\nliver, yellow colour of your skin and eyes, low blood cell counts due to severe\nimmune activation</span>", "ID": "883754f1-2928-47bd-b87a-f3dcfba9fcc3", "Styles": "None", "Classes": "None", "Text": "ever, malaise, enlarged liver, yellow colour of your skin and eyes, low blood cell counts due to severe immune activation", "ParentId": "47a00e56-e9f7-4e31-a8ff-202f6eb424da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Dizziness or fainting, flushing, rash, itching,\nfever, shortness of breath or vomiting, abdominal pain, diarrhoea due to\ninfusion related reaction</span></p>", "ID": "e6a99003-1595-44f2-9144-af9d32df9632", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0cca4d50-c7f8-410e-852f-89ffbf476f88", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e6a99003-1595-44f2-9144-af9d32df9632"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "dc8b35e5-ae74-4570-a610-611e35bfd4a9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0cca4d50-c7f8-410e-852f-89ffbf476f88"}, {"Element": "<span lang=\"EN-GB\">Dizziness or fainting, flushing, rash, itching,\nfever, shortness of breath or vomiting, abdominal pain, diarrhoea due to\ninfusion related reaction</span>", "ID": "26b0ee63-ee78-41b7-90c1-55d925e31a76", "Styles": "None", "Classes": "None", "Text": "Dizziness or fainting, flushing, rash, itching, fever, shortness of breath or vomiting, abdominal pain, diarrhoea due to infusion related reaction", "ParentId": "e6a99003-1595-44f2-9144-af9d32df9632"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Rash, nausea, vomiting, diarrhoea including\nbloody stools (possible symptoms of graft-versus-host disease which is when\ntransplanted cells attack your cells)</span></p>", "ID": "a3cb6787-2534-43af-a9a3-7dce9cdd9310", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2038dacc-5afd-4f6b-81aa-b674690f75af", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a3cb6787-2534-43af-a9a3-7dce9cdd9310"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "499dbb7c-be3a-4f4f-a4a7-893d857901e9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2038dacc-5afd-4f6b-81aa-b674690f75af"}, {"Element": "<span lang=\"EN-GB\">Rash, nausea, vomiting, diarrhoea including\nbloody stools (possible symptoms of graft-versus-host disease which is when\ntransplanted cells attack your cells)</span>", "ID": "5bb37574-2f54-4418-a0f6-5b0661fcaa96", "Styles": "None", "Classes": "None", "Text": "Rash, nausea, vomiting, diarrhoea including bloody stools (possible symptoms of graft-versus-host disease which is when transplanted cells attack your cells)", "ParentId": "a3cb6787-2534-43af-a9a3-7dce9cdd9310"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"color:black;background:white\">Pain in the\njoints</span><span lang=\"EN-GB\"> due to high level of uric acid</span></p>", "ID": "9bf67636-6c35-47a5-8ab9-85760fdfd998", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a88da3c2-da2f-4cec-891a-fd2a8e13be1b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9bf67636-6c35-47a5-8ab9-85760fdfd998"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a395db78-ccd8-4e04-b0ef-c2e3431ef842", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a88da3c2-da2f-4cec-891a-fd2a8e13be1b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:white\">Pain in the\njoints</span>", "ID": "8998bd58-54cc-43d7-9f32-b89bc61012b3", "Styles": "color:black;background:white", "Classes": "None", "Text": "Pain in the joints", "ParentId": "9bf67636-6c35-47a5-8ab9-85760fdfd998"}, {"Element": "<span lang=\"EN-GB\"> due to high level of uric acid</span>", "ID": "e6381293-f307-4b32-8295-c1b528121543", "Styles": "None", "Classes": "None", "Text": " due to high level of uric acid", "ParentId": "9bf67636-6c35-47a5-8ab9-85760fdfd998"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Abnormal blood test results (high level of:\nphosphorus, potassium, calcium, magnesium and sodium, an enzyme called alkaline\nphosphatase to help detect liver disease, fibrin d-dimer, serum ferritin; low\nlevel of: blood protein called albumin, sodium)</span></p>", "ID": "0b62e3ac-5857-4730-af93-045c90755fc3", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "350c8f72-c34b-4b7a-b874-ef840094dcc8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0b62e3ac-5857-4730-af93-045c90755fc3"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7c067c12-cfc2-4dfb-a64c-e11d98da4015", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "350c8f72-c34b-4b7a-b874-ef840094dcc8"}, {"Element": "<span lang=\"EN-GB\">Abnormal blood test results (high level of:\nphosphorus, potassium, calcium, magnesium and sodium, an enzyme called alkaline\nphosphatase to help detect liver disease, fibrin d-dimer, serum ferritin; low\nlevel of: blood protein called albumin, sodium)</span>", "ID": "6034e511-ffe6-4c9b-b27d-77b1f6d1dfd4", "Styles": "None", "Classes": "None", "Text": "Abnormal blood test results (high level of: phosphorus, potassium, calcium, magnesium and sodium, an enzyme called alkaline phosphatase to help detect liver disease, fibrin d-dimer, serum ferritin; low level of: blood protein called albumin, sodium)", "ParentId": "0b62e3ac-5857-4730-af93-045c90755fc3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Convulsion, fits (seizures)</span></p>", "ID": "d4617b16-8333-4c47-a9a2-fa8fda769db7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f85619c1-9bfc-4769-90ca-5bc33ea58e0e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d4617b16-8333-4c47-a9a2-fa8fda769db7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a48960c4-9420-4d4a-a0c6-a82340fac953", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f85619c1-9bfc-4769-90ca-5bc33ea58e0e"}, {"Element": "<span lang=\"EN-GB\">Convulsion, fits (seizures)</span>", "ID": "ee05f008-2b09-4746-b31b-f3e225a66e74", "Styles": "None", "Classes": "None", "Text": "Convulsion, fits (seizures)", "ParentId": "d4617b16-8333-4c47-a9a2-fa8fda769db7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Involuntary or uncontrollable movements</span></p>", "ID": "c2f4cba8-3c5f-494b-8d95-221dbd8fe6d2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "808d47a7-068e-44c3-a0e6-5e9370725ccd", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c2f4cba8-3c5f-494b-8d95-221dbd8fe6d2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f9fc1d2f-d00b-4e39-b3cb-ef003bdaf638", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "808d47a7-068e-44c3-a0e6-5e9370725ccd"}, {"Element": "<span lang=\"EN-GB\">Involuntary or uncontrollable movements</span>", "ID": "6a9d1161-8587-48ff-a20d-1702dcf423a3", "Styles": "None", "Classes": "None", "Text": "Involuntary or uncontrollable movements", "ParentId": "c2f4cba8-3c5f-494b-8d95-221dbd8fe6d2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Tingling or numbness, </span><span lang=\"EN-GB\">difficulty\nmoving because of nerve damage</span></p>", "ID": "3c03f698-17a1-4a69-a199-29d06885ee4c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "42646caa-20f4-4462-9ae9-cf95f99773f0", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3c03f698-17a1-4a69-a199-29d06885ee4c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f966d97c-6ec9-4aac-8e9a-0c9abddc13fd", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "42646caa-20f4-4462-9ae9-cf95f99773f0"}, {"Element": "<span lang=\"EN-GB\">Tingling or numbness, </span>", "ID": "13cdd107-7cb6-4a7b-a5c8-ecef31fdaef3", "Styles": "None", "Classes": "None", "Text": "Tingling or numbness, ", "ParentId": "3c03f698-17a1-4a69-a199-29d06885ee4c"}, {"Element": "<span lang=\"EN-GB\">difficulty\nmoving because of nerve damage</span>", "ID": "469a1f25-4031-4706-8e85-f69fe002f28a", "Styles": "None", "Classes": "None", "Text": "difficulty moving because of nerve damage", "ParentId": "3c03f698-17a1-4a69-a199-29d06885ee4c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Decreased vision</span></p>", "ID": "b68fd82e-6d3b-4f40-aa5c-101ff8319b79", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "78f7151b-e0d0-4153-9e8b-9614f744430e", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b68fd82e-6d3b-4f40-aa5c-101ff8319b79"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "5b37ad5c-2c85-42b3-8951-80b3ae6c551b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "78f7151b-e0d0-4153-9e8b-9614f744430e"}, {"Element": "<span lang=\"EN-GB\">Decreased vision</span>", "ID": "0b17e121-c211-479d-b796-02afd09eec25", "Styles": "None", "Classes": "None", "Text": "Decreased vision", "ParentId": "b68fd82e-6d3b-4f40-aa5c-101ff8319b79"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Thirst</span></p>", "ID": "b9d3622c-ec4b-4ebf-9055-b97f5a92121a", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ce26ac88-a298-4d7f-a6a5-e3aac1278136", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b9d3622c-ec4b-4ebf-9055-b97f5a92121a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "53f30c93-bdf8-4192-8ed4-4b902e9533af", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ce26ac88-a298-4d7f-a6a5-e3aac1278136"}, {"Element": "<span lang=\"EN-GB\">Thirst</span>", "ID": "27626191-2f12-4c1f-b21c-eafbb4d3d108", "Styles": "None", "Classes": "None", "Text": "Thirst", "ParentId": "b9d3622c-ec4b-4ebf-9055-b97f5a92121a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">W</span><span lang=\"EN-GB\">eight loss</span></p>", "ID": "3db2a689-ce4c-450d-8773-f8f4b7f3d96b", "Styles": "margin-top:0in;margin-right:-1.45pt;margin-bottom:\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c7828eef-9792-4398-ae04-652044bb6414", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3db2a689-ce4c-450d-8773-f8f4b7f3d96b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0b0183d1-206b-40c6-b46c-ffbaf97f9735", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c7828eef-9792-4398-ae04-652044bb6414"}, {"Element": "<span lang=\"EN-GB\">W</span>", "ID": "94a1851e-174e-4485-82d1-396fcfbc40df", "Styles": "None", "Classes": "None", "Text": "W", "ParentId": "3db2a689-ce4c-450d-8773-f8f4b7f3d96b"}, {"Element": "<span lang=\"EN-GB\">eight loss</span>", "ID": "8c8247ea-d698-48df-bbc1-964edd41a796", "Styles": "None", "Classes": "None", "Text": "eight loss", "ParentId": "3db2a689-ce4c-450d-8773-f8f4b7f3d96b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Nerve pain</span></p>", "ID": "7c5f5007-76e6-4b2c-be03-19495285d260", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c8c9bff4-30cc-4229-9048-f92b42d40119", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7c5f5007-76e6-4b2c-be03-19495285d260"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "45ac96ec-20ed-4918-a57f-1db601c797aa", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c8c9bff4-30cc-4229-9048-f92b42d40119"}, {"Element": "<span lang=\"EN-GB\">Nerve pain</span>", "ID": "0491f13c-9b12-45d9-b866-0740e14324c4", "Styles": "None", "Classes": "None", "Text": "Nerve pain", "ParentId": "7c5f5007-76e6-4b2c-be03-19495285d260"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Breathlessness, difficulty breathing when lying\ndown, swelling of the feet or legs (possible symptoms of h</span><span lang=\"EN-GB\">eart failure), stopped heart beat</span></p>", "ID": "0cae4ffe-8dc2-4abe-aaf3-0d8b916a7203", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "212a04df-9688-488a-aa66-2e3c70710ff1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0cae4ffe-8dc2-4abe-aaf3-0d8b916a7203"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6f59d5e0-3259-46bb-888c-e0c78f049ac7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "212a04df-9688-488a-aa66-2e3c70710ff1"}, {"Element": "<span lang=\"EN-GB\">Breathlessness, difficulty breathing when lying\ndown, swelling of the feet or legs (possible symptoms of h</span>", "ID": "122abbaa-d9d9-4ed9-8ffd-d0aed2fa4f35", "Styles": "None", "Classes": "None", "Text": "Breathlessness, difficulty breathing when lying down, swelling of the feet or legs (possible symptoms of h", "ParentId": "0cae4ffe-8dc2-4abe-aaf3-0d8b916a7203"}, {"Element": "<span lang=\"EN-GB\">eart failure), stopped heart beat</span>", "ID": "6817ea02-02a7-4f01-9b7e-2a5d0a8cf7f6", "Styles": "None", "Classes": "None", "Text": "eart failure), stopped heart beat", "ParentId": "0cae4ffe-8dc2-4abe-aaf3-0d8b916a7203"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swelling and pain due to blood clots</span></p>", "ID": "1ce1286d-7524-42c4-9a8e-dcb2e04ba5c0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "653ea9e2-c3ac-4b3b-ba54-61dd8ef41ed5", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "1ce1286d-7524-42c4-9a8e-dcb2e04ba5c0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6f5b24d6-2bcc-43aa-81cf-ac01b117fee5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "653ea9e2-c3ac-4b3b-ba54-61dd8ef41ed5"}, {"Element": "<span lang=\"EN-GB\">Swelling and pain due to blood clots</span>", "ID": "48468e79-8b48-4e49-8735-5cde145970f3", "Styles": "None", "Classes": "None", "Text": "Swelling and pain due to blood clots", "ParentId": "1ce1286d-7524-42c4-9a8e-dcb2e04ba5c0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swelling due to fluids leaking from blood\nvessels into the surrounding tissue</span></p>", "ID": "5330b3e4-8440-420a-a379-ba00b9d5ab5d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "62cb01e7-53ee-44f9-ac2e-9b78b72699a7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "5330b3e4-8440-420a-a379-ba00b9d5ab5d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d2f1934c-8fd3-4f0a-a102-91dac9d52527", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "62cb01e7-53ee-44f9-ac2e-9b78b72699a7"}, {"Element": "<span lang=\"EN-GB\">Swelling due to fluids leaking from blood\nvessels into the surrounding tissue</span>", "ID": "6ab1ac1d-5c71-4f9e-8063-65c77305b086", "Styles": "None", "Classes": "None", "Text": "Swelling due to fluids leaking from blood vessels into the surrounding tissue", "ParentId": "5330b3e4-8440-420a-a379-ba00b9d5ab5d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Bloating and discomfort (abdominal distension),due\nto an accumulation of fluid in the abdomen</span></p>", "ID": "7aaa3027-eaff-4c70-b00e-ea2e9a7384ce", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "cd6e7daa-a855-40ce-b46e-238f7269c5e0", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7aaa3027-eaff-4c70-b00e-ea2e9a7384ce"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "be458136-6cc6-4919-a58c-9ee4b0ff85c8", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "cd6e7daa-a855-40ce-b46e-238f7269c5e0"}, {"Element": "<span lang=\"EN-GB\">Bloating and discomfort (abdominal distension),due\nto an accumulation of fluid in the abdomen</span>", "ID": "50b92e05-c58d-4602-bca7-e5da33101694", "Styles": "None", "Classes": "None", "Text": "Bloating and discomfort (abdominal distension),due to an accumulation of fluid in the abdomen", "ParentId": "7aaa3027-eaff-4c70-b00e-ea2e9a7384ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Dry mouth, sore mouth, bleeding in the mouth,\ninflammation in the gums</span></p>", "ID": "c6789f9d-c387-44d5-9312-cda970c9b3ab", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ead07c4a-e411-49b8-8f7d-dfa6525488e1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c6789f9d-c387-44d5-9312-cda970c9b3ab"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "92634e6c-ced0-4cba-9477-4860b17709a0", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ead07c4a-e411-49b8-8f7d-dfa6525488e1"}, {"Element": "<span lang=\"EN-GB\">Dry mouth, sore mouth, bleeding in the mouth,\ninflammation in the gums</span>", "ID": "9df63eda-f180-4934-b6e7-9d47ffed71d7", "Styles": "None", "Classes": "None", "Text": "Dry mouth, sore mouth, bleeding in the mouth, inflammation in the gums", "ParentId": "c6789f9d-c387-44d5-9312-cda970c9b3ab"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Yellow skin and eyes due to abnormally high\nlevels of bilirubin in the blood</span></p>", "ID": "c3ddc25d-d337-4bfb-a454-0b1a65cd8586", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "801013ab-eb54-4ad7-9911-3b4f76e07357", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c3ddc25d-d337-4bfb-a454-0b1a65cd8586"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "add34079-c33d-46fb-8dff-b7f7b94ce797", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "801013ab-eb54-4ad7-9911-3b4f76e07357"}, {"Element": "<span lang=\"EN-GB\">Yellow skin and eyes due to abnormally high\nlevels of bilirubin in the blood</span>", "ID": "30ef6bdc-4ca2-46ea-bb44-77785b06ee42", "Styles": "None", "Classes": "None", "Text": "Yellow skin and eyes due to abnormally high levels of bilirubin in the blood", "ParentId": "c3ddc25d-d337-4bfb-a454-0b1a65cd8586"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Itching</span></p>", "ID": "dbc667c6-0d8c-46a8-8041-a450d6751c96", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f1f6fe2a-5fa8-4afa-bb97-06c92084c5ef", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "dbc667c6-0d8c-46a8-8041-a450d6751c96"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6d3971e2-67ff-4f64-a149-d4a9416e9e8c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f1f6fe2a-5fa8-4afa-bb97-06c92084c5ef"}, {"Element": "<span lang=\"EN-GB\">Itching</span>", "ID": "5df05230-f4be-40c6-9fc3-0e5e8da8ee59", "Styles": "None", "Classes": "None", "Text": "Itching", "ParentId": "dbc667c6-0d8c-46a8-8041-a450d6751c96"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Excessive sweating, n</span><span lang=\"EN-GB\">ight\nsweats</span></p>", "ID": "39d1cdec-e8ac-437a-be4d-a4014f4fb9ac", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "bb9cedd9-3fb2-462c-9aa5-d9c836f90bb6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "39d1cdec-e8ac-437a-be4d-a4014f4fb9ac"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "783a58e9-5a02-45da-a6d5-d12030e3aa14", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "bb9cedd9-3fb2-462c-9aa5-d9c836f90bb6"}, {"Element": "<span lang=\"EN-GB\">Excessive sweating, n</span>", "ID": "64b95b8d-2431-42f8-b3be-9a0ca2fd48c4", "Styles": "None", "Classes": "None", "Text": "Excessive sweating, n", "ParentId": "39d1cdec-e8ac-437a-be4d-a4014f4fb9ac"}, {"Element": "<span lang=\"EN-GB\">ight\nsweats</span>", "ID": "24211849-9ddd-4bbb-b716-934006f1ca9c", "Styles": "None", "Classes": "None", "Text": "ight sweats", "ParentId": "39d1cdec-e8ac-437a-be4d-a4014f4fb9ac"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Bone and back pain</span></p>", "ID": "b93fbf36-40cd-42a2-b8ff-5046c87cc408", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "4547eae4-5ee1-49f4-8c70-a09e775cdee6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b93fbf36-40cd-42a2-b8ff-5046c87cc408"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "80c6a090-99f5-4688-8f28-868ffed59494", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "4547eae4-5ee1-49f4-8c70-a09e775cdee6"}, {"Element": "<span lang=\"EN-GB\">Bone and back pain</span>", "ID": "59a1e438-f1da-4c77-8d24-7c49dc47154a", "Styles": "None", "Classes": "None", "Text": "Bone and back pain", "ParentId": "b93fbf36-40cd-42a2-b8ff-5046c87cc408"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Flu\u2011like illness</span></p>", "ID": "2c8ff1b0-6584-46e2-bf04-5eeb6552b1c2", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "192e72ea-7c3d-405b-bb51-d469c5d7e375", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "2c8ff1b0-6584-46e2-bf04-5eeb6552b1c2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0a979a96-3059-4dae-95a0-fcaac2661462", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "192e72ea-7c3d-405b-bb51-d469c5d7e375"}, {"Element": "<span lang=\"EN-GB\">Flu\u2011like illness</span>", "ID": "cd1a02ef-3942-47fd-81bc-0bb0fe48a5c6", "Styles": "None", "Classes": "None", "Text": "Flu\u2011like illness", "ParentId": "2c8ff1b0-6584-46e2-bf04-5eeb6552b1c2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Failure of multiple organs</span></p>", "ID": "3c5cda7c-dcb4-459d-a27d-3d2bea3985ce", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a621549f-2da4-43e8-8548-76d2a52240a1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3c5cda7c-dcb4-459d-a27d-3d2bea3985ce"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "300c2ccc-c423-47fc-9bc0-42da4b948631", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a621549f-2da4-43e8-8548-76d2a52240a1"}, {"Element": "<span lang=\"EN-GB\">Failure of multiple organs</span>", "ID": "d67d3457-8a36-4b5f-9980-5781b4d8aab3", "Styles": "None", "Classes": "None", "Text": "Failure of multiple organs", "ParentId": "3c5cda7c-dcb4-459d-a27d-3d2bea3985ce"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\">\u00a0</p>", "ID": "e1298f39-5079-4031-9ec8-1951bf9b24ae", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Uncommon: </span></b><i><span lang=\"EN-GB\">may affect up to 1 in\n100\u00a0people</span></i></p>", "ID": "0a372e31-ee13-4ce8-b16c-9cb6a230ee1e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Uncommon: </span></b>", "ID": "6d7267ae-a3e3-4abb-9fe7-0e0b1990a798", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a372e31-ee13-4ce8-b16c-9cb6a230ee1e"}, {"Element": "<span lang=\"EN-GB\">Uncommon: </span>", "ID": "8027f42f-d85d-4db8-b8e8-d90322cf8498", "Styles": "None", "Classes": "None", "Text": "Uncommon: ", "ParentId": "6d7267ae-a3e3-4abb-9fe7-0e0b1990a798"}, {"Element": "<i><span lang=\"EN-GB\">may affect up to 1 in\n100\u00a0people</span></i>", "ID": "d77eddf5-53f2-4e74-968f-c828bc5f203a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a372e31-ee13-4ce8-b16c-9cb6a230ee1e"}, {"Element": "<span lang=\"EN-GB\">may affect up to 1 in\n100\u00a0people</span>", "ID": "ed06efee-f590-4cc8-8aa0-060f0d25549d", "Styles": "None", "Classes": "None", "Text": "may affect up to 1 in 100\u00a0people", "ParentId": "d77eddf5-53f2-4e74-968f-c828bc5f203a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Weakness or paralysis of limbs or face,\ndifficulty speaking (possible symptoms of stroke as a result of reduced blood\nsupply)</span></p>", "ID": "47a2d6a9-3c3c-43e4-b26e-c2a93d63482a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "8ceb8d3b-3623-4704-ba95-b87047f2c34d", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "47a2d6a9-3c3c-43e4-b26e-c2a93d63482a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a0dfd1a8-1f0f-4d0d-be0b-d0c67078f004", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "8ceb8d3b-3623-4704-ba95-b87047f2c34d"}, {"Element": "<span lang=\"EN-GB\">Weakness or paralysis of limbs or face,\ndifficulty speaking (possible symptoms of stroke as a result of reduced blood\nsupply)</span>", "ID": "077d0a70-6d21-4c04-90d8-aa7abb13ef6a", "Styles": "None", "Classes": "None", "Text": "Weakness or paralysis of limbs or face, difficulty speaking (possible symptoms of stroke as a result of reduced blood supply)", "ParentId": "47a2d6a9-3c3c-43e4-b26e-c2a93d63482a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Warm or rapidly reddening skin</span></p>", "ID": "491d343f-58a6-499f-afb9-fd68492bf5a5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "9a139ed8-3549-49fe-952c-fc3b18103006", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "491d343f-58a6-499f-afb9-fd68492bf5a5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "de0b96f8-8bd8-4371-b8da-0e0d79472318", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "9a139ed8-3549-49fe-952c-fc3b18103006"}, {"Element": "<span lang=\"EN-GB\">Warm or rapidly reddening skin</span>", "ID": "ba9f1d3d-6d3c-44b8-8a69-a974d13d48fe", "Styles": "None", "Classes": "None", "Text": "Warm or rapidly reddening skin", "ParentId": "491d343f-58a6-499f-afb9-fd68492bf5a5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Cough that produces phlegm or sometimes blood,\nfever, shortness of breath or difficulty breathing</span></p>", "ID": "4d20335e-d2cf-49dd-aa47-57538b197025", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "07934722-1769-4ce7-9723-4114ef1ee074", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "4d20335e-d2cf-49dd-aa47-57538b197025"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "36f8c418-b09b-49e8-868d-a6aff4cba1bb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "07934722-1769-4ce7-9723-4114ef1ee074"}, {"Element": "<span lang=\"EN-GB\">Cough that produces phlegm or sometimes blood,\nfever, shortness of breath or difficulty breathing</span>", "ID": "2bf207b8-833d-4f50-8c16-dc58d8277442", "Styles": "None", "Classes": "None", "Text": "Cough that produces phlegm or sometimes blood, fever, shortness of breath or difficulty breathing", "ParentId": "4d20335e-d2cf-49dd-aa47-57538b197025"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-1.45pt;line-height:normal\">\u00a0</p>", "ID": "0d119754-57fd-45a3-a8ea-590770957417", "Styles": "margin-right:-1.45pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p>", "ID": "70a7d5ae-73bd-4c22-84b9-1e99aa42f7dc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Reporting of side effects</span></b>", "ID": "8f54936d-4f82-4812-89c4-b7a092ac0f6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "70a7d5ae-73bd-4c22-84b9-1e99aa42f7dc"}, {"Element": "<span lang=\"EN-GB\">Reporting of side effects</span>", "ID": "97ea2e66-2237-489b-9c93-85a12750b70e", "Styles": "None", "Classes": "None", "Text": "Reporting of side effects", "ParentId": "8f54936d-4f82-4812-89c4-b7a092ac0f6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you get any\nside effects, talk to your doctor.</span><span lang=\"EN-GB\" style=\"color:red\"> </span><span lang=\"EN-GB\">This includes any possible side effects not listed in this leaflet.</span><span lang=\"EN-GB\" style='font-family:\"Verdana\",sans-serif'> </span><span lang=\"EN-GB\">You\ncan also report side effects directly via <span style=\"color:black;background:\n#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span><span lang=\"EN-GB\"> By reporting side effects, you can help provide more information on\nthe safety of this medicine.</span></p>", "ID": "6915c18b-7a97-4204-b7e8-fbd7587ff125", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">If you get any\nside effects, talk to your doctor.</span>", "ID": "79d48885-c1a0-4b15-a939-28ca3f35e1a4", "Styles": "None", "Classes": "None", "Text": "If you get any side effects, talk to your doctor.", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<span lang=\"EN-GB\" style=\"color:red\"> </span>", "ID": "70c0b667-2579-45fc-8987-ccd29e70338f", "Styles": "color:red", "Classes": "None", "Text": " ", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<span lang=\"EN-GB\">This includes any possible side effects not listed in this leaflet.</span>", "ID": "1293ca98-9bfb-4481-9732-5ef8e69ece40", "Styles": "None", "Classes": "None", "Text": "This includes any possible side effects not listed in this leaflet.", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Verdana\",sans-serif'> </span>", "ID": "6fa39198-1b6d-41c0-b18c-e01c507c7c7b", "Styles": "font-family:\"Verdana\",sans-serif", "Classes": "None", "Text": " ", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<span lang=\"EN-GB\">You\ncan also report side effects directly via <span style=\"color:black;background:\n#D9D9D9\">the national reporting system listed in </span></span>", "ID": "19519fff-72ea-44aa-873e-5b129971e98f", "Styles": "None", "Classes": "None", "Text": "You can also report side effects directly via ", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<span style=\"color:black;background:\n#D9D9D9\">the national reporting system listed in </span>", "ID": "8873de61-fd32-46a4-9117-e2ee35425ace", "Styles": "color:black;background:\n#D9D9D9", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "19519fff-72ea-44aa-873e-5b129971e98f"}, {"Element": "<span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span>", "ID": "d6f727dc-6144-4c93-8fef-0d72fd788c80", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a>", "ID": "95394650-7684-4dd5-a66a-6fcf66c9ae7f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d6f727dc-6144-4c93-8fef-0d72fd788c80"}, {"Element": "<span style=\"background:#D9D9D9\">Appendix V</span>", "ID": "8ba2714a-a404-476b-b45f-244357917115", "Styles": "background:#D9D9D9", "Classes": "None", "Text": "Appendix V", "ParentId": "95394650-7684-4dd5-a66a-6fcf66c9ae7f"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "8d554a13-27a8-4434-b65c-39519ff59ad6", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<span lang=\"EN-GB\"> By reporting side effects, you can help provide more information on\nthe safety of this medicine.</span>", "ID": "339a1526-3ea6-4b51-acde-b92af730e997", "Styles": "None", "Classes": "None", "Text": " By reporting side effects, you can help provide more information on the safety of this medicine.", "ParentId": "6915c18b-7a97-4204-b7e8-fbd7587ff125"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2dcf8ff2-b93c-4dd3-8e0b-757a405e7dc6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9d9db298-9a75-4b3f-9cfc-4734fddab915", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2dcf8ff2-b93c-4dd3-8e0b-757a405e7dc6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "570656b3-a740-4985-a287-89b1230ff5a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b8ce405-b5d8-4c55-949f-5edb3139d430", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "570656b3-a740-4985-a287-89b1230ff5a7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nKymriah</span></b></p>", "ID": "4c3971c4-7c2d-48c3-a900-2259929f027e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nKymriah</span></b>", "ID": "561e8507-f696-4812-898e-754dbf470215", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4c3971c4-7c2d-48c3-a900-2259929f027e"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nKymriah</span>", "ID": "a377e36b-b67e-4bfb-a0ea-b59f64bb5e64", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store Kymriah", "ParentId": "561e8507-f696-4812-898e-754dbf470215"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "84953c7b-c2bf-4c62-a88a-294aa548a60b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75ae7a47-705b-4951-9dce-6335e535f759", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "84953c7b-c2bf-4c62-a88a-294aa548a60b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">The following information is intended for doctors only.</span></b></p>", "ID": "062082f3-964f-44f5-aa05-4b888bb70ffc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">The following information is intended for doctors only.</span></b>", "ID": "216bf066-c713-4feb-b85c-c4f7cc0bb580", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "062082f3-964f-44f5-aa05-4b888bb70ffc"}, {"Element": "<span lang=\"EN-GB\">The following information is intended for doctors only.</span>", "ID": "491b5790-61f5-44bd-945f-ee8a6d2f5f03", "Styles": "None", "Classes": "None", "Text": "The following information is intended for doctors only.", "ParentId": "216bf066-c713-4feb-b85c-c4f7cc0bb580"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e438f824-4639-465b-8e4d-895d521bffe0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48074871-98dd-415b-9022-4e0a4e046f93", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e438f824-4639-465b-8e4d-895d521bffe0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span></p>", "ID": "f872f116-138b-4ecd-9896-d9fdae31fabf", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span>", "ID": "c1ce636e-c461-4423-b8af-6a9acf2b3c06", "Styles": "None", "Classes": "None", "Text": "Keep this medicine out of the sight and reach of children.", "ParentId": "f872f116-138b-4ecd-9896-d9fdae31fabf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ac0c2146-f207-4938-a5d3-f33c2e621561", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "28d81fe1-e8f9-4673-9aa0-3c7749608992", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ac0c2146-f207-4938-a5d3-f33c2e621561"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Do not use this medicine after the expiry date which is stated on\nthe infusion bag label after EXP. The expiry date refers to the last day of\nthat month.</span></p>", "ID": "4db26356-da5e-4553-a2e7-04f14d1ad00e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Do not use this medicine after the expiry date which is stated on\nthe infusion bag label after EXP. The expiry date refers to the last day of\nthat month.</span>", "ID": "42763f56-a2e8-4a53-b8aa-569f33dcf40d", "Styles": "None", "Classes": "None", "Text": "Do not use this medicine after the expiry date which is stated on the infusion bag label after EXP. The expiry date refers to the last day of that month.", "ParentId": "4db26356-da5e-4553-a2e7-04f14d1ad00e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c3de18b-82e4-4421-b147-4ce1b24b3c13", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eae9f464-6743-47d2-a29e-705517b46581", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c3de18b-82e4-4421-b147-4ce1b24b3c13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Store and transport below \u2011120\u00b0C. Do not thaw the product\nuntil it is ready to be used.</span></p>", "ID": "302423f7-74c9-4c94-93ae-cb2cb720b0e8", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Store and transport below \u2011120\u00b0C. Do not thaw the product\nuntil it is ready to be used.</span>", "ID": "158a6ad0-7591-46c6-ad11-effcaf2cf3f0", "Styles": "None", "Classes": "None", "Text": "Store and transport below \u2011120\u00b0C. Do not thaw the product until it is ready to be used.", "ParentId": "302423f7-74c9-4c94-93ae-cb2cb720b0e8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bb948ec2-699b-4915-9711-a993113762f8", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d63402f-c3f8-4815-a43d-1ecdea44dc12", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bb948ec2-699b-4915-9711-a993113762f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine if the infusion bag is damaged or leaking.</span></p>", "ID": "d7dcddfd-7b61-4dce-838a-d5fc6fabd25b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Do not use this\nmedicine if the infusion bag is damaged or leaking.</span>", "ID": "11f2a41b-f74c-428b-b32f-a437199c2f0e", "Styles": "None", "Classes": "None", "Text": "Do not use this medicine if the infusion bag is damaged or leaking.", "ParentId": "d7dcddfd-7b61-4dce-838a-d5fc6fabd25b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "eff4b329-e0a1-4276-a4bd-0272543ce2db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6a1dc910-8814-4f95-855d-9e1d5d44c36f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eff4b329-e0a1-4276-a4bd-0272543ce2db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine\ncontains genetically\u2011modified blood cells. Local guidelines on handling\nof biological waste should be followed for unused medicine or waste material.</span></p>", "ID": "6bba9118-3537-457a-b0a0-cee4485ad78f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">This medicine\ncontains genetically\u2011modified blood cells. Local guidelines on handling\nof biological waste should be followed for unused medicine or waste material.</span>", "ID": "eef670b0-aaca-4cb2-98c6-76cc0afecc98", "Styles": "None", "Classes": "None", "Text": "This medicine contains genetically\u2011modified blood cells. Local guidelines on handling of biological waste should be followed for unused medicine or waste material.", "ParentId": "6bba9118-3537-457a-b0a0-cee4485ad78f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b89533a7-6fac-4b1e-bfbb-dd4c253667bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "524055e0-af8b-45da-b467-e64f151850ce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b89533a7-6fac-4b1e-bfbb-dd4c253667bc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "470b3122-3eac-456d-83bc-02e2a464a9d9", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d4bd6258-fe13-4cc1-ae6b-75b3cf7f90f9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "470b3122-3eac-456d-83bc-02e2a464a9d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the\npack and other information</span></b></p>", "ID": "2128adef-8ea0-49ed-a205-073fba4e2d34", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the\npack and other information</span></b>", "ID": "dcd69b1e-e77b-470f-a793-38855f291f40", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2128adef-8ea0-49ed-a205-073fba4e2d34"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the\npack and other information</span>", "ID": "c4bc0cb3-d324-4f9e-94cc-e4140e76e7c8", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information", "ParentId": "dcd69b1e-e77b-470f-a793-38855f291f40"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "890bf34e-5586-4934-adc5-0737c063abb8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f91e5636-26ad-40ee-a6b5-94f625d1befb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "890bf34e-5586-4934-adc5-0737c063abb8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Kymriah contains</span></b></p>", "ID": "3dc7e36b-f245-4b69-a9a4-2202e2d8ce00", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">What Kymriah contains</span></b>", "ID": "7f66b93f-c593-4b6e-b77f-0dec90f5bc5e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3dc7e36b-f245-4b69-a9a4-2202e2d8ce00"}, {"Element": "<span lang=\"EN-GB\">What Kymriah contains</span>", "ID": "12d593ae-6e1d-468f-ab59-a0886440d050", "Styles": "None", "Classes": "None", "Text": "What Kymriah contains", "ParentId": "7f66b93f-c593-4b6e-b77f-0dec90f5bc5e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The active substance of Kymriah is called tisagenlecleucel.\nEach infusion bag of Kmyriah contains </span><span lang=\"EN-GB\">tisagenlecleucel cell\ndispersion at a batch\u2011dependent concentration of </span><span lang=\"EN-GB\">autologous\nT cells genetically modified to express an </span><span lang=\"EN-GB\">anti\u2011CD19\nchimeric antigen receptor</span><span lang=\"EN-GB\"> (CAR\u2011positive viable T\ncells). 1 or more bags contain a total of </span>1.2\u00a0x\u00a010<sup>6</sup>\u00a0\u2013\u00a06\u00a0x\u00a010<sup>8\n</sup>CAR+ viable T cells.</p>", "ID": "95ac9162-1386-4c2c-b256-bd914bba79fc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "1.2\u00a0x\u00a010\u00a0\u2013\u00a06\u00a0x\u00a010CAR+ viable T cells.", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "dbc5fe25-f8e8-4a46-9641-ca842aa65b14", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a1778a1e-2a73-4bab-8d9b-d868f12bc14d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "dbc5fe25-f8e8-4a46-9641-ca842aa65b14"}, {"Element": "<span lang=\"EN-GB\">The active substance of Kymriah is called tisagenlecleucel.\nEach infusion bag of Kmyriah contains </span>", "ID": "53bc7b51-d95e-4dab-9327-3c2a94322a6a", "Styles": "None", "Classes": "None", "Text": "The active substance of Kymriah is called tisagenlecleucel. Each infusion bag of Kmyriah contains ", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<span lang=\"EN-GB\">tisagenlecleucel cell\ndispersion at a batch\u2011dependent concentration of </span>", "ID": "2a33a2eb-8fc1-412a-a602-68cdaaaf8910", "Styles": "None", "Classes": "None", "Text": "tisagenlecleucel cell dispersion at a batch\u2011dependent concentration of ", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<span lang=\"EN-GB\">autologous\nT cells genetically modified to express an </span>", "ID": "012a52a0-5ae9-4e2e-a223-3310e10279b4", "Styles": "None", "Classes": "None", "Text": "autologous T cells genetically modified to express an ", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<span lang=\"EN-GB\">anti\u2011CD19\nchimeric antigen receptor</span>", "ID": "2d16fe7f-1c28-4c19-add6-7ae0b7eec7e3", "Styles": "None", "Classes": "None", "Text": "anti\u2011CD19 chimeric antigen receptor", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<span lang=\"EN-GB\"> (CAR\u2011positive viable T\ncells). 1 or more bags contain a total of </span>", "ID": "68371541-b807-4f3a-8402-ec25ca3469ed", "Styles": "None", "Classes": "None", "Text": " (CAR\u2011positive viable T cells). 1 or more bags contain a total of ", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<sup>6</sup>", "ID": "8bc1f4d6-ad29-4cf2-93e7-5a239d3ae3eb", "Styles": "None", "Classes": "None", "Text": "6", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<sup>8\n</sup>", "ID": "8921a385-4712-485f-8ca5-2168d7774070", "Styles": "None", "Classes": "None", "Text": "8 ", "ParentId": "95ac9162-1386-4c2c-b256-bd914bba79fc"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">other ingredients are\nglucose, sodium chloride, human albumin solution, dextran 40 for injection,\ndimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride,\nmagnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate,\naluminium, and water for injections. See section\u00a02, \u201cKymriah contains\nsodium, dimethylsulfoxide (DMSO) and dextran 40\u201d.</span></p>", "ID": "edacffab-0d6a-45b0-ab54-f4dacf098f28", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "339d3637-dc35-4b85-84d3-4e9810c86f7a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "edacffab-0d6a-45b0-ab54-f4dacf098f28"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ee528d0a-4e61-49fd-8ef9-341922549972", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "339d3637-dc35-4b85-84d3-4e9810c86f7a"}, {"Element": "<span lang=\"EN-GB\">The </span>", "ID": "38362299-98e3-4496-b975-d6d81c813561", "Styles": "None", "Classes": "None", "Text": "The ", "ParentId": "edacffab-0d6a-45b0-ab54-f4dacf098f28"}, {"Element": "<span lang=\"EN-GB\">other ingredients are\nglucose, sodium chloride, human albumin solution, dextran 40 for injection,\ndimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride,\nmagnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate,\naluminium, and water for injections. See section\u00a02, \u201cKymriah contains\nsodium, dimethylsulfoxide (DMSO) and dextran 40\u201d.</span>", "ID": "0ea62035-00f0-4291-9cea-24d70ed6c887", "Styles": "None", "Classes": "None", "Text": "other ingredients are glucose, sodium chloride, human albumin solution, dextran 40 for injection, dimethylsulfoxide, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride, sodium\u2011N\u2011acetyltryptophanate, sodium caprylate, aluminium, and water for injections. See section\u00a02, \u201cKymriah contains sodium, dimethylsulfoxide (DMSO) and dextran 40\u201d.", "ParentId": "edacffab-0d6a-45b0-ab54-f4dacf098f28"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c2d97263-d2cb-42f7-9629-15f26e9f789b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b4539a3-0e04-4f88-8a02-28508c1c460a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c2d97263-d2cb-42f7-9629-15f26e9f789b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Kymriah looks like and contents of the pack</span></b></p>", "ID": "eafffc42-64ab-4e6f-99e0-b0b596724d59", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">What Kymriah looks like and contents of the pack</span></b>", "ID": "27418636-5994-4d47-ab09-5a4ddafae0c5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eafffc42-64ab-4e6f-99e0-b0b596724d59"}, {"Element": "<span lang=\"EN-GB\">What Kymriah looks like and contents of the pack</span>", "ID": "85afe996-3d77-4998-8c31-e77345f1e20f", "Styles": "None", "Classes": "None", "Text": "What Kymriah looks like and contents of the pack", "ParentId": "27418636-5994-4d47-ab09-5a4ddafae0c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Kymriah is a cell\ndispersion for infusion. It is supplied as an infusion bag containing a cloudy\nto clear, colourless to slightly yellow dispersion of cells. Each bag contains\n10\u00a0mL to 50\u00a0mL of dispersion.</span></p>", "ID": "715cd114-0621-44b0-9d3e-c263fe38725d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is a cell\ndispersion for infusion. It is supplied as an infusion bag containing a cloudy\nto clear, colourless to slightly yellow dispersion of cells. Each bag contains\n10\u00a0mL to 50\u00a0mL of dispersion.</span>", "ID": "3ee68605-c190-4142-904a-95c4239bea11", "Styles": "None", "Classes": "None", "Text": "Kymriah is a cell dispersion for infusion. It is supplied as an infusion bag containing a cloudy to clear, colourless to slightly yellow dispersion of cells. Each bag contains 10\u00a0mL to 50\u00a0mL of dispersion.", "ParentId": "715cd114-0621-44b0-9d3e-c263fe38725d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0f480f0c-fb4d-4fcb-986b-0d0ce075e4ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "583651f4-8bff-47d3-8c52-ab38e660a093", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0f480f0c-fb4d-4fcb-986b-0d0ce075e4ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p>", "ID": "242c7e33-9316-46a2-be73-f2036a59609d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b>", "ID": "3427619b-d8a2-4b8f-be2e-40f263c946d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "242c7e33-9316-46a2-be73-f2036a59609d"}, {"Element": "<span lang=\"EN-GB\">Marketing Authorisation Holder</span>", "ID": "325064e5-9c78-4920-aac4-8c1d17ec453f", "Styles": "None", "Classes": "None", "Text": "Marketing Authorisation Holder", "ParentId": "3427619b-d8a2-4b8f-be2e-40f263c946d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Novartis Europharm Limited</span></p>", "ID": "19c143e7-06a6-432e-a184-5cbedea70529", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Novartis Europharm Limited</span>", "ID": "5db4ee42-9e52-44d1-b819-6e8daaa4727f", "Styles": "color:black", "Classes": "None", "Text": "Novartis Europharm Limited", "ParentId": "19c143e7-06a6-432e-a184-5cbedea70529"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:4.8pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p>", "ID": "316553ec-4c74-49e6-a520-62317550f5d9", "Styles": "margin-right:4.8pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Vista Building</span>", "ID": "641fffcd-8449-4aaa-a166-b2d3962898b0", "Styles": "color:black", "Classes": "None", "Text": "Vista Building", "ParentId": "316553ec-4c74-49e6-a520-62317550f5d9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:4.8pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p>", "ID": "6ceacad2-b703-41cf-bda5-eb843c222c81", "Styles": "margin-right:4.8pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span>", "ID": "084d2cb7-9c1d-4b70-bc5a-b5d71f8ef494", "Styles": "color:black", "Classes": "None", "Text": "Elm Park, Merrion Road", "ParentId": "6ceacad2-b703-41cf-bda5-eb843c222c81"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:4.8pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p>", "ID": "90ecb7b3-6946-4d7e-baf6-e9502b299c8c", "Styles": "margin-right:4.8pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span>", "ID": "67058de8-36cb-40a5-94b4-d9090204c932", "Styles": "color:black", "Classes": "None", "Text": "Dublin 4", "ParentId": "90ecb7b3-6946-4d7e-baf6-e9502b299c8c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p>", "ID": "402274c8-7221-4492-8a37-7f8b7256057e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Ireland</span>", "ID": "ed596ecc-3b79-4d7a-baf4-99a212279928", "Styles": "color:black", "Classes": "None", "Text": "Ireland", "ParentId": "402274c8-7221-4492-8a37-7f8b7256057e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "56e1b6a5-8bcf-49af-bf9b-99e1406e13cd", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "79d6155e-9bc5-446b-88a2-c505d7482ec7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "56e1b6a5-8bcf-49af-bf9b-99e1406e13cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>", "ID": "824f89ab-6dae-446d-84a2-3fb90e41a656", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Manufacturer</span></b>", "ID": "7bc25f6a-bf73-470d-9a5c-1d933a207201", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "824f89ab-6dae-446d-84a2-3fb90e41a656"}, {"Element": "<span lang=\"EN-GB\">Manufacturer</span>", "ID": "9e1e960f-6af9-4e9c-9140-e3cc6f77ed07", "Styles": "None", "Classes": "None", "Text": "Manufacturer", "ParentId": "7bc25f6a-bf73-470d-9a5c-1d933a207201"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:black\">Novartis Pharma GmbH</span></p>", "ID": "6de65dcb-1fd5-4e8d-aaa9-03968203c5c7", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Novartis Pharma GmbH</span>", "ID": "f70c19cf-4171-4faf-98ab-8233664696c0", "Styles": "color:black", "Classes": "None", "Text": "Novartis Pharma GmbH", "ParentId": "6de65dcb-1fd5-4e8d-aaa9-03968203c5c7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:black\">Roonstrasse 25</span></p>", "ID": "3433f334-cf82-43db-b3c1-0a40f917f730", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Roonstrasse 25</span>", "ID": "c615f689-6ead-4f51-bdc9-070b17b041f6", "Styles": "color:black", "Classes": "None", "Text": "Roonstrasse 25", "ParentId": "3433f334-cf82-43db-b3c1-0a40f917f730"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"color:black\">90429 Nuremberg</span></p>", "ID": "33ef0287-68ce-4cd0-80c0-2efe49fe6b63", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">90429 Nuremberg</span>", "ID": "9166b358-0265-486f-b1f5-702f56518a1a", "Styles": "color:black", "Classes": "None", "Text": "90429 Nuremberg", "ParentId": "33ef0287-68ce-4cd0-80c0-2efe49fe6b63"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Germany</span></p>", "ID": "d0534da0-9856-47b3-acf7-56661e81cc1e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Germany</span>", "ID": "2aae21dd-c566-406e-9197-870893f3299b", "Styles": "None", "Classes": "None", "Text": "Germany", "ParentId": "d0534da0-9856-47b3-acf7-56661e81cc1e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d45fa131-af3c-4792-ac94-7221873a2df7", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "47646ebe-bceb-46b5-8c70-a24ca8e72368", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d45fa131-af3c-4792-ac94-7221873a2df7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span style=\"color:black;background:#D9D9D9\">CELLFORCURE</span></p>", "ID": "0201a46c-60b0-4df3-8a0d-76182dfb2d8c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span style=\"color:black;background:#D9D9D9\">CELLFORCURE</span>", "ID": "4503879a-d9eb-4d94-a7cc-5954a54d58fa", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "CELLFORCURE", "ParentId": "0201a46c-60b0-4df3-8a0d-76182dfb2d8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"FR-CH\" style=\"color:black;background:#D9D9D9\">ZA de Courtab\u0153uf</span></p>", "ID": "1717aa19-c999-4440-8543-6415e51a0d4f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\" style=\"color:black;background:#D9D9D9\">ZA de Courtab\u0153uf</span>", "ID": "01263a03-805b-4a11-b04e-973bc048d232", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "ZA de Courtab\u0153uf", "ParentId": "1717aa19-c999-4440-8543-6415e51a0d4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"FR-CH\" style=\"color:black;background:#D9D9D9\">11 avenue des Tropiques</span></p>", "ID": "a020b802-a77b-474e-8ad1-c0a988c08a6c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"FR-CH\" style=\"color:black;background:#D9D9D9\">11 avenue des Tropiques</span>", "ID": "e7dbc5e6-7ae6-439c-9c78-4f358f835d09", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "11 avenue des Tropiques", "ParentId": "a020b802-a77b-474e-8ad1-c0a988c08a6c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">91940 Les Ulis</span></p>", "ID": "b3139e9c-9789-440a-b035-a252d63b7db4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">91940 Les Ulis</span>", "ID": "fb85db36-aef3-4cd4-9b6f-f6ff217a34b5", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "91940 Les Ulis", "ParentId": "b3139e9c-9789-440a-b035-a252d63b7db4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">France</span></p>", "ID": "ecffd42c-62cd-4fd1-87c9-99597b258c62", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">France</span>", "ID": "26bff6a8-3633-4011-a63c-8bc87bcace34", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "France", "ParentId": "ecffd42c-62cd-4fd1-87c9-99597b258c62"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dbc2e075-460d-451d-ac24-7f1c966937ff", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6dfc1263-52c9-4d15-a79d-be3268310910", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dbc2e075-460d-451d-ac24-7f1c966937ff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal;page-break-after:\navoid\"><span lang=\"EN-GB\">For any information about this medicine, please contact\nthe local representative of the Marketing Authorisation Holder:</span></p>", "ID": "245b1c1d-85b6-4ede-8dbf-21bd45489af8", "Styles": "margin-right:-.1pt;line-height:normal;page-break-after:\navoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">For any information about this medicine, please contact\nthe local representative of the Marketing Authorisation Holder:</span>", "ID": "79b9518b-d893-4fa6-8629-d30c1cadfdef", "Styles": "None", "Classes": "None", "Text": "For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:", "ParentId": "245b1c1d-85b6-4ede-8dbf-21bd45489af8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e2cc3638-8355-40e2-afa0-d50b8b822cfd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a3dfa7aa-85c4-4edb-903f-ca88cd74d1de", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e2cc3638-8355-40e2-afa0-d50b8b822cfd"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"624\">\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">SIA Novartis\n  Baltics Lietuvos filialas</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Tel: +370 5 269\n  16 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Bulgaria\n  EOOD</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b</span><span lang=\"ES\">: +359 2 489 98 28</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +420 225\n  775 111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Hung\u00e1ria Kft.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel.: +36 1\n  457 65 00</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Healthcare A/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: +45 39 16\n  84 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +356 2122\n  2872</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +49 911\n  273 0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +31 </span><span lang=\"DE-CH\" style=\"color:black\">88 04 52 </span><span lang=\"DE-CH\">555</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +372 66\n  30 810</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Novartis\n  Norge AS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Tlf: +47 23\n  05 20 00</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis (Hellas)\n  A.E.B.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 281 17 12</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +43 1 86\n  6570</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis\n  Farmac\u00e9utica, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +34 93\n  306 42 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Tel.: +48 22 375\n  4888</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">T\u00e9l: +33 1 55\n  47 66 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma \u2011\n  Produtos Farmac\u00eauticos, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +351 21\n  000 8600</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel. +385 1\n  6274 220</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Romania SRL</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21 31299\n  01</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Ireland Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +353 1\n  260 12 55</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +386 1\n  300 75 50</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +354 535\n  7000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Novartis Slovakia\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 2\n  5542 5439</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma\n  S.p.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 02 96\n  54 1</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Finland Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Puh/Tel: +358\n  (0)10 6133 200</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +357 22 690 690</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Sverige AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +46 8 732\n  32 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n</tr>\n<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Tel: +371 67 887\n  070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Pharmaceuticals UK Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 1276\n  698370</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>", "ID": "30903476-5692-4273-b1bc-0dd653697226", "Styles": "margin-left:-1.7pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "                ", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">SIA Novartis\n  Baltics Lietuvos filialas</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Tel: +370 5 269\n  16 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n</tr>", "ID": "c81f016e-9d46-4948-a7f4-46d33b810138", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "8fd883b1-57ea-497f-a3ba-2cb4de407294", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c81f016e-9d46-4948-a7f4-46d33b810138"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Belgi\u00eb/Belgique/Belgien</span></b></p>", "ID": "54fd136d-8961-4b46-87dc-a03d79a1d1a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fd883b1-57ea-497f-a3ba-2cb4de407294"}, {"Element": "<b><span lang=\"FR-CH\">Belgi\u00eb/Belgique/Belgien</span></b>", "ID": "6a3428ba-74cf-4a81-b850-ef27b64be0da", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "54fd136d-8961-4b46-87dc-a03d79a1d1a8"}, {"Element": "<span lang=\"FR-CH\">Belgi\u00eb/Belgique/Belgien</span>", "ID": "49e8615e-c1e5-4eba-8727-7ea778c53858", "Styles": "None", "Classes": "None", "Text": "Belgi\u00eb/Belgique/Belgien", "ParentId": "6a3428ba-74cf-4a81-b850-ef27b64be0da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma N.V.</span></p>", "ID": "99775f0b-12b9-4b6f-894f-2dbdea33fad9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fd883b1-57ea-497f-a3ba-2cb4de407294"}, {"Element": "<span lang=\"FR-CH\">Novartis\n  Pharma N.V.</span>", "ID": "351c4a58-a521-4f7c-bba1-7bfbebdf8710", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma N.V.", "ParentId": "99775f0b-12b9-4b6f-894f-2dbdea33fad9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>", "ID": "d9a4b33f-5de8-415c-b52d-23eaa0dbeced", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fd883b1-57ea-497f-a3ba-2cb4de407294"}, {"Element": "<span lang=\"EN-GB\">T\u00e9l/Tel: +32 2\n  246 16 11</span>", "ID": "3df827c3-8f37-4dae-b846-9f44ffb365bb", "Styles": "None", "Classes": "None", "Text": "T\u00e9l/Tel: +32 2   246 16 11", "ParentId": "d9a4b33f-5de8-415c-b52d-23eaa0dbeced"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5b22b20e-996e-40f6-8750-e2d22c9e9dab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8fd883b1-57ea-497f-a3ba-2cb4de407294"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "70d0ae58-d7ae-43c1-a9e6-a6fac97b3b91", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5b22b20e-996e-40f6-8750-e2d22c9e9dab"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Lietuva</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">SIA Novartis\n  Baltics Lietuvos filialas</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Tel: +370 5 269\n  16 50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>", "ID": "076512b6-f1d0-4b47-a929-20e8395153c4", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c81f016e-9d46-4948-a7f4-46d33b810138"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Lietuva</span></b></p>", "ID": "e87be883-7e9f-43cb-9647-f5dcea0055e4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "076512b6-f1d0-4b47-a929-20e8395153c4"}, {"Element": "<b><span lang=\"ES\">Lietuva</span></b>", "ID": "f6f08fef-8926-4d71-a14e-6785d15222ab", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e87be883-7e9f-43cb-9647-f5dcea0055e4"}, {"Element": "<span lang=\"ES\">Lietuva</span>", "ID": "969d08b6-8e19-46dc-b55f-5e66030dd3b7", "Styles": "None", "Classes": "None", "Text": "Lietuva", "ParentId": "f6f08fef-8926-4d71-a14e-6785d15222ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">SIA Novartis\n  Baltics Lietuvos filialas</span></p>", "ID": "0355e4a1-3aa5-4dda-a871-a73cf537968f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "076512b6-f1d0-4b47-a929-20e8395153c4"}, {"Element": "<span lang=\"ES\">SIA Novartis\n  Baltics Lietuvos filialas</span>", "ID": "b23bbb85-d91a-4e10-8752-cf839f5b943b", "Styles": "None", "Classes": "None", "Text": "SIA Novartis   Baltics Lietuvos filialas", "ParentId": "0355e4a1-3aa5-4dda-a871-a73cf537968f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Tel: +370 5 269\n  16 50</span></p>", "ID": "ec21405c-dff3-4094-b5a6-7a372c2718ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "076512b6-f1d0-4b47-a929-20e8395153c4"}, {"Element": "<span lang=\"ES\">Tel: +370 5 269\n  16 50</span>", "ID": "e690df9f-e6e5-4b7b-86d8-ec44c52f00ab", "Styles": "None", "Classes": "None", "Text": "Tel: +370 5 269   16 50", "ParentId": "ec21405c-dff3-4094-b5a6-7a372c2718ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>", "ID": "861d813f-d083-4af8-920d-a4db1d38f951", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "076512b6-f1d0-4b47-a929-20e8395153c4"}, {"Element": "<span lang=\"ES\">\u00a0</span>", "ID": "05abaeab-89f0-4977-b426-d386abcf6b38", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "861d813f-d083-4af8-920d-a4db1d38f951"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Bulgaria\n  EOOD</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b</span><span lang=\"ES\">: +359 2 489 98 28</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>\n</tr>", "ID": "9389fc31-8445-49e6-b450-7c71570c258a", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Bulgaria\n  EOOD</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b</span><span lang=\"ES\">: +359 2 489 98 28</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>", "ID": "6b6df1a0-259b-47ab-8897-ef265a008265", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "9389fc31-8445-49e6-b450-7c71570c258a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>", "ID": "cfc72bec-080c-47e9-8165-059a4bd27135", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b6df1a0-259b-47ab-8897-ef265a008265"}, {"Element": "<b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b>", "ID": "48a29760-e411-45af-8c8f-3ef2d0bd0d47", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cfc72bec-080c-47e9-8165-059a4bd27135"}, {"Element": "<span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span>", "ID": "6362a4f7-c208-4ae3-a38c-6ff542d7402c", "Styles": "None", "Classes": "None", "Text": "\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f", "ParentId": "48a29760-e411-45af-8c8f-3ef2d0bd0d47"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Bulgaria\n  EOOD</span></p>", "ID": "1354b88a-a93f-498f-9980-f3d73dd3e8e4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b6df1a0-259b-47ab-8897-ef265a008265"}, {"Element": "<span lang=\"ES\">Novartis Bulgaria\n  EOOD</span>", "ID": "55097560-9b6d-4f4d-a67c-85da8dfef8d4", "Styles": "None", "Classes": "None", "Text": "Novartis Bulgaria   EOOD", "ParentId": "1354b88a-a93f-498f-9980-f3d73dd3e8e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u0422\u0435\u043b</span><span lang=\"ES\">: +359 2 489 98 28</span></p>", "ID": "a5463d2f-bcc8-4077-9c21-be57b8eb0b33", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b6df1a0-259b-47ab-8897-ef265a008265"}, {"Element": "<span lang=\"EN-GB\">\u0422\u0435\u043b</span>", "ID": "909c7f52-ed0a-465e-92de-745ddb719da6", "Styles": "None", "Classes": "None", "Text": "\u0422\u0435\u043b", "ParentId": "a5463d2f-bcc8-4077-9c21-be57b8eb0b33"}, {"Element": "<span lang=\"ES\">: +359 2 489 98 28</span>", "ID": "e1d1f24a-c1ae-449b-b70f-eb31322d8166", "Styles": "None", "Classes": "None", "Text": ": +359 2 489 98 28", "ParentId": "a5463d2f-bcc8-4077-9c21-be57b8eb0b33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>", "ID": "3539a6a3-48d1-4d79-9cbc-9bc2250f8447", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6b6df1a0-259b-47ab-8897-ef265a008265"}, {"Element": "<span lang=\"ES\">\u00a0</span>", "ID": "8b1a6a17-066a-4019-87c1-27340a1308eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3539a6a3-48d1-4d79-9cbc-9bc2250f8447"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma N.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>\n</td>", "ID": "9e08c260-702f-44a4-add4-93c435f9f22c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "9389fc31-8445-49e6-b450-7c71570c258a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b></p>", "ID": "3b04222d-9605-429b-bf6e-cf5bd45784ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9e08c260-702f-44a4-add4-93c435f9f22c"}, {"Element": "<b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b>", "ID": "1e9e0ebf-f530-45a4-87e9-9a0d8f1be8bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3b04222d-9605-429b-bf6e-cf5bd45784ca"}, {"Element": "<span lang=\"DE-CH\">Luxembourg/Luxemburg</span>", "ID": "79aa6722-980c-44cc-9b94-6fcb9b204cd3", "Styles": "None", "Classes": "None", "Text": "Luxembourg/Luxemburg", "ParentId": "1e9e0ebf-f530-45a4-87e9-9a0d8f1be8bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma N.V.</span></p>", "ID": "3cd3f08c-c9bc-4ac1-a960-cc0afcc9dd35", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9e08c260-702f-44a4-add4-93c435f9f22c"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  Pharma N.V.</span>", "ID": "97930f19-b972-45e9-940e-e074a560e289", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma N.V.", "ParentId": "3cd3f08c-c9bc-4ac1-a960-cc0afcc9dd35"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">T\u00e9l/Tel: +32 2\n  246 16 11</span></p>", "ID": "01849a97-a78b-4ba0-88d1-2b615d3449e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9e08c260-702f-44a4-add4-93c435f9f22c"}, {"Element": "<span lang=\"ES\">T\u00e9l/Tel: +32 2\n  246 16 11</span>", "ID": "c7bc76bf-4b9d-4e25-87d4-9b99ca5fdcda", "Styles": "None", "Classes": "None", "Text": "T\u00e9l/Tel: +32 2   246 16 11", "ParentId": "01849a97-a78b-4ba0-88d1-2b615d3449e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">\u00a0</span></p>", "ID": "cc86f4a1-1651-42f1-aeb5-7fdbfe8d08c1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9e08c260-702f-44a4-add4-93c435f9f22c"}, {"Element": "<span lang=\"ES\">\u00a0</span>", "ID": "b94322a4-6909-40d4-b517-9027368649d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc86f4a1-1651-42f1-aeb5-7fdbfe8d08c1"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +420 225\n  775 111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Hung\u00e1ria Kft.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel.: +36 1\n  457 65 00</span></p>\n</td>\n</tr>", "ID": "f5511917-405f-4501-aa5f-2089c39809d0", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +420 225\n  775 111</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "5c23cd32-a82a-42e3-af0d-302163e40882", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "f5511917-405f-4501-aa5f-2089c39809d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u010cesk\u00e1\n  republika</span></b></p>", "ID": "e8c66419-4ec2-4272-8bf8-1fb6db46aca5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5c23cd32-a82a-42e3-af0d-302163e40882"}, {"Element": "<b><span lang=\"DE-CH\">\u010cesk\u00e1\n  republika</span></b>", "ID": "1cec721f-5c4e-4ce3-bf9b-fa44a25778d9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e8c66419-4ec2-4272-8bf8-1fb6db46aca5"}, {"Element": "<span lang=\"DE-CH\">\u010cesk\u00e1\n  republika</span>", "ID": "6b2a81e1-e1bd-4745-a7ac-178466e085f1", "Styles": "None", "Classes": "None", "Text": "\u010cesk\u00e1   republika", "ParentId": "1cec721f-5c4e-4ce3-bf9b-fa44a25778d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  s.r.o.</span></p>", "ID": "4df9dc24-7900-42cd-ad0e-7aed4c006fc0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5c23cd32-a82a-42e3-af0d-302163e40882"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  s.r.o.</span>", "ID": "eb564e2c-20df-42cb-bea2-3be2e1c4cec4", "Styles": "None", "Classes": "None", "Text": "Novartis   s.r.o.", "ParentId": "4df9dc24-7900-42cd-ad0e-7aed4c006fc0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +420 225\n  775 111</span></p>", "ID": "5940dcf3-1d8a-411e-b72e-f21ce35175ea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5c23cd32-a82a-42e3-af0d-302163e40882"}, {"Element": "<span lang=\"EN-GB\">Tel: +420 225\n  775 111</span>", "ID": "07b6e280-53e7-4a06-9f4b-7ddd0f00bea5", "Styles": "None", "Classes": "None", "Text": "Tel: +420 225   775 111", "ParentId": "5940dcf3-1d8a-411e-b72e-f21ce35175ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "862f0ef1-6835-410d-9753-f0d82b7d465a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5c23cd32-a82a-42e3-af0d-302163e40882"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "81fb1961-abfb-4025-87e6-4a9c5e693527", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "862f0ef1-6835-410d-9753-f0d82b7d465a"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Hung\u00e1ria Kft.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel.: +36 1\n  457 65 00</span></p>\n</td>", "ID": "df82b3ae-56eb-4c1e-b9eb-4736657e03da", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "f5511917-405f-4501-aa5f-2089c39809d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>", "ID": "edd11dd5-ef13-4558-86e8-fd8eb70f42a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df82b3ae-56eb-4c1e-b9eb-4736657e03da"}, {"Element": "<b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b>", "ID": "18ce51ef-8abc-4881-bcf0-662f0fbc1eaa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "edd11dd5-ef13-4558-86e8-fd8eb70f42a1"}, {"Element": "<span lang=\"EN-GB\">Magyarorsz\u00e1g</span>", "ID": "2442265d-a6ed-4cca-9360-e15ece40048c", "Styles": "None", "Classes": "None", "Text": "Magyarorsz\u00e1g", "ParentId": "18ce51ef-8abc-4881-bcf0-662f0fbc1eaa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Hung\u00e1ria Kft.</span></p>", "ID": "5011b468-a2cd-413d-aada-0a4f5a3b231b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df82b3ae-56eb-4c1e-b9eb-4736657e03da"}, {"Element": "<span lang=\"EN-GB\">Novartis\n  Hung\u00e1ria Kft.</span>", "ID": "7377320b-4380-47a0-961f-cdac673acc97", "Styles": "None", "Classes": "None", "Text": "Novartis   Hung\u00e1ria Kft.", "ParentId": "5011b468-a2cd-413d-aada-0a4f5a3b231b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel.: +36 1\n  457 65 00</span></p>", "ID": "52bbc260-5768-4260-8df9-845c03a8b675", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "df82b3ae-56eb-4c1e-b9eb-4736657e03da"}, {"Element": "<span lang=\"EN-GB\">Tel.: +36 1\n  457 65 00</span>", "ID": "1ca76124-bac3-4e6d-acb6-8fa201633b99", "Styles": "None", "Classes": "None", "Text": "Tel.: +36 1   457 65 00", "ParentId": "52bbc260-5768-4260-8df9-845c03a8b675"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Healthcare A/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: +45 39 16\n  84 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +356 2122\n  2872</span></p>\n</td>\n</tr>", "ID": "6568c881-fced-40ff-92d1-0421931c9fc1", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Healthcare A/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: +45 39 16\n  84 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "f8c12bf0-7a15-48c9-860a-a5608945e9e8", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "6568c881-fced-40ff-92d1-0421931c9fc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Danmark</span></b></p>", "ID": "7d9b1105-fef2-48f2-90b4-c5bb5e7a18db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8c12bf0-7a15-48c9-860a-a5608945e9e8"}, {"Element": "<b><span lang=\"EN-GB\">Danmark</span></b>", "ID": "2ed59a2c-3375-4de2-a615-076557c568f2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7d9b1105-fef2-48f2-90b4-c5bb5e7a18db"}, {"Element": "<span lang=\"EN-GB\">Danmark</span>", "ID": "c59b946c-77fd-4bc2-b067-5ab8edb76b49", "Styles": "None", "Classes": "None", "Text": "Danmark", "ParentId": "2ed59a2c-3375-4de2-a615-076557c568f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Healthcare A/S</span></p>", "ID": "e8f1b23e-18c7-456e-8df1-4b88c02da3f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8c12bf0-7a15-48c9-860a-a5608945e9e8"}, {"Element": "<span lang=\"EN-GB\">Novartis\n  Healthcare A/S</span>", "ID": "9701042b-8a7a-4e9b-a3ee-9c57a0d453fc", "Styles": "None", "Classes": "None", "Text": "Novartis   Healthcare A/S", "ParentId": "e8f1b23e-18c7-456e-8df1-4b88c02da3f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tlf: +45 39 16\n  84 00</span></p>", "ID": "c746deda-976f-4c76-b5c3-fddc7454376c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8c12bf0-7a15-48c9-860a-a5608945e9e8"}, {"Element": "<span lang=\"EN-GB\">Tlf: +45 39 16\n  84 00</span>", "ID": "f63fd277-f72f-48f6-9bf1-276c458cc983", "Styles": "None", "Classes": "None", "Text": "Tlf: +45 39 16   84 00", "ParentId": "c746deda-976f-4c76-b5c3-fddc7454376c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "08371166-8291-44a5-a57b-d26a7f810eba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8c12bf0-7a15-48c9-860a-a5608945e9e8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "21066b56-664b-4f41-b049-b97e203eb3ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "08371166-8291-44a5-a57b-d26a7f810eba"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Malta</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +356 2122\n  2872</span></p>\n</td>", "ID": "29df610b-019b-42b5-aab4-fd6e3059dfc8", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "6568c881-fced-40ff-92d1-0421931c9fc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Malta</span></b></p>", "ID": "876d0c46-9853-4649-96e4-eca5748f87a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "29df610b-019b-42b5-aab4-fd6e3059dfc8"}, {"Element": "<b><span lang=\"FR-CH\">Malta</span></b>", "ID": "06b88e9f-583f-47fe-a9e4-7552d3289535", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "876d0c46-9853-4649-96e4-eca5748f87a8"}, {"Element": "<span lang=\"FR-CH\">Malta</span>", "ID": "0ffd1ac8-4ec7-4f75-a77a-b9aa3d1b1eda", "Styles": "None", "Classes": "None", "Text": "Malta", "ParentId": "06b88e9f-583f-47fe-a9e4-7552d3289535"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>", "ID": "d1bbeac6-7ebd-46ee-a70b-bbe91ae89049", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "29df610b-019b-42b5-aab4-fd6e3059dfc8"}, {"Element": "<span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span>", "ID": "ad772810-7571-4df2-89d1-368a5d866562", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma Services Inc.", "ParentId": "d1bbeac6-7ebd-46ee-a70b-bbe91ae89049"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +356 2122\n  2872</span></p>", "ID": "a8f7d335-b086-49a7-8107-b7705b1a759e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "29df610b-019b-42b5-aab4-fd6e3059dfc8"}, {"Element": "<span lang=\"EN-GB\">Tel: +356 2122\n  2872</span>", "ID": "d0a8bba3-b26b-49d0-8111-adb1f2469166", "Styles": "None", "Classes": "None", "Text": "Tel: +356 2122   2872", "ParentId": "a8f7d335-b086-49a7-8107-b7705b1a759e"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +49 911\n  273 0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +31 </span><span lang=\"DE-CH\" style=\"color:black\">88 04 52 </span><span lang=\"DE-CH\">555</span></p>\n</td>\n</tr>", "ID": "68832b61-dfee-45c0-a646-736ca335745c", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Deutschland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +49 911\n  273 0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>", "ID": "10a7d3b1-a14e-4fdf-9907-73d834028472", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "68832b61-dfee-45c0-a646-736ca335745c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Deutschland</span></b></p>", "ID": "dffd3751-df71-4d4a-b9cd-987db594d8ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "10a7d3b1-a14e-4fdf-9907-73d834028472"}, {"Element": "<b><span lang=\"DE-CH\">Deutschland</span></b>", "ID": "71e652ad-2ce5-4540-82eb-2774de313fde", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dffd3751-df71-4d4a-b9cd-987db594d8ce"}, {"Element": "<span lang=\"DE-CH\">Deutschland</span>", "ID": "7248db8b-4194-45a2-9564-922d35c714e7", "Styles": "None", "Classes": "None", "Text": "Deutschland", "ParentId": "71e652ad-2ce5-4540-82eb-2774de313fde"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>", "ID": "37a1b771-5bb4-4894-af8e-4a0d47981d65", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "10a7d3b1-a14e-4fdf-9907-73d834028472"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span>", "ID": "96789c50-4233-4ccd-bda2-fb282ba5985c", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma GmbH", "ParentId": "37a1b771-5bb4-4894-af8e-4a0d47981d65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +49 911\n  273 0</span></p>", "ID": "e8f74b89-4c89-45b5-84b0-12fb6bebf217", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "10a7d3b1-a14e-4fdf-9907-73d834028472"}, {"Element": "<span lang=\"DE-CH\">Tel: +49 911\n  273 0</span>", "ID": "57d18c19-771b-4223-9002-62e0a72048f1", "Styles": "None", "Classes": "None", "Text": "Tel: +49 911   273 0", "ParentId": "e8f74b89-4c89-45b5-84b0-12fb6bebf217"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>", "ID": "7876c180-1e66-48c6-913a-90ff4ff32730", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "10a7d3b1-a14e-4fdf-9907-73d834028472"}, {"Element": "<span lang=\"DE-CH\">\u00a0</span>", "ID": "e9578df3-3f76-4cc7-b3b8-4eb507d18a5f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7876c180-1e66-48c6-913a-90ff4ff32730"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Nederland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma B.V.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +31 </span><span lang=\"DE-CH\" style=\"color:black\">88 04 52 </span><span lang=\"DE-CH\">555</span></p>\n</td>", "ID": "d1c27575-e440-420f-83ca-d795c37623cb", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "68832b61-dfee-45c0-a646-736ca335745c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Nederland</span></b></p>", "ID": "3428606e-d184-4ea7-ab79-cb825281a226", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d1c27575-e440-420f-83ca-d795c37623cb"}, {"Element": "<b><span lang=\"DE-CH\">Nederland</span></b>", "ID": "cccca19c-1fc3-4900-a8e3-1b4a4e90dc4d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3428606e-d184-4ea7-ab79-cb825281a226"}, {"Element": "<span lang=\"DE-CH\">Nederland</span>", "ID": "8f5a3c71-570e-4705-aedb-571f5ac3dc66", "Styles": "None", "Classes": "None", "Text": "Nederland", "ParentId": "cccca19c-1fc3-4900-a8e3-1b4a4e90dc4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma B.V.</span></p>", "ID": "02e674c3-8494-4e51-ab79-40754dd3bead", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d1c27575-e440-420f-83ca-d795c37623cb"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  Pharma B.V.</span>", "ID": "4c6bfd3b-3870-4dd8-80f2-8ef7bd1c694e", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma B.V.", "ParentId": "02e674c3-8494-4e51-ab79-40754dd3bead"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +31 </span><span lang=\"DE-CH\" style=\"color:black\">88 04 52 </span><span lang=\"DE-CH\">555</span></p>", "ID": "98a3a1f1-7aef-4d93-bfd6-8495d07df7aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d1c27575-e440-420f-83ca-d795c37623cb"}, {"Element": "<span lang=\"DE-CH\">Tel: +31 </span>", "ID": "77b5506d-9385-418f-91a7-229ed1147bbf", "Styles": "None", "Classes": "None", "Text": "Tel: +31 ", "ParentId": "98a3a1f1-7aef-4d93-bfd6-8495d07df7aa"}, {"Element": "<span lang=\"DE-CH\" style=\"color:black\">88 04 52 </span>", "ID": "3f1e6284-b544-4fb6-8649-d61d16b5bd68", "Styles": "color:black", "Classes": "None", "Text": "88 04 52 ", "ParentId": "98a3a1f1-7aef-4d93-bfd6-8495d07df7aa"}, {"Element": "<span lang=\"DE-CH\">555</span>", "ID": "3123a38a-4191-4212-b53b-c1cff425b456", "Styles": "None", "Classes": "None", "Text": "555", "ParentId": "98a3a1f1-7aef-4d93-bfd6-8495d07df7aa"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +372 66\n  30 810</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Novartis\n  Norge AS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Tlf: +47 23\n  05 20 00</span></p>\n</td>\n</tr>", "ID": "4fd0180a-5336-4a06-a8db-388974c6c7b3", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Eesti</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics Eesti filiaal</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +372 66\n  30 810</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "5f03d413-9e86-426c-84d7-80ce3485c911", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "4fd0180a-5336-4a06-a8db-388974c6c7b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Eesti</span></b></p>", "ID": "1e4bdeff-f054-46f6-9469-25cdb0083606", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f03d413-9e86-426c-84d7-80ce3485c911"}, {"Element": "<b><span lang=\"IT\">Eesti</span></b>", "ID": "b9027f2d-6a62-492b-8075-113d54650f7c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1e4bdeff-f054-46f6-9469-25cdb0083606"}, {"Element": "<span lang=\"IT\">Eesti</span>", "ID": "1e43479a-9377-47de-90f7-a977f5a356c9", "Styles": "None", "Classes": "None", "Text": "Eesti", "ParentId": "b9027f2d-6a62-492b-8075-113d54650f7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics Eesti filiaal</span></p>", "ID": "6a51f569-abec-4ce6-8443-bb55f4cf728f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f03d413-9e86-426c-84d7-80ce3485c911"}, {"Element": "<span lang=\"IT\">SIA Novartis\n  Baltics Eesti filiaal</span>", "ID": "1c56331e-c526-44ac-8d47-99b027a96229", "Styles": "None", "Classes": "None", "Text": "SIA Novartis   Baltics Eesti filiaal", "ParentId": "6a51f569-abec-4ce6-8443-bb55f4cf728f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +372 66\n  30 810</span></p>", "ID": "b2fb0a6b-a42c-4122-a8ce-6833dcc8f221", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f03d413-9e86-426c-84d7-80ce3485c911"}, {"Element": "<span lang=\"EN-GB\">Tel: +372 66\n  30 810</span>", "ID": "f333b480-86e7-436d-839e-16c83abacbae", "Styles": "None", "Classes": "None", "Text": "Tel: +372 66   30 810", "ParentId": "b2fb0a6b-a42c-4122-a8ce-6833dcc8f221"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "524bc513-e39c-400a-9da0-337147921d21", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f03d413-9e86-426c-84d7-80ce3485c911"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "532b08f2-c5f5-499f-bedd-6e9901a9f75e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "524bc513-e39c-400a-9da0-337147921d21"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\">Norge</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Novartis\n  Norge AS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Tlf: +47 23\n  05 20 00</span></p>\n</td>", "ID": "3cb6f7ac-6823-4969-8729-2a3491f06e78", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "4fd0180a-5336-4a06-a8db-388974c6c7b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\">Norge</span></b></p>", "ID": "e4aa3b3b-1500-467c-b9b3-293aed91a136", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3cb6f7ac-6823-4969-8729-2a3491f06e78"}, {"Element": "<b><span lang=\"NO-BOK\">Norge</span></b>", "ID": "5897737b-1bf2-40ab-98b0-70585ca7e1a6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e4aa3b3b-1500-467c-b9b3-293aed91a136"}, {"Element": "<span lang=\"NO-BOK\">Norge</span>", "ID": "d64f04d6-7a43-4f10-b32d-dd9ac7020970", "Styles": "None", "Classes": "None", "Text": "Norge", "ParentId": "5897737b-1bf2-40ab-98b0-70585ca7e1a6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Novartis\n  Norge AS</span></p>", "ID": "17213300-cbfb-45d5-b24e-ef96e73c78f1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3cb6f7ac-6823-4969-8729-2a3491f06e78"}, {"Element": "<span lang=\"NO-BOK\">Novartis\n  Norge AS</span>", "ID": "e73edaf3-df98-4a6d-9002-8e7c1bc8d624", "Styles": "None", "Classes": "None", "Text": "Novartis   Norge AS", "ParentId": "17213300-cbfb-45d5-b24e-ef96e73c78f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Tlf: +47 23\n  05 20 00</span></p>", "ID": "3d147864-ad9a-4915-9f15-fc39d15cee27", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3cb6f7ac-6823-4969-8729-2a3491f06e78"}, {"Element": "<span lang=\"NO-BOK\">Tlf: +47 23\n  05 20 00</span>", "ID": "02a14f7e-0e7b-4cff-86a2-82a1eca7a3dd", "Styles": "None", "Classes": "None", "Text": "Tlf: +47 23   05 20 00", "ParentId": "3d147864-ad9a-4915-9f15-fc39d15cee27"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis (Hellas)\n  A.E.B.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 281 17 12</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +43 1 86\n  6570</span></p>\n</td>\n</tr>", "ID": "b5619e17-1b79-4a13-a8f2-50c05f70903c", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis (Hellas)\n  A.E.B.E.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 281 17 12</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "52cc9ff8-8c19-4fc9-a96b-32f78614f17b", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "b5619e17-1b79-4a13-a8f2-50c05f70903c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>", "ID": "e5ec94bc-28ce-434b-b6dc-41fcab6342d5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "52cc9ff8-8c19-4fc9-a96b-32f78614f17b"}, {"Element": "<b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b>", "ID": "1c2c2c65-6fcc-45c4-8b1f-a93743121614", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e5ec94bc-28ce-434b-b6dc-41fcab6342d5"}, {"Element": "<span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span>", "ID": "90b93dfa-5df9-4a14-bfce-22eb929845e1", "Styles": "None", "Classes": "None", "Text": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1", "ParentId": "1c2c2c65-6fcc-45c4-8b1f-a93743121614"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis (Hellas)\n  A.E.B.E.</span></p>", "ID": "74a103c7-140f-4fb1-898c-afe5eedd11e0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "52cc9ff8-8c19-4fc9-a96b-32f78614f17b"}, {"Element": "<span lang=\"ES\">Novartis (Hellas)\n  A.E.B.E.</span>", "ID": "d12ed63f-8fd9-47e0-acea-c756dd940674", "Styles": "None", "Classes": "None", "Text": "Novartis (Hellas)   A.E.B.E.", "ParentId": "74a103c7-140f-4fb1-898c-afe5eedd11e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 281 17 12</span></p>", "ID": "5882c623-b079-4a7f-82e8-2b9c4717127a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "52cc9ff8-8c19-4fc9-a96b-32f78614f17b"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +30 210 281 17 12</span>", "ID": "459a2837-4601-48f6-b692-5977abb264c8", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb:   +30 210 281 17 12", "ParentId": "5882c623-b079-4a7f-82e8-2b9c4717127a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fe28df96-f89c-463e-8854-4b5cd3095167", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "52cc9ff8-8c19-4fc9-a96b-32f78614f17b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a286b7b6-4685-466c-9694-49b3700d8397", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fe28df96-f89c-463e-8854-4b5cd3095167"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u00d6sterreich</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +43 1 86\n  6570</span></p>\n</td>", "ID": "9251df60-f580-4982-9349-e0a5ef37e3e8", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "b5619e17-1b79-4a13-a8f2-50c05f70903c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">\u00d6sterreich</span></b></p>", "ID": "a052e540-f012-46ea-af01-d228a8973799", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9251df60-f580-4982-9349-e0a5ef37e3e8"}, {"Element": "<b><span lang=\"DE-CH\">\u00d6sterreich</span></b>", "ID": "dea5975c-02bb-4746-9da8-d2604105412d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a052e540-f012-46ea-af01-d228a8973799"}, {"Element": "<span lang=\"DE-CH\">\u00d6sterreich</span>", "ID": "1a0c7ba9-bedf-41f9-be22-52bd922d8c52", "Styles": "None", "Classes": "None", "Text": "\u00d6sterreich", "ParentId": "dea5975c-02bb-4746-9da8-d2604105412d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span></p>", "ID": "6e3e4612-daeb-4ebe-be86-d63bbcb9ac19", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9251df60-f580-4982-9349-e0a5ef37e3e8"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  Pharma GmbH</span>", "ID": "7ffdc538-0a5a-483c-96e4-c554abe4486c", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma GmbH", "ParentId": "6e3e4612-daeb-4ebe-be86-d63bbcb9ac19"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +43 1 86\n  6570</span></p>", "ID": "581743d8-885a-4559-943a-e607ca857ce9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9251df60-f580-4982-9349-e0a5ef37e3e8"}, {"Element": "<span lang=\"DE-CH\">Tel: +43 1 86\n  6570</span>", "ID": "824a1a23-4706-461b-ae0d-2df8843df9cf", "Styles": "None", "Classes": "None", "Text": "Tel: +43 1 86   6570", "ParentId": "581743d8-885a-4559-943a-e607ca857ce9"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis\n  Farmac\u00e9utica, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +34 93\n  306 42 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Tel.: +48 22 375\n  4888</span></p>\n</td>\n</tr>", "ID": "4a12b992-69c1-46f0-b60f-47f64a9bf720", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis\n  Farmac\u00e9utica, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +34 93\n  306 42 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "9cb4727d-d800-4498-a94f-4e94bc942c70", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "4a12b992-69c1-46f0-b60f-47f64a9bf720"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>", "ID": "f4582841-8688-41b5-996f-83a5acd7a5fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9cb4727d-d800-4498-a94f-4e94bc942c70"}, {"Element": "<b><span lang=\"ES\">Espa\u00f1a</span></b>", "ID": "6e17ea62-7dba-4641-88b5-49a62690b67a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f4582841-8688-41b5-996f-83a5acd7a5fb"}, {"Element": "<span lang=\"ES\">Espa\u00f1a</span>", "ID": "3afb1d72-57eb-4ee6-88fd-3af5023267c4", "Styles": "None", "Classes": "None", "Text": "Espa\u00f1a", "ParentId": "6e17ea62-7dba-4641-88b5-49a62690b67a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis\n  Farmac\u00e9utica, S.A.</span></p>", "ID": "46120445-9fe6-49b7-b4ae-e1f85b66d61b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9cb4727d-d800-4498-a94f-4e94bc942c70"}, {"Element": "<span lang=\"ES\">Novartis\n  Farmac\u00e9utica, S.A.</span>", "ID": "aab6453a-ca34-4c07-93c5-1516a3c1b0a7", "Styles": "None", "Classes": "None", "Text": "Novartis   Farmac\u00e9utica, S.A.", "ParentId": "46120445-9fe6-49b7-b4ae-e1f85b66d61b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +34 93\n  306 42 00</span></p>", "ID": "8a4465e6-eb06-4f27-9ca1-7826d337bfc9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9cb4727d-d800-4498-a94f-4e94bc942c70"}, {"Element": "<span lang=\"EN-GB\">Tel: +34 93\n  306 42 00</span>", "ID": "6cb6f017-f890-4aa2-9ee8-31a46398fa1c", "Styles": "None", "Classes": "None", "Text": "Tel: +34 93   306 42 00", "ParentId": "8a4465e6-eb06-4f27-9ca1-7826d337bfc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6c7e0146-9472-47b2-9bfe-527db72039fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9cb4727d-d800-4498-a94f-4e94bc942c70"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "01c62f50-c86d-473c-a9e0-9d4d67f2d9d7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6c7e0146-9472-47b2-9bfe-527db72039fe"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Polska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Poland Sp. z o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Tel.: +48 22 375\n  4888</span></p>\n</td>", "ID": "005d9eea-dbb2-4e3c-86f6-41290be16c3e", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "4a12b992-69c1-46f0-b60f-47f64a9bf720"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Polska</span></b></p>", "ID": "54c371c9-9226-466e-850e-6bc622c605d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "005d9eea-dbb2-4e3c-86f6-41290be16c3e"}, {"Element": "<b><span lang=\"FR-CH\">Polska</span></b>", "ID": "f88e8c79-c9a3-4a6e-8d71-6c04d025e306", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "54c371c9-9226-466e-850e-6bc622c605d9"}, {"Element": "<span lang=\"FR-CH\">Polska</span>", "ID": "c350509a-d85b-41a4-9035-20762e0f4183", "Styles": "None", "Classes": "None", "Text": "Polska", "ParentId": "f88e8c79-c9a3-4a6e-8d71-6c04d025e306"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Poland Sp. z o.o.</span></p>", "ID": "35c0c5b0-02b0-4178-88e6-aa25393cb65c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "005d9eea-dbb2-4e3c-86f6-41290be16c3e"}, {"Element": "<span lang=\"FR-CH\">Novartis\n  Poland Sp. z o.o.</span>", "ID": "a411f8b3-9bda-490c-a9aa-e9aa798280d5", "Styles": "None", "Classes": "None", "Text": "Novartis   Poland Sp. z o.o.", "ParentId": "35c0c5b0-02b0-4178-88e6-aa25393cb65c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Tel.: +48 22 375\n  4888</span></p>", "ID": "cb111967-ef66-4977-ad17-aa9c6e66b5a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "005d9eea-dbb2-4e3c-86f6-41290be16c3e"}, {"Element": "<span lang=\"FR-CH\">Tel.: +48 22 375\n  4888</span>", "ID": "1bf32c43-b1b2-421e-86d1-6f0150cfaf48", "Styles": "None", "Classes": "None", "Text": "Tel.: +48 22 375   4888", "ParentId": "cb111967-ef66-4977-ad17-aa9c6e66b5a1"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">T\u00e9l: +33 1 55\n  47 66 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma \u2011\n  Produtos Farmac\u00eauticos, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +351 21\n  000 8600</span></p>\n</td>\n</tr>", "ID": "046a9703-2d69-4267-9f9f-3b1309520b98", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">France</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma S.A.S.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">T\u00e9l: +33 1 55\n  47 66 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>\n</td>", "ID": "44d3fca9-bcf8-4151-b2ea-4a55af83f95a", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "046a9703-2d69-4267-9f9f-3b1309520b98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">France</span></b></p>", "ID": "edd50b09-6de2-4900-a212-76a293b1db65", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44d3fca9-bcf8-4151-b2ea-4a55af83f95a"}, {"Element": "<b><span lang=\"FR-CH\">France</span></b>", "ID": "2314f68f-a22d-4175-8728-2fb7f0f4b2ea", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "edd50b09-6de2-4900-a212-76a293b1db65"}, {"Element": "<span lang=\"FR-CH\">France</span>", "ID": "ee470fe8-4a9f-4d53-9ce9-5f71a3b6e86d", "Styles": "None", "Classes": "None", "Text": "France", "ParentId": "2314f68f-a22d-4175-8728-2fb7f0f4b2ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma S.A.S.</span></p>", "ID": "da999274-ed92-4355-87d2-84c9c75e9384", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44d3fca9-bcf8-4151-b2ea-4a55af83f95a"}, {"Element": "<span lang=\"FR-CH\">Novartis\n  Pharma S.A.S.</span>", "ID": "677f05e7-9507-4576-97f3-f17db227df50", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma S.A.S.", "ParentId": "da999274-ed92-4355-87d2-84c9c75e9384"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">T\u00e9l: +33 1 55\n  47 66 00</span></p>", "ID": "cd40e6ba-f83e-47fe-869b-6a168ef940d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44d3fca9-bcf8-4151-b2ea-4a55af83f95a"}, {"Element": "<span lang=\"FR-CH\">T\u00e9l: +33 1 55\n  47 66 00</span>", "ID": "99b97cb3-d187-4a15-99f3-7d9727cb4168", "Styles": "None", "Classes": "None", "Text": "T\u00e9l: +33 1 55   47 66 00", "ParentId": "cd40e6ba-f83e-47fe-869b-6a168ef940d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">\u00a0</span></p>", "ID": "aa2447f2-3fc1-4571-99dd-50933099f856", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44d3fca9-bcf8-4151-b2ea-4a55af83f95a"}, {"Element": "<span lang=\"FR-CH\">\u00a0</span>", "ID": "5859be51-6ed3-4b60-a2e0-d35c95740b5a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa2447f2-3fc1-4571-99dd-50933099f856"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Portugal</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma \u2011\n  Produtos Farmac\u00eauticos, S.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +351 21\n  000 8600</span></p>\n</td>", "ID": "321779d2-3b00-40bb-9c77-596297f513da", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "046a9703-2d69-4267-9f9f-3b1309520b98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Portugal</span></b></p>", "ID": "cd5c8879-641c-42ee-84e0-afd4cf3cb6c8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "321779d2-3b00-40bb-9c77-596297f513da"}, {"Element": "<b><span lang=\"ES\">Portugal</span></b>", "ID": "c3edbd3b-8cb8-4ba8-b339-bc73aa377fbc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd5c8879-641c-42ee-84e0-afd4cf3cb6c8"}, {"Element": "<span lang=\"ES\">Portugal</span>", "ID": "57ac6456-6082-45a8-9a98-f30817d407c6", "Styles": "None", "Classes": "None", "Text": "Portugal", "ParentId": "c3edbd3b-8cb8-4ba8-b339-bc73aa377fbc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma \u2011\n  Produtos Farmac\u00eauticos, S.A.</span></p>", "ID": "4f62225a-7aa3-4085-839f-5afe54c60622", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "321779d2-3b00-40bb-9c77-596297f513da"}, {"Element": "<span lang=\"ES\">Novartis Farma \u2011\n  Produtos Farmac\u00eauticos, S.A.</span>", "ID": "6a1b792a-55d2-4ae3-ad6c-63d968047c70", "Styles": "None", "Classes": "None", "Text": "Novartis Farma \u2011   Produtos Farmac\u00eauticos, S.A.", "ParentId": "4f62225a-7aa3-4085-839f-5afe54c60622"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +351 21\n  000 8600</span></p>", "ID": "e6c6ee88-c582-4a18-86e6-74dcb04b8ebc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "321779d2-3b00-40bb-9c77-596297f513da"}, {"Element": "<span lang=\"EN-GB\">Tel: +351 21\n  000 8600</span>", "ID": "0f315bf3-3ebd-484d-b161-f11047a5d80d", "Styles": "None", "Classes": "None", "Text": "Tel: +351 21   000 8600", "ParentId": "e6c6ee88-c582-4a18-86e6-74dcb04b8ebc"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel. +385 1\n  6274 220</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Romania SRL</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21 31299\n  01</span></p>\n</td>\n</tr>", "ID": "3698072e-66d2-4a73-8174-5d06f1a650a9", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Hrvatska</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Hrvatska d.o.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel. +385 1\n  6274 220</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "94c83df5-c961-45ed-9bd5-41a752f5afea", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "3698072e-66d2-4a73-8174-5d06f1a650a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Hrvatska</span></b></p>", "ID": "fc2a0804-d36f-4207-bbf2-998738a48b2d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94c83df5-c961-45ed-9bd5-41a752f5afea"}, {"Element": "<b><span lang=\"DE-CH\">Hrvatska</span></b>", "ID": "559d38a4-05e9-4f01-a37d-4518457fcc4e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fc2a0804-d36f-4207-bbf2-998738a48b2d"}, {"Element": "<span lang=\"DE-CH\">Hrvatska</span>", "ID": "491580b8-30ce-4196-97ff-8f099e307025", "Styles": "None", "Classes": "None", "Text": "Hrvatska", "ParentId": "559d38a4-05e9-4f01-a37d-4518457fcc4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Hrvatska d.o.o.</span></p>", "ID": "0ee61b5b-2cd5-447f-9685-f22ebe075c18", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94c83df5-c961-45ed-9bd5-41a752f5afea"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  Hrvatska d.o.o.</span>", "ID": "e69056d2-679b-47f5-bd1f-844d8c159700", "Styles": "None", "Classes": "None", "Text": "Novartis   Hrvatska d.o.o.", "ParentId": "0ee61b5b-2cd5-447f-9685-f22ebe075c18"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel. +385 1\n  6274 220</span></p>", "ID": "b2c1d615-fb6b-4f71-8132-9f5d8c6223d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94c83df5-c961-45ed-9bd5-41a752f5afea"}, {"Element": "<span lang=\"EN-GB\">Tel. +385 1\n  6274 220</span>", "ID": "72481e44-8eb9-42a1-bd24-ea836d01369d", "Styles": "None", "Classes": "None", "Text": "Tel. +385 1   6274 220", "ParentId": "b2c1d615-fb6b-4f71-8132-9f5d8c6223d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f1d95c4e-a4e6-4187-b998-a0c4e9467b71", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94c83df5-c961-45ed-9bd5-41a752f5afea"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c69578f-61a6-4335-8e00-43709247c6ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f1d95c4e-a4e6-4187-b998-a0c4e9467b71"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Rom\u00e2nia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Romania SRL</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21 31299\n  01</span></p>\n</td>", "ID": "21d8cf74-34d7-4af9-b9ee-f090e72bf4dd", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "3698072e-66d2-4a73-8174-5d06f1a650a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Rom\u00e2nia</span></b></p>", "ID": "ec87018c-cdac-4bd9-bffa-c7a12f7c959c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "21d8cf74-34d7-4af9-b9ee-f090e72bf4dd"}, {"Element": "<b><span lang=\"FR-CH\">Rom\u00e2nia</span></b>", "ID": "6e45d908-e74a-44ae-91dd-8f1155abdabe", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec87018c-cdac-4bd9-bffa-c7a12f7c959c"}, {"Element": "<span lang=\"FR-CH\">Rom\u00e2nia</span>", "ID": "8876c1d0-0f36-4c59-a591-7ca2521e5903", "Styles": "None", "Classes": "None", "Text": "Rom\u00e2nia", "ParentId": "6e45d908-e74a-44ae-91dd-8f1155abdabe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Romania SRL</span></p>", "ID": "5d521fb3-00c3-435d-801d-ffc1d2491bd0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "21d8cf74-34d7-4af9-b9ee-f090e72bf4dd"}, {"Element": "<span lang=\"FR-CH\">Novartis\n  Pharma Services Romania SRL</span>", "ID": "ab608251-8f72-4254-9788-73f6bf549f32", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma Services Romania SRL", "ParentId": "5d521fb3-00c3-435d-801d-ffc1d2491bd0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21 31299\n  01</span></p>", "ID": "2a169953-c433-47cc-9eca-5f21c16ad72a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "21d8cf74-34d7-4af9-b9ee-f090e72bf4dd"}, {"Element": "<span lang=\"EN-GB\">Tel: +40 21 31299\n  01</span>", "ID": "55b86f7a-4dd0-4737-b1e8-1e31e670ffe4", "Styles": "None", "Classes": "None", "Text": "Tel: +40 21 31299   01", "ParentId": "2a169953-c433-47cc-9eca-5f21c16ad72a"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Ireland Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +353 1\n  260 12 55</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +386 1\n  300 75 50</span></p>\n</td>\n</tr>", "ID": "c3ad250e-4a61-45fd-ba58-6929af143eb4", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Ireland Limited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +353 1\n  260 12 55</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0028755e-6b7f-43ac-af7b-cee3f4fd83eb", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "c3ad250e-4a61-45fd-ba58-6929af143eb4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>", "ID": "2dd85700-eb0b-40f1-98c8-b8652e32a442", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0028755e-6b7f-43ac-af7b-cee3f4fd83eb"}, {"Element": "<b><span lang=\"EN-GB\">Ireland</span></b>", "ID": "d601234a-b28d-4dfc-ac7f-d431bd9f59a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2dd85700-eb0b-40f1-98c8-b8652e32a442"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "21c0acb1-ec54-4615-ac47-269f09dbabde", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "d601234a-b28d-4dfc-ac7f-d431bd9f59a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Ireland Limited</span></p>", "ID": "c3e77ceb-036d-4627-b907-1bec32fdb175", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0028755e-6b7f-43ac-af7b-cee3f4fd83eb"}, {"Element": "<span lang=\"EN-GB\">Novartis\n  Ireland Limited</span>", "ID": "c8339f44-9138-4e31-acb8-ace635b53db8", "Styles": "None", "Classes": "None", "Text": "Novartis   Ireland Limited", "ParentId": "c3e77ceb-036d-4627-b907-1bec32fdb175"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +353 1\n  260 12 55</span></p>", "ID": "6bf8c710-11ac-4cee-8315-87c452d039fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0028755e-6b7f-43ac-af7b-cee3f4fd83eb"}, {"Element": "<span lang=\"EN-GB\">Tel: +353 1\n  260 12 55</span>", "ID": "c4af876b-7d72-4137-ac77-f47f84e419c6", "Styles": "None", "Classes": "None", "Text": "Tel: +353 1   260 12 55", "ParentId": "6bf8c710-11ac-4cee-8315-87c452d039fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d599a82e-c252-4755-99de-6b3a0b355b94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0028755e-6b7f-43ac-af7b-cee3f4fd83eb"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "88d94f1b-f2a5-4319-be0e-8a3576a491d1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d599a82e-c252-4755-99de-6b3a0b355b94"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Slovenija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +386 1\n  300 75 50</span></p>\n</td>", "ID": "c1a65e77-d403-4860-8181-14747e883f7b", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "c3ad250e-4a61-45fd-ba58-6929af143eb4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-CH\">Slovenija</span></b></p>", "ID": "bf4ed020-8532-4610-95d6-06e742ef02d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c1a65e77-d403-4860-8181-14747e883f7b"}, {"Element": "<b><span lang=\"FR-CH\">Slovenija</span></b>", "ID": "ca9d97d3-ad72-4dae-ad03-df4f3966470f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bf4ed020-8532-4610-95d6-06e742ef02d7"}, {"Element": "<span lang=\"FR-CH\">Slovenija</span>", "ID": "ea8ca6d7-a26c-49e0-a686-2f711bf515a0", "Styles": "None", "Classes": "None", "Text": "Slovenija", "ParentId": "ca9d97d3-ad72-4dae-ad03-df4f3966470f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>", "ID": "b6476048-3167-4854-b8c9-b122a2c6320b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c1a65e77-d403-4860-8181-14747e883f7b"}, {"Element": "<span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span>", "ID": "22b7bbd1-48ff-4eff-ba96-4f369761f5bc", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma Services Inc.", "ParentId": "b6476048-3167-4854-b8c9-b122a2c6320b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +386 1\n  300 75 50</span></p>", "ID": "0abf6332-e9fb-4da4-af15-986aedbaa493", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c1a65e77-d403-4860-8181-14747e883f7b"}, {"Element": "<span lang=\"EN-GB\">Tel: +386 1\n  300 75 50</span>", "ID": "922c51d8-c9c2-4cce-9d08-9051d4710a05", "Styles": "None", "Classes": "None", "Text": "Tel: +386 1   300 75 50", "ParentId": "0abf6332-e9fb-4da4-af15-986aedbaa493"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +354 535\n  7000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Novartis Slovakia\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 2\n  5542 5439</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "78961203-5f96-49c1-b59a-0170e4e3dfd9", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +354 535\n  7000</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "68eeb1a5-3da6-4ece-836f-3450cdfa0c97", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "78961203-5f96-49c1-b59a-0170e4e3dfd9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>", "ID": "7fe36480-9eba-4d86-9690-b160cd942b18", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "68eeb1a5-3da6-4ece-836f-3450cdfa0c97"}, {"Element": "<b><span lang=\"EN-GB\">\u00cdsland</span></b>", "ID": "00e184e3-70af-49b7-941a-2e808b5421f6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7fe36480-9eba-4d86-9690-b160cd942b18"}, {"Element": "<span lang=\"EN-GB\">\u00cdsland</span>", "ID": "f1735f7f-97cc-44eb-8c24-5f71c7f4559f", "Styles": "None", "Classes": "None", "Text": "\u00cdsland", "ParentId": "00e184e3-70af-49b7-941a-2e808b5421f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf.</span></p>", "ID": "fdd56c76-ff55-41f3-975c-472650c35350", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "68eeb1a5-3da6-4ece-836f-3450cdfa0c97"}, {"Element": "<span lang=\"EN-GB\">Vistor hf.</span>", "ID": "190ba8bf-1227-4075-9c0d-ff60f1984832", "Styles": "None", "Classes": "None", "Text": "Vistor hf.", "ParentId": "fdd56c76-ff55-41f3-975c-472650c35350"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi: +354 535\n  7000</span></p>", "ID": "79f90dea-8357-49c0-bc5b-d5e923a2bfba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "68eeb1a5-3da6-4ece-836f-3450cdfa0c97"}, {"Element": "<span lang=\"EN-GB\">S\u00edmi: +354 535\n  7000</span>", "ID": "698da04a-12e2-4f87-8489-1303934ca7a7", "Styles": "None", "Classes": "None", "Text": "S\u00edmi: +354 535   7000", "ParentId": "79f90dea-8357-49c0-bc5b-d5e923a2bfba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "65e3d8e0-19df-4ceb-8f13-e6b189affff7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "68eeb1a5-3da6-4ece-836f-3450cdfa0c97"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64b6941b-3daa-4085-beaa-210546e0b9c0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65e3d8e0-19df-4ceb-8f13-e6b189affff7"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Novartis Slovakia\n  s.r.o.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 2\n  5542 5439</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "962a7e44-35fa-442b-a007-72f4fa2d7bcc", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "78961203-5f96-49c1-b59a-0170e4e3dfd9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Slovensk\u00e1\n  republika</span></b></p>", "ID": "260a32e9-0df2-4929-98eb-6d22c766e6ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "962a7e44-35fa-442b-a007-72f4fa2d7bcc"}, {"Element": "<b><span lang=\"IT\">Slovensk\u00e1\n  republika</span></b>", "ID": "436e4ae3-b1f0-491e-ad6b-7dfbe649db99", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "260a32e9-0df2-4929-98eb-6d22c766e6ab"}, {"Element": "<span lang=\"IT\">Slovensk\u00e1\n  republika</span>", "ID": "f699488f-cc19-4a01-be34-45cd3c493f11", "Styles": "None", "Classes": "None", "Text": "Slovensk\u00e1   republika", "ParentId": "436e4ae3-b1f0-491e-ad6b-7dfbe649db99"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Novartis Slovakia\n  s.r.o.</span></p>", "ID": "3e4035d8-2fff-4e9c-90a0-fbde05090d96", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "962a7e44-35fa-442b-a007-72f4fa2d7bcc"}, {"Element": "<span lang=\"IT\">Novartis Slovakia\n  s.r.o.</span>", "ID": "56cda791-3b39-42e3-b7b9-043a3e1913dc", "Styles": "None", "Classes": "None", "Text": "Novartis Slovakia   s.r.o.", "ParentId": "3e4035d8-2fff-4e9c-90a0-fbde05090d96"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 2\n  5542 5439</span></p>", "ID": "cef32638-b0f5-4ae6-a271-5b3fd137df66", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "962a7e44-35fa-442b-a007-72f4fa2d7bcc"}, {"Element": "<span lang=\"EN-GB\">Tel: +421 2\n  5542 5439</span>", "ID": "63b6f173-94ed-47c3-ba4b-2c8bfff7c97f", "Styles": "None", "Classes": "None", "Text": "Tel: +421 2   5542 5439", "ParentId": "cef32638-b0f5-4ae6-a271-5b3fd137df66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cb701106-349d-4e70-b769-43732ce1e6ed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "962a7e44-35fa-442b-a007-72f4fa2d7bcc"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fcb77f76-18bd-4d62-891d-92d45058a330", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cb701106-349d-4e70-b769-43732ce1e6ed"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma\n  S.p.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 02 96\n  54 1</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Finland Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Puh/Tel: +358\n  (0)10 6133 200</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n</tr>", "ID": "16ddf48f-1a25-4c48-8073-38256222a855", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Italia</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma\n  S.p.A.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 02 96\n  54 1</span></p>\n</td>", "ID": "c4f74c84-98f6-4639-8a4c-86481279c875", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "16ddf48f-1a25-4c48-8073-38256222a855"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Italia</span></b></p>", "ID": "be2221b0-784e-40d9-9e7f-608c3fbacdee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c4f74c84-98f6-4639-8a4c-86481279c875"}, {"Element": "<b><span lang=\"ES\">Italia</span></b>", "ID": "814a3a39-e9e2-4389-a6d9-990b87f9d16a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be2221b0-784e-40d9-9e7f-608c3fbacdee"}, {"Element": "<span lang=\"ES\">Italia</span>", "ID": "d0ddaaed-5ba8-48f3-b7d7-d67a798efb66", "Styles": "None", "Classes": "None", "Text": "Italia", "ParentId": "814a3a39-e9e2-4389-a6d9-990b87f9d16a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis Farma\n  S.p.A.</span></p>", "ID": "112194d0-eeb4-46ed-95d6-2911c355c1a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c4f74c84-98f6-4639-8a4c-86481279c875"}, {"Element": "<span lang=\"ES\">Novartis Farma\n  S.p.A.</span>", "ID": "b794abab-0c6f-4407-8d09-bf573b34a8bf", "Styles": "None", "Classes": "None", "Text": "Novartis Farma   S.p.A.", "ParentId": "112194d0-eeb4-46ed-95d6-2911c355c1a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 02 96\n  54 1</span></p>", "ID": "983dc1b5-9ad2-47ca-b1fd-e95a7716565a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c4f74c84-98f6-4639-8a4c-86481279c875"}, {"Element": "<span lang=\"EN-GB\">Tel: +39 02 96\n  54 1</span>", "ID": "b867cbf9-414f-4ccb-b702-73543415fe53", "Styles": "None", "Classes": "None", "Text": "Tel: +39 02 96   54 1", "ParentId": "983dc1b5-9ad2-47ca-b1fd-e95a7716565a"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Suomi/Finland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Finland Oy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Puh/Tel: +358\n  (0)10 6133 200</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>", "ID": "634bd9f4-fdd2-40ce-afe7-8dc08968397f", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "16ddf48f-1a25-4c48-8073-38256222a855"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Suomi/Finland</span></b></p>", "ID": "13acd944-f1e9-434f-899a-da56885840b1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "634bd9f4-fdd2-40ce-afe7-8dc08968397f"}, {"Element": "<b><span lang=\"DE-CH\">Suomi/Finland</span></b>", "ID": "a1f03989-f987-4a79-99ff-737e63721f08", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "13acd944-f1e9-434f-899a-da56885840b1"}, {"Element": "<span lang=\"DE-CH\">Suomi/Finland</span>", "ID": "f141c53c-3136-4e59-aa94-d6d39183b3d4", "Styles": "None", "Classes": "None", "Text": "Suomi/Finland", "ParentId": "a1f03989-f987-4a79-99ff-737e63721f08"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Finland Oy</span></p>", "ID": "a40ed9d3-0365-4966-89d9-253ee7da6ea9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "634bd9f4-fdd2-40ce-afe7-8dc08968397f"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  Finland Oy</span>", "ID": "0fcc3729-ddc4-47b4-b59c-a5c5823baf69", "Styles": "None", "Classes": "None", "Text": "Novartis   Finland Oy", "ParentId": "a40ed9d3-0365-4966-89d9-253ee7da6ea9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Puh/Tel: +358\n  (0)10 6133 200</span></p>", "ID": "e767891f-7e90-47a7-b093-97d00d484fa9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "634bd9f4-fdd2-40ce-afe7-8dc08968397f"}, {"Element": "<span lang=\"DE-CH\">Puh/Tel: +358\n  (0)10 6133 200</span>", "ID": "f1806540-fec8-4e2c-82b0-f68d8b5d3350", "Styles": "None", "Classes": "None", "Text": "Puh/Tel: +358   (0)10 6133 200", "ParentId": "e767891f-7e90-47a7-b093-97d00d484fa9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>", "ID": "c1c91547-d88f-42b5-872f-0a039ebdf521", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "634bd9f4-fdd2-40ce-afe7-8dc08968397f"}, {"Element": "<span lang=\"DE-CH\">\u00a0</span>", "ID": "c92de940-0ff5-42eb-aa84-ac28914dd2d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1c91547-d88f-42b5-872f-0a039ebdf521"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +357 22 690 690</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Sverige AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +46 8 732\n  32 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>\n</tr>", "ID": "d1937b40-47f3-4f6f-8ccf-ebc264dbbb96", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +357 22 690 690</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "8bb5d68b-5b45-42f4-b5b0-5f8005db797d", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "d1937b40-47f3-4f6f-8ccf-ebc264dbbb96"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>", "ID": "c03f2ba1-50ac-4bb2-a359-d7e7e1441e82", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8bb5d68b-5b45-42f4-b5b0-5f8005db797d"}, {"Element": "<b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b>", "ID": "0f936be0-3cc5-4558-8eae-c7732717a282", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c03f2ba1-50ac-4bb2-a359-d7e7e1441e82"}, {"Element": "<span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span>", "ID": "e69ad893-a387-4214-acec-8fa689e9293b", "Styles": "None", "Classes": "None", "Text": "\u039a\u03cd\u03c0\u03c1\u03bf\u03c2", "ParentId": "0f936be0-3cc5-4558-8eae-c7732717a282"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span></p>", "ID": "d82973de-7577-4e63-a69b-ff260289c573", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8bb5d68b-5b45-42f4-b5b0-5f8005db797d"}, {"Element": "<span lang=\"FR-CH\">Novartis\n  Pharma Services Inc.</span>", "ID": "623c3e2e-cb2e-4e65-94ee-ea4e3a57d998", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharma Services Inc.", "ParentId": "d82973de-7577-4e63-a69b-ff260289c573"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +357 22 690 690</span></p>", "ID": "2de68a52-bb83-4125-84af-94e65fc2d29f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8bb5d68b-5b45-42f4-b5b0-5f8005db797d"}, {"Element": "<span lang=\"EN-GB\">\u03a4\u03b7\u03bb:\n  +357 22 690 690</span>", "ID": "fab861b6-918b-422e-9b21-b34c9650a49d", "Styles": "None", "Classes": "None", "Text": "\u03a4\u03b7\u03bb:   +357 22 690 690", "ParentId": "2de68a52-bb83-4125-84af-94e65fc2d29f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5982362e-6299-4901-b433-ec307b1f313f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8bb5d68b-5b45-42f4-b5b0-5f8005db797d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "217bccb9-ec91-4bfd-8f5e-9cac15eb972b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5982362e-6299-4901-b433-ec307b1f313f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Sverige</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Sverige AB</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +46 8 732\n  32 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>\n</td>", "ID": "c6687f5e-0190-4e6b-8900-59ec4daf0519", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "d1937b40-47f3-4f6f-8ccf-ebc264dbbb96"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Sverige</span></b></p>", "ID": "3784ab21-5220-47be-8ba3-216d7eb970e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6687f5e-0190-4e6b-8900-59ec4daf0519"}, {"Element": "<b><span lang=\"DE-CH\">Sverige</span></b>", "ID": "79be550c-3ac6-4eab-aa07-0d21d137fe00", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3784ab21-5220-47be-8ba3-216d7eb970e2"}, {"Element": "<span lang=\"DE-CH\">Sverige</span>", "ID": "7f189b1d-a5dd-4609-a57c-3998c90f479a", "Styles": "None", "Classes": "None", "Text": "Sverige", "ParentId": "79be550c-3ac6-4eab-aa07-0d21d137fe00"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis\n  Sverige AB</span></p>", "ID": "d2789dfe-b07b-4e21-8fb1-1b8aa1f9e14d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6687f5e-0190-4e6b-8900-59ec4daf0519"}, {"Element": "<span lang=\"DE-CH\">Novartis\n  Sverige AB</span>", "ID": "8ba18741-352f-4d7b-9ef5-bcbaaa11d1b3", "Styles": "None", "Classes": "None", "Text": "Novartis   Sverige AB", "ParentId": "d2789dfe-b07b-4e21-8fb1-1b8aa1f9e14d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +46 8 732\n  32 00</span></p>", "ID": "a0c17be0-ff0a-4594-8a0a-75af873c1313", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6687f5e-0190-4e6b-8900-59ec4daf0519"}, {"Element": "<span lang=\"DE-CH\">Tel: +46 8 732\n  32 00</span>", "ID": "6bb8847b-eba8-44b3-9f85-b8b975f5ac95", "Styles": "None", "Classes": "None", "Text": "Tel: +46 8 732   32 00", "ParentId": "a0c17be0-ff0a-4594-8a0a-75af873c1313"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">\u00a0</span></p>", "ID": "04872d3e-0e8f-423f-b67e-b5385b7ef19d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6687f5e-0190-4e6b-8900-59ec4daf0519"}, {"Element": "<span lang=\"DE-CH\">\u00a0</span>", "ID": "17ac95d0-ddd2-4d8e-87ad-8f68f5f5d552", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "04872d3e-0e8f-423f-b67e-b5385b7ef19d"}, {"Element": "<tr style=\"page-break-inside:avoid\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Tel: +371 67 887\n  070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Pharmaceuticals UK Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 1276\n  698370</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "cef08ee6-7b45-4125-8791-5e7262b70cf2", "Styles": "page-break-inside:avoid", "Classes": "None", "Text": "   ", "ParentId": "30903476-5692-4273-b1bc-0dd653697226"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Tel: +371 67 887\n  070</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">\u00a0</span></p>\n</td>", "ID": "e482b923-e689-4a15-9331-840018e9babe", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "cef08ee6-7b45-4125-8791-5e7262b70cf2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Latvija</span></b></p>", "ID": "dd546e2f-d4af-4707-8bd7-1d40d12a5ff2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e482b923-e689-4a15-9331-840018e9babe"}, {"Element": "<b><span lang=\"IT\">Latvija</span></b>", "ID": "7ed09517-128b-4d13-901b-6fc20fa312fa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd546e2f-d4af-4707-8bd7-1d40d12a5ff2"}, {"Element": "<span lang=\"IT\">Latvija</span>", "ID": "b404a0ee-7ee4-4ae5-8028-d51a3a854a19", "Styles": "None", "Classes": "None", "Text": "Latvija", "ParentId": "7ed09517-128b-4d13-901b-6fc20fa312fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis\n  Baltics</span></p>", "ID": "fc1e7a59-5767-4eb8-8c0c-3230316f47ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e482b923-e689-4a15-9331-840018e9babe"}, {"Element": "<span lang=\"IT\">SIA Novartis\n  Baltics</span>", "ID": "f12561f4-10b4-4394-bba9-81c06fce67ff", "Styles": "None", "Classes": "None", "Text": "SIA Novartis   Baltics", "ParentId": "fc1e7a59-5767-4eb8-8c0c-3230316f47ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Tel: +371 67 887\n  070</span></p>", "ID": "427fa545-f0d4-4039-b8f3-4d67f7cab529", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e482b923-e689-4a15-9331-840018e9babe"}, {"Element": "<span lang=\"IT\">Tel: +371 67 887\n  070</span>", "ID": "0f9da723-b78a-4ba0-aa1a-952c8af214d2", "Styles": "None", "Classes": "None", "Text": "Tel: +371 67 887   070", "ParentId": "427fa545-f0d4-4039-b8f3-4d67f7cab529"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">\u00a0</span></p>", "ID": "8a8c77dc-034c-4b8e-bdf6-786f4db1d7c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e482b923-e689-4a15-9331-840018e9babe"}, {"Element": "<span lang=\"IT\">\u00a0</span>", "ID": "4dc7511b-e873-4151-bce2-55d36b629364", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8a8c77dc-034c-4b8e-bdf6-786f4db1d7c2"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Pharmaceuticals UK Ltd.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 1276\n  698370</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "3c07fa9e-f250-408e-8942-35b703e8f885", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "cef08ee6-7b45-4125-8791-5e7262b70cf2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">United\n  Kingdom</span></b></p>", "ID": "236f1ff7-4286-46e2-9741-7832a801e81c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c07fa9e-f250-408e-8942-35b703e8f885"}, {"Element": "<b><span lang=\"EN-GB\">United\n  Kingdom</span></b>", "ID": "11b5d44e-992f-48c0-bcfc-1832f4c5a4fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "236f1ff7-4286-46e2-9741-7832a801e81c"}, {"Element": "<span lang=\"EN-GB\">United\n  Kingdom</span>", "ID": "9c888613-d5fe-4638-9c71-5572432e0396", "Styles": "None", "Classes": "None", "Text": "United   Kingdom", "ParentId": "11b5d44e-992f-48c0-bcfc-1832f4c5a4fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis\n  Pharmaceuticals UK Ltd.</span></p>", "ID": "85f90cfa-f30e-498d-a2aa-1a17a44439b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c07fa9e-f250-408e-8942-35b703e8f885"}, {"Element": "<span lang=\"EN-GB\">Novartis\n  Pharmaceuticals UK Ltd.</span>", "ID": "264cb731-3304-4e9f-95e1-e521b9ac926b", "Styles": "None", "Classes": "None", "Text": "Novartis   Pharmaceuticals UK Ltd.", "ParentId": "85f90cfa-f30e-498d-a2aa-1a17a44439b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 1276\n  698370</span></p>", "ID": "6b52c694-df18-4572-8466-6e00559aac0c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c07fa9e-f250-408e-8942-35b703e8f885"}, {"Element": "<span lang=\"EN-GB\">Tel: +44 1276\n  698370</span>", "ID": "bf564b63-58bf-40fb-bff2-719fa5b365bf", "Styles": "None", "Classes": "None", "Text": "Tel: +44 1276   698370", "ParentId": "6b52c694-df18-4572-8466-6e00559aac0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8a107a4c-7ca2-4b74-a4f7-8906a7ce8682", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c07fa9e-f250-408e-8942-35b703e8f885"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "09acecd2-8d66-45b1-8384-61f8c3c0385a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8a107a4c-7ca2-4b74-a4f7-8906a7ce8682"}, {"Element": "<p class=\"MsoNormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8c36fa0d-6de6-430a-85f5-657a93d9988c", "Styles": "None", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cf8668c4-97c5-446a-86f9-a19fe9a10f60", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8c36fa0d-6de6-430a-85f5-657a93d9988c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><b><span lang=\"EN-GB\">This leaflet was last revised in</span></b></p>", "ID": "ee755764-88ea-48e9-b1a1-36d6aef511fa", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">This leaflet was last revised in</span></b>", "ID": "bc6d38fc-6aec-4106-9fe6-e7e20b975714", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ee755764-88ea-48e9-b1a1-36d6aef511fa"}, {"Element": "<span lang=\"EN-GB\">This leaflet was last revised in</span>", "ID": "763c3ce6-ae3a-486e-9db0-6d11256a62bf", "Styles": "None", "Classes": "None", "Text": "This leaflet was last revised in", "ParentId": "bc6d38fc-6aec-4106-9fe6-e7e20b975714"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7c098a8a-51c2-476c-86de-be91cce6c61b", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a2608548-c488-4c5e-838e-94e8a8c3d510", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7c098a8a-51c2-476c-86de-be91cce6c61b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other sources of information</span></b></p>", "ID": "3a405b98-6cd4-4955-9ffe-9e4fba9c248f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\">Other sources of information</span></b>", "ID": "b6457a51-bb52-43bd-bc74-3e2b114021ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3a405b98-6cd4-4955-9ffe-9e4fba9c248f"}, {"Element": "<span lang=\"EN-GB\">Other sources of information</span>", "ID": "a72ccfeb-c358-4394-aaf1-869e05ba8306", "Styles": "None", "Classes": "None", "Text": "Other sources of information", "ParentId": "b6457a51-bb52-43bd-bc74-3e2b114021ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42f0e3a6-fdbb-40f4-9322-70a319470ce3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d19ccfa-382f-4005-bd44-cd4a820ece9a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42f0e3a6-fdbb-40f4-9322-70a319470ce3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicine is available on the European\nMedicines Agency web site: </span><span lang=\"EN-GB\"><span class=\"MsoHyperlink\">http://www.ema.europa.eu</span></span></p>", "ID": "dc425566-1ef3-4bd7-afdc-4d0399cec74e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Detailed information on this medicine is available on the European\nMedicines Agency web site: </span>", "ID": "e32f9534-3d30-4d39-9d25-2ceb376b6ec1", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicine is available on the European Medicines Agency web site: ", "ParentId": "dc425566-1ef3-4bd7-afdc-4d0399cec74e"}, {"Element": "<span lang=\"EN-GB\"><span class=\"MsoHyperlink\">http://www.ema.europa.eu</span></span>", "ID": "7a0b4720-8372-4936-b80a-59fd1268cd0d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc425566-1ef3-4bd7-afdc-4d0399cec74e"}, {"Element": "<span class=\"MsoHyperlink\">http://www.ema.europa.eu</span>", "ID": "dca66138-261d-41ea-8035-2eb285f4c87a", "Styles": "None", "Classes": "['MsoHyperlink']", "Text": "http://www.ema.europa.eu", "ParentId": "7a0b4720-8372-4936-b80a-59fd1268cd0d"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "dade1d72-984a-43e4-bc44-b117e574032a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "57d8a261-dfa3-48f7-8bc9-6f769ce26ae5", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black", "Classes": "None", "Text": " ", "ParentId": "dade1d72-984a-43e4-bc44-b117e574032a"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "be0ec4d0-04e6-47c1-b02e-d48def33033c", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "57d8a261-dfa3-48f7-8bc9-6f769ce26ae5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.4pt;margin-bottom:\n0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">The following information is intended for\nhealthcare professionals only:</span></b></p>", "ID": "b15ad727-9c8a-4d3b-ac7a-71c9e8baecfb", "Styles": "margin-top:0in;margin-right:-1.4pt;margin-bottom:\n0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">The following information is intended for\nhealthcare professionals only:</span></b>", "ID": "799e36bd-156b-4795-8e2e-1bbe04484bbf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b15ad727-9c8a-4d3b-ac7a-71c9e8baecfb"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">The following information is intended for\nhealthcare professionals only:</span>", "ID": "01e2f07b-e0e2-450e-bd91-85e2196d3ddd", "Styles": "color:black", "Classes": "None", "Text": "The following information is intended for healthcare professionals only:", "ParentId": "799e36bd-156b-4795-8e2e-1bbe04484bbf"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-1.4pt;margin-bottom:\n0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">\u00a0</span></p>", "ID": "8b3f5d0d-2cfe-4322-bb61-67082365de0c", "Styles": "margin-top:0in;margin-right:-1.4pt;margin-bottom:\n0in;margin-left:-1.85pt;margin-bottom:.0001pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">\u00a0</span>", "ID": "40b00dcd-d9e0-432c-bc46-2e260331f323", "Styles": "color:black", "Classes": "None", "Text": "\u00a0", "ParentId": "8b3f5d0d-2cfe-4322-bb61-67082365de0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparation of the infusion bag</span></u></p>", "ID": "0673aed6-8fb2-4ab3-b93a-f9984fc63e60", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Preparation of the infusion bag</span></u>", "ID": "7d637589-9f9a-4596-9f34-a13af527e40c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0673aed6-8fb2-4ab3-b93a-f9984fc63e60"}, {"Element": "<span lang=\"EN-GB\">Preparation of the infusion bag</span>", "ID": "30d55e76-0af3-48ad-a32f-fa8cd9da2446", "Styles": "None", "Classes": "None", "Text": "Preparation of the infusion bag", "ParentId": "7d637589-9f9a-4596-9f34-a13af527e40c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The timing of thaw of Kymriah and of infusion should be coordinated.\nConfirm the infusion time in advance and adjust the start time for thaw so that\nKymriah is available for infusion when the recipient is ready. Once Kymriah has\nbeen thawed and is at room temperature (20\u00b0C\u201125\u00b0C), it should be infused\nwithin 30\u00a0minutes to maintain maximum product viability, including any\ninterruption during the infusion.</span></p>", "ID": "fcded808-99ff-45ff-87c2-4d46f5cede22", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The timing of thaw of Kymriah and of infusion should be coordinated.\nConfirm the infusion time in advance and adjust the start time for thaw so that\nKymriah is available for infusion when the recipient is ready. Once Kymriah has\nbeen thawed and is at room temperature (20\u00b0C\u201125\u00b0C), it should be infused\nwithin 30\u00a0minutes to maintain maximum product viability, including any\ninterruption during the infusion.</span>", "ID": "001842ad-1003-474d-b968-427c118212e0", "Styles": "None", "Classes": "None", "Text": "The timing of thaw of Kymriah and of infusion should be coordinated. Confirm the infusion time in advance and adjust the start time for thaw so that Kymriah is available for infusion when the recipient is ready. Once Kymriah has been thawed and is at room temperature (20\u00b0C\u201125\u00b0C), it should be infused within 30\u00a0minutes to maintain maximum product viability, including any interruption during the infusion.", "ParentId": "fcded808-99ff-45ff-87c2-4d46f5cede22"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "06724d0f-789a-4e02-9eb2-be305c1d1e13", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "87218508-da2d-4930-b6af-90ea606278c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "06724d0f-789a-4e02-9eb2-be305c1d1e13"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The infusion bag should be placed inside a second, sterile bag\nduring thawing to protect ports from contamination and avoid spills in the\nunlikely event of the bag leaking. Kymriah should be thawed at 37\u00b0C using\neither a water bath or dry thaw method until there is no visible ice in the\ninfusion bag. The bag should be removed immediately from the thawing device and\nkept at room temperature (20\u00b0C\u201125\u00b0C) until infusion. If more than one infusion\nbag has been received for the treatment dose (refer to the batch certificate\nfor number of bags constituting one dose), the next bag should only be thawed\nafter the contents of the preceding bag have been infused.</span></p>", "ID": "86a3ef3c-9230-48e3-8ca2-08d47f3e02a1", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The infusion bag should be placed inside a second, sterile bag\nduring thawing to protect ports from contamination and avoid spills in the\nunlikely event of the bag leaking. Kymriah should be thawed at 37\u00b0C using\neither a water bath or dry thaw method until there is no visible ice in the\ninfusion bag. The bag should be removed immediately from the thawing device and\nkept at room temperature (20\u00b0C\u201125\u00b0C) until infusion. If more than one infusion\nbag has been received for the treatment dose (refer to the batch certificate\nfor number of bags constituting one dose), the next bag should only be thawed\nafter the contents of the preceding bag have been infused.</span>", "ID": "1b070271-3c77-497b-bc13-6948c98a35c2", "Styles": "None", "Classes": "None", "Text": "The infusion bag should be placed inside a second, sterile bag during thawing to protect ports from contamination and avoid spills in the unlikely event of the bag leaking. Kymriah should be thawed at 37\u00b0C using either a water bath or dry thaw method until there is no visible ice in the infusion bag. The bag should be removed immediately from the thawing device and kept at room temperature (20\u00b0C\u201125\u00b0C) until infusion. If more than one infusion bag has been received for the treatment dose (refer to the batch certificate for number of bags constituting one dose), the next bag should only be thawed after the contents of the preceding bag have been infused.", "ParentId": "86a3ef3c-9230-48e3-8ca2-08d47f3e02a1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "db4cbf79-65c9-431c-a0a1-a5d59d6b2c9d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "408b6847-81f2-4bbf-9d38-dd64ad33a41e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "db4cbf79-65c9-431c-a0a1-a5d59d6b2c9d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah should not be manipulated. For example, Kymriah should not\nbe washed (spun down and resuspended in new media) prior to infusion.</span></p>", "ID": "f0484e2f-1fd0-4720-b2df-70385861f266", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah should not be manipulated. For example, Kymriah should not\nbe washed (spun down and resuspended in new media) prior to infusion.</span>", "ID": "b1409ace-ae54-4e4b-882d-fa165a471301", "Styles": "None", "Classes": "None", "Text": "Kymriah should not be manipulated. For example, Kymriah should not be washed (spun down and resuspended in new media) prior to infusion.", "ParentId": "f0484e2f-1fd0-4720-b2df-70385861f266"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "afda6424-7b32-4db9-b2bf-aec844146e6a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2b249f93-7edf-456c-a759-e414299b9c91", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "afda6424-7b32-4db9-b2bf-aec844146e6a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The infusion bag(s) should be examined for any breaks or cracks\nprior to thawing. If the infusion bag appears to have been damaged or to be\nleaking, it should not be infused and should be disposed of according to local guidelines\non handling of biological waste.</span></p>", "ID": "1cdbe090-2da1-41e6-85f2-2bd8cd91f8aa", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The infusion bag(s) should be examined for any breaks or cracks\nprior to thawing. If the infusion bag appears to have been damaged or to be\nleaking, it should not be infused and should be disposed of according to local guidelines\non handling of biological waste.</span>", "ID": "42697175-7ff6-4798-ad5d-a244c0c4a21f", "Styles": "None", "Classes": "None", "Text": "The infusion bag(s) should be examined for any breaks or cracks prior to thawing. If the infusion bag appears to have been damaged or to be leaking, it should not be infused and should be disposed of according to local guidelines on handling of biological waste.", "ParentId": "1cdbe090-2da1-41e6-85f2-2bd8cd91f8aa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8ac1d107-6d39-4bb0-ae0a-330818bf61e9", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dcfc2860-c123-4dd5-8c03-aa87a7e74c3d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8ac1d107-6d39-4bb0-ae0a-330818bf61e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u></p>", "ID": "83c3c10e-0242-45fc-99f9-57f4e085f446", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Administration</span></u>", "ID": "4a2028b2-d5dc-4aa4-a4cb-6680de0a6543", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "83c3c10e-0242-45fc-99f9-57f4e085f446"}, {"Element": "<span lang=\"EN-GB\">Administration</span>", "ID": "6323c1c2-d09d-437e-b83e-059d47d1fa04", "Styles": "None", "Classes": "None", "Text": "Administration", "ParentId": "4a2028b2-d5dc-4aa4-a4cb-6680de0a6543"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah intravenous infusion should be administered by a healthcare\nprofessional experienced with immunosuppressed patients and prepared to manage\nanaphylaxis. </span><span lang=\"EN-GB\">Ensure that one dose of tocilizumab per\npatient and emergency equipment are available prior to infusion and during the\nrecovery period. </span><span lang=\"EN-GB\">Hospitals should have access to\nadditional doses of tocilizumab </span><span lang=\"EN-GB\">within 8\u00a0hours</span><span lang=\"EN-GB\">.</span></p>", "ID": "551997d2-a1bf-44ba-91a4-c4c2d0292fea", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah intravenous infusion should be administered by a healthcare\nprofessional experienced with immunosuppressed patients and prepared to manage\nanaphylaxis. </span>", "ID": "68d5291d-0835-42be-a5b9-5e214bc390d7", "Styles": "None", "Classes": "None", "Text": "Kymriah intravenous infusion should be administered by a healthcare professional experienced with immunosuppressed patients and prepared to manage anaphylaxis. ", "ParentId": "551997d2-a1bf-44ba-91a4-c4c2d0292fea"}, {"Element": "<span lang=\"EN-GB\">Ensure that one dose of tocilizumab per\npatient and emergency equipment are available prior to infusion and during the\nrecovery period. </span>", "ID": "245a3b57-5652-489b-8e8a-7e5d17b49b54", "Styles": "None", "Classes": "None", "Text": "Ensure that one dose of tocilizumab per patient and emergency equipment are available prior to infusion and during the recovery period. ", "ParentId": "551997d2-a1bf-44ba-91a4-c4c2d0292fea"}, {"Element": "<span lang=\"EN-GB\">Hospitals should have access to\nadditional doses of tocilizumab </span>", "ID": "0103a048-1c79-40fc-9a6d-bce13a30950c", "Styles": "None", "Classes": "None", "Text": "Hospitals should have access to additional doses of tocilizumab ", "ParentId": "551997d2-a1bf-44ba-91a4-c4c2d0292fea"}, {"Element": "<span lang=\"EN-GB\">within 8\u00a0hours</span>", "ID": "dada9bfe-528c-40e6-96ce-379a6a8093b6", "Styles": "None", "Classes": "None", "Text": "within 8\u00a0hours", "ParentId": "551997d2-a1bf-44ba-91a4-c4c2d0292fea"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "603ff6d5-b0cf-4740-83a6-8ac29671c697", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "551997d2-a1bf-44ba-91a4-c4c2d0292fea"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bba37f1e-f610-4cdf-a16a-fb598f2a0403", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4efc79ab-5674-4e65-b02a-9bd0e963fbab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bba37f1e-f610-4cdf-a16a-fb598f2a0403"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">The patient\u2019s identity should be matched with the patient\nidentifiers on the infusion bag. </span><span lang=\"EN-GB\">Kymriah is for\nautologous use only. Kymriah should be administered as an intravenous infusion\nusing latex\u2011free intravenous tubing without a leukocyte depleting filter,\nat approximately 10 to 20\u00a0mL per minute by gravity flow. All contents of\nthe infusion bags should be infused. Sterile sodium chloride 9\u00a0mg/mL\n(0.9%) solution for injection should be used to prime the tubing prior to\ninfusion as well as rinse it afterwards. When the full volume of Kymriah has\nbeen infused, the infusion bag should be rinsed with 10 to 30\u00a0mL sodium\nchloride 9\u00a0mg/mL (0.9%) solution for injection by back priming to ensure\nas many cells as possible are infused into the patient.</span></p>", "ID": "2ead5efd-b3bb-49c1-8066-d547835a2490", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">The patient\u2019s identity should be matched with the patient\nidentifiers on the infusion bag. </span>", "ID": "ed484e61-3399-4b1e-b6a7-a1c17686c75d", "Styles": "None", "Classes": "None", "Text": "The patient\u2019s identity should be matched with the patient identifiers on the infusion bag. ", "ParentId": "2ead5efd-b3bb-49c1-8066-d547835a2490"}, {"Element": "<span lang=\"EN-GB\">Kymriah is for\nautologous use only. Kymriah should be administered as an intravenous infusion\nusing latex\u2011free intravenous tubing without a leukocyte depleting filter,\nat approximately 10 to 20\u00a0mL per minute by gravity flow. All contents of\nthe infusion bags should be infused. Sterile sodium chloride 9\u00a0mg/mL\n(0.9%) solution for injection should be used to prime the tubing prior to\ninfusion as well as rinse it afterwards. When the full volume of Kymriah has\nbeen infused, the infusion bag should be rinsed with 10 to 30\u00a0mL sodium\nchloride 9\u00a0mg/mL (0.9%) solution for injection by back priming to ensure\nas many cells as possible are infused into the patient.</span>", "ID": "ad127afd-978e-4add-8bfe-4086d48d5a73", "Styles": "None", "Classes": "None", "Text": "Kymriah is for autologous use only. Kymriah should be administered as an intravenous infusion using latex\u2011free intravenous tubing without a leukocyte depleting filter, at approximately 10 to 20\u00a0mL per minute by gravity flow. All contents of the infusion bags should be infused. Sterile sodium chloride 9\u00a0mg/mL (0.9%) solution for injection should be used to prime the tubing prior to infusion as well as rinse it afterwards. When the full volume of Kymriah has been infused, the infusion bag should be rinsed with 10 to 30\u00a0mL sodium chloride 9\u00a0mg/mL (0.9%) solution for injection by back priming to ensure as many cells as possible are infused into the patient.", "ParentId": "2ead5efd-b3bb-49c1-8066-d547835a2490"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f3b247dd-d355-4ab8-a155-1117287d5467", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "49cb560c-dfaf-499a-be1e-688a0d2e2670", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f3b247dd-d355-4ab8-a155-1117287d5467"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Precautions to be taken before handling or administering Kymriah</span></u></p>", "ID": "6e2e53d6-874f-458c-b784-8ffaffab1f24", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<u><span lang=\"EN-GB\">Precautions to be taken before handling or administering Kymriah</span></u>", "ID": "42bffddb-020d-4c0b-b927-0adebd913d6b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6e2e53d6-874f-458c-b784-8ffaffab1f24"}, {"Element": "<span lang=\"EN-GB\">Precautions to be taken before handling or administering Kymriah</span>", "ID": "d76348f6-369f-4226-a701-a4d0f25741d8", "Styles": "None", "Classes": "None", "Text": "Precautions to be taken before handling or administering Kymriah", "ParentId": "42bffddb-020d-4c0b-b927-0adebd913d6b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah contains genetically\u2011modified human blood cells. Local\nguidelines on handling of biological waste should be followed for disposal.</span></p>", "ID": "d5f41c07-b5a7-4418-81c5-e51f73492225", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah contains genetically\u2011modified human blood cells. Local\nguidelines on handling of biological waste should be followed for disposal.</span>", "ID": "754b199c-5745-4b4d-8c79-2e4f7aab4ba9", "Styles": "None", "Classes": "None", "Text": "Kymriah contains genetically\u2011modified human blood cells. Local guidelines on handling of biological waste should be followed for disposal.", "ParentId": "d5f41c07-b5a7-4418-81c5-e51f73492225"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "892d0bbb-774a-4726-afd2-271e1dc5b195", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9fc39a73-cbed-4177-a187-120eabfc60ef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "892d0bbb-774a-4726-afd2-271e1dc5b195"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">All material that has been in contact with Kymriah (solid and liquid\nwaste) should be handled and disposed of as potentially infectious waste in\naccordance with local guidelines on handling of biological waste.</span></p>", "ID": "8e255ddb-4460-4dbe-98bb-885456843692", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">All material that has been in contact with Kymriah (solid and liquid\nwaste) should be handled and disposed of as potentially infectious waste in\naccordance with local guidelines on handling of biological waste.</span>", "ID": "e13921b2-af6b-4760-a7db-6ca06c50471d", "Styles": "None", "Classes": "None", "Text": "All material that has been in contact with Kymriah (solid and liquid waste) should be handled and disposed of as potentially infectious waste in accordance with local guidelines on handling of biological waste.", "ParentId": "8e255ddb-4460-4dbe-98bb-885456843692"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "038d873f-eadd-45b5-b7e2-d435e3786c85", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f2282d28-0c43-468e-bf30-9d0b548b3085", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "038d873f-eadd-45b5-b7e2-d435e3786c85"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah should be transported within the facility in closed, break\u2011proof,\nleak\u2011proof containers.</span></p>", "ID": "a06e94c9-d003-4e6c-9447-44d20693ae3a", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah should be transported within the facility in closed, break\u2011proof,\nleak\u2011proof containers.</span>", "ID": "1900b1ef-8067-4565-b340-57cdf9d82399", "Styles": "None", "Classes": "None", "Text": "Kymriah should be transported within the facility in closed, break\u2011proof, leak\u2011proof containers.", "ParentId": "a06e94c9-d003-4e6c-9447-44d20693ae3a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f00ccf52-88f9-4e4a-9bdc-e0b695d6079d", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3486cce8-a776-4c99-b466-fa7a5b51fb4c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f00ccf52-88f9-4e4a-9bdc-e0b695d6079d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\">Kymriah is prepared from autologous blood of the patient collected\nby leukapheresis. Patient leukapheresis material and Kymriah may carry a risk\nof transmitting infectious viruses to healthcare professionals handling the\nproduct. Accordingly, healthcare professionals should employ appropriate\nprecautions (wearing gloves and glasses) when handling leukapheresis material\nor Kymriah to avoid potential transmission of infectious diseases.</span></p>", "ID": "9d1e5d2e-872e-49b2-860c-6aed429b061e", "Styles": "margin-right:-.1pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">Kymriah is prepared from autologous blood of the patient collected\nby leukapheresis. Patient leukapheresis material and Kymriah may carry a risk\nof transmitting infectious viruses to healthcare professionals handling the\nproduct. Accordingly, healthcare professionals should employ appropriate\nprecautions (wearing gloves and glasses) when handling leukapheresis material\nor Kymriah to avoid potential transmission of infectious diseases.</span>", "ID": "b99bbfaf-35bd-4148-9339-6234ee198250", "Styles": "None", "Classes": "None", "Text": "Kymriah is prepared from autologous blood of the patient collected by leukapheresis. Patient leukapheresis material and Kymriah may carry a risk of transmitting infectious viruses to healthcare professionals handling the product. Accordingly, healthcare professionals should employ appropriate precautions (wearing gloves and glasses) when handling leukapheresis material or Kymriah to avoid potential transmission of infectious diseases.", "ParentId": "9d1e5d2e-872e-49b2-860c-6aed429b061e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e330e08-b820-4366-b3a8-0af4132bcb17", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fa248be5-e55e-4243-9779-a5e681e0dcb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aec744bc-2ece-4526-94b0-7a1b43cc0212", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e330e08-b820-4366-b3a8-0af4132bcb17"}]}